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Commencement address to the Class of 1985 
RESPONSIBILITY 
by Howard Levitin, M.D. 
A short while ago, amid the pomp and ceremony of a marvelous 
tradition. President Giamatti on behalf of Yale University, 
conferred on you the degree of Doctor of Medicine and said, “I 
admit you with all its rights and responsibilities.” 
I would like to spend the next few minutes sharing with you my thoughts on the 
need to maintain a proper balance between the rights and responsibilities of the 
medical profession. It is easy to accept the rights and privileges of your profession, 
and rightly so, for you have worked hard, demonstrated your competence and 
commitment and deserve to enjoy the reward of your effort. 
But, it is equally important to keep ever-present in your mind that the 
responsibilities of your profession are a crucial part of your life and career. 1 will 
dwell more on the need to meet these responsibilities, not to put things out of 
balance, but because it is important to constantly remind ourselves of our 
obligations. 
There are four components of our responsibilities as members of the medical 
profession: 
1. responsibility to ourselves 
2. responsibility to our patients 
3. responsibility to our profession 
4. responsibility to society 
RESPONSIBILITY TO OURSELVES 
You owe it to yourself to enjoy the fruits of your labor, to take pride in your 
profession and to enjoy a very good standard of living, It is equally important that 
you have time for your personal and family life. While being dedicated to your 
work, you should not feel that medicine is an impediment to a good life. Rather, it 
should be complementary to a full and complete realization of your goals in life. 
At the present time, much criticism is being leveled against the medical 
profession, to such a degree that I begin to sense a feeling of guilt among my 
colleagues and young physicians like yourself. For whatever reason society has 
been motivated to diminish its long standing respect, if not reverence for the 
profession, we have nothing to be ashamed of. Modern medicine, through both 
basic research and health care delivery, is doing remarkable things, and the future 
bodes well for further rapid advances in our understanding of biologic function 
and the technology required to apply this knowledge to the good of our patients. 
You are well prepared to take your place in the profession and to participate in the 
continuing battle against disease and human suffering. You have a responsibility 
to continue your education and to keep pace with the progress medicine will make 
during your professional career. 
Balance is the key. Neither be obsessed with the need to be 100 percent 
committed to your work with the inevitable toll it will take on your personal and 
family life, nor allow the prestige and remunerative aspects of the profession to 
become an overriding influence. 
Enjoy the rewards and respond with a lifetime commitment to be a superb 
physician. 
RESPONSIBILITY TO YOUR PATIENTS 
I doubt that we could generate an argument about the 
fact that a good physician should be well informed, 
technically competent and genuinely concerned for the 
welfare of his her patients. But above and beyond this 
given, is the question of the role the patient should and 
can play in matters concerning their own health care and 
the manner in which they approach death. 1 encourage 
you to consider the doctor patient relationship, not as a 
high priest dealing with a supplicant flock, but rather as a 
partnership, with physician and patient working together 
towards the common goal of good health. In this 
partnership, each makes an important contribution in the 
prevention, management and cure of disease and when, 
as is inevitable, dying and death have to be reckoned 
with, the wishes of the patient become an integral part of 
medical management. 
I am unimpressed with the argument that patients do 
not want, or are ill-prepared for this degree of involvement 
in their care. Nor is the argument that meaningful and 
informed decisions require an extensive medical back¬ 
ground. The contribution that the patient can make is not 
a substitute for, or competitive with the medical expertise 
of the physician, but rather, a crucial supplement. Nor is 
involvement in their own care an additional and unde¬ 
sirable emotional burden. I submit that the anxiety 
associated with not knowing and not being involved is 
even greater. Don't let false pride prevent you from 
saying, "I don’t know,” and from sharing the truth, and 
planning treatment with your patients. 
All too often, this subject is placed in the context of a 
crisis situation with immediate life or death decisions, as 
exemplified by the Karen Quinlan case or other “should 
we pull the plug?” situations. While these are important 
dilemmas, I would like to focus more on the role the 
patient should play in the day-to-day prevention and 
management of routine medical problems, and w ill take a 
minute to tell you of a personal experience that might 
help explain my position. 
I broke my ankle many years ago. In the emergency 
room, I was given strong sedation in anticipation of 
anesthesia for a closed reduction of a bad fracture. The 
orthopedic surgeon arrived accompanied by a resident. 
I Hiring the examination, he explained to the resident that 
they could elect to put on a short leg cast or a long leg 
cast He decided on a short leg cast because, he explained, 
I w ould w ant to get back to w'ork as soon as possible, and 
that I would be more mobile in a wheel chair and on 
crutches in a short leg cast. 
call marshalling all of my clouded senses and 
W hich will get me on the tennis court with the 
best chance of full function?” 
He icsponded, “ I he long leg cast, but it will be more 
inconvenient and uncomfortable.” 
As I drifted off into drug-induced oblivion, I muttered, 
“Put on the long leg cast.” 
With the very best of intentions, the surgeon erroneously 
thought that getting back to work would be my highest 
priority. I am happy to report that yesterday, I played 
tennis with a group of medical students and in no way 
embarrassed myself. My ankle is in perfect shape and I 
am forever grateful to that surgeon, and especially to the 
resident. 
The medical options in my case were entirely left to the 
physician. But, because two options existed, and the 
consequences of each carried different implications for 
life style, my contribution was terribly important to me. 
It was based on my needs, which could not have been 
fully appreciated by anyone else. 
There are many advantages to this partnership 
approach. The well informed, involved patient is more 
likely to comply with a jointly arrived at therapeutic 
regimen. There is much evidence in the literature to 
support this conclusion. 
I he well informed and involved patient is more likely 
to have a realistic appraisal of the likely outcome of a 
particular therapeutic or surgical intervention. Anger, 
frustration and disappointment will be minimized when 
the patient has been an informed contributor to his/her 
own care. 1 believe that the current malpractice crisis is 
based more in the anger and disappointment associated 
with unrealistic goals and a feeling of noninvolvement 
than in a sudden upsurge in suboptimal medical care. 1 
find it a paradox that in the over 35 years since 1 
graduated from medical school, the profession has 
acquired the knowledge and skill to do remarkable 
things, but paralleling this remarkable progress, society’s 
regard for the profession is somewhat less than we would 
like it to be. 
Informed consent, always used in the ad hoc situation 
for a particular invasive procedure, should be extended 
to cover the entire scope of medical practice. It begins 
w ith the first contact with your patient and continues for 
the duration of your contact. In this setting, the patient 
will, in a nonthreatening manner, gradually become 
accustomed to participation and will certainly be better 
prepared to discuss difficult decisions when they present 
in the future. It also sets the stage for the patient to let you 
know more about the values that will apply when a crisis 
develops or when decisions that affect life style have to be 
made. We have accepted the idea of a last will and 
testament, a declaration of our wishes concerning the 
disposition of our worldly possessions after we die. Why 
not have a first w ill and testament an opportunity in a 
non-crisis situation, over a period of time, to address the 
issue of the control of our most precious commodity 
—our own life? 
Dr. Howard Levitin, at the podium, addressed the 101 members of the medical Class of 1985 at 
commencement ceremonies held on the Harkness Green on May 24. 
RESPONSIBILITY TO THE PROFESSION 
Do not, as it is claimed the ostrich does, put your head in 
the sand and hope that the issues confronting the medical 
profession will go away. That is the one thing I can assure 
you will not happen. 
Over and over again, 1 hear about all of the bad things 
that are happening to medicine - new government rules 
and regulations, DRG’s, change in Medicare reimburse¬ 
ment, impaired physicians, malpractice inequities, and so 
on. These are important issues that must be addressed. 
In an address given many years ago to the Association 
of American Medical Colleges, Senator Edward M. Kennedy 
called attention to the rising concern for these same issues 
and beseeched the medical profession to get involved in 
proposing solutions or, he indicated, people far less 
aware of the nature of medical practice and with a vested 
interest that was not always compatible with that of the 
medical profession, would promulgate undesirable rules 
and regulations. Indeed, his wisdom and foresight have 
unfortunately come to pass. And, unless you get involved 
and the current state of affairs is not allowed to follow its 
present course, you might look forward to increasing 
control and restrictions, leading ultimately to medicine 
being declared a public utility under the control of a 
regulatory agency. 
Remember that, if and when you emulate the ostrich, 
the unique anatomical configuation required to get your 
head in the sand leaves you remarkably vulnerable. You 
should be concerned w ith your own continuing education 
and the education of the generation of physicians that 
will follow you. 
Medical schools are currently being asked to reevaluate 
the process of medical education. I think it is a good idea 
and, in fact, the education process should be under 
constant scrutiny. However, the call for reassessment 
flows from the absurd assumption that the problems now 
facing medicine can in some way be attributed to 
deficiencies in the method of recruiting and educating 
physicians. It seems that all of the evils that have befallen 
us will disappear if we reduce the amount of basic science 
teaching and include a sprinkling of humanities in the 
curriculum. 
I have trouble accepting the concept that teaching 
humanities (a wonderful idea for its own sake) will 
translate into making physicians more humane. Yale 
medical students and faculty can enjoy a degree of 
satisfaction from the recommendations of the GPEP 
report outlining new proposals that closely approximate 
the curriculum of our school. 
Do not be afraid of peer review when intelligently 
implemented. An effective stimulus to keep up-to-date, is 
in itself, an educational experience and can do much to 
restore confidence in the medical profession. 
You will not escape the issue of cost containment and 
the many secondary issues it raises. The availability of 
good and readily accessible medical care is at risk to 
become more and more a function of ability to pay. 
Regulations establishing fixed prices according to disease 
run the risk of making some patients more desirable than 
others. National Health Insurance, which may or may 
not be a good thing, will be a disaster if left exclusively to 
beaurocratic planning and implementation. 
But, most worrisome of all and potentially destructive, 
is the emergence of large corporate, stock beholden, 
medical industries. “Medicine for profit” will make 









margins important considerations, influencing decisions 
of hospital and health maintenance administrators. Even 
worse, and in my opinion, unconscionable, is the physician 
who has an entrepreneurial interest in the health facility 
w here he she practices. This must lead, at some point, to 
a conflict of interest when the decision to admit, duration 
of stay, and the type of procedures undertaken, translate 
into financial remuneration above and beyond fee-for- 
service. 
Please worry about this important issue. Keep your 
head above the ground. 
RESPONSIBILITY TO SOCIETY 
We are a well informed and concerned segment of our 
society. It is our responsibility to speak out on the broad 
issues that affect the health of our individual citizens and 
society at large. It is appropriate to address the issues of 
prevention and management of health problems. It is not 
a political statement that smoking is bad for your health, 
and I endorse the current practice of labeling cigarettes. 1 
also suggest that nuclear weapons and warheads be 
labeled, “Warning! Undoubtedly hazardous to your 
health”. Similarly, we must become more involved with 
the reasons behind and control of drug, alcohol and 
cigarette abuse. I he deleterious effect of air pollution, 
contaminated water supplies, indiscriminate use and 
disposal of toxic material must command our attention. 
But these are the obvious. I call on you to address the 
more subtle issue of chronic stress, the inevitable conse¬ 
quence of uncertainty, fear, unemployment and failure to 
achieve one’s ambition. We are excessively concerned 
with being number one. competing in a destructive 
manner for material acquisitions. 
I he very fear of survival in the current political climate 
is a health issue. I do not believe the call for available 
cyanide pills on college campuses was a well thought out 
plan that proponents felt should be implemented. It was a 
statement. “We are scared,"and being sacred is not good 
for your health. 
Violence has not been given its proper classification as 
a disease. We should reject violence as entertainment. 
One should not enjoy viewing or participating in violent 
actions. Child abuse, spouse abuse, rape and the assump¬ 
tion that \ iolence is a legitimate way to settle difference, 
are all too prevalent. 
Creed is an illness. I he behavior ol highly paid 
. ol General Dynamics, General Electric and 
I Mutton are manifestations of disturbed behavior, 
us pledge not to succumb to similar temptations, 
s a partnership with your patients can be useful, 
partnership w ith society lead to more effective 
ol such unresolved questions as definition of 
out ion ('I limited health resources, care of the 
indigent and care of the aged. Again, 1 would ask you to 
consider this partnership complimentary not competi¬ 
tive. We have the knowledge and technical competence, 
but everyone has a legitimate role to play in the moral and 
ethical issues we have yet to solve. 
In conclusion, let us temporarily put these issues aside 
for this festive occasion. You deserve the honor and 
pleasure of successful completion of your studies and 
entry into the medical profession. Test and enjoy the title 
“Doctor”, now permanently prefixed to your name and 
share with your family and friends their justifiable pride. 
I know you will all appreciate, especially your parents, 
your transition from paying and indebted student to 
(modest as it may be) wage earner. 
However, the issues addressed today evolve, and 
whatever changes come about, 1 am confident of one 
thing — society will always hold good health as a top 
priority and want excellent medical care. The medical 
profession will continue to offer dedicated men and 
women the opportunity to use their intellectual and 
technical skills in the service of humanity. 
You have chosen well, worked hard and achieved your 
goal. History tells us that in spite of anxiety about your 
forthcoming adventure as a resident, you will do well. 
Congratulations and best w ishes! 
Dr. Levitin, professor of medicine, was associate dean from 
1966 to 19H5. 
CLOSING IN 
ON CANCER 
Dr. Sara Rockwell, professor (adjunct) 
of research in therapeutic radiology, 
(above) is conducting research on the 
use of perfluorochemicals — a chemical 
solution with properties similar to blood 
plasma —in combination with 
radiotherapy to improve treatment of 
solid tumors which are resistant to even 
the best of current treatment. 
T his article is excerpted from a 
forthcoming brochure People 
Conquering Cancer prepared by Marion 
E. Morra, assistant director, with Paula 
A. Wilson, staff assistant, of the Yale 
Comprehensive Cancer Center. 
Photographs are by William Carter. 
Established in 1974, the Yale Cancer Center is one of twenty 
Comprehensive Cancer Centers in the U nited States designated 
by the National Cancer Institute to bring together the best in 
research, diagnosis, treatment and prevention. The Center gives 
to Connecticut and its surrounding states, strong programs in 
basic sciences which are translated rapidly into patient care and treatment. 
Talented and caring individuals, conducting research at the Yale School 
of Medicine and the Yale-New Haven Hospital, are the mainstays of our 
staff and programs. World authorities in the cancer field are here, along 
with patients from Connecticut as well as from cities and towns around the 
nation and from many countries overseas. New national figures in the 
cancer field are created here —with radiation therapists, medical oncolo¬ 
gists and laboratory investigators, trained at the Center, having assumed 
leadership roles in major institutions around the country. 
We are in a particularly exciting and hopeful time in the field of cancer 
research. Discoveries in molecular and cell biology are forging the way to 
an understanding of the basic mechanism by which normal cells turn into 
cancerous ones, supplying new leads towards earlier diagnosis and new 
approaches to therapy which ultimately will lead to a cure for all cancers. 
Our scientists are actively pursuing these and many other areas. Looking 
at oncogenes involved in transforming cells and using this knowledge to 
find new approaches to treatment. Developing new and unique drugs to 
use in combinations which will attack specific kinds of cancerous cells. 
Finding drugs that will have fewer side effects on normal cells. Characterizing 
new radiation treatments in combination with chemotherapy to more 
effectively attack cancer. Devising precise surgical procedures for removing 
tumors. Creating new ways to diagnose cancer earlier. Originating 
strategies in cancer prevention. 
The statistics are also reflecting our new knowledge. Cancer is no longer 
a death sentence — there are more people living with cancer today than 
dying from it. And over half of patients with cancer are being cured of their 
disease. Here at the Cancer Center at Yale, new approaches devised by the 
best talents in scientific research are combined with the compassion and 
commitment of a caring team of doctors, nurses, technicians, social 
workers, dieticians and other professionals. 
Dr. Alan C. Sartorelli 
director of the Yale Comprehensive Cancer Center 
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“Cancer pharmacology . . . 
it’s fertile soil for testing new 
ideas. ” 
—Dr. John Lazo, 
associate professor of pharmacology 
“Our lab is a group of scientists ... its 
location in the Comprehensive Cancer 
Center allows us to bridge the clinical and 
basic research areas, ” said Dr. Lazo. 
“There are very few institutions in this 
country where clinicians can work side by 
side with laboratory scientists. At the 
Cancer Center, we’re physically located next 
to clinical facilities. We have ready access to 
human tumor cells for our studies. Our 
laboratories are within easy reach of the 
doctors who are working with patients and 
we talk with them regularly. We listen to 
their ideas and observations and try to use 
this information in a novel way to 
formulate new therapies, design new drugs 
and test new ideas that could have 
immediate or long-term benefits to 
patients, it’s an exciting and dynamic 
arena in which to do modern cancer 
pharmacology.” 
Much of the work of these research 
scientists has focused on anticancer drugs 
that come from natural products — fungi 
or other organisms — which are very 
difficult to study because they are 
complicated molecules. Bleomycin and 
Adriamycin are examples of 
chemotherapeutic agents which are natural 
products. Drugs made from natural 
products have been one of the most rapidly 
growing classes of compounds in the last 
ten years, and they now represent some of 
the most useful anticancer agents. 
Dr. John S. Lazo 
Dr. Alan C. Sartorelli, professor of pharmacology and director of the center, 
(right) reviews scientific data on new chemotherapeutic agents with 
Dr. Krishnamurthy Shyam, associate research scientist. 
Some of the leaders in the world of chemotherapy research are found in 
Yale’s Department of Pharmacology. Collaborating with scientists in 
medical oncology, they use biochemical and molecular principles to 
innovate new methods of treating cancer. Major advances in the develop¬ 
ment of many of the chemotherapy drugs which today are changing the 
cure rates for thousands of cancer patients around the globe, have come 
from the laboratories of these Cancer Center researchers. 
Dr. Sartorelli’s team is seeking to devise new approaches to treat 
leukemia and other cancers, specifically developing treatments to convert 
cancer cells through maturation to adult non-cancerous cells which are not 
capable of growth. They are using chemical agents to regulate the growth 
of cells by turning a cancer cell into a cell that behaves more like a normal 
one. That is, to make it stop reproducing itself. Research at Yale has 
already demonstrated that this approach works in the test tube. 
With scientists in the Department of Therapeutic Radiology, they are 
searching for biochemical differences between hypoxic cancer cells cells 
that don’t have much oxygen and normal cells that can be exploited with 
therapeutic agents. This information is being used to develop a new group 
of drugs that will preferentially attack these oxygen-deficient cancer cells. 
These drugs will be administered to patients in combination with x-rays 
and other chemotherapeutic agents to allow greater chances for cure. 
Dr. Joseph R. Bertino, professor of medicine and pharmacology, and 
his colleagues are involved in three major areas of investigation: designing 
new anticancer drugs, especially some which would work against the 
vitamin, folic acid, which is necessary for cell growth; trying to 
understand how anticancer drugs work so they can be used more 
effectively in patients; and determining what happens within a cell that 
allows it to become resistant to chemotherapeutic agents. 
Dr. Robert E. Handschumacher, professor of pharmacology, has 
recently isolated a receptor for the drug cyclosporin A, the treatment 
widely used to prevent rejection of transplanted kidneys and other organs. 
He reasoned that since cyclosporin acts on a specific part of the immune 
system T -cells - it might work on patients who have T-cell leukemia or 
related diseases such as mycosis fungoides. His laboratory work spawned 
an unexpected finding: that colon cancers have high concentrations of the 
receptor for cyclosporin. The question of whether these laboratory findings 
will translate into a treatment for patients will be answered through a 
clinical trial conducted by physicians in Yale’s medical oncology clinic. 
“Clinical research is a bridge . . it’s taking care of patients using 
the newest treatments we're discovering in our laboratories 
Dr. Joseph R. Bertino, associate director for clinical research, 
Yale Comprehensive Cancer Center 
Being in the forefront in clinical research means applying to the bedside 
what the finest minds are innovating in basic research. At Yale everyone 
involved in the development of new anticancer drugs works together 
—from the first experiment at the laboratory bench right through to 
treating a patient in the clinic. 
It was at Yale in early 1942, that pharmacologist Dr. Alfred Gilman, 
working with Dr. Gus Lindskog, discovered that the chemical warfare 
agent nitrogen mustard could shrink tumors, giving birth to a new cancer 
science — chemotherapy. 
Fifteen years ago. Dr. Bertino, associate director for clinical resarch at 
the Cancer Center, and an internationally renown medical oncologist, 
and Dr. Morton Kligerman, who at the time, was chairman of the 
Department of Radiology, pioneered the use of x-rays and combination 
chemotherapy for treating Hodgkin’s disease, after noting that many 
patients in remission relapsed in the area of their original tumors. He and 
Drs. James Fischer and Leonard Prosnitz in the Department of Thera¬ 
peutic Radiology, studying the kinetics of the disease in the laboratory, 
decided to give low-dose radiation following chemotherapy treatment. 
Research of this type has made a difference in the cure rate for advanced 
Hodgkin’s disease, which has risen dramatically from 40 to 70 percent. 
Today, clinical research continues at Yale — in designing different 
combinations of drugs, in using special substances to protect normal 
tissues, in developing new chemotherapy agents, and in testing monoclonial 
antibodies and biological response modifiers. The collaboration of pharma¬ 
cologists, biochemists, toxicologists, chemists and medical oncologists, 
working elbow to elbow from the test tube to the patient’s bedside is what 
makes the Yale Comprehensive Cancer Center special. 
In the Section of Gynecologic Oncology, 
patient care is only part of the effort — the 
group is recognized nationally for research 
conducted on several forms of cancer. 
“Tumor markers are particularly 
important with ovarian cancer patients,” 
said Dr. Peter E. Schwartz, director of the 
Section. The markers tend to become 
positive well before there is any medical 
evidence of the disease. 
“We started doing one of the first studies 
in the world looking at the possibility that 
the common cancer of the ovary might 
respond to estrogen,” he explained. “We 
first presented the data in 1978, which 
showed that about half of the common 
cancers of the ovary have estrogen 
receptors. Subsequently, we demonstrated 
that they also contained progesterone 
receptors.” Using tamoxifen, an 
antiestrogenic agent. Dr. Schwartz was 
able to arrest the growth of very rapidly 
growing cancers for periods of three to 
seven months in patients who were not 
expected to have the disease controlled at 
all. 
Other avenues of research include the 
use of new drugs combined with radiation 
therapy to treat cancer of the cervix, work 
with pharmacologists on more effective 
ways to use tamoxifen in advanced ovarian 
cancer patients and studies on a new 
category of endometrial cancer w ithin the 
cell lining of the uterus that, under the 
microscope, looks exactly like ovarian 
cancer. 
“Tumor markers — substances 
in the blood that can tell us if 
cancer has come back before we 
can measure it in other ways — 
are one of the most exciting 
discoveries in the last few 
years. ” — Dr. Peter E. Schwartz, 
director, Section of Gynecologic Oncology 
Dr. Bertino examines a patient with lymphoma whom he has treated with new 
combinations of chemotherapy drugs. 
“The Department of Therapeutic Radiology includes one of the major basic science 
research groups in the country, working towards improving results of radiation therapy. ” 
Dr. James J. Fischer, professor and chairman, Department of Therapeutic Radiology 
Below, a dosimetry package prepared for 
shipment to one of the numerous hospitals 
that call upon Yale's Section of 
Radiological Physics to plan radiation 
treatment for their patients. 
Complex calculations, using a computer, 
are needed to determine doses of radiation 
for each patient, with x-rays often beamed 
from several different directions in order to 
kill the tumor while sparing damage to 
healthy tissues. The Department of 
Therapeutic Radiology specializes in this 
exact science, called dosimetry, and is 
often called upon by hospitals around 
Connecticut and out of state to plan this 
sophisticated mapping. “A physician wires 
us a diagram of the patient’s shape and the 
location of the tumor,” explained Dr. 
Robert J. Schulz, professor of therapeutic 
radiology and chief of the Section of 
Radiologic Physics. Dr. Schulz and his 
colleagues make the calculations and send 
back a prescription for the doctor to carry 
out. “We were one of the first places in the 
countn to specifically train dosimetrists,” 
he said. Students with degrees in one of the 
phssical sciences enter the program and 
arc taught this new specialty. 
Dr. Schulz also directs the Eastern 
' i nter for Radiological Physics, which is 
onsihle for assuring that the dosimetry 
f ir radiation therapy performed at 80 
Is in the northeast meets current 
•r(* for accuracy and is reproducible 
r vtended periods of time. 
The Department of Therapeutic Radiology, one of the oldest and 
largest in the country, treats more than 1,700 new patients a year at the 
Robert E. Hunter Radiation Therapy Center at the Yale-New Haven 
Medical Center, the Phelps Center at the Uncas-on-Thames Hospital in 
Norwich, Connecticut, and the West Haven Veterans Administration 
Hospital. 
“The Department includes one of the major basic science research 
groups in the country, working towards improving results of radiation 
therapy,” said Dr. Fischer. “We have an extremely broad view of what is 
relevant to radiation therapy, and have attempted to mount a research 
effort which covers activities from molecular biology to clinical trials.” 
One advantage of this kind of program is that discoveries made in the 
laboratory may be more quickly applied to patient care. 
For instance, researchers are attempting to overcome the problem of 
hypoxic cancer cells —cells which do not have an adequate supply of 
oxygen. These cells, known to be resistant to radiation occur in tumors 
because a patient’s blood supply is not sufficient to keep up with the rapid 
growth of the tumor. 
Scientists in the Developmental Therapeutics Program of the Department 
of Pharmacology predicted that certain chemotherapy drugs would 
preferentially kill hypoxic tumor cells. They worked with members of the 
Radiobiology Group to show that in animals, these drugs, combined with 
radiation, destroy both tumor areas — those with and without an adequate 
supply of oxygen. This concept has been used to treat patients with 
advanced head and neck cancer and is showing significant improvement in 
tumor control. The successful outcome is a result of cooperation among 
individuals in various fields of basic and applied laboratory research and 
clinical research. 
Dr. Fischer (center) and Dr. Timothy Mate, senior resident in therapeutic 
radiology, discuss a procedure with their patient, who is being treated for 
esophageal cancer. 
The National Cancer Institute recently awarded Yale a program project grant of $3.3 
million for studies by members of the Section of Immunology on the regulation of 
immune response. Dr. Charles A. Janeway, professor of pathology and biology 
(above), is the principal investigator. 
Basement membranes. Epithelial carcinomas. Oncogenes. Receptor mole¬ 
cules. Antigens. Monoclonal antibodies. Tumor necrosis factor. These 
are the tomorrow terms, excitedly discussed by the basic research 
scientists — the group deeply engrossed in the mystery of what makes a 
cell become cancerous and in studying the basic workings of the body to 
solve the cancer riddle. 
Dr. James D. Jamieson, chairman of the Department of Cell Biology, 
and his colleagues, are interested in basement membranes — particularly 
how a tumor cell is able to form a ‘hole’ in the layer of cells, escaping the 
normal boundaries to move through the body and attach itself to another 
layer of cells to form a new tumor. 
“We are also studying epithelial cells,” Dr. Jamieson said. “These cells 
form tissues that cover a surface or line a cavity of the body and act as the 
first line of communication and defense between the external environment 
and the interior of the organism.” 
Epithelial cells are important, since nearly three-quarters of tumors that 
kill — such as breast, lung and prostate cancers — are epithelial tumors. 
Chemotherapy drugs have been most effective against rapidly dividing 
cells, but not against these slow-growing tumors. A very basic question is 
being asked: what is responsible for the growth of epithelial tumors? The 
answer could make a major impact on the future of cancer treatment. 
Dr. Sherman Weissman and the investigators in the Tumor Virology 
Program are looking at the ways tumor viruses grow; how genes express 
themselves, and how gene products affect cells to make them turn into 
cancer cells. Some investigators are doing fundamental studies on the 
regulation of cell proliferation. Others are doing research on cell surface 
antigens — markers which can be used to detect cancer and to deliver 
cancer treatment. Dr. Peter Lengyel, professor of molecular biophysics 
and biochemistry, and his colleagues are investigating the mechanisms 
involved in the action of interferons — protein-like biological regulators 
and other lymphokines. Interferons are part of the body’s defenses 
against infection of a large variety of viruses, and also control the activity 
of the immune system and the growth of cells. They accomplish these 
functions by activating several genes. The Virology Program, representing 
seven departments, is internationally recognized for its pioneering roles in 
introducing new concepts for understanding the basic behavior of cells. 
“Programs in basic research 
— cell biology, tumor virology, 
developmental therapeutics and 
immunology — are closely connected. 
We think it's essential not only for 
these different basic research 
investigators to work together, 
but also to be involved with what's 
happening to human cancer. " 
— Dr. Sherman M. Weissman, 
associate director of basic sciences, 
Yale Comprehensive Cancer Center 
Current research in the Section of 
Immunology is based on the premise that 
cancer cells are distinguishable from 
normal cells, according to Dr. Charles 
Janeway. The immune system detects 
infectious agents and rejects them as 
foreign. 
“It has been known for many years that 
cancer cells are also detectably foreign to 
the immune system,” said Dr. Janeway. 
"However, it is also clear that the immune 
system fails to respond appropriately to 
transformed immune system or cancer cells 
that give rise to tumors.” 
The Yale group, initially directed by the 
late Dr. Richard K. Gershon, has 
hypothesized that some of these failures to 
respond to cancer cells may reflect the 
immune system’s own regulatory signals, 
usually invovled in preventing the system 
from destroying normal self cells. In 
cancer, this regulatory apparatus may also 
block the destruction of the tumor cells 
themselves. 
Using techniques of immunology, 
protein chemistry and molecular genetics, 
Dr. Janeway and his colleagues have 
succeeded in showing that the body does 
indeed have a specific apparatus for 
regulating or suppressing the responses of 
the immune system. However, the detailed 
mechanics of this regulatory system are 
poorly understood, and none of the 
molecules that these cells produce have 
been purified, nor have the genes that 
encode them been identified. 
In current work, the team is using an 
interdisciplinary approach to 
characterizing these products, in order to 
learn how to control them. Effective 
manipulation of the immune system by 
these means could have far-reaching 
implications both for cancer and for other 
immune system disorders. 
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“Cancer prevention at the Cancer Center at Yale has a two- pronged approach — basic epidemiological 
research and carrying out programs for preventing or controlling cancer by early diagnosis 
and by changing our lifestyles. ” 
Melanoma is rising at an alarming rate, 
second only to lung cancer in women. . .it’s 
now one of the most common cancers in 
people born after 1950. 
The Cancer Center's Melanoma Unit is 
among the top three in the country, seeing 
patients from all over the world. Here, 
individuals who are at high risk for 
melanoma are screened. Doctors and 
laboratory researchers map and 
photograph the moles, they biopsy both 
the most abnormal and the most normal in 
patients with a history of melanoma to 
detect and help establish differences 
between normal and cancerous moles. 
The Melanoma Unit, established in 1978 
by Dr. Kirkwood, is a multidisciplinary 
effort, involving medical oncologists, 
surgeons, dermatologists, pathologists, 
pharmacologists, epidemiologists and 
diagnostic imagery . 
The Melanoma Unit has been a pioneer 
in developing new treatments for 
melanoma, including a major continuing 
research effort in the field of interferons, 
biological molecules produced by the body 
to fight against disease. It is joining seven 
other institutions in the country to test the 
use of chemotherapy and interferon in 
combination to treat melanoma. 
Immunologists and oncologists 
associated with the unit are also 
experimenting with biological and 
chemical agents which might change 
melanoma cells, making them into more 
normal ones. In addition, there is ongoing 
research using antibodies to detect and to 
treat the disease. I)r. Kirkwood noted that 
"With the use of diagnostic imaging, we 
can label an antibody with radioactive 
isotopes and trace its localization to the 
tumor. We can perhaps find metastases 
'hut are undetectable by other means in 
patients who have had melanoma. 
'll e re working together 
closely, collaborating in a way 
which is electric. ” Dr John M. 
Kirku i >< id. associate professor of medicine 
>r oj r/ic1 Melanoma l Hit 
Dr. Dwight T. Janerich, associate director for cancer prevention and control 
Dr. Dwight T. Janerich, associate director for cancer prevention and control, 
collaborates with Marion Morra, assistant director of the Cancer Center, on 
programs for preventing cancer in Connecticut residents who are at high risk. 
Much of what is known about cancer comes not only from the laboratory, 
but also from studies of people and how they live, which tell us many things 
about how cancer is caused and how we can prevent it. The Cancer Center’s 
new statewide program for cancer control research takes advantage of 
what is known about how certain cancers occur to find ways to prevent 
them altogether or diagnose them earlier, when they have a better chance of 
being treated successfully. 
Basic research in cancer epidemiology — the study of populations and 
disease demands painstaking accumulation of clues and bits of evidence. 
“For instance,’’said Dr. Janerich, “it is becoming increasingly clear, mainly 
through studying groups of people with colon cancer and those who don’t 
have this disease, that a diet high in bulk and low in fat can minimize the 
risk of getting it. We aren't sure why this happens, but we may be able to 
learn, through major research projects, how to change our eating habits 
and what to add or subtract to make a difference in colon cancer rates.” 
Forecasting what the cancer rates will be in Connecticut in the next 
century, through statistic modeling, is also a part of this research. “For 
epidemiologists, the human population is our laboratory,” continued Dr. 
Janerich. “We are fortunate that in this state we have 50 years of experience 
through the Connecticut Tumor Registry. More than 400,000 cases of 
cancer have been recorded and analyzed. Knowing how' cancer behaves in 
our population, we can forecast the kind and number of cancer cases we 
will have in the year 2000. This gives us time to prepare for these future 
correlations, or to intercede, if possible. 
Information in the Tumor Registry also gives the Cancer Center clues on 
what groups of people in Connecticut are at high risk for the various 
cancers. “With the help of institutions such as the Connecticut Department 
of Health Services, the University of Connecticut Health Center and the 
American Cancer Society, we can look at issues how to get women to do 
breast self-examinations each month, or why blacks have poorer survival 
rates than do whites,” explained Dr. Janerich. The new thrusts will help 
build a foundation for other statewide population-based studies to find 
innovative ways of controlling cancer. 
THE REVOLUTION 
IN MEDICAL DIAGNOSTIC IMAGING 
In just the last decade, the field of medical diagnostic 
imaging has entered into a new era with a dazzling 
spectrum of computer-based technology that has vastly 
improved diagnostic capability, and at the same time, 
created new roles for diagnostic radiologists. 
Computed tomography (CT) scans, first used in the 
1970’s to detect brain tumors, now scan the entire body, 
using computers to organize thousands of x-rays taken 
by a machine which rotates around the patient’s body. 
Recently, quantitative computed tomography (QCT) has 
been developed for a meaningful assessment of cortical 
and trabecular bone mass in vivo for the first time. 
In 1975, the first two grey-scale ultrasound machines 
commercially produced were installed for evaluation in 
San Diego and at Yale. The scans they produced required 
a vivid imagination to discern any detail, and were 
effectively useless in the abdomen, according to Dr. 
Kenneth Taylor, professor of diagnostic radiology, a well 
known leader in the field. “Real-time machines, intro¬ 
duced in 1980, have gradually improved to the superb 
imaging devices we now have, allowing prenatal diagnosis 
and numerous applications in the heart, abdomen, pelvis 
and neonatal brain.” 
Other modalities, including digital subtraction angio¬ 
graphy and Doppler and pulsed Doppler, have contri¬ 
buted to improved diagnosis, localization and determina¬ 
tion of the extent of disease. 
The newest diagnostic tool — and the one causing the 
most excitement — is magnetic resonance imaging 
(MRI). Without the use of ionizing radiation or intra¬ 
venous contrast material, the new technology has opened 
a whole new area of diagnostic imaging. Its unsurpassed 
contrast resolution enables discrimination of the individ¬ 
ual tissues comprising an organ. For example, grey and 
white matter can be distinguished in both the brain and 
the spinal cord. The spinal cord can be directly seen, in 
contrast to the mere shadow identified with myelography. 
Within the uterus, the glandular and muscular layers can 
be delineated. 
“We are doing a great deal of research with MRI 
because it is a new technique with the potential of 
becoming one of our best diagnostic tools,” said Dr. 
Richard H. Greenspan, professor and chairman of the 
Department of Diagnostic Radiology, who is recognized 
for his research in clinical MR imaging. With its MRI 
center soon to be completed, Yale will be one of the 
leaders in the country in MR research and patient 
diagnosis. 
As a result of the greatly improved imaging capabilties 
of these new diagnostic tools, radiologists, have become 
more involved in patient treatment. Drainage procedures, 
percutaneous needle biopsies, stone extractions, angio 
plasties and numerous other interventional procedures 
are performed under the guidance of imaging procedures. 
“Since these procedures can frequently be done on an 
out-patient basis, eliminating the necessity for surgery 
and long-term hospitalization in some cases, this trend 
will undoubtedly continue,” said Dr. Greenspan. 
“A major task which remains to be accomplished is to 
increase the specificity of imaging, thus permitting the 
differentiation of inflammatory disease, tumor, and so 
forth. Extensive research to provide greater specificity is 
being carried out at Yale,” he noted. 
The comfort of the patient, as well as safety are 
important considerations in this explosion of techno¬ 
logical advances in the field. Ultrasound and MRI have 
thus far not revealed any harmful effects, and other new 
techniques offer improved resolution of conventional 
radiographs with smaller doses of radiation to the 
patient. For patients who are unstable, portable x-ray 
units, ultrasound scanners and nuclear medicine cameras 
can be brought to the bedside. 
To achieve maximum results from this extraordinary 
progress in the field, a teaching and consultation program 
for integrated imaging has been developed at Yale. 
“Because of the large number of imaging procedures now 
available, it is necessary to avoid duplication and to plan 
a logical workup of individual patients,” explained Dr. 
Greenspan. “This requires prospective consultation be¬ 
tween the clinician and the radiologist. The choice of 
imaging procedures can no longer be delegated to 
individuals who are not familiar with the advantages and 
the limitations of various imaging methods,” he said. 
“In an attempt to use these modalities to their best 
advantage, we have initiated an innovative prospective 
consultation program. The program will also help to 
educate both the radiologists and the clinicians by 
providing evaluation of the clinical efficacy of the various 
imaging methods.” 
Yale's ultrasound section is one of the country 
leaders in developing blood flow ultrasound, a 
new method which may be useful in detecting 
cancer. 
FIG. 1 
Fig-1 1975 ultrasound scan reportedly shows septated, renal 
cysts. A vivid imagination is required. 
With improved diagnostic imaging techniques, the treatment of 
the fetus at risk in utero with medical or surgical therapy has 
become a reality. Surgical therapy, still under evaluation, has 
included placement of catheters to resolve an obstructive process 
such as hydrocephaly, and to treat the fetus with posterior 
urethral valve obstruction. The use of ultrasound in these 
procedures has eliminated the need for techniques involving 
radiation exposure to ensure proper placement of the catheters. 
One of the impressive results of improved diagnostic 
radiologic techniques is the use of echo cardiology for imaging 
fetal cardiac development. By first determining the structure of 
the normal feta! heart, Drs. Charles Kleinman, John Hobbins 
and Orvan Hess were able to discern fetal cardiac anomalies of 
the gross structure of the heart and ultimately, to study heart 
function and rhythvms. 
After analyzing the various fetal heart arrhythmias, Dr. 
Kleinman. associate professor of pediatrics and diagnostic 
radiology (in photo), developed a treatment for fetal non- 
immune hydrops, a condition long associated with interuterine 
death. To date 19 infants with this condition have been 
successfully treated at Yale. A fetal cardiovascular center was 
established here last spring for diagnostic procedures for 
pregnant women whose fetuses are at at cardiac risk. 
FIG. 2 
Fig.2 Currently, real-time ultrasound machines are available 
which produce dynamic images like a movie. This scan is a 
frozen frame from a real-time tape showing a section through 
fetal trunk. Huge disorganized renal masses are seen (arrows) 
with the aorta between them dividing into the iliac arteries 
below. These appearances indicate infantile, polycystic kidney. 
Fig-3 Continuous wave Doppler and pulse Doppler have 
introduced another modality to assess the presence of flow and 
to quantitate hemodynamic abnormalities. In this figure, 
Doppler wave forms are noted in many vessels around the liver. 
This allows noninvasive detection of perfusion in deep seated 
vessels, (courtesy Radiol) 
Fig. 4 CTscan demonstrating the intimalflap (arrow) in a 
patient with aortic dissection. This study obviated the need for 
arteriography, an invasive procedure. 
FIG 4 
Fig. 5 CT scan of the liver, demonstrating three percutaneously 







Fig. 6. Standard radiographs can only identify the degree of 
bone mass loss when it is as much as 30 to 50 percent. (Fig. 6A). 
Prior to quantitative computed tomography (QCT), evaluation 
of a bone biopsy was the most reliable method for measuring the 
extent of bone present (Fig. 6B). 
Drs. Pamela Jensen and Stylianos Orphanoudakis, associate 
professors of diagnostic radiology, developed a method using 
QCT to measure the bone mass of the distal radius (area 
between the lines in Fig. 6A). This technique permits the 
separate assessment of the thick bone on the cortex and the 
spongy trabecular bone. The computer identifies the high density 
CT values on the cross-sectional CT image corresponding to the 
cortex circled numbers in Fig. 6C, and creates a corresponding 
black line in the center of the cortex (Fig. 6D). The mean value 
of these numbers re flects the cortical bone mass. The trabecular 
bone mass is determined by averaging the CT values in the 
cortex; trabecular bone can then be compared with the normal 
values (Fig. 6E). In the example here, there is both cortical and 
trabecular bone loss due to osteoporosis. 
trtii le is based on material prepared by Hr. Greenspan and 




Fig. 7 Intra-arterial digital subtraction angiography (DSA ) 
demonstrating fine resolution. Note the presence of a small 
ulcerating plaque (arrow) near the origin of the left internal 
carotoid artery. 
Fig. 8A An abdominal aortogram of a 50-year old man with 
hypertension revealed a significant stenosis (arrow) at the origin 
of the left renal artery. 
Fig. 8B Inflated balloon of angioplasy catheter at the site of the 
renal artery stenosis. 
Fig. 8C Abdominal aortigram post-angioplasy indicates there is 
no residual stenosis, and the patient has subsequently become 
normotensive. 
Fig. 9 A Arteriogram demonstrates occlusion of the popliteal 
artery. Fibrinolytic therapy was instituted in place of surgery. 
Fig. 9B Arteriogram obtained 12 hours after local infusion of 
low-dose Streptokinase was instituted. The popliteal artery, 
which was thrombosed due to an aneurysm, has recanalized. The 
streptokinase was infused via a small catheter, the tip of which 
was initially embedded in the thrombus (arrow). 
FIG.8A FIG.8B FIG. 8C 
FIG. 9A 
A major task which remains to be 
accomplished is to increase the specificity 
of imaging. Extensive research in this area 
is being carried out at Yale. 
F1G.9B 
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Magnetic Resonance Imaging Unit enables the viewing of parts 
of the body previously unexplored by other techniques. 
"Magnetic resonance imaging can pick up tumors in locations 
that other technology cannot reach, such as the base of the skull, 
the spine and the pelvis. It's hard to see the soft tissue in these 
areas with a CT scan, but M RI shows it because you can't see 
the overlying bones,"explained Dr. Richard H. Greenspan 
(above) "It's also useful for tumors which have metastasized. " 
MRI, the newest tool in diagnosis, can examine 
soft tissues more clearly than bones. 
FIG II 
Fig. 11 Coronal MR scan through the chest and abdomen 
demonstrating right (RV) and left (LV) ventricles, right (RP) 
and left (LP) pulmonary arteries, and interventricular septum 
(arrow) of the heart, Also note the main portal vein (M) 
branching into the right and left lobes of the liver and the right 
(R) and left (L) hepatic veins. 
FIG 12 
Fig. 12 Coronal MR scan of abdomen showing hepatoma (H), 
high intensity area in right lobe, displacing inferior vena cava 
(large arrow). Note normal left lobe (L), spleen (S), aorta (A) 





Colleagues came from across the nation 
and from overseas on June 22 to pay 
tribute to Dr. Aaron B. Lerner at a 
symposium celebrating his three decades 
of dedication and outstanding accom¬ 
plishments as scientific investigator, clini¬ 
cian and administrator. A member of 
the Yale faculty since 1955, Dr. Lerner 
was appointed chairman when the De¬ 
partment of Dermatology was established 
in 1971 — a post he will hold until he is 
succeeded by Dr. Richard Edelson on 
January 1. 
Dean Leon E. Rosenberg gave the 
opening remarks of the day-long program 
presented by distinguished scientists. “His 
30 years at Yale have been full ones — as 
clinician, teacher, administrator and in¬ 
vestigator. Aaron and the colleagues he 
recruited made Yale’s dermatology pro¬ 
gram a premier one nationally — a 
model for others to praise and to compete 
with,” said Dean Rosenberg. 
“He interested a generation of medical 
students in academic or clinical careers 
in dermatology. He helped train derma¬ 
tology residents and fostered a collegial 
relationship between full time faculty 
and community practitioners without 
the town/ gown tensions so characteristic 
of other clinical specialties. 
“But most of all professionally, Aaron 
has been a scientist. He demonstrated 
his investigative acumen early — during 
medical school when he and Cecil Watson 
discovered the first patient with cryoglob¬ 
ulinemia and isolated the protein from 
serum. When, a few years later, he 
turned his attention to the field of cu¬ 
taneous pigmentation, he proceeded to 
make a series of major contributions 
including: early definition of the mecha¬ 
nism of enzymatic cleavage of phenyl¬ 
alanine and tyrosine; isolation and char¬ 
acterization of melanocyte stimulating 
hormone (MSH) and of melatonin; recog¬ 
nition of the universal nature of vitiligo 
in the animal kingdom; clues to the 
mechanism of action of MSH; and the 
development of experimental therapies 
for melanoma. This work, not surprising¬ 
ly, has brought Aaron considerable ac¬ 
claim, notably the Myron-Gordon Award 
for pigment cell research in 1969, election 
to the National Academy of Sciences in 
1973, and the Lita Annenberg Hazen 
Award for excellence in clinical research 
in 1981. . . 
“I’ll close by saying simply that as 
DR. 1 ERNER 
you, Aaron, prepare to embark on yet 
another phase in your remarkable life 
and illustrious career — that again of 
clinician/' scientist — we wish you every 
success, confident that you will continue 
to make lasting contributions to medi¬ 
cine, to science, to Yale, to your friends, 
and to your family,” Dean Rosenberg 
concluded. 
The symposium faculty included Julius 
Axelrod, Ph.D., chief. Section of Pharma¬ 
cology, Laboratory of Clinical Science, 
NIH; Jack D. Barchas, M.D., professor 
of psychiatry and behavioral sciences, 
Stanford University; Dr. Edelson; 
Thomas B. Fitzpatrick, M.D., professor 
of dermatology, Harvard University; 
Klaus Hofmann, Ph.D., University Pro¬ 
fessor of Experimental Medicine and 
Biochemistry, University of Pittsburgh; 
John A. Parrish, M.D., professor of 
dermatology. Harvard University; John 
A. Pawelek, Ph.D., senior research sci¬ 
entist, dermatology, Yale University; 
Sheldon R. Pinne, M.D., professor of 
medicine, Duke University; Kazuo 
Shizume, M.D., professor of medicine, 
Tokyo Women’s Medical College, and 
Richard J. Wurtman, M.D., professor 
of neuroendocrine regulation, M.I.T. 
Manuscripts based on talks presented 
at the symposium will be published in a 
forthcoming issue of the Yale Journal of 
Biology and Medicine. 
STUDENT RESEARCH 
FELLOWSHIPS 
ESTABLISHED IN HONOR 
OF TWO DISTINGUISHED 
LATE FACULTY 
The Dr. Vernon W. Lippard 
Student Fellowship in Pediatrics 
The William T. Grant Foundation of 
New York has made a $50,000 grant to 
the School of Medicine to establish the 
Dr. Vernon W. Lippard Student Fellow¬ 
ship in Pediatrics. The gift comes during 
the school’s $125 million capital cam¬ 
paign to increase its endowment, meet 
research and program needs and provide 
new and renovated facilities. 
This summer student research fellow¬ 
ship, one of several being established in 
the school, honors Dr. Lippard, who 
died in December 1984. For many years 
the distinguished medical educator, who 
was dean of the school from 1952 to 
1967, served as chairman of the William 
T. Grant Foundation’s Faculty Scholars 
Selection Committee. 
Dr. Robert H. Gifford, associate dean 
for medical education and student affairs, 
said that the new funds will support 
medical student research, adding, “Yale 
School of Medicine is a perfect place to 
generate excitement for student research 
because of the requirement that all stu¬ 
dents must complete a thesis in order to 
graduate, and because of the outstanding 
quality of our students.” Last summer, 
nearly 100 students remained in New 
Haven to work in various laboratories. 
This summer fellowship of $2,250 will 
be awarded annually to one or more 
students working on children’s behavior 
and development in either the Depart¬ 
ment of Pediatrics or the Child Study 
Center. Application deadline is April 1. 
The Richard K. Gershon 
Student Research Fellowship 
The School of Medicine has established 
the Richard K. Gershon Student Re¬ 
search Fellowship with gifts made in 
honor of the late physician-scientist. 
The endowed fellowship will enable a 
young man or woman to spend an extra 
year at the medical school and conduct 
research in the field of immunology or a 
related discipline. The school will present 
the first fellowship in July 1986. 
“We hope that this fellowship and 
others to come will stimulate medical 
students to pursue biomedical research 
careers and to remember Richard Ger- 
shon’s creative scholarship,” said Dean 
Leon E. Rosenberg. 
Dr. Gershon, who died at age 50 in 
July 1983, was professor of pathology, 





Dr. Richard L. Edelson, a noted clinical 
immunologist and teacher, has been 
appointed professor and chairman of 
the Department of Dermatology, effec¬ 
tive January 1, 1986. Dr. Edelson is 
professor and director of research. De¬ 
partment of Dermatology, Columbia 
University’s College of Physicians and 
Surgeons, and associate director of the 
General Clinical Research Center 
(GCRC), Columbia-Presbyterian Medi¬ 
cal Center. He succeeds Dr. Aaron B. 
Lerner, who has been chairman of the 
Department of Dermatology since its 
founding in 1971. 
“Since Rick Edelson graduated from 
the Yale School of Medicine, he has 
made outstanding individual research 
contributions and has skillfully directed 
research programs at Columbia. His com¬ 
mit ment to research, combined with his 
dedication to teaching and patient care 
are key attributes he will bring in leading 
the Department of Dermatology,” said 
Dean Leon E. Rosenberg. 
Dr. Edelson is recognized for his 
research on cutaneous T-cell lymphomas, 
a rare form of leukemia.A graduate of 
Hamilton College, Clinton, New York, 
he received his M.D. degree from Yale in 
1970. He spent the following year as an 
intern in internal medicine, University 
of Chicago Hospital and Clinics, and in 
1971 -72, was resident in dermatology at 
Massachusetts General Hospital. From 
1972 until 1975, he was research associate 
in the Laboratory of Immunology, Na¬ 
tional Institute of Allergy and Infectious 
Diseases, N1H. 
Dr. Edelson joined the faculty of 
Columbia University’s College of Physi¬ 
cians and Surgeons in 1976 as an assistant 
professor of dermatology. He was pro¬ 
moted to associate professor in 1978, 
and in 1983, was named professor and 
director of research in dermatology. He 
has been associate director of the GCRC 
at Columbia Presbyterian Medical Cen¬ 
ter since 1980. 
A member of the American Society 
for Clinical Investigation, he has received 
the Irma I Hirschl Career Investigator 
Award, the McKee Research Prize, and 
i he American Academy of Dermatology 
Scientific Exhibit Award. 
DR HE1RHOLZER 
DR. THIER NAMED 
PRESIDENT OF THE IOM 
Dr. Samuel O. Thier, a noted physician, 
educator, and health care administrator, 
has been selected to become the fifth 
president of the Institute of Medicine 
(IOM). Currently Sterling Professorand 
chairman of the Department of Internal 
Medicine at Yale, Dr. Thier was sworn 
into a five-year term at an inauguration 
during the IOM annual meeting in Wash¬ 
ington on October 16-17. Until January, 
he will be president-designate and will 
commute between posts at Yale and the 
IOM. In January, he assumes the IOM 
presidency on a full-time basis. 
The 650 member Institute of Medicine 
was chartered in 1970 by the National 
Academy of Sciences to enlist distin¬ 
guished members of medical and other 
professions to examine policy matters 
pertaining to the public’s health. As 
president. Dr. Thier will serve on the 
governing board of the National Re¬ 
search Council, the operating arm of the 
NAS and its sister organization, the 
National Academy of Engineering. 
Dr. Thier has been chairman of the 
Department of Internal Medicine since 
1975. During that time he has initiated 
improvement of the training of doctors 
in the field of clinical research and the 
establishment of a network of affiliated 
hospitals throughout southwestern Con¬ 
necticut for providing continuing educa¬ 
tion for internal medicine physicians. In 
addition, he has been responsible for 
initiatives to ensure that the shifting 
focus of medicine from hospital-based 
to more ambulatory care is reflected in 
the university’s residency program. 
The process of finding a successor to Dr. 
Thier as chairman of the Department of 
Internal Medicine is underway. Applica¬ 
tions and nominations are invited. 
Candidates must be qualified for 
faculty appointment at the rank of pro¬ 
fessor, and must be recognized leaders in 
the field with proven ability as scholars, 
clinicians, teachers and administrators. 
Appointment is to be effective July 1986 
or as soon thereafter as possible. Applica¬ 
tions should be submitted prior to Janu¬ 
ary 15, 1986. Qualified women and 
minority group members are encouraged 
to apply. Curriculum vitae and biblio¬ 
graphy should be sent to the Chairman 
of the Search Committee: Dr. Vincent 
T. Marchesi, Department of Pathology, 
Yale University School of Medicine, 333 




TO EPH FACULTY 
Dr. Burton H. Singer has been appointed 
professor of public health (biostatistics) 
and head of the Biostatistics Division in 
the Department of Epidemiology and 
Public Health, effective July 1. Prior to 
his appointment, he had been professor 
of mathematical statistics and since 1983, 
chairman of the Department of Statistics 
at Columbia University. 
Dr. Singer is recognized in academic 
and industrial communities for his broad 
range of statistical expertise in fields as 
diverse as demography, economics, socio¬ 
logy and epidemiology. A graduate of 
Case Institute of Technology, where he 
received his B.S. in engineering science 
in 1959 and his M.S. in mechanical 
engineering in 1961, he received a Ph. D. 
degree in statistics from Stanford Univer¬ 
sity in 1967. 
A member of the Columbia University 
faculty since 1967, Dr. Singer also has 
been adjunct professor at Rockefeller 
University since 1977. From 1979 to 
1981, he was visiting investigator in the 
Biostatistics Laboratory of Sloan-Ket- 
tering Institute for Cancer Research. 
A Fellow of the American Association 
for the Advancement of Science as well 
as of the American Statistical Associa¬ 
tion, Dr. Singer is a member of the 
editorial board of the Springer-Verlag 
Series, “Frontiers of Primary Medicine”, 
and is chairman of the Panel on Immigra¬ 
tion Statistics of the National Research 
Council, National Academy of Sciences. 
He also serves as chairman of the advisory 




Dr. Walter J. H ierholzer, J r., a U niversity 
of Iowa epidemiologist, has returned to 
Yale as professor of medicine and epidem¬ 
iology, and to Yale-New Haven Hospital 
as hospital epidemiologist. His appoint¬ 
ment was effective September 1. 
Dr. Hierholzer, who was at Yale for 
17 years as a student, resident physician 
and a faculty member, has been associate 
professor of medicine and preventive 
medicine at the University of Iowa Col¬ 
lege of Medicine and attending physician, 
consultant in infectious diseases and 
hospital epidemiologist at the University 
of Iowa’s Hospitals and Clinics since 
1976. He also was a consultant and 
hospital epidemiologist at the Veterans 
Administration Medical Center in Iowa 
City. 
At Iowa, Dr. Hierholzer developed a 
nationally recognized program in hospi¬ 
tal epidemiology. The program includes 
an infection control-quality assurance 
support service for which he and others 
developed a computerized infection data 
management system. An international 
corporation now markets the system. 
In addition, the program encompasses 
a regional education and consultation 
service that several Iowa state organiza¬ 
tions support. It serves all hospitals in 
Iowa and some in surrounding states. 
A native of Midland, Michigan, Dr. 
Hierholzer received a B.A. degree from 
Albion College and his M.D. degree 
from Yale in 1961; this was followed by 
residency training at Yale-New Haven 
Hospital. He is a member of Phi Beta 
Kappa and was a Fulbright Scholar to 
Denmark at the Biological Institute of 
the Carlsburg Foundation. 
In 1967, he joined the Yale faculty as 
an instructor in internal medicine and 
the following year, served a postdoctoral 
fellowship in pediatric infectious diseases 
and virology. Between 1970 and 1976, he 
held appointments at the School of 
Medicine, West Haven Veterans Admini¬ 
stration Hospital, and Yale-New Haven 
Hospital, where he served as hospital 
epidemiologist from 1973 to 1976. 
DR. RASTEGAR 
APPOINTED CHIEF OF 
MEDICINE AT VA 
MEDICAL CENTER 
Dr. Asghar Rastegar has been appointed 
associate professor of medicine at Yale, 
and chief of medicine at the West Haven 
Veterans Administration Medical Center. 
An outstanding teacher and administra¬ 
tor whose research interests are in renal 
physiology, he returns to Yale from the 
University of Colorado, where he was 
associate professor of medicine. 
Born in Shiraz, Iran, Dr. Rastegar 
received both his B.A. and M.D. degrees 
from the University of Wisconsin, and 
served his residency at the University of 
Pennsylvania, where he also served a 
renal fellowship and was chief resident 
in medicine. He then returned to Iran, 
where he became dean for academic 
affairs and a leading figure on the medical 
faculty of the Shiraz University School 
of Medicine (formerly Pahlavi Univer¬ 
sity). He spent a sabbatical year at Yale 
in 1977 as visiting associate professor in 
the Department of Internal Medicine. 
Dr. Rastegar spent the year 1983-84 at 
the West Haven VA Medical Center 
prior to his appointment at the University 
of Colorado, where in addition to his 
academic appointment, he was director 
of the residency program in the Depart¬ 
ment of Medicine, and chief of medical 





Dr. Alan H. DeCherney has been desig¬ 
nated the John Slade Ely Professor of 
Obstetrics and Gynecology. Nationally 
recognized for his work in infertility and 
in vitro fertilization. Dr. DeCherney is 
also Chief of the Section of Reproductive 
Endocrinology in the Department of 
Obstetrics and Gynecology. 
In addition to his research and clinical 
activities. Dr. DeCherney is an outstand¬ 
ing teacher. He has coordinated the 
residency program and resident educa¬ 
tion in obstetrics and gynecology at 
Yale-New Haven Hospital, and directed 
the Ambulatory Service Council there 
since 1974. 
A graduate of Muhlenberg College in 
Allentown, Pennsylvania, he received 
his M.D. degree from Temple University 
in 1967. He came to the School of 
Medicine in 1974 as assistant professor 
of obstetrics and gynecology as well as 
chief of the Section of Reproductive Endo¬ 
crinology. In 1979, he was promoted to 
associate professor and in 1984, he was 
appointed professor. Dr. DeCherney 
will assume his new title on January 1. 
The John Slade Ely Chair was estab¬ 
lished in 1906 to honor Dr. Ely, professor 
of medical theory and practice from 
1897 to 1906. The last incumbent of the 
chair was Dr. John McL. Morris, who 
became an emeritus professor in July. 
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LCI RENAMED 
TO HONOR DR. LIPPARD 
The School of Medicine’s Laboratory 
for Clinical Investigation has been 
renamed the Lippard Laboratory for 
Clinical Investigation to honor Dr. 
Vernon W. Lippard, who died last Decem¬ 
ber. The distinguished medical educator 
had been dean of the school from 1952 
to 1967 a time of phenomenal growth 
in its academic programs, faculty and 
facilities. 
Dr. Lippard considered the Laboratory' 
for Clinical Investigation one of his 
proudest accomplishments. Built in 1966 
to provide facilities for the growing 
research needs of the Departments of 
Medicine and Pediatrics, the 10-story 
glass and brick structure reflects his 
concept of the medical school as an 
“academic atmosphere where communi¬ 
cation between clinicians and basic 
scientists is easy and natural, and a line 
between the two is difficult to define.” 
FIVE BECOME 
PROFESSOR EMERITUS 
Five distinguished members of the Yale 
medical faculty retired on July 1, 1985. 
Dr. Elisha Atkins, professor of medi¬ 
cine, is one of the leading investigators 
in the world on the mechanism of fever 
production, and an outstanding clinician 
in the field of infectious disease. He 
received his M.D. degree from the Univer¬ 
sity of Rochester and joined the Yale 
faculty in 1955 after completing postgrad¬ 
uate training at Barnes Hospital and 
Washington University in St. Louis. Dr. 
Atkins also served as master of Saybrook 
College at Yale from 1975 until his 
retirement this year. 
Dean of the School of Medicine from 
1973 to 1984, Dr. Robert Berliner, pro¬ 
fessor of physiology and medicine, has 
been a member of the Yale faculty for 1i 
years. He is a graduate of Yale College 
and Columbia University College of 
Physicians and Surgeons. A world re¬ 
nowned authority on renal physiology, 
Dr Berliner, from 1950 until his appoint¬ 
ment as dean, was at the National Insti¬ 
tutes of Health and was its deputy 
director from 1969 to 1973. 
Dr. VV.W.L. Glenn, the Charles W. 
Ohse Professor of Surgery, has been a 
member of the faculty for 37 years. 
Appointed as an assistant professor in 
1948. He became Yale’s first cardiac 
surgeon; he developed and perfected 
mans early techniques for repair of 
congenital and valvular heart disease. 
More recently he has received interna¬ 
tional recognition for his innovative 
work on radiofrequency pacemakers to 
regulate the heart rate and also respira¬ 
tion. He is a graduate of Jefferson 
Medical College and completed his surgi¬ 
cal residency training at the Massachu¬ 
setts General Hospital. 
Former chief of the Section of Otolar¬ 
yngology, Dr. John A. Kirchner, profes¬ 
sor of surgery (otolaryngology) came to 
Yale in 1951 as an assistant professor 
and the first full-time chief of that 
section. He received his M.D. degree 
from the University of Virginia and 
completed his residency training at the 
Johns Hopkins Hospital. Dr. Kirchner 
soon became widely known in this coun¬ 
try and abroad for his research, which 
has focused especially on the larynx and 
laryngeal cancer. 
Dr. John McLean Morris, the John 
Slade Ely Professor of Gynecology, re¬ 
ceived his M.D. degree from Harvard, 
completed his residency training at the 
Massachusetts General Hospital, and 
was a Damon Runyon clinical research 
fellow at the Radiumhemmet in Stock¬ 
holm, Sweden prior to joining the Yale 
faculty as an associate professor in 1952. 
The gynecologic service here was devel¬ 
oped under Dr. Morris’ leadership. In 
addition to his contributions as an out¬ 
standing clinician, he has also received 
world-wide recognition for research in 
two distinct areas — treatment of gyneco¬ 
logic neoplasms and conception control. 
Dr. Morris has long been concerned 
about the hazards of unlimited popula¬ 
tion growth and the problems of popula¬ 
tion control. 
AWARDS TO FACUTTY 
AND HOUSE STAFF 1985 
The Francis Gilman Blake Award, pre¬ 
sented each year by the graduating class 
to the outstanding teacher of the medical 
sciences was awarded to Dr. Kenneth 
W. Barwick, associate professor of path¬ 
ology. 
Dr. James S. Grober, ’83, a resident in 
internal medicine, was selected by the 
senior class to receive the Betsy Winters 
House Staff Award, presented annually 
to the member of the house staff of Yale- 
New Haven Hospital who has made the 
most significant contribution toward 
the education of medical students. 
The Benedict Harris Award, estab¬ 
lished in 1967 to recognize the private 
physician who has contributed the most 
to the teaching of house staff, was pre¬ 
sented this year to Dr. Steven J. Mason, 
assistant clinical professor of medicine 
(cardiology). 
In addition. Dr. Mason was the recipi¬ 
ent of the first Meyer Etkind Prize, 
awarded to the community physician 
who, in the opinion of the house staff, 
provides the best clinical expertise and 
compassionate care to his or her patients. 
Dr. Mark Marieb, an intern in internal 
medicine, and Dr. Eric Winer, junior 
assistant resident in medicine received 
the Samuel D. Kushlan Awards, recog¬ 
nizing the intern and second-year resident 
who have contributed the most to patient 
care during rotation through the Memor¬ 
ial Unit Medical Service. Selection of 
recipients is made in consultation with 
the clinical faculty and nursing service. 
PROMOTIONS 
AND APPOINTMENTS 
The following members of the medical 
faculty were promoted to professorships 
effective July 1, 1985: Robert S. Adams, 
M.D., clinical professor in the Child 
Study Center; Leonard R. Farber, M.D., 
clinical professor of medicine; John N. 
Forrest, M.D., professor of medicine; 
Thomas W. Hansen, M.D., clinical pro¬ 
fessor of dermatology; Ravinder Nath, 
Ph.D., professor of therapeutic radiology 
(radiologicalphysics); Peter E. Schwartz, 
M.D., professor of obstetrics and gyne¬ 
cology; Dennis D. Spencer, M.D., pro¬ 
fessor of surgery; Robert K-J. Yu, Ph.D., 
professor of neurology; Joseph H. 
Zelson, M.D., clinical professor of 
pediatrics. 
New appointments at the rank of 
clinical professor, effective July 1985 
include Gerald W. Peskin, M.D., clinical 
professor of surgery, and Jack L. West- 
cott, M.D., clinical professor of diag¬ 
nostic radiology. 
The following associate professors 
have been awarded tenure appointments: 
Roland Baron, D.D.S., associate pro¬ 
fessor of surgery (orthopedic); Priscilla 
Dannies, Ph.D., associate professor of 
pharmacology; Ralph I. Horwitz, M.D., 
associate professor of medicine; Laura 
K. Manuelidis, M.D., associate professor 
of neuropathology; Nancy H. Ruddle, 
PhD., associate professor of epidemio¬ 
logy (microbiology), Allen C. Steere, 
Jr., M.D., associate professor of medi¬ 
cine, and Robert B. Tesh, M.D., associate 
professor of epidemiology. 
YALE AWARDED 
$3.5 MILLION TO 
ESTABLISH CENTER IN 
NEUROSCIENCE 
The National Institute of Neurological 
and Communicative Disorders and 
Stroke has awarded $3.5 million to Yale 
University to establish a Javits Center of 
Excellence in Neuroscience in the Section 
of Neuroanatomy. It is one of four 
centers to be established by NINCDS in 
honor of former U.S. Senator Jacob K. 
Javits. 
Dr. Pasko Rakic, chairman of the 
section and Dorys McConnell Duberg 
Professor of Neuroscience is principal 
investigator, and Dr. Patricia S. Gold- 
man-Rakic, professor of neuroscience, 
is co-principal investigator of the center. 
Selected from among 55 institutions, 
the Javits Centers of Excellence in Neuro¬ 
science will be devoted to fundamental 
biological issues of the nervous system 
structure and function. The center at 
Yale will focus on the development, 
plasticity and organization of the neo¬ 
cortex at the molecular, structural and 
functional levels. 
In man, the cerebral cortex constitutes 
by far the largest portion of the brain 
and is the key structure subserving human 
mentation and intellect. Dysfunction of 
the cortex is responsible for numerous 
neurological and psychiatric diseases. 
The N1H Javits Center Award, which is 
for five years, will allow application of 
the most advanced neurobiological tech¬ 
niques to the study of the neocortex. 
STUDY TO FOCUS ON 
INFECTION IN ELDERLY 
IN NURSING HOMES 
The Center for Disease Control has 
awarded two Yale School of Medicine 
professors a contract to conduct an 18- 
month collaborative study of the cause 
and complex nature of infections ac¬ 
quired by elderly residents of nursing 
homes. It is the first study of its kind in 
the country, according to CDC officials. 
Dr. David A. Pearson, associate dean 
and research scientist in public health, 
and Dr. Walter J. Hierholzer, professor 
of medicine and epidemiology and public 
health, plan to define the risks, determine 
who are vulnerable to the infections and 
identify infections which may be pre¬ 
vented in residents of the nation's 18,900 
skilled nursing homes. In addition, they 
intend to develop guidelines for preven¬ 
tion of infections acquired as a result of 
hospitalization or institutionalization (no¬ 
socomial infections. 
By the year 2000, 12 percent of the 
nation’s population will be 65 years or 
older, and life expectancy continues to 
increase. “More and more individuals 
will require temporary and long-term 
care in our nation’s extended care facil¬ 
ities,” said Dr. Pearson. “As a result, 
infection prevention and control are 
viewed as essential requirements for an 
acceptable standard of living for these 
residents.” 
Several known risk factors contribute 
to the infections that elderly persons 
acquire in nursing homes, where residents 
are predominantly female, white, wid¬ 
owed and over age 75. The risk for 
nosocomial infections include decline in 
immune response as people age, the 
burden of chronic underlying diseases, 
nutrition, physiologic changes, alteration 
in mental status and age-related changes 
in various diseases from which they may 
suffer. 
Drs. Pearson and Hierholzer believe 
that specific infection control procedures 
need to be developed for extended care 
facilities which differ from hospitals. 
For example, if nursing home residents 
need to be isolated, then reasonable and 
realistic procedures are needed which 
must represent a balance between risk of 
transmission and the need to maintain 
patients’ psychological and social inte¬ 
grity in the facility’s community. 
Within the past 15 years, hospitals 
with acutely ill patients have started 
programs to reduce infections that their 
patients acquire. However, few studies 
have been done on infections that may 
be acquired by those receiving chronic 
care in nursing homes. 
The Yale study, scheduled to be com¬ 
pleted in December 1986, will involve a 
random survey of 20 percent of the 
licensed, skilled nursing facilities in Con¬ 
necticut. 
SCHOOL RECEIVES 




Long recognized for its leadership in 
child psychiatry, the School of Medicine 
has received a grant of $400,000 from 
the National Institute of Mental Health 
for a five-year training program in child¬ 
hood neuropsychiatric disorders. Dr. 
James F. Leckman, associate professor 
of psychiatry and pediatrics is director 
of the program based in the Child Study 
Center. 
“A training program devoted exclu¬ 
sively to the education and training of 
clinical investigators in child psychiatry 
is urgently needed,” said Dr. Leckman. 
“While biomedical knowledge is expand¬ 
ing at an increasingly rapid rate, there 
are only a handful of active clinical 
investigators in child psychiatry who are 
able to translate new findings of basic 
research into relevant advances in clini¬ 
cal practice.” 
Three fellows will participate in the 
program during the first year, and in 
subsequent years there will be four, each 
of whom will remain in the program for 
two years. It is anticipated that one or 
two fellows will be physicians in child 
psychiatry or pediatrics; the remaining 
two or three will be postdoctoral fellows 
in developmental psychology, analytic 
neurochemistry or human genetics. 
The program will emphasize interdisci¬ 
plinary approaches to childhood neuro¬ 
psychiatric disorders such as infantile 
autism, Tourette’s syndrome, fragile X 
syndrome and attention deficit disorder 
with hypertension. “By focusing on these 
disorders, researchers in the Child Study 
Center have developed a range of clinical 
instruments and neuropharmacological 
and genetic strategies applicable across 
disorders,’’explained Dr. Leckman. “We 
also believe that understanding the mech¬ 
anisms underlying a particular set of 
behaviors as they occur in one syndrome 
hyperactivity, for instance — will 
increase our understanding of similar 
behavior in other disorders.” 
THE CLASS OF ’89 
Sixty-two men and 40 women entered 
the first year medical class in September. 
They are among the 2,619 students repre¬ 
senting 50 colleges who applied for 
admission, and the 199 who were ac¬ 
cepted for the class of 1989. 
Typically, the class is highly qualified 
academically, based on GPA and MCAT 
scores. Ivy League and West Coast 
colleges supplied the most students, and 
while almost all of them are entering 
after four years of college, 11 have 
masters degrees. Five of the new students 
are enrolled in the M.D./Ph.D. program. 
As in all previous classes, the majority 
of the class of 1989 majored in science as 
undergraduates, but 15 concentrated on 
the social sciences while others majored 
in the humanities. In addition to being 
excellent in their academic endeavors, 
they participated extensively in extra¬ 
curricular activities, especially in indepen¬ 
dent study or research. 
continued on page 22 
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PHYSICIAN ASSOCIATES 
HOLD 14th GRADUATION 
Twenty-three students graduated August 
19 from the Physician Associate Program 
at the School of Medicine. They were 
members of the 14th class to complete 
the 24-month program. 
Dr. Alan C. Mermann, chaplain of 
the school and clinical professor of 
pediatrics, delivered the commencement 
address “The lmpasto Experience”, based 
on the life of Vincent Van Gogh, during 
ceremonies held in Mary S. Harkness 
Auditorium. Dr. Mermann developed 
and taught the medical ethics course for 
the 1985 class. 
During the ceremony, several awards 
were presented. Dr. Richard D’Aquila, 
a fellow in the Section of Infectious 
Diseases, and a research fellow in the 
Departments of Therapeutic Radiology, 
Human Genetics, and Molecular Bio¬ 
physics and Biochemistry, received the 
Student Didactic Instructor Award. 
The Student Clinical Instruction 
Award was presented to the Department 
of Obstetrics and Gynecology at Bridge¬ 
port Hospital, a clinical site for Yale PA 
students for more than a decade. 
John Dailinger, a physician associate 
at the Yale Health Plan’s urgent visit 
area, received the Jack Cole Society 
Award, which is presented to an indivi¬ 
dual whom the class believes has made a 
significant contribution to their educa¬ 
tional program, as well as to their 
profession. 
Class of 1989, continued from page 21 
The geographical representation of 
this class, whose average age is 23 and a 
half, is wide ranging from Puerto Rico 
to Oregon. Sixty-two come from the 
East Coast, including 27 from New York 
state and nine from Connecticut; 17 are 
from the West Coast (14 from California). 
Eight students are foreign nationals, and 
there are I I black students and four 
Hispanic Americans. 
! he Department of Epidemiology and 
Public Health, which is an accredited 
school ol public health, registered 105 
students in its first year class — 79 
>men and 26 men. They come from 22 
is well as from Bangladesh, Brazil, 
(ihana, Iran, Spain, Switzerland and the 
of China. As undergraduates, 
:d in the sciences. Seventy- 
s and universities are repre- 
sented by this class of luture public 
AN OPPORTUNITY TO 
ASSIST IN 
UNDERGRADUATE 
MEDICAL EDUCATION IN 
CHINA 
There have been increasing contacts 
between medical schools in this country 
and The People’s Republic of China in 
the six years since the normalization of 
diplomatic relations between the two 
nations. One recent program involving 
the Yale School of Medicine, under the 
auspices of Yale-China Association’s 
Medical Exchange Program, provides 
medical school instruction in the English 
language to a group of selected medical 
students at Hunan Medical College in 
Changsha. 
With a firm background in the lan¬ 
guage, these students have received all of 
their medical classes in English. This 
“English Stream” program is a result of 
the success of the Association’s “Bachelor 
Program” of English instruction which 
was recently revived at the school, 
founded in 1914 as Xing-ya, with the 
help of the Yale School of Medicine and 
alumni. A goal of the program is to 
enable the next generation of Chinese 
physicians to have full access to medical 
advances, foreign training and collegial 
interactions on a global scale. 
The response of the Chinese medical 
students has been enthusiastic. Not only 
have they worked hard on their course 
material, but they have also responded 
warmly to new teaching styles of their 
American teachers. 
Opportunities exist for qualified physi¬ 
cians and basic scientists to offer units to 
undergraduate medical school students 
at Hunan Medical Collge. Periods of 
appointment are flexible, varying from 
four weeks to one semester. Travel is 
paid for by the Yale-China Association 
and living expenses are covered by Hunan 
Medical College. A small stipend for 
domestic travel in China is offered to 
those who teach a full semester, but no 
salary is provided. 
For further information, write or call 
Dr. William C. Summers, Department 
of Therapeutic Radiology, Yale School 
of Medicine, P.O.Box 3333, New Haven, 
CT 06510, (203/785-2980). 
MEDICAL STUDENTS 
RECEIVE AWARDS 
Terry Yee, a second year medical student, 
received the Richard K. Gershon Memo¬ 
rial Summer Student Fellowship of Re¬ 
search in Immunology. As the Gershon 
Fellow, he spent last summer working 
on B-Cell Differentiating Factor Recep¬ 
tor in the laboratory of Dr. Kim Bot- 
tomly, assistant professor of pathology. 
Douglas Black, a fourth year graduate 
student working toward a Ph.D. degree 
in molecular biophysics and biochemis¬ 
try, received a $22,100 Graduate Fellow¬ 
ship Grant from the General Electric 
Foundation. Working in the laboratory 
of Dr. Joan Steitz, professor of molecular 
biophysics and biochemistry, Mr. Black’s 
research is in the structure and function 
of small nuclear ribonucleoproteins in¬ 
volved in gene expression. 
Student Fellowships 
continued from page 17 
immunology and biology at Yale and a 
leader in the exploration of the immune 
system. In his original scientific research, 
he showed that the introduction of an 
antigen into the body produced not only 
the immunological attack on the antigen 
but also the participation of cells that try 
to prevent or suppress the immune re¬ 
sponse. His early work concentrated on 
tumor biology and research into the 
spread of cancer. 
“We deeply appreciate the generous 
contributions that Murray Gershon, 
Dick's father, and many other individuals 
have made to support this student re¬ 
search fellowship,” the dean added. 
Contributions came from more than 
300 donors, including Mr. Gershon of 
New York City, and Dr. Gershon's 
widow, Robyn Gershon, who is director 
of Yale Health Services’ Department of 
Biological Safety. Other gifts were made 
by Dr. Gershon’s family, former students, 
alumni, faculty, fellow research scientists 
and friends. 
The endowed fellowship carries a sti¬ 
pend of $ 10,000, plus a $ 1,000 allowance 
for research support. Any full-time med¬ 
ical student may apply after matricula¬ 
tion, and a special awards committee 
will select the recipient by March 1. 
I 
Faculty News 
Dr. Joseph E. Craft, assistant professor 
of medicine in the Section of Rheumatol¬ 
ogy, is one of 20 outstanding young 
scientists to be named the first Pew 
Scholars in the Biomedical Sciences by 
the Pew Memorial Trust of Philadelphia. 
The scholars were selected because of 
their outstanding promise in basic science 
or clinical research that will help advance 
human health. 
“These awards, presented for the first 
time, will enable accomplished scientists 
to develop their research further,” said 
Dr. Robert W. Berliner, director of the 
Pew Scholars program and professor 
emeritus of physiology and medicine at 
the School of Medicine, where the pro¬ 
gram is administered. In addition to the 
Pew Scholars Award, Dr. Craft received 
a grant from the Lupus Foundation of 
America, Inc. for his research on “Auto¬ 
antigens in Drug-induced Lupus.” 
For research to improve treatment for 
newborns and infants critically ill with 
cardiac or pulmonary disease. Dr. George 
Lister, associate professor of pediatrics 
and anesthesiology, has received a five- 
year Established Investigator Award 
from the American Heart Association. 
The American Heart Association, South 
Central Connecticut Chapter, has named 
Dr. William W.L. Glenn “Man of the 
Year,” recognizing his outstanding con¬ 
tributions to the AHA and to cardiology 
and cardiovascular surgery during the 
past 40 years. Dr. Glenn, Charles W. 
Ohse Professor Emeritus and senior 
research scientist in the Department of 
Surgery, was honored at a dinner on 
September 11. 
Angela R. Holder has been named presi¬ 
dent-elect of the American Society of 
Law and Medicine, a 5,000-member 
organization of lawyers, physicians, 
nurses and hospital administrators. Ms. 
Holder, who is counsel for medicolegal 
affairs at Yale-New Haven Hospital and 
clinical professor of pediatrics (law) in 
the School of Medicine, will become the 
society’s president in July 1986. A noted 
attorney and educator, she is the author 
of several books, including “Legal Issues 
in Pediatrics and Medicine” recently 
published in the second edition by Yale 
University Press. 
The International Society for Optical 
Engineering has presented its 1984 Kings- 
lake Award to Drs. Gene R. Gindi and 
Arthur F. Gmitro, assistant professors 
of diagnostic radiology, for their paper 
“Optical Feature Extraction Via the 
Radon Transform”. The paper, which 
was published in the September-October 
1984 issue of Optical Engineering”, was 
selected from over 141 highly qualified 
technical papers. 
Dr. Gilbert H. Glaser, professor and 
chairman of the Department of Neuro¬ 
logy, was elected an honorary member 
of The Academy of Medicine of Y ugosla- 
via (Croatia) last November, at which 
time he gave an inaugural address in 
Zagreb on “Modern Dynamic Neurology: 
the Search fo Brain Mechanisms”. 
Last fall, Dr. Glaser was visiting professor 
of neurology at Oxford University, con¬ 
ducting neurophysiological research at 
the Department of Experimental Psycho¬ 
logy and The Park Hospital (The Na¬ 
tional Center for Epilepsy in Children). 
For research leading to an understanding 
of how the cerebral cortex processes 
information. Dr. Mriganka Sur has re¬ 
ceived a grant of $100,000 from the 
National Science Foundation. In addi¬ 
tion, Dr. Sur, who is assistant professor 
of neuroanatomy, has been named a 
Sloan Research Fellow. The Alfred P. 
Sloan Foundation identifies and supports 
young scientists who have demonstrated 
special creative ability in the physical 
sciences, neuroscience and economics. 
Dr. Frank H. Ruddle, professor of bio¬ 
logy and human genetics, has been elected 
to the Institute of Medicine. He is known 
throughout the world for his pioneering 
research in mapping specific genes on 
chromosomes and more recently, for his 
work in transplanting foreign genes into 
animal embryos, which opened a broad 
range of possibilities for future studies 
of the chemistry of genetics. Dr. Ruddle 
is a member of the National Academy of 
Sciences and president of the American 
Society of Human Genetics. 
The American Association of Clinical 
Chemists presented the Award for Out¬ 
standing Contributions to Clinical Chem¬ 
istry in a Selected Area to Dr. Peter 
Jatlow, professor and chairman of the 
Department of Laboratory Medicine, in 
recognition of his research on the mea¬ 
surement and clinical pharmacology of 
psychotropic and psychotherapeutic 
drugs, including cocaine and the tricyclic 
antidepressants. Dr. Jatlow's laboratory 
was among the first to describe plasma 
cocaine concentrations after various 
routes of administration, and the relation¬ 
ship of various concentrations to beha¬ 
vioral changes. 
In celebration of the dedication of the 
Seoul National University Children’s 
Hospital October 17 and 18, Dr. Donald 
Cohen delivered the inaugural lecture, 
“The Contributions of Clinical Research 
to the Understanding and Treatment of 
Childhood Psychopathology”. While in 
Korea, Dr. Cohen, director of the Child 
Study Center and professor of pediatrics, 
psychiatry and psychology, gave special 
lectures at the annual meetings of the 
Korean Neuropsychiatric Association 
and the Korean Psychoanalytic Associa¬ 
tion. 
Dr. Perry L. Miller, assistant professor 
of anesthesiology, was a co-recipient of 
the Honeywell-Universita degli Studi di 
Pavia per l’Informatica(HUSPI) Award 
for research published between 1980 and 
1985 in Artificial Intelligence in Medi¬ 
cine. The award, presented at the Inter¬ 
national Symposium on. Artificial Intelli¬ 
gence in Medicine in Pavia, Italy in 
September, recognizes Dr. Miller’s re¬ 
search in developing expert computer 
systems which critique a physician’s plan 
for patient care. 
BOOKS BY FACULTY 
“House Officer Guide to ICU Care 
The Cardiothoracic Surgical Patient”, 
by John A. Elefteriades, M.D., assistant 
professor of surgery (cardiothoracic), 
and Alexander S. Geha, M.Dprofessor 
of surgery and chief of the Section of 
Cardiothoracic Surgery. Aspen Systems 
Corporation (Rockville, MD), 1985. 207 
pp, illus. 
“Surgeons at the Bailey. English Forensic 
Medicine to 1878", by Thomas R. Forbes, 
E.K. Hunt Professor Emeritus of Ana¬ 
tomy and senior research scholar in the 
history of medicine. Yale University 
Press (New Haven)1985. 352 pp. 
“The Kidney: Physiology and Patho¬ 
physiology”, Volumes 1 and 2, edited by 
Donald W. Seldin M.D. and Gerhard 
Giebisch, M.D., Sterling Professor of 
Physiology. Raven Press (New York) 
1985. 2,650 pp, illus. 
“The Patient: Biological, Psychological, 
and Social Dimensions of Medical Prac¬ 
tice”, second edition, edited by Hoyle 
Leigh, M.D., professor of psychiatry, 
and Morton F. Reiser, M.D. professor 
and chairman, Department of Psychiatry. 
Plenum Publishing Corporation (New 




Dr. Woodrow W. Lindenmuth, clinical 
professor of surgery, died on August 2, 
1985. He had been a member of the Yale 
School of Medicine faculty since 1956. 
Dr. Lindenmuth’s work on treatment 
of bleeding esophageal varices, especially 
prophylactic portacaval anastomosis, 
was a major contribution in this complex 
surgical field. 
A graduate of Pennsylvania State 
University and Jefferson Medical Col¬ 
lege, Dr. Lindenmuth was a surgical 
intern at Pennsylvania Hospital and had 
residency training at Boston City Hospi¬ 
tal, Bryn Mawr Hospital and at the E.J. 
Meyer Memorial Hospital in Buffalo, 
New York. From 1945 to 1956, he 
practiced surgery and held appointments 
at Pennsylvania Hospital and Jefferson 
Medical College in Philadelphia. 
In 1956, he was appointed the first 
full-time chief of surgery at the Veterans 
Administration Hospital in West Haven, 
and as an associate clinical professor of 
surgery at Yale. He held this post until 
1968, and during this time developed an 
outstanding teaching service. From 1968 
to 1973, he served as associate chief of 
surgery at Yale-New Haven Hospital 
and director of surgery in the Memorial 
Unit. He was promoted to clinical pro¬ 
fessor in 1971. 
Dr. Lindenmuth was a member of the 
American College of Surgeons, the East¬ 
ern Surgical Society, the New England 
Surgical Society and a past member of 
the Society of Alimentary Surgeons. 
Affectionately known by his many 
friends and associates as “Lindy”, he 
was described by a colleague as “the 
epitome of the compassionate physician, 
the thoughtful surgeon, the admired and 
emulated teacher, the steadfast, honest 
triend, and the loving, devoted husband 
and father.” 
Dr. Lindenmuth is survived by his 
wife, Virginia, and his two daughters 
and two grandchildren. 
JAMES D. HARDY, Ph.D. 
James Daniel Hardy, professor emeritus 
of physiology and epidemiology and 
public health, and director emeritus of 
the John B. Pierce Foundation Labora¬ 
tory. died at his home in Woodbridge on 
September 6 at the age of 81. 
Dr. Hardy was best known for his 
work on body temperature and its regula¬ 
tion. Trained as an astrophysicist at 
John Hopkins University, heapplied his 
knowledge of infrared spectroscopy to 
the measurement of heat radiation from 
the skin at the Russell Sage Institute of 
Pathology at Cornell Medical School. 
Foreseeing the imminence of war, he 
enlisted in the U.S. Navy prior to World 
War 11 and because of his knowledge of 
physics, was assigned to the M ine Sweep¬ 
ing School in England. He swept mines 
from the landing area of Normandy in 
front of the Allied invasion, and later 
retired from the Naval Reserve as a Rear 
Admiral. 
Meanwhile, in 1953 he moved to 
Philadelphia where he simultaneously 
was research director of the U.S. Naval 
Air Development Center's Aviation Med¬ 
ical Acceleration Laboratory (human 
centrifuge) at Johnsville, Pennsylvania, 
and was in charge of graduate studies in 
physiology at the University of Pennsyl¬ 
vania until 1961. By simulation of the 
forces of exit and reentry. Dr. Hardy 
trained the Apollo astronauts to fly the 
spacecratt using the human centrifuge. 
In 1961, Dr. Hardy assumed director¬ 
ship of the John B. Pierce Foundation 
Laboratory in New Haven, and was 
appointed professor of physiology and 
epidemiology and public health at Yale, 
posts he held until I974and 1973, respec¬ 
tively. During that time, he developed 
an active program of environmental 
physiology and health science, supported 
by the Pierce Foundation and govern¬ 
ment agencies. 
A native of Georgetown, Texas, Dr. 
Hardy received an A.B. degree, magna 
cum laiule in 1924, and an M.A. degree 
in 1925. both from the University of 
Mississippi at Oxford, and a Ph.D. 
degree in 1930 from the Johns Hopkins 
University. A member of Phi Beta Kappa 
and Sigma Xi. he was elected to the 
National Academy of Sciences in 1970. 
A lellow ol the American Academy of 
Arts and Sciences, he had been awarded 
honorary doctor of science degrees by 
the Kansas City College of Osteopathy 
and Surgery and from Southwestern 
University, and a donor honoris causa 
by the University ol Lyon's Faculty of 
Medicine and Pharmacy. A.B.D.B. 
NEA MAE NORTON, M.S.S. 
Nea Mae Norton, clinical professor 
emeritus of psychiatry (social work), 
died on April 27. 1985 at the age of 78. 
She had joined the faculty of the Depart¬ 
ment of Psychiatry in 1947 at the invi¬ 
tation of Dr. Eugen Kahn and rose 
through the academic ranks from assis¬ 
tant professor to professor, the only- 
such appointment and honor awarded a 
social worker at Yale. 
During her more than 20 years of full¬ 
time activity. Ms. Norton contributed to 
the development and expansion of the 
department from a handful of full-time 
faculty members to well over 100. This 
development entailed the inauguation of 
three major services in addition to an 
intensive reorganization of the Yale Psy¬ 
chiatric Institute, the original clinical 
base of the department. Ms. Norton was 
involved in all of these innovative enter¬ 
prises, recruiting the staff and teaching, 
monitoring and supervising them through¬ 
out their tenures, in addition to teaching 
medical students, residents and other 
graduate trainees in psychiatric social 
work and psychology. She was a highly 
valued colleague who participated not 
only critically in these developments and 
the day-to-day services, but also in many 
research projects, initially w ith Drs. F.C. 
Redlich and Richard Newman on inter- 
view'ing, and later in family research and 
then, in various service analyses. 
In recognition of her final promotion 
an array of accolades was obtained from 
many leaders in psychiatry and social 
w'ork throughout the country; this dos¬ 
sier reads like a “Who's Who" of Yale 
graduates who have become leaders in 
academic psychiatry and mental health 
services. After her retirement, she main¬ 
tained an important presence in the 
academic and personal lives of members 
of the department until the past two 
years, when she was incapacitated by 
severe arthritis and complications. Her 
impact will also be felt by future genera¬ 
tions because her leadership and concepts 
of social work participation and contribu¬ 
tion to the care of the mentally ill remain 
guideposts for the future. S.F. 
! ALUM%ws 
ASSOCIATION OF YALE 
ALUMNI IN MEDICINE 
HOLDS ANNUAL 
BUSINESS MEETING 
As part of an outstanding Alumni 
Weekend, the annual business meeting 
of the Association was held on Saturday, 
June 8, with Dr. Nicholas Spinelli, presi¬ 
dent, as chairman. 
Following introductory remarks by 
Dr. Spinelli, Dr. Lawrence Pickett read 
obituary citations from the Association 
for two distinguished alumni: Dr. Vernon 
W. Lippard (’29), who served as dean of 
the school from 1952 to 1967, and Dr. 
Courtney C. Bishop (’30), who was chief 
of staff at Yale-New Haven Hospital 
from 1960 to 1973. 
After recognition of a number of 
senior alumni present from classes of 
1921 through 1929 and members of the 
55th reunion class of 1930, Dr. Spinelli 
presented special recognition awards to 
members of the 50th reunion class of 
1935 and welcomed the other five-year 
reunion classes of 1940 through 1980. 
Dean Leon E. Rosenberg reported on 
new appointments to the faculty and to 
the administration of the school. It was 
with special pleasure that he noted Dr. 
Spinelli had been appointed Director of 
Alumni Affairs. He also mentioned that 
search committees are looking for chair¬ 
men for the Departments of Dermato¬ 
logy, Neurology, Psychiatry and Surgery. 
The dean then briefly described new 
construction currently underway or 
planned. These projects include the Mag¬ 
netic Resonance Imaging Center, a new 
building for faculty ambulatory practice, 
expansion of the Medical Library, a new 
Yale Psychiatric Institute, the Eye Center 
for the Department of Ophthalmology 
and Visual Science, and a proposed 
building for the Center for Molecular 
Medicine. 
Following the dean’s report, the Nomi¬ 
nating Committee recommendations 
were presented by Dr. Gilbert Hogan 
and the following were elected by vote of 
the members present: President, Dwight 
Miller (’56); Vice President, Thomas 
Kugelman (’60); Executive Committee 
(each for a term of two years), Joseph 
F.J. Curi (’64), James Q. Haralambie 
(’35), Marie-Louise Johnson (’56), Patri¬ 
cia E. Wanning (’40), Muriel D. Wolf 
(’59). In addition, the following were 
elected as representatives to the Associa¬ 
tion of Yale Alumni (AYA), each for a 
three-year term: Edith M. Jurka (’44), 
Mohandas M. Kini (’65), and Warren D. 
Widmann (’61). 
Following the elections. Dr. Spinelli 
congratulated and cordially welcomed 
those newly elected. He also expressed 
appreciation and thanks to those who 
were leaving the Executive Committee; 
Susan S. Addiss(M.P.H. ’69), J. Roswell 
Gallagher (’30), Thomas P. Kugelman 
(’60), and Richard D. Otis(’49). Apprecia¬ 
tion was also expressed to Marie-Louise 
Johnson and Frederick North, Jr.,(’56) 
for their service as representatives to the 
AYA during the past three years. 
Dr. Dwight Miller, chairman of the 
Association’s Awards Committee pre¬ 
sented Distinguished Alumni Awards - 
Yale chairs with inscribed plaques — to 
Dr. Samuel Kushlanand Dr. J. Roswell 
Gallagher. Dr. Lowell Goodman, chair¬ 
man of the Yale Medical School Alumni 
Fund, then gave a most encouraging 
report which noted that over $300,000 
had been contributed to the Fund , and 
that the 1984-85 goal of $325,000 would 
be reached by June 30. 
At the conclusion of the meeting. 
Dean Rosenberg presented Dr. Spinelli 
with a Distinguished Service Recognition 
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by Alice A.S. Whittier 
The 60th reunion of the class of 1925 was 
unfortunately represented by only one 
member, Alice A.S. Whittier, class agent 
and class secretary. 
Waldo Desmond and his wife had 
planned to attend, but changed their 
plans. He expected to have an operation 
the following week. 
Howard Wood was honored recently 
at his 90th birthday and limits his tra¬ 
velling. Two members are in Florida and 
one is in Georgia. The other members 
did not supply news. 
1930 
55th Reunion 
by Paul Lavietes 
Of 23 survivors of our class, five came to 
New Haven with their spouses for Re¬ 
union Weekend and remained for dinner 
at the Graduates Club on Saturday. 
There were witty and informative talks 
by the new dean and the president of the 
Alumni Association during the annual 
meeting and also at the dinner. 
Seminars by distinguished faculty mem¬ 
bers in the forenoon Saturday were well 
received. There was much stimulating 
interchange between speakers and alumni 
at the annual meeting. 
Knox Finley and his wife Mary Lee 
came farthest from San Francisco, where 
he is still active as a neurologist and 
teacher. Ros Gallagher, who has served 
as chairperson of the committee for 
alumni bequests and endowments for 
years, has a home in New Haven and a 
vacation home in Nova Scotia, where he 
and his wife, Connie, are going for the 
summer. 
Jim Hart and I are almost completely 
retired in New Haven and Moe Lischner 
— in Bloomfield Connecticut. We are all 
fairly fit for our years, as are our wives, 
Peggy, Ruth and Frieda, respectively. It 
was good to join with them and chat 
about old times and recent changes. 
Leonard Greenberg, who taught us 
bacteriology in our preclinical years and 
then went on to get an M.D. degree with 
us, is retired in Long Boat Key, Florida. 
He informed me that he was 92 and his 
wife, 91, and that they could not travel 
to the reunion, much as he would like to 
do so. 
The family of the late Morris Krosnick, 
who was an associate clinical professor 
of pediatrics at Yale, has established an 
annual award to be given to the member 
of the Yale-New Haven Hospital Pedia- 
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tries House Staff who exemplifies the 
“caring, compassionate, and dedicated 
pediatrician.” This year’s recipient was 
Dr. Donald Schwarz. 
1935 
50th Reunion 
by Samuel Kushlan 
Eight members of the class returned for 
our 50th reunion. All were accompanied 
by their lovely wives except for James 
tiaralambie, whose devoted wife died 
recently after a long illness. We appreci¬ 
ated his coming so that we could express 
our appreciation for his decades of de¬ 
voted service as our class agent. Jim 
retired in 1978 to Southbury, Connecti¬ 
cut, after a notable career in pediatrics, 
retiring as clinical professor emeritus at 
Cornell, where he established the first 
pediatric neurology clinic. 
Walt Barney retired in 1982 after 
years of important service in and to 
Milford (Connecticut) Hospital, where 
he played a major role in its development 
and growth as chief of staff for ten years 
and chief of anesthesia for 20 years. 
Sawnie Gaston retired this year after 
an outstanding career in orthopedic and 
trauma surgery, fields in which he re¬ 
ceived national recognition, with most 
of his professional life spent at Columbia- 
Presbyterian in New York, retiring as 
associate professor of clinical ortho¬ 
pedics. More recently, he was actively 
involved in the development of electro¬ 
magnetic stimulation treatment of frac¬ 
ture non-union 
Howard “Jack” Horner retired in 1975 
after an unusual and rewarding career, 
first as a medical missionary in Zaire 
(then the Belgian Congo) from 1939 to 
1954; w hile there he became a fellow of 
the American College of Surgeons in 
1949, fulfilling the requirements under 
difficult conditions. He then returned to 
California to practice and to retire. 
Sam Kushlan retired in 1982 as associ¬ 
ate physician-in-chief of Yale-New Haven 
Hospital, where he continues to be active 
as consultant to the chief-of-staff and as 
clinical professor of medicine, he con¬ 
tinues to serve Yale Alumni in Medicine 
as co-chairman of the Bequests and 
Endowment Program, chairman of the 
former House Staff Alumni Fund Pro¬ 
gram, and alumni representative on the 
Medical School Council. 
Norman Rindge retired after an out¬ 
standing liletime of service to the popu¬ 
lace ot the Clinton-Madison (CT) area 
as family doctor par excellence in the 
best tradition of that great calling. When 
retired, I was present at the heart- 
irming testimonial to him by towns¬ 
people who turned out in the hundreds 
to honor him; it was common for several 
generations of a family to have been his 
devoted patients and to pay tribute to 
him on that memorable day. 
Clark Searle is about to retire after an 
eminent career in pediatrics. In addition 
to having been pediatrician-in-chief of 
the Maple Knoll Hospital in Wyoming, 
Ohio, he was also president for 40 years 
of the Wyoming Medical Center, which 
he organized. 
Walter Thompson retired in 1975 to 
summer in Old Lyme, Connecticut, and 
winter in Grenada, after a long and 
distinguished career in orthopedics in 
New York City. He had been chairman 
of orthopedics at New York University 
and Bellevue Hospital from 1950 to 
1975, having previously been chief-of- 
orthopedics at Walter Reed Hospital in 
Washington, D.C. 
We were the guests of honor at a 
beautiful and sumptuous banquet at the 
Graduates Club, tendered us by the 
School of Medicine. Present also w'ere 
several members of the Class of 1930, 
representatives of other classes, and mem¬ 
bers of the Executive Committee of the 
Alumni Association. Former Dean Rob¬ 
ert Berliner and his wife were present, as 
was Deputy Dean Arthur Ebbert, Jr. 
Larry Pickett ’44, former associate dean, 
was a great toastmaster. Dean Leon 
Rosenberg and his wife were present and 
he spoke graciously about our class. 
Nick Spinelli, ’44, retiring president of 
our Alumni Association and now director 
of alumni affairs, greeted us officially 
and warmly. Sawnie Gaston and I remi¬ 
nisced briefly about our class, as I 
presented each of them to the assembly. 
All in all, a very nice and heartwarming 
evening. 
Several members of the class, unable 
to attend, sent warm greetings: George 
Carden, Edward Carvey, Edward Falsey, 
Howard Groskloss, Mildred Hartshorn 
January, Dana Howe, Bascom Johnson, 
Graham Newbury, John Preece, Edmond 
Sinclair, and Samuel Zelman. Don 
Morris, also unable to attend, was joined 
by his wife in making a most generous 
endowment gift to our Alumni Fund as 
an expression of their devotion to and 




by Donald Johnson 
The 45th reunion was a thoroughly 
enjoyable time. T his report is concerned 
only with those in the Class of 1940 who 
returned for this event. Ron and Betty 
Beckett came down from Bloomfield, 
CT; both look exceedingly well. Betty 
says Ron is retired, and she is sure of this 
since he gets home at 8 o’clock rather 
than later. What a pleasant surprise to 
see Phil Breznia after 45 years; both he 
and his wife are revelling in diminished 
medical activity. Wy and Biddy Dean 
stayed with Jim and Izzy Ferguson. Wy 
looks the same as he did five years ago, 
and Jim is still running, playing tennis 
and generally enjoying retirement. Gene 
Fitzpatrick and his wife came to the 
class dinner at the Quinnipiack Club. He 
has retired from active practice and only 
sees patients on a limited consultation 
basis. Jack and Rosemary Haley came 
to the festivities. Jack had a coronary 
by-pass last year, following a “mild” 
cardiac episode and seems to have toler¬ 
ated it well. Other by-pass recipients 
present were Champ and Mary Louise 
Taylor and Joe and Nancy Sokol. Champ 
is completely retired and spends a good 
part of the year in Virginia where they 
have a retreat. Joe Sokol is still very 
active at Duke with his international 
chronic myeloid leukemia project. Joe 
and Nancy have one son back in West 
Africa and the second in Dallas, both in 
medicine. Hank and Ellen Humphrey 
were down from Ithaca; Hank is about 
ready for retirement in December. Eddy 
and Marty Martin, Jack and Eunie Ells, 
Joe and Eileen Zigarelli were all there 
and all looking so very well. 
Helen (Haury) Woods and husband 
Dick, came all the way from Corpus 
Christi, Texas, having visited along the 
way with friends and children. Pat (Emer¬ 
son) Wanning, still busy with her biofeed¬ 
back interests, was present as was Lee 
Sannella, who came from far-off Cali¬ 
fornia. Lee is still active with his projects, 
particularly those related to ecologic 
matters. Your obedient secretary, still 
very busy with the Red Cross as volunteer 
chairman of the board of directors. 
Blood Services, Northeast Region, can 
report that everyone seemed to enjoy 
returning to New Haven after these 
many years. All expressed the hope that 
at the next reunion — our 50th — we 
will have an extraordinary class turnout 
and a gala program planned. So you 
scientists in the class, you historians, get 
ready for a class of 1940 seminar program 
and write the trip off your taxes! 
1 cannot close this column with out a 
plea for information for future and more 
meaty columns, and a word of regret 
that many, if not all, members of the 
class of 1940 are painfully modest about 
speaking of themselves, their accomplish¬ 




by Frederic Blodgett 
The members of the class of 1945 held a 
most successful 40th reunion, thanks to 
the preplanning of Dick Breck, Al At¬ 
wood, and the assistance of the School 
of Medicine’s Alumni Office, Nick Spi- 
nelli (’44) and Connie Tolliver. 
The program included scientific and 
not so scientific experiences and recollec¬ 
tions. Dick Breck reviewed the war years 
at 333 Cedar Street in a most comprehen¬ 
sive manner with many warm recollec¬ 
tions of our relation to the war effort. 
James Mason (Reeves) told us of medical 
care in Sumatra, while George Naum berg 
described wine makingalongthe Hudson 
River and told us that he has developed 
a top-notch line of choice wines. Ed 
Daniels told us of some highly amusing 
and inspiring experiences during his 
four decades of psychiatry. Though many 
of the class are ready to consider and 
have even made the big step into retire¬ 
ment, Ed is convinced that we all have 
too much to teach the next generation 
and that retirement is not yet justifiable. 
Dick Peters shared with us his insights 
and concerns regarding the rapid changes 
in delivery of medical care. 
The class has produced a wide range 
of investigators, clinicians, directors, 
deans, chairmen, administrators in all 
medical specialties, now widely spread 
over the United States and the rest of the 
world. Not only have we been successful 
professionally, but of the 34 classmates 
who responded to our cards, we now 
know that 34 of the class have produced 
134 children, 92 grandchildren and look 
forward to increasing the latter figure. 
For a supposedly “forgotten wartime 
class”, it looks as though a great deal has 
been accomplished with more to come. 
The development of the School has 
been impressive and gives us confidence 
in the future of the institution and her 




by Lyal Asay and William Bucher 
“I’m sold! Sign me up for the 40th right 
now!” That’s what Margaret Lyman 
said at the end of the 35th reunion of the 
class of 1950 Yale School of Medicine. 
She’s attended five schools and never 
attended a reunion before! 
All who didn’t make it missed a great 
affair, but you were all sorely missed. 
After a day of lectures and meetings 
sponsored by the School of Medicine 
and interspersed with a marvelous compli¬ 
mentary festive luncheon, 1950 gathered 
for cocktails and dinner at Mory’s. Eigh¬ 
teen class members made it (34, including 
widows, sons and spouses). Tom F'erraro 
couldn’t make it but he sent his hand¬ 
some, charming son to take notes on us 
all. His son is an American history 
graduate student at Yale. Ruth Quinn 
Stewart, Bob's widow, brought Jeoffrey 
Quinn, their son, a charming young man 
who has been with Associated Press in 
Hartford, but is about to take a breather 
and write a book on the great conserva¬ 
tionists of America. He must have grown 
tired of us telling him how much he 
resembled the Bob we knew “in the good 
old days”, but he maintained that same 
warm, open interest in people that so 
characterized his father. 
After a fabulous dinner, class secretary 
Lyal Asay (ageless, handsome and witty!) 
conducted the class meeting. We elected 
Bill Delia to hold us all together for the 
next five years. So expect to hear from 
him and send him all news, complaints 
and inspired ideas! 
We talked lovingly of our members 
who are deceased. Jean Smith, Martin’s 
widow, read us a wonderful memorial 
tribute which had been read at the 
service for him in Gloversville, N.Y., 
and told us of a new hospital wing 
named in his honor. Kent told us of his 
last visit with Pat Dowling — a beloved 
general doctor in the waterfront area of 
Seattle; and Dave Frucht told us about 
the great dedication of Marina in her 
work as an ophthalmologist. He attri¬ 
butes the tremendous success of his own 
daughter in overcoming a congenital eye 
problem to the great skill and dedication 
of Marina. This daughter, against the 
early predictions of all other physicians, 
recently graduated from Yale College. 
Bill Delia spoke lovingly of his friend 
Fred “Bones" Vultee, and C.G. Gunn 
told of the death of Bill Newton, who 
was a very respected and beloved surgeon 
and teacher at George Washington Uni¬ 
versity Medical School 
We read letters sent by Milton and 
Betty Lesser, still practicing cardiology 
in Miami Beach; Butch and Peg Felmly, 
who were attending the graduation of 
their son at Jefferson Medical College; 
Bob Sturman, who has given up neurosur¬ 
gery in Waterbury for a more relaxed 
insurance consultant job in Detroit. 
Cynia Shirnm is still in psychiatry in 
Durham, N.C. —affiliated with Duke. 
One son is in radiation therapy at Univer¬ 
sity of Arizona Medical School; the 
other is an architect. 
O.J. Miller writes that he has no 
thought of retiring. He’s just started a 
whole new career as head of Molecular 
Biology at Wayne State University. Dan¬ 
ny and Anita Fine are going to retire to 
half-time medicine, but true to a lifelong 
commitment to making the world a 
better place for us all, they are planning 
to work the other half of their time on 
advancing world nuclear disarmament! 
Jan Lindner and John Strauss couldn’t 
make it either, but they sent best wishes 
and completed the retirement question¬ 
naire (the results of which were included 
in the newsletter which has already been 
sent to all members of the class). Personal 
greetings were brought to us by the 
Buchers from Al Davis — still in internal 
medicine at Long Beach-VA Hospital 
and University of California at Irvine 
Medical School; Charlie and Peg Nugent 
(’51), still at University of Arizona and 
Tucson VA Hospital, and Larry Freed¬ 
man (’51), who has returned from Switzer¬ 
land, lives five houses away from the 
Buchers, and is at UCLA and West Los 
Angeles VA Hospital. Russ Anderson 
had to drop out at the last minute. He 
has remarried since the death of his wife, 
Louise. Many of you may bump into 
him as he travels around the country 
with Joan for the Joint Commission on 
Accreditation of Hospitals. 
Then the highlight of the evening was 
the panel on retirement arranged by Bill 
Bucher. To capture the hysterical report 
of Bob McSherry would be impossible! 
You had to be there or get Jane Baldwin’s 
taped copy. He is retired and he mingled 
computer jargonese with philosophical 
observations which kept us laughing so 
hard I forgot to take notes! Bill Delia on 
the other end of the spectrum, plans 
never to retire, but “to die in the saddle”, 
because he loves money too much, and 
he, too, was his usual witty self. By the 
way, he looks like the same young 
happy-go-lucky kid he did 35 years ago. 
Archie Golden and Naomi have sold 
their home in Wethersfield, closed out 
the family practice (30 years of service) 
and have built a new home on the Cape 
where they were to move this summer. 
He’ll work summers in an outpatient 
clinic there. He told us of a wonderful 
goodbye party where patients of 30 
years came to pay tribute to his many 
years of service as their family doctor. 
Ida Bucher reports that she’s upset that 
Bill’s cutting back to half-time in July 
because she never got the opportunity to 
play that mythical role, created in the 
minds of the lay American public, “the 
rich doctor’s wife”, that person of ele¬ 
gance, style and unending partying! 
The class was honored to have as its 
guests. Dr. Thomas Forbes and his wife. 
He spoke warmly of the early days as 
our anatomy teacher and of his assistant 
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deanship. He surprised and flattered 
some by remembering all kinds of indivi¬ 
dual things about them. He looks wonder¬ 
ful, still has an office at the medical 
school and writes extensively on the 
history of forensic medicine. Subsequent 
to the reunion we received a warm note 
of appreciation for the evening and 
recalling many happy memories. He 
stated Yale can be proud of the doctors 
she graduates and the spouses they choose. 
Prizes for the youngest looking went to 
svelte Marilyn Sugarman Kritchman, 
director of anesthesiology residents at 
NYU, and Yvette Francis McBarnette, 
mother of six, who is involved in sickle 
cell anemia. Starting out as a pediatrician, 
she’s moved to internal medicine as her 
patient population aged. 
The evening ended with a pitch by Sid 
Lee for the upcoming endowment drive 
for the medical school. It is important 
that all of us help in the drive to keep 
Yale School of Medicine on the cutting 
edge of research, both pure and clinical, 
and to maintain the excellence of the 
private university, where freedom of 
inquiry is a prized value. Remember, 
many large corporate donors give in 
proportion to the contribution of the 
alumni ae. So give a little —give a lot 
whatever your pocketbook allows — 
but do give when you’re asked to partici¬ 
pate in the drive. Sid is now', by the way, 
in a new job as executive director of the 
Milbank Fund in New York City. (At¬ 
tention —all grant applicants!!) He is 
also a member of the Yale Development 
Fund Committee seeking to increase the 
medical school endowment. 
Present at the reunion, which included 
Friday night dancing and a hilarious 
Sunday brunch were: John LeRoy, Bill 
Delia, Mrs. Martin Smith (Jean), Tony 
Tyler, Lyal and Bonnie Asay, Kent and 
Barbara Ellis, Marilyn Sugarman Kritch¬ 
man, Archie and Naomi Golden, Ida 
and Bill Bucher, Sylvia Levine Axelrod 
and Bob Axelrod, Jane Baldwin Shum- 
way, Ruth Quinn and Jeoffrey Quinn, 
Dave and Claire Frucht, Gloria Stur- 
man, Sid Lee, Yvette Francis McBarnette 
and Mac, Mag Lyman, CG and Doris 
Gunn, Sheila and Harry McClelland. 
Harry McClelland thinks we should 
plan a mini-interim reunion medical 
meeting (tax deductible you know!) at 
e wonderful resort in two or three 
I he Buchers always attend “Yale 
1 V " wmite” in first of May at Yosemite 
Lodge It' run by Yale Western Office 
and the Natural Science Experts from 
'lose lite 11 anyone would like to come 
with us (quite inexpensive) do let us 
know’ Hikes are arranged to fit each 
i\ capabilities and there’s square 
dancing and barbeques. Any other sug¬ 
gestions? Mag Lyman volunteered her 
farm for a picnic symposium too, and 
some suggested an Elder hostel program. 
Send Bill Delia your ideas. 
Love and best wishes for five years of 
health, wealth and happiness from the 
Buchers and Asays. 
1955 
30th Reunion 
by William Lattanzi 
Twenty-five of our classmates returned 
to New Haven for this reunion. 1 have 
been told by the director of Alumni 
Affairs, Dr. Nicholas Spinelli (’44), that 
the class of '55 once again has gathered 
more returning alumni than any other 
class. From the comments of those who 
returned, it seemed to have been a 
worthwhile experience and one that gave 
all of us great enjoyment. 
Attending all or part of the weekend’s 
activities were the following: Milt Corn, 
Kahler Hench, Dorothy Leib, Alan 
Stone, John Hodge, and Frank Kenney. 
The following alumni returned with their 
wives (or in Gregg Peterson’s case, with 
his daughter): Joe McGuire, Jack Lan¬ 
dau, Nick Coassin, Jim Nolan, Joe 
Camilleri, Greg Peterson, Russ Miller, 
Shep Nuland, Bob Kramer, Jerry Bob- 
ruff, Bill Lattanzi, Padraic Burns, Paul 
Gonick, Bob Reich, Irwin Braverman, 
Bob Peters, Phil Smith, Ed Brennan, 
Paul Calabresi. 
Activities began on Friday afternoon 
with a talk by Dr. Arnold Reiman, 
editor of the New England Journal of 
Medicine. His topic concerned the impact 
of for-profit hospitals on our present 
medical system. After his talk, we spent 
an evening at the home of the Lattanzi’s 
with cocktails and dinner. This was the 
first meeting of some of our classmates 
in the past 30 years. As you can imagine, 
it was an exciting evening. Some of our 
classmates had not been to any reunion 
since we graduated and it became ex¬ 
tremely pleasurable for those of us who 
have attended all of these to be able to 
see them again. We caught up on every¬ 
one’s activities and what has taken place 
in their lives since graduation. A sad 
note was the demise of Ed Coppola 
during the past five years. 
After the activities at Yale on Saturday, 
June 8th, we all gathered at the Oak 
Lane Country Club for dinner. During 
the course of the dinner. Bob Fekety 
called from Michigan and spoke to 
everyone w ho was in attendance. We all 
felt that was a very warm and welcome 
addition to the evening’s entertainment. 
At the dinner, a number of our class rose 
to the occasion and talked about their 
lives and remembrances of things past. 
On Sunday, Jack Landau had invited 
those who could stay in town to a 
brunch at his home. Although few were 
able to attend, it was again, most 
enjoyable. 
The reunion, I think, ended on a very 
high note of good spirits, and genuine 
fondness for one another. 
We had sent a questionnaire to our 
classmates concerning their attitudes and 
feelings towards medicine and the view 
of the Yale School of Medicine. Although 
not enough questionnaires were returned 
for a reliable sample, practically unani¬ 
mous opinions were that: 
1. The Yale system was thought of as 
positive and worthy of support. 
2. Most of the class felt that their lives 
were very satisfying, but at the same 
time, did not feel that the future physi¬ 
cians will find that to be so. This was 
reflected in the fact that most would not 
like to see their children enter medicine 
at this time. 
3. Most of the class engage in sports 
activity of some sort, but do not feel they 
have enough time for relaxation. 
4. Many of the class have received 
distinguished awards and have very im¬ 
pressive bibliographies. 
If energy remains, perhaps in the next 
five years a more extensive questionnaire 
with followup could be done to achieve a 
large enough sample that could be viewed 
upon as reliable 
I would like to thank the committee 
for its efforts and especially Jack Landau 
for arranging the evening at the Oak 
Lane Country Club. 
We all look forward to the 35th. 
Milton Corn has been appointed dean at 
the Georgetowm University School of 
Medicine, effective August 1. 
1960 
25th Reunion 
by Jerrold Post 
The 25th reunion of the class of 1960 was 
a very special occasion for all — awash 
with warm memories and good humor. 
The class sponsored a reunion seminar 
on "The Brain, The Mind, and Behavior.” 
Two of the class’ outstanding neurobio¬ 
logists, Chuck Stevens and Alan Finkel- 
stein, presented fascinating discussions 
of the advances in understanding the 
biological basis of mind. Setting the 
stage for the rest of the weekend, special 
attention was given to the neurochemical 
basis of the seven deadly sins, particularly 
gluttony, lust and sloth. At a more 
microscopic level, this was followed by a 
talk on the social psychology of terrorism 
by Jerry Post. Rick Kindwall wrapped 
up with a fascinating discussion of his 
own esoteric specialty — hyperbaric 
medicine. 
Having made a ritual bow to education, 
the serious concerns of the weekend 
began. After a pleasant reception for all 
returning alumni, hosted by Dean Rosen¬ 
berg, the class repaired to a delightful 
informal evening at Vic and Laura Alt- 
shul’s splendid rambling home in New 
Haven, for a buffet hosted by Vic, Tom 
Kugelman and Jerry Post. The next 
morning brought a series of stimulating 
roundtables, including a very provocative 
discussion of the ethical challenges facing 
contemporary medicine. Forty-four 
strong descended on Mory’s that evening 
for a class dinner, straining both the 
capacity and the patience of that vener¬ 
able institution. One of the highlights 
was a raucous photo session observed 
with bemusement by one of New Haven’s 
street people. After a fine dinner of 
prime rib and stuffed shrimp, we shared 
personal and professional experiences, 
read the letters of classmates unable to 
attend, and caught up on news of other 
members of the class. During this portion 
of the evening, the droll humor of Bob 
Wallach and A1 Ross had the class in a 
state of hilarity. The evening ended with 
the maitre d’ asking us to leave. 
The rich collection of news and scurri¬ 
lous gossip collected during the evening 
and from class letters will be collated in a 
newsletter which will be sent to all this 
summer. 
In attendance were: Festus Adebonojo, 
Vic and Laura Altshul, Ormond Brody, 
Don and Nancy Buebendorf, Gerry and 
Donna Cimino, Frank and Ann Cogli- 
ano, Jon and Carol Courtney, Jim and 
Kitty Eusterman, Alan and Joan Finkel- 
stein, Jim Gilman, Roland and Mar¬ 
guerite Ingram, Dan and Carolyn Jones, 
Rick and Marilyn Kindwall, Sue Klee- 
man, Tom and Alice Kugelman, Ed and 
Jean Lang, Bob Marcus, Don and Pat 
Miller, A1 and Barbara Newcomb, Nick 
and Veda Nichols and their daughter, 
Carol, Fred and Ruth Palace, Jerry and 
Carolyn Post, Nancy Rolick Powell and 
her husband. Bill, Buzz and Pat Robin¬ 
son, Al Ross, Chuck Stevens, Bob Wal¬ 
lach, and May Woo Wang and her 
husband, George. 
On May 31, Jack Barchas presented the 
John P. Flynn Memorial Lecture at 
Yale. Dr. Barchas, who is Nancy Friend 
Pritzker Professor and Associate Chair¬ 
man of Psychiatry at Stanford University, 
spoke on “The Search for Neuroregula¬ 
tors: Neuropeptides and Behavior.” 
1965 
20th Reunion 
No report received 
1970 
15th Reunion 
by Robert Rosa 
The class of 1970 gathered for its reunion 
at the fashionable Quinnipiack Club in 
New Haven where dinner arrangements 
were made by Scott Peterson. The 
evening was very enjoyable and there 
was ample opportunity for everyone to 
talk and describe their recent activities. 
Those present, in most cases accom¬ 
panied by their spouses, included Bruce 
Reitz, who recently moved from the 
rolling hills of Palo Alto to become 
professor of surgery and chief of cardio¬ 
vascular surgery at Johns Hopkins. By 
moving, Bruce has brought heart-lung 
transplantation to the East Coast. Ray 
Tripp is still in Massachusetts and is 
chief of pediatrics at the Emerson Hos¬ 
pital in Concord. Lenny Milstone re¬ 
mains at Yale on the full-time staff in 
dermatology, while Ann Curtis, just 
back from sabbatical in England with 
her husband Jim Fischer, is now head of 
chest radiology at Yale. Also present 
and still in Connecticut, but now on the 
anesthesia staff at St. Vincent’s Hospital 
in Bridgeport, was Jonathan Katz. John 
Blanton is still in New Haven and remains 
a great pediatrician and knitter. Phil 
Steeves journeyed down from Back Bay 
for the evening and revealed that he 
remains active in radiology on the North 
Shore of Masschusetts. Farther up the 
North Shore in Newburyport, Joel 
Rubenstein is practicing psychiatry while 
west of Boston Bruce Wenger is engaged 
in research in thermal physiology. Paul 
Hessler has an active practice in radiology 
in Rhode Island. Gerry Kennealey, who 
finally shaved his moustache because, “1 
no longer need to try to look older,” is 
busily engaged in the practice of oncology 
in the Waterbury area, while Scott Peter¬ 
son remains very busy in the practice of 
ophthalmology in Waterbury, where he 
has established a regional eye center. 
Your class secretary. Bob Rosa, remains 
in Boston, where he directs the Clinical 
Research Center at Beth Israel Hospital 
and dabbles in nephrology. 
Letters were received from classmates 
who could not attend and they reveal 
that Joellen Werne is actively practicing 
psychiatry half-time and raising a family 
full-time; Dan Dederick is on the full¬ 
time anesthesia staff at Brigham and 
Women’s Hospital; Tom Singer (writing 
on stationary from Marrakech) is associ¬ 
ate professor of surgery at Bellevue in 
New York; Ken Khoury is at UCSDand 
recently has taken up jazz dancing and 
ballet (if you can believe that!); Bob 
Litman is in family practice and is also 
an allergist in Ogdensburg, N.Y., where 
he runs a TV program and has recently 
published a novel; and Jonathan Ecker 
got a haircut and is now practicing 
psychiatry in the Syracuse area. 
1975 
I0th Reunion 
by Mary Jane Minkin 
To summarize our reunion we had a 
great time — what else? Our two major 
events were a get-together at my house 
Friday evening, and a more formal 
dinner at the Colony Inn restaurant on 
Saturday. It was a terrific occasion for 
the large local contingent to meet — as 
we never do — and see many out-of- 
towners. We also got lots of letters from 
classmates to read (and make nasty 
comments) — well, you can’t defend 
yourself if not there. 
Local attendees included: Andy Pach- 
ner and wife, Dan Passeri and wife, Sal 
Romano and wife, Henry Cabin and 
wife, Florence Comite (’76) and sister- 
in-law, Harriet Comite (’77), Stan Gale 
and wife, and honorary classmate, Mark 
Ruchman (officially ’76) and wife. Long¬ 
est distance guests were: Haig Dona- 
bedian, still voted class’funniest member, 
Jim Grabman, Hank Willner and Fred 
Sherman, who did manage a few rounds 
of golf. Bob Sandler and wife, Jamie 
Robertson, Rob Malacoff (or should 
Boston be considered local?) and of 
course, your local arranger, me. 
We all decided none of us has changed 
—and we really hadn’t — and enjoyed 
sharing our practice experiences, and 
also reflected how medicine has changed 
so much in ten brief years. Let’s see how 
much more it will change in the next 15, 
and plan even better attendance at our 
25th. 
A gossip sheet is in the printing stage, 
so if you have any class news, please 
send it. Thanks. 
1980 
5th Reunion 
No report received 
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Other Class Notes 
1936 
George Hahn has received the Sigma 
Chi Fraternity’s highest honor for out¬ 
standing achievements in his professional 
field. The 1984-85 Significant Sig Award 
was presented to Dr. Hahn at a Washing¬ 
ton, D.C., Sigma Chi Alumni Chapter 
meeting on June 13, for his medical 
research including carbon dioxide laser 
beam surgery and other cancer treatments 
as professor of gynecology and obstetrics 
at Thomas Jefferson University in Phila¬ 
delphia; and for his outstanding achieve¬ 
ments in the control of cancer for which 
he received the National Division Gold 
Medal Award of the American Cancer 
Society. Dr. Hahn was recognized for 
his leadership in the field; as an active 
member of the Medical Board of Project 
HOPE; as governor of the American 
College of Surgeons; as vice president of 
the American Gynecological and Obstet¬ 
rical Society; and as an officer of many 
other medical societies and associations. 
1952 
New s of Willard and Siegried Centerwall 
has been received. In March, while in 
India during a five-nation lecture tour 
through Asia, Dr. Centerwall was pre¬ 
sented the first J.B.S. Haldane Oration 
Medal from the Society of Bionaturalists 
at Bhopal University. The medal honors 
John Burden Sanderson Haldane (1892- 
1964), one of the world’s pioneers in the 
field of human genetics, who emigrated 
from England in 1957 to spend the rest 
of his life in India. The followingcitation 
accompanied the aw'ard: “The President 
and Fife Servers of the Society record 
with privilege, the outstanding contribu¬ 
tions of Professor Willard R. Centerwall 
in human genetics and animal cytogene¬ 
tics extending over three decades. His 
work on phenylketonuria and extension 
of genetic services for the prevention of 
mental retardation are more than 
exemplary.” 
In New Delhi, Dr. Centerwall was 
chairman of one of the scientific sessions 
if the Seventh World Congress of the 
International Association for the Scienti- 
Study of Mental Deficiency. At Vel- 
South India, he lectured at Christian 
College, where he and his wife 
spent live years as medical missionaries. 
During this time, he started his genetic 
studies in India and has continued them 
during periodic return visits. Dr. Center- 
wall retired in February as professor of 
pediatrics and genetics and director of 
Medical Genetic Services at the Univer¬ 
sity of California, Davis. 
In May, Dr. Siegrid Centerwall was 
awarded an honorary Doctor of Humane 
Letters degree from her alma mater, 
Mount Holyoke College, for a lifetime 
of outstanding professional and humani¬ 
tarian achievements. 
From 1961 through 1966 in India, 
where she went with her husband and six 
young children to work as a missionary, 
she engaged in public health work. On 
her return to this country, her community 
service included developing a program 
for tutoring disadvantaged college stu¬ 
dents. and she has taken active interest 
in affirmative action, women's rights, 
world hunger relief and peace between 
nations. Professionally, she has worked 
in public health clinics, headed maternal 
and child health services in San Ber¬ 
nardino County in Southern California 
and has served on the faculty of the 
Loma Linda U niversity School of Health. 
Dr. Centerwall retired this year from 
the Claifornia Department of Health 
Services, where she was chief of the 
Child Health and Disability Prevention 
Branch. During the last eight and a half 
years, she has headed maternal, adoles¬ 
cent and child health services and under 
her leadership, coordinated child health 
care systems were developed in all the 
counties in California. 
In June, Drs. Centerwall, on personal 
invitation from Norway, participated in 
the dedication of a memorial to the 
Norwegian physician and biochemist. 
Dr. Asbjorn Foiling, who 50 years ago 
discovered phenylketonuria, the heredi¬ 
tary disease known in the U.S. as PKU. 
The Centerwalls were honored for their 
achievements in the I950’s in the U.S. 
with the dietary treatment and the first 
early infancy testing programs for PKU. 
In retirement, the Centerwalls plan to 
write, lecture and consult as well as to 
expand the program of the non-profit 
organization. Light for the Way, Inc., 
which they founded to help families 
whose children have serious medical and 
developmental problems. 
IN MEMORIAM 
Leo J. Hahn 
August 14, 1985 
’18 M.D. 
Daniel M. Thron, M.D. 
February 19, 1985 




Stanley K. Livingston, M.D 
April 25, 1984 
. ’25 ex med 
Eugene C. Beck 
June 13,1985 
’26 M.D. 
Sheldon A. Payne 
May 29, 1985 
’31 M.D. 
Rebecca L. Proctor 
April 10, 1985 
’31 M.D. 
Herbert F. Hirsche 
September 20, 1985 
’31 M.P.H. 
Thomas E. Farthing 
May 7, 1985 
’32 M.D. 
Edward T. O’Donnell 
June 23, 1985 
’34 M.D. 
Thomas F. Hersey, M.D. 
July 9. 1985 
’34 ex med 
Thomas H. Burford 
May 17, 1977 
’36 M.D. 
Lloyd R. Studebaker, M.D. 
May 12, 1984 
’39 ex P.H. 
Robert A. Hettig 
August 8, 1984 
’40 HS 
Meyer J. Plishner 
date unknown 
’40 M.P.H. 
Francis P. Vose 
June 5, 1985 
’42 M.D. 
Nicholas A. Tierney 
November 12, 1984 
'44 HS 
Mathew W. Kobak 
January 16,1985 
47 HS 
Naomi Bitz Markthaler 
March 31, 1985 
'53 M.P.H. 
William A. O’Shea 
June 25, 1984 
'55 HS 
Jane A. Wilkinson 
April 9, 1985 
’57 HS 
Lois W. Tice 
August 2, 1985 
’59 M.D. 
Herbert Rubenstein 
February 24, 1984 
'61 M.P.H. 
Sister Mary Lucina Wierzbicki 
July 23, 1985 ’71 M.P.H. 
Jacques Lagier ’76 HS 
December 25, 1984 
ERRATUM 
Based on incorrect information received 
by the Editorial Office of Yale Medicine, 
the “In Memoriam” listing which ap¬ 
peared in the Spring issue included the 
name of Dr. Joseph H. Zelson, ’69 HS. 
It has since been learned that it was Dr. 
Zelson’s father, Carl, also a pediatrician, 
and not Dr. Joseph Zelson, who died in 
December. We apologize for the error. 
1984 - 1985 ALUMNI FUND REPORT 
FUND OFFICERS 1984 - 85 
Medical School Alumni Fund 
Lowell 1. Goodman, '51, Chairman 
J. Roswell Gallagher, ’30, Bequest 
and Endowment Co-Chairman 
Samuel D. Kushlan, ’35, Bequest 
and Endowment Co-Chairman and 
Chairman, Former House Staff 
Public Health Alumni Fund 
Kathleen H. Howe, ’56, Chairman 
YALE MEDICAL SCHOOL 
ALUMNI FUND BOARD 
Lowell I. Goodman, M.D., ’51, 
Chairman 
J. Roswell Gallagher, M.D., ’30 
Harry Sherman, M.D., '34 
Samuel D. Kushlan, M.D., ’35 
Malvin White, M.D., ’39 
R. Leonard Kemler, M.D., '43 
Nicholas P.R. Spinelli, M.D., ’44 
William McClelland, M.D., ’47 
Harvey L. Young, M.D.,’52 
Harold Bornstein, Jr., M.D., ’53 
Robert Kramer, M.D., ’55 
William Kissick, M.D., '57 
William Waskowitz, M.D., '57 
Nicholas Passarelli, M.D., '59 
Earl Baker, M.D., ’61 
David Hill, M.D., ’65 
Douglas Berv, M.D., '74 
O’Dell Owens, M.D., ’76 
A MESSAGE FROM THE MEDICAL SCHOOL ALUMNI 
FUND CHAIRMAN 
1984-85 was another banner year for the 
Medical School Alumni Fund. Four 
years ago this summer, 1 began my term 
in office by recruiting a number of 
additional Class Agents and announcing 
a goal of $ 190,000 for the 1981-82 cam¬ 
paign year.Each year since then the goal 
has been a little higher and everyone 
responded admirably. In 1983-84 we fell 
a little short, but this year we really came 
through $380,818 and that’s $55,818 
over our goal! The Reunioning Classes 
did their winning bit, as usual, by contri¬ 
buting well over $ 1 10,000. Jim Haralam- 
bie’s group of generous givers from the 
Class of 1935 led the parade with $54,090 
in honor of their 50th, while the Class of 
1960 celebrated their 25th with an impres¬ 
sive total of $ I 1,1 13 under the guidance 
of agents Roland Ingram and Tom 
Kugelman. 
Special notes of thanks to Nick Spin¬ 
elli, who continues to be helpful in 
maintaining contact with the Reunion 
Classes; to that inimitable team of Ros 
Gallagher and Sam Kushlan for their 
efforts on behalf of the Bequest and 
Endowment and Former House Staff 
Programs; and to Bill Waskowitz and all 
the alumni and student phonathon volun¬ 
teers who helped so much to make this 
another memorable and rewarding year 
for the Fund. 
Not all the good news is to be seen just 
in the numbers of dollars given during 
the past year. We now have a Medical 
School Alumni Fund Board of Directors 
responsible for the overall guidance and 
management of the Fund. Four members 
will be immediately active by functioning 
as Vice Chairmen of Agents to help 
maintain bettercommunication with the 
agents; their respective classes are: 
Mai White, ’39 — 1923-1945 
Bill McClelland, ’47 — 1946-1960 
David Hill,’65 1961-1973 
Doug Berv, 74 — 1974-1985 
Our fund could not exist without the 
loyal support of the School’s alumni, 
alumnae, former house officers, parents 
and friends, and I wish to thank everyone 
for their thoughtful contributions. 
Lowell I. Goodman 
A MESSAGE FROM THE DEAN 
Since becoming the dean of our School 
of Medicine last July, I have become 
increasingly aware of the importance of 
the Medical School Alumni Fund in 
providing a source of unrestricted in¬ 
come. For many years, this money has 
been used to provide additional student 
loans. Today, student financial aid contin¬ 
ues to be one of the School’s top priori¬ 
ties. I want to assure you that your 
Medical School Alumni Fund contribu¬ 
tions will continue to be added to the 
Student Revolving Loan Fund. 
In reviewing the report of the Fund 
for 1984-85, I was extremely gratified 
and encouraged to note that the total 
contributions have continued to increase 
and that the goal set for this year has 
been surpassed. I want to thank each of 
you who contributed to the Fund this 
year and to encourage your future sup¬ 
port. I also hope that those graduates 
who did not contribute this year will do 
so in the coming year. 
The success of the Fund’s annual 
giving campaign is due mainly to hard 
work and persistence on the part of the 
class agents and the various officers of 
the Fund. Their contributions of time 
and effort on behalf of the School are 
greatly appreciated. I want especially to 
congratulate Lowell Goodman on the 
tremendous job that he has done as 
chairman, a job which he has held since 
1981. 
At the Alumni weekend in June, I met 
with Lowell, other officers, and a number 
of class agents. We had a very frank 
discussion of how the School might be 
more responsive to some of the alumni 
expectations, especially in regard to ad¬ 
missions. I also had an opportunity on 
that occasion to express my personal 
appreciation to those who have worked 
so loyally on behalf of the Fund. 
In conclusion, I wish to emphasize 
that your support of the School through 
the Alumni Fund is very important and 
that contributions to the Fund will be 
added to the School’s Student Revolving 
Loan Fund to provide financial assistance 
for our students now and for years to 
come. This is certainly worthy of your 
support. 
Leon E. Rosenberg 
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MESSAGE 
TO PUBLIC HEALTH 
GRADUATES AND FRIENDS 
The Department is extremely grateful to 
the 651 alumni, alumnae and friends 
who contributed to the success of the 
1984-85 Public Health Alumni Fund 
Campaign. 
The proceeds of the drive are desig¬ 
nated for student loans, a high priority 
of need, as the cost of graduate education 
continues to escalate. 
The total of $44,986 exceeded the goal 
by 112 percent and includes over $4,000 
raised by an enthusiastic group of volun¬ 
teers from the New Haven area during a 
phonathon in June. 
Kathleen H. Howe 
Chairman 
- AND A MESSAGE 
FROM THE CHAIRMAN 
OF E.P.H. 
That the 1984-85 Alumni Fund Camp¬ 
aign for the Department of E.P.H. ex¬ 
ceeded its goal is due in large part to 
Kaye Howe and her cohort of hard¬ 
working volunteers. It is continually 
evident that the Alumni Fund is an 
important asset to the School, providing 
much needed financial assistance to 
highly qualified graduate students. 
Ourthanksto Kaye Howe and all who 
participated and contributed to this very 
successful campaign. 
Jan A.J. Stolwijk 
MEMORIALS 
Deceased medical alumni (and friends) 
may be memorialized by a gift at any 
time to the Medical School Alumni 
Fund Endowment in the name and class 
of the person so honored. The next-of- 
kin of a deceased medical alumnus/a is 
advised about this In Memoriam Pro¬ 
gram by mailing from New Haven some 
weeks after the School of Medicine 
receives notification of the death. The 
letter of information includes a copy of 
The Testament of Remembrance in which 
the names of all persons so memorialized 
are listed in the medical section by class, 
thus establishing a lasting memorial. 
Donors receive a personal penned note 
of appreciation from me. Your inquiries 
and interest are welcome at any time. 
Deceased alumni and friends so hon¬ 
ored for the first time in 1984-85 were: 
Ernest Russell, '16 and David P. Dunn, 
'60. 
Richard G. Jordan 
Director, In Memoriam Program 
MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION 
FINAL REPORT-1984-85 
YEAR AGENT 1983-84 1983-84 1984-85 1984-85 
TOTAL % PART. TOTAL % PART. 
1423 William Cohen 608 67 541 60 
1424 Myron Sallick 3,652 86 5.081 71 
1425 Alice Whittier 960 77 875 67 
1426 Maxwell Bogin 546 67 551 71 
1427 Harry Zimmerman 975 56 1,048 53 
1928 Max Alpert 3.216 73 3.555 77 
1424 Paul McAlenney 1,612 90 1.192 72 
1430 J. Edward Flynn 2,446 52 15.984 60 
1431 Michael D'Amico 1,90! 68 1.663 83 
1432 Henry Brill 1.366 50 1.725 44 
1433 Franklin Foote 2.107 74 1.537 63 
1434 John Ogilvie 14.929* 61 4.071 65 
1435 James Haralambie 3,736 58 54,090* 70 
1436 George Hahn 4,333 47 5.850 47 
1437 David Dolowitz 1,671 48 753 53 
1438 Nelson Ordway 1,100 63 1,215 74 
1434 Rebecca Solomon 3,231* 57 3.371 62 
1440 James Ferguson 3,750 65 10.793* 67 
1441 Charles Cheney 2.287 64 2,856 64 
1442 Walter Burdette 2,356 61 1.973 54 
144 3 A Dorothea Peck 2.915 66 2.995 69 
1443 B S Brownlee Brinkley 2.686 47 3,164 52 
1444 Nicholas Spinelli 17.394* 74 8,393 61 
1445 Richard Breck 3.350 60 24,854* 65 
1446 A Charles Judd 4,438 56 4.675 56 
1446B Thomas Whelan 2.583 73 3,084 62 
1447 William Roy Brcg 4.918 66 4.700 59 
1448 Paul Koehler 5.251 51 5,407 56 
144 V Daniel Elliott 5.829* 52 3,785 47 
1450 David Frucht 5.230 58 6,781* 71 
Lowell Goodman 5.075 45 5.271 49 
Harvey Young 5.035 46 4.310 43 
Vincent Gott 3.865 56 3,095 45 
1454 John Rose 6.248* 65 5.323 67 
Robert Kramer 4.712 62 8,841* 62 
John Gardner 6.275 49 4.600 36 
Ronald 1 ishbein 3.195 56 3.620 59 
Howard Minners 3,205 73 4.055 68 
Charles Hall 1.715 54 1.570 51 
MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION —continued 
YEAR AGENT 1983-84 
1983-84 1984-85 1984-85 









I959A Asa Barnes 4,185" 58 3,376 64 
1959 B Muriel Wolf 5,930* 66 4,679 46 
I960 A Roland Ingram 4,480 63 7,400* 67 
1960 B Thomas Kugelman 3,800 69 11,113* 71 
1961A Earl Baker 2,430 47 2,625 52 
1961 B Anoush Miridjanian 3,406 50 2,310 44 
I962A A. Richard Pschirrer 2,680 59 2,865 54 
I962B Frank Hartman 1,367 35 1,475 32 
1963 Craig Llewellyn 5,715 54 10,685 56 
1964A William Houghton 3,620* 63 2,100 47 
I964B William Pratt 5,050* 71 5,145 76 
1965 David Hill 3,905 38 8,840* 53 
I966A Mary-Alice Houghton 2,770 80 2,580 66 
I966B Henry Mann 1,355 50 1,975 63 
1967 A James Dowaliby 2,596 69 1,691 47 
I967B Anthony Lovell 4.000 83 3,605 77 
1968 A Frank Lucente 2,801 56 2,701 47 
I968B Donald Lyman 1,865 51 1,800 51 
1969 Lee Jampol 7,948* 62 5,872 52 
1970 James Missett 3,909 49 3,796* 42 
1971A John Cieply 2,486 44 1,942 40 
1971B Barbara Kinder 3,545 58 3,690 63 
1972 Paul l.ucky 3,048 44 4,143 46 
1973 A David Bailey 955 42 1,050 39 
I973B David Johnson 1,415 46 1,135 36 
I973C Jerrold Rosenbaum 1,145 54 1,120 45 
1974 Peter Buchin 1,970* 37 — — 
I974A Amv Schecter — 1,000 38 
I974B Robert Schecter — 850 26 
I975A Daniel Passeri 625 25 1,450* 35 
I975B Mary Jane Minkin 795 18 1,135* 19 
1976 Robert Taylor 1,982 30 2,116 30 
I977A David Kreis 1,200 36 600 21 
I977B Ronald Vender 715 37 820 38 
I978A Duke Cameron 1.340 26 1,360 26 
I978B Seth Powsner 215 21 105 14 
I978C Thomas Smith 580 31 110 20 
1979 A Michael Hausman 365* 21 — — 
Jeffrey Kaine — 266 23 
I979B Laurie Smaldone 465* 18 445 21 
1980 A F.duardo Alfonso 415 29 610* 36 
I980B Mark Bernhardt 415 22 655* 33 
1981 Anthony Urbano 530 19 575 17 
I982A Muriel Cyrus 110 12 65 9 
I982B Jed Gorlin 90 19 135 27 




1 15 17 
1983 A Michael Tom 145 9 170 10 
I983B David Schwartz 1 10 1 1 197 23 
1984A David Astrachan — 140 12 
1984B Jay Kostman — — 121 17 
* Reunion 























Alumni 3480 1674 48 $55,217 $254,710 3509 1613 46 $359,470.50 
Former 
House Staff 945 148 16 1,785 7,095 1004 168 17 9,560.00 
Parents; 
Friends 345 63 18 1.625 1 1.652 366 60 16 11.787.00 
Interest 
Miscellaneous 
Gifts 1 1,319 13,464.42 
Baumgartner 
Match 19,542* 
4770 1885 40 $58,627 $304,319 4879 1841 38 $380,817.50 
■"Balance of $50,000 earned along with Public Health Alumni Fund. 
"Includes $67,372.75 for 3 life income gifts. 
33 
PUBLIC HEALTH ALUMNI FUND CLASS PARTICIPATION 
FINAL REPORT-1984-85 
YEAR AGENT 1983-84 1983-84 1984-85 1984-85 
TOTAL % PART. TOTAL % PART. 
1923-1941 1.791 58 5,770 50 
1942 Eric Mood 265 33 460 80 
1943 Eric Mood 275 31 460 45 
1944 Eric Mood 270 56 260 33 
1945 _ 130 33 1 10 43 
1946 _ 65 22 80 33 
1947 _ 265 39 220 35 
1948 Elizabeth Robinton 7X5 39 1.115 50 
1949 Elizabeth Robinton 440 22 495 36 
1950 Eric Mood 790 50 975 62 
1951 Norton Chaucer 565 37 645 38 
1952 Yolande Lvon 840 39 870 33 
1953 Milton Sisselman 860 42 730 39 
1954 Ruth Taber 70 13 
Eric Mood 45 13 
1955 Frances Ogasawara 535 50 655 50 
1956 David Boyd 555 36 545 29 
1957 Edward DeLouise 470 48 525 57 
1958 Thomas Flynn 765 29 700 29 
1959 Dorothy Wilson 945 48 605 40 
I960 Else Schulze 1.050 54 195 25 
1961 William Slivka 1,300 43 655 50 
1962 A. Kay Reiser 60 10 75 20 
1963 David Dolins 520 33 850 43 
1964 Estelle Siker 895 29 1,220 42 
1965 H Patterson Harris 5X0 29 1.885 50 
1966 Allen Cohen 305 24 220 18 
1967 James Mallov 2.445 36 1.525 41 
I96X Arnold Saslow 1,475 43 1.805 45 
1969 Samuel Korper 1,450 27 1.035 36 
1970 Susan Balter 1.650 35 1.345 31 
1971 John Bihldorff 2,221 53 2,025 49 
1972 Dorothy Lewis 830 34 485 30 
1973 Judith Beatrice 820 20 1.495 29 
1974 A Elizabeth Helming 170 22 
Thomas Benoit 320 35 
1974 li Karen I indfors 525 33 535 44 
1975 Linda Broker 1.391 35 1,667 41 
1976 Elaine Anderson 1,560 34 1,690 35 
1977 Dorothy Rice 1.390 29 1.380 33 
1978 Ann Freedman 1.318 38 1.759 39 
1979 Ralph Tartaglione 2.420 51 1.505 32 
1980 Christina Quinn 1,020 31 1.155 37 
19X1A Diane Goren 805 36 6156 26 
19X1 B Barbara Gaugler 165 24 240 32 
19X2 A Michele Visconti 385 22 265 14 
I9X2B Amy Wilson 475 32 445 39 
19X3 A Jeffrey Hughes 505 39 1.260 24 
1983 B Mary Beth McNernev 300 32 175 16 
1984A Anthony Alberg 110 17 
I9X4B Leslie A. Balch 80 10 
ALUMNI AE TOTALS 38.761 42,590 
Interest misc. gifts 1.755 2.396 — 
Baumgartner Match 3.162 — 
TOTAL 43.678 36% 44,986 35% 
Contributors to the Medical School Alumni Fund 1984-85 
Alumni 
1906 
Charles R. Mitchell * 
1908 
Michael A Parlato * 
1912 
Walter C. Tilden * 
1913 
Ralph E. Taylor * 
1916 
Ernest Russell * 
1919 
Willys M. Monroe * 
1920 
Oscar Brenner * 
1921 
Ella W. Calhoun 
1922 
Maurice Grozin * 
Benedict R Harris 
Chester E. Hurwitz * 
Helen P. Langner 






Hyman Weinstein * 
1924 
John J. Batchelor 
D. Anthony D’Esopo 
David M. Raskind 
Myron A. Sallick 
Harold T. Vogel 
1925 
Dorence S. Cowles 
Waldo F. Desmond 
Henry W Ferris * 
William E. Hall 
Samuel Reback 
Welles A. Standish 
Alice A.S. Whittier 
Howard A. Wood 
1926 
Stanton T. Allison * 
Maxwell Bogin 
William H. Hahn * 





Milton B. Berman 
Wallace R. Bostwick * 
John M. Freiheit * 
Albert Jablonsky 
Nathan Levy 
William C. Meredith 
Moses Rothberg 
Alfred F. Seibert 
M. Dawson Tyson 
Harry M. Zimmerman 
1928 
Max Alpert 
Berthold R. Comeau * 
Sheldon A. Jacobson 
Raymond A. Johnson 
Edward P.J. Kearney 
Ralph E Knutti 
R. Harold Lockhart 
Edward W. Ludwig * 
Nathan E. Ross 
Robert I. Rubinstein 
John M. Russell * 
Alvin A. Schaye * 
Lewis A. Scheuer 
* Deceased 
1929 
James Rae Arneill, Jr. 
John W. Cass, Jr. 
Charles J. Epstein 
Robert A. Frisch 
Olive Gates 
George S. Goldman 
Alexander O. Haff * 
John A Hangen 
Harold J. Harris 
Paul F. McAlenney 
Tony L. Rakieten * 
William F. Roth, Jr. * 
Russell B Scobie 
Robert Tennant 
Newell Raymond Washburn * 




Daniel N. Beers * 
Frederick Fitzherbert Boyce 
Charles A Breck * 
Vincent A. Doroszka 
Knox H. Finley 
J. Edward Flynn 
J Roswell Gallagher 
Leonard Greenburg 
James C. Hart 
Edmund L. Kitzmeyer 
Paul H. Lavietes 
Moses D. Lischner 
James M. Lynch * 
Paul Watson * 
Amy H. Wilson 
Charles L. Wood 
1931 
Henry H Briggs, Jr. 
Benjamin Castleman * 
Michael D’Amico 
Richard L. Frank 
Helen R. Gilmore 
Paul A. Harper 
Harold E. Harrison 
Morris Freund Heller * 
Thomas Jaleski 
A. Philip LaFrance 
Rhoda M. Mickey 
Nelson Newmark 
Sheldon Payne 
Morris L. Rakieten 
James W Reed 
Abraham J. Schechter 
James A. Stringham 
1932 
Louis K. Alpert 
Henry Brill 
Frank Carroll 
Clement C. Clarke 
Joseph P. Donnelly 
Lee E. Farr 
Lewis F. Foster 
Conrad R. Lam 
Arthur J. Present 
Elizabeth M Ramsey 
Benjamin N. Tager 
Myron E. Wegman 
Ronald J. Wehger * 
1933 
Myron J. Adams * 
Fred W. Buse 
Warren P. Cordes 
Franklin M Foote 
Jack Greenberg 
Daniel F. Harvey * 
George K. Hirst 
Raymond E. Miller 
Ashley Pond ill 
Paul L. Saffo 
Sidney Stringer * 
John J. Wolfe 




James F. Blades 
Joseph Budnitz 
Derick A. January 
Theodore P. Merrick 
Herbert C. Miller 
John B. Ogilvie 
Lucien M. Pascucci 
Harry Sherman 
William R. Willard 
George Zalkan * 
1935 
Walter E. Barney 
George A Carden, Jr 
Edgar S. Childs 
Edward F. Falsey 
Sawnie R Gaston 
H. Hoffman Groskloss 
James Quintin Haralambie 
W Howard Horner 
Mildred Hartshorn January 
Samuel D Kushlan 
Donald P. Morris 
Norman E. Peatfield 
Norman P Rindge 
Milton Rose * 
Clark P Searle 




George Henderson Brown 
Lester W. Burket 
Albert W. Diddle 
Franklin F. Ferguson 
Margaret C.L. Gildea 
George D. Gross 
George A. Hahn 
Louise G. Hutchins 
Philip M. Le Compte 
Donald F. Marshall 
Stephen F. Nagyfy 
Frederick A Post 
Margaret Sommers 
Morris Tager 
Edgar W. Warren 
1937 
Edmund R Blower 
Guido A. Deblasio 
David A. Dolowitz 
D. Crosby Greene 
Joseph B. Hollinshead 
Wilbur D. Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P Morrill 
Charles W. Neuhardt 
Morgan Sargent 
Edward J. Shaw 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
1938 
Roy N. Barnett 
Agnes Vernon Bartlett 
Henry L. Carideo 
S. Charles Kasdon 
Benjamin E. Lyons 
Edward Nichols 
Nelson K. Ordway 
Charles J. Petrillo 
Edward W. Pinkham 
James Radcliffe 
Arthur S. Reynolds 
George E. Roberge 
Lester J. Wallman 
J. Richard Zahn 
1939 
Harold H. Coppersmith 
Norman L. Cressy 
William H Druckemiller 
Robert G. Ernst 
John P. Ferguson, Jr. 
Joseph B Forman 
S. Jerome Greenfield 
Margaret A. Lennox 
Ward J. McFarland 
James Peter Murphy 
Russell Nahigian 
Douglas S. Riggs 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
Stuart S. Stevenson 
John D. Tobin 
Arthur S. Tucker 
Darrell G. Voorhees 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 
1940 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
Thaddeus S. Danowski 
Richard E. Dormont 
Robert M. Dunlap 
James F. Ferguson, Jr 
Eugene J. Fitzpatrick, Jr. 
Henry D. Humphrey 
H. Stuart Irons, Jr. 
Donald G. Johnson 
Ira D. LeFevre, Jr. 
Paul D. MacLean 
Edward Martin 
William R. Oakes 
Maurice Ross 
Lee S. Sannella 
W. Norman Sears * 
Joseph E. Sokal 
J. Champneys Taylor 
Patricia E. Wanning 
John B. Wells 
Helen H. Woods 
1941 
Sophia Chamberlain Alway 
Robert H Areson 
W. Randal Bell 
Knute E Berger 
William A. Carey 
Joseph P. Carson, Jr. 
Charles B. Cheney 
Herbert W. Diefendorf 
Robert Dine * 
Lloyd D. Flint 
John Franklin 
Frederick P. Glike 
Sidney L. Lasell 
Bjorn Lih 
F. Eugene Martin 
Willys M. Monroe 
Malcolm C. Murfitt 
Edward B O’Connell 
Robert W. Ollayos 
Gioacchino S. Parrella 
David V Pecora 




Eugene M. de Hostos 
William E. Bloomer 
James M. Bunce 
Walter J. Burdette 
Robert E. Carroll 




Allan V.N. Goodyer 
William Harrison, Jr. 
Leo Kellerman 
John R Lincoln 
Patrick S. Mullins 
Dean Nichols * 
Samuel Ritvo 
Lois Knight Rogers 
Richmond W. Smith, Jr. 
Edgar B. Taft 
Maurice Tulin 
Irving Norman Wolfson 
1943 (March) 
Ralph D Alley 
John R Brobeck 
Lycurgus M. Davey 
Donal L. Dunphy 
Gerard Fountain 
R. Leonard Kemler 
Joseph P. Kriss 
Jonathan T. Lanman 
Douglas Lindsey 
J. Philip Loge 
Henry E. Markley 
Walter J. J. Nero 
Dorothea R. Peck 
Edward F Rabe 
Earl J. Rhoades 
Henry A Riedel 
Bernard R. Rowen 
Marcus E. Sanford 
Edward Hersey Soule 
Hilliard Spitz 
Nicholas M Stahl 
Sophie Trent Stevens 
Oliver G. Stonington 
Robert Lee Taylor 
Frederick A. Waldron 
John J. Weber 
Robert H Wyatt 
1943 (December) 
Richard N. Abbott 
John R Almklov 
David G. Borden 
S. Brownlee Brinkley 
Henry B. Bruyn, Jr 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B. Chase 
Hunter H. Comly 
Norman I Condit 
Thomas D. Cook 
Ronald W. Cooke 
Jean P. Davis 
Joseph I. Epstein 
Robert H Furman 
Victor C. Hackney 
Henry H. Jones 
Joseph Kell 
Sawyer E. Medbury 
Ira A. Rashkoff 
Donald W. Seldin 
Francis A. Spellman 
1944 
Carl E. Andrews 
Edward J. Conway 
George B. Corcoran, Jr 
Frank W. Countryman 
Charles H. Crothers 
Lawrence G. Crowley 
John H. Doherty 
Robert W. Frelick 
Carol Goldenthal 
Charles A. Hall 
Robert 1 Hinkley 
Edith M. Jurka 
John Weaver King 
Frederick F. Krauskopf 
Elias J. Marsh 
Katherine Hawley Martin 
Joseph Massaro 
A. Reese Matteson 
Paul E. Molumphy 
Lawrence K. Pickett 
35 
Haynes W. Sheppard 
Sarah P. Sherwood 
Eugene Smith 
Nicholas P R. Spinelli 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin W. Woodruff 
Rueben Zucker 
1945 
George Howard Allison 
A. John Anlyan 
Albert S. Atwood 
Frederic M. Blodgett 
Richard W Breck 
Louise H. Burr 
Alice Shepard Cary 
Sanford F. Cockerell 
Jay B Cohn 
Thomas P. Cotter 
Edward M. Daniels 
Robert S. Easton 
Sidney S. Feuerstein 
Alice Dershimer Friedman 
Raymond A. Gagliardi 
James D. Gardam 
James R. Mason 
Philip S. Good 
Gove Hambidge, Jr. 
Herbert S. Harned, Jr. 
Paul W. Hoffert 
O Roger Hollan 
Hans R. Huessy 
Inland W. Jones 
William E. Laupus 
Raymond E. Lesser 
Mark McD Lindsey 
Charles E. McLean 
George W. Naumburg, Jr. 
Fitzhugh C. Pannill 
Richard M Peters 
Elliot R Reiner 
Charles E. Sherwood 
Joseph R. Stanton 
Kenneth C. Steele 
1946 
Margaret J. Albrink 
Aaron T. Beck 
Franklin C. Behrle 
Frederick C. Biehusen 
Sanfurd G Bluestein 
Linus W. Cave 
Thomas J. Coleman 
Thomas A. Doe 
Edward F. Edinger 
Geogory E. Flynn 
Martin E Gordon 
Charles S. Judd, Jr. 
Harold King 
Benjamin F. Kitchen, Jr. 
Vincent J. Longo 
Richard H Mann 
Thomas J Mathieu 
Hugh J. McLane 
John H. Morton 
John F. Neville, Jr. 
Laura W. Neville 
Harry Dickson Patton 
Vincent Pepe 
Francis Reilly * 
David H Riege 
Julian A. Sachs 
Donald P. Shcdd 
Richard G. Sisson 
Robert R Wagner 
William J Wcdemeycr, Jr. 
rhomas J. Whelan, Jr. 
Flihu S. Wing 
George R Barnes, Jr. 
M r \ Blansficld 
Albert W. Bostrom, Jr. 
William Roy Brcg, Jr. 
Rocco A. Calandruccio 
John I Cannon 
M Richard Carlin 
Charles R. Cavanagh, Jr. 
Robert A. Chase 
Amoz I. Chemoff 
William F. Collins, Jr. 
Robert P Darrow 
Owen W. Doyle 
Franklin Harold Epstein 
Richard K. Friedlander 
Frank H. Horton 
Robert J. Kerin 
Don F. Kimmerling 
Richard P. Levy 
Brock Lynch 
Victor A. Machcinski 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry 
Philip H. Philbin 
Edgar B. Phillips II 




Patricia B Tudbury 
Ellis J. Van Slyck 
M Henry Williams, Jr. 
1948 
Russell J Barrnett 
George F. Batten 
Allyn G. Bridge 
Ruth E. Cortell 
G Robert Downie 
Elizabeth Fuller Eisner 
Boy Frame 
Emil Frei III 
Julian Frieden 
B. Herold Griffith 
Sylvia Preston Griffiths 
Richard M Hannah 
Ross R Harcus 
W Rayner Johnson 
Paul B Koehler 
Patrick J. McLaughlin, Jr. 
C. Arden Miller 
John P. Morris 
John B Morrison 
David E Morton 
George P. Rostel 
Benjamin F. Rush, Jr. 
Jerome H Shapiro 
William A. Sibley 
Jessie Parkinson Spear 
Anne G. St. Goar 
Paul Talalay 
Wallace W. Turner 
Paul Woodbury Weld 
1949 
William G. Anlyan 
Henry W. Baird 111 
William D. Bevis 
Jonathan S. Bishop 
Mary Pucci Couchman 
Phillip G. Couchman 
N Joel Ehrenkranz 
Daniel W. Elliott 
Albert A. Fisk 
Paul S. Goldstein 
Eleanora C. Gordon 
Frederic W. Gray 
Daniel K. Halvorsen 
Jackson Harris 
Gordon D. Jensen 
Timothy F. Nolan, Jr. 
Richard D. Otis 
Julian I. Pichel 
Edmund L. Piper 
Charles L. Rennell, Jr. 
Daniel Rudman 
William H. Sewell 
Raymond D. Sudarsky 
Mary-Agncs Pratt Wine 
1950 
Russell N. Anderson 
Lyal D. Asay 
Sylvia L. Axelrod 
Malcolm A. Bagshaw 
John E. Borowy 
William H. Bucher 
Alvin Davis 
Claude W. Delia 
Kent Ellis 
Thomas J. Ferraro, Jr. 
Daniel Fine 
David A. Frucht 
Carl A. Gagliardi 
Archie J. Golden 
Marilyn M. Kritchman 
Lucian S. Lapinski 
Sidney S. Lee 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry L. McClelland 
John H Meyers 
Orlando J. Miller 
Robert T. Sceery 
Cynia B. Shimm 
Jane B Shumway 
Martin Smith * 
Myra D. Tyler 
1951 
Karel Bedrich Absolon 
W Robert Adams 
Thomas T. Amatruda, Jr. 
Stanley D Ardell 
Muriel H Bagshaw 
Eleanor Clay Bigley 
John J. Egan 
Daniel X. Freedman 
Sidney S. Furst 
Joseph M. Garland 
Ralph M. Gofstein 
Lowell J. Goodman 
John T. Groel 
Robert N. Hamburger 
John V. Haxo 
Carrold K. Iverson 
Paul D. Millikin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Charles A. Nugent, Jr. 
Gerard B. Odell 
Jose Felix Patino 
Arthur A. Pava 
Majic S. Potsaid 
William F. Stephenson 
Harold M. Sterling 
William Taylor * 
1952 
John W. Arnold 
Frank R. Coughlin. Jr. 
Philip Gardner Deane 
Raymond S. Duff 
James R Durham 
Richard D. Floyd 
William Joseph Johnson 
Thomas S. Kelly 
James Kent Luce 
Robert F. Owen 
Robert G. Petersdorf 
Leon A. Phillips 
John Macklin Roberts 
Leonard Rush 
Mary Wheatland Schley 
Donald H. Schultz 
Robert B. Schultz 
Virginia Lee Swanson 
John H Wagner, Jr. 
Doris L. Wethers 
John L. Wolff 




Harold D. Bornstein, Jr. 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
Louis R.M. Del Guercio 
James P. Dunn 
Donnell Dencil Etzwiler 
Robert Emanuel Hamlisch 
A. Daniel Hauser 
George L. Hoffmann 
David Purdy Holman 
Peter Biggs Hukill 
Richard Robert Knowles III 
Robert N. Melnick 
Harvey Martin Peck 
Warwick Potter, Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
Barbara F. Rosenburg 
Irwin K. Rosenburg 
Virginia C. Saft 
Ora K. Smith 
Lynn Cortland Stoker 
William Junior Vandervort 
William August Wilson 
1954 
Frank P. Berg 
Richard J Bouchard 
George N. Bowers, Jr. 
Ralph K. Campbell 
John R Cole 
Arthur C. Crovatto 
Donald D Davis 
Walter J. Freeman 
John A. Gariepy 
Edward J. Gerety 
Frank L. Gruskay 
Nicholas A. Halasz 
Walker R Heap. Jr. 
Eva H Henriksen 
Samuel J. Hunter 
Herbert S. Hurwitz 
Robert J T Joy 
Donald S. Kornfeld 
Lowell A. Kristensen 
Richard Lamb 
Harry C. Miller, Jr. 
Paul N. Newfeld 
James .1. Nora 
Lowell E. Olson 
William J. Paule 
Anthony V. Piccirillo 
Richard D. Pullen 
Jacques M. Quen 
Edwin R. Ranzenhofer 
Earl D Rees 
David M. Robinson 
John Keith Rose 
Elihu M. Schimmel 
Leonard M. Silverman 
Robert L. Stein 
John W. Vosskuhler 
1955 
John B. Atwater 
John C. Bailar III 
George E. Becker 
E. Edward Bittar 
Jerome Bobruff 
Douglas G. Boyden 
Irwin M, Braverman 
Edward Noel Brennan 
Padraic Burns 
Leo R Cardillo 
Nicholas A. Coassin 
Edward D. Coppola * 
Milton Corn 
Pasquale James Costa 
Robert G. Crounse 
John G. Daley 
Fred Wendell Doyle 
William O. Edward 
Leroy Engel 
F. Robert Fekety. Jr. 
Mahlon V.R. Freeman 
Barbara W. Gibson 
Rudolph J. Goerke III 
Paul Gonick 
Ion Gresser 
John H. Hodge 
D. Franklin Johnson, Jr. 
Harry O. Kendall 
David R Kessler 
Robert A. Kramer 
William E. Lattanzi 
Roger Lester 
Alexander Maitland III 
Joseph S. McGuire, Jr. 
Guy M. McKhann 
Russell Miller, Jr. 
David Joseph Nelligan 
Robert C. Nodine 
James P. Nolan, Jr. 
Sherwin B. Nuland 
Gloria C. Onque 
John C. Pace, Jr. 
Robert H Peters, Jr. 
Gregory Peterson, Jr. 
F. Brantley Scott, Jr. 
Phillip W 'Smith 
Alan A. Stone 
1956 
Levon Z Boyajian 
Thomas M. Brown 
Rosalie A Burns 
Chandler Dawson 
S. Evans Downing 
Gilbert M. Eisner 
Thomas F. Ferris 
Armen Charles Haig 
John Herd Hart 
William H Hindle 
Marie-Louise T. Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Leo Lutwak 
Preston C. Manning 
Dwight F. Miller 
Norman F. Moon 
Donald J Nalebuff 
A. Frederick North, Jr. 
David A Page 
Stewart E. Purse] 
Edward C. Senay 
Benjamin A. Shaver, Jr. 
Daniel R Silbert 
1957 
Donald Agostinelli 
Joseph S. Amenta 
Louis V. Avioli 
Jack Norman Blechner 
Richard I. Breuer 
Harry C. Briggs 
Carl A. Brinkman 
John P Carey 
Albert K. Chun-Hoon 
Harold Dick Cross 
John D’Agostino. Jr. 
Thomas H. Danaher 
James R Dorr 
Edward Louis Eyerman, Jr. 
Harold J. Fallon, Jr. 
Robert E. Fishbein 
Ronald H. Fishbein 
Anthony L. Fons Ill 
Elizabeth H. Forsyth 
Robert H Glass 
Anne H Good 
Jack Peter Green 
Gilbert F. Hogan 
Warren R Johnson 
Richard Lee Kahler 
Stanley E. Kilty 
William L. Kissick 
George C. Knovick 
Jack Levin 
Mark D. Marshall 
David E. Martin III 
Howard A. Minners 
Robert K Modlin 
Hugh Lamson Moffet 
George Albert Nelson, Jr. 
Herbert A. Newman 
Thomas Francis O'Brien. Jr 
Joseph S. Pagano 
Raymond E. Phillips 
Clifford B Reifler 
Arnold Schoolman 
Kenneth A. Simon 
Gilbert B Solitare 
Robert W. Southworth 
Donald C. Stahl 
Arthur Taub 
William J. Waskowitz 
James G. Zimmer 
Deceased 
1958 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
John P Arnot 
Gerard N. Burrow 
David A. Carlson 
John A. Carlston 
John A. Creatura 
Lawrence Dubin 
Donald A. Duncan 
Joel C. Eberlin 
Michael E. Fishman 
Peter A. Flynn 
Raymond A Gaito 
John C. Gallagher 
James Greenwald 
Charles A. Hall, Jr. 
Michael Kashgarian 
Jay Ward Kislak 
Theodore W. Lieberman 
Myron Lotz 
Thomas J. Mauro, Jr. 
Michael J. McCabe 
Andrew Joseph McGowan, Jr. 
John A. Merritt, Jr. 
David W. O’Keeffe 
Carol F. Phillips 
David M. Pugh 
William B. Radcliffe 
Paul A. Rudnick 
William W. Schlaepfer 
Thomas R. Shea 
Edward Lloyd Socolow 
Raymond W. Turner 
Margaret Smith Wenzel 
Joseph P. Wierzbinski III 
John Patrick Wood 
1959 
Scott Ingram Allen 
Carol J. Amick 
Robert M. Amick 
Asa Barnes, Jr. 
Francis A. Beer 
William C. Butterfield 
Edward Call, Jr. 
Sidney M. Cohen 
Ronald C. De Conti 
Gerald Fenichel 
Robert L. Fisher 
Paul Jay Friedman 
Robert J. Gonyea 
Gerald B Gordon 
W. Keith Hadley 
James H Halsey, Jr. 
William H Heydorn Me 
C. Richard Hinckley 
Leonard Inker 
John J. Jasaitis 
Edvardas Kaminskas 
Herbert J. Kaufmann, Jr. 
David W. Kingsbury 
Myron S. S. Lee 
Kathryn Huxtable Lewis 
Daniel L. Macken 
John C. Marsh 
James A. O’Neill, Jr. 
Robert H. Ostberg 
Nicholas M. Passarelli 
Charles A. Phillips 
James R. Ralph 
David Pardee Reed 
Joseph Douglass Robinson, Jr. 
Joseph D. Saccio 
Marvin L. Schulman 
David B. Skinner 
Sanford P. Solomon 
Lisa A. Steiner 
Leo H Von Euler 
Muriel D. Wolf 
1960 
Festus O. Adebonojo 
Victor Altshul 
Jack D. Barchas 
Colin Mercer Bioor 
Ormond V. Brody 
* Deceased 
Donald P. Buebendorf 
Stanley M. K. Chung 
Gerald N. Cimmino 
Jon E. Courtney 
Louis A. D’Avanzo 
Malm Dollinger 
David P. Dunn * 
Caldwell B. Esselstyn, Jr. 
Warren H. Fisher 
Paul Jay Friedman 
Alvin E. Friedman-Kien 
Eugene C. Gaenslen, Jr. 
James I. Gilman 
Maxwell E. Gottesman 
Sylvia D. Grant 
Roland H. Ingram, Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Susan T. Kleeman 
Thomas P. Kugelman 




Eugene G. McCarthy, Jr. 
Donald L. Miller 
Richard G. Morrill 
Michael J. Moynihan 
Allan W. Newcomb 
Buford L. Nichols, Jr. 
J. Thomas Okin 
Jerrold M. Post 
Nancy Rolick Powell 
Albert Matthew Ross 
Daniel J Rubin 
John J. Schrogie 
Fred Stargardter 
Charles F. Stevens 
Robert C. Wallach 
May Yung-Fun Woo Wang 
Ronald A. Yankee 
1961 
Kenneth A. Arndt 
Earl L. Baker 
Frank H. Baker 
Albert A. Bechtoldt, Jr 
Robert S. Briggs 
David William Brook 
Paul David Deiter 
Ralph J. DePonte 
Ronald A. Dierwechter 
Jon Dudley Dorman 
T. Wayne Downey 
John E. Fenn 
Norbert Fleisig 
Edward C. Gilbert 
Louis D. Hunt 
Richard L. Keefe 
Thomas Kirsch 
Robert lssac Levy 
Hugh James Lurie 
Anoush Miridjanian 
Richard Allen Moore 
Norman 1. Moss 
John Curtis Parker 
John Pearce, Jr. 
Elaine Pitt 
Roy E. Ronke, Jr. 
Stanley G. Schade 
Robert N. Taub 
Hugh C. Thompson 111 
Franklin H. Top, Jr. 
David E. Weaver 
Warren D. Widmann 
1962 
Michael H. Alderman 
Charles B. Anderson 
Frederic P. Anderson 
Dean E. Burget, Jr. 
Fredric K. Cantor 
Ray Allen Carlsen 
Thomas Newell Chase 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
I. Bruce Elfenbein 
Roderick C. Haff 
Patricia C. Hassakis 
Victor W. Hurst 111 
Walter Watson Karney 
Glenn L. Kelly 
David E. Knoop 
Manual J Lipson 
John P. Lynch 
Malcolm A. Martin 
Allan L. Mattern 
Stanley E. Matyszewski 
William G. Meffert 
George Stuart Miller 
William A. Miller 
Malcolm S. Mitchell 
David D. Nicholas 
Joseph Ross 
James A. E. Spencer 
H. Oliver Stoutland 
Seth Thaler 
Sherwood Waldron, Jr. 
Stewart R. Wright 
1963 
Arthur Howard Ackerman 
Miguel R. Alonso 
V. Richard Back 
Charles W. Carl, Jr. 
Theodore J. Chu 
Gordon S. Cohen 
John E. Conte, Jr. 
David F. Cross 
Dudley Seth Danoff 
Judith Malm Davis 
Andrew Edin 
David H. Fram 
William T. Friedewald 
David H. Fulmer 
Alexander R Gaudio 
Lee D. Goldberg 
Peter B. Gregory 
Benjamin Keith Harris 
Harold P. Kaplan 
Constantine D. Kyropoulos 
William B. Lehmann 
Craig H. Llewellyn 
Edward G. Lund, Jr. 
Sally Lockwood Marchesi 
Vincent T. Marchesi 
Robert H Margulis 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R. Pinnell 
Jay M. Pomerantz 
Gene R Profant 
Lee Bland Talner 
Thomas W. Tillack 
Peter V. Tishler 
Lawrence Tremonti 
Peter G. Weiner 
Jerome Allen Winer 
Alfred J. Wise 
1964 
Berton W. Ashman 
Leland S. Berger 
Philip Blume 
Anthony J. Bravo 
Robert M Briggs 
Thomas A. Cardella 
Joseph F. J. Curi 
Alfonso Esguerra 
Norman C. Fost 
Peter A. Gross 
John F. B, Haney 
Gene 1. Higashi 
Lawrence Horwitz 
William J. Houghton 
William E. Knight 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
James S. Levine 
Paul R. Lightfoot, Jr. 
Richard Murray Linburg 
Andrew E. MacMahon 
William F. Matchett 
Thomas O. McCann 
Robert L. Mitchell 
James J. Murphy 
Donald A. O'Kieffe 
William B Pratt 
Stanley J. Rosenberg 
Jonathan J. Russ 
Richard P. Saik 
Stephen A. Schacher 
Norman Scher 
Robert L. Shelton 
Donald G. Skinner 
A. Thomas Snoke 
Richard C. Stillman 





Susan A. Aoki 
John H M. Austin 
Paul Balter 
Victor J Burner 
Thomas B. Caldwell III 
David G. Campbell 
Dewey A. Christmas, Jr. 
Robert M. Cohn 
Michael J. Cummings 
Phyllis Hurwitz Duvdevani 
David S. Fedson 
Robert I. Finkel 
Frank J. Grady 
Gary Lawrence Gross 
Robert Andre Gryboski 
James K. Gude 
Reid R. Heffner, Jr. 
David A. Hill 
Carl E. Hunt 
Robert H. Koehl 
Richard J Kozera 
David J. Kupfer 
David B. Leof 
Sandra Chook Levine 
Mark W. Lischner 
Philip D. Manfredi 
Walter W. Noll 
A. Lawrence Ossais 
John A. Parrish 
Robert L. Pickens 
Alan N. Rachleff 
William A. Renert 
George B. Rowland 
John H Seashore 
Margretta Ann Reed Seashore 
Charles J. Semonsky 
David M. Shames 
David P. Simmons 
Robert T. Solis 
Alan William Stone 
Robert G. Weiner 
Bert Yuan-Shu Wong 
1966 
Benjamin F. Balme 
John D. Baxter 
Frank C, Bell 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Joseph A, Donadio 
Robert E. Dragon 
Marvin A. Eisengart 
Jared M. Emery 
Robert N. Frank 
Robert C. George 
Peter D. Gibbons 
Stanley I. Greenspan 
J. McLeod Griffiss 
Robert A. Gunn 
Stuart T Hauser 
Jay G. Hayden 
Mary Alice Houghton 
Richard J. Howard 
Bruce W. Jackson 
Gordon R. Kelly 
Neal Koss 
Stuart M. Kotler 
Wilbur L. Kukes 
David C. Law 
Lynne L. Levitsky 
Henry B. Mann 
Robert L. McRoberts 
John Stephens Melish 
Marian Matheke Melish 
Harold Mellin 
Eli H. Newberger 
Neil J. Peterson 
William D. Peterson 
Joel Singer 
James D. Slavin, Jr. 
Gary L. Townsend 
Lee Van Lenten 
Joan T. Wayland 
Jon S. Wayland 
John W. Wickenden 
William B. Yeagley 
Arne S. Youngberg 
Richard B. Yules 
1967 
Daniel L Arons 
Arthur L. Beaudet 
Daniel J. Booser 
Gary C. Burget 
William T. Cave, Jr. 
Marian C. Davidson 
James J. Dineen 
James M. Dowaliby, Jr. 
John A. Drews 
Peter R Egbert 
Herbert W. Felsenfeld 
Melvin Victor Goldblat 
Richard J Hart 
Richard L. Heppner 
Peter N. Herbert 
George P Herr 
David L. Ingram 
Anthony P. Lovell 
Stephen W. Miller 
William J. Mitchell 
Joseph L. Morris 
Jennifer Robinson Niebyl 
John O. Pastore 
William E. Perkins 
Brian F. Rigney 
Robert I Roy 
Jonathan L. Saveli 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith, Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B. Swett 
M. David Tilson III 
Karen H. Toker 
George Tyler 
Robert A. Vogel 
Joseph F. Walter 
Martin Wand 
Robert J. Winer 
Robert S. K. Young 
Ihor George Zachary 
Peter M. Zeman 
1968 
Philip L. Barry 
Daniel I. Becker 
Grace Jordison Boxer 
William Catalona 
Donald R. Coustan 
Edward M. Druy 
Barbara M. Egbert 
Alan G. Finesilver 
Richard A. Getnick 
Mark Gilbert Grand 
Leonard Grauer 
Ralph S. Greco 
Kevin N, Hennessey 
John R. Hill, Jr. 
Harry S. Holcomb III 
Thomas R. Johnson 
Jeffrey S. Lee 
Frank E. Lucente 
Donald O. Lyman 
Rodrigo Martinez 
HaTmon Michelson 
David P. Millett 
Richard P Mills 
Peter Nicholas, Jr. 
37 
John A Ogden 
Margot Onek 
Jackson B E. Pickett 111 
Charles T. Post, Jr. 
Joseph L. Renda 
Gordon H. Sasaki 
Frederick C. Sherman 
Elizabeth M. Short 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
James L Weiss 
Per Henrik Wickstrom 
1969 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
N. Roger Cooke 
Richard J. Daly 
Charles A. Dinarello 
Ralph J. Falkenstein 
Gary S. Farnham 
William H. Frazier 
Royal J. Gay 
David A. Geer 
Sander G. Censer 
Robert O Gordon 
Steven M Herzberg 
Thomas C. Howard 
Lee M. Jampol 
Joel Mark Kaufman 
Paul H. Kelker 
John J. Kelly, Jr. 
Stephen Krant 
Elliot M. Livstone 
Robert L. Marier 
Arnold F. Mazur 
Ellen B Milstone 
Thomas F. Minehan 
Bruce K. Nagle 
Lionel M. Nelson 
Nancy Olmsted 
Deborah A Putnam 
N Burgess Record, Jr. 
Joseph D. Robinson 
Joseph M Rochford 
Dennis J Rudzinski 
David J Sahn 
Adrian M. Schnall 
David J Schulak 
Gerald J. Smallberg 
Michael S. Toren 
Robert J. Walat 
Steven C. White 
1970 
William Romney Burke 
Henry Chessin 
Michael J. Chusid 
C. Norman Coleman 
Michael D. Danzig 
Jonathan Ecker 
Robert Alan Epstein 
Bruce A. Fabric 
Thomas H. Gouge 
Paul C. Hesslcr 
Jay H Hoofnagle 
Jonathan D. Katz 
Gerard T Kennealey 
Ely A Kirschncr 
William G Koehnc 
Mark A Korsten 
IJiomas L Lewis 
Robert B Litman 
Anne W. Lucky 
Leonard M Milstone 
lames R Missclt 
Bruce A Reitz 
Robert M Rosa 
Joel 1- Rubinstein 
Dennis E. Shield 
Stuart S. Shorr 
Richard A St. Ongc 
Ray W l ripp III 
Brian Weiss 




Judith L. Bader 
Laurie J Bleicher 
Willard Cates, Jr. 
John L. Cieply 
Frederick L. Cohn 
Andrew D. Cook 
Edward C. Cottle 
Michael Cynamon 
John S. Ebersole 
Leonard 1. Eisenfeld 
Harvey Fernbach 
Fred Finkelman 
Jared J Gardner 
Richard Gloor 
Michael J. Hart 
William W Hay, Jr. 
Barbara K Kinder 
Michael E. Klein 
William L. Krinsky 
David H. Lippman 
Samuel S. Masters 
Wallace J Matthews, Jr. 
John C. Mills 
Patrick T. Minihan 
Steven H Moffic 
Richard Albert Moggio 
Richard R Neufeld 
Martin Paris 
John A. Patti 
Barry Bruce Perlman 
Michael C. Piercey 
Anthony V. Proto, Jr. 
Barry S. Rand 
David M Rinzler 
Douglas R. Schmidt 
John Smiarowski 
James P. Southwick 
Jonathan W. Stewart 
Daniel R Synkowski 
Richard D. Travers 
Yvonne E. Vaucher 
Paul A. Vignola 
Robert B Vranian 
Albert Carl Weihl 
Daniel G. Wright 
1972 
Robert D. Arbeit 
R Michael Buckley, Jr. 
Michael A. Catalano 
Leonard H. Cohen 
Philip L. Cohen 
Gloria Cummings * 
Norman M Dinerman 
William H. Druckemiller, Jr. 
William F. Duke 
John W. Foster, Jr. 
M Fleix Freshwater 
John P. Fulkerson 
Dorothy M. Gohdes 
Bruce B Haak 
Andrew E. Hoover 
Thomas L. Horn 
Vernon H Humbert, Jr. 
Fred Hyde 
Anthony H. Jackson 
Jesse B Jupiter 
Roy A. Kaplan 
Donald L. Kent 
David L Kneapler 
Paul A. Lucky 
Harry L. Malech 
Jeffrey S. Menkes 
Jerome H. Meyer 
Jorge A Motta 
Thomas H. Ogden 
Edward J. Olinger 
John N. Posch 
William L. Risser 
Philip M. Rothfeld 
John S. Smolowe 
Frederick D. Stockwell 
Philip J. Wcyman 
Michael W. Yogman 
Steven M. Zcldis 
1973 
David Nelson Bailey 
Mary Ann Brunstetter-Shafer 
Marvin M. Chassin 
Joseph M. Connors 
David L. Coulter 
Christopher M. Doran 
Joseph W Eichenbaum 
Jane H Ferguson 
Richard J. Fingeroth 
Robert A. Florin 
Robert E. Galloway 
Lee Goldman 
Gary T. Grimes 
Neal Handel 
David C. Johnson 
Andrew G. Kadar 
Lynne M. Liptay 
George Lister, Jr. 
Harold R Mancusi-Ungaro, Jr. 
Mark G.F. McCormick 
David E. Peach 
Charles F. Reynolds III 
James S. Robertson 
Harry S Romanowitz 
Jerrold F Rosenbaum 
Robert A. Sirota 
John R. Stratton 
James F. Sullivan 
Thomas F. Sweeney 
Robert J. Ursano 
Christine A. Walsh 
Marc A. Weinberg 
Richard S K. Young 
Randall M. Zusman 
1974 
Irving M. Asher 
Douglas A. Berv 
Bruce David Blumberg 
Neil Blumberg 
Peter J. Buchin 
Bert D Collier, Jr. 
Paul David 
Vincent A. Di Maria 
Michael K. Eshelman 
Irl L. Extein 
Allan B. Friedland 
Michael A. Gerber 
David Grant 
Robert C. Jimerson 
Ancil A. Jones 
Saul Lande 
Edward L. Marut 
Richard C. Pasternak 
Andrew L Ries 
David Z Ritvo 
Daniel 1 Rosenthal 
Amy S. Schechter 
Robert J Schechter 
Carol C Teitz 
John Jones Thompson 
1975 
Ralph E Binder 
Neil Blumberg 
William S Bush 
Carl C. Chi 
Stanley W Gale 
Elizabeth R Gawron 
Carol L. Kandall 
Richard J. Loewenstein 
Bruce B. McLucas 
Hyman J Milstein 
Mary Jane Minkin 
Robert G. Nankin 
Andrew B. Newman 
Edwin G. Olson 
Vivian Reznik 
James F. Robertson III 
Salvatore V. Romano, Jr. 
Fred P. Rosenfelt 
Richard L. Roth 
Robert S. Sandler 
Steven A. Schwartz 
George H. Talbot 
Mark F. Wheeler 
Henry S. Willner 
David W. Wiltse 
Douglas R. Zusman 
1976 
Sarah S. Auchincloss 
Alfredo L Axtmayer 
John C. Bartlett 
Peter B Bitterman 
Sharon L. Bonney 
Roger A Boshes 
Randall D. Cebul 
John D. Clemens 
Geoffrey Etherington 
Leonard Firestone 
Rose Hannah Goldman 
Glenn A. Gorlitsky 
Avi J. Hettena 
Norman V. Kohn 
William J. Lederer 
William K. Levy 
George W. Luedke 
Douglas G Mann 
Paul R Ramirez 
Mark C. Ruchman 
Lawrence E. Samelson 
John T. Sladky 
Bonita F. Stanton 
Peter M. Ting 
Frank B Watkins 
John C. Wiles 
Carol M. Ziminski 
1977 
John J. Boronow 
Stuart Brian Dubin 
Sybil E. Duchin 
Susan Firestone 
James A. Fox 
Julia B Frank 
Steven R Hahn 
Robert W. Hand 
Jeffrey Neal Hausfeld 
Karen G Kelly 
David J Kreis, Jr 
Alice Y. Matoba 
Margaret S. McKenna 
Robert J. Mitchell 
Alan S. Penziner 
Steven J. Scheinman 
Ricky M. Schneider 
Simeon A. Schwartz 
Mark S. Smith 
Gail M. Sullivan 
Ronald J. Vender 
Steven L. Warsof 
John E. Whitcomb 
J. Douglas White 
1978 
Thomas T Amatruda 
Richard J. Baron 
Booker T Bush, Jr. 
Duke E. Cameron 
Emily A. Fine 
Stuart M Forman 
Arthur M. Gershkoff 
Nancy E. Good 
Linda J Hall 
Jerald D Hansing 
Robert Hershfield 
Robert L. Kraft 
Cynthia S. Kretschmar 
Kendrick E. Lee 
Kenneth L. Marek 
Steven M. Shoum 
Donald C. Simonson 
Caroline R. Taylor 
Marcia J. Wade 
Jonathan D. Weinberg 
Sharon R. Weinstein 




David A Brenner 
Ken Burkus 
Orlando Fernandez 
Joel I. Franck 
John Jay Gargus 
David E. Golan 
Bruce Halperin 
Edward C. Halperin 
Jeffrey L. Kaine 
Leslie Jay Katz 
Michael K. Lindsay 
Westley Reeves 
Jean Rosenthal 
Gary L. Schaer 
Eric A. Schwartz 
Cynthia Anne Sherman 
Jill A. Silverman 
John T. Woo 
Jeffrey Work 
1980 
David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R Aronson 
Alan B Astrow 
David Allen August 
Jay M. Baraban 
Mark S. Bernhardt 
Patricia Church Brown 
Daryl Fraser Browne 
Stuart L. Bursten 
Michael M. Chang 
Thomas F. Deering 
Forrest John Doud 
Todd J Garvin 
Marc F. Glickstein 
David Jay Goldberg 
Gary 1. Greenwald 
Maria White Greenwald 
Barry M. Kacinski 
David Kass 
Mary C Kornei 
Theodore W. Marcy 
Cesar R. Molina 
Steven Ira Rosenfeld 
Alan E. Schlesinger 
John A. Selling 
Hillel D. Skoff 
Marcia R. Taylor 
Nancy T. Taylor 
Mary Hill Wise 
Lawrence H Young 
1981 
Cynthia B. Aten 
Alicia Barela 
Susan Burdette 
Patricia A Burke 
Christine M Duranceau 
Louis Essandoh 
Paula M. Fracasso 
Ramona Q. Fung 
Judy E. Garber 
Robert S. Goldman 
Laurie J. Gordon 
Scott A. Hundahl 
Barton N. Milestone 
Robert M. Milstein 
David A. Paly 
Barbara A Roach 
Sheryl A. Ryan 
John C. Wong 
1982 
Thomas J. Brennan 
Muriel Cyrus 
Liba E. Goldblum 
Jed B Gorlin 
Daphne Hsu 
Kathleen Anne Nolan 
Joyce A O'Shaughnessy 
Dan B Odenheimer 
Christopher N. Otis 
Carrie A Redlich 
Paula C. Schlesinger 
William M. Sikov 
Albert L. Ungricht 
Stephanie Wolf-Rosenblui 




Nancy Kraemer Crocker 
James S. Grober 
Ana Maria Lamas 
Laurie Margolies 
Dan A. Oren 
Augusta S. Roth 
David E. Schwartz 
Michael Silverberg 
Daniel M Sosin 
Philip M. Spiro 
Kenichi Takeshita 
Nancy K Terrell 
1984 
Charles S. Abrams 
John F. Babich 
Leonard O Bell 
Barbara Ann Coda 
Jeffrey N. Katz 
Michel Kliot 
Jay R Kostman 
Richard L Leff 
Paul B. Rothman 
Mark Stein 
Andrew L. Sternlicht 
Susan P. Tredwell 
Contributors to the 





John J. Batchelor 
1927 
Alice S. Baldwin 
1929 
Mitchell B Stock 
1930 




Edward B Bosworth 
Evelyn H. Halpin 
Elizabeth Murphy 
1934 
Ival A. Merchant 
Iwao M. Moriyama 
Amy H. Wilson 
1935 
Franklin M. Foote 
Almeda King 
1936 
M. Allen Pond 
1937 
Lidie V. Dyer 
William R. Willard 
1938 
Willard H. Boynton 
Richard K.C. Lee 
Katharine Hawley Martin 
1939 
Carl I. Cohen 
James C. Hart 
Frances S. Miller 
1940 
Elizabeth H. Pitney 
Meyer J. Plishner 
Ruth G. Taylor 
1941 
Roslyn L. MacNish 




Henry F. Canby 
Leonard Parente 
Arthur B Robins 
Charles D. Spangler 
1943 
Julius Elston 
Carolyn S. Koffler 
Eric W Mood 
Miriam H Rohde 
Jane L. White 
1944 
Massimo Calabresi 
Jean F. Heston 
Jane Y. Parker 
1945 
Roslyn R Bilford 
Mary B. Dale 
Naomi Barer Golden 
Joe B. Graber 
Lois M. Jund 
Naomi Helen Kalajan 
1946 
Dorothy B. Hamilton 
Dorothy Y. Kirk 
D Patricia Nelson 
1947 
Sidney S. Chipman 
Anne E. Fulton 
Lillian L. Konick 
Raymond W. Leonard 
JoAnn S. Lewis 
Rosa Frances Montgomery 
Jean M. Pinder 
Samuel Zibit 
1948 
Chester S. Bowers 
John B. Dibeler 
Mary L. Ellis 
Mary Margaret Fitzgerald 
Samuel S. Herman 
Richard E Johnson 
Beatrice H. Kaasch 
Dorothea S. LaBelle 
Hiram Sibley 
1949 
Eleanor C. Connolly 
M. Otis Flanary 
Edgar L. Geibel 
Eleanor P. Kostant 
Hilda H. Kroeger 
Christine R. Owre 
William B. Parsons 
Elizabeth D Robinton 
1950 
Wyntha T. Boothe 
Henry G Brickman 
Ida M Bucher 
Helen P. Cleary 
Austin J. Evans 
Jerome M. Glassman 
Dorothy R Granoff 
Eugene K. Harris 
Martha P. Jayne 
Everette D Reese 
Frances K. Reynolds 
Nathan M. Simon 
John D. Thompson 
1951 
Joseph Axelrod 
Clarissa E. Boyd 
Norton G. Chaucer 
Homer P. Hopkins, Jr. 
Robert L. Johnson 
George Kraus 
Leonard F. Menczer 
Elizabeth Ulrich Throm 
Virginia E. Torres 
Alexander J. Tutles 
Walter Wenkert 
1952 
Cahil H. Corbacioglu 
Mary M. Del Piero 
Howard Dunphy 
Malcolm C. Hope 
Charles Holway Lawrence 
Sidney S. Lee 
Helen Kardys Loria 
Yolande F. Lyon 
Anne Barlow Ramsay 
Brena B. Wolff 
1953 
Jeanette Averill 
Harold Robert Bernshock 
Graydon Dorsch 
William H Hermann 
Barbara J. Lee 
Laurence K Rainsford 
Milton H Sisselman 
Constance B. Thomas 
Donald N. Zehl 
1954 
Donald R Cowan 
Alvin Hamburg 
1955 
Constance T. Beemer 
Lester M Borstein 
Charline S. Buck 
Amy L. Cawley 
Israel Gitlitz 
Morris London 
Mary Me C. Mogan 
Frances R. Ogasawara 
Ann Peverley 
Gerald Rosenblatt 
Daniel E. Ross 
1956 
David D Boyd 
Kathleen H. Howe 
Paul C. Kaufman 
Mary K. Ochiai 
Floyd D Parrish 




Lee De Cady, Jr. 
William A. Clermont 
Edward R. DeLouise 
Sheldon Selig King 
Edna May Klutas 
William R. Metzger 
Jerome R. Sapolsky 
Shirley T. Steidel 
Paul W. Sternlof 
Patricia A. Viscosi 
1958 
Josephine Blanchett 
Helen H Davenport 
Thomas T. Flynn 
Normand E. Girard 
Edward H. Noroian 
Joseph A. Scorpion 
Mary K. Spiker 
Thomas P. Weil 
1959 
Joshua I. Cohen 
Raymond S. Duff 
Bennett I Enowitch 
John T. Foster 
Marvin A. Lavenhar 
Hugh J. Maher 
Feme G. Moore 
Lee J. Podolin 
John S. Pullman 
Ellwyn D Spiker 
Mattie Lee D. Wade 
Dorothy M. Wilson 
1960 
Kathryn L. D’Amico 
Wouter Ekker 
Maxine Geeslin 
Rose A. lannotta 
Hannah Clark Russell 
Else Niebuhr Schulze 
1961 
Gordon R Beem 
Mary S Blackburn 
Benjamin L. Capili 
Alfred E. Fletcher 
Helen M. O’Connell 
Margaret R. Parker 
Joseph T. Prekup 
Angela M Russo 
William R. Slivka 
Harold W. Wicks 
1962 
A. Kay Keiser 
Thomas R Mayhugh 
1963 
Dorothy Weichert Brockway 
Hantp Coley 
Raul R. Cuadrado 
David Dolins 
Frank M. Isbell 
Edward M Kenney 
Jean M. Maynard 
David R. Sheehan 
Samuel B Webb, Jr. 
1964 
Maria S. Baisier 
Elizabeth C. Beilis 
James J. Culhane 
Katherine Maria Detre 
Linda F. George 
Neal L. Maslan 
Theodore Rosenberg 
Estelle Siker 
Monroe W. Spero 
Claudewell Sidney Thomas 
1965 
Robert M. Edwards 
Edgar W Francisco, III 
Monte Nelson Frazier 
H. Patterson Harris, Jr 
William C. Harvey 
James F. Jekel 
Michael E. Kove 
Peter J Levin 
Elliot A. Segal 
Wallace W. Smith 
Viola J. Spinelh 
Matagiese G. Tunoa 
Sarah I.. Turner 
David S Weiner 
1966 
Allen Cohen 
Amalia P Crago 
Diana B Fischer 
Norman M Gervais 
Jennifer L. Kelsey 
Nancy Alfred Persily 
1967 
Carlos E. Alvarez Herrera 
Peter T. Elliot-Wotton 
Caroline Fong-Cheng 
Richard W. Gerry 
Ann Gomez 
Alberta S. Jacoby 
Steven Jonas 
Joel Kavet 
Lawrence J. Krone 
Joseph F. Kukla 
Dennis J. Magid 
Patricia D Mail 
James M. Malloy 
Brigitte Prusoff 
Beth M. Whelan 
Irma Willner 
Robert L. Woodward 
1968 
Doris Storms Brenner 
Philip D. Cobb 
Sonia M. Colon 
Joseph L. Dorsey 
Robert R. Everett 
L. Carol Fernow 
Carl R Fischer 
Michael J. Geaney 
Francis J. Greaney, Jr. 
Harold C. Lovely 
Jean C. MacCorison 
John M Patton 
Richard L. Petrelli 
Bobby G. Rowe 
Arnold R. Saslow 
Elizabeth A. Small 
Martha F. Steel 
Sheila W. Wellington 
Elizabeth C. Wright 
1969 
Susan S. Addiss 
Jean Parker Cobb 
Victor Crown 
James M Dawson, Jr. 
Sharon A. Garcia 
Gerald R Harpel 
Sylvia N. Holtzberg 
Charles C. Jeffrey 
Samuel P. Korper 
Judith B. Nichipor 
Samuel D Rowley 
Marva Serotkin 
Wanda Vierthaler 
Robert L. Young 
Chester W. Zarnoch, Jr. 
1970 
Susan W Balter 
Robert T. Beeman 
Arthur A. Berarducci 
Michael B. Bracken 
Hamilton B Brown, Jr. 
Shan Cretin 
Walter M. Gawlak 
Robert S. Gureasko 
C.P.Noel McCarthy 
Anthony M. Orlando 
Nancy Norton Reitz 
Charlotte F. Schwartz 
Stephen Skorcz 
Donald S. Wilkinson 




Evelyn J Bromet 
William F. Carey, Jr. 
Willard Cates, Jr. 
Katrina H Clark 
John A. Daeley 
Harvey Fernback 
William P. Ferretti 
Anne-Marie A. Foltz 
Sara P. Hartman 
Wanda J. Hatmaker 
William P. Koughan 
Bernard G Koval 
Mark J. Magenheim 
Eugene S. Mayer 
Joseph S. McManus 
Nancy P. Mogielnicki 
Wan Hin Ooi 
David A. Osgood 
Caro] L. Paul 
Marcia Russell 
Jane Silver 
Walter O. Spitzer 
Robert E. Steele 
Barbara R. Stoloff 




David P. Barone 
Steven H. Beloff 
Catherine A. Connolly 
Thomas F. Frist 
Daphne Dej Gemmill 
Jean T. Harrison 
Dorothy N. Lewis 
Gerald Miller 
Sergio Ruschel 
Jo Ann K. Silverstein 
Laurence A. Tanner 
Frederick A. Vago 
Joyce R. Waksman 
Owen L. Wood 
1973 
Emily M. Barclay 
Karen D. Brabill 
Eva Danielsson Cohen 
Bernice E. Coleman 
Marie L. Dargan 
Ellen B Dolt 
Schula Russell Hobbs 
Chang S. Lao 
Dennis P May 
Marjorie E. Nelson 
Gary Dean Sax 
Janet B. Schoenberg 
Alice S. Stark 
Thomas J. Stranova 
Irene Trowell-Harris 
Larry S. Webber 
Bonnie C. Yankaskas 
Carl J. Zack 
1974 
1 Willard Abrahams 
Rose Salisbury Beer 
Gregory Belok 
Thomas A. Benoit 
Olga M. Brown 
Carl A Cappello 
J Breckenridge Eagle 
Elizabeth M. Helming 
Roberta Lawerence 
Karen K Lindfors 
Nancy F Meneelv 
Nils R Richardson 
Deborah Rose 
Carole T. Schreiber 
Shelly S. Shanok 
Donald R Showalter 
Abigail L. Smith 
J Lawrence Tanenbaum 
Myrna M. Weissman 
Bienvenido G. Yangco 
1975 
Clayton A. Ajello 
Edith N Baum 
Ralph E Binder 
Gerald F. Bisbee, Jr. 
Linda K Broker 
Hillary Demby 
Linda K. Demlo 
William J. Grego, Jr. 
Anne H Hall 
Edward J. Halloran 
Kenneth G Hill 
Elizabeth T. Hunter 
Rosemary M. Johnson 
Barbara R. Untcrman Jones 
Susan M Kaetz 
Philip D Kennedy 
James E Knoben 
Kathy S Kohn 
Patrick W Uskey 
Stuart 1 Lcfkowich 
Sheldon M. Levy 
l ots S. Michaels 
I ilccn M O'Gara 
Mary W. Palshaw 
William P. Quinn 
I dward V Sargent 
Nancy F Stroup 
R i . in d ' hiu-Ping fang 
Franziska U. Ulrich 
Vera B. Walline 
Audrey S. Weiner 
Marion Lee Wu 
1976 
Peter B. Aaronson 
William F. Appicelli 
Agueda N. Deans 
Joanna M Erikson 
Paul H. Etkind 
Robert H. Frazier 
Gail lies Genvert 
Linda J. Goodhart 
Karen A. Gordon 
Raymond E. Grier 
Janet Heinrich 
Robert T. Kauer 
Robert A. Knauf 
Janina Levy 
Robert C. Marquardt 
Lawrence V Meagher, Jr. 
Gino A. Nalli 
Ruth Fitch Quah 
James B Rokos 
Robert Risdon Schwarz 
Mary Jo Shepard 
Robert Silten 
Marcia A Testa 
Gladys A. Williams 
Thomas S. Wingardner, Jr. 
1977 
Richard B Burford, Jr. 
Patrick F. Carone 
Jeffrey Allen Cassis 
Dennis K. Dang 
Annette T. Eichenbaum 
Gerard J Foley 
Barbara L. Gervis 
Henry C. Gift 
Ellen D. Jaslow 
Rhona Kantor Kershnar 
Teri J Klein 
Ronald F. LaPensee 
Wendy K. Lefkowich 
Polly W, Marvin 
Sharon A Mulgrew 
James M O'Connor 
Kristin K. O'Connor 
Harris Pastides 
Linda Mendelsohn Pottern 
Dorothy A. Rice 
William T. Richards 
Lynne E. Rosenwald 
Abby Rothschild 
Anthony V. Sardinas 
Carroll Schilling 
Gail M. Sullivan 
Rose M. Truax 
Thomas H. Ulfelder 
Leon F. Vinci 
1978 
David S. Abernethy 
Vijaya V. Bapat 
Kathleen M Berman 
William Harvey Blitz 
Alan B Bloch 
Maura Carley 
Robert J Fensterheim 
Robert H. Frazier 
Ann T. Freedman 
Janice F. Gold 
James Gonzalez 
Cynthia R. Gross 
Patricia S. Harfst 
Nancy G. Hildreth 
Stephen W Hildreth 
David W. Houck 
William A. Howard 
Margaret Long Karis 
Roslyn I. Liss 
Christopher M Maylhan 
Marguerite Nelligan 
Michael H. Owens 
Trudec Parentcau 
Ellen J. ReiOcr 
Irene Schapiro 
Michelle D. Schoenberger 
Robert E. Schwartz 
Roberta Jo Shapiro 
Gloria Shappy-Meickle 
Karen Wolchuck Sher 
Roberta Nancy Silbert 
Alan J. Siniscalchi 
Martyn R. Smith 
Marie Stoeckel 
Sydney S. Tang 
Rolando Antonio Thorne 
R Bradford Walker 
Lucy Ellen Weiger 
1979 
Bruce S Anderson 
Virginia P. Bainbridge 
Gertrud S Berkowitz. 
Marianne Berwick 
Marna P Borgstrom 
Russell J. Bramlage 
Elizabeth S. Carter 




Kathe P. Fox 
Judith B Gancher 
Lucinda H Gerson 
Debra Haffner 




Renee S. Leary 
Mary Elizabeth Lorenzi 
Osvaldo Marrero 
Laure C. Nichols 
Betty J Reid 
Marcia C. Richardson 
George B Rowland 
Ralph Tartaglione, Jr. 
Elizabeth Tedder 
Mary Jane A. Teta 
llene B Wachs 
Louise Wise 
1980 
Gary J Aboff 
Frederick R Aronson 
Curtis S. Breslin 
Antoinette M Brooke 
Richard L Buck 
Gary L. Busack 
Deborah J. Carr 
Sheila Conneen 
Diane L. Denis 
Audrey L. Fetter 
Beth M. Finkelstein 
Barbara H. Granger 
Susan Greenberg 
Ellen B Greif 
Samuel S. Hamilton 
James P Harisiades 
Virginia S. Humphrey 
Helen E Kelly 
Yee-Lean Lee 
Robert V. Levine 
Kathleen A. Lewis 
Paul A. Locke 
Leroy F. Ludwig 
James S. Marks 
Linda L. Moraga 
Anne E. Morrison 
Steven Morrow 
Ann L. Prestipino 
Christina P. Quinn 
Jeri Ann Rose 
Susan L. Schwartz 
Lydia A. Selling 
Jane T. Siegal 
Marsha L. Silverman 
Judith Stavisky 
Richard Gerard Stracqualursi 
Thomas A. Tobin 
Tal Ben-Dashan Widdes 
Philip A. Witman 
Marie L. Zanotti 
1981 
Jean Adnopoz 
Patricia J. Checko 
Rollin C. Chew 
Ann M. Dunbar 
Julia Eisenstein 
Brian J. Foley 
Kristen H. Forrest 
Robert Fox 
Judy E. Garber 
Barbara A Gaugler 
Marie F. Gavula 
Louis M. Gonzalez 
Joan Urauhart Goodman 
Susan A Hart 
Susan E. Jennings 
Thomas J. Krause 
Jill L. Lapides 
Katherine M. McCormack 
Blackford Middleton 
Marlee D. Mooney 
Charles W. Nelson 
Mary E. Papke 
Maureen T. Power 
Elizabeth N. Shapiro 
Karin Swanson 
Nancy Schlesinger Weiss 
1982 
Jamie L. Amaral 
Jenny I. Andrus 
Francis L. Crowley 
James L Hadler 
Denise Heinemann 
Constance M. Jarowey 
Charles A. Klivans 
Linda F. Me Caig 
William F. McKeon 
David L Mork 
Jill A. Okrent 
Carolyn Xavier Orcutt 
Marie Zullo Rice 
Sally R Rinaldi 
Christopher J. Rogers 
Dale Allan Rublee 
Lisa E. Stone 
Yukiko Tomabechi 
Michele T. Visconti 
Sandra Michaelson Warren 
Daniel Wartenberg 
Alvin C. White 





Mark L. Dembert 
Robert A Duncan 
Susan Faris 
James N. Gaito 
Ellen M. Ginzler 
Daniel A. Graybill 
Cindy Lou Jajich 
Nancy R. Kellett 
Allen F. Levy 
Wendy L. McGill 
Beverly Y. Nipper 
Jeannee M Parker 
Barbra G. Rabson 
William Sabella 
Marilyn F. Vine 
Nancy K. Wright 
1984 
Leslie A. Balch 
Linda Balzano 
V. Deborah C. Carroll 
Carolyn H. Grantham-Millman 
Penny H Hausser 
Cynthia A. Hymes 
Jean G. Larson 
John S. LaBella 
Theresa Marie O'Connor 
Julie A. Russem 
Gerald L. Springer 
Carey Vames 
Contributors to the 
Public Health Alumni 
Fund 1984-85 
Friends 
Thomas H.G. Aitken 
Edward M. Cohart 
Wilbur G. Downs 
Adolf Pharo Gagge 
Edward M. Opton 
Contributors to the 
Medical School Alumni 
Fund 1984-85 
Former House Staff 
Robert A. Achtel 
Frederick W. Ackroyd 
N. Erick Albert 
John L. Albrigo 
Neil S. Alex 
Adel H. Ayoub 
Robert G. Bachand 
Ronald J. Bailey 
David B Baldwin 
Carl Bennett Bean 
Robert Berger 
Gregory Kent Bergey 
Larry Berte 
Kenneth R. Berv 
Mary C. Bibro 
Ralph Daniel Bien 
Robert M Black 
William K. Boss 
Laurence A. Boxer 
Alan L. Breed 
Steven A. Brody 
Marvin B Brooks 
Thomas N. Byrne 
Dennis J. Card 
Victor Carpiniello 
J. Richard Casuccio 
Joseph B. Chandler 
Whei C. Chang 
Richard Allen Chase 
Chang Song Choi 
Michael Chun 
David L. Copen 
Robert E. Crootof 
Jeffrey P. Cullen 
F. Mitchell Cummins 
Harvey Davis 
Richard K. Donabedian 
William R. Drucker 
Tom W. Duke 
Marlene R. Eckstein 
Stephen A. Edelstein 
Daniel S. Egbert 
David E Eibling 
Lawrence B Eisenberg 
Malcolm Mitchell Ellison 
Walter Ettinger 
Alvan R. Feinstein 
Richard Webster Finner 
Daniel J. Friedenson 
Gary E. Friedlaender 
Norman H Gahm 
Henry B Garrison 
David M. Gershenson 
V. Philip Glassman 
Barry Goldberg 
Nelson H Goldberg 
Isaac Goodrich 
Paul Ned Graffagnino 
Willard F. Greenwald 
Robert J. Gross 
Gordon W. Grundy 
Joseph Guaraldo 
William R Haas 
Hedda Ann Litowitz Haning 
Stanley Hersh 
Douglas P. Hobson 
Melvin Horwitz 
David Smith Hubbell 
Eric A Hyson 
Robert Orville Jensen 
Rollin M. Johnson 
Robert M. Johnston 
Wayne Julian 
Norman Kaplan 
Jill P. Karpel 
Michael W. Keith 
David J. Keller 
Stephen King 
Samuel C. Klagsbrun 
Lawrence E. Klein 
Thomas J. Koontz 
Eugene Kuchner 
Joel C. Labow 
Sheri J. Lagin 
Emmanuel Landau 
Joan L. Lasser 
John T. Latham 
Douglas M. Levin 
Stanley B. Levine 
Peter G. Levinson 
Arthur L. Levy 
John D. Lewis 





Edward J. Manwell 
Stephen Mariani 
Frank Masino 
Richard J. Maunder 
Pamela M. McBogg 
John P. McGovern 
Thalia Mesologites 
Patrick E. Moriarty 
Hans C. Muechler 
Seymour Cy Nash 
Richard A. Norton 
Joseph Manuel Ortiz 
Raymond L. Osborne 
Robert L. Paltzik 
Elaine Beguin Panitz 
Pradip M. Pathare 
Gordon K. Phillips 
Edward L. Racek 
Donald C. Rankin 









Susan Lynn Schley 
Robert Schnurr 
James Thomas Sehn 
Richard Alan Selzer 
Thomas E. Shaffer 
Daniel W. Shapiro 
Ezra A. Sharp 
Joel Silidker 
Frederic N. Silverman 
Ethan A H. Sims 
Richard I. Staiman 
Sally K. Stansfield 
John G. Steciw 
Sturla Stefansson 
Elsa L. Stone 
Fred Leslie Strieker 
Craig Summers 
Herbert Tabor 
Imad F. Tabry 
Theodore Tyberg 
Daniel W. VanHeeckeren 
Douglas Viets 
Romulo L. Villar 
Milton Virshup 
E. Maurice Wakeman 
Thomas A. Warthin 
Alan Weinberg 
Ssu I. Weng 
Herbert Allan Wenner 
George Wharton 
Robert R. White 




Robert P. Yoo 
Robert C. Young 
Andrew Zaruski 
Richard Walter Zimmerman 
Lawrence H. Zingesser 
Louis Zinterhofer 
Contributors to the 
Medical School Alumni 
Fund 1984-85 
Parents and Friends 
Kurt 1. Altman 
Dr, & Mrs. Dorrance I. Anderson 
Stanley August 
Mr. Robert August 
Drs. John & Marie Babich 
Edwin Beall 
Malcolm Brochin 
Hariet F. Brown * 
Mr. & Mrs. Ormonde L. Brown 
John C. Cate IV 
Ms. Minnie R. Cartwright 
Mr. & Mrs. Abe Cazen 
Ms. Betty Chelmow 
Mr. & Mrs. Richard S. Childs 
Evis J. Coda 
Mr. & Mrs. Sidney J. Cohen 
Willibald H. Conzen 
Lawrence Deangelis 
Mr. & Mrs. Kenneth T. Doran 
William G. Dyess 
Max Finkelman 
Mr. Peter J. Fried 
Jose M. Garcia-Madrid 
William J. German * 
Myron Greengold 
Barbara J. Guillette 
Kenneth H. Gutner 
Dr. Earl Hellerstein 
Frederick W. Heilman 
Carl Hirshfield 
Gloria F. Holmes 
John F. Keaney 






Mr. & Mrs. Lewis Nankin 
Mr. & Mrs. Victor M. Newman 
William G. O’Donnell 
Mary M. Olson 
Dr Gideon A. Oren 
Dr. Richard D. Otis 
Dr. & Mrs. Levi V. Perry 
Patricia H. Powell 
R Donald Reich 
Barry D. Reznik 
Yolanda Rivero 
Joel G. Roth 
Dr. & Mrs. Carl E. Rothschild 
Mr. & Mrs. Jack Saltz 
Harold & Frances Sampson 
Joseph Schlesinger 
Mohan N. Shrestha 
Melvin L. Schwartz 
Arthur A. Shachner 
Mr. & Mrs. Philip Soskis 
Mrs. Leo Teitz 
Thomas M. Tierney 
Mrs. Albina K. Vazquez 
Mr. Harold Weinberg 
Mr. & Mrs. Milton Weinberg 
Jack Weingold 
James Wells * 
Tony Y. Wong 
Paul M. Zabetakis 
* The help of medical school alumni is 
crucial to enhance teaching and research. 
But it is also essential for another reason 
and that is to maintain what l call the 
freedom to educate as we at Yale think 
best. We face the all too real possibility 
that our autonomy to teach the students 
we select, to hire the faculty we wish, to 
engage in the research we design, to 
practice medicine when, where, and how 
it must be practiced will gradually 
deteriorate without adequate resources. 
“Essentially and ultimately, our 
autonomy is at stake. Universities have as 
their challenge for the next generation 
the definition and defense of their lawful 
independence as institutions. We must 
preserve this spiritual and intellectual 
independence because it promotes 
teaching, learning, research, and because 
it protects minority opinion, dissent, and 
criticism as well as all those other values 
we share as a whole with the country at 
its very best. 
“And that is why unrestricted 
endowment is so important. There are no 
funds more vital for preserving the 
intangible, essential value of the medical 
school, that freedom of choice so 
necessary to a great academic 
institution. ” 
President A. Bartlett Giamatti 
in his address to Yale medical alumni, June 8, 1985 
* Deceased 
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a deans ’ dialogue 
Deans Leon E. Rosenberg of the School of Medicine and 
Guido Calabresi of the Law School spoke to standing room 
only audiences as they discussed such medicolegal issues as 
malpractice law, bioethics and third party payors in a two- 
part series billed as “A Deans’ Dialogue: Law and Medicine 
in Confrontation.” On December 2, Dean Rosenberg ad¬ 
dressed medical and law students and faculty in the Law 
School Auditorium; and on the following Monday, Dean 
Calabresi spoke before a similar audience in the medical 
school’s Harkness Auditorium. Each dean responded to the 
other’s remarks following the talks. 
Dean Rosenberg set the tone of the dialogue when he 
expressed deep concern about the future of the medical 
profession, predicated on the “pervasive, unwelcome, 
crushing embrace of medicine by law. 
“Every participant in the health care system doctors, 
nurses, hospital administrators, paramedical personnel - is 
beset by an onslaught of new laws and regulations affecting 
every phase of medicine - from care of the critically ill 
newborn to that of the terminally ill aged; from the decision 
to terminate a pregnancy to that concerned with termination 
of life-support systems; from criteria for hospital admission 
to those involved with Medicare reimbursement; from ‘Baby 
Doe’ regulations to ‘squeal’ laws,” he said. 
“And worst of all, because it is the most personal, 
physicians are forced to live with the spector of malpractice 
litigation constantly in their minds’ eye. This legal assault 
has occurred so swif tly and has been implemented so harshly 
that it has begun to erase some of the very attractions long 
associated with pursuing a medical career autonomy. 
independence, approbation, inquiry,” Dean Rosenberg 
added. 
“The issue, in my view, is not whether law has a legitimate 
claim to a greater scrutiny of and control over medicine, for 
clearly it does. Rather, the question is whether the legal 
means being used to control medicine and the conduct of 
some of the lawyers implementing the laws are moving our 
society in a direction such that the largest number of people 
have available the highest quality health care,” he said. 
“Sadly, my answer to this question is ‘NO’ ”, 
Dean Rosenberg cited two examples to support this 
response. The first had to do with attempts to decrease the 
enormous cost of hospitalizing patients, such as the Diagnos- 
tic Related Group system of hospital reimbursement and 
other strategies which are aimed at keeping people out of the 
hospital who don’t need to be there, such as the recently 
implemented program of the federal Healthcare Financing 
Administration (HCFA) which manages Medicare regula¬ 
tions. 
This program mandates that all Medicare patients sched¬ 
uled for elective surgery or emergency admission to any 
hospital in Connecticut will be required to have pre¬ 
admission screening and certification from the state’s HCFA 
delegate - the Connecticut Peer Review Organization 
(CPRO). If the admitting physician fails to comply, either 
by not seeking certification or by admitting the patient 
despite denial of the request for certification by the CPRO, 
neither theTiospital nor the physician will receive reimburse¬ 
ment from Medicare. Private insurance carriers, according 
to the dean, are establishing similar pre-admissioin approval 
T. Charles Erickson 
Dean Rosenberg 
systems with perhaps even tighter controls. 
“The message is clear,” he said. “In the name of cost 
containment, it has been determined that the judgement of 
CPRO or insurance company personnel based on no patient 
contact is superior to that of the physician caring for the 
patient . . . This is health care by a bureaucracy out of 
contact with the patient and out of touch with the physician. 
It tends to mock the age-old ethical precepts that each 
patient is unique, that the physician’s first obligation is to his 
or her patient, and that clinical skill, knowledge and 
judgement are gained by experience. How can the many 
subtle determinants leading to the decision to hospitalize an 
elderly person be reduced to the simplicity of ‘yes/no’ 
certification by telephone? Who will be held culpable if a 
patient deemed uncertifiable for admission dies at home for 
want of hospital attention? When does the life of one person 
count for more than the dollars of many?” he asked. 
1 he other issue is medical malpractice litigation — an 
incendiary topic that is front page news. 
“Professional rivalry between physicians and lawyers is 
understandable, perhaps inevitable. The hostility, misunder¬ 
standing, and antagonism which now characterize the 
dialogue between members of the two disciplines in the area 
of malpractice, however, has reached unacceptable pro¬ 
portions. It poses a threat to the two warring professions 
who may soon hear from the public something like ‘a pox on 
both your houses.’ More importantly, it places at risk the 
very quality of health care physicians are committed to 
provide and lawyers are bound to protect. If, for example, a 
ignilicant fraction of obstetricians stop delivering babies 
i \ »ung M.D.’s follow suit by going into other less 
ion-liable specialties, then one day maternal and 
ml.mt mortality rates will begin to climb. Clearly, wisdom 
dictates changing course before such dire consequences 
occur,” advised Dean Rosenberg. 
To underscore the magnitude of the malpractice crisis. 
Dean Rosenberg cited a few statistics including that fact that 
in 1983, one of every five practicing physicians in the United 
States was sued for malpractice with a total of 42,000 
malpractice claims lodged in that one year; for all physicians, 
premiums for malpractice insurance increased by 238 percent 
between 1975 and 1984 and in that same interval, mean 
physician income increased by 92 percent; in 1975, the 
average malpractice judgement was $95,000 and in 1984, it 
was $338,000, and in 1984, the national cost for the practice 
of “defensive medicine” was estimated at $15 billion. 
The legal definition of medical malpractice is straightfor¬ 
ward and originated under the law of torts, noted Dean 
Rosenberg. According to the law, once a physician-patient 
relationship has been established, the physician is obligated 
to diagnose and treat that patient with “due care”. Failure to 
do so constitutes negligence for which the injured patient 
may sue and recover monetary damages. 
“It is this claim of negligence which lies at the heart of the 
medical malpractice problem,” he contended. “All physicians 
know that medicine is an imperfect science, that maloccur- 
rences take place, and that some maloccurrences result from 
negligence and incompetence.” 
“The issue, in my view, is not whether law has a 
legitimate claim to a greater scrutiny of and 
control over medicine, for clearly it does. 
Rather, the question is whether the legal means 
being used to control medicine and the conduct 
of some of the lawyers implementing the laws 
are moving our society in a direction such that 
the largest number of people have available the 
highest quality of health care. ” Dean Rosenberg 
As to why the issue of medical malpractice is so explosive. 
Dean Rosenberg maintains this is largely a function ot the 
vast ignorance of physicians about law, and the equally 
cavernous ignorance of lawyers about medicine. “II physi¬ 
cians understood that the law doesn’t believe in absolute 
truth but rather employs an adversary system to resolve 
conflicts by coming as close to the truth as possible, they 
might not see a claim of professional negligence as such a 
mortal threat to their self esteem. 
“If lawyers understood that medicine has no adversary 
other than illness, injury, or death and that the practice ol 
medicine depends on the willingness of patients to believe in 
their physician’s expertise, they might understand why a 
charge of professional negligence tends to undermine the 
very authority and trust so crucial to the doctor-patient 
relationship,” he said. “Because the vast majority of law 
students are not required to take a course in ‘biomedical law’ 
and most medical students learn little if any ‘legal medicine’, 
both groups are socialized into their respective professions 
without any positive endorsement of the other. Thus, the 
bright, aggressive, ambitious people who become our doctors 
and lawyers substitute professional chauvinism for mutual 
understanding and learn only too well how to use words like 
‘shyster’, ‘quack’, ‘ambulance chaser’ or ‘butcher’. 
“ . . This legal assault has occurred so swiftly 
and has been implemented so harshly that it has 
begun to erase some of the very attractions long 
associated with pursuing a medical career — 
autonomy, independence, approbation, inquiry. ” 
— Dean Rosenberg 
“Can it surprise us then, that when members of these two 
professions, who have had so little contact with each other 
during their formative years, confront each other in the 
charged, complex and visible cauldron of medical malprac¬ 
tice litigation, that physicians scream that our society must 
do something to keep rapacious lawyers from destroying 
our system of health care, and lawyers yell back that society 
must do something to keep incompetent doctors from 
killing and maiming people?” 
Since what we as a society are doing about medical 
malpractice obviously isn’t working, we must do something 
else, according to the medical school dean. First and 
foremost, we must begin to educate the public to the fact 
that medical care can sometimes be “hazardous to your 
health” and that “physicians cannot always solve patients’ 
problems and may even make them worse; that there are 
inherent contradictions in the demands for medical care of 
high quality and equally affordable cost; and that this 
country has among the best health care systems in the world 
because the great majority of its practicing physicians are 
well trained, skillful and caring.” 
Lawyers, he said, must learn that there is a real and critical 
difference between maloccurrence and malpractice; that 
physicians speak truthfully when they say that being sued 
for malpractice is among the most devastating and disfiguring 
catastrophies that can happen to them, and that demanding 
a standard of professional responsibility from physicians 
more rigorous than that expected for themselves is the 
ultimate hypocrisy. 
In turn, the dean said that physicians must learn that the 
venerable contract between doctor and patient must be 
rewritten so that the physician is viewed as a partner in the 
transaction rather than as an infallible, unchallengable 
authority, and that “failure to discipline and weed out 
incompetent or impaired physicians has so eroded the 
public’s confidence that they, the patients, not we, the 
doctors, are the primary focus of our ethical concerns; and 
that the single most effective safeguard against malpractice 
suits is the bond established between doctor and patient 
through informed consent and thoughtful communication.” 
This educational agenda is long and challenging. It will be 
achieved only if it is addressed in the classrooms of our 
medical and law schools, in the workrooms of our news 
media, in the board rooms of our insurance companies, and 
in the living room of our citizens. While all this is going on, 1 
believe we must modify — perhaps even overhaul the 
legal system which adjudicates professional liability claims... 
“Broader reform measures, aimed at lawyers and physi¬ 
cians, must be considered to put some limit on damages for 
pain and suffering, to subject contingency fees to a sliding 
scale by which the attorney for the plaintiff’s fraction of 
monetary damages falls as the size of the judgement rises; to 
require periodic rather than lump sum payments for large 
awards; to mandate risk-management programs for physi¬ 
cians and hospitals; to insist that insurance companies make 
data concerning malpractice awards available to state 
agencies responsible for discipling physicians, and to fund 
expanded state disciplinary agencies by increasing fees for 
licensure from physicians and allocating the additional 
revenue to the disciplinary authority. Such reforms will not 
do away with medical injury, negligence or incompetence. 
They will, however, demonstrate to physicians and lawyers 
alike that the threat to the public’s health posed by the 
current malpractice litigation nightmare must be contained 
until something better comes along,” predicted the dean. 
The way out of the malpractice dilemma, he contends, is 
through educating the public as well as physicians and 
lawyers, and by modifying the legal system which adjudicates 
professional liability claims. A possible solution, he sug¬ 
gested, would be a “no-fault”-based national compensation 
system for medical injury along the general lines of work¬ 
men's compensation or automobile accident liability. 
In conclusion he said, “The constraints, contradictions, 
and contumely currently being heaped on physicians are not 
justified by any errors physicians have committed in meeting 
their professional and social responsibilities. The medical 
profession must be given back a central role in the develop¬ 
ment of national health care strategies because it is among 
the few groups with the expertise to help make some of the 
difficult choices which lie ahead. The public, through the 
law, and lawyers, through their professional behavior, must 
show restraint in the demands they make of Medicine 
because, in the final analysis, the public stands to lose the 
most if the profession of Medicine is diminished and, by 
being diminished, attracts to its ranks a less capable and 
dedicated breed of physician. Surely, that is not the way to 
ensure one of our citizens’ unalienable rights — to life.” 
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“One of the troubling things about the whole 
discussion of malpractice is how often doctors 
on the one side and lawyers on the other, seem 
to be primarily concerned with what malpractice 
law means for them rather than what it means 
for patients. ” — Dean Calabresi 
In his talk on December 9, Dean Calabresi responded, 
“One of the troubling things about the whole discussion of 
malpractice is how often doctors on the one side and lawyers 
on the other, seem to be primarily concerned with what 
malpractice law means for them rather than what it means 
for patients.” Malpractice law' fails to induce better medical 
care and to efficiently compensate patients who sutler severe 
medical ill effects, because instead it produces “outrageously 
wasteful defensive medicine,” observed the Law School 
dean, whose father and brother are physicians. 
Wh\ do we stay with malpractice? Because other methods 
of inducing better medical care are equally flawed, according 
to Dean Calabresi. 
In response to Dean Rosenberg’s proposal for implementa¬ 
tion of a no-fault-based national compensation system, the 
law school dean advised, “We still can, and should, decide 
w hat medical maloccurrences are sufficiently dire to justify 
such a compensation system. I here may be differences on 
this question, but how ever resolved the cost of the approach 
is likely to be small compared to the disaster of our current 
malpractice law. To do it today, however, we would have to 
make such a fund take the place of the malpractice suit, for 
we cannot roll things back and return to the pious fraud 
malpractice was,” he said. “We have all eaten the fruit ol the 
Tree of Knowledge and can no longer successfully pretend 
that we are seeking medical perfection through a do-nothing 
malpractice law, while compensating injured parties through 
another system . . . 
“We can only get out of our mess by admitting what is 
hard to admit, that lots of errors and maloccurrences will 
occur, that as to all but the grossest (which self-regulation or 
patient choice may control), there isn’t anything we can do, 
and that the best we can do is alleviate the suffering of those 
most severely injured." 
Leaving the subject of malpractice, he turned to two areas 
that concern him about how physicians behave today, both 
involving failure on the part of physicians to take responsi¬ 
bility. “They both will lead, are leading, to precisely the kind 
of crushing embrace of medicine by law that Dean Rosenberg 
suggested was disastrous,” he cautioned. 
I he first is the area of payments and insurance for medical 
care, which he contends is not viewed by most doctors as 
nothing they should become involved in, except when 
“somehow the insurance system ends up asking them to fill 
out outrageous forms or paying them less than they think 
they should get.” And yet, he believes, it is one of the factors 
that most destroys a decent patient-physician relationship. 
“How can a patient believe that a doctor or hospital cares 
for her or his w'ell being when entrance to a hospital or to a 
doctor’s office — often however dire the emergency - 
awaits proof of insurance or other form of capacity to 
pay? How can the patient believe the doctor cares, when 
after treatment or discharge, in many, many cases the 
patient is left unaided to fill out forms that believe me 
—strain the capacity of highly trained lawyers or accountants?”, 
asked Dean Calabresi. 
“How can any semblance of relationship persist when 
after the ’third-party-carrier’ has inevitably returned the 
forms as inadequately filled, or sent to the w rong carrier, or 
with a reimbursement that bears no relationship to the 
doctor’s or hospital’s bill, the patient is faced by a dunning 
letter from doctor or hospital threatening interest or far 
worse penalties, if no payment is made at once?” he asked. 
“It is there that 1 and many lawyers would find the medical 
profession wanting,” he said. 
“Why are doctors and their associations not lobbying, 
shouting, writing letters, and as important, joining lawyers 
in drafting bills to create a system of health care insurance 
that is speedy, efficient, and easily understood by the 
ordinary patient?” 
When he raises this question with doctors as well as with 
lawyers. Dean Calabresi said, he is usually told that there 
isn’t time for such lobbying and thinking and bill writing. 
“But there is time (on both sides) to lobby and fuss about 
malpractice... No. it is not a matter of time, but a matter of 
interest, of caring.” 
The second issue of physician responsibility is harder and 
more deeply important in that it deals with doctors being 
willing to take responsibility for desperately ill patients. 
“There are. I think, few things more scandalous than doctors 
who, when a patient and that patient’s family have said that 
extraordinary medical treatment should be avoided, neverthe¬ 
less insist on such treatment, or worse, ask that a court 
decide for them whether treatment must take place, or 
whether the plug should be pulled.” 
“In the past, doctors made analogous decisions routinely, 
and admittedly were criticized for being high-handed and 
not communicating with patient and family,” said Dean 
Calabresi. “They were told they were playing God and 
shouldn’t. There is plenty of room, however, between 
playing God and trying to duck the responsibility that being 
a member of a profession has to entail. It is for being 
unwilling to act in this middle zone of uncertainty that 
doctors have been most severely criticized by legal scholars. 
“ Why are doctors and their associations not 
lobbying, shouting, writing letters, and as 
important, joining lawyers in drafting bills to 
create a system of health care insurance that is 
speedy, efficient, and easily understood by the 
ordinary patient?” Dean Calabresi 
"Here, as in so many things between law and medicine, 
there is a fundamental lack of understanding by each 
profession of what the other is about,” he pointed out. "The 
doctor who seeks legal assurance that a tragic choice should 
be made in one way (while keeping the patient and family in 
limbo), believes that the law is set of clear rules that can give 
‘yes’and ‘no’answers to conduct, and can do it publicly. The 
law knows that this cannot be so, that often the law will 
declare one thing and permit the opposite precisely because 
it is the only way to allow a society to cleave to conflicting 
ideals,” he added, citing an example of euthanasia to explain 
his point. 
“When a doctor invokes the law in such a situation, that 
doctor not only fails to give the patient and family the care 
they have a right to — which means immediate care but 
also starts a process that goes a long way toward establishing 
the crushing embrace the doctor will later, properly, complain 
about,” said Dean Calabresi.". . .to people outside of 
medicine, a doctor’s role is not just to keep people alive at all 
costs; it is to care for them, to treat them according to their 
best interest. That, as 1 said earlier, involves a decent 
medical payment system, but it also involves allowing 
people to die with dignity and without having to go to court 
to do so. . . ” 
.. .a doctor's role is not just to keep people alive 
at all costs, it is to care for them, to treat them 
according to their best interest. That involves a 
decent medical payment system, but it also 
involves allowing people to die with dignity and 
without having to go to court to do so. . . ” 
Dean Calabresi 
Dean Calabresi noted that one person's death with dignity 
is another person’s premature abandonment, which is just 
one reason why yes or no legal rules wont’work. “It requires 
exquisite sensitivity to the particular situation of the particu¬ 
lar patient and that patient’s family,” he explained. 
. . .“Most doctors fear the crushing embrace of the law. 
Most thoughtful lawyers fear being called in to regulate 
medicine. They fear the same embrace just as strongly,” he 
said in conclusion. “If the embrace comes, then, it is because 
the professions have not worked together to find ways of 
accomplishing what the public desires of us. There are things 
the public wants that cannot be given to it perfection in 
medicine and simple rules in law. 
“But there are things the public wants that can be given it 
the capacity to cope financially with catastrophic medical 
maloccurrences, the possibility of having decent medical 
care without being badgered by bureaucrats armed with 
unintelligible financial forms and requirements before and 
after treatment, and the chance to live without the fear of 
either being discarded prematurely or being kept alive in 
intolerable conditions. If lawyers and doctors, both, focus 
more on these things that the public wants from us in our 
interactions, and less on what benefits ns or frightens ns 
most in those interactions, we will be able to respond to the 
public, be true to our calling, and, in the long run, also 
remain the professions we would wish to be.” 
Dean Calabresi 
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TRACKING THE EPSTEIN-BARR VIRUS 
Dr. /. George Miller won't let up until he pinpoints the mechanism which allows EBV to persist. 
Thus far, his research team has found a rearranged piece of viral DNA which seems to control 
latency, perhaps causing the virus to replicate. 
by Grace Breitstein 
T7 
or more than 15 years. Dr. I. George Miller has 
relentlessly pursued a scoundrel the Epstein- 
JL Barr virus (EBV). 
EBV, a member of the herpes virus family first discovered 
in 1964, has been associated with infectious mononucleosis, 
several cancers and, most recently, with Acquired Immune 
Deficiency Syndrome (AIDS) in infants and children. 
The direction of his research and the key challenge before 
Dr. Miller, the 48-year old John F. Enders Professor of 
Pediatric Infectious Diseases at Yale, has been to acquire 
clues as to how EBV persists. 
“I'm interested in figuring out the basic mechanism of 
how the virus interacts with the lymphocyte, its usual 
target,” said Dr. Miller. “How does it change the behavior of 
the cell, so that a normal cell takes on the direction of 
becoming a cancer cell?” 
The \ irus, when added to a normal cell in a culture, causes 
the cell to grow continuously, a process Dr. Miller has 
termed immortalization. It is unknown which particular 
EBV gene immortalizes the cell, causing the virus to persist 
in a latent, or dormant form inside the cell. 
“If the virus were to start to replicate, it would kill the 
cell,” said Dr. Miller. “So a very important problem to 
resolve is what keeps the virus from replicating and what 
controls the process of latency.” 
An exciting finding of his research team here has been a 
rearranged piece of viral DNA which seems to control 
latency. When put into the cell, it causes the latent virus to 
replicate. 
Working with Dr. Miller on that study were Jill Country¬ 
man, a graduate student in biochemistry, and Dr. Hal 
Jenson, a postdoctoral fellow in pediatrics and epidemiology, 
and recipient of an N1H Physician Scientist Award for the 
study of basic science related to clinical problems. 
Dr. Miller’s accomplishments thus far earn him warm 
praise from his colleagues. Dr. Dorothy M. Horstmann, 
John R. Paul Professor Emeritus of Epidemiology, describes 
Dr. Miller as a “remarkably able and imaginative in¬ 
vestigator. 
“He knows how to ask the right questions and he gets 
around to answering them,’’she said. Dr. Horstmann noted 
Dr Miller’s early work in which, using information derived 
from studies on the Marmoset monkey, he devised a tissue 
ulture system that subsequently allowed for the study of 
I BV around the world. 
i BV was first isolated in tissues of patients with Burkitt’s 
nphoma, a form of cancer prevalent in parts of East 
and later in a nose cancer common among Chinese 
Hnally, EBV has been associated with cancer in 
suffering from immune deficiencies that resulted 
I tccts ol drugs used in organ transplants. This led 
Dr. Miller to pursue a hypothesis of EBV’s association with 
AIDS in children. 
The largest and most complicated of viruses, EBV 
contains as many as 75 different genes, most of which are 
involved in replicating the virus. A subset of no more than 
ten and no fewer than three genes has been implicated as the 
primary culprits, said Dr. Miller. Much of his work focuses 
on finding out how those genes function. Answers to such 
questions could lead to ideas on how to cure the cells by 
destroying the virus, perhaps with drugs developed to have a 
crucial point of attack. 
Meanwhile, Dr. Miller and his colleagues have called 
attention to the association between EBV and AIDS and the 
complications the virus causes in infected infants and 
children. He and other AIDS researchers in his laboratory 
have detected EBV in tissue extracts from the lungs of nine 
children and from the brain of one child after examining 
specimens from 18 infants and children w'ith AIDS. 
In some cases. Dr. Miller has found EBV to be pervasive 
in children with A1DS. The virus was readily recovered from 
the blood and saliva of a seven-month old boy born heroin- 
addicted to a 27-year-old prostitute. The infant’s lung 
Dr. Miller's mentor, the late Nobel Prize-winning 
virologist John F. Enders, conducted research which led 
to vaccines that fight against childhood diseases, including 
polio and German measles. His message to Dr. Miller 
conveys a sense of the warm relationship that existed 
between the two scientists. 
biopsy showed normal air spaces in the lung being replaced 
by EBV-infected tissue. 
The findings, reported in a December issue of The Lancet, 
underscore the importance of EBV as the cause of various 
complications, including cancer of the brain and a form of 
chronic pneumonia, in children with AIDS. 
“It may be that cells in the lung support replication of the 
virus, especially in patients with immune deficiencies,” Dr. 
Miller said during a January medical oncology conference 
he conducted on AIDS in children. 
Children, according to Dr. Miller, appear to be more 
susceptible to EBV-related complications than adults, 
possibly because of the sequence of events surrounding the 
time in which they contact AIDS. The HTLV virus which 
causes AIDS may somehow predispose children to acquiring 
complications after being EBV-infected. 
“One reason may be that adults probably contract the 
AIDS virus after they’ve been infected with EBV,” Dr. 
Miller said. “So they’ve already developed a certain amount 
of immunity to the virus and have brought it under control.” 
Children, on the other hand, may develop EBV while they 
are already infected with the AIDS virus. “It’s more 
simultaneous,” he said. 
Most recently. Dr. Miller and a Yale medical research 
team have begun studying how children with AIDS become 
infected with HTLV III, the causative agent of AIDS. They 
hope to identify the risks of transmission, particularly 
among siblings. 
Those participating in the study include: Dr. Warren A. 
Andiman, associate professor of pediatrics and epidemio¬ 
logy; Dr. Ben Katz, a Pfizer postdoctoral fellow; Dr. Karen 
Dahl, an N1H postdoctoral fellow; and Kelsey Martin, a 
first-year medical student. 
“We know they are born into a family with high-risk 
members,” said Dr. Miller. “The mother and father are 
usually drug abusers. Sometimes the father may be bisexual 
or occasionally, he may be hemophiliac. 
“We’re working on the question of why some people get 
sick and others don’t, and exploring the possibility that 
there might be a difference in the viruses, some of which are 
killer viruses and some of which aren’t.” 
In these and other areas of research. Dr. Miller has 
employed the quiet precision and conviction of his mentor, 
the late Nobel Prize-winning virologist and Yale College 
alumnus, John F. Enders, whose chair Dr. Miller has held at 
Yale since it was created in 1976. 
Dr. Enders’ work advanced the fight against cancer and 
led to vaccines that fight against many childhood diseases, 
including polio and the German measles. Dr. Miller worked 
under his instruction from 1966 to 1969 as a fellow at 
Harvard Medical School, where together they studied the 
ways viruses infect normal lymphocytes. 
Dr. Miller said he hopes that he emulates the style and 
techniques of Dr. Enders, who “was interested in straddling 
the line between medicine, its practical problems and basic 
research.” 
Dr. Miller’s background and career do indeed reflect his 
mentor’s influence. Born in Chicago, Dr. Miller graduated 
cum laude from Harvard College and from Harvard Medical 
School in 1962. He wrote his medical school thesis on 
techniques developed to measure the production of inter¬ 
feron, a protein produced in the cell to fight viral replication. 
Aftera residency at the University Hospitals of Cleveland, 
Dr. Miller served as Epidemic Intelligence Service Officer 
Exercising patience and persistence, Dr. I. George Miller, 
the John F. Enders Professor of Pediatric Infectious 
Diseases, has studied the Epstein-Barr virus and its 
association with several cancers, mononucleosis and with 
AIDS in children. Pictured above in his laboratory, Dr. 
Miller examines recombinant DNA clones. 
for the Communicable Disease Center in Atlanta, and later 
as chief of the center’s virus unit. 
Following his work with Dr. Enders at Harvard, Dr. 
Miller joined the Yale medical faculty in 1969 as assistant 
professor of pediatrics and epidemiology, and in 1972 he 
became an associate professor. In 1982, Dr. Miller received 
the Squibb Award from the Infectious Disease Society for 
his work regarding the growth of EBV. 
His wish-list includes seeing greater research efforts 
aimed at linking a number of viruses and cancer. 
“There are four or five viruses where the evidence is good 
that they cause cancer in humans,” Dr. Miller said. “The 
time is very much ripe for studying these viruses.” One such 
virus, hepatitis B, is believed to cause cancer of the liver. 
Another, the papilloma virus, may cause cervical cancer. 
For pleasure, good health and mostly as relief from the 
stress of his day-to-day research. Dr. Miller jogs 20 miles 
each week, plays the piano, and retreats to a country home 
in Vermont where he keeps plenty of wood to chop. 
His wife, Arlette, a real estate agent and avid potter, is no 
stranger to Yale either. From 1974 - 84, she taught pottery to 
hospitalized children at the Yale Psychiatric Institute. 
1 he Millers have three children: Liza, 23, an editor for the 
Harvard Business Review, John, 20, a junior at Swarthmore 
College; and David, 16, an 11 th grader at Hopkins Grammar 
School. 
Grace Breitstein, is staff writer to the School o f 
Medicine’s Office of Public Relations. 
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DIGESTIVE DISEASES RESEARCH: continuing the Yale legacy 
With basic scientists and clinicians working side by side, recent advances in treatment for some of 
man’s most troubling diseases are more rapidly delivered from the research bench to the bedside. 
by Marje Noyes The prognosis lor an infant born with biliary 
atresia is devastating. Almost as somber are 
prospects for children diagnosed as having cystic 
fibrosis or adults with inflammatory bowel disease 
oreirrhosis of the liver. According to the National Digestive 
Diseases Educational Program, an estimated 20 million 
persons in the United States are chronically ill, and more 
Americans are hospitalized with digestive diseases than with 
any other group of disorders. 
Research being done in the Digestive Diseases Division at 
Yale may significantly change the outlook for many of these 
patients. Established in 19X2 under the direction of Dr. 
James Boyer, professor of medicine, the division combines 
the interests and expertise of the Gastroenterology Unit (GI) 
and the Liver Study Unit in a wide range of studies of the 
digestive system. Recognized for its pioneering research into 
the causes and treatment of these diseases, and for its 
outstanding postdoctoral training program, it is as well, a 
major referral center for patients with digestive disorders of 
all kinds. 
The achievements of the Digestive Diseases Division area 
result, in part, of the legacy of Dr. Howard Spiro, professor 
of medicine, one of Yale’s most distinguished gastroenterolo¬ 
gists, w ho for 27 years as its founder and director, shaped the 
development of the G1 Unit; and of Dr. Gerald Klatskin, the 
David Paige Smith Professor Emeritus of Medicine, who 
founded the first liver study unit in the country at Yale in 
194X. 
The GI Unit and Liver Study Unit have changed a great 
deal in the last decade. With the formation of the division, 
there are more researchers and clinicians working side by 
side whose interests cover a much broader range than before 
in keeping with the expanding disciplines in this field. 
In 19X4, following nearly Jour decades of 
pioneering work on liver function and disease, 
Yale received a $2.4 million Digestive Diseases 
Research Center grant from the National 
Institutes of Health to establish one of the first 
three federally funded liver centers in the 
country. Directed by Dr. Royer, it integrates the 
rk of 19 principal investigators and IS 
nporting full-time faculty from eight 
rtments, in a broad based program ranging 
a sic research on the cellular and 
tar levels to therapeutic trials in patients 
triplications of chronic liver disease. 
William Carter 
A video-enhanced image of a liver cell couplet appears on 
the screen behind Dr. James Boyer. 
The list of almost 50 postdoctoral fellows who trained with 
Dr. Klatskin from 1958 until his retirement reads like a 
“Who’s Who in Liver Disease Research.” One of these 
fellows was Dr. Boyer, who assumed leadership of the Liver 
Study Unit on Dr. Klatskin's retirement in 1978. A graduate 
of Johns Hopkins School of Medicine intent on a career in 
infectious diseases, he changed course while on duty with the 
Public Health Service in Calcutta in the ’60s, where he 
worked wath patients with liver disease. 
Then as now, Yale was one of three or four major centers 
for training in this field, and the only one with strong clinical 
as well as research orientation. 
“I came here in 1965 to interveiw for a fellowship 
appointment,” recalls Dr. Boyer. “I had hardly explained 
the purpose of my visit w hen Dr. Klatskin spied the box of 
liver biopsies I had brought from India. He’d been to India 
as well, and after examining my slides under the microscope 
in minute detail without saying a word, he launched into a 
full discussion of the subject, complete with background 
literature, as though he’d just prepared the most comprehen¬ 
sive review!” 
Since the time of his fellowship. Dr. Boyer’s main research 
interest has been the mechanism of the hepatic bile secretory 
and transport process. 
“I saw an isolated perfused liver preparation make golden 
bile one day while I w'as a fellow, and have been fascinated 
ever since with how that process works in this cell system.” 
Recently, Dr. Boyer and his colleagues achieved a major 
advance in liver disease research by isolating a liver cell 
couplet two liver cells joined together at the bile 
canaliculus, the site on the cell where bile is made. In 
collaboration w ith Drs. Anil Gautam, assistant professor of 
medicine, and Dr. Jurig Graf, a physiologist from the 
University of Vienna, they have been able to obtain a 
definition of the electrophysiological events occuring at the 
site. This enables for the first time, the measurement of the 
secretory volume and an accurate determination of the 
driving forces for the movement of water and solutes from 
the liver cell. 
Because of the complex anatomy of the liver, it previously 
was impossible to sample primary bile secretion at the level 
at which it is made. 
“By the time we were able to collect the secretion, it had 
passed over several different cell types. It was like trying to 
understand the source of spring water from the Adirondacks 
by collecting the effluent of the Hudson River at Battery 
Park,’’explained Dr. Boyer. “The cell couplet system allows 
us to get directly to the source.” 
Production of bile is one of the liver’s most important 
functions, and when it is injured by disease, this process is 
almost always impaired. With the cell couplet system, 
researchers now can determine whether or not an agent 
stimulates or inhibits the primary secretion. This should 
eventually lead to the development of more effective agents 
for stimulating bile secretion and modulating this important 
excretory function. 
“The more we know about the normal process of the 
system, the better we will be able to understand and then 
correct the pathological physiology of the disease,’’explained 
Dr. Boyer. 
William Carter 
The focus of postdoctoral training is an acquisition of 
scientific skills and the application of these skills to 
important basic science or clinical problems related to 
digestive diseases. Dr. John Helzberg. above, also 
working with Dr. Gordon, is using the new technique of 
nuclear magnetic resonance spectrometry to assess the 
effects of alcohol on oxygen consumption by the liver. 
The postdoctoral training program in the 
Digestive Diseases Division is one of the largest 
in the country, and attracts highly qualified 
individuals from the U.S. and abroad. In 
addition, Yale medical students and house staff 
receive training from faculty in the division. 
Dr. Ellen Gordon, pro fessor (adjunct) of research in 
medicine, and an internationally recognized biochemist 
(right) is conducting studies on hepatic bilirubin 
metabolism to identify the chemical nature and source of 
a recently discovered bilirubin metabolite to better 
understand liver metabolic abnormalities. Working in her 
laboratory as a postdoctoral fellow is Dr. Neil Sitiith 
(left), one of nine postdoctoral fellows in the Digestive 




Dr. Henry Binder 
Studies of the pathogenesis of liver cirrhosis by Dr. 
Bernard Davis, a postdoctoral fellow in the Liver Study 
l nit working in the laboratory of Dr. Joseph Madri, 
assistant professor of pathology, is an example of the 
< ali her as well as interdisciplinary nature of training in 
'ioth the Gl and l iver Study Units. In an effort to 
understand the mechanisms of fibrogenesis, Drs. Madri 
/ Davis have focused on a recently isolated cell, the ho 
i d. which produces connective tissue and stores vitamin 
I In particular, they are investigating the role of vitamin 
I in controlling the cirrhotic process. 
Five years ago, the World Health Organization 
established the investigation and control of 
diarrheal diseases as one of the major goals for 
the next decade. Investigation into the causes 
and treatment of these diseases by Dr. Binder 
and Dr. Dobbins constitutes a significant 
portion of research interests in the GI Unit. 
In 1982, Dr. Howard Spiro decided to devote a greater 
portion of his time to caring for his patients as well as 
directing the Humanities in Medicine Lecture Series, which 
he founded; Dr. Boyer had been appointed chief of the 
division that combined the liver and Gl units, and Dr. Henry 
Binder, professor of medicine and director of the General 
Clinical Research Center at Yale, was named head of 
gastroenterology research in the division. 
Dr. Binder, who had planned a career in Gl diseases from 
the day he entered the New York University School of 
Medicine, came to Yale as a fellow in 1963. and with the 
exception of three years (two in military service), has been 
here ever since. 
“Yale is a very stimulating place to be in terms of digestive 
diseases,” he said, citing such colleagues as Dr. Spiro and 
Dr. Robert Donaldson, the David Paige Smith Professor of 
Medicine and acting chairman of the Department of 
Internal Medicine, who is a former president of the American 
Gastroenterology Association and editor for seven years of 
the journal Gastroenterology. 
Dr. Donaldson and Dr. Cyrus Kapadia, associate profes¬ 
sor of medicine, are conducting research to better understand 
the mechanism of transport of vitamin B12 and other 
essential nutrients made available to the body through the 
intrinsic factor — a substance produced by normal gastro¬ 
intestinal mucosa. This research, with implications for 
understanding peptic ulcer disease, is being done in labora¬ 
tories in the Veterans Administration Medical Center at 
W est Haven with support of a VA Merit Review Grant. 
Dr. Binder’s own research interest for many years has 
been mechanisms of diarrheal diseases and in particular, the 
role of the colon as a transporting organ in health and 
disease especially diarrheal diseases. The thrust of his 
w ork has been to identify the regulation of colonic electro¬ 
lyte transport to determine which agents stimulate absorption 
and w'hich ones are associated with secretion. 
In an investigation of the effects of corticoid steroids on 
the intestines, he demonstrated that glucocorticoids, previ¬ 
ously thought not to affect electrolyte transport, have a very 
decided effect, and in fact, stimulate active cellular absorp¬ 
tion. This research has led to the development of new7 
treatment regimens w ith glucocorticoids, such as prednisone, 
for a variety of serious intestinal disorders including Crohn's 
disease and ulcerative colitis. 
Research in the Division covers a wide range from 
basic research at the cellular and molecular levels 
to clinical trials at the bedside. . . 
LIVER 
Research into the pathophysiology 
and pharmacologic control of 
portal hypertension in patients as 
well as animal models is being done 
in the liver bloodflow laboratory at 
the VA Medical Center in West 
Haven. Directed by Dr. Roberto 
Groszmann, associate professor of 
medicine, this laboratory is a major 
research and training resource. 
Also at the VAMC, Dr. Harold O. 
Conn, professor of medicine and 
chief of the Liver Disease Unit, Dr. 
Grozsmann and Dr. Colin Atterbury, 
associate professor of medicine, are 
conducting therapeutic trials in 
patients with complications of 
chronic liver disease. They have 
demonstrated that drug and 
hormone therapy reduces portal 
hypertension. 
Comprehensive interdisciplinary 
studies of the mechanisms of bile 
secretion and jaundice in the 
laboratory of Dr. James Boyer, 
professor of medicine and director 
of the l.iver Center, led to the 
important discovery of the liver cell 
couplet culture system, enabling for 
the first time the sampling of 
primary bile secretion. This 
research is being done in 
collaboration with Drs. Anil 
Gautam, assistant professor of 
medicine and Dr. Jurig Graf, a 
physiologist from the University of 
Vienna. 
Hepatic metabolic abnormalities 
are being investigated by Dr. Ellen 
Gordon, professor (adjunct) of 
research in medicine, and her 
colleagues in studies to measure the 
effects of alcohol on the energy 
level of the liver, and the 
differential effect of hepatic 
metabolism of alcohol in different 
areas of the liver lobule — an 
important problem relating to the 
development of alcohol tolerance. 
In addition. Dr. Gordon has 
developed a research program to 
study mechanisms of hepatic 
bilirubin metabolism. 
A special program in pediatric 
hepatology, organized by Dr. 
Caroline Riely, associate professor 
of medicine, includes clinical studies 
of the effects of intravenous feeding 
on hepatic function, the natural 
history of hepatic arterial dysplasia 
and the evaluation of non-invasive 
methods of assessing hepatic 
structure. The program also 
evaluates the incidence and causes 
of liver disease in pregnancy. 
CLINICAL NUTRITION 
Dr. Rosemarie Fisher, associate 
professor of medicine and director 
of the GI Unit at the VAMC, heads 
the recently established clinical 
nutrition consultative service of the 
G1 Unit, and is responsible for 
promoting protocols for 
intravenous nutritional support for 
patients with digestive diseases in 
Yale-New Haven Hospital and the 
VA Medical Center. 
esophagus 
GALL BLADDER 
Dr. Adrian Reuben, assistant 
professor of medicine, is 
investigating the mechanisms of bile 
lipid excretion in animals and man, 
an important problem in 
understanding how gallstones are 
formed and how they might be 
dissolved with medication. 
GITRACT 
ESOPHAGUS 
Dr. Morris Traube, assistant 
professor of medicine, is studying 
the mechanisms of swallowing and 
reflux to gain a better 
understanding of motility disorders 
such as swallowing difficulties and 
heartburn, which affect many 
people. 
STOMACH 
Research by Dr. Cyrus Kapadia, 
associate professor of medicine, and 
Dr. Robert Donaldson, David 
Paige Smith Professor of Medicine, 
is directed toward increasing 
knowledge about the intestinal 
transport of cobalamin (vitamin 
Bo) and the control of intestinal 
secretory function in the stomach 
that relate to peptic ulcer disease. 
PANCREAS 
In studies to learn more about the 
mechanisms of the pancreas, one of 
the least understood components of 
the GI system. Dr. Fred Gorelick, 
associate professor of medicine, in 
collaboration with Dr. James 
Jamieson, professor and chairman 
ot the Department of Cell Biology, 
has undertaken a comprehensive 
study of the pancreatic acinar cell 
for a better understanding of the 
mechanisms involved in the release 
of secretory protein in the pancreas. 
INTESTINES 
Dr. Henry Binder, professor of 
medicine and director of research in 
the GI Unit, and Dr. John 
Dobbins, associate professor of 
medicine, direct a comprehensive 
program to study the mechanisms 
of absorption and secretion of fluid 
in diarrheal diseases in human 
patients and animal models. Dr. 
Dobbins’ research is directed at the 
mechanisms and hormonal effects 
of electrolyte transport in the 
intestine; Dr Binder has focused his 
work on intestinal peptide and 
corticosteroid receptors, and the 
mechanism of colonic potassium 
transport. 
In addition to its important programs in 
research and training, the Digestive Diseases 
Division is a major tertiary care resource for 
digestive disorders in Connecticut and the 
northeast, from Boston to New York. The 
combined GI and liver outpatient clinics average 
over 2,000 patient visits each year. 
This service will soon be greatly enhanced with the comple¬ 
tion of a new, considerably enlarged clinical endoscopic 
center on the third floor of the Boardman Building. Directed 
by Dr. John Dobbins, associate professor of medicine, this 
Yale-New Haven Hospital facility serving physicians at Yale 
as well as from the community, will provide endoscopic 
procedures for biopsy, removal of stones by non-invasive 
techniques, canulation and other procedures, such as liver 
biopsy, on an inpatient as well as outpatient basis. 
When the Liver Research Center was established here a 
little over a year ago, Joyce Willig, co-chairman of the 
Connecticut Chapter of the American Liver Foundation, 
commented, “It is extremely heartening to know that a 
major center to find out what causes liver failure and how to 
prevent its consequences, has been established at a place like 
Yale.” 
M rs. Willig, w ho is a liver transplant recipient, has been a 
patient in the Liver Study Unit for a number of years. She 
was referring to the fact that “bench” scientists doing the 
most basic research on digestive disorders work side by side 
with clinicians who care for patients. As a result, the most 
up-to-date information about the causes and treatment of 
diseases of the digestive system can rapidly be applied at the 
bedside. 
For years, these scientists and clinicians have been 
working in incredibly cramped and outmoded facilities. The 
hospital’s new endoscopic service is the first step in expanding 
and improving these conditions. Soon to be started are 
projects for a centrally located conference room to be named 
in honor of Dr. Spiro, and a library to house Dr. Klatskin’s 
remarkable collection of more than 50,000 kodachromes 
from nearly 10,000 liver specimens — considered the most 
comprehensive and useful resource in the world for investi¬ 
gating the natural history of liver disease. 
Further plans, awaiting funding, include enlarging and 
renovating offices and laboratories of both units. 
“We look forward,” said Dr. Boyer, “to the next few 
years, when, finally, space renovations will provide new 
facilities commensurate with the excellence of our faculty, 
staff and programs.” 
Marje Noyes 
Dr. Fred Gorelick, associate pro fessor of medicine, (left) 
combines basic research in the mechanism of the pancreas 
with patient care. 
HERE AND ABOUT 
Center for Molecular Medicine to be Built at School 
A New Research Matrix: 
Yale and Howard Hughes Medical Institute join to create new Center 
The School of Medicine, in cooperation 
with the Howard Hughes Medical Insti¬ 
tute (HHM1), plans to create a $25 
million Center for Molecular Medicine 
that will provide a new facility in which 
basic and clinical researchers will work 
together to advance biomedical science 
and improve health. 
The project represents an innovative 
approach to biomedical research and a 
major extension of the scientific collabora¬ 
tion between the School of Medicine and 
the HHMI. At the new center, Yale and 
H H M1 researchers will work to discover 
how human cells function in isolation 
and in the context of whole tissues and 
intact organisms. 
“This Center for Molecular Medicine 
will enhance the future of biomedical 
sciences at Yale and strengthen applica¬ 
tions in health care,” said Dr. Leon E. 
Rosenberg, the dean of the School of 
Medicine who has focused his own re¬ 
search on inherited metabolic disorders 
in children. 
“We plan to create a new research 
matrix at Yale’s Center for Molecular 
Medicine by organizing scientific research 
along programmatic rather than depart¬ 
mental lines,”the dean said. “By bringing 
the laboratories of basic scientists and 
clinical investigators together, we hope to 
accelerate the translation of fundamental 
information about human biology into 
new preventive, diagnostic and therapeu¬ 
tic strategies.” 
To understand human biology at the 
molecular level and foster information 
flow between basic scientists and physi¬ 
cians, researchers will likely concentrate 
in these major areas: organization, regula¬ 
tion and expression of genes; cellular and 
molecular basis of the nervous system’s 
function; carcinogenesis, or causes of 
cancer, with special emphasis on regula¬ 
tion of the cell cycle and the role of 
oncogenes; neuroendocrine modulation 
of homeostasis and behavior, and the 
study of the body’s disease-fighting im¬ 
mune system. 
“These endeavors share a common 
conceptual basis in modern advance cellu¬ 
lar and molecular biology and depend in 
large measure on such powerful methodo¬ 
logies as recombinant DNA technology, 
characterization of protein structure and 
monoclonal antibody production,” Dr. 
Rosenberg said. 
In an agreement between Yale Univer¬ 
sity and the Howard Hughes Medical 
Institute of Bethesda, Md., Yale will plan 
and construct the new I 10,000 gross- 
square-foot medical research facility for 
Yale and HHMI to use. 
Yale scientists and HHMI scientists, 
who will also be Yale faculty members, 
will conduct research in the building and 
will share core laboratories. These core 
laboratories, which will be available to 
the entire Yale medical school faculty, 
will generate state-of-the-art data on nucle¬ 
ic acid and protein chemistry. A hybri- 
doma facility will produce monoclonal 
antibodies. 
“This project exemplifies the Howard 
Hughes Medical Institute’s purpose of 
promoting basic scientific knowledge in 
molecular genetics, immunology, metabo¬ 
lism and neuroscience,” said Dr. Donald 
S. Fredrickson, HHMI president and 
chief executive officer of the Hughes 
medical research organization, a not-for- 
profit-entity. He also is former director 
of the National Institutes of Health. 
The Howard Hughes Medical Institute 
has earmarked $15 million toward con¬ 
struction of the Center for Molecular 
Medicine. The construction funds com¬ 
prise only a portion of the more than $50 
million which institute officials have al¬ 
located for medical research operations 
at Yale. 
Yale is one of 22 academic medical 
centers where the institute conducts affilia¬ 
ted research programs, and these collabor¬ 
ations often involve the most advanced 
research. Yale and HHMI have been 
affiliated formally since 1977, just 24 
years after H ughes, an aviator and indus¬ 
trialist, founded the institute (1953). Its 
funding and endowment comes from 
proceeds of the Hughes Aircraft Corpor¬ 
ation sale. 
The molecular medicine building will 
be constructed on University-owned land 
on the medical school campus and will 
connect with the Sterling Hall of Medi¬ 
cine. Yale officials estimate that the facility 
will be completed in 1989. 
Yale University President A. Bartlett 
Giamatti has selected the New Haven 
architectural firm of Cesar Pelli & Associ¬ 
ates to design the new center. Mr. Pelli 
wasdean of Yale’s School of Architecture 
between 1977 and 1984 and now is profes¬ 
sor of architecture. 
Dr. Fredrickson 
Dean Rosenberg 
Coordinating the Yale project is Wil¬ 
liam C. Brainard, provost of the Univer¬ 
sity and professor of economics. At the 
School of Medicine, Dean Rosenberg 
has appointed a special advisory commit¬ 
tee to assist in planning the proposed 
Center for Molecular Medicine. Commit¬ 
tee members include: Drs. Emile Boul- 
paep, chairman. Department of Physio¬ 
logy; William konigsberg, chairman. 
Department of Molecular Biophysics and 
Biochemistry; George Palade, Sterling 
Professor Emeritus and Senior Research 
Scientist, Department of Cell Biology 
and special advisor to the dean; Robert 
M. Donaldson, acting chairman. Depart¬ 
ment of Internal Medicine and David 
Paige Smith Professor of Medicine. 
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Dr. Collins Appointed 
Chairman of Surgery 
I)r. William F. Collins, Jr., a renowned 
neurosurgeon, has been appointed chair¬ 
man of the Department of Surgery, effec¬ 
tive immediately. Dr. Collins, the Harvey 
and Kate Cushing Professor of Surgery, 
has been acting chairman of the depart¬ 
ment since September 1984 and head of 
the Section of Neurosurgery since 1967. 
“We are pleased that Bill Collins will 
continue to lead the Department of Sur¬ 
gery.” said Dr. Leon E. Rosenberg, dean 
of the School of Medicine. “Not only is 
he a consummate neurosurgeon whose 
research into the understanding and treat¬ 
ment of pain is recognized worldwide, he 
is also an extremely capable administrator 
and loyal alumnus of this university and 
its medical school.” 
A native of New Haven, Dr. Collins 
received a B.S. degree in 1944 and an 
M.D. degree in 1947 from Yale. In addi¬ 
tion to his studies on pain, he has focused 
his research interests on pituitary tumors 
and acute spinal cord injury, and has 
contributed over 100 papers on these 
topics to the scientific literature. 
Following internship in surgery, then 
residency in neurosurgery at Barnes Hos¬ 
pital in St. Louis, Dr. Collins served two 
years as captain in the U.S. Army Medical 
Corps and was a fellow in neurophysio¬ 
logy at Washington University in St. 
1 ouis. before beginning his career in 
academic medicine as an instructor in 
n urosurgery at Case Western Reserve 
University in 1954. He was associate 
sor there, when in 1963 he was 
cd professor and chairman of 
it eery at The Medical College of 
5 iigima in Richmond. 
ns returned to Yale in 1967 as 
i and head of the Section of 
Neurosurgery. In 1970, he was named the 
Harvey and Kate Cushing Professor. 
The editor of the Journal of Neurosur¬ 
gery, he is as well a member of a number 
of scientific societies including: American 
Surgical Association. American Academy 
of Neurological Surgery, American As¬ 
sociation of Neurological Surgeons (mem¬ 
ber of the Board ot Directors 1974-77), 
American College of Surgeons, American 
Physiological Society. AOA, Association 
for Research in Nervous and Mental 
Disease. Neurosurgical Society for 
America (president 1973-74), Research 
Society of Neurological Surgeons and 
the Society of Neurological Surgeons 
(president 1984-85) 
New Psychiatric Service 
for Children Opens 
A Children's Psychiatric Inpatient Service 
opened in November on Winchester 1, is 
expected to serve as a national resource 
forchildren with serious psychiatric, beha¬ 
vioral or developmental disorders. Dr. 
Joseph Woolston, associate clinical pro¬ 
fessor in the Child Study Center and 
psychiatry is the director. 
The result of long collaborative effort 
between the Child Study Center and 
Yale-New Haven Hospital, the 12-bed 
unit will offer diagnostic evaluation, crisis 
intervention and short-term treatment 
for pre-school through adolescent children 
with mental health problems such as 
severe eating disorders, depression, au¬ 
tism, psychosomatic illnesses, attention 
deficiency disorders, schizophrenia and 
Tourette’s syndrome. Family involvement, 
as well as a school program are important 
elements in the treatment program devel¬ 
oped for pediatric-psychiatric patients in 
the new unit. 
New Yale President 
Committed to Scholarship 
and Professionalism 
Benno C. Schmidt, Jr., the Columbia 
University Law School dean who was 
named Yale University's 20th president, 
has strong commitments to academics 
and scholarship, expressing the belief 
"that scholarly striving is the predicate of 
vigor in teaching.” 
At a December 10 press conference to 
announce his appointment, Mr. 
Schmidt reaffirmed his commitment to 
scholarship and said that “a great center 
of learning, such as Yale, must be strong 
in the sciences. 
“One of Bart’s (President A. Bartlett 
Giamatti) great contributions has been to 
strengthen Yale’s commitment to the 
sciences, and that is a commitment that I 
will strive to maintain. 
In his prepared statement, the 43-year 
old legal scholar said, “Yale is one of the 
signal achievements that is America;. . . 
As a place where knowledge is advanced, 
where scientific investigation and human¬ 
istic inquiry are nourished, where artistic 
creation is stimulated, Yale stands almost 
alone in importance in the world .... 
"Yale’s greatness carries an urgent need 
to guard against the fall of excellence into 
exclusivity, of refinement into precious¬ 
ness, of elegance into class and con¬ 
vention.” 
Mr. Schmidt, who also is the Harlan 
Fiske Stone Professor of Constitutional 
Law, will return July I to Yale, where he 
graduated from the College in 1963 and 
the Law School in 1966. 
A member of the Columbia Law School 
faculty since 1969, he is an internationally 
recognized authority on constitutional 
law, the history ol the Supreme Court 
and mass communications law in the 
United States. 
The president designate said that he 
will continue to speak out on scholarship 
and professionalism in Constitutional 
law, including freedom of the press, race 
relations, and problems of secrecy in 
national security. To those concerns, he 
said he would add speaking out on issues 
in higher education. 
Library Acquires 
Cushing Letter 
More insight on the late Dr. Harvey 
Cushing’s pursuit of rare medical books 
may be gleaned from one of his letters 
that an anonymous donor has given to 
the Yale Medical Library. 
Dr. Cushing, a neurosurgeon who 
helped shape the library collection, wrote 
the two-and-a-half-page letter to Jens 
Christian Bay, librarian of the John 
Crerer Library in Chicago, telling Bay 
that he collects books by Dr. Daniel 
Drake. "1 don’t possess a copy of the 
Discourses of the Interior Valley. I shall 
have to do (some scouring until) 1 find 
one in the original covers. If you ever run 
across one do let me know. I shall have 
your address bound and put along-side 
my Drake volume,” Dr. Cushing writes 
encouragingly in his own hand. 
About the letter, Ferenc A. Gyorgyey, 
historical librarian, said. “While Yale has 
the most complete collection of correspon¬ 
dence addressed to Dr. Cushing, letters in 
his own hand to his correspondents are 
scarce, and this one is in fine condition.” 
The two Drake volumes were purchased 
in 1936, just three years before Dr. Cush¬ 
ing’s death. They are among the library’s 
30 some volumes by Dr. Drake, a scientist, 
physician and leader in medical education. 
FACULTY NEWS 
Dr. Albert J. Solnit. the Sterling Profes¬ 
sor in the Child Study Center, Pediatrics 
and Psychiatry, was named the Sigmund 
Freud Visiting Professor at Hebrew Uni¬ 
versity’s Sigmund Freud Center in Jerusa¬ 
lem lor the academic year 1985-86. He is 
one of the conveners of an International 
Symposium on "A Psychoanalytical View 
of Play and Trauma” being given at the 
center March 16 - 20. 
At its annual meeting in November, the 
American Public Health Association pre¬ 
sented Dr. Mvrna Weissnian, with the 
1985 Rema Lapouse Mental Health Epi¬ 
demiology Award for her “significant 
contributions to the scientific understand¬ 
ing of the epidemiology and control of 
mental disorders."The award established 
in 1972, is the only major award in the 
world for outstanding contributions to 
the field of mental health epidemiology. 
Dr. Weissman, professor of psychiatry 
and epidemiology, is director of the De¬ 
pression Research Unit, a joint program 
of the Department of Psychiatry and the 
Connecticut Mental Health Center. 
Dr. Dorothy Horstmann presented Part 
I of the Second Annual K.F.Meyer Lec¬ 
ture, “Can Poliovirus be Eradicated?” 
The lecture was held in December by the 
George Williams Hooper Foundation at 
the University of Southern California. 
Dr. Horstmann, John Rodman Paul Pro¬ 
fessor Emeritus of Epidemiology and 
Pediatrics, is known throughout the world 
for her pioneering research on poliomye¬ 
litis which led to the discovery of a 
vaccine for the disease. The title of her 
lecture was, “The Present: Epidemio¬ 
logical Realities and Challenges.” 
The 1985 Graham Eddy Endoscopic 
Award was presented to Dr. Fiji Yanagi- 
sawa for his videotape “Videolaryngo¬ 
scopy a Comparison of Fiberscopic 
and Telescopic Documentation.’’The tape 
demonstrates the physiology and patho¬ 
logy of the larynx using a flexible fiber- 
scope and a rigid telescope. He also 
organized and presented two of his video¬ 
tapes in the academic program of the 
Movie Session in Otolaryngology at the 
1985 Clinical Congress of the American 
College of Surgeons, held in Chicago in 
October. In addition. Dr. Yanagisawa 
and Dr. Martin Gordon, associate clinical 
professor of medicine, served on the jury 
of the International Film Festival at the 
XIII World Congress of Otorhinolaryngo¬ 
logy, held in Miami last May. 
Shanghai First Medical College has 
named Dr. Robert K. Yu, as Honorary 
Professor, the highest honor of that uni¬ 
versity. Dr. Y u is professor of neurology. 
The American Gastroenterology Associa¬ 
tion has presented the 1986 Morton Gross- 
man Research Fellowship Award to Dr. 
Fred Corelick. This prestigious award, 
which carries a stipend of $30,000, sup¬ 
ports junior faculty during sabbatical 
years and enables them to pursue research 
goals. Dr. Gorelick, associate professor 
of medicine, is investigating the mechan¬ 
isms of the pancreas at the cellular level. 
Dr. Bruce R. Pitt, associate professor of 
anesthesiology, has received an Estab¬ 
lished lnvestigatorship award from the 
American Heart Association. For a five 
year period. Dr. Pitt will be studying 
biochemical actions as they relate to high 
blood pressure and pulmonary vascular 
disease. The focus of the project is to 
develop a diagnostic test of pulmonary 
vascular pathology to be used in newborns 
and aid in understanding congenital heart 
disease. 
The F. Paul Anderson Award for Scienti¬ 
fic Achievement, the highest honor of the 
American Society of Heating, Refriger¬ 
ating and Air-Conditioning Engineers 
(ASHRAE), was presented to Dr. A. 
Pharo Gagge, professor emeritus of epi¬ 
demiology, at a meeting of the society in 
San Francisco on January 20. A well 
known author, researcher and educator 
in the field of environmental physiology. 
Dr. Gagge has made numerous contribu¬ 
tions during the past 50 years to know¬ 
ledge of the effects of indoor environment 
on human comfort and health. He is a 
fellow emeritus and consultant to the 
John B. Pierce Foundation Laboratory. 
At the annual meeting of the American 
Epilepsy Society in December, Dr. Rich¬ 
ard H. Mattson was elected president of 
the 1,250-member society of physicians, 
scientists and other professionals. Dr. 
Mattson, professor of neurology and 
chief of the neurology service at the West 
Haven Veterans Administration Medical 
Center, and Ins colleagues recently re¬ 
ceived a $2.5 million, five-year multi¬ 
center grant from the VA Cooperative 
Studies group to investigate the treatment 
of epilepsy. 
Dr. Peter S. Aronson was the first recip¬ 
ient of the Young Investigator’s Award 
given annually by the American Heart 
Association and the American Society of 
Nephrology for outstanding nephrologic 
research. The award which includes a 
$5,000 prize, was presented to Dr. Aron¬ 
son, associate professor of medicine and 
physiology, at the annual meeting of the 
American Society of Nephrology, held in 
New Orleans on December 18th. 
The 28th Murray S. Danforth Oration 
was delivered by Dr. Wayne (). South- 
wick, professor of surgery (orthopaedics) 
on November 14. The oration is presented 
each year by a distinguished orthopaedic 
surgeon during a three-day tenure as 
surgeon-in-chief pro tempore of the De¬ 
partment of Orthopaedics and Rehabilita¬ 
tion, Rhode Island Hospital, and Brown 
University. The title of Dr. Southwick’s 
talk was “Cervical Spondylosis.” 
The American Public Health Association 
presented its 1985 Distinguished Service 
and Professional Achievements Award 
in Environmental Health to Dr. Eric 
Mood, associate clinical professor of 
public health (environmental health), for 
his research and teaching in environmental 
health and his contributions in interna¬ 
tional health programs over several de¬ 
cades. Dr. Mood, who recently retired 
after 25 years as a member of the Expert 
Advisory Committee on Environmental 
Health, WHO, is editor of Housing and 
Health soon to be released by the A PH A. 
It includes a revised version of the APH A’s 
and CDC’s recommended minimum 
housing standards developed in 1952 
under the leadership of the late professor 
C.-E.A. Winslow, the first chairman of 
the Department of Epidemiology and 
Public Health. 
Dr. Kurt Stenn, professor of dermatology 
and pathology, was elected president of 
the American Society for Dermatopatho- 
logy for a one-year term beginning De¬ 
cember I, 1985. 
In November, Dr. David Seligson, pro¬ 
fessor of laboratory medicine, was visiting 
professor in the Department of Labora¬ 
tory Medicine and Pathology at the Uni¬ 
versity of Minnesota, and in December, 
in the Department of Laboratory Medi¬ 
cine at the University of California, San 
Francisco. The topic of his talks was 
bilirubin covalently bound to albumin, 
issues concerning laboratory medicine 
and resident training. 
As the newly elected chairperson of the 
National Coalition of Arts Therapy. Dr. 
David R. Johnson, in November presided 
over the first conference of the six national 
arts therapy organziations respresenting 
over 12,000 art, music, dance, drama and 
psychodrama therapists in the country. 
Dr. Johnson is assistant clinical professor 
of psychiatry. 
Dr. Clarence Sasaki, professor of surgery 
and head of the Section of Otolaryn¬ 
gology. has been appointed to the National 
Institutes of Health Study Section on 
“Sensory disorders and language.” He is 




March of Dimes Awards 
Yale Researchers a 
Half-Million Dollars in Grants 
The March of Dimes Birth Defects Foun¬ 
dation has awarded $463,000 in grants to 
support projects by 21 Yale researchers 
designed to better understand the cause 
and improve methods for preventing and 
treating birth defects. 
Statistics indicate that approximately 
one child in fourteen is born with a birth 
defect, ranging from prematurity and low 
birth weight to spina bifida. "Research is 
the key." said William Carey, president 
of the New Haven County March of 
Dimes, in announcing the grants, “and it 
is encouraging to see the March of Dimes 
Birth Defects Foundation backing so 
substantially the research being conducted 
at Yale.” 
1 he research includes a study of central 
nervous system maldevelopment by Dr. 
Karl Herrup, associate professor of hu¬ 
man genetics; investigation into causes 
and treatments of brain hemorrhage in 
premature newborns by Dr. Laura Ment. 
associate professor of pediatrics and neuro¬ 
logy. and basic research by Dr. Kay 
Tanaka, professor of human genetics, in 
isovaleric acidemia, a cause of infant 
death and retardation. 
Other projects to receive funding from 
the March of Dimes include basic research 
on embryo development by Dr. Elizabeth 
Dolci, associate research scientist in cell 
biology; continuing letal heart research 
by Dr. Charles Kleinman. associate profes¬ 
sor of pediatrics and diagnostic radiology; 
and basic studies of damaged visual nerve 
pathways being done by Dr. Douglas 
hrost, assistant professor of neuroanato¬ 
my Dr. Albert Reece, assistant professor 
of obstetrics and gynecology received a 
grant for his work on disruption of 
embryo development by various metabolic 
abnormalities of maternal diabetes, and 
Dr. Mark Mooseker, associate professor 
ot biology and cell biology, was awarded 
funding for his research on cellular protein 
production. 
Other Yale researchers to receive March 
ol Dimes grants include: Dr. Michael 
Bracken, associate professor (adjunct) of 
research in epidemiology and obstetrics 
and gynecology; Dr. Mark Cullen, associ¬ 
ate professor of medicine and epidemiolo- 
. Dr. John Ilobbins, professor of obste- 
and gynecology and diagnostic radi- 
Dr. ( Tiarles Greer, assistant profes- 
>1 surgery and neuroanatomy; Dr. 
t l.evenson, assistant professor of 
biology: 1 )r Maurice Mahoney, pro¬ 
em.m genetics, pediatrics and 
a and gynecology, and Dr. Jon 
assistant professor ol pathology, 
r l iank Ruddle, professor of 
human genetics; Dr. Mrinal 
Sanyal, research scientist in obstetrics 
and gynecology; Dr. David Scott, assis¬ 
tant professor of pediatrics; Dr. Margretta 
Seashore, associate professor of human 
genetics and pediatrics, and Dr. Sara 
Sparrow, associate professor in the Child 
Study Center. 
New Procedure Extends 
in vitro Fertilization 
Physicians at the School ol Medicine will 
begin performing a rare procedure that 
they predict will increase pregnancy rates 
for infertile couples and decrease the 
chance of multiple pregnancies. 
The new procedure combines cryopre- 
servation, or freezing, of human embryos 
with earlier work in in vitro fertilization, 
now an accepted method to treat infertil¬ 
ity, and embryo transfer. 
Nationally, one in five couples is infer¬ 
tile, and the cause of the infertility is 
evenly divided between men and women, 
according to Dr. Alan H. DeCherney, the 
John Slade Ely Professor of Obstetrics 
and Gynecology, who will lead the medical 
team. 
“Cryopreservation, potentially, could 
increase the universal pregnancy rate 
with in vitro fertilization and provide 
additional hope tor those couples who 
desperately want to become parents," he 
said. This infrequently performed proce¬ 
dure. he believes, will benefit patients 
with tubal diseases, unexplained infertili¬ 
ty, sperm antibodies and diseases of the 
membrane lining the womb or uterus. 
Dr. DeCherney describes the procedure 
as “very technical. . . The principle is 
simple, but technically it is difficult to 
lreeze the embryos.” 
Basically, a woman’s eggs are collected 
during a laparoscopy, an exam using an 
illuminated tubular instrument. In a petri 
dish, the eggs are fertilized with her 
husband's sperm as part of the in vitro 
fertilization process. 
It is at this point that cryopreservation, 
the procedure's new dimension, occurs. 
The fertilized embryos are rapidly frozen 
and stored. “If embryos will withstand 
freezing and remain viable, the hardy 
embryos will survive,” according to Dr. 
DeCherney. Later, an embryo may be 
thawed and transferred to the woman’s 
uterus when it is most prepared to receive 
one. If the first attempt doesn’t result in 
pregnancy, then the remaining embryos 
may be reimplanted. 
Dr. DeCherney cites several advan¬ 
tages ol the procedure. First, physicians 
will transfer no more than four embryos 
at a time to the woman’s uterus, decreasing 
the chance of multiple pregnancies. “By 
saving some embryos through cryopreser¬ 
vation. additional embryo transfers may 
occur without repeating the laparoscopy 
or ultrasound egg collection,” he said. 
This procedure also prov ides physicians 
and patients with opportunities for more 
flexible timing. “We can return embryos 
to a woman in 'unstimulated cycles’, or at 
a time when she is not taking hormone 
medication that may prevent pregnancy,” 
explained Dr. DeCherney. “We also may 
transfer the embryos at the normal devel¬ 
opmental stage in the menstrual cycle 
and hopefully, increase the chance for 
pregnancy.” 
The Yale team plans to initiate this 
procedure because of previous success 
with in vitro fertilization, improvements 
in cryopreservation techniques and the 
adaptation or transfer of successful animal 
research to human beings, according to 
the gynecologist. 
Since May 1983. Dr. DeCherney and 
the health care team have performed in 
vitro fertilization for couples, a prelude 
to this new procedure. More than 80 
pregnancies have resulted, and the labora¬ 
tory’s fertilization rate has reached 80 
percent of all eggs. 
At present, cryopreservation of embry¬ 
os and reimplantations are being per¬ 
formed in Australia, England, Holland 
and in the United States at the University 
of Southern California. Forapproximate- 
ly ten years, reproductive and endocrine 
studies involving animals have been con¬ 
ducted to develop safe and effective pro- 
ced ures and to determine vvhether embry- 
os will remain viable, and if so, tor how 
long. In the U.S., this research has been 
extended so that embryo freezing has 
become the norm for breeding purebred 
livestock. 
“What we have learned from animal 
studies, we now are ready to apply to 
humans to increase pregnancy rates," Dr. 
DeCherney said. “This gives us an op¬ 
portunity to better understand human 
reproduction.” 
During the past seven months, the Yale 
team, coordinated by Dr. Jeffrey B. Rus¬ 
sell, a fellow in reproductive endocrinol¬ 
ogy, has prepared to perform this pro¬ 
cedure by familiarizing themselves with 
new equipment and techniques. 1 hey 
also have conducted extensive research 
with mouse embryos, testing freezing 
solutions and techniques of freezing and 
thawing embryos. 
After card ul consideration, the School 
of Medicine’s 26-member Human Investi¬ 
gation Committee of medical and non¬ 
medical professionals, students and com¬ 
munity representatives approved the 
procedure. The committee, chaired by 
Dr. Robert .1. Levine, professor of medi¬ 
cine, developed specific guidelines, in 
conjunction with the gynecologists, to 
assure safety for both the women and the 
frozen embryos. 
According to the guidelines, women 
will receive only their own frozen embryos, 
and only those couples in which the 
husband has an adequate sperm count 
will be considered for the procedure. 
Frozen human embryos will be stored at 
Yale-New Haven Hospital for no longer 
than two years because there is not 
enough experience with long-term storage. 
Although federal law permits research 
on embryos, no research will be conducted 
at Yale, according to Dr. L.evine. 
Revised Procedure May 
Prove a Major Step in Heart 
Attack Treatment 
Yale researchers have been given the go 
ahead by the National Institutes of Health 
to streamline clinical trials that might 
yield significant results in the treatment 
of acute heart attack. 
The crux of the revised procedure to 
rapidly dissolve blood clots in acute heart 
attack patients is the elimination of prelim¬ 
inary diagnosis by angiogram and immedi¬ 
ate intravenous injection into the coronary 
artery of a new, more effective clot¬ 
dissolving drug. The drug, tissue plasmino¬ 
gen activator, (t-PA), acts to dissolve 
clots within 30 to 60 minutes after 
administration. 
Previous studies demonstrated that the 
sooner after onset of heart attack symp¬ 
toms clots were dissolved the better the 
prognosis for recovery. “We view this as a 
major step forward in the treatment of 
acute myocardial infarction,” said Dr. 
Tawrence S. Cohen, the Ebenezer K. 
Hunt Professor of Medicine who is co¬ 
principal investigator of the trial with Dr. 
Charles K. Francis, associate professor 
of medicine. “Our studies have shown 
that it is important to dissolve clots 
within the shortest possible time after the 
onset of the attack. By eliminating the 
angiogram, we can save up to two hours.” 
Dr. Cohen stressed that the first four 
hours after onset of heart attack are the 
most critical. After that, the heart muscle 
is irreparably damaged. 
The procedure is part of a major multi¬ 
center study of thrombolysis in myocardi¬ 
al infarction (T1M1) sponsored by the 
N1H for collaborative clinical trials of 
new treatment for acute heart attack. In 
1983, the NIH awarded more than $1.5 
million to Yale to establish one of three 
core laboratories and a clinical unit for 
the TIM I study. Dr. Barry Zaret, the 
Robert W. Berliner Professor of Internal 
Medicine, is director of the core labora¬ 
tory for radionucleotide evaluation, and 
Dr. Francis is principal investigator of 
the clinical unit of Yale’s portion of the 
12-center TIM 1 study. 
Until recently, there was no drugavail- 
able to dissolve blood clots in coronary 
arteries. The first such anticoagulant, 
streptokinase, proved effective when ad¬ 
ministered by catheter into the heart 
muscle, but this procedure requires tech¬ 
nology not available in many hospitals, 
thus limiting the use ot the drug. 
In the first phase of the TIM1 study, 
the Yale research team observed clot 
dissolving properties of streptokinase 
administered intravenously. When t-PA 
became available for research purposes a 
little over a year ago, they compared it to 
streptokinase and found the new drug 
almost twice as effective in rapidly dis¬ 
solving clots in coronary arteries. More¬ 
over, because it acts specifically on clots 
with minimum effects on other clotting 
factors, t-PA reduces the risk of excessive 
bleeding. 
The recent NIH decision to eliminate 
preliminary diagnosis by angiogram was 
based on results of treatment of 50 patients 
in Yale-New H aven Hospital and a total 
of almost 600 patients treated in the 
twelve medical institutions participating 
in the TIM I study. As yet, there is not 
sufficient data to demonstrate whether or 
not t-PA is superior to streptokinase in 
reducing mortality or improving the qual¬ 
ity of recovery from acute heart attack. 
The new anticoagulent is a synthetic 
agent produced by recombinant DNA 
technology. Still classified as an investiga¬ 
tional drug, t-PA is available only to 
studies such as TIMI. 
Because research to date underscores 
the importance of dissolving blood clots 
in the coronary artery early in the episode. 
Dr. Francis and his colleagues are optimis¬ 
tic about the potential for the revised 
procedure to greatly improve treatment 
of heart attack. The next step in their 
research will be to administer t-PA in 
combination with balloon angiography. 
To be eligible for the treatment, patients 
must arrive at Yale New Haven Hospital 
within the first four hours after onset of 
heart attack symptoms, be under age 75, 
have no other life threatening disease or 
bleeding disorder, and their electrocardio¬ 
graph reading must suggest they are 
having heart attack. 
In addition to Drs. Francis, Cohen and 
Zaret. members of the research team 
include Dr. Frans Wackers, associate 
professor of diagnositc radiology and 
medicine, who is associate director of 
Yale’s TIM1 core laboratory, Caroline 
Piscelli, associate in research in medicine, 
and Joan Girard Amatruda. nurse 
specialist. 
Menopause Study to 
Determine Hormone Impact 
The effects of the ovarian hormones on 
women’s functions, particularly upon sen¬ 
sory perception, during and after meno¬ 
pause, are being studied by researchers in 
the Department of Obstetrics and Gyne¬ 
cology. 
Hormonal changes may markedly alter 
a woman’s sense of touch, taste and 
smell, affecting her life at work and at 
home, the researcher say. The three-year 
study’s ultimate goal would be to restore 
women to their normal functioning, ac- 
cordingto Dr. Philip M. Sarrel,associate 
professor of obstetrics and gynecology 
and psychiatry. 
“We hope to sort out the symptoms 
women experience, and to identify those 
which require estrogen replacement,” said 
Dr. Sarrel, principal investigator of the 
$700,000 multidisciplinary study funded 
by the National Institute on Aging. 
Between 100 and 120 women will be 
evaluated for 22-week periods each, during 
which they will undergo a series of psycho¬ 
logical. dermatological, neurological and 
physiological studies. 
The team of investigators includes: Dr. 
Tawrence E. Marks, professor of epidemio¬ 
logy and psychology; Dr. William M. 
Glazer, associate professor of psychiatry 
and Dr. Irwin M. Braverman, professor 
of dermatology. Dr. Hal Morgenstern, 
associate professor of epidemiology and 
public health, is the program’s statistical 
analyses consultant. Research assistants 
include: Mary Ellen Rousseau, a nurse 
practitioner; Valerie Abbott, assistant 
for psychological studies and Dr. Jean 
Bolognia, postdoctoral fellow in derma¬ 
tology. 
Hypothesis for New AIDS 
Treatment Evaluated 
To halt the progression of Acquired 
Immune Deficiency Syndrome (AIDS). 
Dr. Nancy H. Ruddle has proposed inter¬ 
fering with the virus-infected cell’s produc¬ 
tion of a protein called lymphotoxin. 
Lymphotoxins are proteins with de¬ 
structive characteristics normally pro¬ 
duced by white blood cells to fight tumor 
cells. When produced in very high quanti¬ 
ties, as they may be in AIDS, lympho- 
toxins cause the cell to self destruct, 
accordingto Dr. Ruddle, associate profes¬ 
sor of epidemiology. 
Should her hypothesis prove correct. 
Dr. Ruddle has proposed treatment that 
differs from the conventional therapy for 
AIDS, which is to try to restore T cells, 
the virus-infected white blood cells, after 
they are killed. Her approach focuses on 
interfering with the mechanisms that de¬ 
stroys the cells in the first place. 
“If the lymphotoxins are responsible 
17 
f or the pathogenesis, — inhibit the patho¬ 
genesis. allow the system to recover for 
awhile and then try to deal with the 
v irus," said Dr. Ruddle. Her hypothesis 
and proposals for possible treatment of 
AIDS appear in the January issue of 
Immunology Today, a British journal. 
A protein of HTLV-III, the A1DS- 
causing v irus, activates the host T cells, 
the white blood cells which HTLV-III 
infects, to produce the destructive lympho- 
toxins, according to Dr. Ruddle. “T cells 
can in fact be killed by a product they are 
making,” she said. 
Dr. Ruddle believes that lymphotoxins 
may cause several characteristics of AIDS, 
such as reduced body weight and a.smaller 
number of circulating T cells. Lympho¬ 
toxins inhibit an enzyme essential for 
lipid metabolism, thus disturbing the 
digestion of certain foods, especially fats. 
II her hypothesis proves correct. Dr. 
Ruddle proposes several ways to reverse 
the fatal course of the disease: 
Inhibit lymphotoxin activity either by 
addingan antibody to it or binding it so it 
doesn't feed back on the T cells and kill 
them. 
Block the receptor, or the site of attach¬ 
ment. for lymphotoxin in the T cell. 
"11 you understand what components 
make up the receptor, then you can 
actually present the patient with those 
components in a high enough quantity to 
compete with the receptor for lympho¬ 
toxin," Dr. Ruddle explained. 
The receptors have already been shown 
to contain certain sugars to w hich lympho¬ 
toxins will bind, she added. With an 
understanding of the protein structure of 
the receptor, agents could be introduced 
to stop the lymphotoxin from binding to 
the receptor and killing the cell. 
Dr. Ruddle applied for a patent and 
has prepared a proposal for a grant to 
develop research at Vale that would test 
her hypothesis regarding lymphotoxin 
production in AIDS. The T cells, it 
seems, may be producing lymphotoxins 
in an “inappropriate fashion.” 
I hus lar. Dr. Ruddle has tested the 
serum of 12 AIDS patients for lympho¬ 
toxin content. The serum of some 100 
AIDS patients will be tested by the 
study’s end. Of the 12 tested, eight have 
contained the destructive protein. Further¬ 
more, Dr. Ruddle obtained growth media 
of HTLV-III infected lymphocytes and 
non-infected lymphocytes from non- 
AIDS patients. She found that the cells 
infected with the virus produced lym¬ 
photoxins. 
Dr. Ruddle obtained the growth media 
Irom Dr. Lee Rainer, an M l). Ph D. 
jraduate from Yale, who is assistant 
po 'lessor ol hematology and oncology at 
shinglon University in St. Louis. I he 
lest i suits, although preliminary, support 
hei hypothesis, according to Dr. Ruddle. 
IK 
BENEDICT R. HARRIS, M.D. 
Dr. Benedict Harris, clinical professor 
emeritus of medicine and public health 
died on November 3, at the age of 86. 
Ben Harris had a long and distinguished 
medical career. Following two older 
brothers who also received their M.D.’s 
from Yale, he had his house staff training 
at New Haven Hospital from 1922-24. He 
did postgraduate work in cardiology at 
Johns Hopkins and at the Herzstation in 
Vienna, after hav ing been an instructor in 
medicine at Yale from 1924 to 1927. 
Dr. Harris returned to New Haven to 
practice internal medicine and cardiology 
from 1929 to 1967. during w hich time he 
developed a reputation as a superb clini¬ 
cian and teacher and rose to clinical 
professor medicine in 1961. From 1959 to 
1967, he was associate chief of medicine 
at the Grace-New' Haven Community 
Hospital. In charge of the Community 
Medicine Division, he molded this into 
an integral part of the Department of 
Medicine and began the difficult task of 
bringing together the community physi¬ 
cians, the hospital and the medical school 
by his effective and trustworthy leader¬ 
ship. 
In 1964, he was appointed clinical 
professor of medicine and public health 
(medical care) w hen he became associated 
with Dr. Isidore Falk in the project 
“Performance of a Study to Develop 
Standards for Audit of Medical Services” 
w hich became the basis for what we know 
today as Diagnostic Related Groups 
(DRGs). In 1965. he became the first 
medical director of the Sound View Re¬ 
habilitation Center, an expression of his 
interest in care for patients still needing 
professional attention after hospital 
discharge. 
At the time of his retirement as associate 
chief of medicine in 1967, the first year 
assistant residents in medicine, a percep¬ 
tive and critical group, honored him by 
establishing the Benedict R. Harris A- 
ward. It is given annually to the commun¬ 
ity physician w ho contributed the most to 
the education of the medical house staff. 
However, Dr. Harris was far from 
ready to retire from medicine. From 1967 
to 1969. he was chief of medicine at the 
Atomic Bomb Casualty Commission in 
Hiroshima, Japan, as well as principal 
investigator of the Department of Collab¬ 
orative Studies of the National Heart 
Institute -NIH for Japan. As a Navy 
lieutenant commander in 1945, he had 
been among the first medical personnel 
to enter Nagasaki to offer medical care 
following the atomic bomb explosion 
there. On his return from Hiroshima, he 
resumed his private practice in New Haven 
and did not retire completely from medi¬ 
cine until 1983. 
He is survived by his wife. Pearl, his 
tw'o daughters, his five grandchildren and 
his great-grandchild. S.D.K. 
WILLIAM M. LESSER. Ph.D. 
William M. Lesser, Ph.D., director of 
psychological training at Waterbury Hos¬ 
pital Health Center, died suddenly on 
June 28. 1985 at age 53. Dr. Lesser 
graduated from the Bronx High School 
of Science, received his bachelor’s and 
master’s degrees from the City College of 
New York, and his doctorate from Michi¬ 
gan State University. 
An assistant clinical professor of psychi¬ 
atry and a member of the executive 
committee of the Section of Psychology 
at the Yale School of Medicine, he was a 
Diplomate in Clinical Psychology of the 
American Board of Professional Psycho¬ 
logy, and a member of the American 
Psychological Association. He was active 
on various committees and served two 
terms on the Board of Directors of CPA. 
In private practice in Torrington, Connect¬ 
icut, he was a consultant to the Connecti¬ 
cut Junior Republic, the Northwest Child 
and Family Services and Lark Institute. 
Dr. Lesser’s civic interests included 
volunteer services to Litchfield Hospice 
and the American Cancer Society. He 
was actively involved in the American 
Field Service of Litchfield, and for many 
years, headed a committee to locate host 
families there for foreign students. He 
was a member, trustee and past-president 
of the Litchfield B’nai B’rith in Torring¬ 
ton. SB. 
ERNST M. MYLON, M.D. 
Dr. Ernst M. Mylon, associate professor 
emeritus of pathology, died at his home 
in New Haven on October 15 following a 
long illness. He was 90 years old. 
Born in Schneidemuehl, Germany, he 
received his doctor of medicine degree 
from Friedrich Wilhelm University in 
Berlin in 1920. Prior to coming to the 
United States, he held faculty posts in 
Berlin and subsequently, at the Univer¬ 
sity of Belgrade, Yugoslavia. 
Dr. Mvlon came to New Haven in 
1938, when he was appointed a special 
research fellow in pathology at Yale. The 
following year, he became a research 
assistant in pathology, with the rank of 
assistant professor. He was elected to the 
Yale chapter of Sigma Xi in 1940, and in 
1944, he was promoted to research associate 
with the rank of associate professor. 
From 1951 until his retirement in 1963, 
he was an associate professor on the 
regular academic faculty. 
Dr. Mylon was appointed Director of 
Laboratories at the Lawrence and Memo¬ 
rial Hospitals in New London in 1951 
under a contract with Yale, and developed 
a residency training program there. Al¬ 
though he held his post at New London 
until his retirement, he continued to 
teach medical students in the pathology 
course at Yale. Dr. Mylon was the author 
of numerous scientific publications, parti¬ 
cularly in the field of vascular pathology. 
The husband of the late Hildegard 
Joseph Mylon, he is survived bv a 
daughter, Inge Yaffe of Thomaston; a 
son, Peter Mylon of Syracuse, New York; 
six grandchildren and a great-grandchild. 
Memorial contributions may be made 
to the Professor Ernst Mylon and Hilde- 
garde Mylon Scholarship Fund at the 
Yale School of Medicine. A.E. 
CECIL J.HODSON, M.B..B.S. 
Cecil John Hodson, professor emeritus 
of diagnostic radiology, died at his home 
in Sussex, England on December 2, after 
several months of illness. 
Born in England, John Hodson received 
his medical training in London. During 
World War II, he served in Britain’s 
armed services in North Africa and Italy 
as an officer of the Royal Army Medical 
Corps and was cited for outstanding 
performance. 
He began his academic career in 1946, 
and as a chest radiologist, made several 
original and important observations, pri¬ 
marily concerned with pediatric thoracic 
disease. At the end of 1949, he became 
deputy director of the X-ray Diagnostic 
Department at University College Hospi¬ 
tal, London and became director of that 
department in 1961. He left London in 
1970 to become professor of radiology at 
Memorial University of Newfoundland 
in St. Johns. 
Dr. Hodson joined the Yale faculty in 
October 1975 as professor of radiology 
and head of the Renal Section. He became 
professor emeritus in July 1984. 
During his distinguished career Dr. 
Hodson served as secretary and diagnostic 
vice president to The Faculty of Radiolo¬ 
gists in England. As chairman of the 
museum board of The Faculty, he was 
personally responsible for initiation of 
one of the largest X-ray museums in the 
world. He also was advisor in radiology 
to the M inister of Health for three years, 
and in 1981, was awarded an honorary 
fellowship in the American College of 
Radiology. 
Dr. Hodson had an extremely produc¬ 
tive career which is reflected in the ap¬ 
proximately 100 original publications and 
chapters in books, and many speaking 
engagements at national and international 
meetings. Although in his brief term as a 
chest radiologist he made several original 
and innovative contributions to the field, 
his major research interest — spanning a 
period of 25 years - - was concerned with 
the kidney. These endeavors led to his 
defining a new entity, reflux nephropathy 
- a classical model of what a long-term 
investigation should be. 
With imagination, background know¬ 
ledge, persistence, hard work and novel 
experimental design. Dr. Hodson defined 
and revolutionized medical perception of 
the entity, despite considerable resistance 
from those holding to established doctrine. 
This work will probably save many chil¬ 
dren from irreversible kidney disease, 
provides a firm basis for therapy and 
represents a real and valuable contribution 
to medicine one that will have lasting 
effects. 
His quiet determination, high stan¬ 
dards, excellence as a radiologist and 
physician and absolute honesty were in¬ 
spirational to those who knew and worked 
with Dr. Hodson. His interests were not 
only in medicine and kidney disease. He 
was an excellent sailor, an enthusiastic 
climber and a member of the Alpine Ski 
Club. An avid rugby player. Dr. Hodson 
was coach to the Yale rugby team before 
his illness. He was also an amateur singer 
of some repute. 
John Hodson could best be classified 
as a giant of a man in all ways. Those who 
knew him well, personally feel an intense 
loss at his death. The Yale Department of 
Diagnostic Radiology is in the process of 




A pleasant tradition of the past is revived — informally 
then. . . 
Along table set with a fresh 
cloth and magnificent brass 
candlesticks was laden with 
plates of sweets and sand¬ 
wiches. Tea from handsome 
samovars at either end was 
graciously served in china cups and 
saucers by medical school faculty 
wives and their friends. 
Small groups of professors and 
students and their guests were 
gathered in amiable conversation. 
Everyone in the Yale medical 
community was welcomed. 
The faculty-student teas held 
every weekday from October to 
March, were started in the AOs by 
Dean Milton Winternitz, reportedly 
to provide medical students with at 
least one good meal a day and to 
teach them “the social graces.” 
Most students then lived in three 
shabby apartment buildings on 
Howard Avenue or in boarding 
houses scattered throughout the 
city. There were only a couple of 
inexpensive restaurants in the 
neighborhood, and opportunities 
for students to get together socially 
were few and far between. 
“1 suspect the refreshments served 
at the teas were almost the only 
supper some students had many 
days,” observed Dr. Thomas R. 
Forbes, the Ebenezer K. Hunt 
Professor Emeritus of Anatomy. 
Dr. Forbes’wife Helen, and Mrs. 
Vernon Lippard, the wife of Dean 
Lippard, managed the teas 
for more than a decade. 
The students were in luck, recalls 
Dr. Forbes, who was assistant, then 
associate dean for students from 
1948 to 1968. “There was the 
atmosphere of an informal tea 
party. Faculty ladies from the 
various departments in the medical 
school and their friends arranged an 
attractive table, welcomed the 
guests and poured countless cups of 
tea. They all seemed to enjoy 
themselves.” 
In a letter written to Mrs. Forbes 
in 1954, Mrs. Lippard noted that 
tea was served on 99 days that year 
to 15,933 persons — with an 
average attendance of 161 each day, 
at a cost of five-and-a-half cents per 
person! “Judging from the numbers 
who come and from what 
individual students have said, the 
teas are very much appreciated 
indeed,” she said. 
Times and attitudes change, and 
seven years later, the wives of the 
Board of Permanent Officers 
reluctantly decided to discontinue 
the daily teas, at least temporarily, 
because attendance had dwindled 
away. The Edward S. Harkness 
Hall, completed in 1956, with its 
spacious dining room and 
comfortable lounge replete with 
w'ood panelling, fireplace and a 
grand piano, provided students with 
nourishment and social amenities 
the teas had so graciously given 




In the 20 years since, faculty and 
student numbers have almost 
doubled; many students again live 
off campus and feel the need for 
more “interaction, understanding, 
knowledge and friendship between 
faculty and students.” In January 
1983, at the request of a committee 
of first- and second-years students. 
Dean Robert Berliner revived the 
teas. 
What they lack in grace and 
elegance, the department-sponsored 
gatherings held in the Beaumont 
Room on the first Thursday each 
academic month, make up for in 
imagination. Once the Beaumont 
Room was marvelously 
transformed into a disco - complete 
with Bashing lights and music. But 
mostly the entertainment is, as in 
days past, gathering together in 
pleasant conversation. 
Jugs of wine and cider and cans 
of soda have replaced tea served in 
stately samovars. Refreshments 
prepared by students may include 
cookies and sandwiches, but are 
just as likely to be scoops of 
homemade ice cream or baskets of 
fresh strawberries (in December!) 
with pots of hot fudge sauce to dip 
them in. Guests help themselves, 
and dress is decidedly informal. 
As in teas of the ’40s and ’50s. 
though, the mood is warm and 
friendly and everyone has a good 
time. 
Marje Noyes 
Dr. Thomas Forbes, right, enjoyed the earlier teas, and appears 
also to enjoy the recent versions. 
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ALUMNI NEWS 
A New Policy for Alumni Children Applying for Admission 
What is the School's policy with regard to 
applications for admission from children 
of medical school alumni? The question 
is frequently asked, and this policy has 
been under careful review during the past 
year by Dean Rosenbergand members of 
his stall. 
Dr. Robert Gifford, associate dean for 
medical education and student affairs, 
has discussed the current policy with 
various alumni groups during the past 
tall He feels that all alumni should be 
acquainted with the current policy. Our 
alumni leaders concur, and that is the 
reason for this report. 
Dr. Gifford has said that he will person¬ 
ally follow up on the application of 
anyone identified as the child of an 
alumnus or alumna of the medical school. 
As of the current year, all children of Yale 
medical school alumni who apply for 
admission will be granted an interview. 
The interview w ill be given by members 
of the Admissions Committee or by the 
Associate Dean for Medical Education 
and Student Affairs. The associate dean 
also serves as an ex-officio member of the 
Admissions Committee and can bring all 
of the necessary information to the atten¬ 
tion of that body. 
Since there are close to 3000 applica¬ 
tions each year, only five or six hundred 
of the most qualified regular applicants 
can be interviewed. From this pool, the 
Admissions Committee usually accepts 
about 200 of the top candidates in order 
to fill the class of 102 students. Thus, only 
one out of every 15 is accepted, 
and one out of every 30 applicants is 
eventually enrolled. As you can see, this 
is an extremely competitive business and 
many well qualified candidates will have 
to be turned down. 
However, all children of medical school 
alumni will now be automatically inter¬ 
viewed, bypassing the usual screening 
procedure. Of course, all final decisions 
regarding admission will remain with the 
Admissions Committee. 
We hope that the school's new policy 
regarding alumni children, and Dr. Gif¬ 
ford's personal contacts with these appli¬ 
cants and their families will help soothe 
some of the unhappiness and disappoint¬ 
ment of those alumni whose children are 
not accepted. 
Letters commenting on this report are 
most welcome. They should be sent to the 
Editor, and will be shared with Dr. 
Gifford and the alumni leadership. 
CLASS NOTES 
1929 
On October 6. Kay and Russell Scobie 
celebrated their fiftieth wedding anniver¬ 
sary. The event was marked by an organ 
recital and reception at Calvary Presby¬ 
terian Church in Newburgh. New' York. 
Just prior to this event, a planting honor¬ 
ing the Scobies for their loyalty and 
service to the community was dedicated 
in the local historic park. 
1944 
Robert Cooke has been appointed chair¬ 
man of the Department of Pediatrics at 
the State University of New York at 
Buffalo. He is also pediatrician-in-chief 
at Children’s Hospital of Buffalo. 
Dr. Cooke is a board member for the 
International Special Olympics, the As¬ 
sociation of Retarded Children in Erie 
Counts and the Encylcopedia of Bioethics 
<ind is chairman of the Scientific Advisory 
Board of the Joseph P. Kennedy, Jr. 
I undation. He is a past president of the 
Society for Pediatric Research. 
lie has held the positions of president 
I ili Medical College of Pennsylvania, 
chancellor for health affairs at the 
a \ of Wisconsin and pediatrician- 
ai the Johns Hopkins Hospital. 
Dr. ( • kc is the father of six children; he 
! his familv li\c in Orchard Park, N.Y. 
1946 
Donald Shedd, at Roswell Park Memorial 
Institute in Buffalo, New' York, writes 
that he was a guest speaker at a meeting 
on head and neck surgery held in Goiania, 
Brazil, near Brasilia, last May. He is co¬ 
editor of a new book concerned with 
recent results of basic research and treat¬ 
ment of head and neck cancer, “Proceed¬ 
ings of the First International Conference 
of the Society of Head and Neck Surgeons 
and the American Society for Head and 
Neck Surgery”. It was published in August 
by B.C.Decker. Inc. 
1947 
At recent inaugural ceremonies of an 
International Conference on Thalassemia 
held in Bangkok, Amoz Chernoff was 
honored as a founder of thalassemia 
research in Thailand. A “Citation of 
Recognition” was presented to him by 
H.R.H. Princess MahaChakri Sirindhorn 
on behalf of her father. His Majesty 
Bhumidol Adulyade. King of Thailand. 
Dr. Chernoff, a resident of Potomac, 
Maryland, is currently director. Division 
of Blood Diseases and Resources, Na¬ 
tional Heart, Fung and Blood Institute, 
National Institutes of Health. 
1948 
A profile of Boy Frame. w hich appeared 
in the American College of Physicians’ 
Observer in September, summarized Dr. 
Frame's career, noting him as one of the 
top specialists in bone and mineral metabo¬ 
lism in the country. A few months previ¬ 
ously, he had been named chairman of 
the Department of Medicine at Henry 
Ford Hospital in Detroit; he is also 
clinical professor of medicine at the Uni¬ 
versity of Michigan Medical School. 
Dr. Frame’s civic support is evidenced 
by his work with the Detroit Lions. From 
1965 to 1975 he conducted all physical 
examinations of the players, coaches and 
management and for about eight years, 
traveled with the team. 
Dr. and Mrs. Frame have three children, 
the oldest of whom is also a physician. 
"One of the most pleasant experiences of 
my life,” he says, “was working with Rick 
in the hospital, doing rounds together.” 
He has also been very actively working 
with other young physicians — first as 
ACP Governor for Michigan (he was 
named Governor of the Year in 1981), 
and now as Regent, he has been a prime 
mover in the Associates’ program which 
has become fairly W'ell integrated into the 
College, both at the local and the national 
level. This development is, in his opinion. 
necessary for the continued growth of the 
College. 
Although he claims not to have made 
any outstanding contributions, he notes, 
"1 have been interested in metabolic bone 
disease, particularly some of the more 
unusual and rare forms, and I have had 
the opportunity to see patients with certain 
diseases that were so rare that they had, 
up to that time, not been recognized. My 
associates and 1 were able to carry out 
certain investigations and studies, particu¬ 
larly bone biopspy interpretation, in order 
to understand the nature of underlying 
bone disease.” 
1959 
In the November 1985 issue of Surfer 
magazine, Malcolm Ing was one of several 
Honolulu residents who were featured as 
having an avid interest in the sport of 
surfing outside of their professional ca¬ 
reers. Dr. Ing, who is chief of Ophthal¬ 
mology at the University of Hawaii and 
at Queen’s Medical Center as well as 
president of the Hawaii Ophthalmologi- 
cal Association, has been a surfing enthusi- 
ast since he was 15 and recalls his most 
memorable surfing experience which was 
in 1967, when he rode alone at Honolua 
Bay in double overhead waves. His interest 
has not waivered over the years and in 
addition to the pleasure of the sport itself, 
he considers surfing to be “one of the best 
ways of dealing with the stresses of daily 
professional life. When I’m sitting on my 
board late in the day, 1 get to watch the 
moon come up over Diamond Head, a 
rainbow in Manoa Valley and a beautiful 
sun setting over the Waianae mountain 
range the effect of this activity is 
indescribable except to say that it stabil¬ 
izes my mind and body after a day in the 
operating room.” Dr. Ing advises young 
surfers “to remind themselves that the 
body is the temple of the soul and that if 
they keep it in good shape, they ought to 
be able to go on surfing well into their 
seventies and eighties just as I plan to 
do.” 
1961 
Roland Paegle and his wife, Grazina, 
were in New Haven last spring for the 
30th reunion of Roland’s Yale College 
class. A recent letter notes that he thought 
the co-ed arrangement at his alma mater 
was a marked improvement over the 
males only policy during his college years. 
During his reunion visit, he also had an 
opportunity to visit the School of Medi¬ 
cine. The Paegles have been located in 
Marion, Indiana for the past two years. 
1963 
Jon FesseI,who has been in private prac¬ 
tice in the New Haven area for 15 years 
and is assistant clinical professor of medi¬ 
cine at Yale, has been appointed chief of 
internal medicine at the Yale Health 
Plan. 
1952 
A class note in the fall issue told of recent activities of Willard 
and Siegried Centerwall and of various honors they have 
received. The photograph (left) received subsequently shows the 
Centerwalls at the memorial to Dr. Asbjorn Foiling, the 
Norwegian physician and biochemist who discovered 
phenylketonuria 50 years ago. The Centerwalls participated in 
the dedication of this memorial in Norway last June and were 
honored for their work in the 1950's with dietary treatment of 
PKU and the first early infancy testing programs for this 
disorder. 
NOTE: The Yale School of Medicine 
Office of Alumni Affairs has relocated to 
the Suite 3D, Sterling Apartment 
Building, 350 Congress Avenue. The 
mailing address remains: Office of Alumni 
Affairs, 333 Cedar St., P.O.Box 3333, 
New Haven, CT 06510; phone (203) 785- 
4674. 
Constance Q. Tolliver has been named 




Grace Jordison Boxer, who is associate 
chief of staff for education at the Ann 
Arhor Veterans Administration Medical 
Center, was one of 60 participants selected 
to attend the prestigious Leadership VA 
training program. Leadership VA is de¬ 
signed to identify gifted leaders in the 
Veterans Administration and to enrich 
their career development through an in¬ 
tense year-long leadership training period. 
She and her husband, Laurence Boxer 
(’68 HS), who is director of Pediatric 
Hematology-Oncology at Mott Children's 
Hospital and professor of pediatrics at 
the University of Michigan School of 
Medicine, live in Ann Arbor with their 
nine-year-old son, David. 
1969 
Charles Dinarello was the Elisha Atkins 
Visiting Professor at Yale School of 
Medicine in February and lectured on 
“Changing Concepts of the Pathogenesis 
of Fever.” Dr. Dinarello is professor of 
medicine and pediatrics at Tults Univer¬ 
sity School of Medicine in Boston. 
Elliot Livstone, who was associate profes¬ 
sor at Yale before leaving to practice 
gastroenterology in Sarasota, Florida, 
was the major guest lecturer at the First 
Norbert Schnog lecture at the Yale Com¬ 
prehensive Cancer Center in September. 
He spoke on “Pancreatic Cancer: Current 
Status and Prospects lor the Future.” 
Dr. Livstone noted that because pancre¬ 
atic cancer produces only vague symptoms 
and there is no adequate screening test 
for it, the disease is usually discovered in 
an advanced state. Reporting on clinical 
trials now underway for this disease, he 
discussed the different kinds of chemother¬ 
apy being used and stated that the com¬ 
bined therapies have prolonged survival 
for many people. 
“The future,” Dr. Livstone said, "is in 
using monoclonal antibodies both for 
finding the tumors and for treating the 
disease. New imaging technology should 
also help us find pancreatic cancer earlier. 
Norbert and Sue Schnog of Westport, 
Connecticut, sponsored the lectureship 
at Yale Comprehensive Cancer Center, 
where Mr. Schnog has been under treat¬ 
ment for pancreatic cancer. They have 
established the lectureship to help foster 
an attitude of positive thinking in the 
medical community so that physicians 
v. ill focus on ways to treat the disease and 
to help stimulate additional research by 
increasing communication among those 
who are already working in this area. 
1974 
Frank Brown is director of Medical Af¬ 
fairs at Neema Emergency Medical, a 
primary care physician group and manage¬ 
ment services firm based in Philadelphia. 
He wrote that he has been appointed 
chairman of The American College of 
Emergency Physicians’national Member¬ 
ship Constitution and By-Laws Commit¬ 
tee. For the past two years. Dr. Brown 
has served as the College's project director 
for International Membership Affairs. 
1977 
Ricky Schneider of Bryn Mawr, Pennsyl¬ 
vania has been elected to fellowship in the 
American College of Cardiology. Dr. 
Schneider is director of nuclear cardiology 
and assistant professor of clinical medicine 
at Presbyerian-U niversity of Pennsylvania 
Medical Center in Philadelphia. 
Harvey Berger wrote that on February I 
he became Senior Vice President of Medi¬ 
cal Affairs and Director of the diagnostic 
imaging and immunotherapy programs 
at Centocor, Incorporated. He noted that 
Centocor has, since its founding in 1979, 
been committed to the development of 
unique radiopharmaceuticals and thera¬ 
peutic products based on monclonal anti¬ 
bodies and to strong collaborations with 
academic institutions. Dr. Berger also 
will be a member of the Nuclear Medicine 
faculty at the University of Pennsylvania. 
1982 
Craig Lewis wrote recently: "1 am now 
completing my first six months of a three- 
year commitment with the National 
Health Service Corps in Yap State of the 
Federated States of Micronesia, where I 
am practicing internal medicine. Yap 
hopes that an internist on island may 
decrease the need for costly referrals. 1 
am discovering with some surprise, that 
quite good medicine can often be practiced 
without knowledge of anion and osmolar 
gaps. Of greatest excitement to me have 
been seafaring excursions to the dispen¬ 
saries of the little known outer island 
atolls for both emergency care and routine 
support. 1 would strongly encourage a 
Third World experience for anyone in 
medicine so inclined.” 
1984 
Dan Oren is the author of “Joining The 
Club: A History of Jews and Yale.” This 
book, the product often years of research, 
was published in February by the Yale 
University Press. The study began as a 
term paper when he was a sophomore in 
Yale College in 1976 and in his senior 
year was expanded to a history thesis. 
With encouragement from his professors 
and help of the American Jewish Archive, 
he decided to write the book while he was 
a medical student and finished it about 
thetime he received his M.D. degree. T he 
book documents the dark history of anti- 
Semitism and discrimination at Yale 
which, along with Harvard. Princeton 
and other prestigious educational institu¬ 
tions, was considered to be “the club” in 
American social hierarchy. There is com¬ 
ment about the School of Medicine admis¬ 
sions policies instituted under the aegis of 
Dean Winternit/. 
Dr. Oren is currently a postdoctoral 




As of October 21. Thomas Stranova of 
North Easton, Massachusetts became 
dean for administration at the Tufts 
University School of Medicine in Boston. 
He has been associate director and chief 
executive officer in hospitals in Wisconsin, 
California and Indianaand most recently, 
chief executive officer at the Veteran’s 
Administration Medical Center in Brock¬ 
ton West Roxbury. A lecturer at Harvard 
Medical School, he was also on the 
clinical faculty of the Harvard University 
School of Public Health. 
Mr. Stranova is a board member of the 
Association of American Medical Col¬ 
leges’Council of Teaching Hospitals and 
is a member of the Governor’s Health 
Coordinating Council for Massachusetts. 
Within the VA system, he had been on 
the VA Management Information Systems 
Task Force, and the VA Strategic Manage¬ 
ment Task Force. 
Mr. Stranova and his wife, Mary, have 
three children Thomas .1. Jr., 14; 
Nichole, 8; and Dana, 5. 
HAVE WE HEARD 
FROM YOU? 
We’d like to. Please send news of awards, 
recent publications, professional appoint¬ 
ment or other items of interest to the 
Editor, Yale Medicine, P.O. Box 3333, 
333 Cedar Street, New Haven, CT06510 
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A TIME OF CHANGE 
IN MEMORIAM 
Ella Wakeman Calhoun 
November 27, 1985 
’2IM.D. 
Benedict R. Harris 
November 3, 1985 
’22 M.D. 
Julius A. Olean 





William .1. Logan 
November 15, 1985 
’25 M.D. 
Rebecca Proctor 
April 10, 1985 
’31 M.D. 
Russel] A. Anthony 
August 23, 1985 
'42 MS 
Mrs. Edith M. Blakeley 
June 15. 1985 
’46 M.P.H. 
M. Otis Flanary 
September 27, 1985 
'49 M.P.H. 
John P. Lamb, Jr. 
1981 (?) 
’49 M.P.H. 
In his "State of Our School”address to the faculty in September 1984, Dean Leon 
E. Rosenberg said, “II you join me in aspiring to be vibrant as well as vital, and to 
soar as well as be sound, then we must strive even harder for excellence and be 
prepared for change. It is this challenge of change which I see as the major agenda 
item ot my deanship and it will take many forms.” 
In fact, in the ensuing two years, there have been many changes, and some of the 
most visible are quickly noted by alumni when they return to the School to find an 
old building finely renovated for a new use, or a building under construction on a 
parking lot. The pounding of jack hammers and screech of skill saws that has 
become part of the environment here, will go on as our school continues to improve 
and expand its facilities to remain at the forefront of medicine of the future. Some 
of the projects begun in 1984 are nearing completion; others, such as the new 
Center for Molecular Medicine and expansion of the Medical Library, are still on 
the draw ing board. 
It is a time of change and a time of excitement. 
David Yakouhian 
On April 10 and II, a major symposium 
on “Perspectives in the Management of 
Eye Diseases" will celebrate the opening 
of the Yale Eye Center for Clinical Re¬ 
search in the completely renovated Board- 
man Building. The $2.5 million project is 
the culmination of 23 years of planning 
by Dr. Marvin Sears, right in photo, who 
has been chairman of the Department of 
Ophthalmology and Visual Science since 
it was founded in 1971. A regional, 
national and international referral re¬ 
source, the Eye Center will be the only 
facility of its kind between Boston and 
New York for persons requiring diagnosis 
and treatment of eye disease. 
Katie Krauss 
On a chilly day in February, the new nine-ton magnet for the 
Magnetic Resonance Center was hoisted into the mostly under¬ 
ground addition to the LCI building at the corner of Davenport 
and Howard Avenues. The MR Center, a joint project of the 
medical school and Yale-New Haven Hospital, will bring together 
)ale’s research and clinical activities in magnetic resonance 
technology — considered one of the most important developments 
in medicine in this decade. The building including offices, labora¬ 
tories and patient care rooms, will be equipped with two whole 
body scanners, a small animal instrument and a high field 
spectrometer. The four magnets will have a combined strength of 
almost 450,000 times that of the earth's magnetic field. 
Marie Noyes 
Across Howard Avenue from the MR Center, the Yale Center for 
Ambulatory Medicine is becoming a reality. The facility, which 
will consolidate clinics and offices of the Yale Faculty Practice 
Plan currently scattered in 17 locations throughout the medical 
center, is expected to attract individuals on an outpatient basis 
f rom a wide geographic area for specialty and consultative services. 
The estimated completion date for this project is February 1987. 
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ALUMNI WEEKEND 1986 
HIGHLIGHTS 
subject to change 
FRIDAY, JUNE 6 
8:30 Medical Alumni/ae Registration 
1:00 -3:00 Yale School of Medicine Class of 1961 Reunion Seminar 
"Retrospective and Prospective Views. Twenty-five Years after Graduation." Speakers to include Kenneth 
Arndt: David Brook; Philip Felig; Marguerite Stein Lederberg; Robert Levy; Vincent Marchesi; Charles 
Sachatello; Robert daub; John Weil; Warren Widmann; John Woodward 
1:15-2:30 Yale Child Study Center Grand Rounds 
2:30-3:30 V ale C hild Study Center Open House 
3:00 Special Alumni/ae Presentation 
"Physicians and the Nuclear Arms Race”, John O. Pastore. M.D. ’67, Associate Professor of Medicine, Tufts 
University; Secretary, International Physicians for the Prevention of Nuclear War. 
4:00 Yale School of Medicine Special Address 
" The Challenge of Yale Medicine: Protecting Excellence in an Unpredictable Environment”, Samuel O.Thier, 
M.D., President, Institute of Medicine, National Academy of Sciences 
5:00 Dean’s Reception 
(Medical School, Public Health and Nursing Alumni/ae, Faculty, Students and Guests are invited) 
7:30-9:00 Medical Alumni/ae Reunion Dinner* 
9:00-1:00 V ale School of Medicine Reunion Dance** 
Co-sponsored by the Yale School of Medicine 1986 Reunion Class. (All Yale-New Haven Medical Community 
and Guests are invited) 
PUBLIC HEALTH 
Association of Vale Alumni ae in Public Health (AYAPH) and Yale University Hospital Administration 
Alumni Association (YUHAAA) 
"The Urban Public Health Crisis” 
8:30-9:30 Registration and Coffee 
9:30-10:00 Welcome and Opening Remarks 
10:15-12:00 Concurrent Sessions**** 
AYAPH Workshop 1 “Critical Urban Public Health, Environmental Health and Mental Health Issues”. 
YUHAAA Workshop 1 “Impact of the Prospective Payment System on City Hospitals”. 
Speakers for both workshops to be announced 
12:15 - 2:00 Luncheon*** 
Special Presentation to be announced 
2:15-4:00 Concurrent Sessions**** 
AYAPH Workshop II "Minority Health Issues of the Eighties”. 
Yl IIAAA Workshop II “Fighting the High Cost of Care with Alternative Payment Systems”. 
Speakers lor both workshops to be announced 
4:15-5:00 Annual Meetings — AYAPH and YUHAAA 











Medical Alunini/ae Registration 
Remarks: A.Bartlett Giamatti, President, Yale University 
Seminars 
I. “Seventy-five Years of Child Development at Yale”. Moderator: Donald Cohen, M.D., director, Child Stud) 
Center. Participants: David Musto M.D.; Melvin Lewis, M.D.; James Leckman, M.D. 
II. “Medical Education and Student Affairs”. Participants: Robert Gifford, M.D., associate dean. Medical 
Education and Student Affairs; Thomas Lentz, M.D.; Pamela Nyiri 
III. “New Directions in Geriatrics at Yale”. Participants: Leo Cooney, Jr., M.D., director, Continuing Care 
Unit, Y-NHH; Ronald Miller, M.D.; Mary Tinetti, M.D. 
IV. “Recent Advances in the Understanding and Treatment of Affective Illness” Participants: George R. 
Heninger, M.D. director, Abraham Ribicoff Research Facilities; Dennis S. Charney, M.D., chief, Clinical 
Research Unit; Lawrence Price, M.D. 
Guided Tours: Yale Art Gallery; Yale Center for British Art; Historic Sections of New Haven 
Annual Meeting of the Association of Yale Alumni in Medicine 
Sherry 
Buffet Luncheon 
Yale School of Medicine Class of 1961 Dialogues 
School of Medicine Alumni Fund Class Agents Meeting 
Guided Tour: New Facilities of the Yale Eye Center for Clinical Research 
Individual class parties and dinners for the five year reunion classes (’26, ’31, ’36, '41, ’46, ’51, ’56, '61, ’66, ’71, ’76, ’81). 
Information will be available at Alumni registration Desk. 
^Prepaid advanced reservations required. Reservations limited 
**Prepaid advanced reservations required. For additional information, contact Connie Q. Tolliver, Assistant to the Director, Otlice ol Alumni 
Affairs, Yale School of Medicine, P.O. Box 3333, New Haven, CT 06510, (203) 785-4674 
***Prepaid advanced reservations required (luncheon cost to be announced) 
****Program fee $30 per person. For additional information contact Elizabeth Lorenzi, M.P.H. 79, Alumni/ae Activities Coordinator, 
Epidemiology and Public Health, Yale School of Medicine, P O.Box 3333, New Haven, CT 06510, (203) 785-4845 
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CAMPAIGN UPDATE 
Nearly $70 million received to date 
Dr. and Mrs. A. John Anlyan 
Mr. and Mrs. Adrian C. Israel with Dean Rosenberg 
By mid-January, the School of Medi¬ 
cine had received gifts and pledges 
amounting to $69,054,556 toward its 
$125 million capital campaign. 
“We have received gifts from foun¬ 
dations, corporations and individuals, 
including alumni of Yale College as 
well as of the medical school,” said 
Sue B. Dorn, associate vice president 
and director of medical school develop¬ 
ment. “The dollars recognize the 
School's past and attest to the enthusi¬ 
asm for the direction it is taking.” 
Highlights of the campaign so far 
include a gift of $1 million for renova¬ 
tion of research space in the Section 
of Molecular Neurobiology from one 
of the School’s distinguished alumni. 
Dr. A. John Anlyan, '42 S, '45 M.D., 
and his wife, Betty Jane Renneckar 
Anlyan, of San Francisco, California. 
A prominent surgeon, recently re¬ 
tired, Dr. Anlyan has been a consistent 
supporter of the medical school over 
the years. In addition to serving on 
the Yale Development Board, he is a 
member of the National Volunteer 
Committee for the Campaign for the 
Yale School of Medicine. Dr. and 
Mrs. Anlyan’s contribution will fur¬ 
ther important research being done 
at Yale to determine the structure 
and function of the brain at the 
molecular level. 
Two major gifts have been received 
toward construction of the Magnetic 
Resonance Center. The Pew Memor¬ 
ial Trust of Philadelphia has given 
$ 1.5 million, and Mr. and Mrs. Adrian 
C. Israel of Stamford, Connecticut, 
and their family have contributed 
$1,250,000 toward the project. 
Mr. Israel, who received a B.S. 
degree in 1936 from Yale’s Sheffield 
Scientific School, directs his family 
business in White Plains, New York. 
Active in alumni and fund raising 
activities for many years, he has 
served on the Yale Development 
Board since 1946. 
Dr. William W.L. Glenn The Israel family gift completes 
the school’s drive for construction of 
the Magnetic Resonance Center, ac¬ 
cording to Mrs. Dorn. The center, 
which represents an important ad¬ 
vance in research and patient care, is 
scheduled for completion this year. 
Pledges have been received of 
$500,000 from the Charles E. Culpep¬ 
er Foundation to establish the Charles 
E. Culpeper Fund in honor of Dr. 
William W. E. Glenn, and of $ 125,000 
from International Playtex Corpora¬ 
tion toward research in clinical epidem¬ 
iology. Inaddition, agift of $100,000 
from the Surdna Foundation of New 
York will endow a research venture 
fund in human genetics. 
The Charles E. Culpeper Fund in 
honor of Dr. William W.F.Glenn 
recognizes the Charles W. Ohse Pro¬ 
fessor Emeritus of Surgery, who is 
well known to alumni as an out¬ 
standing teacher and surgeon, and is 
recognized throughout the world for 
his pioneering work on radiofre¬ 
quency pacemakers to regulate heart¬ 
beat and respiration. 
By providing financial support, 
the endowed permanent research ven¬ 
ture fund will permit the school’s 
most promising young physicians to 
pursue personal research interests 
early in their career, allowing them to 
become eligible for support from 
traditional funding sources several 
years sooner than is normally the 
case. 
In addition, Mr. H. P.J.Duberg of 
Hobe Sound, Florida has given 
$100,000 to establish a research fund 
in neurosurgery. A graduate of the 
Yale College Class of 1930, Mr. Du- 
berg has had a strong interest in the 
School of Medicine for a number of 
years, contributing to student finan¬ 
cial aid as well as supporting young 
faculty research. In 1978, he estab¬ 
lished the Dorys McConnell Duberg 
Professorship in Neuroscience in 
honor of his late wife. 
PROGRESS REPORT SUMMARY 
As of January 10, 1986 
Received Outstanding Pledges Total 
Building $ 3,723,773 $ 16,198,927 $ 29,922,700 
Endowment $ 2,798,673 $ 6,892,503 S 9,691 1 76 
Equipment $ 616,963 $ 459,552 $ 1,076,515 
Loan Funds $ 435,855 $ 0 $ 435,855 
Research $ 14,594,172 $ 11,919,205 $ 26,513,377 
Various $ 1,024,320 $ 0 $ 1,024,320 
Operations $ 237,221 $ 193,392 $ 430,613 
TOTAL $ 23,430,977 $ 45,663,579 $ 69,094,556 
SOURCE 





















Watch this page each issue during 
the Campaign for the Yale School of 
Medicine for a campaign update. 
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Yale School of Medicine - Community Hospital Affiliations 
A TWO WAY STREET 
THAT IS WIDE OPEN 
by James D. Kenney, M.D. 
Just over twenty years ago, during the era of “The Great 
Society,” Congress passed public law 89-239 (The Heart 
Disease, Cancer and Stroke Amendments of 1965), which 
enabled regional planning for the establishment and linkage 
of health services. Those who drew up the legislation might 
now be seen as having built better than they knew for, 
although they expected significant technical advances in 
health care, they could not have predicted the “imaging 
revolution” which was to occur in the next two decades, nor 
the extraordinary advances which were to occur in microsur¬ 
gery, transplantation, manipulation of the immune response, 
antibiotic therapy and the technology of intensive care. 
Certain early sophistication, such as arterial blood gas 
determinations and cardiac monitoring, had begun to be 
widely available, however, and the architects of regional 
medical planning (not yet called “health care delivery”) 
sought to develop relationships which would enable easy 
dissemination of new knowledge and technology. Although 
they sought to involve the consumer public in this planning, 
they aimed, as specified in the law, “to accomplish these ends 
without interfering with the patterns or the methods of 
financing of patient care or professional practice, or with the 
administration of hospitals, and in cooperation with prac¬ 
ticing physicians, medical center officials, hospital admini¬ 
strators and representatives for appropriate voluntary 
health agencies.” The focal points for this sought-for unity 
were to be the major medical centers. Professional leadership 
at the various institutions in the scheme was to enable its 
coherence. 
The situation in Connecticut which preexisted this plan¬ 
ning effort was already developed. Standards of care were 
generally good and all hospitals were JCAH approved. 
There were no proprietary hospitals. I he geographic area 
was small, transportation was good and there were no 
specific geographic barriers. Many institutional linkages 
already existed, and the schools of medicine were already a 
recognized “presence.” Regional teaching and consulting by 
Yale faculty had been provided for many years, sometimes 
through the Dean’s Office and sometimes on an individual 
basis. To use the schools of medicine as focal points for 
planning was perceived as reasonable and proper. The 
Connecticut Regional Medical Program (CRMP) was 
established. 
Dr. Kenney, clinical professor of medicine, is associate dean for graduate 
and continuing education. 
STRUCTURE 
The key feature of the new pattern was to be the installation 
of fulltime chiefs of service in regional hospitals. These 
physicians were to relate to schools of medicine in two ways: 
first by virtue of their having faculty appointments and 
second, by having the initial funding of their salaries come to 
their parent institutions through affiliated schools of medi¬ 
cine. Their loyalties and interests would be directed to the 
institutions in which they worked, to their colleagues in the 
profession and to the schools of medicine in which they had 
appointments. 
Public influence on the scheme was to be exerted through 
the appropriation of funds fora number of “field demonstra¬ 
tions” which were to influence the conduct of events within 
the affiliation. The traditional counter-position of physicians 
and hospitals was to be modified by introduction of the 
consumer “third force” and key personnel. 
ACCOUNTANCY 
In the five years 1968 through 1973, under the terms of 
formal affiliation agreements, positions were created and 
most of them filled for 75 hospital-based physicians at 
various Connecticut hospitals. In Yale’s case, the affiliation 
agreements have been continued in all instances but one and 
have been refined and renegotiated over succeeding years. 
The School of Medicine now has affiliation agreements with 
ten hospitals (Bridgeport, Danbury, Greenwich, Griffin 
Hospital in Derby, Hospital of St. Raphael in New Haven, 
Lawrence and Memorial Hospitals in New London, Norwalk 
Hospital, St. Mary’s Hospital in Waterbury, St. Vincent’s 
Hospital in Bridgeport and Waterbury Hospital). 
A number of efforts are enabled in this way, including 
contracts for teaching by Yale faculty, rotation of house 
officers from Yale-New Haven Hospital to some six regional 
hospitals, and from eight regional hospitals to Yale-New 
Haven Medical Center. Physicians in fellowship training 
rotate to five regional institutions from the School of 
Medicine, and fellows from two — sometimes three - 
regional hospitals have come to Yale to expand their 
training. 
Yale’s influence on scholarly events at regional institutions 
has been magnified in several ways. One worth special 
mention is that of contracts for didactic services, first 
developed under Dr. Samuel Thier, until recently, chairman 
of the Department of Internal Medicine. Such contracts not 
only provide Yale faculty teaching, but also include adver¬ 
tising by the school of residency training at the affiliated 
institutions and enabling of rotations for fellows and 
housestaff, thus improving the fabric of internal medicine 
education. At present, some 40 contracts exist between 
several Yale departments and their regional hospital 
counterparts. 
In the final analysis, however, it is the fulltime chiefs at 
regional hospitals who are the strong points in the linkage. 
They have become “prudent buyers” of academic substance 
from Yale while, at the same time, they serve as leaders in 
organizing graduate and continuing education at their own 
institutions. During the academic year, the regional chiefs of 
medicine meet monthly at one of the affiliated institutions 
for dinner and a review of common concerns and opportun¬ 
ities. The Yale chairman attends these meetings. Less 
frequent, but regular meetings of their surgical colleagues 
occur as well. 
UNIQUENESS 
As this scheme has matured, a very large number of 
successful enterprises have blossomed. The excellent Depart¬ 
ment of Pediatrics at Bridgeport Hospital, where Yale 
residents go for regular training, and which enables out¬ 
patient care for a nearby underprivileged area, is one 
example. The faculty at Danbury Hospital is not only 
notable for skills in nuclear medicine and cardiology, but is 
in a general way, strong enough to enable the hospital to 
present its first “Research Day” this year. 
Lawrence and Memorial Hospitals have no house staff 
but provide for continuing education for the attending staff 
under the terms of several contracts. That hospital, located 
near nuclear power generators on the Thames River, the 
submarine base at Groton, and a number of industrial 
enterprises which carry with them some possibility of 
occupational hazard, has drawn upon the expertise of Yale's 
Section of Occupational medicine and has set up an 
occupational medicine clinic. In May, 1985, after Three 
Mile Island but before Chernobyl, the hospital sponsored a 
state-of-the-art program on “Medical Aspects of Radiation 
Emergencies.” Dr. Paul Hoffer, Yale radiologist, was a 
principal in planning this program. 
St. Raphael’s Hospital, nearby in New Haven and an easy 
site for the extension of Yale programs is closely involved in 
several important ways. The school’s Department of Pedia¬ 
trics joins the hospital departments at both Yale-New Haven 
Hospital and St. Raphael’s Hospital in common purpose. 
No less than four fellowship programs in internal medicine 
include a rotation to St. Raphael’s Hospital, thus enriching 
internal medicine training at that institution, while working 
with an experienced group of senior physicians. Because of 
the existence of the Yale Comprehensive Cancer Center, an 
outpatient cancer chemotherapy facility was enabled at St. 
Raphael’s Hospital through an NIH grant. The grant linked 
programs at St. Raphael’s to Yale, which provided protocols, 
biostatistical aid and an academic base. All of these 
developments have been enabled by perceptive leadership 
on the part of St. Raphael-based physicians. 
Excellent overall programs at Waterbury and St. Mary’s 
Hospitals, to both of which Yale-New Haven medical 
residents have rotated, deserve mention. Both have been 
popular with the housestaff; the present chief resident in 
medicine at Waterbury Hospital moved there from the Yale- 
New Haven training program. As the School of Medicine’s 
program in human genetics has matured, its outreach to 
regional hospitals has been extended. Substantial programs 
in human genetics are now in place at Bridgeport, Danbury 
and Norwalk Hospitals. At this last hospital, the Yale 
presence has been so substantial that its now retired 
director, Norman Brady, referred to it some years ago as 
“Yale’s campus in Norwalk.” Programs at Greenwich, 
Griffin and St. Vincent’s hospitals also have special qualities. 
A LARGER CAMPUS? 
The observation about “Yale’s campus” at a regional 
hospital was in some measure prescient. At the Office of 
Graduate and Continuing Education, records are kept of the 
weekly education programs at all regional hospitals. The 
School’s presence at these institutions is unmistakable. Yale 
faculty participate in lectures, seminars, ward rounds and 
even clinic work. Their impact upon the general standard of 
medical practice at these institutions is inevitable. 
At the same time, however, the capacity of regional 
hospitals to do for themselves has grown as well. A good 
example is the recent establishment of a Liaison Committee 
for Surgical Education, which has a strong Yale base but has 
equally strong leadership from chairmen of the four regional 
hospitals with free-standing residencies. Their programs are 
reinforced by the provision of solid teaching from Yale 
faculty in basic sciences, essential for any surgical residency 
program. At the same time, the four chiefs have themselves 
arranged to be active participants in a quality control 
mechanism at each other’s institutions, not depending upon 
Yale for the provision of all academic leadership but 
working with the Yale department. The bridge between 
Yale-New Haven Hospital and St. Raphael’s Hospital in 
pediatrics is a sound one; it not only provides an excellent 
base for the training of house officers, but it enhances the 
practicing community of pediatricians in New Haven. 
Recently, at a meeting of the Medical School Council to 
which representatives from all affiliated hospitals were 
invited. Dr. Robert Gifford, associate dean for medical 
education and student affairs, set forth an invitation and a 
challenge to them to participate even more fully in the work 
of the medical school. The now common perception that 
inpatient care needs to be associated with an ever stronger 
component of outpatient practice and a broader institutional 
base, is as true at Yale as it is anywhere else. 
Opportunity has thus emerged for even closer ties between 
the School of Medicine and affiliated hospitals in time to 
come. First class clerkships and intensive teaching at 
regional institutions can find a place in the curriculum. A 
director of medical education at one regional hospital 
recently speculated that in the future we might not only have 
“one campus”, but even a disappearance of the notion of 
“town and gown.” As he put it, “everybody would be gown.” 
THE FUTURE 
It is conceivable that the affiliations instituted in the late 
1960s, which have clearly become a functioning and success¬ 
ful part of the larger pattern of health care in the state of 
Connecticut will continue to evolve successfully. When one 
reviews early documents pertaining to our present establish¬ 
ment, a comment by Dr. Arthur Ebbert, Jr., deputy dean of 
the medical school, at the first Conference on Yale University 
School of Medicine - Community Hospital Relations in 
September 1969, stands out. At that time. Dr. Ebbert said, 
“Let me emphasize that to be effective and to be lasting, the 
medical school-community hospital relationship must be a 
two-way street. Each party must see definite benefits. A 
one-way relationship will eventually lead to a dead end and 
ultimate failure.” 
It is pleasant to report that the two-way street remains 
wide open. The relationships are healthy ones, with the 
collegiality of physicians perhaps the most important among 
them. Just as the profession in Connecticut was strong at the 
time of the establishment of regional medical planning, it 
has remained strong and, in significant ways, truly a 
profession. In these days, when medical practice and the 
provision of health care are increasingly viewed as businesses 
and as physicians become anxious about a dominant role for 
payors in health care, the facts of intellectual progress and 
collegiality which have been significantly aided by the 
regional hospital affiliations are pleasant to contemplate. 
We hope to see them grow stronger. 
an innovative education development program 
by Marje Noyes 
The Martin Luther King, Jr. Elementary School in New 
Haven has become a model for scholastic and social 
achievement for inner city schools throughout the country. 
Located in a deteriorating neighborhood, with 99 percent of 
its pupils minority children of mostly welfare dependent 
parents, and a teaching staff that is 50 percent black and 50 
percent white, this school was the first to participate in a 
school development plan designed to raise the expectations 
and achievements of inner city children. 
The program, begun in 1968 as a joint project of the Yale 
Child Study Center and the New Haven school system, is 
focused on the school’s psychological makeup and the 
triangular relationship between students, teachers and 
parents. So successful have been the results in the King 
School, that it is being introduced throughout the New 
Haven school system as well as in schools in Stamford, 
Connecticut, Benton Harbor, Michigan and Prince George’s 
County, Maryland. 
The mastermind of this innovative approach to education 
is Dr. James P. Comer, Maurice Falk Professor in the Child 
Study Center and Psychiatry at Yale and author of School 
Power (1980), who has received wide recognition for his 
w ork in promoting a better understanding of the problems 
as well as the potentials in educating minority children of 
low income lamilies. In developing the program. Dr. Comer 
harked back to the days before large scale technology and 
science had eroded some of the basic tenets of the social 
structure of the nation. 
Before the proliferation of cars and TV, children learned 
how to deal with life through examples set by their parents 
and teachers and other important authority figures and 
behavioral models, according to Dr. Comer. Schools were 
an important part of the social fabric of the community, 
whether they were inner city or rural, and there was a feeling 
ot mutual respect and trust between school and home. 
"When 1 went to the grocery store with my mother and 
father in the 1940s, it was a rare day that we did not 
counter someone from my elementary school the 
ustodian, the principal, the secretary or a teacher. There 
add always bean exchange of pleasantries and sometimes. 
an exchange about my school behavior or achievement. The 
knowledge that my parents knew and appeared to like and 
respect the people at my school had a profound impact on 
my behavior,” recalled Dr. Comer. “The authority my 
parents held by virtue of the care and guidance they gave me 
was transferred directly to the people who ran the school. 
My parents were physically present at school only on 
visiting days and other special occasions, but their involve¬ 
ment with the school, though indirect, was meaningful and 
constant.” 
The aim of the school development program at King 
Elementary School, and subsequently the other schools that 
have participated in the project, was to restore a reasonable 
degree of trust, mutual respect and consensus about objec¬ 
tives and methods of education among the school staff, 
pupils and their parents, while at the same time being 
responsive to contemporary needs and social concerns. 
“Given the complexity of the modern 
world, today ’v students need more adult 
help than children did in the past. 
Programs that involve parents effectively 
in the schools can provide a desirable 
context for teaching and learning. ” 
Dr. Comer 
“A disproportionate number of children of low income 
families are academically and socially underdeveloped,” 
explained Dr. Comer. “They require assistance in developing 
skills needed for school success, but because most staff 
members are not trained to provide such assistance, they 
tend almost automatically to label the behavior of these 
pupils as ‘bad’, and they view them as less able than other 
students. The teachers punish the children or hold low 
expectations of them, which in turn, results in inadequate 
Dr. Comer 
teaching efforts,” he continued. “This adds to distrust, 
alienation and conflict between home and school, further 
eroding the relationships among all involved in the education 
experience. Adequate learning is then not possible.” 
Based largely on principles of mental health, the School 
Development Program applies techniques of intervention 
and primary prevention to basic problems oi inner city 
schools. The strategy is to coordinate school management, 
curriculum and staff development with the teaching and 
learning process. 
The assumption is that the vast majority of children can 
acquire the psychological, social and academic competencies 
required to function sufficiently in and after school when the 
school environment is adequate, according to Dr. Comer. 
The hypothesis is that, as the organization and management 
system of a school successfully provides all participants in 
the education process — students, school staff and parents 
- with sufficient educational and interactional skills and 
support, the academic achievement and social performance 
of students will improve and provide residual academic, 
social and psychological benefits to students. 
The rationale for this hypothesis is drawn from an 
ecological perspective, which suggests that underlying and 
major causes of dysfunction in human systems or institutions 
is more on an interactional than a largely interpersonal or 
individual basis, and is due to organizational and manage¬ 
ment limitations as much, or more than, individual short¬ 
comings. Dr. Comer describes the case of a young transfer 
student to the King School as a case in point. 
The eight-year old boy was dropped off at the King 
School, which is in a neighborhood that couldn’t be in 
further contrast to the small rural town in North Carolina 
that he had come from. He was taken almost at once to his 
classroom. The teacher, who had received three transfer 
students only the week before, had the exasperated look ot 
“all I need is another one.” 
The little boy had just come from a warm family, school, 
church and community setting in which he had felt secure. A 
well-meaning relative had brought him north to get “a better 
education.” Here he was, alone in a strange city, living with a 
relative he barely knew, and in a school totally different 
from the one he had been attending. 
“He took one look around the classroom full of strangers, 
kicked the teacher in the leg and ran out. It was a classic fight 
and llight reaction to separation anxiety and fear,” observed 
Dr. Comer. 
In many schools, the child would have been punished. 
Instead, the psychosocial dynamics of his behavior were 
discussed. The teachers planned ways to welcome him and 
help him adjust to his new environment. The incident also 
pointed up some deficiencies in the school system’s transfer 
process, which have since been modified. 
“Intervention is a process, not a package of materials, 
instruetional methods, behavior modification techniques or 
personnel,” explained Dr. Comer. There are four key 
elements to the program: a representative governance and 
management group; a parent participation group; a mental 
health program and team, and a curriculum and staff 
development program. 
Teachers, parents and aides select their representatives to 
the 12-member representative governance and management 
group, which is headed by the school principal. This 
important body identifies problems and opportunities within 
the school, matches resources with school needs, develops 
and implements programs to address the problems and 
opportunities, and evaluates programs and modifies them 
appropriately. All of the adults in the school feel represented 
in the decision-making process as a result of the activities of 
this group. 
In addition to selecting a representative to serve on the 
governance and management body, the parent’s group 
participates in the parent-aide program, in which a parent 
serves as an aide in each classroom for approximately 15 
hours a week, receiving a minimum wage. Parent aides are 
the core of the parent group, which also sponsors a variety of 
programs in support of enhancing the school climate and 
achievement goals. Their presence and participation with 
the staff ensures a culturally consistent social and academic 
program, so that children do not feel the social distance 
between home, primary social network and school. In turn. 
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“Frequently, efforts at instituting major 
change fail because too little attention is 
paid to personal relationships and to 
bureaucracy issues that are common to 
all organizations, but are potentially 
more problematic in schools because 
children are developing and thus 
vulnerable, their parents though able, are 
underdeveloped, and most school 
personnel lack preparation to address 
these Conditions." - Dr. Comer 
involvement of parents promotes a good feeling about the 
school to other parents and to the community in general. 
I he mental health team - psychiatrist, social worker, 
psychologist-program evaluator and helping teacher — is 
organized in a way that enables staff and parents to apply 
principles of the social and behavioral sciences to every 
aspect of the school practice. For instance, the team has 
helped teachers understand and apply child-development 
theory and practice in ways that assist a child in trouble to 
leave the classroom gracefully; that promote adjustment of a 
transfer student; that teach children in conflict to learn to 
negotiate rather than to fight it out; that help teachers grasp 
why many parents are reluctant to participate in school 
programs; that help the president of the parent group to 
develop programs that keep members interested and in¬ 
volved, and that help the school principal appreciate the 
value of parent and teacher participation in what had long 
been considered the school administration’s territory. 
Have Dr. Comer's strategies worked? If progress in the 
Martin Luther King, Jr. Elementary School and two other 
New Haven elementary schools that have been participating 
in the School Development Program since the 1970s, is any 
indication, the answer is a resounding yes. These interven¬ 
tions have reduced distrust, alienation and conflict and have 
led to increased staff energies and expectations of each other 
and of their students. As the social climate improved, the 
level of learning gradually increased. 
In 1969, when the program began, fourth grade students 
in King Elementary School trailed the national average in 
reading and mathematics by 19 and 18 months respectively. 
Pupil and staff attendance was poor, classroom behavior 
often resembled bedlam, and staff-parent relationships were 
poor at best. 
After some tribulations in the beginning, testing the 
resolve ol the most determined educators, the school began 
to make measurable progress. By 1984, the fourth graders 
were one year above grade level in reading and math. They 
were tied for third out of 26 New Haven schools. King third 
aders ranked fifth in mastery of skills, and the school has 
:ed lirst or second in attendance four of the last five 
\ 1982 study showed that seventh grade students who 
tided King scored higher in all academic areas than 
n w ith similar socio-economic backgrounds who had 
i I other New Haven public elementary schools. And, 
not a single teacher has voluntarily left the school since 1975. 
The School Development Program is one of the longest 
running public school-university cooperative school improve¬ 
ment efforts in the country. Although the intervention 
methods have been modified slightly for cost effectiveness 
during the eighteen years since it began, their intent remains 
essentially the same. A program designed to train educators 
to serve as intervenors and to use the intervention process 
model was initiated in 1980 and continues. Evaluation of the 
program has been ongoing and is currently a major focus. 
The original approach of carrying out general evaluations 
has moved toward more detailed research to study the long¬ 
term effects of the intervention and to pursue other research 
questions. 
“Our program, and others like it in other cities, clearly 
show that inner city children can learn at significantly higher 
levels than is common,” said Dr. Comer. “It is the obligation 
of each school and school system to make this possible.” 
“The poor education low income 
minority children receive in inner city 
schools contributes heavily to our social 
problems: unemployment and 
underemployment, welfare dependency, 
troubled race relations, delinquency, 
crime. Inner city children can achieve at a 
much higher level. ” Dr. Comer 
“The blood is the Life” — Deuteronomy, 12:23 
“Blood is the originating cause of all men's diseases” — 
Baba Bathra, 111.58a 
researchers and clinicians in the Section of Hematology join in a concerted effort to discover causes of 
DISORDERS OF BLOOD 
by Marje Noyes 
From the earliest times, philosophers and scientists have 
theorized about the origin and meaning of blood. The 
unprecendented advances in medical technology during the 
past quarter century have done much to unravel the 
mysteries of this “vitaI ingredient ”, but many questions 
remain unanswered, and more importantly, cure and preven¬ 
tion of disorders of blood remain elusive. 
Researchers in the Section of Hematology at Yale 
including Drs. Bernard Forget, Sally Marchesi, 
Edward Benz and Paul Lebowitz, are working to 
answer some very basic questions for a better 
understanding of the causes of inherited disorders and 
cancers of blood. Using techniques of molecular and cellular 
biology and molecular genetics to study normal and ab¬ 
normal blood cells, their work is mainly directed at genes for 
hemoglobin, the principal protein of red blood cells, and at 
oncogenes of blood cells. 
“Red blood cells have served as a key to experimental 
medicine throughout the history of modern biology,” said 
Dr. Benz. “They form the most accessible tissue in the 
human body, and are much simpler than most cells. You can 
easily get an idea about which substances are the key 
ingredients — which are the most important molecules, and 
then develop antibody or DNA or RNA probes to look at 
other tissues for similar proteins in order to understand how 
they function.” 
“The things we have learned about normal hemoglobin 
gene structure, as well as about defects of these genes, have, 
in fact, been found to be true in other gene systems as well,” 
observed Dr. Forget, professor of medicine and human 
genetics, and head of the Section of Hematology. 
Dr. Forget’s research is concerned with the molecular 
genetics of globin gene expression and genes for the red cell 
membrane protein called spectrin. Dr. Marchesi is studying 
the spectrin, the major protein of the red cel! cytoskeleton. 
Dr. Benz is conducting research to increase knowledge 
about the genetic regulation of blood cell differentiation and 
the molecular genetics of inherited blood disorders. Dr. 
Lebowitz has focused his work on the mechanisms of 
malignancy in hematological tumors. Much of their work is 
done in collaboration with investigators in cell biology, 
human genetics, physiology and pathology. 
n outstanding example of this collaboration is 
research to determine the cause of beta thalassemia 
/ Y by Dr. Forget and Dr. Sherman Weissman, profes 
JL jk.sor of human genetics, medicine and molecular 
biophysics and biochemistry. The work began 20 years ago 
when the two were at the National Institutes of Health in 
Bethesda, studying the biochemical defect involved in 
thalassemia. Later at Yale, using the then newly developed 
recombinant DNA techniques for cloning globin genes, they 
discovered the precise genetic cause of this devastating 
anemia in a child of Greek ancestry. Thirty-seven different 
mutations of the hemoglobin gene that can cause beta 
thalassemia have since been identified by various investi¬ 
gators and the research continues. 
Drs. Lorget, Weissman and Benz subsequently were able 
to demonstrate how the initial gene mutation causes deficien¬ 
cy in hemoglobin synthesis by altering the precursor messen¬ 
ger RNA molecules. The studies have this far provided a 
means for precise diagnosis in utero for thalassemia and for 
sickle cell disease. Studies on thalassemia here, and at 
several other medical centers, provided the first opportunity 
to study a human disease at the level of DNA and RNA 
sequences of specific genes. 
“The lessons we have learned from studying hemoglobin 
genes in thalassemia can be applied to a whole gamut of 
inherited diseases,” said Dr. Forget. 
In normal persons, hemoglobin present during fetal life is 
different in structure from that of hemoglobin shortly after 
birth. Both of these hemoglobins have two pairs of subunits 
or chains — the alpha chains and the beta-like chains. 
“The difference between fetal and adult hemoglobin lies in 
the beta-like chain,"explained Dr. Forget. Fetal hemoglobin 
contains a pair of gamma chains; adult hemoglobin, a pair 
of beta chains. The switch from fetal to adult hemoglobin 
—the turning off of the gamma chain gene and turning on of 
the beta chain gene — takes place during the first six months 
of life. 
Beta thalassemia and sickle cell disease are the result of a 
defect in the beta chain. In sickle cell disease, the defect is 
characterized by an abnormal amino acid in the structure of 
the beta chain. In beta thalassemia, it results in little or no 
production of beta chains. 
“If it were possible to suppress the switch from fetal to 
adult hemoglobin in individuals diagnosed as having one of 
these disorders, we could prevent the deleterious conse¬ 
quences of these diseases,” said Dr. Forget. 
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Dr. Forget 
In research to discover the genetic mechanism that 
regulates the switch from the gamma chain to the beta chain, 
he and his colleagues are studying individuals with hereditary 
persistence of fetal hemoglobin (HPFH), found predomin¬ 
antly in persons of African and Mediterranean ancestry, 
where the gamma chain is not switched off and the beta 
chain is suppressed. Persons with HPFH present no clinical 
symptoms and are able to lead perfectly normal lives, 
according to Dr. Forget. 
“With the use of recombinant DNA technology, we have 
been able to isolate the gamma genes of H PFH individuals 
and to determine where the abnormality is located," said 
Dr. Forget. “Now' our work is to identify the negative and 
positive factors that may be involved in the failure to sw itch; 
to purify them and to find the genes responsible for them.” 
And how would these discoveries be applied therapeutical¬ 
ly? One way might be to modify the genes for these factors by 
genetic engineering so that factors which normally recognize 
the beta gene would instead, recognize the gamma gene and 
turn it on. Another approach might be to introduce a 
normal beta globin gene into bone marrow cells which have 
only abnormal beta genes. “But we are many years away 
from that type of gene therapy,” said Dr. Forget. 
In another study, he is investigating the genes for the red 
blood cell membrane protein called spectrin. In broad 
terms, this study is directed at understanding tissue specificity 
of gene expression. 
"By studying the red cell spectrin gene and comparing its 
regulatory regions to those of the brain spectrin gene, we 
ought to find out what signals are present that specify a 
certain program of gene expression in certain types of cells,” 
commented Dr. Forget. 
Hemoglobin genes are present in all cells, but only 
i unction in red cells. Why are certain genes turned on only in 
. rtain cells and not in others? “The determining feature 
ast reside in the DNA structure of the genes. By comparing 
structure of globin and red cell spectrin genes it should 
ssible to identify common features that might be the 
n s for tissue specificity,” he explained. 
While Dr. Forget is investigating gene specificity in 
red cell spectrin. Dr. Sally Marchesi, associate 
professor of medicine, is studying the structure 
of spectrin itself. Analyzing blood samples from 
the same patients, the two laboratories are working in 
concert Dr. Forget and his colleagues are hoping to 
determine specific abnormalities of a gene which will 
confirm what Dr. Marchesi and investigators in her labora¬ 
tory find out about spectrin protein. 
A graduate of the School of Medicine, Dr. Marchesi’s 
interest in hematology began when she was an N1H fellow in 
the laboratory of Dr. Christian Anfinsen, a well known 
protein chemist. After further training, specifically in hema¬ 
tology, she returned to Yale as an assistant professor of 
medicine and pathology, doing research, teaching and 
caring for patients. 
At the time when knowledge of the structure of cell 
proteins had advanced to the point where it could be applied 
to studies of blood disorders, her clinical activity and ability 
to recognize patients with specific hematologic abnormalities 
were important assets in the laboratory. Earlier, working 
with platelet membranes. Dr. Marchesi was able to identify 
specific platelet surface glycoproteins and make antibodies 
to these membrane components which were subsequently 
used to study megakaryocyte growth in bone marrow tissue. 
In 1978, she turned her attention to studies of spectrin 
protein, in collaboration with Dr. Vincent Marchesi, chair¬ 
man of the Department of Pathology, who is recognized 
worldwide for his research on cell membranes. Membrane 
proteins are important to the shape of the red blood cell, 
which is normally discoid, but which has remarkable 
properties of deformability which allow it to pass through 
tiny capillaries during its 120-day life span. 
There is a group of anemias, characterized by abnormal 
red cell shapes, the most common of w hich are elliptocytosis 
and spherocytosis. These cells are poorly deformable and 
are damaged as they pass through tiny capillaries and 
sinusoids in the spleen. However, the hemoglobin and 
enzymes within the cells appear to be normal. 
“By process of elimination, it was thought that these 
abnormalities in cell shape were due to inherited abnormali¬ 
ties in the red cell membrane itself,” commented Dr. 
Marchesi. 
There are spectrin-like proteins in most tissues in humans 
and other species which are quite similar even across species 
barriers. Red cell spectrin is a specialized version of this class 
of structural protein, engineered in concert with other 
membrane proteins to allow the deformability characteristics 
of red cell membrane necessary for normal life span. “For 
that reason, we believe a mutation of spectrin (or of other 
membrane proteins) might be the culprit determining the 
unusual shapes of cells found in spherocytosis and ellipto¬ 
cytosis.” 
Dr. Marchesi is studying blood from patients and their 
families with these anemias, both of which are inherited as 
autosomal dominant disorders. She has found that a high 
percentage of black families with elliptocytosis have a 
mutation in spectrin near the amino terminal end of the 
alpha chain, which causes that section of the molecule to be 
more easily broken down by certain enzymes. 
“We have analyzed fragments of spectrin to get the actual 
amino acid sequence near unstable regions of the molecule 
and have found that, in tw o types of elliptocytosis, a single 
amino acid substitution causes the change of shape and 
Dr. Marchesi 
shortens the life span of the cell,” she said. “This is similar to 
sickle cell hemoglobin, in which a single amino acid 
substitution produces devastating changes in the physical 
properties of the beta globin chain. 
Studies of recessive spherocytosis, a rare form of anemia 
in which both parents show no evidence of the disorder, but 
one or more children have severe, life threatening anemias, 
have indicated an abnormality in the alpha chain of spectrin, 
distinct from the mutation found in elliptocytosis. 
“We assume that the gene present in the bone marrow 
stem cells, which is eventually expressed in the mature red 
cells, is the specific gene for that hematopoetic cell line,” 
explained Dr. Marchesi. 
Research on protein membranes is complicated, and as in 
much of hematology research, considerable time elapses 
between findings. Persistence and dedication are key words. 
“We are studying the chemistry of spectrin and other 
membrane proteins which have been characterized well 
enough to allow us to screen large numbers of people with 
anemia and abnormally shaped red cells to try to determine 
if abnormal proteins are the cause,” said Dr. Marchesi. 
“Once an abnormality is found by these ‘screening tests’, we 
continue our studies of the apparently abnormal protein, in 
so far as we can, to identify the mutation. Dr. Edward Benz and Dr. Forget began their 
research association at Harvard Medical School 
several years before either came to Yale. Dr. Benz 
was a medical student working in the laboratory 
with Dr. Forget, who was a fellow in hematology there. 
Following postgraduate training at N1H, Dr. Benz came to 
Yale in 1978 as a fellow in hematology. Current activities in 
his lab are about equally divided between continuing studies 
on hemoglobin RNA and research on cell differentiation in 
leukemia. 
Based on previous studies of the role of globin gene 
mutations in messenger RNA (mRNA) in thalassemia, and 
subsequent characterization of these mutations. Dr. Benz, 
associate professor of medicine, has been doing research to 
discover how they disrupt RNA metabolism. 
“We have found some surprising effects of those mutations 
on mRNA that are revealing some previously unknown 
facts about the way RNA molecules are metabolized in 
normal cells,” said Dr. Benz. 
For example, there are some changes in a gene that cause 
the messenger RNA to be untranslatable. The mRNA is 
synthesized, but a mutation in one base will prevent it from 
being translated to a protein. 
“It’s obvious that you can’t make hemoglobin if you can't 
make one of its protein components,” he explained. “What’s 
not obvious is that mRNA doesn’t accumulate in normal 
amounts, indicating that not only is it not functioning, it’s 
not being produced in adequate amounts as well.” 
These findings indicate that many steps are necessary for 
the RNA molecule to be synthesized, to be processed from 
the precursor to the mature form in the nucleus, to get out 
into the cytoplasm and to function in other words, to be 
translated into globin protein. 
“You have to be able to study the physiology of the 
message as well as to know its anatomy,” said Dr. Benz. 
“This information may give us a way to look at some basic 
mechanisms that might he involved in RNA production in 
all cells. 
In another direction. Dr. Benz and his colleagues have 
cloned the gene for the protein, lactoferrin, and are using it 
as a marker for studies on leukemia. Feukemia is the result 
of failure of white cells to mature. Factoferrin is present only 
in the most mature of white cells. 
Dr. Benz 
All photographs for this article are by William Carter. 
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“Analyzing these genes allows us to search for the 
components necessary for white cells to mature,” explained 
Dr. Benz. “By comparing what we learn about normal 
processes of cell differentiation with processes in leukemic 
cells, we hope to discover the molecular basis for failure of 
leukemic cells to mature. With the DNA probe for lacto- 
ferrin, we can study the expression of it, and ask why it 
doesn’t appear in leukemia. 
“Lactoferrin is one of the targets for what goes wrong in a 
leukemia cell. If we can get our hands onto whatever is 
happening to lactoferrin in leukemia, it could give us a 
preview of what is happening to the entire cell in the 
leukemic process,” explained Dr. Benz. Early in the 1980s, oncogenes became one of the 
hottest subjects in cancer research. These genes are 
derived from normal precursors called proto-oncogenes 
which all animals, including man, carry. There is 
evidence that proto-oncogenes become activated to form 
oncogenes by several mechanisms including chemical 
changes mutations, combination with other genes or an 
increase in their number - amplification. Scientists have 
become increasingly interested in the possibility that onco¬ 
genes play an important role in the development of many 
human malignancies. 
One such scientist is Dr. Paul Lebowitz, who also came to 
Yale from Harvard Medical School via fellowship training 
at the N1H Until 1980, his major research efforts had been 
directed at simian virus 40 a virus which has served as a 
model for malignant cellular transformation. Then, in 1981, 
w hile on sabbatical leave in the labortory of Dr. Edward 
Scolnick at N1H, he became interested in human oncogenic 
genes. "I was in the right place at the right time.” 
I he primary focus in Dr. Lebowitz’s current research is 
elucidating mechanisms by which human leukemias 
lop and progress. To do this, he is studying chronic 
logcnous leukemia, an extremely favorable type of 
mia for study, since the disease can be divided into two 
distinct phases and current evidence suggests that there are 
three distinct steps involved in its development and pro¬ 
gression. 
The disease starts with a very indolent, chronic phase that 
can be fairly well controlled with chemotherapy. This stage 
typically lasts for three or four years, when it transforms into 
an acute leukemic phase called blast-crisis, either myeloid or 
lymphoid. This phase can only be put into remission with 
successful bone marrow transplantation. 
“There appear to be three oncogenic events involved in 
the development and progression of this disease,” commented 
Dr. Lebowitz. “It’s important to work on each of them 
because, when we identify an oncogenic event, it provides a 
potential target for chemotherapy or other therapeutic 
approaches in the future.” 
There is reason to believe there is an initial step which 
affects one hematological stem cell and causes all its 
daughter cells to grow very rapidly. According to Dr. 
Lebowitz, this step has received little attention from 
scientists. 
The second step, well known to most investigators, is 
marked by a chromosomal abnormality caused by transloca¬ 
tion of chromosome 9 and chromosome 22. The resulting 
abnormal chromosome 22 is known as the “Philadelphia” 
chromosome. It is found in most patients with CML and is 
the best means for diagnosing the disease. As a result of this 
translocation, a proto-oncogenic gene in chromosome 9, 
called the ABL gene, comes under the control of a new gene 
on chromosome 22, called the BCR gene. This results in the 
production of a hybrid BCR-ABL messenger RNA and a 
hybrid protein, which appears to be oncogenic. Thus, this 
step fixes the malignant state in CML cells. 
“The third event is the one which converts the chronic 
phase to the aggressive phase,” said Dr. Lebow itz. It could 
be two separate steps: one which leads to a lymphoid blast 
crisis in some patients or an alternative one which leads to a 
myeloid blast crisis. 
Little is known about the first or third events, according 
to Dr. Lebowitz, who is interested in the mechanisms of the 
disease as well as in approaches to changing their course. 
“We are trying to develop methods by which we can take 
leukemic cells from CML patients and convert them back to 
normal cells,” he explained. “For example, since acute 
leukemia is the result of failure of cells to differentiate, we 
would like to get these cells to start differentiating again, 
thereby reversing the leukemic state.” 
To accomplish this, he and his colleagues are studying the 
possibility of introducing certain genes which play an 
important role in normal cell differentiation, into leukemic 
cells. They are doing this by means of transfection now, but 
eventually hope to introduce genes into the malignant cells 
by means of a virus. 
In this research, they are now focusing on a specific gene 
the FOS gene. “We introduce the gene into the cell under 
control of an inducible promotor, which is like an on-off 
sw itch. When we turn the switch on, does the cell begin to 
differentiate? When we turn it off, will the cell reverse back 
to a non-differentiating cell?” 
In related studies, the laboratory is attempting to force 
leukemic cells to make antisense messenger RNA by intro¬ 
ducing antisense genes. There is evidence, according to Dr. 
Lebowitz, that antisense RNA w ill neutralize the sense RNA 
for a specific gene. 
“With CML, we are anxious to get the leukemic cells to 
make antisense RNA specifically directed against the villain 
BCR gene,” he explained. 
All of this work has implications for other leukemias as 
well as for CM L. “We are working on a model system,” said 
Dr. Lebowitz. “If a FOS gene differentiates CM1. cells, can 
it cause differentiation in other leukemic cell types? If the 
FOS gene doesn’t work, might not some other differentiation- 
inducing gene? But that is a long way in the future,” he 
added. 
In addition to doing basic research on disorders of blood, 
Drs. Lebowitz, Benz, Marchesi and Forget care for patients 
in the hematology clinic. “Hematology is an ideal field for 
combining basic science with clinical activities. The tissue of 
interest is readily available and so basic studies of blood 
cells, both structural and functional, can be done on human 
cells,” explained Dr. Marchesi. “Hypotheses concerning 
disease states derived from these studies may also be readily 
tested on patients with the disorder. A call from another 
hematologist concerning a patient he or she has seen, has 
frequently led to additional blood samples for our study, 
expanding our data base on a particular problem and in 
some instances, producing entirely new information.” 
This is very important to progress in discovering ways to 
prevent and treat hematologic disorders, according to Dr. 
Thomas Duffy, professor of medicine in the Section of 
Hematology. “This interaction between basic scientists and 
clinicians makes the significant difference between places 
like Yale and institutions where they do only basic research.” Regarded as an outstanding hematologist and teacher. 
Dr. Duffy came to Yale as an associate professor 
from the Johns Hopkins School of Medicine in 
1976. In addition to caring for patients with 
hematologic diseases, he is involved in clinical research in 
several areas. 
Recently, he and his colleagues participated in a nationwide 
clinical trial to test the efficacy of the drug, interferon, in 
treating hairy cell leukemia, a rare form of cancer of the 
blood. “The trial resulted in a remarkable success in the 
palliation, if not the cure, of this life-threatening disease,” 
commented Dr. Duffy. As a result, the federal government 
has approved the commercial use of alpha-interferon against 
hairy cell leukemia, the first time the genetically produced 
antiviral drug has been made available by prescription. 
With the demonstrated effectiveness of interferon on one 
type of leukemia. Dr. Duffy has just begun a clinical trial to 
test its use in treatment of agnogenic myeloid metaplasia. 
This is a proliferative chronic form of cancer of the blood for 
which there is no current therapy, other than symptomatic 
support. 
Clinical studies in hematology are not only directed at 
leukemias. For instance, in collaboration with researchers in 
the Department of Obstetrics and Gynecology, Dr. Duffy is 
studying the causes of toxemia in pregnancy, which typically 
occurs only in the third trimester, and in many cases is 
manifested in thrombocytopenia. In observations of a large 
number of pregnant women, they have found that hemato¬ 
logic lesions occurring in the first or second trimesters were 
predictors of toxemia in the third trimester. 
“This suggests that, although it presents only in the third 
trimester, toxemia represents the final stage of a pathologi¬ 
cal process that begins earlier in pregnancy,” explained Dr. 
Duffy. “With this information, we can focus on the symptoms 
throughout pregnancy, before they result in the acute phase. 
One of the dilemmas for physicians and medical 
school teachers is the wide gap between new 
knowledge acquired in the laboratory and current 
treatment available at the bedside. The problem 
has been aggravated by the news media which has greatly 
increased coverage of medicine in recent years. 
“The patient population and the public in general, are 
being led to believe that the scientific breakthroughs they 
read about in newspapers and magazines and see on TV are 
immediately applicable,’’said Dr. Duffy. “Take forexample, 
the widely reported work of Dr. Steven Rosenberg with 
leukocyte activated killer cells and interleuken 2. I didn’t see 
one patient over the following several weeks after it was 
reported in the popular press, who didn’t want immediate 
access to that therapeutic breakthrough, which, of course, 
isn’t available. 
“So many of the problems of hematology have not lent 
themselves to easy solution,” he commented. “For instance, 
management of patients with sickle cell disease is much the 
same as it was thirty years ago. The work by Dr. Forget and 
his group has been responsible for revolutionizing our 
knowledge about gene control of hemoglobin synthesis. 
Once the code has been broken, the implications for clinical 
management will be staggering. 
“The media is creating extraordinary expectations on the 
part of the patient that cannot yet be met,” Dr. Duffy 
continued. “We as physicians have to be honest and say ‘yes, 
we seem very close to some extraordinary breakthroughs in 
treatment of leukemias and anemias, but not today, maybe 
tomorrow’. ” 
I here is much to be learned, researchers in the Section of 
Hematology agree. But a great deal has been accomplished 
in a very short while, and they are optimistic that the 
research being done here and elsew here will eventually lead 
to prevention or cure of blood disorders which have plagued 
mankind for centuries. 
Dr. Duffy 
CWBS — a forum for discussion, an ombudsman for student complaints and central clearing-house for improving student life 
by Ian A. Cook 
Numerous authors, both from within the medical community 
and from without, have commented extensively on the 
demanding tasks a medical student faces in the process of 
becoming a physician. Beyond the obvious academic chal¬ 
lenges of medical school, students at Yale and other schools 
encounter stressful situations which arise from the multitude 
of intellectual, social, economic and personal demands 
placed upon them. This spring marked the second anniversary 
of a bold experiment in medical education at Yale, which 
addresses these concerns through a Committee on the Well 
Being of Students (CWBS). 
Each year, the Medical School Council (MSC) has 
devoted a meeting entirely to a discussion of “Student 
Initiated Issues.” Two years ago, a group of students 
reviewed the minutes of the previous decade’s Student 
Initiated Issue meetings; this revealed that a handful of 
issues appeared again and again as those viewed by the 
students as important. It was noted as well, that the issues 
they had identified were precisely the ones for which no 
on-going administrative structure existed. 
This being the case, the president of the Student Council 
and the student MSC representative appealed to the Medical 
School Council to establish a standing committee and thus 
provide the tool needed by students, faculty and administra¬ 
tion alike to work together to solve these problems. 
Unanimous approval of the students’ proposal led to the 
formation of a Committee on the Well Being of Students, 
charged with the broad task of coordinating and promoting 
“activities and resources related to student life and well 
being." To work toward this goal, the membership of the 
committee was established as five students and five faculty 
representatives, including the associate dean of Medical 
Education and Student Affairs and the chaplain as members 
ex officiis. 
Through student survey and discussion at that time, the 
committtee identified six areas of concern. They were: 
facilities, advising, administration, activities, parking and 
academics. 
In its two years of operation, the CWBS has been involved 
in a number of these matters, especially the Edward S. 
Harkness Hall dormitory, the advising program, parking 
and safety and issues surrounding how' the academic 
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environment influences student well being. The CWBS has 
sought to define its role in the medical school as being a 
forum for discussion, an ombudsman for student complaints, 
and a central clearing-house for improving student life. The 
CWBS was originally envisioned as an entity through which 
interested and motivated students, faculty and administrators 
could meet and pool resources to solve cooperatively the 
problems they perceived. It had not been the students’ 
intention that this committee would solve all the myriad 
problems itself, but rather, that it would serve a vital role by 
connecting those w ith needs to those w ith resources. To this 
end, the CWBS has often provided the initiative to study 
problems faced by Yale medical students and to involve 
those who may influence the situation in discussion of the 
pertinent issues. The breadth and depth of the involvement 
of the CWBS in the medical center is best appreciated by 
examining its efforts. 
FACILITIES 
Last year, presentations were made bv students about the 
Hark ness Hall dormitory, which was built in 1955 and is 
presently the only university housing facility open to 
medical students. It was reported that Harkness Hall was in 
a state of disrepair, with conditions vividly described by 
students and shown to administrators with a tour of 
Harkness that the CWBS arranged. Acting in a “watch-dog” 
capacity, the committee helped to motivate some striking 
changes, some of w hich have been accomplished, others of 
which are still promised. New beds and mattresses, room 
furnishings, re-papered hallways and retiled floors have 
contributed much to the ambiance of the dormitory. 
ADVISING 
Two sorts of advising programs have attracted the attention 
of the CWBS; there are programs of faculty advising the 
students, and of students helping each other. The chaplain 
of the school. Dr. Alan Mermann, has taken the leadership 
role in overseeing the Faculty-Student Program. At present, 
small groups of first-year students are assigned to faculty 
members in the fall, and these groups may meet more or less 
regularly throughout the year. 
Topics of discussion range from concrete suggestions for 
good textbooks and the recreational activities in New 
Haven, to more philosophical issues of what it means to be a 
good physician, and how best to be prepared for the 
continual self-education which is demanded of physicians 
throughout their careers. Many aspects of the program are 
being reviewed and guidelines will be formulated to help 
make this an integral part of medical student life. 
Also of note in the area of advising are the student-to- 
student programs. This past year, in which there was a 
The “bold experiment” undertaken by the 
CWBS is working. But rather than resting on its 
laurels, the CWBS has sought to turn attention 
to the intertwined issues of parking and safety 
and to matters of educational philosophy. 
re-birth of the Third Year - First Year Program, in which a 
third-year student takes a group of first-year students under 
his or her wing, helps them to ad just to the many demands of 
being a medical student at Yale, and demystifies the process 
of learning to be a physician. 
Another program of advising takes place when fourth- 
year students help the third-year students make their 
transition to the wards. In the past, this successful program 
consisted of one meeting in the first week of the clinical 
experience to discuss the transition itself, and another 
meeting in January to discuss what challenges the fourth 
year presents. This has been run by student coordinators 
since its inception, and the CWBS has elected to help 
perpetuate this program by coordinating the resources 
which a fourth-year student must draw upon to run the 
events. 
ADMINISTRATION 
At times, the students have felt distant from the administra¬ 
tion of the School of Medicine. The students’ sense of well 
being depends in a large part on the belief that those in 
power are actively interested in the issues which concern 
students. To help promote informed discussion, the CWBS 
developed a vehicle known as a “Town Meeting,” through 
which the student body could have an opportunity to meet 
with members of the faculty or administration for open 
discussion. In this preliminary series of meetings, Dean 
Rosenberg and Associate Dean Gifford were able to discuss 
openly issues of mutual concern with the student body as a 
whole, such as the student parking situation, the medical 
school’s committment to minority students and to the Office 
for Women in Medicine and the trends in the educational 
mission of the school. 
ACTIVITIES 
One of the original charges of the CWBS was to “coordinate 
and promote resources.’’The students here are both creative 
and energetic, as the breadth and quality of their many 
academic and extracurricular activities well illustrate. Each 
year, certain types of projects are devised and carried out: 
lecture series, social functions, athletic events, doing electives 
away and others. Yet each year, these projects often had to 
be started from scratch, as there were no effective ways to 
help perpetuate this practical information. 
I he CWBS has undertaken the creation and maintenance 
of such a collection of information by establishing a set of 
open files to which all students may refer. This information, 
not surprisingly, comes from the narrative reports by 
students who have undertaken projects and who describe 
what was done, how it was done and how one might do 
things differently. 
SOME ISSUES MERIT 
CONTINUED VIGOROUS ATTENTION 
With all these things happening, one can safely say that the 
“bold experiment” undertaken by the CWBS is working. 
But rather than resting on its collective laurels, the CWBS 
has sought to turn the school’s attention to a number of 
issues where significant concern still needs to be focused. 
The intertwined issues of parking and safety have been 
under much discussion, as have matters of educational 
philosophy by a newly-established Student Ad Hoc Commit¬ 
tee on Educational Issues. 
PARKING 
Parking is one of the chronic problems which had been 
discussed before the MSC for about a decade. Before the Air 
Rights Garage was opened two years ago, the students had 
been led to believe that they would be able to park there. 
This, sadly, did not come to be, and the students who 
commuted to school and had been parking in other lots 
suddenly lost all parking privileges. The priorities list for 
available lots did not list students at the bottom of the list; 
students weren’t on the list at all. 
The complex political issues which involve the university, 
the medical center and the city have left students to park 
where ever they might. This has all too often meant on the 
street in dangerous areas in unsafe neighborhoods sur¬ 
rounding the medical school. Thankfully, violent assaults 
have been the exception rather than the rule, though thousands 
of dollars worth of vandalism has also occurred. Drs. 
Gifford and Rosenberg have worked to find ways which 
would allow students to come to classes with a minimal risk 
to property and personal safety, and discussions are on-going. 
ACADEMICS AND THE STUDENT AD HOC 
COMMITTEE ON EDUCATIONAE ISSUES 
In this past year, students became more active discussants of 
the educational mission of the School ot Medicine. A group 
of students formed a working group known as the Student 
Ad Hoc Committee on Educational Issues. These were 
elected student leaders who serve on the Medical School 
Council, on the Curriculum Committee, as class and 
Student Council presidents, on CWBS, and as student 
representatives to the AAMC. 
Why, it was asked, had these active students formed yet 
another committee? They were students who have worked 
hard toward improving the quality of education and liie at 
this school, and were keenly aware that medical education is 
under careful scrutiny and re-evaluation by medical educa¬ 
tors throughout the country. The AAMC’s “GPEP Report" 
is the most well known of these, for example, and recom- 
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mended ideas which sound very much like the original 
philosophy that motivated the educational structure known 
as the Yale System: an emphasis on independent learning 
skills rather than memorizing facts, minimizing class time in 
favor ol seminars and labs, and reinforcing study options 
compatible with continued, independent learning. 
As students who participate on various administrative 
and educational committees, they were also keenly aware 
that the new administration has fostered a re-examination 
of parts of the Yale System and has proposed changes, 
especially regardingevaluation and the place of the National 
Board examinations in the medical school curriculum. 
At first, student concerns centered on how instituting 
exams might affect the education and experience at Yale. It 
was felt that to examine this issue, a dialogue was needed 
between students who had worked on curriculum commit¬ 
tees, those who had worked on administrative organs, for 
example the Medical School Council, and those who 
worked on issues of student well being, for example the 
CWBS. Such a dialogue, it seemed, was unfortunately not 
consistently present among faculty members of these same 
groups. After numerous meetings, heated debate and much 
soul searching, it was recognized that exams were not the 
issue; rather, that what was needed was a comprehensive, 
bjective look at the Yale System, its strong points and its 
relative weaknesses. 
To help identify the school’s underlying strengths and 
problems, the Ad Hoc Committee has surveyed the students 
on numerous occasions. The committee and CWBS were 
responsible for planning and conducting the “Town 
Meetings” with the deans. After many months of study and 
discussion, a number of core concerns emerged and were 
shared with the faculty and the administration. Students 
have raised the question of how Yale can best offer medical 
education which prepares one for a career in medical 
practice, research or teaching given the rapidly changing 
nature of medicine itself. Many of the nation’s brightest 
medical educators are studing how best to train physicians 
in the face of an “information explosion” in the basic and 
clinical sciences. 
A fundamental finding which has come forth from the 
discussions is that it is more demanding to be successful in 
running an open educational system, whose end goal is 
students who have mastered the skill of educating themselves 
and taking responsibility for their own continuing education, 
than in running a regimented one. It requires considerable 
individual interaction between the students and faculty, the 
kind of interaction that doctoral students enjoy at Yale. 
The CWBS and students at large, realize that for an 
effective educational partnership to function at Yale, we 
must all be committed to improving the interactions between 
faculty, administration and students. 
DR. BARBARA BACHMANN 
her work affects literally thousands of research projects around the world 
Although the exact nature of Dr. Bar¬ 
bara Bachmann’s work is known to 
only a few people in the medical school, 
thousands of scientists from the world 
over refer to her laboratory. Dr. Bach- 
mann, senior research scientist in the 
Department of Human Genetics, is 
curator of the Escherichia coli Genetic 
Stock Center located in the Sterling 
Hall of Medicine. Last month, the 
United States Federation for Culture 
Collections honored her with the J. 
Roger Porter Award in recognition of 
her efforts in developing and preserving 
this important international resource 
for biomedical research. 
“The award is well deserved,” com¬ 
mented Dr. Edward A. Adelberg, profes¬ 
sor of human genetics, whose own 
extensive collection of genetically 
marked strains of E. coli was the nucleus 
of the stock center’s collection. 
“Barbara Bachmann’s research and 
the data she has compiled have systema¬ 
tized the genetics of this complex bacter¬ 
ium to a degree unequalled for any 
other organism,” he said. “Her publica- 
tions on E.coli are recognzied as mile¬ 
stones in the literature, and the genetic 
map and charts of various pedigrees of 
the bacteria she has prepared are the 
referral base for all scientists who do 
molecular genetics.” 
The E.coli Genetic Stock Center con¬ 
tains more that 5,000 mutant strains of 
this bacterium, which for many years 
has been the most convenient and 
widely used organism for elucidating 
fundamental biochemical and genetic 
mechanisms common to most living 
things. The strains are stored in a freeze 
dried state and also as glyceriolized 
liquid cultures in Dr. Bachmann’s com¬ 
pact laboratory, along with meticulous 
records and files on each of the 5,000 
strains. 
Last year, more than 6,000 requests 
were received and filled by Dr. Bach- 
mann and her assistants, Cynthia Del- 
Vecchio and Ann Hayden. The stock 
center is far more than a repository for 
genetically marked strains of E. coli 
and the service that sends them out on 
request, however. Each request filled is 
accompanied by papers listing the name. 
Dr. Bachmann 
designation, sex and chromosome 
markers of the particular strain and a 
note, “Please return the second sheet 
with your comments on it. We need this 
feedback.” 
Dr. Bachmann takes these comments 
into account, according to Dr. K. 
Brooks Low, professor (adjunct) of 
research in therapeutic radiology and a 
long-time user of the collection. “Scien¬ 
tists frequently consult her about the 
appropriateness of a particular strain 
to their research,” explained Dr. Low. 
“Her knowledge of every facet of this 
immense collection and her ability to 
interpret the experiences of the scientists 
who use it, make her unique in the field 
of organism collections.” 
The E. coli Genetic Stock Center 
began in the 1960’s in Dr. Adelberg’s 
laboratory. A pioneer in the field of E. 
coli bacterial genetics, he had built up 
one of the largest collections at the time 
of genetically marked strains of E. coli 
anywhere. “Defacto, my lab had become 
the center for their distribution to 
scientists in this country and abroad,” 
recalled Dr. Adelberg. “The requests 
became so numerous that responding 
to them became a burden.” 
Dr. Bachmann came to the labora¬ 
tory as a research associate in 1968 
from the Department of Microbiology 
at New York University Medical Center. 
“Not only did she reorganize my entire 
collection, she began acquiring hun¬ 
dreds of key strains from well-known 
collections in France and England as 
well. By painstakingly researching the 
notebooks of the scientists, she was 
able to trace the pedigree of each of the 
strains, which she then published."The 
E. coli Genetic Stock Center has re¬ 
ceived funding from the National Sci¬ 
ence Foundation since 1971. 
A graduate of Baker U niversity, Bald¬ 
win City, Kansas, Barbara J. Bachmann 
received a M.S. degree in bacteriology 
from the University of Kentucky in 
1947, and a Ph.D. degree in microbio¬ 
logy in 1954 from Stanford University, 
where she worked under the preceptor- 
ship of the eminent microbiologist, the 
late C.B. van Niel. She first came to 
Yale in 1958 as a lecturer in microbio¬ 
logy, and returned in 1968 after four 
years at N.Y.U. Medical Center. 
In addition to her curatorial postition, 
she is a lecturer in the Department of 
Biology and has taught microbiology 
there for 23 years. “Her students are 
fortunate,” said Dr. Adelberg. “She is 
an excellent and dedicated teacher who 
teaches in the ecological tradition of 
enrichment culture taught by her men¬ 
tor, Dr. van Niel.” 
A quiet, unassuming and intensely 
private person. Dr. Bachmann sets 
very high standards for everything she 
does, including her hobbies, according 
to Dr. Low. She was overheard a few 
years ago telling a friend that she had 
just purchased a garden with a house. 
"That is a typical reflection of her love 
for gardening,” said Dr. Low. “She is 
as well, an enthusiastic bird watcher 
and keyboard musician.” 
“Barbara Bachmann is an unusual 
person,”said Dr. Adelberg. “Everything 
she does is meticulously and intelligently 
done — examples of how things should 
be done.” — Marje Noyes 
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PERCEPTIONS OF RISK 
The importance of the public's perceptions of risks lies in the impact they have on decisions of lawmakers. 
by Grace Breitstein 
A mother and infant are blown out ot an 
airliner in a terrorist attack in Europe. 
Swedish Prime Minister Olot Palme is 
gunned down and his assailant remains 
unknown. A nuclear power meltdown in 
Russia leaves some dead, many hospital- 
i/ed and surrounding countries in a panic 
over radiation levels. 
Although isolated incidences, each front 
page report scares and moves the public 
to exercise greater caution and perhaps 
to take action to improve the safety of a 
particular technology. They shape the 
general public's perceptions of such techno¬ 
logies as air travel, hand guns and nuclear 
power. 
The most important effect is the in¬ 
security and fear generated in the public, 
but another important consequence of 
these perceptions, one researcher notes, 
lies in the ultimate effect they have on the 
decisions reached by state and federal 
lawmakers. 
“Political actions by individuals in 
power are more likely to be taken based 
on the perceptions people have rather 
than on the actual risks." says Dr. Jan 
A..I. Stolwijk, Susan Dwight Bliss Profes¬ 
sor and chairman of the Department of 
Epidemiology and Public Health. 
With that in mind. Dr. Stolwijk and 
several colleagues set out to analyze 
"people” perceptions. They evaluated the 
general public’s perceptions of the risks, 
benefits and the current strictness of 
safety standards in six controversial areas 
handguns, nuclear power, nuclear 
weapons, industrial chemicals, automo¬ 
bile travel and air travel. 
Their findings provide insights into the 
psycho-social factors that influence how 
perceptions form. 
“People live with a presumption of 
safety. It allows us not to worry constantly 
about what might go wrong. When some¬ 
thing happens to change that presump¬ 
tion, such as what happened at Love 
Canal, restoring it may be almost impos¬ 
sible."says Dr. Stolwijk, one of a team of 
consultants investigating the habitability 
ol New York’s I ove Canal, from where 
239 families were relocated in 1978 and 
1979 due to chemical spills. 
Often, individuals exaggerate the risks 
>1 a technology to further environmental 
goals, according to Dr. Stolwijk, causing 
unnecessary anxiety. At I.ove Canal, for 
sample, the risks have not proved high 
nit fear runs high because of mis¬ 
information. 
1 hese days, it seems like the ‘in’ thing 
■s to make people aware of the terrible 
at might lurk around the corner,” 
“Familiar risks are more 
likely to be ignored. You feel 
you are not going to get into 
an automobile accident. But 
if chemicals are spilled by 
some large, impersonal 
corporation, and moreover, 
those chemicals could cause 
an incurable disease, you’re 
going to perceive the risk of 
that technology as higher, 
even if more people die from 
automobile accidents than 
from chemical spills.” 
Findings of the two-year, $500,000 
study, funded by the National Science 
Foundation, will be published by the 
Russell Sage Foundation Press in New 
York City. The report, in book form, is 
being written by Dr. Leroy C. Gould, 
professor of criminology at the University 
of Florida in Tallahassee, who was a 
coinvestigator of the study. 
The general public’s perceptions were 
compared with those of two other groups: 
technology and environmental advocates. 
Each group reported the level of strictness 
they desired for regulations in each area, 
so that their desire for safety could be 
compared with their perceptions of cur¬ 
rent safety standards. To analyze the 
relationship between perceived risks and 
actions taken, the researchers assessed 
the number of political actions members 
of each group reported taking in each 
category. 
Highlights of the findings show the 
general public: 
Perceives an even greater need for 
stricter safety standards for using indus¬ 
trial chemicals than the environmental 
advocates. “We're now dealing with strong 
political pressure from the public for 
further regulation on industrial chemicals 
when strict standards may already be in 
place,” says Dr. Stolwijk, 
Takes more frequent action, from 
signing petitions to suing, than previously 
believed, according to Dr. Stolwijk, 
Perceives handguns, automobile travel 
and air travel as a “very great" risk more 
often than either advocacy group. 
— Perceives a relatively low risk for auto¬ 
mobile travel and a very high risk for 
being exposed to industrial chemicals. 
The perception of lack of control over a 
particular technology can cause its risk to 
be perceived as high, he explains. 
“Familiar risks are more likely to be 
ignored,” he says. “You feel, after all, that 
you are not going to get into an automo¬ 
bile accident. But if chemicals are spilled 
by some large, impersonal corporation, 
and moreover, those chemicals could 
cause an incurable disease, you’re going 
to perceive the risk of that technology as 
higher, even if more people die from 
automobile accidents than from chemical 
spills.” 
Demographic factors, such as age, sex, 
education or income, didn’t seem to 
influence the perceived risks and benefits 
of a technology, according to the study. 
The Yale Roper Center, a survey re¬ 
search resource for faculty members 
throughout the university, conducted in¬ 
terviews in Connecticut. The National 
Opinion Research Center, a non-profit 
organization associated w ith the Univer¬ 
sity of Chicago, did the field work in 
Arizona. 
Some 400 questions were asked of 
1,320 people, 1,021 of whom were sampled 
from the general public, with the remain¬ 
der making up the advocacy group 
samples. 
Coinvestigators included Drs. Donald 
R. DeLucaand Wendy Horow itz, associ¬ 
ate research scientists at the Institution 
for Social and Policy Studies; Dr. Leonard 
W. Doob. Sterling Professor Emeritus of 
Psychology; Dr. Gerald T. Gardner, pro¬ 
fessor of psychology at the University of 
Michigan in Dearborn and Dr. Adrian 
Tiemann, of Digital Interface Inc., a 
Manhattan consulting firm. 
Post script: The Russian reactor failure 
at Chernobyl indicates that in a more 
closed society in which news and informa¬ 
tion is tightly controlled, the public percep¬ 
tions are quite different. Dr. Stolwijk 
observed. “It is likely that the level of 
concern in neighboring countries down¬ 
wind from the stricken reactor was greater 
than in nearby Kiev, the third largest city 
in the U.S.S.R. It is clear that the risk to 
the immediate surroundings beyond the 
evacuation zone was much greater than 
the risk to Poland or Sweden," he says. 
“The public perceptions which were 
studied in the U.S. clearly rely on a free 
flow of information and effective news 
coverage by the media.” 
HERE AND ABOUT 
MR Center Open 
For Patient Care 
On May 15, after months of careful 
planning to the last detail, the patient 
care facilities of the Magnetic Resonance 
Center were opened. The research compo¬ 
nent of the center is expected to be 
completed later this summer, and a dedica¬ 
tion ceremony is being planned for early 
fall. 
A joint project of the School of Medi¬ 
cine and Yale-New Haven Hospital, the 
M R Center will bring together the institu¬ 
tions’ research and clinical activities in 
magnetic resonance technology — con¬ 
sidered one of the most important develop¬ 
ments in medicine in this decade. When 
completed, the building including offices, 
laboratories and patient care rooms, will 
be equipped with two whole body scan¬ 
ners, a small animal instrument and a 
high-field spectrometer. The four magnets 
will have a combined strength of almost 
450,000 times that of the earth's magnetic 
field a factor that was key to the 
planning of the building. 
Eunding for construction of the new 
facility was provided in part by two 
major gifts to the School of Medicine and 
by generous donations to the hospital’s 
Annual Appeal. 
The Pew Memorial Trust of Philadel¬ 
phia gave $1.5 million toward construc¬ 
tion of research space, and M r. and M rs. 
Adrian C. Israel of Stamford, Con¬ 
necticut, and their family contributed 
$1,250,000 toward building projects in 
the center. Both gifts were contributed as 
part of the school’s $125 million capital 
campaign, announced a year ago. 
In addition. General Electric Company, 
manufacturer of the magnetic resonance 
imagers, lent philanthropic support 
through a significant discount toward the 
clinical care unit. In addition, GE pre¬ 
sented a major donation for the building, 
furnishing and equipping of the MR 
Center conference room. The company 
also has a research agreement with the 
School of Medicine to contribute on¬ 
going funds to support MR research. 
Yale Eye Center Opens 
A clinical symposium of distinguished 
ophthalmologists followed by a gala 
dinner dance celebrated the opening of 
the Yale Eye Center for Clinical Reseach 
on April 10-11. The events, which also 
included a special program for ophthalmic 
nurses and technicians, were typical of 
the scholarship, dedication and creativity 
that have marked the development of the 
center all along. 
Sponsored by the Department of Oph¬ 
thalmology and Visual Science, the clini¬ 
cal symposium, “Perspectives in the Man¬ 
agement of Eye Disease,” brought to¬ 
gether a group of 40 internationally prom¬ 
inent professionals to present and discuss 
critical issues in the study and treatment 
of eye diseases. 
“Our goal in sponsoring this event was 
to share knowledge about scientific ad¬ 
vancements, and debate new methods of 
intervention and correction of eye disease 
to develop perspectives in management,” 
said Dr. Marvin Sears, chairman of the 
Department of Ophthalmology and Visual 
Science since its establishment in 1971, 
and a recognized leader in research on 
diseases of the eye. Under Dr. Sears’ 
leadership, the department has earned a 
world-wide reputation for its significant 
contributions to thedevelopment of treat¬ 
ments for blinding eye diseases. 
The $2.5 million project, the culmina¬ 
tion of 23 years of planning by Dr. Sears, 
is a regional, national and international 
referral resource for persons requiring 
diagnosis and treatment of eye diseases. 
Housed in the extensively renovated 
Boardman Building, which is centrally 
located in the Medical Center and adjacent 
to the Department of Ophthalmology 
and Visual Science’s research laboratories, 
the new Eye Center will integrate patient 
care with basic research and teaching 
activities. With an entrance off Cedar 
Street, the center includes a general eye 
clinic, and treatment centers for retinal 
and corneal diseases, strabismus and 
glaucoma. 
Cancer Control Research 
Unit Established at Yale 
With a $6.5 Million Grant 
Connecticut will become a national labora¬ 
tory for research in controlling cancer 
with the establishment of the Cancer 
Control Research Unit for Connecticut 
at Yale. Announcement of the new pro¬ 
gram, which was awarded $6.5 million 
for the first three years by the National 
Cancer Institute, was made at a press 
conference on April 8. 
“Connecticut’s longstanding light a- 
gainst cancer takes yet another important 
step forward today,” said Connecticut’s 
Governor William O’Neill at the press 
conference. “The fact that our state has 
been singled out by the National Cancer 
Institute for this grant speaks volumes 
about our state. The $6.5 million grant 
says, or perhaps reaffirms, that Con¬ 
necticut is at the forefront of medical 
inquiry and consequently, medical treat¬ 
ment.” 
Dr. Dwight T. Janerich, professor of 
epidemiology anti public health and medi¬ 
cal director of the State of Connecticut 
Tumor Registry, will direct the program, 
with Marion E. Morra, assistant director 
of the Yale Comprehensive Cancer Center, 
responsible for the outreach components. 
In addition to the Cancer Center, participa- 
tingagencies will include the Yale Depart¬ 
ment of Epidemiology and Public Health, 
the State of Connecticut Department of 
Health Services and the University of 
Connecticut Health Center. 
Program is only the second federally 
funded program of its kind 
The program, which was awarded fol¬ 
lowing intensive national competition, 
and is one of only two such programs in 
the nation, will have seven major projects: 
improving early detection of cervical can¬ 
cer; decreasing adolescent use of smoke¬ 
less tobacco; effects of race and social 
factors on stage at diagnosis; interventions 
to improve use of breast cancer screening; 
case-control study of lethal melanoma 
and skin examinations; microbial and 
biochemical predictors of colorectal carci¬ 
noma, and a paired-community approach 
to colorectal cancer control being con¬ 
ducted in collaboration with the School 
of Medicine, State University of New 
York at Stony Brook. 
“We believe that with the help of the 
many agencies in Connecticut involved in 
the fight against cancer, this major effort 
in cancer control can find new means to 
detect and prevent some of the most 
serious forms of cancer, making our 
Connecticut-based program a national 
model for cancer control,” said Dr. Alan 
C. Sartorelli, director of the Yale Compre¬ 
hensive Cancer Center. 
Advisory committees will monitor and 
review the Cancer Control Research 
Elnit's Program 
Two committees have been formed to 
advise the program. The first, the Connect¬ 
icut Advisory Committee, has been estab¬ 
lished to ensure that the major organiza¬ 
tions are kept informed and participate 
actively in the project. This committee 
has been structured to allow maximum 
participation at a decision making level 
by major health agencies and institutions 
in the state. 
The second group, the Scientific Ad¬ 
visory Committee, includes people inter¬ 
nationally known in the field of cancer 
research who review the work accom¬ 
plished and advise on luture research 
directions. T his committee is composed 
of experts in the fields of cancer epidemio¬ 
logy, cancer control, behavioral science 
and health policy management. 
17 
Community Mental 
Health Leader Appointed 
Chairman of Psychiatry 
Dr. Tischler 
Dr. Gary L. Tischler, professor of psychi¬ 
atry and director of the Yale Psychiatric 
Institute, has been appointed chairman 
of the School of Medicine's Department 
of Psychiatry and chief of the psychiatry 
service at Yale-New Haven Hospital, 
effective July 1. 
He succeeds Dr. Morton F. Reiser, the 
Charles B.G. Murphy Professor of Psychi¬ 
atry, who has been chairman of the 
medical school's department for 16 years, 
and Dr. Malcolm B. Bowers, Jr., the 
hospital’s chief of psychiatry since 1973. 
In addition. Dr. Tischler will continue as 
director of Y.P.I., a position he has held 
since 1979. 
On his appointment. Dean Teon E. 
Rosenberg said, “Gary Tischler possesses 
the experience and vision to lead one of 
this country’s truly premier psychiatry 
departments - a department which spans 
the broad spectrum of biological, psycho¬ 
logical and social dimensions of mental 
health and illness in human life. He has 
demonstrated outstanding skills as an 
administrator, educator and researcher 
and is dedicated to quality clinical services 
for mentally ill people.” 
Dr. Tischler, who also directs Yale’s 
Mental Health Services Research Training 
Program, has focused his career on com¬ 
munity mental health issues. He also has 
a strong interest in social psychiatry and 
psychiatric epidemiology. 
He joined the Yale medical faculty in 
1967 as assistant professor, and from 
1967 to 1978, concurrently was associated 
with the Connecticut Mental Health Cen¬ 
ter, serving as associate director for six 
years. Dr. Tischler chairs a National 
Institute of Mental Health’s study section 
on epidemiology and mental health ser¬ 
vices research. In 1978-79, he was the 
tudy director of President Jimmy Carter’s 
Commission on Mental Health which led 
to recommendations regarding future 
directions for community mental health 
services and mental health evaluation 
and research. 
A native of Newark, New Jersey, Dr. 
Tischler received an A.B. degree in 1957 
from Hamilton College and an M.D. 
degree in 1961 from the University of 
Pennsylvania. He completed an internship 
at Kings County Hospital in Brooklyn, 
New York, and a residency training in 
psychiatry at Yale. He served in the U.S. 
Army Medical Corps from 1965 to 1967. 
He has written more than 70 publica¬ 
tions in areas of psychiatric epidemiology, 
health services research and social psychia¬ 
try. Active in numerous professional or¬ 
ganizations. Dr. Tischler is a fellow of the 
American Psychiatric Association, Ameri¬ 
can College of Mental Health Administra¬ 
tion and the American Association for 
Social Psychiatry. 
Dr. Tamborlane Named 
Program Director of 
Children s CRC 
Dr. William V. Tamborlane Jr., professor 
of pediatrics, has been named program 
director of the Children’s Clinical Re¬ 
search Center and head of the Division of 
Endocrinology and Diabetes. In these 
appointments, he succeeds Dr. Myron 
Genel, associate dean for government 
and community relations. 
The school’s five-bed Children’s Clinical 
Research Center provides a clinical setting 
for physicians to study medical and neuro¬ 
psychiatric disorders. Opened in 1963, it 
is among 78 such centers at major medical 
institutions in the U.S., supported by 
grants from the U.S. Public Health Ser¬ 
vices, National Institutes of Health’s Di¬ 
vision of Research Resources. 
Dr. Tamborlane, who has focused his 
research on insulin-dependent diabetes in 
children and young adults, was one of the 
first to introduce constant infusion insulin 
therapy using a portable pump. At pre¬ 
sent. he is conducting metabolic studies 
in diabetes to prevent long-term degenera¬ 
tive complications, such as blindness and 
vascular problems. 
Dr. Tamborlane received a B.S. degree 
in 1968, and an M.D. degree in 1972 from 
Georgetown University and completed 
his residency training at Georgetown 
University Hospital. Following a post¬ 
doctoral fellowship at the Yale School of 
Medicine, he joined the Yale faculty in 
1977 as an assistant professor of pedia¬ 
trics. Last year, the Juvenile Diabetes 
Foundation presented him the Mary Jane 
Kugel Award in recognition of his contri¬ 
butions while serving a three-year term 
on its Medical Science Advisory Board. 
Four Members of 





Dr. Reiser, Chairman of 
Psychiatry for 17 Years 
A “Mind, Brain and Body”symposium in 
May brought together leading neurobiolo¬ 
gists and psychoanalysts to share know- 
lege of brain mechanisms underlying 
human behaviorand mental phenomenon, 
and to honor Dr. Morton F. Reiser, the 
Charles B.G. Murphy Professor of Psychi¬ 
atry, who retires as chairman of the 
Department of Psychiatry on July I. 
Past president of the American Psycho¬ 
analytical Association, Dr. Reiser has 
helped chart national directions for neuro- 
biological research and, as an educator, 
invented ways of combining teaching 
about neuroscience and psychological 
theory in order to enhance the practice of 
the disciplines. A graduate of the Univer¬ 
sity of Cincinnati, where he received B.S. 
and M.D. degrees, he has been a member 
of the Yale medical faculty since 1969. 
“In much of his work over the years. 
Dr. Reiser has been trying to connect the 
psychology and social psychology of beha¬ 
vior with the biology of behavior and 
understand how they interrelate,” said 
Dr. Boris M. Astrachan. professor of 
psychiatry and director of the symposium. 
“The goal of the symposium was to get 
various disciplines talking together in 
what is now considered one of the hottest 
areas of science,” said Dr. Astrachan. 
“We’re learning that this elegant ner¬ 
vous system which mediates in our feelings 
and sensations is very similar to the 
nervous system of lower animals and gets 
elaborated in this thinking brain, a re¬ 
markable organism that is able to remem¬ 
ber and build upon memory.” 
Dr. Reiser is the author of “Mind, 
Brain, Body: Toward a Convergence of 
Psychoanalysis and Neurobiology” (1984) 
and co-author of “The Patient: Biological, 
Psychological and Social Dimensions of 
Medical Practice”(1980). A fellow of the 
American Association for the Advance¬ 
ment of Science and of the American 
College of Psychiatrists, he also serves on 
the editorial boards of publications, in- 
cludmg “Psychoanalysis and Contempor¬ 
ary Science," “Psychiatry in Medicine” 
and the “International Journal of Psycho¬ 
analytic Psychotherapy.” 
Dr. Glaser, First Chairman of 
the Department of Neurology 
Some 25 neurologists, present and former 
colleagues of Dr. Gilbert H. Glaser, dis¬ 
cussed advances in understanding and 
treating diseases of the nervous system at 
a May 17 symposium honoring the first 
chairman and founder 34 years ago of the 
Yale Department of Neurology. Dr. 
Glaser is retiring as chairman as of July I. 
“Everything that has occurred in the 
department is directly or indirectly a 
result of Dr. Glaser’s efforts,” said Dr. 
Jonathan H. Pincus, professor of neuro¬ 
logy, who was director of the all-day 
symposium. “His contribution to neuro¬ 
logy has been tremendous.” 
Dr. Glaser joined the medical school in 
1952 after positions that included chief 
resident in neurology, senior research 
scientist and ehief in neurology, senior 
research scientist and chief of the neuro¬ 
logy clinic at Columbia-Presbyterian Med¬ 
ical Center in New York. Dr. Glaser 
graduated in 1943 with honors from 
Columbia University’s College of Physi¬ 
cians and Surgeons. 
In the last 20 years. Dr. Glaser focused 
the department’s research effort on epi¬ 
lepsy. In addition, under his leadership, 
Yale physicians were among the first to 
participate in clinical trials of 1-dopa, the 
most effective treatment for Parkinson’s 
disease. 
“His contribution to neurology has 
been tremendous,” said Dr. Pincus. 
“There is literally not’a subject he hasn’t 
written about,” he added, referring to Dr. 
Glaser’s more than 200 published articles 
addressing the subjects of epilepsy, move¬ 
ment disorders, demyelinating disease, 
muscle disease, the complications of inter¬ 
nal diseases and the borderline between 
neurology and psychiatry. 
Participants in the symposium dis¬ 
cussed these topics and others in tribute 
to Dr. Glaser’s accomplishments. 
Dr. Morris, 
Distinguished Gynecologist 
Friends and colleagues paid tribute to 
Dr. John McL. Morris with a symposium 
and dinner dance on April 19. The oc¬ 
casion celebrated the noted gynecologist’s 
34 years as a dedicated teacher, physician 
and researcher. 
Dr. Morris, the John Slade Ely Profes¬ 
sor Emeritus of Gynecology, is a graduate 
of Harvard Medical School. Following 
residency training at the Massachusetts 
General Hospital, he was a Damon Run¬ 
yon clinical research fellow at the Radium- 
hemmet in Stockholm, Sweden, before 
joining the Yale medical faculty in 1952 
as an associate professor. 
The gynecologic service at Yale was 
developed under the leadership of Dr. 
Morris, who is widely recognized as an 
outstanding clinician. In addition, he is 
recognized worldwide for research in the 
treatment of gynecologic neoplasms, and 
for his contributions to conception 
control. 
Among the participants in the symposi¬ 
um honoring Dr. Morris were four mem¬ 
bers of the Yale medical faculty: Drs. 
Virginia Stuermer, associate clinical pro¬ 
fessor of obstetrics and gynecology; James 
J. Fischer, professor and chairman of the 
Department of Therapeutic Radiology; 
Peter E. Schwartz, professor of obstetrics 
and gynecology, and Frederick Naftolin, 
professor and chairman of the Depart¬ 
ment of Obstetrics and Gynecology. 
Dr. Downs, Founder of the 
International Health Travel 
Fellowship Program 
The School of Medicine’s international 
health travel fellowship program has been 
named in honor of its founder. Dr. 
Wilbur G. Downs, clinical professor of 
epidemiology. 
“The travel program is now a cherished 
tradition here at Yale and the envy of 
other institutions,” said Dr. Curtis L. 
Patton, professor of epidemiology (micro¬ 
biology) and chairman of the school’s 
Committee on International Health. He 
outlined the program’s history at a May 
15 dinner, honoring Dr. Downs and 
announcing that the fellowships have 
been designated the Wilbur G. Downs 
International Health Travel Fellowships. 
While Dr. Downs was associate director 
of The Rockefeller Foundation, he con¬ 
ceived the idea for the international travel 
program. It started in 1965 with three 
students traveling to Brazil and in 1986, 
14 students will visit 13 countries. 
During the intervening years, more 
than 180 students have participated in the 
program that Dr. Downs initated to give 
students the experience of working for at 
least two months and sometimes as long 
as a year on a specific project in a 
research laboratory or in the field in a 
foreign country. The students selected, 
receive travel expenses and a minimal 
stipend. In turn, they report on their 
research and travel experiences — experi¬ 
ences which have influenced many career 
choices. 
Dr.Downs, who received A.B. and 
M.D. degrees from Cornell University 
and an M.P.H. degree from The Johns 
Hopkins School of Medicine, was associ¬ 
ate director of The Rockefeller Founda¬ 
tion from 1963 to 1971. For 22 previous 
years, he was a foundation field staff 
member, responsible for malaria field 
programs in Trinidad and Mexico. In 
1963, he was appointed professor of 
epidemiology at Yale, and from 1965 
until 1971, hedirected the Yale Arbovirus 
Research Unit. 
Dr. Downs is a member of the Expert 
Committee on Viruses, World Health 
Organization. He has been the principal 
investigator of the Senegal River Pilot 
Health Program, a Yale project sponsored 




Dr. William Prusoff, a distinguished re¬ 
search scientist in antiviral therapy, visited 
Meharry School of Medicine in April as 
the college’s first Sterling Drug Visiting 
Professor. During his visit. Dr. Prusoff, 
professor of pharmacology, delivered the 
first Ralph Cazort Lecture on "The Pres¬ 
ent and Future Status of Viral Chemother¬ 
apy.” The Sterling Drug Company has 
established the visiting professor program 
to promote the interchange of knowledge 
among colleges in the field of pharma¬ 
cology. 
Dr. Michael J. Bannon, assistant profes¬ 
sor of psychiatry and pharmacology. Dr. 
Robert B. Innis, assistant professor of 
psychiatry (neuroscience), and Dr. Rod¬ 
rigo O. Kuljis. instructor in neuroan- 
atomy, have been awarded $25,000 Sloan 
Research Fellowships. The award pro¬ 
gram established by the Alfred P Sloan 
Foundation of New York, aids young 
scientists w ho teach at American colleges 
and universities. 
Dr. Alan C. Sartorelli, director of the 
Comprehensive Cancer Center, began a 
one-year term as president of the Ameri¬ 
can Association for Cancer Research Inc. 
on May 7, at the association’s annual 
meeting in Los Angeles. I he association 
brings together cancer researchers to dis¬ 
cuss new or significant observations and 
to foster research on cancer. 
Earlier this spring. Dr Sartorelli re¬ 
ceived the bronze medal award for experi¬ 
mental therapeutics from the American 
Society for Pharmacology and Experimen¬ 
tal Therapeutics during the society’s an¬ 
nual meeting held in St. Louis. 
Eleven young scientists in the Yale Com¬ 
prehensive Cancer Center have received 
the New Haven Foundation’s Argali L. 
and Anna (i. Hull Cancer Research 
Awards They are Drs. Paula Kavathas, 
assistant professor of laboratory medicine; 
Richard Anderson, postdoctoral fellow 
in pathology ; John Woods, postdoctoral 
fellow in cell biology ; Susan Keyes, associ¬ 
ate research scientist in pharmacology; 
Susan Kelley, postdoctoral tellow in onco¬ 
logy: John Flory. research associate in 
human genetics; Bruce Littlefield, assis¬ 
tant professor of obstetrics and gyneco¬ 
logy. Jeffrey Radding. postdoctoral fellow 
in internal medicine; Basil Rigas, post¬ 
doctoral fellow in human genetics; Grace 
Vitkauskas.associate research scientist in 
pharmacology . Also, Dr. Alfons Bonde. 
research associate in internal medicine, 
ind Mary Kay Knobf, R.N., M.S.N., 
use specialist and lecturer in surgery 
(oncology). 
Dr. George E. Palade, professor emeritus 
of cell biology, special advisor to the dean 
of the School of Medicine and senior 
research scientist in cell biology, has been 
named to a four-year term on the Adv isory 
Committee to the director of the National 
Institutes ol Health. 
In addition. Dr. Palade received honor¬ 
ary' degrees from two distinguished univer¬ 
sities this spring. Columbia University 
awarded him an honorary doctor of 
science degree for the "isolation and 
characterization of subcellular compo¬ 
nents as a major research tool,” and for 
solving "the major problem of fixation of 
tissues for electron microscopy, enabling 
that technique to become a critical tool 
for research in biology and diagnosis in 
medicine.” At commencement exercises 
in June, New York University awarded 
Dr. Palade a doctor of science degree for 
“bringing the light of understanding to 
the microcosmos of the living cell.” 
The American Cancer Society has a- 
warded a two-year grant of $151,000 to 
Dr. Kenneth Taylor for the study of 
tumor vascularity by means of the use of 
Doppler Ultrasound. Dr. Taylor, pro¬ 
fessor of diagnostic radiology, is well 
known for developing the use of ultra¬ 
sound for diagnostic procedures. 
The honor of Fellow of the Institute was 
conferred on Dr. Robert Shope by the 
Queensland Institute of Medical Research 
in recognition of his distinguished contri¬ 
butions to the furtherance of medical 
science. Dr. Shope is professor of epidemi¬ 
ology and director of the Yale Arbovirus 
Research Unit. 
Dr. Joseph McGuire, professor of derma¬ 
tology, who was recently appointed presi¬ 
dent-elect of the Society of Investigative 
Dermatology, was visiting professor of 
dermatology at Hunan Medical College 
during April and May. 
The YaleScienceand Engineering Associa¬ 
tion has presented its 1986 Award for the 
Advancement of Basic and Applied Sci¬ 
ence to Dr. Alvan R. Feinstein. professor 
of medicine and epidemiology, and co¬ 
director of the Robert Wood Johnson 
Clinical Scholars Program at Yale. The 
association, which includes some 1.000 
Yale science and engineering alumni, 
honored Dr. Feinstein for his work to 
advance quantitative research in epidemiol¬ 
ogy and for his efforts in establishing 
clinical epidemiology as a new scientific 
discipline in medical research. 
Dr. Norman Talner. professor ol pedia¬ 
trics, is one of four cardiologists appointed 
as Fulbright v isiting professors in a teach¬ 
ing program in Hong Kong. Kuala Lum¬ 
pur. Malaysia and Rangoon. Burma trom 
March 27 to April II. The good-will 
medical science mission, conducted at the 
request of medical societies of those 
countries, was jointly sponsored by the 
American College of Cardiology and the 
Fulbright Commissions. 
Dr. Pasko Rakic. Dorvs McConnell Du- 
berg Professor of Neuroscience and chair¬ 
man of the Section of Neuroanatomy, 
organized a conference entitled "Brain 
Beyond Genes: Epigenetic Regulation of 
Synaptic Circuits and their Function”, 
held in New York City on June 2-4. 
Dr. Rakic was one of 15 scientists to 
present data and ideas about the mole¬ 
cular, cellular, physiological and psycho¬ 
logical mechanisms underlying cellular 
interactions in the brain and their biomedi¬ 
cal and social implications. The confer¬ 
ence was sponsored by the Institute for 
Child Development Research. 
The New Haven Foundation presented 
an Elm-Ivy Award to Kay D. Codish, 
citing her as a force in "creating, imple- 
mentingand monitoring policies on affirm¬ 
ative action, sexual harassment and day 
care.” In addition to directing the School 
of Medicine’s Office for Women in Medi¬ 
cine, Ms. Codish has been active in the 
AIDS Project in New Haven, the Wo¬ 
men’s Self-Defense Alliance. Arts Coun¬ 
cil of New Haven and Handicapped 
Artists. Inc. 
BOOKS BY FACULTY 
“Legal Issues in Pediatrics and Adolescent 
Medicine”, Second Edition. Revised and 
Enlarged, by Angela R. Holder, clinical 
professor of pediatrics (law). Yale Univer¬ 
sity Press (New Haven, CT) 1985. 
“The Psychoanalytic Study of the Child,” 
Vol. 40, by Albert J. Solnit, Sterling 
Professor in the Child Study Center, 
Pediatrics and Psychiatry, RuthS. Eissler, 
and Peter B. Neubauer. Yale University 
Press (New Haven. CT) 1985. 
“The Biochemical Basis of Neuropharma¬ 
cology”, Fifth Edition, by Jack R. Cooper. 
professor of pharmacology, Floyd E. 
Bloom and Robert H. Roth .professor of 
psychiatry and pharmacology. Oxford 
University Press (New York) 1986. 
"Reproductive Failure”, edited by Alan 
H. DeCherney, M.D., John Slade Ely 
Professor of Obstetrics and Gynecology. 
Churchill Livingstone (New York) 1986. 
“Understanding Your Immune System”, 
by Marion E. Morra, assistant director, 
Yale Comprehensive Cancer Center, and 
Eve Potts. Avon Books (New York) 
1986. 
Two members of the School of Medicine 
faculty. Dr.George E. Palade and Dr. 
Joan A. Steitz, were awarded the National 
Medal of Science by President Ronald 
Reagan. They were among 20 scientists 
nationwide to receive the awards at the 
ceremony held at the White House on 
March 12. 
Dr. Palade, Sterling Professor Emeritus 
of Cell Biology, special advisor to the 
dean, and senior research scientist in cell 
biology, was recognized for his pioneering 
discoveries of fundamental structures in 
living cells through studies combining 
electron microscopy and biochemistry. 
"These contributions stimulated the 
growth in the field of cell biology, which 
he continues to inspire through his own 
research and leadership and active col¬ 
laboration and the training of new investi¬ 
gators,"said the White House in awarding 
the prize. 
Dr. Steitz, professor of molecular bio¬ 
physics and biochemistry, received the 
national award for her discovery of at 
least six new components of cells which 
are significant in understanding the mole¬ 
cular biology of autoimmune diseases, 
such as lupus and rheumatoid arthritis. 
“Her discovery of at least six new compo¬ 
nents of cellular machinery is an accom¬ 
plishment of great distinction in both 
basic molecular biology and in the clinical 
treatment of autoimmune disease,” said 
the White House. Receiving the award 
from President Reagan, said Dr. Steitz, 
“was a great honor." 
Animal Care Program 
Receives Full 
Reaccreditation 
The American Association for Accred¬ 
itation of Laboratory Animal Care 
(AAALAC) hasapproved full reaccredita¬ 
tion for three years for the School of 
Medicine’s animal care program. 
In addition, the National Institutes of 
Health’s Division of Research Resources 
has awarded the medical school a 
$771,000 grant to help renovate laboratory 
animal facilities in Sterling Hall of 
Medicine. 
“Reaccreditation and the N1H renova¬ 
tion grant are major acknowledgements 
of the school’s comprehensive program 
for the care of laboratory animals used in 
more than 300 biomedical research pro¬ 
jects,"according to Dr. Robert O. Jacoby, 
associate professor of comparative medi¬ 
cine and head of the Division of Animal 
Care. 
AAALAC, a national nonprofit organi¬ 
zation, inspects and accredits laboratory 
animal programs. The medical school’s 
participation in the program, which began 
in 1967, is voluntary. 
“Accreditation by AAALAC is viewed 
by the N1H as the best means to demon¬ 
strate compliance with regulations and 
policies that govern the care and use of 
animals in federally sponsored research,” 
explained Dr. Jacoby. Yale’s Animal 
Care and Use Committee, chaired by Dr. 
Martine Y.K. Armstrong, intensified re¬ 
views of research that involves animals 
before new federal regulations governing 
animal use became effective January 1, 
according to Dr. Jacoby. 
ERRATUM 
An item in the fall 1985 issue (Here and 
About, page 20) states that Dr. John A. 
Kirchner came to Yale in 1951 as the first 
full-time chief of the Section of Otolaryn¬ 
gology. It has been brought to our atten¬ 
tion that Dr. Norton Canfield was the 
first full-time chief of that section from 
1933 to 1951. Dr. Canfield is currently 
living in M iami, Florida, and recently has 
been consultant in audiology at the M iami 
Hearing and Speech Center working on 
the cochlear implant project. 
IN PROGRESS 
New Drug Combination 
to Treat Brain Tumors 
A new , investigational treatment for malig¬ 
nant glioma, the most common of adult 
brain tumors, has been developed at the 
at the Yale School of Medicine. 
Combininga known chemotherapeutic 
agent with a class of anti-psychotic drugs 
appears to markedly increase the killing 
of tumor cells, according to researchers 
in the Brain Tumor Study Group at the 
Yale Comprehensive Cancer Center. They 
have studied the safety of this treatment 
in the past year, during the first phase of a 
clinical trial that involved 18 patients. 
“We are encouraged by our preliminary 
results in the laboratory and are optimistic 
that the combination will be well toler¬ 
ated,"said Dr. William N. Hait, assistant 
professor of medicine, in whose laboratory 
the project began in collaboration with 
Dr. John S. Lazo, associate professor of 
pharmacology. 
The anti-psychotic drugs, known as 
phenothiazines, concentrate in the brain 
and may overcome a major problem in 
treating malignant glioma —the inability 
of most cancer-fighting drugs to get from 
the blood into the brain. Phenothiazines 
appear to inhibit the protein calmodulin 
that is involved in cellular division, thus 
helping the chemotherapeutic agent bleo¬ 
mycin to attack cancer cells and halt the 
tumor’s growth, the researchers report. 
I he high-grade brain tumor, glioblasto¬ 
ma multiforme, is usually incurable and 
fatal. The most common treatment in¬ 
volves surgery, in which part of the tumor 
is removed. Radiation and chemotherapy 
treatments follow. 
“Because of the tumor’s nature, it’s 
difficult to remove it entirely, without 
removing a small portion of the normal 
brain, sometimes leaving the person with 
impaired function,” said Dr. Hait. 
In the newly developed treatment, labor¬ 
atory studies demonstrated that the ability 
of the chemotherapeutic agent, bleomycin, 
to kill cancer cells increased. 
“Our studies showed that when calmodu¬ 
lin inhibitors were combined with bleomy¬ 
cin, almost 500 times more cancer cells 
were killed than when either drug was 
given independently,” said Dr. Hait. He 
and Dr. Lazo first conducted animal 
studies and then a study in patients to 
assure the safety of the combination. 
I he 18 patients treated had no longer 
responded to traditional chemotherapy, 
said Dr. Hait. The clinical trial, approved 
by the medical school’s Human Investiga- 
i ion ('ommittec, was designed to help the 
archers determine the tolerable doses 
ol phenothiazines with bleomycin and 
the side effects resulting from the new 
drug combination. 
Preliminary results have proved “prom¬ 
ising,” according to Dr. Hait. Most pa¬ 
tients tolerated the drug combination 
very well compared to patient responses 
to most chemotherapies, although the 
expected side effects of chemotherapy oc¬ 
curred. These preliminary results are sum¬ 
marized in the current proceedings of the 
American Society of Clinical Oncology. 
A full report has been submitted to 
Cancer Treat mem Reports. 
Side effects, all related to the anti¬ 
psychotic drug, included sleepiness and 
some anxiety that discontinued as soon 
as the treatment was stopped. Some lung 
toxicity resulted from the bleomycin, but 
not greater than expected from this drug 
used alone, the researchers reported. 
They chose to focus on brain tumors, 
rather than on another form of cancer, 
because of phenothiazines’action in the 
brain. "The striking thing about phenothia¬ 
zines is that they accumulate in the brain, 
thereby concentrating in the area that 
they are needed in concentration,” com¬ 
mented Dr. Hait. 
Most drugs don't reach as high concen¬ 
trations in the central nervous system as 
they do peripherally because of a pheno¬ 
menon known as the “blood brain bar¬ 
rier,” which keeps things out of the brain. 
Phenothiazines can pass through that 
barrier, explained Dr. Hait, and poten¬ 
tially augment the effects of bleomycin. 
Coinvestigators in the multidisciplinary 
Brain Tumor Study Group include Drs. 
Joseph Piepmeier, assistant professor of 
surgery (neurosurgery); Thomas N. Byrne, 
assistant clinical professor of neurology; 
Henry J. Durivage, associate research 
scientist in medicine, and Douglas Reed, 
assistant professor of diagnostic radio¬ 
logy. The American Cancer Society, the 
National Institutes of Health and Bristol- 
Myers Company in Wallingford, funded 
the study with basic research grants to¬ 
taling $162,500. 
Yale Researchers Achieve 
Breakthrough in 
Treatment of Severe Burns 
A new chapter in the annals of transplanta¬ 
tion was written recently by a team of 
Yale-New Haven Medical Center physi¬ 
cians who successfully treated a critically 
injured burn patient by transplanting 
skin donor dermis and the patient’s own 
laboratory-cultured epidermis to the 
wound site. 
J he procedure, announced at a hospital 
news conference on April 4, marks the 
first time human skin has been permanent¬ 
ly transplanted from donor to host with¬ 
out the use of immunosuppressives. The 
breakthrough was made by three Yale 
School of Medicine physicians: Drs. 
Charles Cuono, associate professor of 
surgery (plastic and reconstructive), 
Robert Langdon, assistant professor of 
dermatology and Joseph McGuire, profes¬ 
sor of dermatology. 
Over the last decade, skin transplanta¬ 
tion has been used widely to treat burn 
victims, but because of the rejection- 
phenomenon, the use of full-thickness 
donor skin (dermal and epidermal layers) 
can be be applied only as a stopgap 
measure. Through the Yale team's work, 
however, it appears dermal transplants 
can be permanently accepted by the host 
if the donor epidermis is removed. 
It was November of last year when a 
white, middle-aged male was brought to 
Yale-New Haven Hospital with third 
degree burns to 55 percent of his body 
from his chest to his ankles. Placed under 
the care of Dr. Cuono and the nurses in 
the Surgical Intensive Care Unit, the 
patient’s injured skin was debrided and 
cryopreserved cadaver allograft skin from 
the Yale Skin Bank was placed on the 
wound bed. 
Keratinocyte cultures were initiated 
with cells from the patient’s uninjured 
skin and these cultures were expanded in 
vivo. Techniques similar to those used by 
Dr. Langdon to expand the cultures had 
been used elsewhere in the United States 
but through his refinements in the process, 
he was able to expand the cultures more 
rapidly. 
On the patient’s 32nd day in the hospi¬ 
tal, a cylindrical air-driven carborundum 
wheel was used to literally sand off the 
epidermal layer of the allograft on his 
torso, leaving only the less antigenic 
dermal bed. The patient’s own epidermal 
cultures, grown in 35 six-centimeter 
dishes, were used to resurface this exposed 
dermal bed. Each disc of epidermis was 
approximately two-cells thick at the time 
of application. 
The epidermal discs were covered for 
seven days, and then re-examined. The 
physicians were excited to find the cultures 
had adapted to their dermal bed and 
grown. The procedure was repeated on 
the abdomen beginning on the 42nd day, 
and the results were equally positive. By 
the 52nd day, the patient was walking 
and he was discharged from Yale-New 
Haven Hospital on the 71st day. To date, 
the patient has displayed no signs of 
rejecting the foreign dermis. 
Drs. Cuono, McGuire and Langdon 
emphasized their achievement was built 
on the work of other scientists. “None of 
the techniques, taken individually, were 
developed here,” Dr. Cuono said. “We’ve 
just put them together and exploited 
certain aspects of the biology of the skin.” 
The procedure demonstrated several 
advantages over previously applied forms 
of treatment. A rule of thumb is that a 
burn patient will require three days in the 
hospital for each percent of the body 
burned 150 to 175 days in the case of 
this patient. Though given only a 20 
percent chance of survival on admission, 
he was discharged after only 71 days. 
Scarring is the most visible consequence 
of severe burns, but the Yale team's 
approach helps reduce scarring by adding 
dermis which provides flexibility and 
durability to skin. It is the lack of dermis 
which results in the lumpy scars and 
contractions which commonly afflict re¬ 
covered burn victims. The addition of 
dermis not only gives the injured flesh a 
more natural texture, but also makes it 
more resistant to injury. 
Infection, the leading cause of death 
for burn victims, tends to set in during the 
weeks of recovery when skin grafts are 
being harvested to cover the patient’s 
wounds. By using cryopreserved skin 
from a skin bank, surgeons are able to 
completely cover the wound site within 
days of the accident, effectively protect¬ 
ing the patient from infection and theoreti¬ 
cally improving morbidity rates. 
- Tom Urtz 
Enzyme Understanding 
First Step in Aiding 
Heart Disease Patients 
To design better drugs and improve a 
current drug used to treat patients with 
heart disorders, Yale researchers have 
been studying the structure and functions 
of a life-sustaining enzyme. The enzyme 
or protein, sodium potassium ATPase, 
affects the sensitivity and resistance in 
different organisms to digitalis, a drug 
used to treat heart disease patients. 
“We think that by understanding as¬ 
pects of structure/ function organization, 
we can begin to think of better ways to 
design drugs to treat people with heart 
disease,’’said Dr. Robert Levenson, assis¬ 
tant professor of cell biology, the principal 
investigator of the study. 
The enzyme is the cellular receptor of a 
family of compounds including digitalis, 
which stimulate the heart muscle. But, 
digitalis presents complications to some 
people, including nausea, vomiting, loss 
of appetite and abnormal heart activity. 
“The dose that is therapeutic and the 
one that is toxic are not very different,” 
said Dr. Levenson. 
Information derived from an under¬ 
standing of the enzyme’s structure, such 
as pinpointing important sites for drug 
binding and drug interaction, could pave 
the way for a more effective drug treat¬ 
ment, according to Dr. Levenson. The 
researchers isolated the DNA sequence 
coding for the sodium potassium ATPase 
using recombinant DNA techniques. 
Patients can get sick from digitalis, 
according to Dr. Levenson, because the 
drug is non-specific. It can affect the 
enzymes in many tissues and not only the 
enzyme in heart muscle. 
“We could possibly design a better 
drug that would be safer, if we knew 
exactly where the drug bound and how it 
interacts with the protein,” he said. “There 
may be something different about this 
enzyme in the heart that we can take 
advantage of, so that the drug designed 
will only or preferentially act with the 
heart form of the enzyme.” 
Finally, this enzyme, which helps to 
sustain life by regulating ion transport 
into and out of cells, may also prove 
important toward developing diagnostic 
tests for several genetic diseases, including 
hypertension, cystic fibrosis and muscular 
dystrophy. The defects leading to these 
diseases may lie in the gene coding for 
systems which transport ions, said Dr. 
Levenson. 
The ongoing research, which began 
two years ago, has been funded through 
grants totalling $420,000 from the Ameri¬ 
can Heart Association, the National Can¬ 
cer Institute, the Cystic Fibrosis Founda¬ 
tion and the March of Dimes. Coinvestiga¬ 
tors include Drs. Janet Emanuel, associate 
research scientist in cell biology and Dr. 
Edward J. Benz, associate professor of 
medicine and human genetics. 
Antiviral Drugs Tested 
in Army-funded Study 
Numerous anti-viral drugs are being tested 
by Yale investigators who hope to develop 
those that could treat a wide range of 
virus-caused diseases, from yellow fever 
to AIDS. Approximately 500 drugs will 
be tested over the next five years during a 
$1.5 million study funded by the U.S. 
Army. 
“This study involves private industry, 
defense and academia working together 
to develop specific anti-viral drugs,” said 
Dr. Gregory H. Tignor, associate pro¬ 
fessor of epidemiology, the study’s princi¬ 
pal investigator. “It gives us access to 
hundreds of anti-viral drugs that would 
otherwise go untested.” 
Each drug is first evaluated in tissue 
culture to determine its worthiness for 
further study, according to Dr. Tignor. 
Researchers test for toxicity before fur¬ 
ther testing to determine an estimate of 
the drug’s potential efficacy in humans. 
If an important anti-viral drug is pin¬ 
pointed, Dr. Tignor and his coinvestiga¬ 
tors would collaborate with the drug’s 
manufacturers in completing the necessary 
preliminary tests leading to preliminary 
trials in humans and ultimate governmen¬ 
tal approval for marketing the drug. 
Coinvestigators in the study include: 
Dr. Robert E. Shope, professor of epi¬ 
demiology and director of the Yale Arbo¬ 
virus Research Unit; Dr. Abigail Smith, 
associate professor of comparative medi¬ 
cine and epidemiology, and Dr. Thomas 
G. Burrage, associate research scientist 
and lecturer in epidemiology. 
“We’re looking for a drug that has a 
high safety index,” said Dr. Shope. “It 
should have minimal toxicity and be 
effective at low concentrations.” 
The drugs will be evaluated primarily 
with the yellow fever virus. The Yale 
Arbovirus Research Unit has a long 
association with studies on yellow fever 
virus. A vaccine was developed 45 years 
ago at Yale by the late Max Theiler, who 
received the Nobel Prize for his work on 
the vaccine. Later, Dr. Theiler worked 
with Drs. Shope and Tignor. 
23 
Yale Surgeons Analyze 
Heart Valve Replacements 
In studies to determine which valve type 
is better for heart valve replacement 
surgery. Yale surgeons have analyzed 
two main types of valves. After review ing 
more than 1.100 biological and mechani¬ 
cal valves inserted in adults during an 
11-year period, they have concluded that 
little direct evidence exists to strongly 
support one type of valve over another. 
"All ot the valves have problems, and 
the problems cancel each other out. If 
you look at failure rates, there is no clear 
advantage of one type over another,” said 
Dr. Graeme L. Hammond, professor of 
surgery. 
Basically , patients who received mechan¬ 
ical heart valves experienced a higher 
incidence of blood clotting, while those 
who were given hiological, or pig heart, 
valves registered a higher incidence of 
valve failure, according to Dr. Hammond, 
who co-authored the study with Dr. 
Alexander S. Geha, professor of surgery. 
Dr. Gary S. Kopf. associate professor of 
surgery, and Dr. Sabet W. Hashim, assis¬ 
tant professor of surgery. 
After assessing problems of biological 
and mechanical valves and addressing 
questions about which may be better the 
researchers concluded that the final valve 
selection is relative. "As physicians and 
patients discuss risks and benefits of the 
respective valves before deciding which 
to use, they must take into account the 
individual’s age, reliability to self-medi- 
cate, activity level and anticipated life 
expectancy.” said Dr. Hammond. 
In their study the research team ana¬ 
lyzed I. I 16 valves inserted in 1,012 adults, 
aged 18 to 88 from January 1974 through 
January 1985 at Yale-New Haven Hospi¬ 
tal. Six-hundred-and-six biological valves 
were implanted in 533 patients, and 479 
individuals received 510 mechanical 
valves. ITie Yale surgeons examined the 
valves for such complications as blood 
clotting, anticoagulation-related hemor¬ 
rhage. valve susceptibility to infection, 
valve leaks, valve failure and the need for 
reoperation. 
" I here is no artificial valve that is as 
good as the normal God-given valve,” 
Dr. Hammond said. Human heart valves 
are flexible, openingand closing easily as 
the human heart beats 40 million times a 
year. No man-made material similarly 
Ilexes as often w ithout wearing out. 
Biological valves and the three w idely 
used mechanical valves that the Yale 
team evaluated eventually fail. Dr. Ham¬ 
mond noted. Complications generally 
begin to appear two or three years after 
valve replacement surgery. 
The pig valves that surgeons sew into 
their patients, can’t regenerate themselves 
like human valves do. In addition, calcium 
may build up in the porcine valves; fatty 
acids and cholesterol can infiltrate them. 
“Our data showed that biological valves 
deteriorate more than mechanical valves,” 
commented Dr. Hammond. A total of 
11.4 percent of the patients with biological 
valves experienced valve failure, com¬ 
pared with 4.5 percent of those with 
mechanical valves. J orn leaflets and calci¬ 
fication caused most, or 69 of the 606, 
biological valve failures, with a sharp 
increase occurring six years after replace¬ 
ment surgery. 
At the same time, patients who received 
mechanical valves experienced other com¬ 
plications which were equally serious. 
For example, clotting, leaflet jamming, 
tissue ingrowth and material degradation 
occurred in 26 of the 510 mechanical 
valves. 
"We found that blood clots occurred in 
2.3 percent of all the mechanical valves, 
compared with 0.7 percent in the biologi¬ 
cal valves,” Dr. Hammond reported. 
Heart valve disease is most common 
among adults W'ho had rheumatic or 
scarlet feveras children. Work on refining 
replacement heart valves and in devel¬ 
oping new ones to eliminate problems 




1 he Robert Wood Johnson Foundation 
has granted the School of Medicine 
$1,017,000 to support the Foundation's 
clinical Scholars Program for three addi¬ 
tional years. The gift was made as part of 
the school’s S125 million capital campaign. 
Since its beginning in 1974. the Clinical 
Scholars Program at Yale has provided a 
fellowship period of training for post¬ 
graduate physicians working in clinical 
epidemiology, health care delivery or 
health policy. More than 40 American 
physicians and various foreign visitors 
have attended the program. 
Dr. Alvan R. Feinstein. professor of 
medicine and epidemiology, and Dr. 
Ralph I. Horowitz, associate professor of 
medicine and epidemiology, areco-direc- 
tors of the program. Four new scholars 
are selected each year from about 30 
applicants. They study quantitative clini¬ 
cal epidemiology, attend seminars in 
health policy, delivery and the social 
sciences and conduct research projects 
during the two-year fellowship period. 
OBITUARIES 
Robert Reese Berneike, M.D. 
Dr. Robert R. Berneike, associate clinical 
professor of surgery (urology), died at 
Yale-New Haven Hospital on March 15, 
1986 following a lengthy illness. 
Born in Cleveland, Ohio, on October 
23, 1915, he received a bachelor’s degree 
in 1937 and his medical degree in 1941 
from Case Western Reserve University in 
Cleveland, where he was elected to AOA 
prior to graduation. Dr. Berneike received 
postdoctoral training in surgery and urolo¬ 
gy at the New Haven Hospital and was 
certified by the American Board of Urolo¬ 
gy in 1948. He served on the full-time 
faculty at Yale under Dr. Clyde Deming 
from 1946 to 1949. He then entered the 
private practice of urology which he 
maintained in New Haven from 1949 
until 1983, when he retired. 
He was very active in the clinical 
teaching program at Yale, as well as on 
the staff at both hospitals in New Haven. 
He served as president of the medical 
staff at Yale-New Haven Hospital in 
1968-1969, president of the New Haven 
Medical Association in 1973-1974, and 
president of The New England Section of 
The American Urologic Association in 
1974-1975. He was associate chief of the 
Section Urology at Yale-New Haven Hos¬ 
pital from 1946 to 1963 and was chief of 
chief of the Urologic Service at The 
Hospital of Saint Raphael from 1963 to 
1980. He also was involved in many 
community activities and had been chair¬ 
man of the Board of Education in Wood- 
bridge from 1965 to 1971. 
Gerald Klatskin, M.D. 
Dr. Gerald Klatskin, an internationally 
known liver specialist who was the David 
Paige Smith Professor Emeritus of Medi¬ 
cine, died on Thursday, March 27 at his 
home in Hamden following a lengthy 
illness. He was 75. 
He is survived hy his wife, the former 
Ethelyn Elmer Henry, professor emeritus 
of psychology and pediatrics in the Yale 
Child Study Center; two daughters, Jane 
K. Herner of Santa Barbara, California, 
and Ann Klatskin of New Haven; a son, 
Robert of Los Angeles, California, and 
three grandchildren. 
He was born May 14, 1910 in New 
York City, the son of Archy and Cecelia 
Golub Klatskin. He completed a bache¬ 
lor’s degree in 1929 at Cornell University, 
where he was elected a member of Phi 
Beta Kappa, and received his M.D. degree 
from Cornell Medical College in 1933, 
graduating first in his class. He took his 
internship and residency in medicine at 
New Haven Hospital between 1933 and 
1935 and then went to Rochester, N.Y., 
where he was an intern in surgery and an 
associate resident in medicine at Strong 
Memorial Hospital from 1935-37. He 
was an instructor in medicine at the 
University of Rochester for a year before 
joining the Yale medical faculty in 1937. 
His academic career at Yale was inter¬ 
rupted by World War II, and he served in 
the U.S. Army Medical Corps between 
1942 and 1946, achieving the rank of 
lieutenant colonel. 
When he returned to Yale in 1946, he 
was appointed assistant professor of medi¬ 
cine, a post he held for two years. He was 
then named associate professor of medi¬ 
cine in 1948 and professor in 1957. A year 
later, he became the David Paige Smith 
Professor of Medicine, and then professor 
emeritus in July 1978. 
A member of numerous professional 
organizations. Dr. Klatskin helped found 
the American Association for the Study 
of Liver Diseases in 1948 and served as its 
president in 1957-1958. He served as a 
member of several National Institutes of 
Health committees, including the Gastro¬ 
intestinal Nutrition and Liver Disease 
Training Committee between 1959 and 
1964, and also as a consultant to the 
Surgeon-General’s U.S. Army Medical 
Research and Development Command 
from 1965 to 1975. 
In May 1983, the American Gastroenter¬ 
ological Association awarded Dr. Klat¬ 
skin the Julius Friedenwald Medal, honor¬ 
ing him on the 50th anniversary of his 
distinguished medical career. Among his 
other honors. Dr. Klatskin was presented 
the American College of Physicians’ Mas¬ 
tership and Distinguished Teacher A- 
wards in 1974and 1979, respectively. He 
was a member of Alpha Omega Alpha, 
the national medical honor society, and 
Sigma Xi, the national scientific society. 
At Yale, he was the first recipient of the 
Francis Gilman Blake Award for out¬ 
standing medical student teaching in 1952. 
Dr. Klatskin is best known for his 
contributions to the correlations between 
biochemical and biological abnormalities 
and the clinical features of the diseased 
liver. He was a pioneer in the development 
of liver biopsy techniques and their histo¬ 
logical interpretation, techniques devel¬ 
oped in 1947 that are still used today. He 
and his colleagues accumulated more 
than 50,000 microscopic slides and cor¬ 
related clinical data from nearly 10,000 
liver biopsy specimens. 
His scholarship also encompassed the 
entire spectrum of clinical liver diseases, 
ranging from chronic hepatitis to alcoholic 
liver injury. Dr. Klatskin’s scientific and 
scholarly accomplishments include the 
first demonstration that viral hepatitis 
and the Australian antigen are associated 
with chronic hepatitis. 
He documented the beneficial effects 
of alcohol withdrawal on the natural 
history of alcoholic liver disease. He 
described the prognostic significance of 
acute liver cell injury in hepatitis, devel¬ 
oped evidence for an association between 
the general anesthesic halothan and hepa¬ 
titis, and identified the clinical significance 
of granuloma in liver biopsies. He also 
recognized that certain cancers present as 
a bile duct bifurcation tumor, the so- 
called Klatskin’s tumor, and recognized 
the common association of fever with 
Laennec’s cirrhosis. 
Undoubtedly the greatest beneficiaries 
of Dr. Klatskin’s skills were the 47 postdoc¬ 
toral fellows who came to Yale to train 
with him during the years from 1951 to 
1978. Of these, 34 hold positions in 
academic medicine, 19 are full professors, 
seven have become chairmen of depart¬ 
ments and one is a dean. 
A memorial service was held for Dr. 
Klatskin on June 6, in the Yale Medical 
Historical Library. Contributions in his 
memory may be made to the Yale Liver 
Study Unit, 333 Cedar Street, New Haven, 
CT 06510, or to the charity of one’s 
choice. 
Ira Vaughan Hiscock, M.P.H. 
Dr. Ira V. Hiscock, for many years a 
leader in public health in the United 
States, died April 4, 1986, in Doylestown, 
Pennsylvania. Dr. Hiscock was a member 
of the faculty at Yale University from 
1920 to 1960, retiring as Anna M. Lauder 
Professor of Public Health and chairman 
of the Department of Public Health. 
Dr. Hiscock was born in Farmington, 
Maine in 1892. He received B.A. and 
M.A. degrees from Wesleyan University 
(Connecticut) and the M.P.H. degree 
from Yale University. 
During his career. Dr. Hiscock con¬ 
ducted comprehensive health surveys 
throughout the United States and in 
American Samoa. For many years, he 
was chairman or secretary of expert 
panels of the World Health Organization 
in Geneva, Switzerland. On his retirement 
from Yale, he was awarded a Carnegie 
Visiting Professorship in Public Health 
at the University of Hawaii. 
Dr. Hiscock’s many honors and awards 
included an honorary Doctor of Science 
degree from Wesleyan University and an 
Honorary Doctor of Medicine from the 
Connecticut State Medical Society. The 
American Public Health Association pre¬ 
sented him with the Sedgwick Memorial 
Medal in 1962. His other honors include 
the Public Service Award of the Connecti¬ 
cut Bar Association, the C.-E.A. Winslow 
Award of the Connecticut Public Health 
Association and the Lemuel Shattuck 
Award of the Massachusetts Public 
Health Association. Yale honored him in 
1978 with the dedication of the Ira V. 
Hiscock Library in the Laboratory of 
Epidemiology and Public Health. 
Dr. Hiscock served as president of the 
American Public Health Association, the 
National Health Council, the Associa¬ 
tion of Schools of Public Health and the 
National Society for the Prevention of 
Blindness. He was a veteran of both 
World Wars. In WW II, as a colonel, he 
was chief of Public Health, Civil Affairs 
Division, War Department and was a- 
warded the Legion of Merit. He served 31 
years, with eight years of active duty. 
His published books include: Commun¬ 
ity Health Organization; Public Health 
in Hawaii; District Health Administra¬ 
tion, and Ways to Community Health 
Education. 
Dr. Hiscock is survived by his son, 
William McC. Hiscock, of Baltimore, 
Maryland; his daughter, Margaret H. 
Weatherly, of Mt. Laurel, New Jersey; 
seven grandchildren and onegreatgrand- 
daughter. 
The Ira V. Hiscock Memorial Scholar¬ 
ship Fund has been established in the 
Department of Epidemiology and Public 
Health. Gifts may be made to the fund, 
care of the Yale Public Health Alumnae 




Dr. Petersdorf, ’52, to Head AAMC 
As of September 1986, Robert Peters¬ 
dorf, M.D., ’52, who is vice-chancellor 
for health sciences and dean of the 
University of California, San Diego, 
School of Medicine, will be president 
and chief executive officer of the Associ¬ 
ation of American Medical Colleges in 
Washington, D.C. The AAMC, formed 
in 1876, represents 127 U.S. medical 
schools, more than 400 teaching hospi¬ 
tals, over 70 medical professional socie¬ 
ties, and the U.S. medical students. 
Dr. Petersdorf succeeds Dr. John A. 
Cooper, who is retiring from the posi¬ 
tion he has held since 1969. In com¬ 
menting on the appointment. Dr. 
Cooper praised the selection of Dr. 
Petersdorf, calling him “a longtime 
friend who has an outstanding national 
reputation forstrongand effective lead¬ 
ership in academic medicine. 
“He is a distinguished scientist, a 
superb clinician, who is deeply inter¬ 
ested in medical education and the 
nation's teaching hospitals,” said Dr. 
Cooper. “Dr. Petersdorf is recognized 
as one of the outstanding investigators 
and clinicians in internal medicine and 
infectious diseases in the United States.” 
The newly appointed AAMC presi¬ 
dent has served with a wide variety of 
national organizations. As a member 
of the Accreditation Council for Gradu¬ 
ate Medical Education, he has fought 
for high standards for the residency 
training programs in U.S. hospitals, a 
subject on which he has frequently 
written, and in 1977 -78, he was chair¬ 
man of the AAMC Assembly. He has 
served as president of the American 
Dr. Petersdorf 
College of Physicians, of the Associa¬ 
tion of American Physicians, of the 
Association of Professors of Medicine, 
and as chairman of the Board of Gover¬ 
nors of the American Board oflnternal 
Medicine. He is also a member of the 
Institute of Medicine of the National 
Academy of Sciences. 
Of Dr. Petersdorfs appointment. 
Dr. Virginia Weldon, AAMC chairman 
and deputy vice chancellor for medical 
affairs at Washington University School 
of Medicine, said that “he assumes the 
leadership of the Association at a time 
of great uncertainty for the medical 
profession and for academic medical 
centers in particular. He brings to the 
association a depth of experience in 
medical education, biomedical research 
and patient care that makes him unique¬ 
ly qualified for this role.” 
Dr. Richard Janeway, vice president 
for health affairs and executive dean of 
Bowman Gray School of Medicine and 
AAMC Presidential Search Committee 
chairman, commented, “The nation’s 
medical school and teaching hospitals 
respect Dr. Petersdorfs record of accom¬ 
plishment and his wide ranging experi¬ 
ence and wisdom. He worked his way 
through the medical school academic 
ranks, having been chairman of the 
Department of Medicine at the Univer¬ 
sity of Washington School of Medicine 
at Seattle, a spot he held with distinction 
for 15 years; serving as president of 
Brigham and Women’s Hospital in 
Boston from 1979 to 1981 when he then 
assumed his present responsibilities at 
the University of California, San Di¬ 
ego,” said Dr. Janeway. 
“He is one of the few people in the 
country with outstanding qualifications 
in academics, medical college adminis¬ 
tration and hospital direction, thus 
touching the three major constituent 
parts of the association. This wide 
ranging experience equips Dr. Peters¬ 
dorf well as he assumes the leadership 
of the association.” 
Dr. Petersdorf has been an editor of 
Harrison’s Principles oflnternal Medi¬ 
cine since 1968. He has published over 
300 papers, his chief areas of interest 
having been the pathogenesis, epidemi¬ 
ology, diagnosis and treatment of bacter¬ 
ial infections, including urinary tract 
infections, meningitis, bacterial endocar¬ 
ditis and gram negative bacteremia, 
along with an in-depth study of fever. 
DUKE - YALE 
Conference 
Facing an Era of Upheaval: the 
C hanging Environment of Medical 
Education and Medical Practice 
More than 100 alumni from the Yale and 
Duke classes of 1948, 1949 and 1950 
gathered in April to discuss the profound 
changes in medical care and education 
that have occurred during the last three 
decades. The three-day conference in 
Durham, North Carolina, brought to- 
gethera diverse group of physicians, each 
with 30 to 35 years of practice, research, 
education and administrative experience. 
“It allowed an interesting group of 
leaders in American medicine to assemble 
and provide one another with insights 
into some of the problems we face in 
academic institutions and in society,” 
said Dr. Nicholas P.R. Spinelli, director 
of medical alumni affairs and associate 
clinical professor of medicine, who 
served on the planning committee for the 
conference. 
Dr. An!van 
The meeting, the first of its kind for the 
two institutions, was hosted by Dr. Leon 
E. Rosenberg, dean of the Yale School of 
Medicine, and by Dr. William G. Anlyan 
(Yale med ’49), chancellor for health 
affairs at Duke. Topics ranged from the 
changing criteria for admission to medical 
school to a keynote address focusing on 
the impact of regulation, health main¬ 
tenance organizations and the corporatiza¬ 
tion of medicine. 
The goal, according to Dr. Spinelli, 
was to bring together classmates from a 
mid-20th century era, who now hold a 
variety of positions of authority and 
responsibility. Most of the alumni 
gathered were between the ages of 59 and 
62 and will probably pursue theircurrent 
activities for another five to ten years. 
“Generally speaking, it was a means of 
exchanging information among people 
with the expertise to direct change in the 
future,” said Dr. Spinelli. 
In addition to Dr. Anlyan, Yale medical 
school alumni participating in the confer¬ 
ence included: Drs. Robert G. Petersdorf, 
Paul Talalay, Lewis P. Rowland, Paul 
Goldstein, A|bert Fisk, C. Arden Miller, 
William F. Collins, Jr., Sidney S. Lee, 
Ben Rush and Lyal Asay. Dr. Petersdorf 
delivered the keynote address 
In summing up the conference. Dr. 
Rosenberg noted the enormous opportun¬ 
ities which accompany the dramatic 
changes in medicine today. 
Dr. Rosenberg 
“It is time tor a reaffirmation of the 
responsibility of physicians to serve the 
public, to care for people, and to place 
our clients’needs above our own self-interest,” 
said the dean, who echoed several 
speakers’ comments. “If we are going to 
recover the place that physicians once 
had in our society and that we believe it 
deserves, we must convey to our citizens 
the feeling that when we speak out, we are 
speaking out for them, not for ourselves.” 
CLASS NOTES 
194.1 
A reception to celebrate Rocko Fasa- 
nella’s career in ophthalmology was held 
at the New Haven Lawn Club on May 30. 
Dr. Fasanella noted that he was not 
retiring and that his future activities 
would include consultations, second opin¬ 
ions and office surgery. He also plans to 
do research on blepharospasm in hope of 
finding a more lasting cure and to conduct 
a re-evaluation of Dr. Leon Stone’s classic 
studies on regeneration of the optic nerve. 
1944 
Fulfilling a dream to return to the United 
States and to the Yale School of Medicine, 
Nora Harnden Mason of Cumbria, Eng¬ 
land, did return during the week of 
November 23rd, 1985. Noracameto Yale 
during World War 11 and the blitz, when 
many students in England were trans- 
terred to American schools. 
For her first visit back, she was hosted 
by her classmate, Nick Spinelli, who is 
now director of Alumni Affairs. Nora 
was accompanied by her son. Dr. Robert 
Mason, who is on the junior faculty of 
Guy’s Hospital in London in the Depart¬ 
ment of Surgery, where he is active in 
research involving gastric and pancreatic 
carcinoma. Robert had visited New Haven 
ten years ago as a medical student. 
Three exciting days in New York fol¬ 
lowed, where, beyond revisiting the con¬ 
ventional tourist haunts, visits to the 
United Nations and the Metropolitan 
Opera were much enjoyed. They were 
also guests of Edith Jurka. The group 
then spent three days at the Yale-New 
Haven Medical Center where Barbara 
Kinder (71), associate professor of sur¬ 
gery, provided Robert and Nora with 
inside views of surgery at Yale at the 
present time. Paul Molumphy and his 
wife Ann, assisted in revealing the “new” 
Dr. Mason 
27 
New Haven to Nora, who found both the 
city and the medical school entirely 
changed. 
The Masons left for Boston, where for 
one week, Robert was the guest of Dr. 
Rob Skillman, of Massachusetts General 
Hospital, whom he assisted in gastrointes¬ 
tinal surgery. Nora sends her best wishes 
to all of her classmates whom she regretted 
not seeing. 
1945 
Raymond Gagliardi of Pontiac, M ichigan 
was elected president-elect of the Ameri¬ 
can Roentgen Ray Society at its 86th 
annual meeting in Washington, D.C. in 
April. He has served as the ARRS secre¬ 
tary since 1980 and is an active member 
of the American College of Radiology 
and the Radiological Society of North 
America. Dr. Gagliardi is chief radiologist 
at St. Joseph Mercy Hospital in Pontiac 
and associate professor of clinical radio¬ 
logy at Wayne State University School of 
Medicine. 
The Medical College of Wisconsin pre¬ 
sented its distinguished service award to 
Frederic Blodgett for his contributions to 
the development of rapid protoporphyrin 
quantitation, considered the most accur¬ 
ate method for detecting lead-poisoning. 
In 1984. Dr. Blodgett, professorof pedia¬ 
trics at WCM, received the Job Lewis 
Smith Award from the American Acad¬ 
emy of Pediatrics in recognition of his 
outstanding services to children. 
1946 
Friends and colleagues honored Gerald 
Shattuck on May 1 on the occasion of his 
retirement from his pediatric practice in 
Portsmouth, New Hampshire. It was 
noted that “during his 35 years of practice. 
Dr. Shattuck exemplified the medical 
profession w ith his dedication and profes¬ 
sional commitment to the health and 
welfare of our community.” 
1947 
Franklin Epstein wrote in March: “As 
you know, I left Yale in 1972 to head up 
the Harvard Department of Medicine at 
Boston City Hospital and to become 
director of Harvard's JTiorndike Memori¬ 
al Laboratory at that institution. From 
1973- 1980.1 directed Harvard’s Depart¬ 
ment of Medicine at Beth Israel Hospital 
as the Herrman Blumgart Professor of 
Medicine. Since 1980, I have headed that 
institution’s Division of Nephrology, as 
the William Applebaum Professor of 
Medicine.” 
In December 1985, Dr. Epstein re- 
ved the John P. Peters Award of the 
American Society of Nephrology for "dis¬ 
tinguished contributions to the mechan- 
ii' i'i disease." I he award was presented 
lo him by Thomas Ferris (’56). 
! n addition. Dr Epstein is an associate 
tv: of the Yen England Journal of 
Medicine. “I have just been named presi¬ 
dent of the Mount Desert Island Biologi¬ 
cal Laboratory in Salisbury Cove. Maine,” 
he wrote, “where many Yale people have 
visited and worked." 
1949 
In a recent letter to class agent Dan 
Elliott. George Anderson wrote that he is 
"fully retired after 30 years' of active 
military service (five years WW II and 25 
years USAF), also I I years with the 
Texas Department of Health. Lots of 
travel and activity in such a career — the 
medals and war stories are only the up¬ 
front part of a life of hard work, dedication 
and early retirement. At 53, I started a 
new and second career in public health.” 
He says that his oldest son has followed 
in his footsteps: University of Michigan 
School of Medicine, Tulane School of 
Public Health. USAF training in aero¬ 
space medicine. He is now in the Surgeon 
General’s office in Washington, D.C., a 
colonel with 19 years of active service. 
Dr. Anderson sends his regards to all. 
Dan Elliott has been named president 
elect of the Central Surgical Association, 
an organization whose members are sur¬ 
geons from 16 eastern and midwestern 
states and four Canadian provinces. He 
will take office as president in 1987. 
Dr. Elliott has served as professor and 
chairman of surgery at Wright State 
University School of Medicine since 1976 
and also serves on the active medical 
staffs of Kettering Memorial Hospital 
and Miami Valley Hospital in Dayton. In 
addition to being on the courtesy staffs of 
six other hospitals in Dayton, he is a 
consultant to the Dayton Veterans Admin¬ 
istration Medical Center and the USAF 
Medical Center at Wright-Patterson Air 
Force Base. He lives in Kettering, Ohio. 
Lawrence Shulman has been appointed 
acting director of the new National Insti¬ 
tute of Arthritis and Musculoskeletal and 
Skin Diseases at the National Institutes 
of Health in Bethesda, Maryland. This 
institute has recently been established 
under provisions of the Health Research 
Extension Act of 1985. Dr. Shulman 
joined the staff of the NIH in 1976; he 
previously was on the faculty of The 
Johns Hopkins University School of Med¬ 
icine, where he served as director of the 
Connective Tissue Division in the Depart¬ 
ment of Medicine. 
1950 
Lloyd Felmy has provided some addition¬ 
al information about faculty-student teas 
(Yale Medicine, winter 1986 issue). “1 
enjoyed reading your article on ‘Faculty- 
Student Teas’ very much. Brought back 
memories: both pre-and post- WW1I. I 
was originally a member of the Class of 
'44. However, I dropped out of school to 
enter the Navy; and returned after the 
war to graduate with the Class of ’50. 
“When I came back to school in 1946, 1 
found that the teas had been discontinued. 
Having made the contacts previously, I 
got in touch w ith M rs. Gardner and a few 
of the faculty wives and discussed the 
restarting of the afternoon teas. To finance 
the teas, the Class of ’50 also re-estab¬ 
lished the Aesculapian Frolics: same hav¬ 
ing paid the expenses of the teas before 
the war. We continued the Frolics during 
our tenure at the school. Sorry you 
missed those facts when writing your 
article. Anyway, just thought you'd like 
to know.” 
1966 
Reynold Spector. who is a professor of 
internal medicine and pharmacology at 
the University of Iowa, has been appointed 
the director of the General Clinical Re¬ 
search Center at that institution. Dr. 
Spector joined the Iowa faculty in 1968. 
In 1983-84, he was visiting professor of 
biochemistry at Stanford U niversity where 
he worked in molecular biology. He is a 
member of numerous scientific societies, 
including the American Society for Clini¬ 
cal Investigation and the Association of 
American Physicians. 
1973 
As of March 1. Da\ id Coulter is associate 
professor of pediatrics and neurology 
and director of pediatric neurology at 
Boston University School of Medicine. 
He is also director of pediatric neurology 
at Boston City Hospital. “I came to 
Boston from the University of Texas 
Medical Branch at Galveston, where I 
w'as associate professor of neurology and 
pediatrics. I am primarily interested in 
epilepsy and mental retardation, and as 
of June 1. w ill be president of the Ameri¬ 
can Academy of Mental Retardation. At 
Boston University, 1 will be establishing 
and directing the pediatric epilepsy pro¬ 
gram to provide services to children w ith 
epilepsy and their families. 
"My wife. Mary C. Cetteto. Ph D., is 
executive director of the Accreditation 
Council for Serv ices to Mentally Retarded 
and Developmental^ Disabled Persons. 
The Council’s executive offices are also 
moving to Boston, bringing a national 
perspective on quality assurance in 
MR DD programs to the New England 
area. Mary and I will be living in an old 
Victorian house in Natick." 
1983 
Tufts University’s Alumni Association, 
presented its distinguished service citation 
for faculty excellence to Theoharis C. 
Theoharides. He is assistant professor of 
biochemistry, pharmacology and clinical 
pharmacology, and director of medical 
pharmacology at Tufts. 
Elizabeth Nolan, now working in the 
Emergency Department at Coronado Hos¬ 
pital in Coronado, California, returned 
to Yale for a visit in April, in addition to 
her medical activities in California, she is 
writing fiction and children’s stories. 
Abby Van Voorheesand Jeffrey Chodake- 
witz (’81), were married on April 20 in 
Woodbridge, Connecticut. Both are at 
Yale; Dr. Van Voorhees is a resident in 
dermatology, and Dr. Chodakewitz is a 
fellow in infectious diseases. 
PUBLIC HEALTH 
1983 
William Sabella has recently been ap¬ 
pointed AIDS Education Coordinator 
for the State of Connecticut. 
HOUSE STAFF 
1962 
At a ceremony in May at the Cathedral of 
the Sacred Heart in Newark, New Jersey, 
Dr. Leon G. Smith received papal honors 
and was inducted as a Knight of St. 
Gregory in the Order of St. Gregory the 
Great. Pope Gregory XVI instituted the 
award to honor his subjects for their 
loyalty, piety and virtue in defending the 
Holy See. Director of medicine and chief 
of infectious diseases at St. Michael’s 
Medical Center in Newark, Dr. Smith is 
co-founder with his wife, Margaret, of 
Queen of Angels Family Health Service, 
a voluntary organization that gives medi¬ 
cal aid to indigent residents of Newark. 
Dr. Beeson's Chief Residents Hold Reunion 
Dr. Thomas Ferris, class of ’56 and house staff ’63, sent the above photo with the 
following information: “I am enclosing a picture of the reunion of Paul Beeson’s 
Chief Residents, held in Washington at the time of the clinical meetings. Seated 
from left to right: Phil Bondy, chief of staff. West Haven VAH and professor of 
medicine, Yale; Larry Freedman, professor of medicine, UCLA and chief of 
medicine at Wadsworth VA Hospital; Paul Beeson; Bob Petersdorf, vice chancellor 
of medicine. University of California, San Diego and president-elect of the AAMC; 
Gerry Burrow, professor and chairman of medicine. University of Toronto. 
“Standing: Tom Amatruda, director of medicine, Waterbury Hospital; Sylvester 
Ryan, staff physician, St. Mary’s Hospital, Waterbury; Eli Schimmel, professor of 
medicine, Boston University School of Medicine and chief of medicine, Boston VA 
Hospital; Ken Johnson, staff physician, Benedictine Hospital, Kingston, N.Y.; Jim 
Nolan, professor and chairman of medicine, State University of New York, 
Buffalo; Dick Kahler, staff cardiologist, Scripps Clinic, La Jolla, CA.; Tom Ferris, 
professor and chairman of medicine. University of Minnesota; Herb Lubs, 
professor of genetics, University of Miami Medical School; Hal Conn, professor ot 
of medicine, Yale. 
“I think this picture will bring back memories to many former students and 
housestaff at Yale. It was a memorable occasion for those of us present.” 
IN MEMORIAM 
Louis M. Shapiro, M.D. 
November 6, 1985 
’21 ex med 
Ira V. Hiscock 
April 3, 1986 
’21 M.P.H. 
F. Erwin Tracy, 
April 26, 1985 
’29 M.D. 
A. Philip La France 
April 18, 1985 
’31 M.D. 
Ival A. Merchant 
December 16, 1985 
’34 M.P.H. 
Graham C. Newbury 
December 22, 1985 
’35 M.D. 
Prof. William W. Walcott 
February 23, 1986 
’38 ex med 
John A. Murtagh, M.D. 
January 15, 1986 
’38 H.S. 
Roderick Macdonald, M.D. 
July 27, 1985 
’42 H.S. 
Ashley Pond 111 
March 17, 1986 
’33 M.D. 
Robert Lee Taylor 
November 13, 1985 
’43 M.D. 
Robert R. Berneike, M.D. 
March 15, 1986 
’46 H.S. 
John P. Dowling 
September 29, 1985 
’56 M.P.H. 
Hugo Saenz Noguerol, M.D 
March 29, 1986 
.’59 M.P.H. 
Bernhard H. Lisker 




In May, 1985 The Campaign for the Yale School of Medicine 
was formally launched. A t that time, S32 million in gifts and 
pledges had been raised toward the $125 million campaign goal. 
School officials are exceptionally pleased to announce that the 
campaign total now stands at more than $84 million — a $52 
million increase in the past year (see progress report summary). 
This progress is encouraging, but the task that remains is 
formidable. Only 23 percent of the endowment goal of $59 
million has been achieved, and an even smaller percentage of the 
funds needed for the renovation of laboratories is in hand. 
During the coming year, campaign volunteers will focus more of 
their efforts upon contacting medical alumni and parents for 
major gifts to the campaign. 
Kingsley Fellowship Endowment Announced 
The Francis G. Kingsley Memorial Fellow¬ 
ship Fund has been established in the 
School of Medicine to honor a longtime 
friend of the school. The fellowship is the 
result of gifts from family and friends of 
Mr. Kingsley, including 5500,000 each 
from Milliken and Company, and Mercan¬ 
tile Stores Company. At the time of his 
death in January, Mr. Kingsley was an 
officer and director of each company. 
A graduate of Syracuse University and 
the Tondon School of Economics, Mr. 
Kingsley was first employed by Mercantile 
in 1932, and became president of the 
department store chain two years later. 
In 1941, he joined Milliken and Com¬ 
pany, textile manufacturers, and was 
named chairman of Mercantile. In addi¬ 
tion to these major corporate duties, he 
served as financial advisor to the Manhat¬ 
tan Project, which was responsible for 
the design and assembly of the first 
atomic bomb. 
H is special interest in the school began 
when his daughter. Ora Kingsley Smith, 
M.D. '53, enrolled in the School of 
Medicine. She is an associate fellow of 
the John B. Pierce Foundation, an affiliate 
of Yale University. 
The Kingsley Fellowship will be 
awarded to young investigators at Yale 
whose research shows great promise. 
Awards will be for one to three years, and 
are not restricted to a specific department 
or discipline. 
Dean Leon E. Rosenberg, who will be 
responsible for the final selection of Kings¬ 
ley Fellows, stressed the Fellowship's 
potential to advance medical knowledge. 
"Since most funding is based on a physi¬ 
cian's record of achievement, junior facul¬ 
ty members rarely have adequate support 
for their own research. Often, the most 
talented young scientists are relegated to 
an assistant’s role in projects directed by 
more senior faculty members. This is 
unfortunate, because it delays the pursuit 
of personal research interests at a time 
when the outstanding young physician is 
especially energetic, creative and enthusi¬ 
astic. The Kingsley Fellowship addresses 
this problem head-on.” 
The late Francis G. Kingsley 
Lionel .I.M.Delevingne 
Tax Reform and the 
Campaign for the Yale 
School of Medicine 
The U.S. Senate’s passage ot a tax- 
reform bill is intended to reduce the tax 
rates for most Americans, while elimin¬ 
ating many deductions. Both House and 
Senate versions of the bill preserve the 
deduction for charitable contributions 
but, if enacted, the bill should create 
additional incentives to make charitable 
gifts before December 31, 1986. This is 
because the reduction in tax rates increases 
the after-tax costs of making gifts. 
For example, a $10,000 donor in the 
50 percent bracket has an after-tax cost 
of $5,000 for that gift ($10,000 minus 
$5,000 credit for deduction). If that 
donor’s tax bracket is reduced to 30 
percent, a likely compromise between the 
two bills, the after tax cost of the same 
gift rises to $7,000 ($10,000 minus $3,000 
credit for deduction). 
The Campaign for the School oi Medi¬ 
cine is a five-year effort because it will 
take that long to reach all alumni and 
friends in a personal and effective way. If 
you wish to give to the campaign this year 
due to tax considerations and have not 
yet been contacted, please write or call 
the Office of Medical Development for 
more information. 
Frank A. Sprole, Y.C. '42, of New York 
has been named co-chairman of The 
Campaign for the Yale School of Medi¬ 
cine Volunteer Committee. Mr. Sprole, 
who is also chairman of Special Gifts for 
the 45th Reunion of the Class of ’42, has 
recently retired as vice-chairman of the 
board of Bristol-Myers company, where 
he spent most of his professional career. 
He currently serves as a director of The 
Bristol-Myers Fund, Inc. 
PROGRESS REPORT SUMMARY 
As of May 31, 1986 
Outstanding 
Received Pledges Total 
Building $ 5,874,812 $ 24,476,007 $ 30,350,819 
Endowment $ 6,789,109 $ 7,358.376 $ 14,147,485 
Equipment $ 616,963 $ 0 $ 616,963 
Loan Funds $ 479,793 $ 0 $ 479,793 
Research $ 23,433,155 $ 13,456,298 $ 36,889,453 
Various $ 1,024,320 $ 0 $ 1,024,320 
Operations $ 706,062 $ 0 $ 706,062 




Corporations $ 7,379,523 $ 5,669,192 $ 13,048,715 
Foundations $ 13,723,051 $ 8,392,951 $ 22,116,002 
Individuals $ 9,343,655 $ 13,900,945 $ 23,244,600 
Other $ 8,477,985 $ 17,327,593 $ 25,805,578 
TOTAL $38,924,214 $ 45,290,681 $ 84,214,895 
As the School of Medicine moves to 
expand its fund-raising capabilities, a 
new addition to the Office of Development 
staff is Will Melton. A graduate of the 
University of Virginia, Mr. Melton comes 
to Yale from Northfield Mount Hermon 
School, where he served as development 
director for six years and had oversight of 
that school's successful $10 million capital 
campaign. 
His duties will include organizing the 
solicitation of medical alumni for the 
Campaign for the Yale School of Medi¬ 
cine, and making alumni more aware of 
creative ways to help the school through 
life income trusts and gifts of real estate 
or other highly appreciated property. 
The Office of Medical Development 
solicits gifts and grants for endowment, 
facilities and non-governmental research 
funds for the School of Medicine. The 
Medical School Alumni Fund, a separate 
entity, conducts the annual giving pro¬ 
gram to provide funds for student aid. 
The address of the Office of Medical 
Development is: 350 Congress Avenue, 
3C, New Haven, CT 06519; telephone 
(203) 785-4420. 
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CLASS OF 1986 Residency Positions 
CALIFORNIA 
Harbor-UCLA Medical Center, Torrance 
Cynthia Dyess, Surgery 
Joe Kurosu, Transitional 
Stanford University Hospital 
Richard Gates, General Surgery 
UCLA Neuropsychiatric Institute, 
Los Angeles 
Kimberli McCallum, Psychiatry 
University of California Hospitals, 
San Francisco 
Sophie Cole, Internal Medicine 
Gerard Doherty, General Surgery 
Liangge Hsu, Medicine 
Bruce Jacobson, Surgery 
David Kaku, Internal Medicine 
Clinton Lindo, Internal Medicine 
Mary Nakamura, Internal Medicine 
Louise Sanematsu, Pediatrics 
Chris Takimoto, Internal Medicine 
University of California San Diego 
Affiliated Hospitals 
Daniel Fierer, Internal Medicine 
COLORADO 
University of Colorado Affiliated 
Hospitals, Denver 
Gail Mizner, Medicine 
llena Norton, Psychiatry 
Andrew Steele, Internal Medicine 
CONNECTICUT 
Danbury Hospital 
Amanda Dill, Internal Medicine 
Mount Sinai Hospital, Hartford 
Dae Song, Medicine 
St. Vincent’s Medical Center, Bridgeport 
Eric Bernstein, Transitional 
Vale-New Haven Medii Center 
Catharine Arnold, In nal Medicine 
William Esterline, General Surgery 
David Frank, Internal Medicine 
James Goldenring, General Surgery 
Cynthia Hall, Obstetrics & Gynecology 
Jacqueline Hodge, Pediatrics 
Stacey Mandelbaum, Obstetrics 
Gynecology 
Timothy McGowen, Orthopedic Surgery 
Lynne Perry, Internal Medicine 
Steven Peterec, Pediatrics 
Paula Rackoff, Internal Medicine 
Donald Reich, Psychiatry 
Ernesto Roederer, Psychiatry 
Marcus Walker, Psychiatry 
Julia Whiteside, Medicine 
FLORIDA 
Jackson Memorial Hospital, Miami 
Richard Bridgewater, General Surgery 
ILLINOIS 
McGaw Medical Center- 
Northwestern University, Chicago 
Richard Lewis, Medicine 
Benjamin Li, General Surgery 
MAINE 
Maine Medical Center, Portland 
Barbara Harvey, Internal Medicine 
1 wrence Sampson, General Surgery 
MARYLAND 
Francis Scott Key Medical Center, 
Baltimore 
Robert Study, Internal Medicine 
Johns Hopkins Hospital, Baltimore 
Raymond Chung, Internal Medicine 
Mary Greene, Pediatrics 
Univeristy of Maryland Hospital, 
Baltimore 
Young Kim, Internal Medicine 
MASSACHUSETTS 
Boston I niversity Affdiated Hospitals, 
Boston 
Danilo Castro, General Surgery 
Brigham and Women's Hospital, Boston 
Laird Madison, Internal Medicine 
Matthew Moore, Surgery 
Gregory Orloff, Internal Medicine 
Kimberlee, Sorem, Obstetrics 
& Gyneology 
Cambridge Hospital 
Roberto Lewis-Fernandez, Transitional 
Children's Hospital, Boston 
Jonathan Alpert, Pediatrics 
Stephen Roth, Pediatrics 
Massachusetts General Hospital, Boston 
Michael Grossbard, Internal Medicine 
Thomas Lynch, Internal Medicine 
Mount Auburn Hospital, Cambridge 
George Sachs, Medicine 
New England Deaconess Hospital, Boston 
Samir Bhatt, Surgery 
New England Medical Center Hospital, 
Boston 
Dory Altmann, Internal Medicine 
John Wysolmerski, Internal Medicine 
MICHIGAN 
University of Michigan Affiliated Hospital, 
Ann Arbor 
Paul Wang, Pediatrics 
MINNESOTA 
University of Minnesota Hospitals, 
Minneapolis 
Jeremy Holtzman, Internal Medicine 
Robert Kinney, Internal Medicine 
Brian Lombardo, Family Practice 
Steven Waisbren, General Surgery 
MISSOURI 
Barnes Hospital, St. Louis 
Gary Shapira, Pathology 
NEW JERSEY 
St. Barnabas Medical Center, Livingston 
Betty Klein, Transitional 
Maxine Spicer, Obstetrics & Gynecology 
NEW YORK 
Beth Israel Hospital, New York 
Gary Hirshfield, Medicine 
Columbia-Presbyterian Hospital, New York 
Margaret Alexander, Surgery 
Long Island Jewish Medical Center, 
New Hyde Park 
Glenn Faust, General Surgery 
Nassau Hospital, Mineola 
Young Kang, Medicine 
New York University Medical Center, 
New York 
Paul DeRenzi, Internal Medicine 
Mark Lipian, Pediatrics 
Jeffrey Schneider, Internal Medicine 
Roosevelt Hospital, New York 
Michael Sherman, General Surgery 
State University Of New York- 
Kings County Hospital, Brooklyn 
Alfred Harrington, Pediatrics 
The New York Hospital, New York 
W. Lee Bailey, Internal Medicine 
Paul Chang. Internal Medicine 
Andrew Costin, Internal Medicine 
Manuel Litchman, Internal Medicine 
University of Rochester Associated 
Hospital Programs, Rochester 
Miriam Tatum, Pediatrics 
W ilson Hospital, Johnson City 
Reginald Windom, Transitional 
NORTH CAROLINA 
Duke University Medical Center, Durham 
Raymond Cuevo, Internal Medicine 
Ronald Weigel, General Surgery 
OREGON 
Oregon Health Sciences University, Portland 
Sean Jones, Medicine 
Lisa Yee, General Surgery 
PENNSYLVANIA 
Abington Memorial Hospital, Abington 
Bethanne Moore-Sanders, Medicine 
Bryn Mawr Hospital 
Eric Suan, Medicine 
Hospital of the I’niversity of Pennsylvania, 
Philadelphia 
Jeffrey Carpenter, General Surgery 
Hospitals of the University Health Center 
of Pittsburgh 
David Atkins. Internal Medicine 
John Detre, Internal Medicine 
Temple University Hospital, Philadelphia 
Andrew Conn, Internal Medicine 
RHODE ISLAND 
Miriam Hospital, Providence 
Andrea Stone, Medicine 
Rhode Island Hospital, Providence 
Antoinette Lloyd, Internal Medicine 
TENNESSEE 
Vanderbilt University Hospital, Nashville 
Allen Ries, Internal Medicine 
TEXAS 
Baylor College of Medicine 
Affiliated Hospitals, Houston 
Duncan Fischer, Surgery 
University of Texas Southwestern 
Affiliated Hospitals, Dallas 
Mahesh Shrestha, Internal Medicine 
VERMONT 
Medical Center Hospital of Vermont, 
Burlington 
Michael Miller, General Surgery 
WASHINGTON 
University of Washington 
Affiliated Hospitals, Seattle 
Richard Gibbs, Family Practice 
Elizabeth Plotkin, Medicine 
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YJB&M OBSERVES 
60 YEARS OF PUBLICATION 
What makes the Yale School of Medicine special? The Yale Sys¬ 
tem? The thesis requirement? An outstanding study body work¬ 
ing with a superior faculty? 
All of these exceptional features characterize Yale, says Dr. 
Philip K. Bondy, associate dean for the Veterans Administra¬ 
tion Medical Center. To them he adds another: The Yale Journal 
of Biology and Medicine. 
Yale is the only American school that offers students an op¬ 
portunity to edit and publish an internationally recognized jour¬ 
nal of medical science, says Dr. Bondy, the Journal’s editor-in- 
chief. 
In 1987, the Journal will celebrate its 60th year of publica¬ 
tion, and yet another group of first-year medical and graduate 
students will join the board of editors to be introduced to the 
medical publishing world. 
Over the years, the Journal’s contents have reflected the con¬ 
tinuity of medical investigation. The first issue, which appeared 
in October 1928, included a paper by Dr. James D. Trask, 
professor of pediatrics, on “Comparative Immunology in 
Pediatrics.” 
Sixty years later, the Journal will publish the American Col¬ 
lege of Epidemiology’s tribute to Dr. Alfreds. Evans, the John 
Rodman Paul Professor of Epidemiology who also served as a 
Journal editor-in-chief. The issue will once again discuss recent 
advances in pediatric immunology. 
In its first year of publication, the Journal presented papers 
on infectious diseases, embryology, nutritional deficiency dis¬ 
eases, community health, trauma, medical history and cancer. 
The material published today continues to cover the breadth of 
the past, although the level of sophistication has changed. 
MANUSCRIPT REVIEW 
The Journal’s long life can be attributed, in part, to the continu¬ 
ing dedication of successive generations of Yale medical stu¬ 
dents and faculty, according to Dr. Bondy. The task of review¬ 
ing manuscripts and readying them for publication is handled 
by the editorial board of 30 student editors and nine faculty as¬ 
sociate editors. Each December, eight to 14 apprentice student 
editors are chosen through a competition. At the end of the 
spring semester, if they have fulfilled the requirements of re¬ 
viewing assigned manuscripts and submitting one or two writ¬ 
ten book reviews, most usually become full-fledged board 
members. 
Although this seems simple enough, a strict adherence to 
deadlines and meeting attendance is required. According to Dr. 
Bondy, the selection process is unquestionably elitist, which is 
appropriate, because it recruits outstanding students. Proof of 
this is the unusually high proportion of prizes garnered by the 
Journal’s student editors each year at commencement. In 1986, 
for example, 14 awards were presented to seven of the nine 
graduating members of the Journal board. Two weeks earlier, 
at student research day, three of these same students were 
awarded prizes from only five presented. 
The Yale Journal of 
'Biology and YMedicine 
The Yale Journal 
of Biology & Medicine 
The Yale Journal of 
Biology & Medicine 
ACADEMIC PRESS 
New York and London 
Through the years, Yale Journal readers have seen graphic design 
changes. Early volumes featured a silhouette of Dr. Nathan Smith, 
professor of the theory and practice of physic, surgery and obstetrics 
when the Medical Institution of Yale College opened in 1813. Recent 
covers use different typographical elements to present the scholarly 
articles and book reviews. 
What advantage does a student on the editorial board have be¬ 
sides seeing his or her name on the masthead six times a year? 
Although the majority of the student editors are candidates for 
the medical degree, some are enrolled in the combined M.D.- 
Ph.D. program and others are working toward the Ph.D. in 
epidemiology or one of the basic sciences. They quickly learn 
to sharpen their critical skills as they evaluate submitted manu¬ 
scripts. 
Every paper is reviewed jointly by a student editor and a fac¬ 
ulty member recommended by the entire board. This can be one 
of the faculty associate editors, but more often than not it is 
someone selected from the medical school at large. It occasion¬ 
ally becomes necessary for the faculty reviewer to temper the 
tone of the student’s review, although most of the time they 
1 
agree. This close collaboration between the student and faculty 
expert is one of the major benefits of editorial board member¬ 
ship. It often results in a newfound friendship. 
After the student editor and faculty reviewer have met and 
thoroughly evaluated each manuscript, the student presents his 
or her findings to the board, which meets twice a month over 
lunch in the Beaumont Room. After the presentation, the papers 
are openly discussed, and the entire board decides whether or 
not to publish the article. Although this first such session can 
be a traumatic experience for the neophyte reviewer, it soon be¬ 
comes second nature. 
Approximately four years ago, the board of editors formed 
an executive committee. This began as the brainchild of student 
editors Mariano Garcia-Bianco and Duncan Fischer, and now 
it meets a few times a year to discuss and resolve Journal affairs 
and editorial problems. Three students meet with the managing 
editor and three faculty editors, and through this experience all 
learn about publishing stages—from author to reviewer to copy 
editor to press to final product. They also get a taste of market¬ 
ing, promotion and sales. Thus, the Yale Journal of Biology and 
Medicine, in addition to teaching the students good scientific 
writing and editing skills, acquaints them with the business side 
of journal publishing. 
Currently, the Journal’s board of editors includes these stu¬ 
dents: Craig Basson, Jennifer F. Bock, Jonathan A. Borden, 
Maureen E. Brady, Robert K. Brown, David Chelmow, Chieh- 
Min Fan, James M. Ford, Louis Glazer, Subba Rao Gollamudi, 
Laurence A. Greenbaum, Andrew Griffith, Stephen B. Gruber, 
Sunil Hingorani, Paul A. Khavari, Marc Levesque, Peggy M. 
Liao, Lewis Lipsey, Elan D. Louis, Michael Mockovak, John 
W. Mott, Sina Nasri-Chenijani, Kenneth E. Newhouse, Lisa 
Ragen, Tarik M. Ramahi, Henry Rice, Seth Rosenthal, Sally 
Wade, Greg M. Yarrington and Hedayatollah Zaghi. 
Dr. Emile L. Boulpaep, professor and chairman of the De¬ 
partment of Physiology, is deputy editor-in-chief. Other faculty 
members who serve as associate editors are: Robert S. Balti¬ 
more, Priscilla S. Dannies, Stephen C. Edberg, James F. Jekel, 
G.J. Walker Smith, JohnT. Stitt and Arthur J. Viseltear. 
Suzanne Lande is the publisher/managing editor; Rose 
Jacobowitz is copy/production editor. 
TOPICS 
During the past eight years, the Journal has concentrated on 
publishing proceedings of international symposia. Some of the 
more recent topics covered are schizophrenia, Lyme disease, 
mycopiasmology and pediatric critical care. 
For the first time in its history, the Journal, in co-operation 
with the Section of Rheumatology, co-sponsored “The First In¬ 
ternational Symposium on Lyme Disease.” Two of the student 
editors were among the five guest co-editors of the resulting 
July-August 1984 issue, which subsequently was republished in 
hardback and is still selling briskly. In 1983, the Journal pub¬ 
lished “Current Insights in Mycopiasmology,” which resulted 
in a tome of more than 600 pages—an entire year’s pages in one 
issue. Other symposium issues have been redone in book form 
and sold worldwide. 
For years, the Journal has celebrated the careers of notable 
Yale medical faculty with festschrift issues in their honor. Dr. 
Bondy says. Recent issues include tributes to Drs. Dorothy 
Horstmann, Elisha Atkins, Aaron Lemer and the late Gerald 
Klatskin. In preparation for spring 1987 is a symposium issue 
to honor Dr. Gilbert H. Glaser. 
All of these activities have kept the Journal active and 
healthy. In recognizing its contributions to Yale medical educa¬ 
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tion. Dr. Robert H. Gifford, associate dean for medical educa¬ 
tion and student affairs, has agreed to consider membership on 
the Journal’s editorial board as an elective in the medical school 
curriculum. 
The Journal welcomes this formal recognition of excellence 
and the high caliber of its contribution to a Yale medical educa¬ 
tion. It accepts the additional responsibilities associated with 
becoming a recognized element of the course of study. Dr. 
Bondy says. “We have every confidence that the basic nature 
of this unique Yale enterprise will not wilt under the academic 
burden. It will continue to be a collegial and congenial group. 
Its special nature will survive.” 
But the proof of any publication is in the reading. The Jour¬ 
nal’s success is reflected in its widely distributed readership, 
mostly to medical libraries scattered throughout 40 countries on 
six continents. Libraries in 13 Third World countries subscribe, 
as well as seven in the Eastern Block, including the People’s 
Republic of China, the USSR and Czechoslovakia. The Yale 
medical word reaches the entire globe. 
The Journal welcomes additional support from Yale medical 
alumni and invites individual subscriptions. Thus, future gener¬ 
ations of Yale medical students will be able to benefit from the 
special medical publishing opportunities the Journal offers the 
Yale community. 
STUDENT EDITORS LAUD 
JOURNAL EXPERIENCES 
My student editor experience precipitated valuable interactions 
with some of Yale’s preeminent medical scholars. More 
often than not, what started as a meeting to discuss a 
manuscript with an esteemed professor developed into a 
valuable dialogue on topics sometimes scientific, sometimes 
philosophical and sometimes just interesting. 
Harris Pastides, Ph.D. ’80 
Epidemiology and Public Health 
Seeing my own work in print, in the form of published book 
reviews, and seeing the impact of my work in revised 
manuscripts was a source of enormous pride to me. The 
experience of critically analyzing research design and 
presentation formed an emerging desire to pursue a career 
in research and academics....My memories, then, are grateful 
ones—among the unique educational opportunities offered 
at Yale, the Journal is one of the best! 
Kathleen A. Nolan, M.D. ’82 
Working on the Journal allowed meaningful contact with 
clinical and research faculty in diverse disciplines. My 
involvement with symposia and serving on the executive 
committee provided some problem-solving challenges that 
were unlike most of my medical school responsibilities. 
Robert W. Arnold, M.D. '84 
Not only was my experience as a student editor one of my 
most rewarding experiences as a medical student, in terms 
of learning scientific material and interacting with very 
knowledgeable faculty members, but it was also a considerable 
amount of fun. 
Duncan K. Fischer, M.D., Ph.D. ’86 
THE YALE SYSTEM 
THE EARLY YEARS 
by Arthur J. Viseltear, Ph.D. 
“Time dissipates into shining ether the solid angularity of 
facts”. 
Ralph Waldo Emerson, 1841 
The Yale System—or plan, or philosophy, or program—is 
most closely associated with Milton Wintemitz, dean of the 
school from 1920 to 1935. Wintemitz's portrait is displayed 
next to the dean’s office. I invite you to see it, for it was Winter- 
nitz and his predecessor, George Blumer, who began the pro¬ 
cess that brought Yale to the front rank of medical schools in 
the United States. 
Many changes have occurred at Yale since the School of 
Medicine opened in 1813 as the Medical Institution of Yale Col¬ 
lege. Throughout the 19th century, distinguished faculty taught 
here and much was accomplished, but money was scarce, and 
the single building housing the school was “uninspired and 
obsolete.” 
In the 19th and early 20th centuries, medical education was 
primarily lectures and demonstrations. Medical schools, with 
rare exceptions, were only steps above grammar schools. By the 
early 20th century not much had changed, except that entrance 
requirements at Yale were stiffened to include at least two years 
in college and not just a high school or preparatory school 
diploma. 
Blumer and Wintemitz looked at the state of affairs—as had 
Lewellys Barker at Hopkins, William Pepper at Pennsylvania, 
Charles Eliot at Harvard and James Angell Sr. at Michigan— 
and said it was all wrong. Medical schools, including Yale, 
needed more science, fewer didactic lectures, better students, 
additional laboratories and more money. 
Abraham Flexner studied early Yale in 1909 and concluded 
that its medical school was at a crossroad. To bring the medical 
school into the front rank of schools, he wrote, Yale needed en¬ 
dowment, closer ties to a hospital, additional basic science and 
clinical laboratories and a full-time faculty. Thanks to George 
Blumer, the support of Yale’s president and corporation, and 
gifts from the Rockefeller Foundation and private donors, Yale 
achieved these goals; but, although standing at the threshold, 
something else was needed, and that something else had to do 
with the curriculum. 
PEDAGOGIC EXPERIMENTS 
Wintemitz thought about a modern Yale and initiated discus¬ 
sions that led to “pedagogic experiments”—experiments that 
ultimately formed the basis of the Yale Plan—each designed to 
Dr. Viseltear, associate professor of the history of medicine and 
public health, presented this report to the Medical School Council 
on Oct. 2. “The Yale Plan of Medical Education: The Early Years” 
will appear in its entirety in the November-December 1986 issue of 
the Yale Journal of Biology and Medicine. 
give Yale’s medical school “personality,” “individuality,” 
something that would make medical educators sit up and “take 
notice.” 
The basic and clinical sciences had advanced in the late 19th 
and early 20th centuries with great speed, and the temptation 
was for professors to continue to add to their courses without 
discarding older parts and without periodically reorganizing 
each course to correspond to the new developments in each 
science. 
Professor F.P Underhill, chairman of Yale’s Curriculum 
Committee, reported in 1922 that the student had become “the 
defenseless recipient of an overwhelming mass of facts which 
he may or may not be able to correlate.” Regarding professors, 
Underhill wrote, “In their enthusiasm for teaching [their own 
subjects] there is the decided tendency [for each professor] to 
over-teach—to expect the students to become in turn a finished 
anatomist, physiologist or pathologist. ” 
Underhill believed that a curriculum so arranged discouraged 
initiative and independence and filled the students with required 
work, leaving no free time for electives, independent research, 
reading in the library or contemplation. Wintemitz accepted 
Underhill’s conclusions and, in the early 1920s, recommended 
that the number of course hours be reduced by more than 1,200 
hours—one full year. Electives were substituted for required 
courses, a change that Wintemitz believed would “permit stu¬ 
dents to exercise their individuality,” to pace themselves and 
to try things out. 
A second pedagogic experiment, the M.D. thesis, in exis¬ 
tence at Yale since the mid-19th century, was reaffirmed. With 
more time available, more opportunities for basic and clinical 
science, Wintemitz reasoned that there would be a “premium 
on research” and, with proper faculty supervision, student 
theses would become truly valuable educational experiences. 
A third principle of the plan was a belief that the Yale medical 
school should be a graduate school and that students need not 
be “spoon-fed.” The memorization of “a mass of facts,” said 
Yale System advocates, was far less important than a well- 
rounded education in fundamental principles, training in 
methods of investigation, and above all, the acquisition of the 
scientific habit of mind, all of which could be achieved if the 
medical school were a graduate school. 
Students would no longer be regimented, but instead would 
attend lectures, enroll in electives, prepare their M.D. theses, 
and when ready, sit for two comprehensive examinations. As 
students were to advance at their own paces, it mattered not to 
the faculty if students took their qualifying examinations after 
one year or after three years. All that mattered was that students, 
treated now as adults, would make their own decisions. 
The examinations, designed and administered by a Yale com¬ 
mittee of basic scientists and clinicians, were comprehensive 
and difficult, having been based on examinations for member¬ 
ship in the Royal College of Physicians and the tripos given at 
Oxford and Cambridge. Indeed, it was even recommended that 
examiners be selected from schools other than Yale, to assure 
that the examinations would be truly extramural. 
The comprehensive examinations were given three or four 
times during the year and were in four parts: short and long an- 
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swer questions, an essay (which lasted only a year as it proved 
too difficult for the faculty to grade), a practical (substituted for 
the essay) and an oral. The examinations introduced in 1927 and 
evaluated in 1929 revealed that, of the 160 students sitting for 
the exams in this two-year period, 120 (or 75 percent) had 
passed and 40 failed. Of the 40 failing, 10 passed the second 
time around and 12 flunked out. Seventeen took the exam yet 
a third time, but the Board of Permanent Officers’ records are 
fuzzy regarding the fates of these students. 
CONTROVERSY 
The Yale System was studied and restudied in the early years. 
Special committees of the faculty looked at the plan throughout 
the 1930s and in the years during and immediately following 
World War II. There was much discussion, similar in many 
ways to the discussions that took place in 1985-86. As may well 
be expected, some believed in the plan, others wished to modify 
it, and another group regarded it with disdain or indifference. 
Samuel Harvey, chairman of Yale’s Department of Surgery 
for almost two decades, strongly supported the plan. In a 1941 
paper, Harvey presented his ideas on medical education in gen¬ 
eral and the Yale Plan in particular. Harvey believed that the im¬ 
portant qualities for student physicians were integrity, intelli¬ 
gence, capacity for work, and judgment and skill in using the 
scientific method, none of which, he believed, could be taught 
in lectures. 
Give students examinations in courses and check attendance, 
and you defeat the purposes of graduate education, he said. Stu¬ 
dents learned on their own; they learned in the lab; they learned 
from each other; they learned in small groups. Students also 
learned by being led to the literature, which they would absorb 
themselves. This was a better idea than having it “eructated by 
the teacher whose ruminative assistance [would] not be avail¬ 
able for them in [their] future life. ” 
"Medical education,’’ Harvey concluded, “was a continuing 
process of growth..., a sensitive process, for the most part auto- 
catalytic, which responded most favorably to a proper environ¬ 
ment,” an environment that Harvey and like-minded colleagues 
believed should be based on small group teaching and indepen¬ 
dent research, the absence of course examinations (“which dis¬ 
couraged the proper type of study”), an emphasis on electives, 
and the close relationship of students with faculty who pos¬ 
sessed uncommon capacity for initiating and sustaining first- 
rate work. 
The Yale System also had opponents. The common, recur¬ 
ring complaint was that the system was faculty intensive. Small 
group teaching and the M.D. thesis were considered valuable, 
but took faculty away from their own research. The comprehen¬ 
sive examinations also were considered inappropriate. Winter- 
nitz wanted the examinations to be written by Yale faculty from 
both the basic science and the clinical departments, but agreed 
to accept the external National Board Examinations in 1932 
when his faculty complained that preparing and administering 
the internal exam was difficult and intruded into their primary 
responsibilities for teaching, service and research. 
Five years later, after the faculty found that almost all (99.4 
percent) of the students sitting for the external National Board 
Examination had passed, they voted to restore to the faculty the 
responsibility for preparing internal exams. If there were a com¬ 
prehensive exam, they argued, Yale should be responsible for 
evaluating its own students. This policy remained in effect until 
1942, when, owing to the exigencies of World War II, the exams 
of the National Board were once again substituted for Yale’s 
comprehensives. 
Other faculty evaluators reviewed the original objectives of 
the exam and concluded that both the Yale and National Board 
exams were less than optimum. Both tested only discrete sub¬ 
jects and cognate disciplines and, as such, did not permit stu¬ 
dents to “correlate their knowledge”; nor were the exams de¬ 
signed to be “integrative,” as they were intended, serving the 
important purpose of revealing to students “the essential unity” 
or synergy of basic science courses with each other and with the 
clinical years. 
Equally distressing was the fate of those students who did not 
pass Yale’s comprehensive exam. Did Yale have a continuing 
responsibility for such students? Some said “yes”; others said 
“no.” 
REAFFIRMATION OF PLAN 
Despite the ambiguous conclusions of the evaluation commit¬ 
tees and the occasional faculty polarization regarding the com¬ 
prehensive exams, each element comprising the Yale System— 
small-group teaching, electives, comprehensive examinations 
prepared and administered either by a committee composed of 
Yale faculty or by the National Board, the absence of individual 
course examinations, the M.D. thesis, the spirit of a graduate 
school, the acceptance of the principle that Yale medical stu¬ 
dents were adults—remained intact, was institutionalized, 
legitimized, and in the early years, reaffirmed by both the facul¬ 
ty and Wintemitz’s successors. Stanhope Bayne-Jones, Francis 
Gilman Blake andC.N.H. Long. 
The basic elements of the Yale Plan did not change in the 
early years because the social contract between faculty and stu¬ 
dents had not changed. As originally set forth in the Curriculum 
Committee report of 1928: 
“Fundamental to [the Yale Plan] is the concept that the 
medical student is a mature individual, is strongly moti¬ 
vated to learn and requires guidance and stimulation 
rather than compulsion or competition for relative standing 
in his group. Equally basic is the concept that if [students 
are] given unusual privileges [they] must assume more 
than usual responsibility for [their] education.” 
And, as Francis Gilman Blake wrote in 1941, the principal 
element in the Yale Plan was: 
“the too often overlooked fact that [medical students 
are adults] already embarked upon [their] own life’s 
work and the obvious corollary that [students] must 
learn both to pilot [their] own boat and assure to a large 
extent the responsibility for acquiring that content of 
knowledge which is necessary for [them] in charting 
[their] future professional course.” 
I submit that it is this social contract—which, in the early 
years, was and remains now in part responsible for Yale’s essen¬ 
tial character—that is the ethos of the Yale Plan. 
As we review our past traditions and legacies in the light of 
present needs and concerns, it is important to remember that the 
Yale System, which has evolved for more that 60 years, been 
modified and fine-tuned but never abandoned, remains the dis¬ 
tinguishing feature of Yale medicine. 
Pedagogic experiments, faculty and administrators, curricula 
revisions, courses, departments, sections and institutes have 
come and gone; but the Yale System remains the essential ele¬ 
ment in the mix of ingredients that has made the Yale School 




DURING THE LAST 
THREE DECADES 
by Arthur Ebbert Jr., M.D. 
In 1952 and 1953, the Yale plan of medical education underwent 
a comprehensive review and reappraisal. This was precipitated 
by three concurrent phenomena: the appointment of a new dean 
in 1952, the growth of the faculty and some skepticism toward 
the plan by faculty who had been recruited from other schools. 
Although the new dean. Dr. Vernon Lippard, had received 
his M.D. from Yale in 1929 and was a strong supporter of the 
plan, the November 1952 minutes of the school’s executive 
committee, composed of the department chairmen, noted, “It 
was the consensus of opinion that there exists a real need for 
clarification of what is meant by the Yale Plan and what are its 
underlying principles. ” 
The following March, a Curriculum Committee was ap¬ 
pointed “to define the Yale system of medical education and 
make recommendations for such changes in this system as 
seemed to be in order.” The executive committee also recom¬ 
mended studying the place of the National Board Examinations 
in the Yale System. 
CURRICULUM REPORT 
The report of the Curriculum Committee was presented to the 
school’s Board of Permanent Officers in May 1953. I would like 
to quote from the introductory paragraphs of that report. 
“The purpose of this statement is to reaffirm the confidence 
of the faculty of the School of Medicine in the methods 
of instruction which, over the past 30 years, have become 
known as the 'Yale System’ and to define the program 
so that faculty and students may begin the next academic 
year with a common understanding of its objectives and 
procedures and with freedom from confusion arising 
from misinterpretation. After a periodic review, minor 
revisions of current practices have been adopted and it 
is expected that, with further experience, other revisions 
will be recommended but the basic philosophy underlying 
the program is believed to be sound. 
“The program is distinguished by the following charac¬ 
teristics: (1) the required thesis, (2) lack of fixed course 
requirements for qualified students, (3) emphasis on 
elective courses, (4) absence of required course 
examinations.” 
The report goes on to discuss these characteristics of the Yale 
System. In the section describing evaluation, the report notes 
that during pre-clinical years, examinations were to be offered 
but were neither required nor graded for record. At the end of 
each basic course, the department concerned was to submit a 
composite narrative opinion of the student’s achievement, sum¬ 
marized as “satisfactory” or “unsatisfactory.” Progress com¬ 
mittees were to be appointed to evaluate the achievement of stu¬ 
dents in each year and certify to the dean’s office that students 
were eligible to take the National Board Examinations. 
Dr. Ebbert, deputy dean, presented this report to the Medical 
School Council on Oct. 2. 
According to this report, the committees were expected to 
reach their decisions by using all information at their disposal 
and were privileged to give special examinations when neces¬ 
sary. Completion of the National Board Examinations was re¬ 
quired for advancement from the pre-clinical to clinical years 
and for graduation; however, responsibility for a student’s ad¬ 
vancement rested in the progress committees and, finally, in the 
Board of Permanent Officers. 
Dean Lippard published an article entitled “The Yale Plan of 
Medical Education After 30 Years” in the Journal of Medical 
Education in September 1954. 1 recommend this to those who 
want more detailed information about the plan as it existed at 
that time. I would like to note that, in the article. Dean Lippard 
made the following statement: “No educational program worth 
its salt ever has or ever will be in final form. To be effective, 
it must be subjected to constant evaluation and improvement. ” 
To my knowledge there was very little change in the program 
of medical education over the next 10 or 12 years. The Curricu¬ 
lum Committee, concerned primarily with scheduling problems 
resulting from expanding knowledge, strove to protect elective 
time and to improve elective courses. The question of whether 
or not the school should continue to require the National Board 
Examinations recurred periodically. 
THE NEW CURRICULUM 
In February 1965, appointing the Committee to Re-evaluate the 
Goals of Medical Education and their Implementation at Yale, 
Dean Lippard commented: “The traditional curriculum of 
American medical schools, adopted 60 years ago, was designed 
to prepare physicians to enter practice on graduation. Although 
methods of instruction and course content have changed, the 
courses offered and the time allotted to them have remained rel¬ 
atively constant, despite the ever-increasing mass of knowl¬ 
edge, the variety of careers open to medical school graduates, 
the extension of postdoctoral educational experience, and the 
changing role of medicine in society.” 
This committee, chaired by Dr. Byron Waksman, labored for 
more than a year. In April 1966, its recommendations were ap¬ 
proved by the school’s Board of Permanent Officers. Although 
these recommendations established what subsequently became 
known as “the new curriculum,” they did not change the basic 
principles or characteristics of the Yale Plan. 
Among the recommendations was that an Office of Associate 
Dean for Curriculum be established to provide, for the first 
time, an administrative mechanism for the year-to-year supervi¬ 
sion of the curriculum by an officer of the school. Dr. Howard 
Levitin was appointed to that post in the fall of 1966. The Curri¬ 
culum Committee worked hard for two years to develop the new 
curriculum for the class entering in September 1968. 
Time does not permit a detailed description of the new curri¬ 
culum; however, the key features were as follows: 
1. Some reduction in the initial time devoted to the 
study of basic sciences, with considerable reduction in 
time for the gross anatomy course. 
2. Early introduction of the students to clinical medicine, 
requiring that students spend six weeks of the first summer 
in a clinical setting. 
3. The opportunity to study advanced basic science 
following clinical clerkships. 
4. A flexible program during the last one-and-one-half 
years, allowing students to plan their own curricula in 
consultation with their advisers. This became known as 
the multiple track system. Each available track was to 
include graduate level science courses, appropriate 
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clinical experience, and courses correlating clinical 
medicine and fundamental science. The tracks were 
"biology in medicine,” "behavioral medicine,” “com¬ 
munity medicine” and "growth and development.” 
Each third-year student was expected to select one of 
these tracks. 
5. An extended outpatient clinic experience. 
REAPPRAISAL 
The introduction of the new curriculum and the increase in class 
size to 102 in 1971 put added strain on the evaluation system. 
Because most faculty did not have enough protracted contact 
with students to evaluate their progress, the Medical School 
Council appointed a committee to look at the pre-clinical 
courses and the evaluation of students. 
The report of this group was adopted by the council in the 
spring of 1973. The major recommendation of that committee, 
chaired by Dr. Michael Kashgarian, was that each pre-clinical 
course would be required to offer students three evaluation op¬ 
tions, including an oral or written examination; a report on the 
student’s performance in conferences, seminars or laboratory 
exercises; and the presentation of papers. However, no grades 
as such were to be recorded. 
About this same time, in 1973, the Medical School Council 
directed the Curriculum Committee to redesign the pre-clinical 
curriculum with changes in content, sequence and time alloca¬ 
tion. Two major changes became effective in the fall of 1975. 
The summer clinical experience following the first year was 
made optional instead of required, and the multiple track system 
in the last three semesters was eliminated. Thus, in 1975 the 
curriculum returned to the general format that existed prior to 
the introduction of the so-called new curriculum in 1968; how¬ 
ever, the clinical correlation lectures and tutorials in the first 
year were retained. 
Two additional changes dealing with evaluation should be 
mentioned. Beginning with the class entering in September 
1977, students were required, in addition to receiving a passing 
total score on the Part I National Board Examination, to receive 
passing grades in each of the component subjects of the exami¬ 
nation. In December 1977, the Curriculum Committee recom¬ 
mended mandatory anonymous course examinations in the pre- 
clinical courses. Before this was implemented, though, the 
word “mandatory” was deleted and replaced with a statement 
indicating that students were expected to participate. 
To this brief summary of events, I would like to add a com¬ 
ment about the accreditation of the school in 1983. Accredita¬ 
tion is the responsibility of a group called the Liaison Commit¬ 
tee on Medical Education (LCME), which represents the Amer¬ 
ican Medical Association (AMA) Council on Medical Educa¬ 
tion and the Association of American Medical Colleges 
(AAMC). 
Although the school received a highly complimentary report 
and was accredited for the maximum period of 10 years, the vis¬ 
iting survey team expressed concern regarding curriculum and 
evaluation. The report states: "The Curriculum Committee ap¬ 
pears to be more occupied with minor adjustments to the opera¬ 
tion of the academic programs and less with fundamental educa¬ 
tional philosophy and its implementation,” and “Aside from 
student performance on the National Boards, the existing evalu¬ 
ation system is unconventional and evidence of its effectiveness 
is largely anecdotal.” 
EVALUATION OF STUDENTS 
by Robert H. Gifford, M.D. 
The Yale System has been an important part of life at Yale Uni¬ 
versity School of Medicine since 1931. Although it has under¬ 
gone minor modifications in the intervening years, its essential 
spirit has remained intact and it is a major reason why students 
elect to come to New Haven for their medical education. Inter¬ 
estingly, no firm agreement exists on how to evaluate students 
under the Yale System. 
Although the system uses neither letter grades nor class rank¬ 
ings, the faculty always has attempted to recognize excellence 
and, conversely, to identify students in academic difficulty so 
they can receive special help. When students apply to residency 
programs, letters to hospitals must indicate each candidate’s 
specific strengths. Obviously, not all students can make superb 
laboratory investigators nor can everyone become a skillful 
neurosurgeon. However, all students must prove to the faculty 
that they have attained minimal proficiency in each required 
course or clerkship. 
The evaluation of performance and the proof of minimal 
proficiency require two very different scales of measurement 
that are frequently blurred in students’ minds. Thus, the ques¬ 
tion is not whether there will be evaluations or whether there 
will be minimal proficiency hurdles to overcome, but rather 
how will these be done and how will they be kept separate from 
each other. 
In the past year, the Curriculum Committees and Medical 
School Council have considered changes in the traditional 
method of determining minimum competence. Some of the 
reasons behind the changes are as follows: 
1. To provide an alternative to the National Board 
Examination, which will discontinue providing individual 
subject scores after 1988. Yale will need a new method 
of ensuring that students have learned the basic principles 
of each course before moving into the clinical years. 
2. To provide a means for students in academic difficulty 
to become aware of their deficiencies during the course 
in question, rather than after the second year has been 
completed and students already have started their clinical 
training. 
3. To encourage more students to participate in and take 
advantage of course offerings as they are given, rather 
than leaving the bulk of study to the weeks before the 
National Board Examination. 
4. To stimulate the development of a well-established 
and easily accessible system of remedial help for students 
who might want it. 
5. To provide the faculty with a better yardstick of its 
teaching. 
6. To dissociate the evaluation of performance from the 
evaluation of minimum competence. 
7. To preserve the spirit of the “Yale System” of medical 
education. 
During the past year, students, faculty and administrators in the 
School of Medicine reviewed the student evaluation system. Earlier 
this fall, Yale Medicine asked Dr. Gifford, associate dean for 
medical education and student affairs, to comment on the Yale 
System. His article complements the preceding historical 
presentations to the Medical School Council. 
PERFORMANCE AND PROFICIENCY 
The methods used to evaluate performance have not changed. 
The faculty of each required basic science course and each re¬ 
quired clinical clerkship must submit a descriptive evaluation 
of every student to the associate dean for medical education and 
student affairs. No letter grades are assigned, although relative 
terms such as “outstanding,” “excellent” or “very good” may 
be used occasionally. No attempt is made to establish a grading 
“curve” or to rank the class in any order. 
In the basic sciences, students are given evaluation options 
at the beginning of each course. Although most evaluations re¬ 
sult from students' participation in seminars, labs and tutorials, 
alternative methods include a special written or oral examina¬ 
tion or presentation of a paper or other project. In their evalua¬ 
tions, the basic science faculty generally comment on partici¬ 
pation, level of knowledge, preparation and quality of a paper 
presented. 
The clinical faculty generally base their comments on daily 
observations of each student’s clinical and interpersonal skills, 
knowledge base, problem-solving ability and adherence to as¬ 
signed responsibilities. 
The students have access to their evaluations at any time. One 
copy of each is retained by the department, second copies go 
in students’ permanent records, and third copies are available 
for students to keep. 
Each basic science department that teaches a major course 
must offer all students one written, minimum competency, 
anonymous examination. Although all students have been 
expected to participate anonymously in these exams, only 
about 60 percent actually have done so. Following extensive 
discussions during the past academic year, the Medical School 
Council approved a resolution that all students must take an 
anonymous minimum competency examination in each course, 
beginning with the class entering in September 1986. 
The concept of minimum competency implies that all stu¬ 
dents should be able to pass an examination on fundamental 
facts and principles of each discipline taught. 
Although current teaching should not necessarily change to 
dwell on these facts and principles, the faculty will be responsi¬ 
ble for informing students in advance of the areas considered 
important for medical students to know particularly well. The 
anonymous minimum competency examination should test only 
these areas. The examination should be written in such a way 
that each student who has participated in the coursework should 
be able to pass with a score of at least 6590. 
There should be one required anonymous minimum compe¬ 
tency examination per course. However, course directors are 
encouraged to offer their customary examinations throughout 
the course. Students will be expected to take these examinations 
as well, but with no requirement to pass or to identify them¬ 
selves in any way. The regular examinations will merely serve 
as guides to the students as to their overall competence in each 
discipline. However, students wishing to choose an examina¬ 
tion for evaluation and students who must take a course for 
graded credit (for example, M.D./Ph.D. students) could use the 
regular examinations for credit. 
REMEDIATION 
DMS that the deficiency has been corrected either by taking 
another minimum proficiency exam or by some other method 
agreed upon by the DMS and student (e.g. oral exam, extended 
conversations during study). 
The deficiency must be corrected before clinical rotations 
begin. Students who fail the make-up examinations must iden¬ 
tify themselves to the associate dean for medical education and 
student affairs for counseling. Failure a third time will lead to 
a review by the progress committee to determine appropriate 
dispositions. 
Under this new system, students still will be required to take 
Part I of the National Board Examination but will be required 
to pass only the overall test. Several weeks of review are allotted 
following the fourth semester for preparation and study for the 
boards. 
All departments will provide easily accessible tutorial pro¬ 
grams for any students who wish extra help, special tutoring, 
or re-testing. An individual in each department whom students 
can easily approach will fulfill this function. Students will have 
access to practical examinations and computer programs for re¬ 
view and self-teaching. A special computer room and learning 
center for students is being developed adjacent to the teaching 
laboratories in Lauder Hall and should be in place during the 
coming academic year. This tutorial system will be developed 
in more detail. 
Students who fail the minimum competence section of the 
examination are on their honor to contact the director of medical 
studies (DMS) in the appropriate department, to receive addi¬ 




by Samuel O. Thier, M.D. KNOWLEDGE 
I want to add my congratulations to the graduating class and to 
talk about what’s ahead as medicine moves into an almost un¬ 
precedented period of change. When you move into a rapidly 
changing system, it becomes important to have guiding princi¬ 
ples clearly in mind so that pressing financial and organizational 
changes won’t distort what you’ve been taught. 
As you leave Yale, you will learn as I did in the last few 
months, that the name Yale stays with you, and it means quite 
a bit. You carry with you 300 years of credibility, excellence 
and the responsibility to continue that tradition. 
As you move into the medical profession, you also inherit 
millenia of tradition. It has been exciting most of the time, re¬ 
sulting in a remarkable social contract of which you are now' 
part. You will have a lifetime of learning ahead. You will have 
the opportunity to share with people their times of crisis, to 
guide them, to heal them and perhaps to prevent their illness. 
You will have their trust and respect and you will have security. 
To maintain that contract you have to meet your professional 
responsibilities. 
I would like to talk with you about professional responsibili¬ 
ties, to put some of them in perspective and to discuss how the 
traditions of medicine and of Yale ultimately may come to¬ 
gether. Justice Louis Brandeis provided most of my definition 
of a profession: a profession is the keeper of a body of knowl¬ 
edge learned more from experience than memory. It is responsi¬ 
ble for maintaining and advancing that knowledge and passing 
it on to the next generation. It has a code of ethics with a signifi¬ 
cant component of service to others. It sets and enforces its own 
standards, and it values performance above reward. I’d like to 
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What about knowledge? We have the greatest knowledge base 
applied to the practice of medicine in the history' of mankind, 
and the practice of medicine has been more firmly based on sci¬ 
entific principles. 
What about passing that knowledge on to the next genera¬ 
tion? As students look to you as house officers, it will be a little 
scary but fun. We don’t do a bad job at medical education. For 
the last hundred years, we have operated with a simple set of 
principles. Our educational process is founded on the connec¬ 
tion between basic sciences and clinical medicine. It rejected 
apprenticeship for the more rigorous bedside teaching of the 
clinical clerkship. It is based on problem solving, not memory. 
In the next few years, many suggestions will be made to 
change our educational principles because the way medicine is 
practiced is changing. But those simple principles have taken 
us from general practice in horse-and-buggy times through the 
development of hospitals to academic medical centers, HMOs 
and other providers. The principles have served us well. We 
may require some reorganization, but the principles are firm. 
Don’t allow them to be abandoned lightly. 
Reading about medical education from the Journal of the 
American Medical Association: “The most common criticism 
made at present by older practitioners is that young graduates 
have been taught a great deal about the mechanism of disease 
but very little about the practice of medicine, or to put it more 
bluntly, they are too scientific and do not know how to take care 
of patients. When one considers the amazing progress of sci¬ 
ence and its relation to medicine during the last 30 years, and 
the enormous mass of scientific material which must be made 
available to the modem physician, it is not surprising that the 
schools have tended to concern themselves more and more with 
this phase of the educational problem.” 
The article continues to talk about the art of medicine, con¬ 
cluding, “The art of medicine and the science of medicine are 
not antagonistic but supplementary to each other. ” 
That was written in 1927 by Francis Peabody. Things have 
not changed as much as we sometimes like to think. Do keep 
your perspective. The criticism of medicine that I just presented 
should always exist. When you do not hear that criticism any¬ 
more, then medicine has ceased to advance. 
If you are not better educated in the science of medicine than 
I was when I graduated, we have not advanced, and the educa¬ 
tional system has not functioned. If I, after 30 years of experi¬ 
ence caring for patients, have not learned something more about 
how to interact with patients, then I have been something of a 
stone during that time. 
Dr. Shimon Glick notes that the words “patient” and “com¬ 
passion” have a common root. Don’t forget that root. It’s hard 
to construct a common root with client or consumer. You’re still 
taking care of patients. 
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What about advancing knowledge? We have done spectacu¬ 
larly well in advancing knowledge in what is, probably, the 
most exciting time in the history of medical science. People 
have told you all your lives that the way in which medicine ad¬ 
vances is to have a basic observation applied through clinical 
research and eventually have it translated into clinical practice. 
It almost never happens that way. In fact, it has been very much 
the opposite. 
People at the bedside have always asked questions and sought 
answers: ultimately explaining empiric observations on the 
basis of science. Trying to explain sickle cell anemia led to our 
understanding of the tertiary structure of proteins and trying to 
sort out thalassemia led to an understanding of advances in 
molecular genetics. It was not virology and immunology that 
taught us about immunization, but immunization that made us 
understand what virology and immunology had to contribute. 
Do not forget the importance of trained clinical observation. It 
leads to very important questions, and it is an inseparable part¬ 
ner in the science of medicine. 
As we move to gene therapy and new areas of medically as¬ 
sisted conception, for example, we will introduce therapies that 
will have predictable and unpredictable effects. The rate at 
which these new technologies and approaches are introduced is 
occurring rapidly, we desperately need people who can make 
the observations that will provide the insights into biology that 
unexpected clinical events offer. We must also examine the 
legal and ethical foundations of our new technologies because 
the public will require careful and understandable answers to the 
complex questions that are going to be raised. 
This brings me to the question of ethics. Does medicine have 
a code of ethics, and is it committed to a component of service 
to others? It has, but it could do a lot better in expressing it. 
The original code of ethics that guided medicine was a code 
of interaction between physicians. It didn’t get to where we 
should be today: our primary responsibility and commitment to 
our patients overriding virtually everything else we do. This 
simple ethical principle becomes critical to keep in mind be¬ 
cause it is threatened dramatically as we are asked to restrict 
access to care and to new technology. 
RESPONSIBILITIES 
You have two responsibilities. Remember George Bernard 
Shaw’s Doctor's Dilemma when thinking about them. Shaw 
didn’t think highly of physicians. He wrote of a physician who 
was in love with the wife of a man with a treatable disease. That 
physician was faced with the challenge of whether to treat the 
patient and lose this woman he coveted, or whether to not treat 
the patient, let him die and potentially have the woman as his 
wife. As you might guess, Shaw allows the physician to allow 
the patient to die; the woman runs off with somebody else, so 
there is some equity in the system, but there is a conflict of inter¬ 
est in the system. 
Remember that you may be asked to take on a conflict of in¬ 
terest that other professionals are not. No sane lawyer would be 
advocate and judge in the same case. You cannot simultane¬ 
ously be advocate for your patient and the judge of the patient’s 
right to scarce resources. When patients come to you, they have 
every right to expect that you will be their advocate, care for 
them and defend them. When you are separate from patients, 
you may deal, as an informed professional, with decisions 
based on cost-benefit analysis of various technologies or treat¬ 
ments. But you must never allow yourselves to be forced to do 
both simultaneously, or you will find yourself in an untenable 
position. 
You may face restricted resources for medical care, just when 
we have the greatest opportunity for care. It will require some 
balancing of values that will go beyond consideration of re¬ 
sources and require you to put idealism above pragmatism in 
certain circumstances. And remember, as Dr. Rosenberg said, 
that this is an idealistic profession and that you should not feel 
uncomfortable for putting your idealism ahead of pragmatism 
in the care of your patients. 
What about the other requirements for being a profession? Do 
we set and enforce our standards? Yes, we do. We set fairly high 
standards. We may not always police our own profession the 
way I hope we would, and I’m particularly sad that we don’t 
always comfort our own professionals when they’re impaired 
as well as we should. In the future, more openness will be im¬ 
portant in setting and enforcing standards. With some compas¬ 
sion in the system, enforcement becomes more humane. 
We must avoid allowing our standards to become those of a 
trade. We must avoid allowing those who structure the organiza¬ 
tion of medicine to tell us what physicians should be trained to 
do and what standards they should meet. Physicians may have 
to meet standards of those organizations, but they must meet the 
profession’s standards first. We ought to be willing to press for 
higher standards and mechanisms of reevaluation so that pa¬ 
tients will know whether you are as good 10 to 20 years from 
now as when you started in practice. 
PERFORMANCE 
What about valuing performance above reward? The greatest 
criticism is now leveled at that area of the medical profession, 
and I think not unfairly. The question is, do we perform only 
if we’re reimbursed? We have a long tradition that says we care 
for those who need it, regardless of the ability to pay. In the last 
20 years, through well-intended mechanisms of insurance, 
Medicare and Medicaid, we have provided coverage for pa¬ 
tients, but we also have allowed a generation of physicians to 
grow up thinking that they didn’t have a responsibility to care 
for those patients for whom there was no reimbursement. That 
is a very dangerous position for our profession. 
For example, should a colonoscopy, reimbursed at $500, be 
done when one that is reimbursed at $100 and is equally medi¬ 
cally indicated is not? Is that what we’re actually saying? Do 
we really think that technical skills are so important that we 
value them more than we value cognitive skills or principles? 
If we mean that, then we ought to say that. We ought to say if 
reimbursement is reduced, patients will not be served. Then we 
have to answer ’’Who will not serve?” If the answer is “the 
medical profession,” then we have forfeited our professional 
social contract. 
As you go forward, then you will find a lot of rhetoric, self-in¬ 
terest and difficulty in defining when one is dealing with princi¬ 
ple or self-interest. Your professional responsibility is to argue 
from any vantage point you wish, but to be honest in identifying 
the motives from which you’re operating. 
As a group from Yale, you should be responsible for introduc¬ 
ing light and truth to the argument. I am confident that this class 
of students, with the value systems that I have seen over the 
years at this institution, with the qualities of excellence, can 
meet these challenges. If you do, the change should be an enor¬ 
mous opportunity to set right those things we haven’t quite got¬ 
ten right and to protect those things we have. 





Dr. Stephen Waxman 
to Head Neurology 
Dr. Stephen G. Waxman, professor and as¬ 
sociate chairman of the Stanford University 
School of Medicine Department of Neurol¬ 
ogy, became chairman of the School of 
Medicine’s Department of Neurology and 
chief of neurology at Yale-New Haven Hos¬ 
pital on July 15. 
Dr. Waxman succeeds Dr. Gilbert H. 
Glaser, who relinquished the medical 
school chairmanship he held for 34 years. 
“At Stanford, Stephen Waxman has con¬ 
ducted elegant research on nerve cell 
growth aimed, ultimately, at advancing the 
treatment of neurological diseases such as 
multiple sclerosis, spinal cord injury and 
stroke," said Dr. Leon E. Rosenberg, 
Dean. “We are delighted that, while con¬ 
tinuing his outstanding work in New 
Haven, he will lead our educational, re¬ 
search and patient care programs in the criti¬ 
cal discipline of neurology. ” 
Dr. Waxman, who is internationally 
known for his research on regeneration of 
nerve cells and adaptive response of the ner¬ 
vous system to illness and injury, led a Stan¬ 
ford research group that delineated the 
molecular changes of the nerve fiber during 
clinical remissions of multiple sclerosis. 
A native of Newark, N.J., Dr. Waxman 
received an A.B. degree cum laude in 1967 
from Harvard College and Ph.D. and M.D. 
degrees in 1970 and 1972, respectively, 
from Albert Einstein College of Medicine in 
New York City. He completed his residency 
training in neurology at Boston City Hospi¬ 
tal and was a visiting research fellow at 
Massachusetts Institute of Technology. 
Dr. Stephen G. Waxman 
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In 1978, Dr. Waxman joined the Stanford 
medical school faculty as professor and 
concurrently served as chief of the 
neurological unit at the Palo Alto Veterans 
Administration Medical Center. In 1981, 
he was named associate chairman of the 
department. 
Dr. Waxman, who has co-authored more 
than 165 scientific articles based on his re¬ 
search, is associate editor of the Journal of 
Neurological Sciences and the Journal of 
Neurocytology. He also serves on the edito¬ 
rial boards of five other journals and as a re- 
viewerformorethan lOotherpublications. 
The National Institute for Advanced Edu¬ 
cation in the Sciences presented him the 
First Annual Trygve Tuve Memorial Award 
for Outstanding Contributions in the 
Biomedical Sciences in 1973. Two years 
later, he received a research career develop¬ 
ment award from the National Institute of 
Neurological and Communicative Disor¬ 
ders and Stroke. 
Merle Waxman to Head 
Women in Medicine 
Merle Waxman, who previously served as 
assistant ombudsman at Stanford Univer¬ 
sity Medical Center, has been named direc¬ 
tor of the Office for Women in Medicine. 
She succeeds Kay D. Codish. 
In announcing the appointment. Dr. 
Leon E. Rosenberg, Dean, said "Merle 
Waxman possesses outstanding leadership 
and communication skills which will enable 
her to carry out the office’s diverse respon¬ 
sibilities. Ms. Waxman’s experience in 
non-litigious conflict resolution and advo¬ 
cacy will be of great value to our women 
students and faculty members who are con¬ 
cerned with affirmative action, recruitment, 
advancement and counseling. ” 
At Yale, Ms. Waxman will direct the 










professional standing and personal lives of 
women in medicine and the biomedical sci¬ 
ences. The office provides advisory and ad¬ 
vocacy services and helps women counter 
prejudice, discrimination and sex-role 
stereotyping. 
Ms. Waxman also will serve as a liaison 
with the University administration and as an 
advocate for local and national women’s 
medical issues. 
A native of Newark, N.J., Ms. Waxman 
received a B.S. degree in 1968 from Boston 
University and an M A. degree in 1972 
from the City University of New York. Her 
professional experiences range from work¬ 
ing as a research assistant in neurology to 
serving as a speech consultant and therapist. 
Between 1983 and August 1986, Ms. 
Waxman was assistant ombudsman at Stan¬ 
ford University Medical Center where she 
specialized in conflict resolution and formu¬ 
lated policies and procedures to facilitate 
non-litigious dispute resolution. 
Dr. Gary Friedlaender 




The Yale School of Medicine and Yale-New 
Haven Hospital have established a new De¬ 
partment of Orthopaedics and Rehabilita¬ 
tion, and Dr. Gary E. Friedlaender has been 
named the first chairman of the school’s de¬ 
partment and chief of the hospital’s service. 
Dr. Friedlaender, a member of the 
School of Medicine faculty and an attending 
surgeon at Y-NHH since 1976, will expand 
the existing orthopaedics program that pre¬ 
viously was a section within the Department 
of Surgery. 
The new Department of Orthopaedics 
and Rehabilitation combines surgical and 
medical approaches to disorders of the mus¬ 
culoskeletal system, along with a program 
in rehabilitation, as reflected in the depart¬ 
ment's name. The opportunities and chal¬ 
lenges presented by the scope of activities 
will be met by sections of clinical or¬ 
thopaedics, rehabilitation and research. The 
full-time faculty includes eight clinicians 
with interest and nationally recognized ex¬ 
pertise in the spine, joint reconstruction, 
trauma, arthritis, pediatrics, oncology, 
bone transplantation and complex surgery 
of the hand and foot. The department also 
includes five basic scientists highly re¬ 
spected for their continuing contributions to 
the biology, biochemistry, immunology 
and biomechanics of the skeleton. 
Dr. Friedlaender looks forward to adding 
and expanding expertise in sports medicine 
and rehabilitation and more fully utilizing 
the teaching and clinical skills of the 40-50 
members of the community-based or¬ 
thopaedic faculty. Five residents are ac- 
Dr. Gary E. Friedlaender 
cepted annually in the four-year residency 
training program. 
“In establishing the new department, the 
School of Medicine is making a greater in¬ 
stitutional commitment to enhancing the 
teaching, research and patient care pertain¬ 
ing to the musculoskeletal system,” said 
Dr. Leon E. Rosenberg. “Gary Friedlaen- 
der’s fine research on bone transplantation 
and his superb leadership will significantly 
advance orthopaedics at Yale. ” 
A native of Detroit, Mich., Dr. Fried¬ 
laender received a B.S. degree with distinc¬ 
tion from the University of Michigan in 
1967 and an M.D. degree from Michigan’s 
School of Medicine in 1969. He was an in¬ 
tern and surgical assistant resident at the 
University of Michigan Medical Center and 
completed his orthopaedic residency train¬ 
ing at Newington Children’s Hospital and 
Y-NHHin 1974. 
Dr. Friedlaender first came to Yale in 
1971 as a National Institutes of Health post¬ 
doctoral research fellow in surgery, oncol¬ 
ogy and immunology, during which he de¬ 
veloped his interests in bone transplanta¬ 
tion. 
In his clinical work and research. Dr. 
Friedlaender has specialized in oncology re¬ 
construction. He has been particularly inter¬ 
ested in limb-sparing tumor resection fol¬ 
lowed by skeleton repair using bone trans¬ 
plants, and has developed many aspects of 
this innovative surgery. 
His contributions include assessment of 
the influence of chemotherapy and radiation 
therapy on intact bone, fracture repair and 
graft incorporation, an understanding of im¬ 
mune responses to bone transplants and 
methods for safely and efficiently banking 
bone. As part of this work, he founded and 
directs the Yale Bone Bank. 
Dr. Friedlaender has served as president 
of the American Association of Tissue 
Banks and the American Council on Trans¬ 
plantation (ACT). He founded ACT, a cen¬ 
tralized resource for information, educa¬ 
tion, program support and coordination of 
national activities pertaining to organ and 
tissue donation and transplantation. He is a 
fellow of the American College of Surgeons 
and the American Academy of Orthopaedic 
Surgeons. 
At Yale, Dr. Friedlaender has directed 
the orthopaedic oncology and transplanta¬ 
tion immunobiology laboratory since 1977 
and the orthopaedic research program since 
1981. He was named professor of surgery 
(orthopaedics) in 1984 and concurrently 
served as chief of Y-NHH’s orthopaedic 
service. 
In 1982, Dr. Friedlaender received the 
Kappa Delta Award for Outstanding Or¬ 
thopaedic Research from the American 
Academy of Orthopaedic Surgeons and the 
Orthopaedic Research Society. He has writ¬ 
ten extensively on tissue banking, fracture 
healing and bone allografts and coedited 
three textbooks on these subjects. 
Dr. Richard Greenspan 
Named Associate Dean 
Dr. Richard H. Greenspan, professor and 
chairman of the Yale School of Medicine’s 
Department of Diagnostic Radiology, has 
been appointed to the newly created posi¬ 
tion of associate dean for clinical affairs. 
“Dick Greenspan brings strong experi¬ 
ence in clinical medicine to this new post. 
He has demonstrated his medical and ad¬ 
ministrative abilities in leading Diagnostic 
Radiology, a department which provides 
the highest quality patient care and offers 
superb clinical training programs. He also 
possesses a record of excellence in teaching 
and research and a broad knowledge of 
health care financing,” said Dr. Leon E. 
Rosenberg, Dean. 
“As associate dean for clinical affairs, 
Dick Greenspan will provide the leadership 
to establish an office that will further devel¬ 
op and coordinate clinical care by our full¬ 
time faculty physicians,” the dean said. 
“He also will encourage the development of 
new and innovative clinical programs by 
working in cooperation with the school’s 
clinical department chairmen and with col¬ 
leagues at Yale-New Haven Hospital. ” 
In his new position. Dr. Greenspan will 
chair the executive committee of the Facul¬ 
ty Practice Plan, established in 1981 to 
bring together administrative, management 
and financial activities of the full-time fac¬ 
ulty physicians. 
Dr. Greenspan, who has served as de¬ 
partment chairman and chief of diagnostic 
imaging at Y-NHH since 1973, is known in¬ 
ternationally for his research in clinical 
magnetic resonance imaging. He was one of 
the medical faculty members instrumental 
in planning the Magnetic Resonance Cen¬ 
ter, a joint school-hospital project that 
opened in May. 
He first came to Yale in 1960 as assistant 
professor of radiology and was named pro¬ 
fessor in 1964. Between 1968 and 1973, he 
served on the medical faculty at the Univer¬ 
sity of California at San Francisco. 
Dr. Richard H. Greenspan 
When Dr. Greenspan returned to become 
the first chairman of the Department of 
Diagnostic Radiology, he focused on the 
study and techniques of diagnosing illnes¬ 
ses using radiologic methods. His research 
has encompassed a major project to 
evaluate the accuracy of current diagnostic 
techniques for patients suspected of having 
pulmonary embolism. 
A native of New York City, Dr. 
Greenspan received a B.A. degree in 1944 
from Columbia University, and four years 
later was awarded an M.D. degree, magna 
cum laude, from Syracuse University Col¬ 
lege of Medicine. 
Dr. Greenspan interned at Michael Reese 
Hospital in Chicago and then worked in the 
hospital’s gastrointestinal research depart¬ 
ment. Between 1950 and 1952, he took resi¬ 
dency training in internal medicine at the 
University of Minnesota Hospitals and, 
after a two-year stint in the U.S. Air Force, 
returned to Minnesota for radiology train¬ 
ing. In 1957 he became an instructor and 
later an assistant professor in the radiology 
department there. 
He has written more than 100 articles for 
scientific publications and for eight years 
served as editor-in-chief of the journal 
Investigative Radiology. 
A member of numerous national profes¬ 
sional committees. Dr. Greenspan is a past 
president of the Fleischner Society and the 
Association of University Radiologists 
(AUR). He received the gold medal from 
the AUR in 1984. 
A fellow of the American College of 
Radiology and a member of Sigma Xi and 
Alpha Omega Alpha, Dr. Greenspan was a 
National Science Foundation Senior Post¬ 
doctoral Fellow in 1966 and a Josiah Macy 
Jr. Foundation Faculty Scholar in 1980. 
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Class of 1990 
Brings Diversity 
Women comprise 35 percent of the first- 
year class that enrolled this fall at the Yale 
School of Medicine. The 36 women were 
among the 102 students selected for the 
Class of 1990 from 2,326 applicants. Ac¬ 
cording to Dr. Robert H. Gifford, associate 
dean for medical education and student af¬ 
fairs, the enrollment of women has doubled 
in the last 20 years. 
The increased enrollment of women at 
the school has made Yale “a better place,” 
says Dr. Gifford. Speaking at the mid-Sep¬ 
tember opening of a Yale Medical Library 
exhibit on the school’s early women 
graduates, Dr. Gifford said: “There has 
been a new life and a new sensitivity in¬ 
stilled in all of us. Some of our rough edges 
have been smoothed. We have learned for 
certain that gender has absolutely nothing to 
do with one’s ability to be a physician. We 
owe a great debt to those who led the way 
The Class of 1990 includes one student 
accepted through the early decision plan, 
seven students enrolled in the M.D./Ph.D. 
program and six children of Yale University 
alumni (four of the parents are medical 
alumni). Eight of the first-year students 
hold master’s degrees: one has a Ph. D. 
Black Americans and other minority stu¬ 
dents comprise 26 percent of the Class of 
1990. Three of the first-year students are 
foreign nationals. Students in the Class of 
1990 range in age from 19 to 39, with a 
mean age of 23.5. 
The majority of the Class of 1990 were 
science majors as undergraduates, with 
biology, biochemistry and chemistry being 
the dominant areas of concentration. 
Twenty-seven percent of the class majored 
in the humanities and social sciences. As an 
undergraduate group, the Class of 1990 
earned a mean cumulative grade-point aver¬ 
age of 3.69. 
The first-year students now enrolled 
earned their undergraduate degrees at 54 
colleges throughout the United States and 
one in England. Fourteen are Yale alumni, 
10 came from Stanford, six each graduated 
from Harvard and Brown. Although New 
England college degrees are heavily rep¬ 
resented (41), more than half of the Class of 
1990 hold degrees from colleges in the 
Southeastern, West Coast and Mid-Atlantic 
states. 
In the Department of Epidemiology and 
Public Health, 99 students are enrolled in 
the first-year class. The EPH Class of 1990 
includes 64 women; 22 Black, Hispanic and 
Asian Americans; and 15 foreign nationals. 
The first-year students come from 26 states 
and 12 countries. Thirty hold M.D. de¬ 
grees, 10 are nurses; the remainder earned 
undergraduate degrees in the sciences and 
liberal arts. The Department of Epidemiol¬ 
ogy and Public Health, in addition to being 
a department of the medical school, is an 
accredited school of public health. 
Minority Students 
Conduct Research 
Eight students from the Greater New Haven 
area participated in the School of Medicine 
Summer Research Apprenticeship Program 
for Minority High School Students. 
The eight-week, federally funded pro¬ 
gram provided the minority students with 
meaningful experiences in various aspects 
of biomedical science and health care to 
stimulate their interest in careers in science. 
The students were introduced to various 
settings in the medical school and the John 
B. Pierce Foundation Laboratory. They at¬ 
tended a weekly lecture series and spent 30 
hours a week in laboratory research with 
Yale faculty members who helped them un¬ 
derstand biomedical research and learn 
technical skills involved in conducting 
research. 
Since the program started in 1980, 57 stu¬ 
dents, including those in 1986, have partici¬ 
pated at Yale. It is designed for minority stu¬ 
dents who identify themselves as being 
Black, Hispanic, American Indian, Alas¬ 
kan native or Pacific Islander/Asian. The 
Yale program is one of 74 that the National 
Institutes of Health, Division of Research 
Resources funds at medical schools in 33 
states, Washington, DC., and Puerto Rico. 
IN PROGRESS 
NIDA Funds Research 
Center on Cocaine 
and Opioid Abuse 
A new Clinical Research Center to develop 
improved ways to treat people with opioid 
and cocaine abuse problems has been estab- 
I ished at the School of Medicine. 
Dr. Herbert D. Kleber, professor of psy¬ 
chiatry, will direct the new center for which 
the National Institute on Drug Abuse 
(NIDA) has granted Yale University 
$1,491,000 during the next five years. This 
is one of two centers NIDA has funded na¬ 
tionally. 
“The center, which arises out of research 
that medical school faculty members have 
conducted during the past 17 years in the 
Connecticut Mental Health Center and APT 
Foundation’s Substance Abuse Treatment 
Unit, will lend a new coherence and breadth 
toourwork,” Dr. Kleber says. 
“We will undertake several major new 
projects, including the first comprehensive 
study in humans of the transition from 
methadone treatment to naltrexone via a 
new agent, buprenorphine,” Dr. Kleber 
says. “By switching patients from 
methadone to buprenorphine before nal¬ 
trexone, we hope to alleviate withdrawal 
problems and improve the success rate for 
treatment.” 
Methadone, an agonist, has been widely 
used to treat opioid addicts; these patients 
generally stay in treatment programs but re¬ 
main opioid dependent. Naltrexone, an an¬ 
tagonist, does not produce opioid depen¬ 
dence, but it can be difficult for patients to 
begin and remain in treatment programs. 
Besides Dr. Kleber, the new Clinical Re¬ 
search Center leaders include Dr. Bruce J. 
Rounsaville, associate professor of psychi¬ 
atry, as scientific director, and Dr. Thomas 
R. Kosten, assistant professor of psychi¬ 
atry, as associate scientific director. 
Dr. Kosten will head the treatment re¬ 
search division that will develop and test in¬ 
novative treatment approaches. 
Dr. Frank H. Gawin, assistant professor 
of psychiatry, and Dr. Robert Byck, profes¬ 
sor of psychiatry and pharmacology, will 
study the clinical interaction of cocaine with 
three commonly used treatment drugs 
that may affect either cocaine treatment or 
toxicity. 
Dr. Dennis S. Charney, associate profes¬ 
sor of psychiatry, will head the neurobiol¬ 
ogy division to investigate the neurochemi¬ 
cal, neuroendocrine and neuropharmaco- 
logical correlates of opioid and cocaine 
use and withdrawal in humans. 
In the project. Dr. Charney will investi¬ 
gate whether hormonal changes that result 
from long-term drug use are related to 
the development of drug withdrawal syn¬ 
dromes and the response to specific treat¬ 
ment. 
“At the new Clinical Research Center, 
we also will coordinate Yale’s rich training 
programs and research resources on sub¬ 
stance abuse disorders," Dr. Kleber adds. 
Seminars on drug abuse treatment and 
training opportunities at the Substance 
Abuse Unit and other sites will increase the 
number of health professionals skilled in 
treating opioid and cocaine abusers from all 
walks of life. 
Pediatricians to Assist 
Children at Camp 
Some physicians and staff in the School of 
Medicine Department of Pediatrics may go 
to camp in Northeastern Connecticut next 
summer as part of actor Paul Newman’s 
dream to open the Hole-in-the-Wall Gang 
Camp. 
Boys and girls who have cancer, blood 
diseases or other life-threatening diseases 
will enjoy camp experiences, much as 
healthy youngsters do, under safe and rela¬ 
tively unobtrusive medical supervision. 
The camp is to be constructed on a 267-acre 
site, with a 47-acre lake, that overlaps the 
town boundaries of Ashford and Eastford. 
The camp will be closely associated with 
the Department of Pediatrics and Yale-New 
Haven Hospital, both of which will cooper¬ 
ate to provide medical services and co- 
12 
ordinate medical care with other camp 
activities. 
Dr. Howard A. Pearson, professor and 
chairman of pediatrics, said that the chil¬ 
dren with chronic illnesses will be assured 
of having fun, as well as the proper medical 
supervision. “We will provide first-class 
quality medical backup on the site so the 
children and their parents will have no 
concerns.” 
Dr. Pearson will provide medical super¬ 
vision for the camp. Among the seven phy¬ 
sicians serving on the medical advisory 
board are Yale's Dr. Peter Beardsley, as¬ 
sociate professor of pediatrics, and Dr. 
Diane Komp, professor of pediatrics. In ad¬ 
dition, Dr. Arnold Altman, Y-NHH House 
Staff 1965-66, serves on the advisory 
board. He is head of the University of 
Connecticut Health Center Division of 
Hematology/Oncology. 
At a mid-September press conference an¬ 
nouncing the camp. Dr. Myron Genel, as¬ 
sociate dean for government and communi¬ 
ty affairs, said, “The need for a camp for 
seriously ill children has been created by the 
success of basic and clinical biomedical re¬ 
search which enables a majority of children 
to survive, but often with major disabilities. 
Yale faculty have made and continue to 
make major contributions to this effort. ” 
The camp will accommodate the special 
needs of children aged 7 to 17 years with 
multiple diagnoses, and at the same time 
will provide them with outdoor experiences 
in an “Old West” spirit. Campers will live 
in log cabins, visit a corral filled with ani¬ 
mals, sing in an old-fashioned music hall, 
swim, canoe, hike and camp out overnight. 
Actor Newman, who lives in Westport, 
Conn., hopes the camp will open next sum¬ 
mer for two, two-week sessions for approx¬ 
imately 50 children. In the future, enroll¬ 
ment is anticipated to increase to some 150 
children for eight, two-week sessions. Chil¬ 
dren will attend the camp at no cost. 
The estimated cost to build and endow 
the camp is $8 million and Paul Newman’s 
food companies, which make popcorn, 
salad dressing and spaghetti sauce, will pro¬ 
vide half the funds. 
FACULTY NEWS 
Dr. Donald J. Cohen, director of the Child 
Study Center and professor of pediatrics, 
psychiatry and psychology, was elected 
vice president of the International Associa¬ 
tion of Child and Adolescent Psychiatry and 
Allied Professions at its international con¬ 
gress in Paris in July. 
Lisa F. Berkman, associate professor of 
epidemiology, is the principal investigator 
for one of four core studies in the MacAr- 
thur Foundation Research Program on Suc¬ 
cessful Aging. While previous studies have 
concentrated solely on changes that occur 
with age, this investigation focuses on iden¬ 
tifying factors that account for the variabil¬ 
ity in functioning found among people of 
the same age. A better understanding of the 
psychosocial, environmental and biomedi¬ 
cal influences in aging processes and of how 
these processes influence physical and men¬ 
tal health is expected. 
Dr. Steven D. Helgerson and Dr. James 
F. Jekel were named co-recipients of the 
1986 Distinguished Teaching Award that 
the Epidemiology and Public Health Stu¬ 
dent Organization presented this spring. 
They were recognized for their teaching 
ability, excellence in and contribution to 
their field, concern for students and dedica¬ 
tion to the department’s educational pro¬ 
gram. Dr. Helgerson is assistant clinical 
professor of epidemiology and public 
health, while Dr. Jekel is the Charles E-A. 
Winslow Professor of Public Health. 
The American Public Health Association 
and its Maternal and Child Health Section 
presented the 1986 Martha May Eliot 
Award to Dr. George A. Silver, professor 
emeritus of public health, at its annual 
meeting in Las Vegas, Nev. The award, 
which honors its namesake, the former head 
of the federal Children’s Bureau, recog¬ 
nized Dr. Silver as “the nation’s foremost 
exponent of public policies which give spe¬ 
cial priority to the needs of children.” 
Three Become Emeritus 
Three members of the Yale faculty retired 
July 1, 1986. 
Dr. Jack W. Cole, Ensign Professor of 
Surgery and vice chairman of the Depart¬ 
ment of Surgery, is considered an authority 
on intestinal cancer. He has done extensive 
research on the physiological and structural 
changes that occur in tissue and blood cells 
as a result of surgical stress. He was chair¬ 
man of the Department of Surgery from 
1966 to 1975 and director of the Com¬ 
prehensive Cancer Center from 1976 to 
1984. 
William R. Goff, Ph.D., professor of 
neurology and psychology, held joint ap¬ 
pointments at the medical school and the 
Veterans Administration Medical Center, 
where he served as chief of the Neuro¬ 
psychology Laboratory since 1964. There, 
he developed and established innovative re¬ 
search methods and instrumentation, which 
were applied to basic problems of sensory 
neurophysiology and to clinical problems in 
epilepsy and brain-damaged individuals. 
Dr. Martha F. Leonard, professor in the 
Child Study Center and professor of pediat¬ 
rics, has been a faculty member for 24 
years. Her work on youngsters has covered 
a range of interests, from studies of infants 
who refuse to eat to research on first-born 
infants from disadvantaged families, to de¬ 





Myma M. Weissman, Ph D., professor of 
psychiatry and epidemiology and director 
of the Depression Research Unit at Yale, 
and Gerald L. Klerman, M.D., formerly 
professor of psychiatry .and director of the 
Connecticut Mental Health Center at Yale 
School of Medicine, have been awarded the 
prestigious Anna-Monika Prize for their re¬ 
search on testing the effectiveness of 
psychotherapy and drugs in treating clinical 
depression. 
The Anna-Monika Foundation presented 
the international award at a ceremony at the 
University of Basel. The prize, presented 
every two years, recognizes recent ad¬ 
vances in knowledge in understanding the 
causes and treatment for depression. 
Since 1967, Drs. Weissman and Klerman 
and their colleagues have developed new 
treatment approaches and have evaluated 
their effectiveness in treating clinically de¬ 
pressed patients. Results of two major 
studies indicate that drugs and interpersonal 
psychotherapy, used together, are most ef¬ 
fective to treat acute depression. 
During the research, the group developed 
interpersonal psychotherapy (IPT), a brief 
treatment focusing on the reduction of de¬ 
pressive symptoms and interpersonal prob¬ 
lems often associated with clinical depres¬ 
sion. These problems include: grief, inter¬ 
personal disputes, role transitions or inter¬ 
personal deficits. 
Interpersonal psychotherapy, which they 
have described in a book Interpersonal 
Psychotherapy of Depression, published by 
Basic Books in 1984, was selected by the 
National Institute of Mental Health (NIMH) 
as one of the treatments in a multi-centered 
clinical trial of drugs and psychotherapy 
conducted in three university centers. 
Shortly before Drs. Weissman and Kler¬ 
man received the Anna-Monika Prize, the 
NIMH announced the study’s results and re¬ 
ported that IPT was as effective as drugs in 
reducing the symptoms of depression over 
a 12-week period. Dr. Klerman currently is 
professor of psychiatry at Cornell Univer¬ 
sity Medical College. 
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ALUMNI NEWS 
Dr. George W. Namburg Jr., a 1945 graduate of Yale medical school who 
practices psychiatry in Manhattan and serves as an associate clinical professor 
of psychiatry at the Mount Sinai School of Medicine, has combined his working 
knowledge of chemistry, physics and bacteriology with his love of farming 
and wine to develop the North Salem Vineyard. Approximately 60 medical 
alumni and their guests from Westchester and Fairfield counties gathered Oct. 
11 for a cookout and winery tour at the vineyard Dr. Namburg planted in 
1965 with 36 grapevine varieties. Dean Leon E. Rosenberg met informally 
with medical and FPH alumni at North Salem, N.Y., just as he has done this 
year with alumni in Durham, N.C.; Hartford, New Haven and San Francisco, 
Calif. Talking on the winery balcony, from left to right, are: Dr. Namburg, 
Dr. Dwight F. Miller, president of the Association of Yale Alumni in Medicine, 
Diane Rosenberg and Dean Rosenberg. 
Dr. Martin E. Gordon ’46, associate clini¬ 
cal professor of medicine at the Yale School 
of Medicine, continues to consult in gas¬ 
troenterology and lecture nationally on the 
new medical specialty, emporiatrics (medi¬ 
cal problems of travel). He delivered the an¬ 
nual lecture of the Southern California En¬ 
doscopy Society, “Rudolf Schindler - 
Glimpses of the Endoscopic Pioneer,” and 
presented a paper on “The Gastroen¬ 
terologist Becomes Emporiatrist - A Short 
Step in Resolving Diagnostic Dilemmas of 
the Traveler” at the American College of 
Gastroenterology’s annual meeting in At¬ 
lanta, Ga. 
Dr. Gordon has developed the "POCK¬ 
ET DOC,” a medical aid for travelers, a 
sequel to the “GLOBAL DISEASE 
GUIDE,” which was designed as a pre- and 
post-travel diagnostic device for physicians 
and hospitals. 
Dr. Joseph S. Pagano 57, has been ap¬ 
pointed to the Lineberger Professorship in 
Cancer Research at the University of North 
Carolina at Chapel Hill. The professorship 
was established with part of a gift from the 
Lineberger family, pioneers in the textile 
industry in North Carolina. Dr. Pagano is a 
professor in the departments of medicine, 
microbiology and immunology in the 
school of medicine and director of the 
Lineberger Cancer Research Center. 
Dr. Mohandas M. Kini ’65, of 
Wakefield, Mass., met with Prime Minister 
Rajiv Gandhi in New Delhi, India in March. 
Mr. Gandhi was the honored guest at a func¬ 
tion held by the Medical Research Founda¬ 
tion, a non-profit institution providing med¬ 
ical and surgical eye care in Madras, India. 
Dr. Kini has been an honorary consultant to 
the Medical Research Foundation since its 
inception in 1978. He has taught and trained 
Medical Research Foundation consultants 
at the Massachusetts Eye & Ear Infirmary 
and Boston University Medical Center. Dr. 
Kini is on the staff of the Massachusetts 
Eye & Ear Infirmary, University Hospital, 
Melrose-Wakefield and Malden Hospitals. 
Dr. Anthony Proto ’71, of Midlothian, 
Va., was named a fellow of the American 
College of Radiology at its annual meeting 
in Baltimore, Md 
Dr. Allan L. Naarden, HS '71, was pro¬ 
moted to clinical professor of neurology at 
the University of Texas Health Science 
Center at Dallas on July I. 
Dr. Louis V. Kirchhoff ’77, has re¬ 
ceived the prestigious Syntex Scholars Pro¬ 
gram Award. One of two researchers 
selected nationally, he was awarded a three- 
year, $150,000 grant to study Chagas’ dis¬ 
ease, aD illness caused by the parasite 
Trypanosoma cruzi. Dr. Kirchhoff is an as- 
sistant professor in the infectious diseases 
division of the University of Iowa College 
of Medicine, department of internal 
medicine. 
The annual Maxwell Bogin Pediatric Lec¬ 
ture at Bridgeport Hospital in Connecticut 
featured four speakers, including Dr. 
Robert S. Baltimore, associate professor of 
pediatrics and epidemiology. Dr. Bogin at¬ 
tended the day-long event. In spite of lim¬ 
ited activities, he helped with the North 
Salem Vineyard event for Dean Rosenberg 
and continues his long service as Fund Class 
Agent for the Class of 1926. 
Dr. Michael B. Mayor '65, was appointed 
chairman of the orthopaedics division at 
Dartmouth-Hitchcock Medical Center in 
July. Since 1971, he has been associated 
with the Hitchcock Clinic as an orthopaedic 
staff surgeon and has achieved the rank of 
associate professor of clinical surgery. 
At the 130th annual meeting of the Hawaii 
Medical Association’s House of Delegates, 
Dr. William H. Hindle 56 of Honolulu 
was presented a Presidential Medal. The 
Hawaii Medical Political Action Commit¬ 
tee also presented him an award for out¬ 
standing contributions as chairman of the 
Task Force on Tort Reform. 
IOM Elects New Members 
Three of the 30 new members elected to the 
Institute of Medicine are affiliated with the 
Yale School of Medicine. The new mem¬ 
bers, who began their terms July 1, are 
Frederick C. Battaglia, M.D. '57, 
Paul G. Quie, M.D. '53, and Robert G. 
Shulman, Ph.D., professor of molecular 
biophysics and biochemistry. 
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ALUMNI WEEKEND 
JUNE 5 and 6 
For entertainment, 
education and a bit 
of nostalgia, plan 
now to attend! 
NEW BOOKS 
The Scientific Basis of Clinical Pharmacol¬ 
ogy: Principles and Examples, by Reynold 
Spector, M.D. '66, professor of internal 
medicine and pharmacology. University of 
Iowa College of Medicine. Little, Brown 
and Company, (Boston, Mass.) 1986, 538 
PP 
The Physiology and Biochemistry of the 
Uterus in Pregnancy and Labor, edited by 
Gabor Huszar, M. D., associate professor of 
obstetrics and gynecology and pediatrics. 
CRC Press, Inc., (Boca Raton, Fla.) 1986, 
328 pp. 
Automated Visual Field Testing: Techniques 
of Examination and Interpretation, by 
David E. Silverstone, M.D., assistant clini¬ 
cal professor of ophthalmology and visual 
science, and Joy Hirsch, Ph.D., associate 
professor of ophthalmology and visual sci¬ 
ence. Appleton-Century-Crofts, (Norwalk, 
Conn.) 1986, 384pp. 
Ethics & Regulation of Clinical Research, 
second edition, by Robert J. Levine, M.D., 
professor of medicine. Urban & Schwar- 
zenberg, (Baltimore, Md.) 1986, 370 pp. 
Methods in Observational Epidemiology, 
by Jennifer L. Kelsey, Columbia University 
School of Public Health; W. Douglas 
Thompson, assistant professor of 
epidemiology, and Alfred S. Evans, M.D., 
John Rodman Paul Professor of Epidemiol¬ 
ogy and director of the World Serum Bank. 
Monographs in Epidemiology & Biostatis¬ 
tics series, 1986,384 pp. 
Expert Critiquing Systems: Practice-Based 
Medical Consultation by Computer, by 
Perry L. Miller, M.D., assistant professor 
of anesthesiology. Springer-Verlag, (New 
York) 1986, 182 pp. 
When A Doctor Hates A Patient: And Other 
Chapters in a Young Physician’s Life, by 
Richard E. Peschel, M.D., Ph D. 'll, as¬ 
sociate professor of therapeutic radiology 
and director of the residency program in 
therapeutic radiology, and Enid Rhodes 
Peschel, co-director of the Program for 
Humanities in Medicine. University of 
California Press, (Berkeley, Calif.) 1986. 
OBITUARIES 
Seymour Lipsky, M.D. 
Dr. Seymour “Sandy” Lipsky, professor 
emeritus of laboratory medicine, died on 
Sept. 20, 1986 at Yale-New Haven Hospital 
after a long illness. He had been director 
and professor of physical sciences and pro¬ 
fessor in the Department of Laboratory 
Medicine until his retirement in July 1985. 
He was 62. 
He received a B.A. degree from Univer¬ 
sity Heights College in 1944 and an M.D. 
degree from the State University of New 
York College of Medicine in 1949. After 
completing his residency training in 
medicine at the University of California in 
1952, he began his career at Yale as a post¬ 
doctoral research fellow in the Department 
of Medicine. He was named instructor in 
1955, assistant professor in 1956, associate 
professor in 1966 and promoted to full pro¬ 
fessor in 1968. 
Dr. Lipsky trained as a physician in inter¬ 
nal medicine but established himself in 
physical biochemistry. He made many orig¬ 
inal contributions to the development of 
gas chromatography and its use in bio¬ 
chemistry. 
He received many honors and awards, in¬ 
cluding an honorary M. A. degree from Yale 
University in 1968, the M. Tswett Award of 
the Academy of Sciences by the USSR in 
1978, an unusual distinction for an Ameri¬ 
can scientist, and the Tswett Medal of the 
International Symposium on Advances in 
Chromatography in 1982. 
Dr. Lipsky served as vice chairman to a 
special advisory committee of the National 
Heart Institute from 1960 to 1963. He was 
involved with the National Aeronautics and 
Space Administration from 1961 to 1970. 
He served as consultant to the Lunar Sci¬ 
ences Subcommittee and Lunar and Plane¬ 
tary Program Committee, and was the prin¬ 
cipal experimenter for the Surveyor Lunar 
Soft Landing Mission and for the detection 
of organic compounds and gases on the sur¬ 
face of Mars. He also was a member of the 
National Academy of Sciences Postdoctoral 
Fellowship Committee. 
Dr. Lipsky is survived by his wife. Pearl 
Reitman Lipsky; a daughter, Jan Lipsky of 
Lincoln, Mass.; two sons, John Lipsky of 
Hamden, Conn, and James Lipsky of Bos¬ 
ton, Mass.; and one grandchild. 
Robert S. Adams, M.D. 
Dr. Robert S. Adams, clinical professor in 
the Yale Child Study Center and Depart¬ 
ment of Psychiatry, died on Sept. 29, 1986 
at his home in Woodbridge, after a two-year 
battle with amyotrophic lateral sclerosis. 
He was 62. 
Dr. Adams had a distinguished medical 
career. He received his B.A. degree from 
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Columbia College in 1945 and his M.D. de¬ 
gree from Columbia College of Physicians 
and Surgeons in 1948. He completed his in¬ 
ternship and residence in medicine at Bos¬ 
ton City Hospital in 1950 and subsequently 
trained in psychiatry at the Boston VA Hos¬ 
pital and in child psychiatry at Mas¬ 
sachusetts General Hospital and the James 
Jackson Putnam Children's Center in Bos¬ 
ton, Mass. He finished his training in adult 
and child psychoanalysis at the Western 
New England Psychoanalytic Institute. 
Dr. Adams was director of the Waterbury 
Child Guidance Clinic from 1957 to 1986 
and consultant to the Taft School from 1963 
to 1968. He also was president of the Con¬ 
necticut Council of Psychiatrists, and from 
1980 to 1982 was president of the American 
Association of Psychiatric Services for 
Children. 
In addition. Dr. Adams served on several 
national committees, and was chairman of 
the Committee on Early Periodic Screening 
of both the American Academy of Child 
Psychiatry and the American Association of 
Psychiatric Services for Children. He also 
was a member of the editorial board of 
the Journal of the American Academy of 
Child Psychiatry and published papers on 
consultation. 
He received many awards and citations 
for his contributions to national, state and 
community mental health programs for 
children and their families. Dr. Adams was 
given the Outstanding Practitioner Award 
from the American Association of Psychiat¬ 
ric Services for Children in 1986, a certifi¬ 
cate of appreciation from the State of Con¬ 
necticut Department of Children and Youth 
Services in 1985, and the Phoebe Bennet 
Award from the Connecticut Association of 
Mental Health Clinics forChildren in 1986. 
He is survived by his wife, Irene, and his 
children, Lisa, Jeffrey and Jonathan. 
Louis R. Mattie, M.D. 
Dr. Louis R. Mattie, assistant clinical pro¬ 
fessor of medicine, died June 22, 1986 at 
Yale-New Haven Hospital. Dr. Mattie, a 
native of New Haven, received his M.D. 
degree from the Yale School of Medicine in 
1952 and was a postdoctoral fellow in car¬ 
diology from 1955 to 1956, when he began 
his private practice. He was a past president 
of the New Haven Heart Association. 
He is survived by his wife, Camile 
Panico Mattie; his mother, Lucy Ragozzino 
Mattie; a daughter, Michelle Mattie 
Geremia; a son, David P. Mattie; two sis¬ 
ters, Mary Elpi and Anne Ferguson; and a 
brother. Dr. Edward Mattie. 
IN MEMORIAM 
Fu-Chun Yen 
November 29, 1970 
'09 M.D. 
William Wyatt Strange, M.D. 
April 27, 1985 
'19 HS 
Milton B. Berman 
July 11, 1986 
'27 M.D. 
Edward E. Harkavy 
July 25, 1986 
'27 M.D. 
Edgar I. Boggs, M.D. 
1984 
'22 HS 
Gonsalvo C. Williams Jr. 
April 26, 1986 
'25 M.D. 
Lewis Dickar 
August 20, 1986 
'30 M.D. 
Vernon P. Williams, M.D. 
April 6, 1986 
'32 HS 
Carl Hendricks Wies 
April 22, 1986 
'32 M.D. 
Ashley Pond III 
March 17, 1986 
'33 M.D. 
Donald P. Morris 
July 1986 
'35 M.D. 
Fernald C. Fitts 
June 13, 1986 
'36 M.D. 
Franklin F. Ferguson 
March 8, 1986 
'36 M.D. 
George A. Hahn, M.D. 
May 2, 1986 
'36 HS 
Albert W. Dautrich 
May 3, 1986 
'39 M.D. 
John A. Murtagh, M.D. 
January 15, 1986 
'38 HS 
William R. Haas, M.D. 
June 25, 1986 
'40 HS 
Nina Toll 
May 22, 1986 
41 M.P.H. 
William Astrom Ahroon, M.D 
October 1983 
'43 HS 
Robert R. Bemeike, M.D. 
March 15, 1986 
'46 HS 
Charles W. Karpinski 
January 9, 1986 
'47 M.D. 
Louis R. Mattie 
June 22, 1986 
'52 M.D. 
Archie J. Golden 
May 9, 1986 
'50 M.D. 
Charles W. Chace 
June 16, 1986 
'52 M.D. 
Dorothea Abt 
June 9, 1986 
'53 M.P.H. 
Edwin R. Ranzenhofer 
July 7, 1986 
'54 M.D. 
Col. David M. Robinson 
April 28, 1986 
'54 M.D. 
Dr. Israel Gitlitz 
March 17, 1986 
'55 D PH 
Marvin L. Schulman 
August 18, 1986 
’59 M.D. 
Edward Call Jr. 
December 16, 1985 
'59 M.D. 
Charles R. Carrington, M.D. 
September 1985 
'64 HS 
Bernhard H. Lisker 
April 8, 1986 
'75 M.D. 
Charles T. Davisson 
June 20, 1986 
'78 M.D. 
Terry Newlove, M.D. 
May 18, 1985 
'79 HS 
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THE CAMPAIGN FOR THE 
YALE SCHOOL OF MEDICINE 
Campaign Update 
The new Magnetic Resonance Center was 
dedicated on November 19. This first com¬ 
pleted project of The Campaign for the Yale 
School of Medicine symbolizes the cam¬ 
paign's goal to insure the school’s leader¬ 
ship in the advancement of medical science. 
Many challenges remain for the cam¬ 
paign’s leaders. More than $40 million in 
endowment gifts is required, and the search 
continues for gifts to support laboratory 




A number of significant developments have 
occurred in recent months regarding corpo¬ 
rate gifts for The Campaign for the Yale 
School of Medicine. 
The Corporate Consortium for Clinical 
Epidemiology is well on its way to comple¬ 
tion. This project seeks $1.25 million from 
10 corporate members over a five-year 
period. It is intended to improve the capa¬ 
bility of Yale’s Clinical Epidemiology Unit 
to evaluate the safety and efficacy of health 
care products. This funding will help the 
unit develop alternatives to the randomized 
clinical trial method of research. Presently, 
five corporate members have been enlisted: 
Proctor and Gamble Co., Pfizer Inc., Scher¬ 
ing-Plough Corp., Boehringer Ingelheim 
Ltd. and International Playtex Inc. Mem¬ 
bers of the consortium will hold their first 
meeting in January 1987. 
The School of Medicine will receive 
more than $400,000 of computer equipment 
for instruction and research during the next 
12 months. This equipment is from Project 
Eli, which is to support the use of instruc¬ 
tional computer workstations throughout 
the campus. The core of Project Eli is 
formed by a $6.5 million grant from Inter¬ 
national Business Machines Corp. 
The Merck Company Foundation will 
participate in the campaign with a $ 150,000 
gift to renovate one of the main gastroen¬ 
terological laboratories in the Division of 
Digestive Diseases. This gift was generated 
by the long-standing relationship between 
Merck and Yale in life sciences research. 
Recent campaign gifts have been made 
by GTE—$75,000 for minority scholar¬ 
ships in medicine and by Harvey Hubbell 
Incorporated—$75,000 for geriatric 
medicine. These and other Connecticut 
companies seem well aware that the Yale 
School of Medicine, one of two medical 
schools in the state, maintains and improves 
the high quality of health care that Connec¬ 
ticut citizens have come to expect. 
Tax Reform and Gifts 
in 1986 
The sweeping tax reform that Congress ap¬ 
proved in September raised many questions 
about the law’s impact on higher education, 
particularly charitable giving. Leaders of 
The Campaign for the Yale School of 
Medicine have followed the new tax mea¬ 
sure throughout the past year. 
"Once people understand the new rules 
on giving, contributions to Yale will con¬ 
tinue to grow,” says Frank A. Sprole, co- 
chairman of the campaign. "However, 
1986 holds some special advantages for 
donors who have already made up their 
minds to help the campaign.” Mr. Sprole, 
a 1942 graduate of Yale College who 
studied law at Columbia, says he wants 
people to understand the new rules on giv¬ 
ing because “the tax benefits make it possi¬ 
ble to give a little more. ” 
Although he believes people should be 
aware of the tax aspects of their contribu¬ 
tions, Mr. Sprole emphasized other motiva¬ 
tions for giving. "Our gifts are intellectual 
and spiritual expressions of ourselves rather 
than just a line on one’s tax return. To many 
people, their time is even more precious 
than money, and yet those same busy 
people volunteer their time to help univer¬ 
sities, hospitals, churches or synagogues 
without any prospect of a tax benefit. That 
desire to help others is the primary reason 
most people give to the campaign. ” 
Profiles of Donors Who Benefit 
by Giving Before December 31, 1986 
Non-itemizer: He rents his apartment and 
has no major medical expenses, so it makes 
sense to file a short form (1040A). Each 
year he gives to financial aid for medical 
students. In 1986 for the first time, the non- 
itemizer can deduct 100 percent of the total 
amount contributed to Yale and other qual¬ 
ified charitable organizations. Tax reform 
will eliminate this new “above the line” de¬ 
duction in 1987. 
Donor in the 50 percent tax bracket: Her 
high income is taxed heavily, forcing her to 
plan each deduction carefully. Since her top 
tax rate will fall to 38.5 percent in 1987, she 
calculates that she can actually give more to 
Yale by making a major contribution in 
1986. For example, a $100,000 gift with 
her 50 percent bracket saves $50,000 in 
taxes, while the same gift in 1987 saves 
only $38,500. 
Donor with appreciated property: He is 
concerned about the alternative minimum 
tax, yet he wants to help the campaign by 
giving Yale a building lot he bought three 
years ago for $5,000. Today it is worth 
$25,000. He can donate that land in 1986, 
eliminate the capita! gains tax and take a tax 
deduction for the full value of the property. 
In 1987, appreciation of the donated prop¬ 
erty ($20,000) would be included in cal¬ 
culating any alternative minimum tax 
(AMT) liability. The AMT was designed to 
ensure that taxpayers who claim large de¬ 
ductions do not escape tax altogether. 
If you are considering a gift in 1986 and 
have questions about the campaign or the 
impact of tax reform on your giving, contact 
the Office of Development, Yale School of 
Medicine, 350 Congress Avenue, 3-C, 
New Haven, Conn. 06519, or call Will 
Melton (203) 785-4420 or Sue Dorn (212) 
759-1356 of the medical development staff. 
Progress Report Summary 
As of September 30, 1986 
PROJECTS 
General Endowment 6,350,120 
Professorships 8,299,012 
Fellowships 3,385,816 
Total Endowment $18,034,948 
Center for Molecular 20,100,000 
Medicine 2,775,000 
Magnetic Resonance Center 2,884,500 




Total Facilities and 
Equipment 
$38,920,692 












by Nicholas P R. Spinelli, M.D. 
The June rains did not dampen alumni/ae 
spirits at one of our largest and warmest 
reunions. The weekend began with a semi¬ 
nar planned by the 25th reunion class at 
which 11 members of the Class of 1961 
summarized their clinical and research ca¬ 
reers. Papers were presented by Drs. Ken¬ 
neth D. Arndt, David W. Brook, Philip 
Felig, Margurite Stein Lederberg, Robert 1. 
Levy, VincentT. Marchesi, Charles R. Sac- 
hateilo, Robert N. Taub, John V. Weil, John 
R. Woodward and Warren D. Widmann. 
Dr. Widmann moderated the seminar. 
Dr. Samuel O. Thier, president of the 
Institute of Medicine, delivered the key¬ 
note address on “The Challenge to Yale 
Medicine: Protecting Excellence in an 
Unpredictable Environment.” Before his 
speech. Dr. John D. Pastore ’67, associate 
professor of medicine at Tufts University 
and secretary of the International Physi¬ 
cians for the Prevention of Nuclear War, 
spoke on “Physicians and the Nuclear Arms 
Race.” The organization was awarded the 
1985 Nobel Peace Prize. 
A new feature for any returning alumni/ 
ae was the Medical Reunion Dinner on Fri¬ 
day in the Presidents’ Room at Woolsey 
Hall. A dance followed in Commons, and 
the entire Yale medical family, including 
the Yale-New Haven Hospital staff, was in¬ 
vited. Despite the rain, the attendees en¬ 
joyed dancing in this unusual environment. 
Both entertaining events may become tradi¬ 
tions of future reunions. 
Outgoing Yale President A. Bartlett 
Giamatti greeted a standing-room-only 
crowd of alumni and guests on Saturday 
morning. Then, at the Association of Yale 
Alumni in Medicine annual business meet¬ 
ing, President Dwight F. Miller ’56 pre¬ 
sided, and Dean Leon E. Rosenberg pre¬ 
sented the traditional “State of the School” 
message. The appointment of department 
chairmen was announced, and details of six 
major construction projects were presented. 
Dr. Lawrence Pickett ’44 and Dr. Russell 
Scobie ’29 were presented Distinguished 
Service Alumni Awards for 1986. 
Dr. Lowell Goodman ’51, chairman of 
the Medical School Alumni Fund, reported 
that $418,816 had been collected. (The final 
figure was to reach a record $512,145). 
Kathleen Howe reported that $30,000 had 
been collected for the Department of 
Epidemiology and Public Health. 
Dr. Nicholas PR. Spinelli is associate dean 
for medical alumni affairs. 
Dean Rosenberg presented a citation to 
Dr. Goodman as outgoing chairman and an¬ 
nounced that Dr. Leonard Kemler ’43 
would become the new chairman in July. 
Dr. Miller greeted each reunion class, 
from the 50th led by Philip LeCompte to the 
fifth by Barbara Ross. Special citations 
were presented to each member of the 50th 
reunion class. Special recognition to senior 
alumni present included Arthur Griswold 
’21, Helen Langner ’22, David Raskind 
’24, Maxwell Bogin ’26 (60th reunion), and 
Michael D’Amico and Ben Klotz, both ’31 
(55th reunion). 
The traditional sherry hour and sumptu¬ 
ous Alumni Day luncheon followed in 
Harkness Hall. 
On Saturday afternoon, the Class of 1961 
held an unstructured dialogue with three 
generations of physicians. Two faculty 
members who taught them. Dr. Tom Forbes 
in anatomy and Dr. Samuel Kushlan '35 in 
internal medicine, were guests. Also par¬ 
ticipating were members of the Class of 
1989: Valerie Asher, Steven Bharucha, 
Howard Kesselman, Greg Koshkarian, 
John Mott, Marjorie Scharoun and Jonathan 
Shifren. The discussion—truly a genera¬ 
tional dialogue—provided an interesting 
orientation for the young students whose 
time to come promises so much wrenching 
change. The 1986 reunion also celebrated 
the 75th anniversary of child development 
and child psychiatry at Yale with lectures in 
the Yale Child Study Center. Other educa¬ 
tional seminars focused on geriatrics, treat¬ 
ment of affective illnesses and medical edu¬ 
cation, including admissions. 
Individual class dinners were held on 
Saturday evening. The fourth annual 
“Friends of the 50th" dinner, sponsored by 
the medical school to honor alumni at their 
50th reunion, was held at the Graduates 
Club. Approximately 100, mostly older or 
non-reunion alumni, enjoyed a gala eve¬ 
ning, with nine returning graduates from the 
Class of 1936 recounting personal experi¬ 
ences. 
A special feature was the presence of 
Class of 1981 members who returned for 
their first reunion as guests of the school. A 
record 21 returnees, one fifth of the class, 
came with 15 guests. These happy young 
people added a note of pleasant celebration 
and enjoyed the dialogue with the older 
physicians. This successful gesture prom¬ 






by Philip M. LeCompte 
Ours was a bang-up reunion which took 
place in almost constant rain (our spirits un¬ 
dampened). Friday afternoon events were 
followed by the Dean’s reception where 
there was plenty to drink and lots of shrimp. 
Dinner at Woolsey Hall was attended by Ed 
Sullivan and sister Pat Kober, Fritz Post 
and yours truly with wife Jean. 
After a farewell address by retiring Presi¬ 
dent A Bartlett Giamatti, our class was pre¬ 
sented special greetings from the President 
and Secretary of the University, complete 
with Yale Seal and a blue ribbon, believe it 
or not! Individual citations were given to 
each member of the class. 
On Saturday evening, we attended a deli¬ 
cious dinner at the Graduates Club spon¬ 
sored by the Yale Alumni Association. The 
first reunion of the Class of 1981 was simi¬ 
larly feted, and the combination of 21 of 
their number with us and about 30 other 
guests was delightful! Hosted by Larry 
Pickett and Nick Spinelli, introductions of 
our class followed. Each delivered brief 
autobiographical sketches. 
Our group included: Bill Barry with wife 
Ceil; Lester Burket with wife Grace; Nick 
D’Esopo with wife Rose; AI Diddle; Phil 
LeCompte with wife Jean; Dan McGil- 
licuddy; Steven Nagfy with wife Alla; 
Fritz Post; Ed Sullivan with sister Pat 
Kober. 
The evening's sad note was the an¬ 
nouncement of the death of George Hahn, 
our class agent, whom we had expected to 
be with us. George had an illustrious career 
in gynecology at Temple School of 
Medicine. A George Hahn Memorial has 
been established, and checks may be sent 
to: Yale Medical School Alumni Fund, 
George Hahn Memorial, P.O. Box 1890, 
New Haven, Conn. 06507. 
Our reunion was a memorable event, and 
we all look forward to a reprise for our 55th. 
1941 
45th Reunion 
by Robert W. Ollayos 
Thirteen class members attended the reun¬ 
ion that was hosted, as usual, by Charles 
18 
Cheney. Attending, with their wives, were 
David Pecora (and daughter Ann), Bjorn 
Lih, Bob Gilbert, Pete Duncan, Bill Ken¬ 
ney, Jack Parella, Willys Monroe (with 
news of John Franklin and Lloyd Flint), 
Bill Carey, Fred Glike, Bill Diefendorf 
and BobOllayos. 
Sending greetings were Sophie Cham¬ 
berlin Alway, Ed Connell, Bob Areson, 
Knute Berger and Randy Bell. 
Under the hospitable eye of Charlie 
Cheney, the group enjoyed the informative 
and entertaining weekend program that the 
medical school sponsored. The class dinner 
at the Graduates Club was crowded and 
convivial, as all were joined by the Classes 
of 1936 and 1981 for cocktails. 
1946 
40th Reunion 
by Gregory E. Flynn 
Members of the Class of 1946 who attended 
their reunion thoroughly enjoyed them¬ 
selves. They were Molly Joralemon Al- 
Trink and husband Will, Bill Banfield, 
Tim and Phyllis Beck, Frank and Peg 
Behrle, Fred and Evette Biehusen, Sandy 
Bluestein, Jim Cooney, Bob and Linda 
Cooper, Greg and Peggy Flynn, Marty 
and Evelyn Gordon, Charlie and Mary 
Judd, Ben and Ava Kitchen, the 
Kleemans, Vinnie and Rosina Longo, 
Dick and Jerry Mann, Tom and Coli 
Mathieu, Joe Morris, the John Mortons, 
the Tom Murphys, Jack and Laura 
Neville, Vinnie and June Pepe, Julie 
Sachs, Don and Charlotte Shedd, Dick and 
Mitzi Sisson, Colby Stearns, Bruce 
Thayer, the Bob Wagners, Bill and 
Madori Wedemeyer, Hugh Williams, Eli 
and Emma Sue Wing and Tom and Norma 
Whelan. 
The formal program was interesting. 
Physical changes in the medical center were 
impressive. The Friday night dinner-dance 
was delightful. 
On Saturday afternoon we visited the 
Gordons’ beautiful home at Lindsay Lake 
where we spent a laughter-filled afternoon. 
Saturday dinner in the Captain’s Room at 
Mory’s was a magic evening emceed by 
Don (Dorian Gray) Shedd - only Hugh 
Williams changed less. Everyone was stir¬ 
red by a vintage rendition of “McNamara’s 
Band" by the talented General Tom 
Whelan. 
Don limited all to three minutes to sum¬ 
marize their past 40 years. Charming us 
with stories were Joe Morris, Julie Sachs, 
Bill Banfield on glider flying, Don Shedd 
on surf sailing, Bruce Thayer and yours 
truly on scuba diving. 
More seriously, we remembered all who 
did not attend and hope you’ll be with us the 
next time. We want more time together. 
Never will we find companions whose iden¬ 
tities are so similar: depression-bom, with 
mutual goals, ethics, dedications and 
philosophical values. How fortunate we 











Dean Leon Rosenberg 
(left), William Kissick 
'57 M.D., ’61 Ph D. 
with reunion guests 
Lawrence Pickett '44 M.D., recipient of 
1986 Alumni in Medicine Distinguished 
Service Award 
Dwight Miller '56 M.D., president. 
Association of Yale Alumni in Medicine, 
congratulates Russell Scobie ’29 M.D., 
the 1986 Alumni in Medicine Distinguished 
Service Award recipient. 
American Medicine." Our patient relation¬ 
ships were based on affection and personal 
interest. I hope Yale’s new physicians will 
experience the same fulfillment we have. 
The class’s professional accomplish¬ 
ments are most impressive and would take 
a book to enumerate. We can all take pride 
in Yale Med. ’46. 
1951 
35th Reunion 
by John Sullivan 
The reunion was modest this time. Most of 
the people we talked to are gung ho for the 
40th and were taking a raincheck on the 
35th. So be it, we enjoyed it. The academic 
program was as it should be: thoughtful and 
stimulating. 
Friday night was a fun night with the 
Dean’s reception, cocktails and a dinner- 
dance at Woolsey for all Yale medical fam¬ 
ily and guests. As 1 understand it, the medi¬ 
cal alumni dinner-dance was Lowell Good¬ 
man’s idea. This guy gets better with time. 
Saturday night was a seafood luau at Ina 
and Sid Furst’s wonderful beach home in 
Woodmont. It was the ideal spot for our 
group. We had the Tom Amatrudas, the 
Lowell Goodmans, the John Haxos, the 
Carrold Iversons, the Frank Allens, the 
Paul Bruchs, the Walter Morgans, Jocy- 
lin Malkin, the John Sullivans and the Sid 
Fursts. Much, much, much talk of the good 
old days, pictures of families. 




by Dwight F. Miller 
Twenty-four classmates convened in New 
Haven for a congenial reunion to celebrate 
our 30 years out. The reunion found every¬ 
one in good health and good spirits with 
youthful vigor. Between cocktails hosted 
by the Gardners, dinner hosted by the 
Downings and a New England clambake 
dinner at the Amarante Seacliff Inn, a spirit 
of kinship prevailed. All of the school ac¬ 
tivities were greatly enjoyed. 
Present were Alan Apfel, Alfred Be- 
rend, Leo Boyajian, Thomas Brown, 
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John Carroll, Edwin Child, Chandler 
Dawson, Steven Downing, Mitchell 
Edson, Gilbert Eisner, Tom Ferris, John 
Gardner, Bill Gryboski, Al Gurwitt, 
John Hart, Bill Hindle, Marie-Louise 
Johnson, Jerome Klein, Dwight Miller, 
A. Frederick North, Bill O’Brien, David 
Page, Robert Scheig and James Scheuer. 
1961 
25th Reunion 
by Anoush Miridjanian 
On Friday, the first day of our reunion, 31 
classmates and guests gathered to hear 11 
colleagues summarize their academic and 
clinical activities. The following afternoon, 
they assembled as three generations of Yale 
medicine, with Drs. Tom Forbes and Sam 
Kushlan as special guests, and seven stu¬ 
dents from the Class of 1989. 
The dialogue was intensely interesting. 
Each classmate summarized his 25 years of 
medical experience and perspectives of the 
rapid changes in medicine, as well as 
changing expectations of a society. Present 
conflicts and confusion in medicine fueled 
the dialogue. 
The first-year medical students presented 
their concerns about the future character of 
medical practice, and a lively discourse 
emerged. The “old grads” felt that student 
participation should be part of future reun¬ 
ions. 
A heartwarming dinner at Mory’s wound 
up the event, which was our most entertain¬ 
ing and delightful reunion. 
Attending the reunion were Kenneth 
Arndt, Earl Baker, Robert Briggs, David 
Brook, Lawrence Chiaramonte, Paul 
Deiter, Wayne Downey, Philip Felig, 
John Fenn, Norbert Fleisig, Royal Hud¬ 
son, Joseph Jasaitis, Marguerite Leder- 
berg, Robert Levy, Robert Livingston, 
George Lordi, Hugh Lurie, Sally Mar- 
chesi, David Matloff, Anoush Miridja¬ 
nian, Richard Moore, Norman Moss, 
John Pearce, Elaine Pitt, Roy Ronke, 
Charles Sachatello, Franklin Top, John 
Weil, Warren Widmann, Murray Witt- 
ner and John Woodward. 
1966 
20th Reunion 
by Donald J. Cohen 
The Class of 1966 gathered for dinner at 
the New Haven Lawn Club. Dr. Alvan 
Feinstein, our instructor in physical diag¬ 
nosis and now a famous epidemiologist/ 
methodologist, was invited as a special 
guest. He discussed where Yale medicine 
has been and where it is now going. There 
was broad agreement that our era was ex¬ 
ceptionally fine for clinical education at 
Yale. 
At dinner one highlight was an open dis¬ 
cussion in which each member described 
his life and work, in and out of medicine. 
The range of careers and achievements is 
extraordinary. We also shared information 
about other classmates, accounting for 34 of 
them. 
Clarence Sasaki and Donald Cohen 
have joined David Melchinger as class sec¬ 
retaries. Anyone with information to share 
or ideas for future reunions should com¬ 
municate with them. 
Seventeen returnees (with spouses and 
guests) who registered were Donald 
Cohen, Joseph Donadio, Anthony Fap- 
piano, Peter Gibbons, J. McLeod 
Griffiss, Stuart Hauser, William 
Houghton, John Howard, Neal Koss, 
Harvey Mann, Caroline McCagg, Wil¬ 
liam Peterson, James Sansing, Clarence 




by Barbara Kinder 
The class reunion dinner was elegantly pro¬ 
vided at the home of John and Ellen Eber- 
sole. Everyone enjoyed the nostalgia, re¬ 
miniscences and the hilarity. All felt that 
maturity was progressing satisfactorily for 
the '7 lers. 
Attending the reunion were Ward Cates, 
John Cieply, Frederick Cohn, David 
Cossman, John Ebersole, Leonard 
Eisenfeld, John Foster, Richard Kauf¬ 
man, Barbara Kinder, William Krinsky, 
David Lippman, William Mangione, 
John Mills, Richard Moggio, John Patti, 
Barry Perlman, Michael Piercey, Irving 
Raphael, David Rinzler, Douglas 
Schmidt, Richard TYavers, Paul Vignola 
and Albert Weihl. 
1976 
10th Reunion 
by Robert Taylor 
Despite “typical” New Haven weather, the 
showers did not dampen the festivities as 
the Class of 1976 gathered for its 10th reun¬ 
ion dinner. Alfred Axtmeyer was even 
forgiven for his photo-finish planning. 
Mileage Plus awards went to Jack Tauber 
and Glenn Gorlitsky, both of whom de¬ 
serted Los Angeles for the weekend. 
Helping make quick work of acres of 
steamers and gallons of clam chowder were 
Florence Comite and husband, Henry 
Cabin ’75, Todd Estroff, Mark Cullen, 
Roger Boshes and Dan Schuster. Bill 
Levy came up from Pennsylvania and 
was joined by Dan Rahn and Charlie 
Swenson. 
The weather may have thwarted Rich 
Pelker and Ken Dobuler in their attempts 
to recruit a crew for an America’s Cup chal¬ 
lenge. Challenging the freeway was strenu¬ 
ous enough for most, including Sarah Au- 
chincloss, who arrived from New York, and 
Peter Swanson, who had the same experi¬ 
ence coming from the opposite direction. 
Soon to be a New Yorker again, Sid Man- 
delbaum nearly accepted Peter Ting’s 
offer for a high-performance driving lesson, 
leaving former mechanics Chris Golles and 
John Elefteriades to wonder what hap¬ 
pened to Sid's judgment. By the end of the 
evening however, these and other critical is¬ 
sues had been resolved, and it was unani¬ 
mously agreed to give it a go for another 
10 years. 
Twenty-five members of the class at¬ 
tended. They were Sarah Auchincloss, Al¬ 
fredo Axtmayer, Sharon Bonney, Roger 
Boshes, Florence Comite, Mark Cullen, 
Kenneth Dobuler, John Elefteriades, 
Todd Estroff, Ira Gewolb, Rose 
Goldman, Glenn Gorlitsky, Randall 
Hawkins, Christopher Jolles, Richard 
Kayne, William Levy, Sid Mandelbaum, 
Larry Markowitz, Richard Pelker, 
Daniel Rahn, Daniel Schuster, Peter 
Swanson, Charlie Swenson, Jack 
Tauber, Robert Taylor and Peter Ting. 
1981 
5th Reunion 
by Barbara Ross and Anthony Urbano 
The Class of 1981 held its first medical class 
reunion, and according to the Alumni 
Office records was numerically and in spirit 
the most successful 5th reunion ever. 
Twenty-one classmates, and a total of 32 
guests, convened as guests of the School of 
Medicine for the traditional "Friends of the 
50th” dinner. Class officers Barbara Ross, 
secretary, and Anthony Urbano, class 
agent, handled the arrangements. 
One fourth of the group assembled for the 
Friday program, while three-fourths of 
the group, still involved in graduate train¬ 
ing, were able to attend only the dinner 
Saturday. 
It was a wonderful party. We suggest that 
the Medical Alumni Association mix the 
old classes with the young next year. It was 
pleasant and easy to share medical school 
experiences with graduates 50 years out. 
We had a wonderful evening seeing one 
another again. It was great to see everyone 
happy and, especially, so successful and 
fulfilled. We hope to see everyone again for 
our 10th reunion. In reminiscing, those of 
us who have been away from Yale for some 
time were surprised to see how much the 
medical center and New Haven have 
changed. 
After the party, we were guests of Bob 
Goldman and his wife. Bob is at Yale-New 
Haven Hospital in the section of molecular 
neurobiology. Present were Ada Adimora, 
Peter Arvan, Cynthia Aten, Joan 
Bengtson, Louann Brizendine, Jeff 
Chodakewitz, Mariano Garcia, Robert 
Goldman, Mark Kasper, Robert Kenet, 
Thomas Kievan, David Lebwohl, Yvette 
Matory, Rose McCann, Donald Moore, 
David Paly, Robert Portney, Patrice 
Rehm, Barbara Ross, Dovelet Shashou 
and Anthony Urbano. 
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1985-1986 ALUMNI FUND REPORT 
A Message from the Dean 
The men and women who have graduated 
from the Yale School of Medicine are to be 
commended for their generous contribu¬ 
tions to the Medical School Alumni Fund. 
As you may know, the contributions sur¬ 
passed the half-million dollar mark—an 
impressive and record-breaking feat. 
As dean of the School of Medicine, I 
greatly value these contributions and wish 
to tell you that I have continued to direct all 
of these unrestricted gifts toward student as¬ 
sistance and the Student Revolving Loan 
Fund. By offering students this financial as¬ 
sistance we are assured of accepting and 
educating the brightest young people—re¬ 
gardless of their economic background— 
who will become tomorrow’s leaders in sci¬ 
entific research and medical care. 
In addition, more of our students are 
electing to take a fifth year to pursue 
independent research. The alumni’s strong 
support encourages students to expand 
their educational program and avail them¬ 
selves of Yale's distinguished educational 
resources. 
Drs. Lowell I. Goodman, Nicholas PR. 
Spinelli and other alumni fund-raising lead¬ 
ers have done a superb job in generating 
gifts to enlarge the Medical School Alumni 
Fund. I am extremely pleased and proud of 
the strong support the medical alumni offer 
their school. 
In the months ahead, I look forward to 
talking with you about our students, faculty 
and the many exciting developments within 
the Yale School of Medicine. Your con¬ 
tinued support and generosity make it possi¬ 
ble for me to fulfill my role as dean. 
Leon E. Rosenberg 
Dean 
Message from the Medical School Alumni Fund Chairman 
Christmas in July! 
Ever since I heard the news in July that the 1985-86 total gifts had topped the $500,000 
mark. I’ve been virtually speechless. 
The campaign got off to a good start last fall, and each month seemed to pick up a little 
more steam. Shortly after Christmas we began to hear rumors about a couple of large 
gifts and by spring-time everybody knew that we were really on a roll! 
Reunion weekend came and went in a blur and a whirl and a kind of numb anticipation. 
Once or twice I was heard to mumble “wouldn’t it really be great if...” Without being 
able to put my dare-to-dream—big wish into words. 
And then the word came through—the generous alumni and friends of the Yale School of 
Medicine had done themselves proud by assembling the largest largess ever. It will give 
my successor, Len Kemler, a suitable challenge for the next few years and should provide 
everyone who participated in the 1985-86 campaign a real warm glow of satisfaction. 
Hats off to the Class of 1936 for its bell ringing gift of $108,906 in celebration of its 
50 years of Yale doctorhood. 
Hallelujah to the Class of 1946 for the establishment of the Sanfurd G. Bluestein and 
Class of 1946 Scholarship Fund. Kudos to the entire crew of class agents who worked 
their magic ways with suasive and gentle entreaty. 
A paean of praise to the entire cast of contributors for their history-making response. 
I know that I shall be forever thankful to Yale for taking me under her wing way back in 
1946. I am even more grateful for the opportunity I have had as chairman these past five 
years to express my appreciation. 
YALE MEDICAL SCHOOL 
ALUMNI FUND BOARD 
Lowell I. Goodman, M.D. '51 chairman 
J. Roswell Gallagher, M.D. ’30 
Harry Sherman, M.D. ’34 
Samuel D. Kushlan, M.D. ’35 
Malvin White, M.D. ’39 
R. Leonard Kemler, M.D. ’43 
Nicholas RR. Spinelli, M.D. '44 
William McClelland, M.D. '47 
Harvey L. Young, M.D. ’52 
Harold Bomstein Jr., M.D. ’53 
Robert A. Kramer, M.D. ’55 
William Kissick, M.D. ’57 
William Waskowitz, M.D. ’57 
Nicholas Passarelli, M.D. ’59 
Earl Baker, M.D. ’61 
David Hill, M.D. ’65 
Douglas Berv, M.D. ’74 
O’Dell Owens, M.D. ’76 
FUND OFFICERS 1985-86 
Medical School Alumni Fund 
Lowell I. Goodman, M.D. ’51, chairman 
J. Roswell Gallagher, M.D. ’30 
Bequest and endowment co-chairman 
Samuel D. Kushlan, M.D. ’35 
Bequest and endowment co-chairman, 
and chairman, former house staff 
By the time you read this, another campaign year will be under way. My closing comment Public Health Alumni Fund 
will be a hopeful one: let’s keep the Medical School Alumni Fund growing and see if we Kathleen H. Howe, M.P.H. ’56, 
can reach the million dollar mark by 1991. chairman 
Lowell I. Goodman 
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Messages to Graduates and Friends of Epidemiology 
and Public Health 
The Department of Epidemiology and Pub¬ 
lic Health and its students are very grateful 
to the 618 alumni who contributed a total of 
$37,450 to the Yale Public Health Alumni 
Fund. The contributions of Kay Howe, the 
class agents and the telephone squads have 
been very important in inspiring our alumni 
in theircontinuing generosity. 
These funds, used for student support, 
have become increasingly necessary as the 
support of public health education by the 
federal government keeps diminishing. 
Many of our alumni recognize their good 
fortune in having graduated during times of 
much more adequate federal support and 
give so that current students can be spared 
some of the ever-increasing educational 
debt burdens. Compared with 10 years ago, 
the cost of education has more than dou¬ 
bled, and the level of federal support has 
been reduced to one third. 
Jan A.J. Stolwijk 
Chairman and Susan Dwight Bliss Profes¬ 
sor of Epidemiology and Public Health 
There is little I can add to Dr. Stolwijk's 
message except an expression of my warm 
gratitude to everyone who participated in 
this year’s Public Health Fund drive. To all 
those who supported the drive financially; 
to those who, in addition, gave unselfishly 
of their time as class agents; to those who 
joined in camaraderie for two phonathons in 
the spring, 1 extend my heartfelt thanks. 
Kathleen H. Howe 
Chairman 
Public Health Alumni Fund 
Recent Gifts to the Medical 
School Alumni Fund 
Each year, thousands of School of Medicine 
alumni and friends give to the Alumni Fund 
to provide support essential to the school’s 
educational strength. Each gift is important, 
helping to underwrite operating costs while 
eloquently expressing the generosity of the 
many individuals who believe in the 
school’s mission. Each has been gratefully 
received. These three examples represent 
the commitment and generosity of those 
who continue to offer that support. 
she might otherwise have made. It also en¬ 
abled her to endow a permanent memorial 
to her husband while providing scholarship 
assistance so vital to many students who 
pursue medical education at Yale. 
These gifts, and more than 2,000 other 
gifts to the Medical School Alumni Fund 
during the past campaign year, help to 
ensure the distinction of the School 
of Medicine’s teaching and research 
programs. 
A Gift to Honor the 
Memory of Parents 
Sanfurd G. Blue stein and 
the Class of 1946 
Scholarship Fund 
Recognizing the importance of an adequate 
source of financial support for medical stu¬ 
dents, Sanfurd G. Bluestein established a 
special challenge fund on the occasion of 
the 40th reunion of the Class of 1946. 
Dr. Bluestein of Montclair, N.J., pro¬ 
vided matching gifts—at nearly two-for- 
one—for all contributions made to the 
Medical School Alumni Fund by members 
of the Class of 1946. This spring, the school 
established a scholarship fund named to 
honor this principal donor and the class, 
with whose generous assistance the new 
fund was created. The fund will remain a 
challenge, since members of the Class of 
1946 and friends may add to it in the future. 
Memorials 
Deceased medical alumni and friends may 
be memorialized by a gift at any time to the 
Medical School Alumni Fund Endowment 
in the name and class of the person so hon¬ 
ored. The next-of-kin of a deceased medical 
alumnus/a is advised about this In 
Memoriam Program by a mailing from 
New Haven some weeks after the School of 
Medicine receives notification of the death. 
The letter of information includes a copy of 
The Testament of Remembrance in which 
the names of all persons so memorialized 
are listed in the medical section by class, 
thus establishing a lasting memorial. 
Donors receive a personal penned note of 
appreciation from me. Your inquiries and 
interest are welcome at any time. 
Deceased alumni and friends so honored 
for the first time in 1985-86 were; Eli Rubin 
'25, Thomas Farthing ’32, Francis Guida 
'34, George Hahn ’36, Francis Vose ’42, 
Allan Green '48, Lois Tice ’59, Gertrude 
Spinelli andT. Beers Townsend. 
Giving Life Insurance 
to Yale 
Earlier this year, an alumna in her early 70s 
who wishes to remain anonymous made a 
gift of a fully paid-up $50,000 life insurance 
policy to Yale. She made the gift after hav¬ 
ing made a single policy premium payment 
of $15,000. Proceeds from the policy will 
be used to establish a scholarship in the 
name of her late husband, who also 
graduated from the Yale School of 
Medicine. 
The gift of a life insurance policy enabled 
her to make a much larger gift to Yale than 
During the past fiscal year, on the occasion 
of this 50th reunion, a donor who prefers to 
remain anonymous established a charitable 
gift annuity in memory of his parents, both 
of whom also were physicians. The 
$100,000 gift will endow a special fund that 
the School of Medicine will use to provide 
financial assistance to students in the form 
of scholarships or loans. 
Because the annual proceeds from the 
Medical School Alumni Fund will enable 
the school to address student needs as they 
develop, the gift provides important flexi¬ 
bility to the school’s financial aid program. 
That helps balance the operating budget. It 
is also essential to the quality of the educa¬ 
tional process because it provides encour¬ 
agement and support to new generations of 
physicians and medical scientists as they 
prepare for careers in medicine. 
Richard G. Jordan 
Director, In Memoriam Program 
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Medical School Alumni Fund Class Participation 
Final Report - 1985-86 
1984-5 1984-5 1985-6 1985-6 
YEAR AGENT TOTAL % PART. TOTAL % PART. 
1922 and prior 1,995 — 2,180 — 
1923 William Cohen 541 60 553 67 
1924 Myron Sallick 5,081 71 — — 
David M. Raskind — — 1,873 67 
1925 Alice Whittier 875 67 755 70 
1926 Maxwell Bogin 551 71 2,927 83 
1927 Harry Zimmerman 1,048 53 1,025 60 
1928 Max Alpert 3,555 77 3,569 77 
1929 Paul McAlenney 1,192 72 1,341 67 
1930 J. Edward Flynn 15,984 60 6,072 70 
1931 Michael D’Amico 1,663 83 2,923 79 
1932 Henry Brill 1,725 44 2,066 54 
1933 Franklin Foote 1,537 63 1,944 73 
1934 John Ogilvie 4,071 65 3,898 50 
1935 James Haralambie 54,090* 70 12,837 57 
1936 George Hahn 5,850 47 108,906* 53 
1937 David Dolowitz 753 53 1,540 53 
1938 Nelson Ordway 1,215 74 1,065 53 
1939 Rebecca Solomon 3,371 62 18,441 67 
1940 James Ferguson 10,793* 67 8,453 54 
1941 Charles Cheney 2,856 64 3,692* 69 
1942 Walter Burdette 1,973 54 2,519 53 
1943A Dorothea Peck 2,995 69 2,908 70 
1943B S. Brownlee Brinkley 3,164 52 2,171 55 
1944 Nicholas Spinelli 8,393 61 6,014 76 
1945 Richard Breck 24,854* 65 4,025 60 
1946A Charles Judd 4,675 56 38,826 70 
1946B Thomas Whelan 3,084 62 19,274 81 
7,759 58 58,100* 75 
1947 William Roy Breg 4,700 59 4,925 59 
1948 Paul Koehler 5,407 56 6,067 62 
1949 Daniel Elliott 3,785 47 3,970 55 
1950 David Frucht 6,781* 71 4,486 76 
1951 Lowell Goodman 5,271 49 6,884* 52 
1952 Harvey Young 4,310 43 8,432 57 
1953 Vincent Gott 3,095 45 3,665 52 
1954 John Rose 5,323 67 5,088 68 
1955 Robert Kramer 8,841* 62 6,370 60 
1956 John Gardner 4,600 36 15,300* 57 
1957A Ronald Fishbein 3,620 59 4,576 61 
1957B Howard Minners 4,055 68 3,545 68 
7,675 48 8,121 64 
1958A Charles Hall 1,570 51 2,660 60 
1958B Paul Rudnick 4,010 56 4,135 65 
5,580 54 6,795 62 
1959A Asa Barnes 3,376 64 9,542 64 
1959B Muriel Wolf 4,679 46 4,355 66 
8,054 55 13,898 65 
1960A Roland Ingram 7,400 67 — — 
Victor Altshul — — 4,399 58 
1960B Thomas Kugelman 11,113 71 4,420 58 
18,213* 69 8,819 58 
1961A Earl Baker 2,625 52 3,625 45 
196 IB Anoush Miridjanian 2,310 44 9,375 56 
4,935 48 13,000* 51 
1962A A. Richard Pschirrer 2,865 54 2,300 54 
1962B Frank Hartman 1,475 32 1,800 25 
4,340 43 4,100 40 
1963 Craig Llewellyn 10,685 56 7,395 58 
1964A William Houghton 2,100 47 3,285 61 
1964B William Pratt 5,145 76 5,845 82 
7,245 62 9,130 72 
1965 David Hill 8,840* 53 5,455 47 
1966A Mary-Alice Houghton 2,580 66 3,500 69 
1966B Henry Mann 1,975 63 1,945 49 
4,555 64 5,445* 59 
1967A James Dowaliby 1,691 47 2,587 64 
1967B Anthony Lovell 3,605 77 4,290 77 
5,296 72 6,877 70 
1968A Frank Lucente 2,701 47 3,077 45 
I968B Donald Lyman 1,800 51 2,490 49 
4,501 49 5,567 47 
1969 Lee Jampol 5,872 52 6,516 60 
1970 James Missett 3,796* 42 3,526 45 
1971A John Cieply 1,942 40 4,691 61 
1971B Barbara Kinder 3,690 63 5,720 60 
5,632 54 10,411* 61 
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MEDICAL SCHOOL ALUMNI FUND CLASS PARTICIPATION —continued 
1984-5 1984-5 1985-6 1985-6 
YEAR AGENT TOTAL % PART. TOTAL % PART. 
1972 Paul Lucky 4,143 46 4,983 41 
I973A David Bailey 1,050 39 — — 
Lee Goldman — — 1,170 42 
1973B David Johnson 1,135 36 — _ 
John McQuade — — 848 32 
1973C Jerrold Rosenbaum 1,120 45 970 38 
3,305 40 2.988 38 
19 74A Amy Schecter 1,000 38 1,645 50 
I974B Robert Schecter 850 26 725 23 
1,850 22 2,370 37 
I975A Daniel Passeri 1,450 35 850 29 
I975B Mary Jane Minkin 1,135 19 865 16 
2,585 27 1,715 23 
1976 Robert Taylor 2,116 30 3,370* 39 
1977A David Kreis 600 21 — _ 
Attilio Granata — — 760 29 
I977B Ronald Vender 820 38 590 33 
1,420 29 1,350 31 
1978A Duke Cameron 1.360 26 1,105 26 
1978B Seth Powsner 105 14 150 21 
I978C Thomas Smith 110 20 265 47 
1,575 23 1,520 29 
1979A Jeffrey Kaine 266 23 391 28 
1979B Laurie Smaldone 445 21 — _ 
Cynthia Sherman - — 490 19 
711 22 881 23 
1980A Eduardo Alfonso 610 36 525 33 
I980B Mark Bernhardt 655 33 — — 
Cesar Molina — — 345 19 
1,265* 34 870 26 
1981 Anthony Urbano 575 17 1,310* 24 
1982A Muriel Cyrus 65 9 335 13 
I982B Jed Gorlin 135 27 110 23 
I982C Stephanie Wolf-Rosenbaum 115 17 235 36 
315 16 680 21 
1983A Michael Tom 170 10 175 11 
I983B David Schwartz 197 23 360 24 
367 76 535 16 
I984A David Astrachan 140 12 — — 
Hingge Hsu — — 210 14 
I984B Jay Kostman 121 17 115 9 
261 14 325 11 
1985A Robert Higgins — — 1,355 83 
I985B Fred Santoro — — 585 100 
I985C Javier Vizoso — — 359 100 
2,299 97 
* Reunion 




SOLI- CONTRI- PARTICI- 
CITED BUTORS PATION 
Alumni 3.509 1,613 46 
Former 
House Staff 1,004 168 17 
















$346,006* 3,583 1,773 50 $467,234° 
9,560 1,002 181 18 11,821 
11,787 432 79 18 8.558 
13,464 14,532 
$380,818 5,017 2,035 41 $502,145 
•Includes $67,373 for 3 life income gifts, 
" Includes $113,975 in life income gifts. 
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Public Health Alumni Fund Class Participation 
Final Report - 1985-86 
1984-5 1984-5 1985-6 1985-6 
YEAR AGENT TOTAL % PART. TOTAL % PART. 
1923-1941 _ _ _ _ 5,770 — 2,159 — 
1942 Eric Mood 460 80 420 60 
1943 Eric Mood 460 45 90 27 
1944 Eric Mood 260 33 275 22 
1945 — 110 43 135 50 
1946 — 80 33 75 29 
1947 — 220 35 330 48 
1948 Elizabeth Robinton 1,115 50 675 44 
1949 Elizabeth Robinton 495 36 465 33 
1950 Eric Mood 975 62 685 43 
1951 Norton Chaucer 645 38 600 50 
1952 Yolande Lyon 870 33 695 41 
1953 Milton Sisselman 730 39 810 52 
1954 Eric Mood 45 13 85 21 
1955 Frances Ogasawara 655 50 485 44 
1956 David Boyd 545 29 672 50 
1957 Edward DeLouise 525 57 705 52 
1958 Thomas Flynn 700 29 — — 
Philip Hallen — — 1,175 29 
1959 Dorothy Wilson 605 40 430 38 
1960 Else Schulze 195 25 — — 
R. John C. Pearson — — 1,159 43 
1961 William Slivka 655 50 1,075 40 
1962 A. Kay Keiser 75 20 — — 
Thomas R. Mayhugh — — 175 30 
1963 David Dolins 850 43 785 38 
1964 Estelle Siker 1,220 42 640 33 
1965 H. Patterson Harris 1,885 50 600 31 
1966 Allen Cohen 220 18 280 27 
1967 James Malloy 1,525 41 1,185 32 
1968 Arnold Saslow 1,805 45 1,705 51 
1969 Samuel Korper 1,035 36 955 32 
1970 Susan Balter 1,345 31 1,533 31 
1971 John Bihldorff 2,025 49 1,803 53 
1972 Dorothy Lewis 485 30 385 17 
1973 Judith Beatrice 1,495 29 1,160 31 
1974A Thomas Benoit 320 35 290 26 
1974B Karen Lindfors 535 44 475 40 
1975 Linda Broker 1,667 41 1,602 35 
1976 Elaine Anderson 1,690 35 1,140 30 
1977 Dorothy Rice 1,380 33 918 29 
1978 Ann Freedman 1,759 39 1,123 29 
1979A Catherine H. Norton — — 535 25 
1979B Ralph Tartaglione 1,505 32 460 38 
1980 Christina Quinn 1,155 37 1,050 27 
1981A Diane Goren 615 26 
Angelo DeVita — — 745 27 
1981 B Barbara Gaugler 240 32 490 36 
1982A Michele Visconti 265 14 — — 
Constance M. Jarowey — — 460 18 
1982B Amy Wilson 445 39 — — 
Jean L. Milton — — 290 30 
1983A Jeffrey Hughes 1,260 24 315 25 
1983B Mary Beth McNerney 175 16 190 22 
1984A Anthony Alberg 110 17 215 22 
1984B Leslie A. Balch 80 10 50 5 
1985A Joan M. Cleary — — 268 19 
1985B Katherine Santella — — 180 11 
ALUMNI/AE TOTALS 42,590 — 35,201 _ 
Interest/misc. gifts 2,396 — 2,339 — 
Baumgartner Match — - — — 
TOTAL 44,986 35% 37,540 32% 
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Contributors to the Medical School Alumni Fund 1985-86 
Alumni 
1906 
Charles R. Mitchell* 
1908 
Michael A. Parlato* 
1912 
Walter C. Tilden* 
1913 









Chester E. Hurwitz* 




Julius A. Olean* 
Hyman W. Weinstein* 
1924 
John J. Batchelor 
David M Raskind 
Myron A. Sallick 
Harold T. Vogel 
1925 
Waldo F. Desmond 
William E. Hall 
Samuel Reback 
Eli H. Rubin* 
Welles A. Standish 
Alice A. S. Whittier 
Howard A Wood 
1926 
Stanton T. Allison* 
Maxwell Bogin 
William H. Hahn* 




Joseph T. Matteis 
1927 
Milton B. Berman 
Wallace R Bostwick* 




William C. Meredith 
Moses Rothberg 
Theodore H Sills 
M. Dawson Tyson 
Harry M. Zimmerman 
1928 
Max Alpert 
Louis M. D’Esopo 
Sheldon A. Jacobson 
Raymond A. Johnson 
Edward P J. Kearney 
Ralph E. Knutti 
R. Harold Lockhart 
Edward W. Ludwig* 
Nathan E. Ross 
Robert I. Rubinstein 
John M. Russell* 
Alvin A. Schaye* 
Lewis A. Scheuer 
1929 
James Rae Arncill, Jr. 
Charles J. Epstein 
Robert A. Frisch 
Olive Gates 
George S. Goldman 
Alexander O. Haff* 
•Deceased 
Mr. John A. Hangen 
Harold J. Harris 
Paul F. McAlenney 
Tony L. Rakieten* 
William F. Roth* 
Russell B. Scobie 
Robert Tennant 
Newell R. Washburn* 
Julius G. Weiner* 




Daniel N. Beers* 
Ignacio Bird-Acosta 
Frederick Fitzherbert Boyce 
Charles A. Breck* 
Lewis Dickar 
Vincent A. Doroszka 
Knox H. Finley 
J. Edward Flynn 
J Roswell Gallagher 
James C. Hart 
Edmund L. Kitzmeyer 
Paul H Lavietes 
Moses D. Lischner 
James M. Lynch* 
Paul Watson* 
Amy H. Wilson 
Charles L. Wood 
1931 
Henry H Briggs, Jr 
Benjamin Castleman* 
Michael D’Amico 
Morris F. Heller* 
Helen R. Gilmore 
Paul A. Harper 
Harold E. Harrison 
Thomas C. Jaleski 
Rhoda M. Mickey 
Nelson Newmark 
James W Reed 
Abraham J. Schechter 
Max Taffel 
1932 
Louis K Alpert 
Henry Bnll 
Frank Carroll 
Clement C. Clarke 
Joseph P Donnelly 
Lee E. Farr 
Thomas E. Farthing* 
Lewis F. Foster 
Conrad R Lam 
Mario L. Palmieri 
Arthur J. Present 
Elizabeth M. Ramsey 
Benjamin N. Tager 
Rudolph E. Vandeveer 
Myron E. Wegman 
Roland J. Wehger* 
1933 
Myron J. Adams* 
Fred W. Buse 
Warren P Cordes 
Franklin M. Foote 
Jack Greenberg 
Daniel F. Harvey* 
George K Hirst 
John G. Martin 
Raymond E. Miller 
Ashley Pond III* 
Paul L. Saffo 
Sidney Stringer* 
John j. Wolfe 




James F. Blades 
Francis P. Guida * 
Derick A. January 
Herbert C. Miller 
John B. Ogilvie 
• Deceased 




George A. Carden, Jr 
Edgar S. Childs 
Sawnie R. Gaston 
H Hoffman Groskloss 
James Quintin Haralambie 
W. Howard Horner 
Mildred Hartshorn January 
Samuel D. Kushlan 
Donald P Morris* 
Norman E. Peatfield 
Norman P. Rindge 
Milton Rose* 




George Henderson Brown 
Dean Lester W Burket 
Albert W. Diddle 
Margaret C. L. Gildea 
George Hahn* 
Louise G. Hutchins 
E. Robbins Kimball 
Philip M. LeCompte 
E. James Mulligan 
Stephen F. Nagyfy 
Frederick A. Post 
Hugh Allan Smith 
Margaret Sommers 
Morris Tager 
Rafael Arrillaga Torrens 
Edgar W. Warren 
1937 
David A. Dolowitz 
D. Crosby Greene 
Joseph B. Hollingshead 
Wilbur D Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P Morrill 
Charles W. Neuhardt 
Alan A. Rozen 
Morgan Sargent 
Edward J Shaw 
Albert D. Spicer 
John M. TTiomas 
Jean Wells 
Mrs. Lucille R. Wiepert 
Lorande M. Woodruff 
1938 
Roy N. Barnett 
Henry L. Carideo 
S. Charles Kasdon 
Edward Nichols 
Nelson K Ordway 
Edward E. Pinkham, Jr. 
James Radcliffe, Jr. 
George E. Roberge 
Lester J. Wallman 
J. Richard Zahn 
1939 
Harold H Coppersmith 
Norman L. Cressy 
William H. Druckemiller 
Robert G. Ernst* 
John P Ferguson, Jr. 
Joseph B. Forman 
S. Jerome Greenfield 
Paul E Huston 
Nathaniel Kerugsberg 
Arthur E. Laidlaw 
Margaret A. Lennox 
Ward J McFarland 
James Peter Murphy 
Russell Nahigian 
Douglas S. Riggs 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
John D. Tobin 
Darrell G. Voorhees 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 
1940 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
Thaddeus S. Danowski 
Robert M. Dunlap 
James F. Ferguson, Jr. 
Eugene J. Fitzpatrick, Jr. 
H. Stuart Irons, Jr. 
Donald G. Johnson 
Ira D LeFevre, Jr. 
Edward Martin 
William R. Oakes 
W. Norman Sears* 
Joseph E. Sokal 
J. Champneys Taylor 
Patricia E. Wanning 
John B Wells 
Helen H. Woods 
1941 
Sophia C. Alway 
Robert H. Areson 
W Randal Bell 
Knute E. Berger 
William A. Carey 
Joseph P. Carson, Jr. 
Charles B. Cheney 
Herbert W. Diefendorf 
Robert Dine* 
Peter A. Duncan 
Lloyd D. Flint 
John Franklin 
Robert L. Gilbert 
William Edmund Kenney 
William Lee 
Bjorn Lih 
F. Eugene Martin 
John R McDermott 
Willys M. Monroe 
Edward B O'Connell 
Robert W. Ollayos 
Gioacchino S. Parrella 
David V. Pec ora 




Eugene M. de Hostos 
James M. Bunce 
Walter J Burdette 
Robert E. Carroll 
Vincent J. Collins 




Allan V. N. Goodyer 
William Harrison, Jr. 
John R Lincoln 
Patrick S. Mullins 
Dean Nichols* 
Michael A. Puzak 
Samuel Ritvo 
Richmond W. Smith, Jr. 
Edgar B. Taft 
Maurice Tulin 
Francis P Voss* 
Irving Norman Wolfson 
1943 March 
Ralph D Alley 
John R Brobeck 
Lycurgus M. Davey 
Gerard Fountain 
R. Leonard Kemler 
Joseph P Kriss 
Jonathan T. Lanman 
Douglas Lindsey 
J Philip Loge 
Henry E. Markley 
Walter J. J. Nero 
Dorothea R Peck 
Edward F. Rabe 
Earl J Rhodes 
Henry A. Riedel 
Bernard R Rowen 
Marcus E. Sanford 
Robert A. Sears 
Edward Hersey Soule 
Hilliard Spitz 
Nicholas M. Stahl 
Sophie Trent Stevens 
Oliver G. Stonington 
Frederick A. Waldron 
John J. Weber 
Robert H. Wyatt 
1943 December 
Richard N. Abbott 
John R Almklov 
David G. Borden 
Robert F. Bradley 
S. Brownlee Brinkley 
Henry H Bruyn, Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B. Chase 
Hunter H Comly 
Norman 1. Condit 
Ronald W. Cooke 
Joseph I. Epstein 
Robert H. Furman 
Victor C. Hackney 
Paul W. Hughes 
Frank R Hurlbutt, Jr. 
Henry H. Jones 
Sawyer E. Medbury 
Ira A. Rashkoff 
Donald W. Seldin 
Francis A. Spellman 
1944 
Carl Andrews 
Edward J. Conway 
John C. Coolidge 
George B Corcoran, Jr 
Frank W Countryman 
Charles H. Crothers 
Lawrence G. Crowley 
John H Doherty 
Robert W Frelick 
Carol Goldenthal 
Charles A. Hall 
Howard B. Hamilton 
Ward S. Jenkins 
Edith M. Jurka 
Jerome J. Kaye 
John Weaver King 
Frederick F. Krauskopf 
Elias J. Marsh 
Katharine Hawley Martin 
Mrs. Nora Harnden Mason 
Joseph Massaro 
A. Reese Matteson 
Paul E. Molumphy 
Russell R Monroe 
Lawrence K. Pickett 
Laurence G. Roth 
Haynes W. Sheppard 
Sarah P. Sherwood 
Eugene Smith 
Nicholas P R. Spinelli 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin W. Woodruff 
Reuben Zucker 
1945 
George Howard Allison 
A. John Anlyan 
Albert S. Atwood 
Frederic M Blodgett 
Richard W. Breck 
Louise H Burr 
Alice Shepard Cary 
Jay B Cohn 
26 
Thomas P. Cotter 
Edward M. Daniels 
Richard R. Dyer 
Robert S. Easton 
Alice Dershimer Friedman 
Raymond A. Gagliardi 
Philip S. Good 
Gove Hambidge, Jr 
Herbert S. Harned, Jr. 
O. Roger Hollan 
Hans R Huessy 
Leland W Jones 
William E. Laupus 
Raymond E. Lesser 
Garner L. Lewis 
Mark McD Lindsey 
Charles E McLean 
George W. Naumburg 
Richard M. Peters 
Elliot R Reiner 
Charles E. Sherwood 
Joseph R. Stanton 
Kenneth C. Steele 
1946 
Margaret J. Albnnk 
William G. Banfield, Jr. 
Franklin C. Behrle 
Frederick C. Biehusen 
Sanfurd G Bluestein 
Linus W. Cave 
Thomas J. Coleman 
Fred C. Collier 
James F. Cooney 
George C. Cusick 
Thomas A. Doe 
Edward F. Edinger 
Gregory E. Flynn 
Martin E. Gordon 
Charles S. Judd, Jr. 
Harold King 
Benjamin F. Kitchen, Jr 
James A. Kleeman 
Vincent J. Longo 
Richard H. Mann 
Thomas J Mathieu 
Hugh J. McLane 
Joe D Morris 
John H. Morton 
Thomas J Murphy 
John F. Neville, Jr. 
Laura W. Neville 
Vincent Pepe 
David H Riege 
Francis G. Reilly* 
Phillips E. Roth 
Julian A. Sachs 
Donald P Shedd 
Richard G. Sisson 
Colby S. Stearns 
R Bruce Thayer 
Robert H. Wagner 
William J. Wedemeyer, Jr. 
Thomas J Whelan, Jr. 
Hugh R Williams 
Elihu S. Wing, Jr. 
1947 
George R Barnes, Jr. 
Albert W. Bostrom, Jr 
John E. Bowers 
William Roy Breg, Jr. 
Rocco A. Calandruccio 
John L. Cannon 
M. Richard Carlin 
Charles R. Cavanagh, Jr. 
Roland G. Chambers 
Amoz I Chernoff 
William F. Collins, Jr. 
Robert P Darrow 
Archie L. Dean, Jr. 
Owen W. Doyle 
Franklin Harold Epstein 
Richard K. Friedlander 
Frank H Horton 
Robert J. Kerin 
Don F. Kimmerling 
Richard P Levy 
Brock Lynch 
Victor A. Machcinski 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry 
Philip H. Philbin 




Patricia B Tudbury 
Ellis J. Van Slyck 
M. Henry Williams, Jr. 
Sumner Root Ziegra 
1948 
Russell J. Barrnett 
George F. Batten 
Edith M. Beck 
Allyn G. Bridge 
Lee Buckingham Brown 
Richard Steele Buker, Jr. 
Arthur L. Coleman, Jr. 
Ruth E. Cortell 
G. Robert Downie 
Marie C. Duncan 
Elizabeth Fuller Eisner 
Boy Frame 
Emil Frei 3d 
Julian Frieden 
Allan Green* 
B. Herold Griffith 
Sylvia Preston Griffiths 
Richard M. Hannah 
Ross R Harcus 
W. Rayner Johnson 
Paul B Koehler 
Robert E. Lempke 
C. Arden Miller 
John P. Morris 
Richard C. Peterson 
George P. Rostel 
Benjamin F. Rush, Jr. 
Gabriel A. Saviano* 
Jerome H. Shapiro 
Jessie Parkinson Spear 
Anne G. St. Goar 
Paul Talalay 
Wallace W. Turner 
Paul Woodbury Weld 
1949 
George R. Anderson 
William G. Anlyan 
Alfred E. Bacon, Jr. 
Henry W Baird III 
Jonathan S. Bishop 
Thomas L. Chiffele 
Mary Pucci Couchman 
Phillip G. Couchman 
N. Joel Ehrenkranz 
Daniel W. Elliott 
Gunnar O. Eng 
Albert A. Fisk 
Paul S. Goldstein 
Eleanora C. Gordon 
Frederic W. Gray 
Jackson Harris 
Robert C. Howard 
Benjamin A. Johnson 
Orval I McKay 
Timothy F. Nolan, Jr. 
Julian I Pichel 
Edmund L. Piper 
Charles L. Rennell, Jr. 
Murray Z. Rosenberg 
Daniel Rudman 
R. David Sudarsky 
Martha Vaughan 
Mary-Agnes P Wine 
1950 
Russell N. Anderson 
Lyal D. Asay 
Malcolm A. Bagshaw 
John E. Borowy 
William H. Bucher 
Alvin Davis 
Claude W. Delia 
Kent Ellis 
Thomas J. Ferraro, Jr. 
♦Deceased 
Daniel Fine 
David A. Frucht 
Chesterfield G. Gunr, Jr. 
Melvin H. Kaplan 
Lucian S. Lapinski 
Sidney S. Lee 
John B LeRoy 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry McClelland* 
John H. Meyers 
Orlando J. Miller 
Robert T. Sceery 
Cynia B. Shimm 
Jane B. Shumway 
Martin Smith* 
John S. Strauss 
Robert H. Sturman 
1951 
Karel Bedrich Absolon 
W. Robert Adams 
Thomas T. Amatruda, Jr. 
Stanley D. Ardell 
Muriel H. Bagshaw 
Eleanor Clay Bigley 
John J. Egan 
Daniel X. Freedman 
Sidney S. Furst 
Joseph M. Garland 
Ralph M. Gofstein 
Lowell I. Goodman 
John T. Groel 
Robert N. Hamburger 
Carrold K. Iverson 
William Kiekhofer 
Jocelyn S. Malkin 
John J. McGarry 
Paul D Millikin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Charles A. Nugent, Jr. 
Gerard B. Odell 
Arthur A. Pava 
Majic S. Potsaid 
William F. Stephenson 
William Taylor* 
1952 
Richard N. deNiord, Jr. 
Frank A. Carone 
Siegried A. Centerwall 
Willard R. Centerwall 
Philip Gardner Deane 
Raymond S. Duff 
James R Durham 
John P. Filley 
Richard D. Floyd 
Robert P Gerety 
Thomas S. Kelly 
James Kent Luce 
Wilbur P. McNulty, Jr. 
N. Karle Mottet 
Robert F. Owen 
Sidney Nathan Paly 
Robert G. Petersdorf 
Leon A. Phillips 
John Macklin Roberts 
Leonard Rush 
Mary Wheatland Schley 
Donald H. Schultz 
Robert B. Schultz 
Virginia Lee Swanson 
John H Wagner, Jr. 
Doris L. Wethers 
John L. Wolff 




Harold D Bornstein, Jr 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
James P. Dunn 
Donnell Dencil Etzwiler 
Thomas O. Gentsch 
Vincent Lynn Gott 
Robert Emanuel Hamlisch 
George L. Hoffmann 
David Purdy Holman 
Peter Biggs Hukill 
Richard Robert Knowles, 3d 
Hildegard Mueller Leslie 
Preston Lee Leslie 
John Dutch Lord 
Robert N. Melnick 
Warwick Potter, Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
John C Roberts 
Barbara F. Rosenberg 
Irwin K. Rosenberg 
Virginia C. Saft 
Howard Willis Smith 
Ora K. Smith 
Lynn Cortland Stoker 
William Junior Vandervort 
William August Wilson 
1954 
Frank P Berg 
Richard J. Bouchard 
George N. Bowers, Jr 
Ralph K. Campbell 
John R Cole 
Alan H. Covey 
Arthur C. Crovatto 
Donald D Davis 
Frederick J. Fiederlein 
Walter J. Freeman 
John A. Gariepy 
Edward J. Gerety 
Frank L. Gruskay 
Nicholas A. Halasz 
Robert P. Hatch 
Walker R Heap, Jr. 
Herbert S. Hurwitz 
Robert F. Hustead 
Robert J. T. Joy 
Donald S. Kornfeld 
Lowell A. Kristensen 
Richard Lamb 
Harry C. Miller, Jr 
Paul N. Neufeld 
James J. Nora 
William J. Paule 
Anthony V. Piccirillo 
Richard D Pullen 
Jacques M. Quen 
Earl D. Rees 
John Keith Rose 
Elihu M. Schimmel 
Leonard M. Silverman 
Robert L. Stein 
John W. Vosskuhler 
1955 
John B. Atwater 
John C. Bailar III 
George E. Becker 
E. Edward Bittar 
Douglas G. Boyden 
Joseph I. Boylan, Jr. 
Irwin M. Braverman 
Edward Noel Brennan 
Padraic Burns 
Leo R. Cardillo 
Nicholas A. Coassin 
Edward D. Coppola* 
Milton Corn 
Pasquale James Costa 
Robert G. Crounse 
John G. Daley 
Fred Wendell Doyle 
William O. Edward 
Leroy Engel 
F Robert Fekety, Jr. 
Mahlon V. R. Freeman 
James Conway Garlington 
Barbara W. Gibson 
Paul Gonick 
Ion Gresser 
John H. Hodge 
D. Franklin Johnson, Jr 
Harry O. Kendall 
David R Kessler 
Robert A. Kramer 
James Lum 
Alexander Maitland III 
Joseph S. McGuire, Jr. 
Robert C. Nodine 
Gloria C. Onque 
John C. Pace, Jr. 
Robert H. Peters, Jr 
Gregory Peterson, Jr. 
Robert A. Reich 
Paul J. Robinson 
F. Brantley Scott, Jr. 
Clement B. Sledge 
Phillip W Smith 
Alan A. Stone 
Alexander Zuckerbraum 
1956 
Alan E. Apfel 
Levon Z. Boyajian 
Thomas M. Brown 
Dr. Rosalie A. Burns 
John F. Carroll 
Joseph C. Cerny 
Edwin L. Child 
James C. Collias 
Donald J Dalessio 
S. Evans Downing 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
John H Gardner III 
Sumner Gochberg 
Robert H Groves 
Arne G. Haavik 
Armen Charles Haig 
William H Hindle 
Marie-Louise T. Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Leo Lutwak 
Preston C. Manning 
Robert McDivitt 
Dwight F. Miller 
Elmer T. Mitchell, Jr. 
Donald J. Nalebuff 
RADM William M. Narva 
A. Frederick North, Jr. 
David A Page 
George W. Paulson 
Stewart E. Pursel 
Robert Lee Scheig 
James Scheuer 
Edward C. Senay 
Benjamin A. Shaver, Jr. 
Donald William Sherrick 
Daniel R Silbert 
1957 
Donald Agostinelli 
Joseph S. Amenta 
Jack Norman Blechner 
Richard I Breuer 
Harry C. Briggs 
Carl A. Brinkman 
John P. Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
John D'Agostino, Jr. 
Thomas H. Danaher 
James R. Dorr 
Salvatore Falbo 
Harold J. Fallon, Jr. 
Robert E. Fishbein 
Ronald H Fishbein 
Anthony L. Fons 3d 
Elizabeth H. Forsyth 
Gary A. Fry 
Robert H. Glass 
Anne H. Good 
Jack Peter Green 
Gilbert F. Hogan 
Warren R. Johnson 
Stanley E. Kilty 
William L. Kissick 
Edgar H. Levin 
Jack Levin 
Mark D. Marshall 
David E. Martin III 
27 
Howard A. Minners 
Robert K. Modlin 
Hugh Lamson Moffet 
George Albert Nelson, Jr. 
Herbert A. Newman 
Thomas Francis O’Brien, Jr. 
Joseph S. Pagano 
Raymond E. Phillips 
Clifford B. Reifler 
Arnold Schoolman 
Stanley Simbonis 
Kenneth A. Simon 
Charles A. Slanetz, Jr. 
Gilbert B Solitare 
Robert W. South worth 
Donald C. Stahl 
Arthur Taub 
William J Waskowitz 
1958 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
Dr. John P. Arnot 
Peter Alfred Benson 
Gerard N. Burrow 
Benjamtn Bursten 
David A. Carlson 
John A. Carlston 
Robert V. Diserens 
Donald A. Duncan 
Joel C. Eberlin 
Philip R. Fazzone 
Michael E. Fishman 
Raymond A. Gaito 
John C. Gallagher 
Marcia Kraft Goin 
William M. Gould 
James Greenwald 
Michael Kashgarian 
Haskins K Kashima 
Jay Ward Kislak 
Theodore W. Lieberman 
Myron Lotz 
Michael J. McCabe 
Leo T. McCallum 
Andrew Joseph McGowan, Jr. 
Robert S. Neuwirth 
David W O’Keeffe 
Carol F. Phillips 
David M. Pugh 
William B. Radcliffe 
Paul A. Rudnick 
William W. Schlaepfer 
Thomas R. Shea 
Bruce H. Sklarew 
Richard E. Sledden 
Edward Lloyd Socolow 
Raymond W. Turner 
Margaret Smith Wenzel 
Joseph P. Wierzbinski 3d 
John Patrick Wood 
Pauline B Wood 
1959 
Scott Ingram Allen 
Carol J Amick 
Robert M. Amick 
Asa Barnes, Jr. 
Jack F. Bowers 
William C. Butterfield 
Edwin M. Clayton 
Sicney M. Cohen 
Lyall S. Crary, Jr. 
Ronald C. De Conti 
William L. Donegan 
Gerald Fenichel 
Robert L. Fisher 
Paul Jay Friedman 
Robert L. Fisher 
Paul Jay Friedman 
Robert J. Gonyea 
Gerald B. Gordon 
W. Keith Hadley 
William H. Heydorn 
C Richard Hinckley 
Leonard Inker 
John J. Jasaitis 
Edvardas Kaminskas 
David W. Kingsbury 
•Deceased 
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Myron S. S. Lee 
Kathryn Huxtable Lewis 
Raymond Mark 
John C. Marsh 
Brian J McGrath 
D. Kent Morest 
James A. O’Neill, Jr. 
Robert H. Ostberg 
Nicholas M. Passarelli 
Charles A. Phillips 
Lincoln T. Potter 
James D. Prokop 
James R Ralph 
David Pardee Reed 
Joseph D. Saccio 
Marc D. Schwartz 
Sanford P. Solomon 
.Gene W. Spector 
James J. Stagnone 
Lisa A. Steiner 
John S. Strauss 
Lois Tice* 
Leo H. Von Euler 
Robert E. Waugh 
Muriel D. Wolf 
1960 
Victor Altshul 
Alan W. Ames 
Jack D Barchas 
Colin Mercer Bloor 
Ormond V. Brody 
Donald P. Buebendorf 
Stanley M. K. Chung 
Louis A. D'Avanzo 
David Dunn* 
March Enders 
Caldwell B. Esselstyn, Jr. 
Warren H. Fisher 
Paul Jay Friedman 
Eugene C. Gaenslen, Jr. 
James I. Gilman 
Maxwell E. Gottesman 
Sylvia D. Grant 
Roland H. Ingram, Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P Kindwall 
Susan T. Kleeman 
Thomas P. Kugelman 
Edward R. Lang 
Thomas Lau 
Thomas L. Lincoln 
Edward Longo 
Eugene G. McCarthy 
Donald L. Miller 
Richard G Morrill 
Allan W. Newcomb 
Buford L. Nichols, Jr. 
Fred Palace 
Albert Matthew Ross 
John J. Schrogie 
Fred Stargardter 
Constantine M. Voyagis 
Robert C. Wallach 
May Yung-Fun Woo Wang 
Ronald A. Yankee 
1961 
Kenneth A. Ardt 
Earl L. Baker 
Albert A. Bechtoldt, Jr. 
Robert S. Briggs 
David William Brook 
Paul David Deiter 
Ralph J. DePonte 
Ronald A. Dierwechter 
Jon Dudley Dorman 
John E. Fenn 
Norbert Fleisig 
Edward C. Gilbert 
Louis D. Hunt 
Joseph E. Jasaitis 
Richard L. Keefe 
Robert Isaac Levy 
Hugh James Lurie 
David B. Matloff 
Anoush Miridjanian 
Richard Allen Moore 
Norman 1. Moss 
John Curtis Parker 
Elaine Pitt 
William M. Rogoway 
Roy E. Ronke, Jr. 
Thomas H, Sakoda 
Stanley G. Schade 
Robert N. Taub 
Hugh C. Thompson III 
Franklin H. Top, Jr. 
David E. Weaver 
Warren D. Widmann 
Murray Wittner 
John R. Woodward 
1962 
Michael H. Alderman 
Charles B. Anderson 
Frederic P. Anderson 
Dean E. Burget, Jr. 
Frederic K Cantor 
Ray Allen Carlsen 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
I Bruce Elfenbein 
John W. Foreman 
Stephen John Flicker 
Roger P. Friedenthal 
John N. German 
John T. Harrington 
Patricia C. Hassakis 
J. Dale Howe 
Victor W. Hurst III 
Gary Jacobson 
Glenn L. Kelly 
David E. Knoop 
John P. Lynch 
Stanley E. Matyszewski 
William A. Miller 
Malcolm S. Mitchell 
A. Richard Pschirrer 
James A. E. Spencer 
H Oliver Stoutland 
Seth Thaler 
Sherwood Waldron Jr. 
1963 
Arthur Howard Ackerman 
Miguel R. Alonso 
V Richard Back 
Charles W. Carl, Jr. 
Theodore J. Chu 
Gordon S. Cohen 
John E. Conte, Jr. 
David F. Cross 
James S. Dalsimer 
Dudley Seth Danoff 
Andrew Edin 
B. Allen Flaxman 
David H. Fram 
William T. Friedewald 
David H. Fulmer 
Alexander R. Gaudio 
Vincent F. Geremia, Jr. 
Lee D. Goldberg 
Peter B Gregory 
Benjamin Keith Harris 
Brian C. Judd 
Constantine D. Kyropoulos 
William B Lehmann 
Craig H. Llewellyn 
Edward G. Lund, Jr. 
Sally Lockwood Marchesi 
Vincent T. Marchesi 
Robert H Margulis 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R. Pinnell 
Jay M. Pomerantz 
Gene R Profant 
Berkely L. Rich 
Lee Bland Talner 
Peter V. Tishler 
Lawrence Tremonti 
Gary Van Galder 
Peter G. Weiner 
Jerome Allen Winer 
Alfred J. Wise 
1964 
William A. Alonso 
Berton W, Ashman 
Sidney M. Baker 
Leland S. Berger 
Philip Blume 
Anthony J. Bravo 
Robert M Briggs 
Joseph F J. Curi 
Mary V. Digangi 
Alfonso Esguerra 
Anthony Ferrante 
Norman C. Fost 
Peter A. Gross 
John F B. Haney 
Gene I. Higashi 
Richard Hockman 
Lawrence Horwitz 
William J. Houghton 
Sue Kimm 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
James S. Levine 
Paul R. Lightfoot, Jr 
Richard Murray Linburg 
Robert W. Lyons 
William F. Matchett 
Thomas O McCann 
Alan H. Morris 
James J. Murphy 
Donald A. O’Kieffe 
William B. Pratt 
Jack S. Rice, Jr. 
Stanley Rosenberg 
Jonathan J. Russ 
Saul M. Schanberg 
Robert L. Shelton 
Major Tadashi Shimada 
Diane Shrier 
Donald G. Skinner 
A. Thomas Snoke 
Richard C. Stillman 
Lyall C. Stilp II 





Susan A. Aoki 
Thomas T. Aoki 
John H. M. Austin 
Paul Balter 
Victor J Burner 
Thomas B. Caldwell III 
David G. Campbell 
Robert M. Cohn 
Michael J. Cummings 
Phyllis Hurwitz Duvdevani 
David S. Fedson 
Robert I. Finkel 
Gary Lawrence Gross 
Robert Andre Gryboski 
Reid R Heffner, Jr. 
David A Hill 
Carl E. Hunt 
Ronald J Karpick 
Mohandas M. Kini 
Richard J. Kozera 
David J Kupfer 
David B. Leof 
Sandra Chook Levine 
Mark W. Lischner 
Walter W. Noll 
A. Lawrence Ossias 
John A. Parrish 
Robert L. Pickens 
Alan N. Rachleff 
John H Seashore 
Margaretta Ann Reed Seashore 
Charles J. Semonsky 
David M. Shames 
David P. Simmons 
Harlan Spitz 
Alan William Stone 
Bert Yuan-Shu Wong 
1966 
Benjamin F. Balme 
John D. Baxter 
Frank C. Bell 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Jospeh A. Donadio 
Robert E. Dragon 
Marvin A. Eisengart 
Jared M. Emery 
Peter M. Fitzer 
Robert N. Frank 
Robert C. George 
Peter D. Gibbons 
Stanley I. Greenspan 
J. McLead Griffiss 
Robert A. Gunn 
Henry G. Hanley 
Jay G. Hayden 
Mary Alice Houghton 
Richard J. Howard 
Bruce W. Jackson 
Gordon R Kelly 
Neal Koss 
Stuart M. Kotler 
Wilbur L. Kukes 
David C. Law 
Lynne L. Levitsky 
John Stephens Melish 
Marian Matheke Melish 
Harold Mellin 
William D. Peterson 
Joel Singer 
James D. Slavin, Jr. 
Mark Snider 
Gary Love Townsend 
Lee Van Lenten 
Joan T. Wayland 
Jon S. Wayland 
John W. Wickenden 
Arne S. Youngberg 
1967 
Daniel L. Arons 
Arthur L. Beaudet 
Richard S. Bockman 
Daniel Booser 
Gary C Burget 
William H. Cave, Jr. 
Mary Williams Clark 
Cynthia Rapp Curry 
Marian C. Davidson 
James J. Dineen 
Timothy J. Dondero. Jr. 
James M. Dowaliby II 
John A. Drews 
Peter R. Egbert 
Herbert W. Felsenfeld 
Melvin Victor Goldblat 
Richard J, Hart 
Richard L. Heppner 
Peter N. Herbert 
George P Herr 
Melvyn Ko rob kin 
Carl E. Lane 
Anthony P Lovell 
Ralph G. Maurer 
Stephen W. Miller 
William J. Mitchell 
Joseph L. Morris 
Jennifer Robinson Niebyl 
John O. Pastore 
William E. Perkins 
Brian F. Rigney 
Robert I. Roy 
Jonathan L. Saveli 
Stephen C. Schimpff 
Sidney C. Smith, Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B. Swett 
M. David Tilson 111 
Karen H. Toker 
George Tyler 
Robert A. Vogel 
Robert A. Vollero 
Joseph F. Walter 
Martin Wand 
Redford B. Williams, Jr. 
Robert J. Winer 
Robert S. K. Young 
Peter M. Zeman 
1968 
Donald R Coustan 
Robert G. Dillard 
Edward M Drury 
Barbara Mayer Egbert 
Alan G. Finesilver 
William F. Flynn 
Richard A. Getnick 
Mark Gilbert Grand 
Leonard Grauer 
Ralph S. Greco 
Kevin N. Hennessey 
John R Hill II 
Harry Holcomb III 
Jeffrey S. Lee 
Ellen Marks Lippman 
Frank E. Lucente 
Donald O. Lyman 
Rodrigo Martinez 
David P. Millett 
Richard P Mills 
Richard M. Morehead, Jr. 
John A. Ogden 
James W. Ogilvie 
Jackson B E. Pickett 111 
Joseph L. Renda 
Gordon H. Sasaki 
Jacob .1 Schlesinger 
Frederick C. Sherman 
Elizabeth M. Short 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
Per Henrik Wickstrom 
Creed W. Wood 
1969 
Charles S. Angell 
David G Ansel 
David W. Barry 
Robert E. Belliveau 
David A. Berkowitz 
William F. Bynum 
N Roger Cooke 
Leo M. Cooney, Jr. 
Richard J Daly 
Michael W. Dennis 
Charles A. Dinarello 
Douglass T. Domoto 
Ralph J. Falkenstein 
Gary S. Farnham 
Lesley Forman Fishelman 
Steven A. Frankel 
Anna S. Gail 
Royal J. Gay 
Sander G. Genser 
Robert O. Gordon 
Thomas C. Howard 
Lee M. Jampol 
Joel Mark Kaufman 
Paul H. Kelker 
John J. Kelly, Jr. 
Rowena Korobkin 
Lynn G. Lagerquist, Jr. 
Michael R. Liebowitz 
Elliot M. Livstone 
Robert Marier 
Arnold F. Mazur 
Ellen B, Milstone 
Thomas F. Minehan 
Bruce K. Nagle 
Lionel M. Nelson 
Nancy Olmsted 
Deborah A. Putnam 
Joseph M, Rochford 
Joseph D. Robinson 
Dennis J. Rudzinski 
David J. Sahn 
Adrian M. Schnall 
David J. Schulak 
Gerald J. Smallberg 
Michael S. Toren 
Robert J Walat 
Stephen R. Webb 
1970 
Elissa B. Arons 
William Romney Burke 
Michael J. Chusid 
C. Norman Coleman 
Michael D. Danzig 
Daniel Frizell Dedrick 
Margaret W. DeLano 
Jonathan Ecker 
Richard L. Edelson 
Robert Alan Epstein 
Bruce A. Fabric 
Thomas H. Gouge 
Marcus W. Hedgcock, Jr 
Paul Hessler 
Jay H. Hoofnagle 
Mark A. Korsten 
Thomas L. Lewis 
Robert B. Litman 
Anne W. Lucky 
Jay W. Marks 
Leonard M. Milstone 
James R. Missett 
William K. Mueller 
W. Scott Peterson 
Robert M. Rosa 
Joel F. Rubinstein 
Dennis E. Shield 
Stuart S. Shorr 
Richard A. St. Onge 
Philip E. Steeves 
Daniel A. Symonds 





Judith L. Bader 
Gregory W. Bartha 
Michael .1 Beierle 
Laurie J Bleicher 
Bruce Block 
Marian H. Block 
Williard Cates, Jr 
John L. Cieply 
Frederick L. Cohn 
Andrew D. Cook 
David Cossman 
Edward C. Cottle 
Michael Cynamon 
John S. Ebersole 
Leonard I. Eisenfeld 
Harvey Fernbach 
Fred Finkelm-tn 
John W. Foster, Jr. 
Jared J, Gardner 
Richard Gloor 
Jerold Alan Haber 
Michael J. Hart 
William W. Hay, Jr. 
Richard Katzman 
Richard E. Kaufman 
Barbara K. Kinder 
Stuart R. Kleeman 
William L. Krinsky 
David H. Lippman 
William J. Mangione 
Samuel S. Masters 
John C. Mills 
Patrick T. Minihan 
Steven H. Moffic 
Richard Albert Moggio 
Martin Paris 
Robert Park 
John A. Patti 
Barry Bruce Perlman 
Stuart B Phillips 
Michael C. Piercey 
Anthony V. Proto 
Barry S. Rand 
Irving G Raphael 
David M. RinzJer 
Douglas R, Schmidt 
James P. Southwick 
Jonathan W. Stewart 
Richard D. Travers 
Yvonne E. Vaucher 
Paul A. Vignola 
Robert B. Vranian 
Ray C. Walker 
Burns Woodward 
1972 
Robert D. Arbeit 
* Deceased 
Michael A. Catalano 
Philip L. Cohen 
Gloria Cummings* 
Robert F. Deblasi 
Norman M. Dinerman 
William H. Druckmiller, Jr. 
M. Felix Freshwater 
Dorothy M. Gohdes 
Andrew E. Hoover 
Thomas L. Horn 
Vernon H. Humbert, Jr. 
Anthony H. Jackson 
Jesse B. Jupiter 
Roy A. Kaplan 
Donald L. Kent 
David L. Kneapler 
Philip L. Lebowitz 
Theodore M. Levin 
Paul A. Lucky 
Jeffrey S. Menkes 
Jerome H. Meyer 
David B. Moyer, Jr. 
John P. O’Grady 
Thomas H. Ogden 
Edward J. Olinger 
William L. Risser 
Philip M. Rothfeld 
John S. Smolowe 
Frederick D. Stockwell 
Lawrence P Temkin 
Philip J. Weyman 
Michael W. Yogman 
Steven M. Zeldis 
1973 
David Nelson Bailey 
Richard P Bozof 
Mary Ann Brunstetter-Shafer 
James N. Campbell 
Marvin M. Chassin 
Joseph M. Connors 
Carolyn G. Dedrick 
Christopher M. Doran 
Joseph W. Eichenbaum 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert A. Florin 
Lee Goldman 
Gary T Grimes 
Andrew G. Kadar 
Michael S. Kramer 
Mark G. F. McCormick 
John F. McQuade III 
Jerry Nagler 
Claes M. Nilsson 
David E. Peach 
David Pickar 
Charles F. Reynolds III 
James S. Robertson 
Harry S. Romanowitz 
Jerrold F. Rosenbaum 
Robert A Sirota 
James F. Sullivan 
Robert J. Ursano 
Christine A. Walsh 
Marc A. Weinberg 
Richard S. K. Young 
1974 
Stephen B. Arnold 
Irving M. Asher 
Leonard I Banco 
Douglas A. Berv 
Bruce David Blumberg 
Neil Blumberg 
Peter J. Buchin 
Bert D. Collier, Jr. 
Paul David 
Vincent A. Di Maria 
Irl L. Extein 
Reginald K. Franklin 
Allan B Friedland 
Michael A. Gerber 
Ary Louis Goldberger 
David Grant 
Robert F. Hempton 
Ancil A. Jones 
Saul Lande 
Olusegun O. Lawoyin 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
Amy S. Schechter 
Robert J. Schechter 
James A. Strom 
George H. Talbot 
Carol C. Teitz 
John Jones Thompson 
1975 
Ralph E Binder 
William S. Bush 
Rodney J. Butch 
Brendan Clifford 
Carol L. Kandall 
Kevin Kane 
Robert F. Malacoff 
Hyman J. Milstein 
Mary Jane Minkin 
Robert G. Nankin 
Andrew B. Newman 
Edwin G. Olson 
Vivian Reznik 
Philip J. Rich 
Fred P. Rosenfelt 
Robert S. Sandler 
Steven A. Schwartz 
Sydney Z. Spiesel 
Barbara J Stoll 
Mark F. Wheeler 
Henry S. Willner 
David M. Zwerdling 
1976 
Sarah S. Auchincloss 
Alfredo L. Axtmayer 
John C. Bartlett 
Peter B Bitterman 
Alan B. Bloch 
Sharon L. Bonney 
Roger A. Boshes 
Randall D. Cebul 
Joseph Ciabattoni 
John D. Clemens 
Mark R. Cullen 
Geoffrey Etherington 
Leonard Firestone 
Ira H. Gewolb 
Rose Hannah Goldman 
Glenn A. Gorlitsky 
Joel Kabak 
Norman V. Kohn 
William J. Lederer 
William K. Levy 
George W. Luedke 
Douglas G. Mann 
James L. Rosenzweig 
Mark C. Ruchman 
Susan H. K. Ryu 
Lawrence E. Samelson 
Richard S. Schottenfeld 
John T. Sladky 
Bonita F. Stanton 
F. Peter Swanson, Jr. 
Jacob E. Tauber 
Robert F Taylor 
Peter M. Ting 
John C. Wiles 
Carol M. Ziminski 
1977 
John J Boronow 
Christopher S. Clark 
Stuart Brian Dubin 
Marybeth Ezaki 
Susan Firestone 
James A. Fox 
Julia B. Frank 
Attilio V. Granata 
Steven R. Hahn 
Robert W. Hand 
Jeffrey Neal Hausfeld 
Bruce L. Innis 
Joseph J. Jacobs 
Howard K. Koh 
Margaret S. McKenna 
Robert J. Mitchell 
Alan S. Penzinger 
Theordore M. Pitts 
Leonard A. Rappaport 
Susan Bromberg Schneider 
Phyllis A. Taufield 
Steven L. Warsof 
John E. Whitcomb 
J Douglas White 
Daniel Wohlgelernter 
1978 
Thomas T. Amatruda 
Michael J. Anderson 
Richard J. Baron 
Joann N. Bodurtha 
Booker T. Bush, Jr. 
Duke E. Cameron 
Emilio L. Cruz III 
Emily A. Fine 
Eugene Glenn Fong 
Stuart M. Forman 
Arthur M. Gershkoff 
Linda J. Hall 
Jerald D. Hansing 
Robert Hershfield 
Elizabeth S. Hodgson 
Robert L. Kraft 
Cynthia S. Kretschmar 
Michael R. Lerner 
Kenneth L. Marek 
Noreen F. Rossi 
Sally Rudicel 
Steven M. Shoum 
Donald C. Simonson 
Thomas Joseph Smith 
Stanley J. Tillinghast 
Sharon R. Weinstein 




David A. Brenner 
Ken Burkus 
Stuart L. Bursten 
Isabel Cunningham 
Orlando Fernandez 
Joel I. Franck 
John Jay Gargus 
David E. Golan 
Bruce Halpenn 
Edward C. Halperin 
Jeffrey L. Kaine 
Helen H. Kay 
Michael K. Lindsay 
David E. Ness 
Jean Rosenthal 
Gary L. Schaer 
Cynthia Anne Sherman 
Thomas Trumble 
John T Woo 
Jeffrey Work 
1980 
David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R. Aronson 
David Allen August 
Jay M. Baraban 
Patricia Church Brown 
Michael W. Champeau 
Michael M. Chang 
Thomas F. Deering 
Jeffrey Neil Dornbusch 
Forrest John Doud 
Todd J Garvin 
Marc F, Glickstein 
David Jay Goldberg 
Gary I. Greenwald 
Mr. George B. Holmes, Jr. 
Jonathan L. Jacobs 
Theodore W. Marcy 
Suzanne M. Matsui 
Cesar R. Molina 
Jane G. Schweitzer 
John A. Selling 
Marcia R. Taylor 
Walter H. Williams 
1981 




Stephen Wilson Burgos 
Patricia A. Burke 
Marc D. Coltrera 
Christine M. Duranceau 
Louis Essandoh 
Johnathan M. Fine 
Paula M. Fracasso 
Ramona Q. Fung 
Judy E. Garber 
Robert S. Goldman 
Sol Hamburg 
Alan Heimann 
Scott A. Hundahl 
Robert M. Milstein 
Robert B Portney 
Barbara A. Roach 
Dovelet Shashau 
Bernard H P. Shen 
Martin H. Teicher 
Anthony M. Urbano 
Nancy E. Vinton 
Aizik L. Wolf 
John C. Wong 
1982 
Sylvia R. Beck 
Rise Maura Chait 
Richard J. Doan 
Keith L. Gladstien 
Liba E. Goldblum 




Kathleen Anne Nolan 
Joyce A. O'Shaughnessy 
Came A. Redlich 
Robert J. Rizzo 
Robert M. Rohrbaugh 
William M. Sikov 
Henry J. Stern 
Lynn T. Tanoue 
Albert L. Ungricht 
David A. White 
Stephanie Wolf-Rosenblum 
1983 
John Taylor Adams* 
Amos Bodner 
Robert E. Bookstein 
Elena Citkowitz 
Ana Maria Lamas 
Adam Lerner 
John H. Neal 
Dan A. Oren 
Augusta S. Roth 
Leonard B. Saltz 
David E. Schwartz 
Michael Silverberg 
Daniel M. Sosin 
Philip M. Spiro 
Kenichi Takeshita 
Pamela Leslie Zeitlin 
1984 
Charles S. Abrams 
David 1. Astrachan 
John F. Babich 
Leonard O. Bell 
Barbara Ann Coda 
Donald Ingber 
Michel Kliot 
Jay R. Kostman 
Steven A. Porcelli 
Paul B Rothman 
Andrew L. Sternlicht 
1985 
David M. A]win 
Brian H, Annex 
Robert A. Aronowitz 
Jaime I. Arroyo 
Michael Behrman 
Barry D Bergquist 
J Alexander Bodkin 
Stafford R Broumand 
Vance Brown 
JoAnne Burger 
Jennifer L. Calagan 
Jane E. Carter 
Peter Chang Sing 
•Deceased 
Alice S. Y. Chi 
Terri L. Cornelison 
Julie Ann Danaherson 
Bryan DeSouza 
Calixto E. Dimas 
Carol F. Farver 
Guy Fried 
William D. Gaillard 
Richard Bruce Garber 
Michael W Gilbert 
Samuel Goos 




Robert S. D Higgins 
Marie Hobart 
Victor W. Hsu 
Virginia S. Huang 
Stuart Neal Isaacs 
Darlyne A. Johnson 
Michael A. Johnson 
Robert Klitzman 
Susan Korrick 
Shirley J. Lee 
Jonathan Lewin 
Ronald M. Lisan 
Ted W. Love 





Kathleen F. Maurer 
John Jerome Merendino 
Marnin A. Merrick 
Brent Moelleken 
Susan E. Moore 
Jeffrey Morton 
Elizabeth G. Moy 
Jon Nakamoto 
Robert D. Needlman 
Lisa Nelson-Robinson 
Thomas Newton 
Richard George Parker 
Leslye C. Pennypacker 
Samuel Richard Pesin 
Eric Murname Poeschia 
Anne Regenstein 
Ellen C. Rieur 
David J. Roberts 
John R Roberts 
Paul Roberts 
Peter A. Rubin 
Richard A Ruiz 
Greg A. Sachs 
Reginald J. Sanders 
Fred Santoro 
Edward B. Savage 
Joshua D Schor 
Sara A. Schutzman 
Mark Shachner 
Timothy Alan Shapiro 
Peter Shile 
Collin Smikle 
Robert C. Smith 
Joshua David Sparrow 
Aaron Stone 
Timothy H. Tanner 
Louis J. Tesoro 
Tina N. Tillis 
Mark Topazian 
Edward S. Tyau 
Pablo Vazquez-Seoane 
Javier Vizoso 
Steven B. Warren 
Kimball Woodward 
Janet K. Young 
1986 
Jay Gates 
Contributors to the 
Public Health Alumni 
Fund 1985-86 
1921 
Ira V. Hiscock* 
1922 
Alice G. Laanes 
1926 
John J. Batchelor 
1927 
Alice S. Baldwin 
1930 





Edward B Bosworth 
Eunice Nickerson Tyler 
1934 
Amy H Hunter-Wilson 
Iwao M. Moriyama 
1935 
Franklin M. Foote 
Almeda King 
1936 
M. Allen Pond 
1937 
Lidie V. Dyer 
1938 
Willard H Boynton 
Richard K. C. Lee 
Katharine Hawley Martin 
Lucy S. Morgan 
Jean H. Nelbach 
1939 
Carl I. Cohen 
James C. Hart 
1940 
Elizabeth H. Pitney 
Ruth G. Taylor 
1941 
Rosyln L. MacNish 
A. Helen Martikainen 




Arthur B. Robins 
Charles D. Spangler 
1943 
Carolyn S. Koffler 
Adele P Schlosser 
Jane L. White 
1944 
Jean F. Heston 
Jane Y. Parker 
1945 
Roslyn R. Bilford 
Mary B Dale 
Naomi Barer Golden 
Joe B Graber 
Lois M Jund 
John C. Potkay 
Maxine B Sandison 
1946 
Dorothy B Hamilton 
D. Patricia Nelson 
1947 
Sidney S. Chipman 
Anne E. Fulton 
Lillian L. Konick 
Raymond W. Leonard 
JoAnn S. Lewis 
Rosa Frances Montgomery 
Paul A. Pamplona 
Jean M. Pinder 
Cecil G. Sheps 
Samuel Zibit 
1948 
Chester S. Bowers 
Mary L. Ellis 
Mary Margaret Fitzgerald 
Samuel S. Herman 
Richard E. Johnson 
Beatrice H. Kaasch 
Dorothea S. La Belle 
Hiram Sibley 
1949 
Eleanor C. Connolly 
Edgar L. Geibel 
Hilda H Kroeger 
Christine R Owre 
William B Parsons 
Elizabeth D. Robinton 
Mary C. Springer 
1950 
Henry G. Bnckman 
Helen P. Cleary 
Austin J. Evans 
Jerome M. Glassman 
Dorothy R. Granoff 
Eugene K. Harris 
Dorothy E Reese 
Frances K Reynolds 
Nathan M. Simon 
1951 
Joseph Alexrod 
Clarissa E. Boyd 
Clarence William Bushnell 
Norton G. Chaucer 
Joanne E. Finley 
Florencia M. Herrera 
Robert L. Johnson 
Leonard S. Krassner 
Leonard F. Menczer 
Emi T. Rausch 
Jessie Parkinson Spear 
Angelica Z. Syseskey 
Elizabeth Ulrich Throm 
Walter Wenkert 
1952 
Cahit H. Corbacioglu 
Howard Dunphy 
Joanna Adele Henry 
Malcolm C. Hope 
Charles Holway Lawrance 
Sidney S. Lee 
Helen Kardys Loria 
Yolande F. Lyon 
Richard B. Ogrean 
Jeanne Ellen Paty 
Anne Barlow Ramsay 
Brena B Wolff 
1953 
Jeannette Averill 
Harold Robert Bernshock 
Abraham Robert Cutcher 
Cecilia Frances Di Cocco 
Graydon Dorsch 
William H. Hermann 
Barbara J Lee 
Laurence K. Rainsford 
Milton H Sisselman 
Constance B. Thomas 
Donald N. Zehl 
1954 
Donald R. Cowan 
Cavin P Hatcher 
Ruth M. Taber 
1955 
Constance T. Beemer 
Lester M, Bornstein 
Charline S. Buck 
Amy L. Cawley 
Morris London 
Mary Me C. Mogan 
Frances R. Ogasawara 
Gerald Rosenblatt 
1956 
E. St. George Anderson 
David D. Boyd 
Lois Blatchford Fuller 
Kathleen H. Howe 
Paul C. Kaufman 
John F. Mullett 
Julia R. Nole 
Mary K. Ochiai 
Floyd D Parrish 
Alice M. Wagner 
1957 
Janet Beach 
Lee De Cady 
William A. Clermont 
Gaston Jules Deslouches 
Edward R. DeLouise 
Sheldon Selig King 
Edna May Klutas 
William R Metzger 
Jerome R Sapolsky 
Shirley T. Steidel 
Patricia A. Viscosi 
1958 
Josephine Blanchett 
Helen H. Davenport 
Thomas T. Flynn 
Normand E. Girard 
Philip B. Hallen 
Edward H. Noroian 
Joseph A. Scorpion 
Thomas P. Weil 
1959 
Cesar A. Aleman 
Raymond S. Duff 
Bennett I. Enowitch 
Folly Hofer 
Marvin A. Lavenhar 
Hugh J. Maher 
Lee J. Podolin 
Ellwyn D. Spiker 
Mattie Lee D. Wade 
Kenneth J. Williams 
Dorothy M. Wilson 
1960 
Bruce A. Barron 
Thaddeus B Curtz* 
Kathryn L. D'Amico 
Wouter Ekker 
Maxine Geeslin 
Rose A. Iannotta 
Katharine Anna Keppel 
Lowell Stern Levin 
Vatividad A. Ngo 
R. John C. Pearson 
Hannah Clark Russell 
1961 
Gordon R. Beem 
Martin Donabedian 
Alfred E. Fletcher 
Helen M. O’Connell 
Margaret P. Parker 
Joseph T. Prekup 
William R. Slivka 
Harold W. Wicks 
1962 
Richard B Blakney 
James E. Bowes 
Thomas R. Mayhugh 
1963 
Dorothy Weichert Brockway 
Raul R Cuadrado 
David Dolins 
Frank M. Isbell 
Edward M. Kenney 
Jean M. Maynard 
David R. Sheehan 
Samuel B. Webb, Jr. 
1964 
Maria S. Baisier 
Bartley H. Calder 
Katherine Maria Detre 
Carole S. Profant 
Theodore Rosenberg 
Estelle Siker 
Monroe W. Spero 
Claudell Sidney Thomas 
1965 
Robert M. Edwards 
Monte Nelson Frazier 
H. Patterson Harris Jr. 
James F. Jekel 
Michael E Kove 
Peter J. Levin 
Elliot A. Segal 
Viola J. Spinelli 




Anne B Collart 
Amalia P. Crago 
Dorothy Noyes Kane Evans 
Diana B. Fischer 
Jennifer L. Kelsey 
Robert C. Lowrie 
1967 






Elisabeth Mueller Mahjoub 
Particia D. Mail 
James M. Malloy 
Brigitte Prusoff 
Bruce Steinhardt 
Beth M. Whelan 
Irma Willner 
1968 
Richard W. Ashton 
Philip D. Cobb 
Sonia M. Colon 
Joseph L. Dorsey 
Robert R Everett 
L. Carol Fernow 
Carl R. Fischer 
Francis J. Greaney 
Chester H. Johnson 
Susan F. Klein 
R. Elizabeth Leif 
Jean C. MacCorison 
Robert F. Monsse 
John M. Patton 
Richard L. Petrelli 
Arnold R. Saslow 
Doreen P. Sharabati 
Elizabeth A. Small 
Martha F. Steel 
Sheila W. Wellington 
Elizabeth C. Wright 
1969 
Susan S. Addiss 
Janet A. Albrecht 
Victor Crown 
James M. Dawson Jr. 
Sharon A. Garcia 
Gerald R. Harpel 
Sylvia N. Holtzberg 
Charles C. Jeffrey 
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DEAN: COMMITTED, BULLISH ON 
YALE SCHOOL OF MEDICINE 
Editor’s note: Shortly after Dr. Leon E. Rosenberg became 
Dean of the Yale School of Medicine in July 1984, he addressed 
the faculty on the “state of the school.” Now, YALE 
MEDICINE has asked Dean Rosenberg to pause and make 
some observations on the school today for alumni. 
YALE MEDICINE: You have served as Dean of the Yale 
School of Medicine for nearly three years. In retrospect, what 
have been the greatest “challengesfor change?” 
DEAN: The greatest challenges the school has faced during the 
past 2Vi years have related to the clinical departments. That is 
not to say that the school can take for granted its basic science 
departments where we are strong across the board, and second 
to none. This strength must be preserved and enhanced, while 
we address a number of challenges in the clinical departments. 
First and foremost of these is the recruitment of new chair¬ 
men. In 2Vi years, we have recruited new chairmen in dermatol¬ 
ogy, neurology, surgery, psychiatry and orthopaedics. We are 
currently seeking new chairmen in internal medicine, pediatrics 
and diagnostic radiology. Thus, within the five-year term of my 
deanship, most of the clinical department chairmanships will 
have turned over. 
This represents a profound change in the school’s leadership 
and a profound challenge to the administration. I have spent 
more time on these recruitment efforts than on any other single 
item of the school’s agenda; that is as it should be because our 
chairmen set the tone, shape the faculty and fashion the 
priorities for their respective areas. 
But the challenge for change in clinical medicine goes 
beyond the recruitment of new chairmen. The entire fabric of 
clinical medicine in the United States is undergoing an up¬ 
heaval, and academic medical centers are certainly not insulated 
from the tumult. 
Our country has become enormously worried about health 
care costs; this has resulted in an increasingly tight embrace of 
medicine by laws affecting every phase of clinical practice. For 
example, enormous pressures exist to take care of patients as 
outpatients rather than in hospitals, yet hospitalized patients 
have been the bulwark of clinical teaching programs in the 
United States for the last 40 years. 
We must find new settings in which to educate third- and 
fourth-year students; such settings include health maintenance 
organizations (HMOs) in the city of New Haven (such as the 
Yale Health Plan and the Community Health Care Plan), private 
offices of physicians who have clinical faculty appointments in 
the school, and the hospitals in Connecticut with which we have 
affiliation agreements. 
Another major issue we’ve been addressing concerns the 
need to increase the commitment of our full-time faculty to de¬ 
liver outstanding tertiary care. I wish to see the Yale-New 
Haven Medical Center become the pre-eminent medical center 
between New York and Boston. Only in this way will we bring 
research and teaching in the clinical departments to the high 
level currently achieved in our basic science departments. 
Finally, we must redouble our efforts to educate humane, 
ethical, responsible physicians whose primary commitment will 
be to serve the public interest—not their own private interests 
or those of organized medicine. Only in this way will we reverse 
the national trend to humble physicians. 
YALE MEDICINE: We have heard controversial reports 
about the national health manpower situation and the “doctor 
glut.” Does the School of Medicine have a position on this 
issue, and does the school contemplate changes in class size? 
DEAN: No medical school can fail to be concerned about the 
oversupply of physicians and the decreasing number of young 
people who are applying to medical schools. In the past seven 
years, we have seen a 20 percent fall in the number of applicants 
to the Yale School of Medicine. Therefore, we are experienc¬ 
ing—just as every other medical school is—the realization that 
young people today do not see medicine as attractive a career 
as they once did. 
The question facing the Yale School of Medicine is whether 
this demographic information should push us to decrease our 
class size. Even though the total number of applicants has de¬ 
creased, we still receive more than 2,300 applications for 102 
places in our incoming class, and we are still attracting as out¬ 
standing a group of future physicians as we ever have; that is, 
we’ve seen no fall off in the quality of our students. For that 
reason, we do not believe that we must reduce class size in order 
to maintain quality standards. 
Nonetheless, there is some pressure to reduce class size in 
order to demonstrate in the only clear way we can that we are 
concerned about an oversupply of physicians. For the present, 
we have decided not to change class size simply to send a 
“signal.” 
YALE MEDICINE: Have medical students and their 
academic qualifications and career goals changed perceptibly 
during the past 25 or 30 years? 
DEAN: As I just said, we have not seen less intelligent, humane 
or committed people going into medicine, but certainly career 
goals have changed. 
1 
More of our students are interested in careers in such special¬ 
ities as anesthesiology, ophthalmology, radiology and or¬ 
thopedic surgery; fewer of our graduates are interested in pri¬ 
mary care fields, such as internal medicine and obstetrics. In 
part, career decisions reflect economic opportunities and the 
cost of medical education. 
Eighty percent of our students graduate with significant 
debts—the average debt currently being $39,000. It seems un¬ 
avoidable that this amount of indebtedness already has affected 
career plans of some students; and if indebtedness increases, it 
will affect career plans of even more students. That is why we 
are working so hard to provide more loan and scholarship assist¬ 
ance to students. 
YALE MEDICINE: Would you please comment on the in¬ 
creasing number of women and minority group students in the 
School of Medicine today and their experience here? 
DEAN: The medical school has been attracting more and more 
qualified women; and they now comprise 30-40 percent of the 
incoming class annually, and this has been the case for the past 
five years. In my judgment, it will not be long before 50 percent 
of our student body will be women, and then the gender issue 
in medical school enrollment will become moot. 
Approximately 15 percent of our class is composed of fine 
students from minority backgrounds: black, Hispanic and 
Oriental. We work hard to find and recruit outstanding members 
of minority groups because the national pool is small and com¬ 
petition is keen. It is very important to our country that an in¬ 
creasing number of black and Hispanic physicians be trained; 
Yale is committed to this effort. 
YALE MEDICINE: The senior thesis has been a Yale tradi¬ 
tion. Is the discipline of research today just as strong in 
Yale's training of medical students? If so, could you cite some 
examples. 
DEAN: The commitment to acquire and disseminate new infor¬ 
mation remains as central a mission to the School of Medicine 
as it has ever been. That commitment is present at every level 
of the institution, including the medical students. 
We are proud of our tradition of requiring a thesis for every 
graduate of the School of Medicine. We are making every effort 
to strengthen the thesis requirement. Recently, a thesis subcom¬ 
mittee of the curriculum committee has been appointed to moni¬ 
tor and administer the thesis program. This year, for the first 
time, student research day will include a large poster session for 
all interested students as well as the traditional platform presen¬ 
tations by prize-winning ones. 
We are also trying to identify more funds to support students 
1 
Speaking at the Magnetic Resonance Center dedication in mid- November, Dean Leon E Rosenberg said the new technology will 

















doing research. In addition to providing summer stipends for an 
increasingly large number of students, we recently have ob¬ 
tained funds which enable 12-14 students annually to take a full 
year out of the traditional four-year curriculum in order to do 
research with a faculty member in the School of Medicine. We 
have also obtained a training grant from the National Institutes 
of Health to support student research. 
YALE MEDICINE: Many exciting developments in the 
biomedical sciences are occurring very rapidly. In what areas 
are Yale medical researchers making contributions? 
DEAN: If I were to answer that question in detail, it would take 
a tome to do so. We have outstanding researchers in many areas 
of the basic and clinical sciences. 
Perhaps it is more appropriate for us to ask if there are areas 
where the Yale School of Medicine is not as strongly rep¬ 
resented as it would like to be in research. I can think of a few 
such areas, and we must do something about them. We are not 
as prominent in AIDS research as we should be, nor are we as 
strong in molecular oncology or microbiology. These and other 
areas will be emphasized in faculty recruitment efforts. 
YALE MEDICINE: The medical school has several construc¬ 
tion projects in various stages. Could you give us a brief update 
on them? 
DEAN: It’s nice to be able to talk about buildings that are going 
up because they signal a sense of growth and vitality. 
• We have just dedicated the Magnetic Resonance Center, a 
joint undertaking of the School of Medicine and Yale-New 
Haven Hospital. I believe it is the finest center of its kind cur¬ 
rently in the country today. 
• We are two-thirds of the way toward completing the Yale 
Clinic Building, which will be devoted to the full-time facul¬ 
ty’s efforts in treating ambulatory patients. Before the end 
of this calendar year, that 90,000-square foot building will 
be in full operation. Finally, management of ambulatory pa¬ 
tients by full-time faculty physicians will be coordinated in 
a group-practice setting worthy of this institution. 
• Demolition is about to begin in preparation for construction 
of the new Yale Psychiatric Institute. We hope to have the 
YPI back on campus within 24 months, and that will be an 
exciting addition to both the clinical care and the educational 
components in psychiatry at the school. 
• Planning for the new library addition has advanced. We anti¬ 
cipate that during the next three months ground will be bro¬ 
ken for this major expansion of the library, thanks to the 
magnificent gift from Betsey Cushing Whitney and her 
family. 
By 1989, the medical school will have a vanguard library 
with expanded reading room facilities and significantly in¬ 
creased amount of computer capability for information re¬ 
trieval. This will provide us with a library commensurate 
with the skill and aspirations of the school’s scholars. 
• Finally, and as close to my heart as anything in my deanship, 
is the Center for Molecular Medicine, a joint enterprise of 
the School of Medicine and the Howard Hughes Medical In¬ 
stitute. We hope to break ground in November 1987 for that 
building, which will be located immediately adjacent to the 
Hope Building along Congress Avenue. The building will 
consist of four floors of new research laboratories, each or¬ 
ganized along programmatic themes. One program will be 
directed toward molecular genetics, a second toward 
molecular neurobiology, a third toward molecular oncology, 
and a fourth program has yet to be named. The genetics and 
neurobiology programs will be supported by the Howard 
Hughes Medical Institute; the other two will be supported by 
Yale-acquired funds. 
YALE MEDICINE: Along with the Medical School Develop¬ 
ment Office, you have been working diligently to meet the goals 
of the Capital Campaign. What have been some of the greatest 
successes during the campaign? 
DEAN: Within a 2‘/2-year period, we have come well more than 
halfway toward the campaign’s stated goal of raising $125 mil¬ 
lion for the School of Medicine. At latest count pledges and re¬ 
ceipts total almost exactly $ 100 million. 
Among the largest gifts have been those from Betsey Whit¬ 
ney, the Howard Hughes Medical Institute, Irving and Neison 
Harris and Mr. and Mrs. Adrian C. Israel. It is heartening to 
see the number of friends, alumni and organizations that have 
contributed to the campaign. 
This support makes us feel cautiously optimistic that we can 
achieve the goal of raising $125 million. The acquisition of 
those funds is vital to the school’s remaining one of the truly 
great, research-intensive schools of medicine in the world. I 
hope the alumni know how much we need to strengthen the 
financial base of the school. The Yale School of Medicine has 
the smallest endowment of the top 10 medical schools in the 
United States; that must be addressed. 
In fact, endowment funds have been the most difficult to raise 
thus far. We will almost certainly meet our goals in acquiring 
funds for buildings and for research programs, but we are only 
about 25 percent of the way toward meeting our goal in identify¬ 
ing new endowment funds. This must be the major emphasis for 
the remainder of the campaign. 
YALE MEDICINE: In conclusion, do you have any other 
general observations about the state of the Yale University 
School of Medicine? 
DEAN: When I took this job, I was bullish on the School of 
Medicine and on Yale University. I may be a little sadder and 
wiser than I was then, but my commitment and my bullishness 
have not diminished a bit. I continue to believe that this is a great 
school in a great university, and I continue to believe in 
medicine, despite the many challenges facing it. We must aspire 
to be even greater as we address the enormous opportunities and 
equally enormous problems in our field—which, I hope, is still 
acalling. 
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YALE RESEARCHERS LOOK 
BEYOND CLICHES OF AGING 
by Phyllis Joffe 
It’s a fact: more of us are getting—and staying—old than ever 
before. 
Half of all human beings who have ever lived are now alive. 
According to the U.S. Bureau of the Census, an estimated 35 
million Americans will be over 65 by the year 2000. Between 
2000 and 2050, as "baby boomers” enter their mid-60s, the el¬ 
derly population is expected to nearly double to include more 
than 22 percent of the total U.S. population. 
Not only has life expectancy increased, but people also are 
living healthier as they age. Medical researchers who once 
believed chronic illnesses and disabilities to be a normal and 
irreversible part of the aging process now know that with pre¬ 
vention and treatment, people can live rich, active lives well 
into their 80s and beyond. 
At Yale, gerontology is a multidisciplinary concern. 
Throughout the School of Medicine, researchers are challeng¬ 
ing stereotypes of aging and making profound new discoveries 
that hold the promise of improved health care and quality of life 
for all. What follows is only a sample of that work. 
BASELINE EPIDEMIOLOGY 
Although the elder population explosion began in the mid- 
1960s, it didn’t capture the attention of the public—and the 
medical establishment—until several years later. 
“Most epidemiologic studies, until very recently, have char¬ 
acteristically looked at people from 18 through 65,” says Dr. 
Adrian M. Ostfeld, the Anna M. R. Lauder Professor of 
Epidemiology and Public Health at the School of Medicine. Dr. 
Ostfeld says interest shifted when the 1970 census data showed 
a growing population of elders and a rapid drop in deaths from 
heart disease and stroke. 
In 1971, Dr. Ostfeld and Stanislav V. Kasl, Ph.D., professor 
of epidemiology, received major funding from the National 
Institute on Aging to study the health effects of forcing el¬ 
derly people to move from their homes. 
Now, Dr. Ostfeld and LisaF. Berkman, Ph.D., associate pro¬ 
fessor of epidemiology, are co-principal investigators for the 
Yale Health and Aging Project, part of an NIA benchmark study 
entitled “Established Populations for Epidemiologic Studies of 
the Elderly” (EPESE). NIA published the first phase of the lon¬ 
gitudinal study, the Resource Data Book, last December. 
Under the direction of Dr. Ostfeld and Professor Berkman, 
School of Medicine researchers have gathered baseline data 
Phyllis Joffe is writer, broadcast specialist for the School of Medicine 
Office of Public Information. 
since 1982 on more than 2,800 New Haven residents, ages 65 
and older. Similar work has taken place in East Boston. Mass.; 
Iowa and Washington Counties, Iowa; and Durham, N.C. The 
Yale Health and Aging Project received $2.5 million for the 
New Haven research. The entire national project is funded until 
1988. 
The EPESE project is expected to identify predictors of mor¬ 
tality, hospitalization and placement in long-term care facili¬ 
ties, and it will study risk factors for disability and chronic 
diseases in the elderly. 
“The data book enables us to move from caricature, conjec¬ 
ture and stereotype to having hard information,” says Dr. 
Ostfeld. “It provides us with baseline characteristics of some of 
the major economic and social problems of older people....It 
will enable us to determine how disability, disease, and social 
and economic characteristics interact.” 
Dr. Ostfeld believes that the EPESE data also will prove valu¬ 
able in the development of future public policy and services. “I 
anticipate that relatively soon, we'll be developing publications 
on what factors cause people to enter nursing homes and how 
we might plan wisely for their rate of entry. When we begin to 
understand more about how ways of living influence survival, 
we will be in a position to develop more rational programs to 
help older people prolong their lives.” 
Unlike most prior studies on aging, EPESE is community- 
based. This distinction is important, says Professor Berkman. 
"Most previous studies have been on very selected popula- 
Dr. Adrian M. Ostfeld, the Anna M.R. Lauder Professor of 
Epidemiology and Public Health, and Lisa R. Berkman, Ph.D., 
associate professor of epidemiology, are principal co-investigators 
on a benchmark NIA study on aging. Since 1982, they have gathered 
baseline data on 2,800 elderly New Haven residents. The data 











tions—people in nursing homes, people who are volunteers or 
are highly successful. But until now, we’ve had very little idea 
about how most of the people who are over 65 are living. 
“When you look at older people who are living in a communi¬ 
ty, some of the stereotypes change. For instance, most of the 
people we interviewed maintained high levels of functioning, 
most led independent lives, most were able to take care of them¬ 
selves, and most were able to be quite physically active and 
mentally alert.” 
For example, 90 percent of those studied in New Haven were 
able to walk and bathe without assistance. Twenty percent re¬ 
quired help getting from a bed to a chair, getting out of bed or 
dressing, whereas only about two percent needed help in toilet¬ 
ing, grooming and eating. 
Even when disabilities exist, they may not be permanent. Ac¬ 
cording to the Yale team, some people who were function¬ 
ally disabled when first interviewed at baseline in 1982 had 
recovered from their disabilities a year later. 
Says Professor Berkman: “This stands in contrast to the kinds 
of studies that have been done before where you only look at 
people on this kind of inevitable, downward course. So while 
people do change, and obviously people do change for the 
worse, they also change for the better.” 
Whereas nursing home studies have tended to conclude that 
“older people are frail and unable to maintain many of their abil¬ 
ities over a long time,” she says, the NIA data indicates that this 
is only true for some large segment of those over 85 in the popu¬ 
lation. Rather, elders are a far more heterogeneous and produc¬ 
tive group than stereotypes indicate. 
“By and large,” says Dr. Ostfeld, “people in their late 60s, 
early and middle 70s, are able to attend all the meetings, do all 
the work, stay in touch and be completely responsible in getting 
any kind of job done that doesn’t require a great deal of muscle. 
From the middle 70s to the middle 80s, people are able to do 
a reasonable day’s work at most things, most of the time.” 
Professor Berkman and Dr. Ostfeld say they hope the EPESE 
data will help health care professionals look beyond accepted 
stereotypes of aging. “We need to separate things that are usual 
or expected changes of aging from common diseases that can 
be treated,” says Dr. Ostfeld. 
The EPESE data has become a resource at the School of 
Medicine for other research on aging. As one of 15 researchers 
on the MacArthur Research Program on Successful Aging, a 
national project supported by the John D. and Catherine T. Mac¬ 
Arthur Foundation, Professor Berkman is using the EPESE co¬ 
hort to determine the factors that make people age successfully, 
both physically and psychologically. 
CLINICAL STUDIES 
With funding from the Robert Wood Johnson Foundation, Pro¬ 
fessor Berkman and Dr. Leo M. Cooney Jr., associate professor 
of medicine and a 1969 medical school graduate, are conducting 
an EPESE substudy on factors that predict recovery from illness 
among elders. 
Dr. Cooney is director of the Yale Program in Geriatric 
Medicine, which has developed an extensive clinical base that 
serves as a resource for teaching and collaborative work. The 
program includes an inpatient geriatric rehabilitation unit and 
the Geriatric Assessment Clinic at Yale-New Haven Hospital; 
medical directorship of a nursing home; and a geriatric evalua¬ 
tion unit, rehabilitation unit and outpatient geriatric clinic at the 
West Haven Veterans Administration Medical Center. 
Other faculty members in the program are Drs. Mary E. 
Tinetti, Ronald L. Miller, Gail M. Sullivan, Sharon K. Inouye 
and Margaret A. Drickamer, all assistant professors of 
medicine. 
In collaboration with Robert Fetter, the Harold E. Hines Jr. 
Professor of Health Care Management at the Yale School of Or¬ 
ganization and Management; and Brant E. Fries, Ph.D., of the 
University of Michigan School of Public Health, Dr. Cooney 
developed Resource Utilization Groups, a method of classify¬ 
ing long-term care patients according to their needs. This sys¬ 
tem now serves as the method for nursing home reimbursement 
in New York State and in Veterans Administration facilities 
throughout the country. 
Dr. Tinetti’s research on the problems of falls among the el¬ 
derly includes the development of a predictive index that will 
assist in fall prevention. The Robert Wood Johnson Foundation 
provided funding for this work, which was the basis for a Na¬ 
tional Institute on Aging Academic Award recently granted to 
Dr. Tinetti. 
Together with Dr. Ostfeld and Dr. Alvan R. Feinstein, pro¬ 
fessor of medicine and epidemiology. Dr. Tinetti also has been 
studying the effects of falls on participants in the EPESE cohort. 
Dr. Miller organized a collaborative effort with the infection 
control nurses in 28 nursing homes to study the true complica¬ 
tion rate in nursing homes of indwelling bladder catheters. This 
group also has agreed to work with Drs. Tinetti and Miller to 
look at the risks and benefits of using common nursing home 
interventions, such as restraints, for patients with multiple 
illnesses. 
“The differences among nursing home patients, the multiple 
reasons for using an intervention, the difficulty in separating the 
effects of the intervention from the effects of the patient’s pre¬ 
existing health status, and the lack of clear-cut outcome mea¬ 
sures render the usual intervention research techniques inappro¬ 
priate for nursing home patients,” says Dr. Tinetti. 
Drs. Cooney and Feinstein are attempting to identify some 
predictors of nursing home care needs for hospitalized elderly 
patients. They have developed an index that will predict the 
need for care at home and for nursing home placement, with the 
particular goal of identifying those patients who would benefit 
most from aggressive intervention designed to prevent nursing 
home placement. 
In the area of basic science research. Dr. Cooney and Nanne 
Scholhamer, social worker for the Geriatric Assessment Clinic, 
have developed a program with Dr. Elias E. Manuelidis, profes¬ 
sor of neuropathology(surgery) and neurology, that enables pa¬ 
tients’ families to have postmortem examinations done on the 
brains of Alzheimer’s disease victims. More than 40 examina¬ 
tions have been conducted thus far. 
At the West Haven VAMC nursing home unit. Dr. Drickamer 
has been studying the use of functional assessment in setting 
goals and planning for care of elderly nursing home patients. 
Also at the VAMC, Dr. Sullivan is investigating the problem 
of iatrogenic illness in the elderly, and Dr. Sharon Inouye is 
looking at the complications of various investigative procedures 
in elderly patients. 
Says Dr. Cooney: “All of these geriatric program research ef¬ 
forts are examples of the information that can be obtained from 
the close cooperation of clinicians—who are involved in the 
day-to-day problems of the frail elderly—and clinical and basic 
science investigators.” 
In a separate but relevant project, David A. Pearson, Ph D., 
research scientist and associate dean for public health; and Dr. 
Walter Hierholzer Jr., professor of medicine and epidemiology 
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and YNHH epidemiologist, epidemiology and infection con¬ 
trol, are conducting an 18-month collaborative study on nosoco¬ 
mial (institutionally induced) infections in nursing homes. The 
research is funded through a contract from the Centers for Dis¬ 
ease Control. 
The CDC estimates that nosocomial infections already cause 
more than 20,000 deaths and contribute to an additional 60,000 
in hospitals each year. Although the annual indirect cost of 
treating these infections is thought to be around $2.5 billion for 
hospitals alone, little is known about the scope of the infections 
in nursing homes. 
The Yale researchers plan to define the risks, identify priority 
areas and develop guidelines for preventing nosocomial infec¬ 
tions in the nation’s 18,900 skilled nursing homes. This is the 
first study of its kind in the country, according to the CDC. The 
findings are expected to be available early in the fall. 
SYSTOLIC HYPERTENSION 
Octogenarians and their elders make up the fastest-growing 
population group in the United States. They also have the high¬ 
est incidence of isolated systolic hypertension (ISH), a condi¬ 
tion characterized by systolic pressure elevated to more than 
160 mm Hg, while the diastolic remains in the normal range of 
less than 90 mm Hg. 
In the population at large—excluding the elderly—eleva¬ 
tions of systolic pressure in the absence of elevated diastolic are 
unusual. So, although ISH is now estimated to affect more than 
three million Americans over age 60, relatively few studies 
have looked seriously at the condition. 
“In the past, no American trials of hypertension treatment 
studied anybody who was older than 69 years of age when the 
study began. Furthermore, no one has ever looked at whether 
or not we should treat isolated systolic hypertension, in this or 
any population,” says Dr. Henry L. Black, associate professor 
of medicine and director of the hypertension service at Yale- 
New Haven Hospital. “We have many very healthy elderly 
people now, who are facing a new kind of problem and really 
don’t know what to do about it.” 
Dr. Black is principal investigator for the Systolic Hyperten¬ 
sion in the Elderly Program (SHEP) at the School of Medicine. 
This seven-year clinical trial sponsored by the National Heart, 
Lung and Blood Institute and NIA has been underway at 17 cen¬ 
ters nationwide since March 1985. The program is expected to 
determine whether standard antihypertensive drug therapy for 
ISH will reduce the incidence of strokes in elderly people. 
The past 15-20 years have shown that systolic blood pressure 
is a better predictor of all hypertension-related complications 
than is diastolic pressure. People with systolic elevations of 
blood pressure (ISH) have an increased all-cause mortality rate, 
twice as many heart attacks, and three times the number of 
strokes and angina than do those with normal blood pressure. 
Yet, many physicians argue that ISH is a natural consequence 
of aging and the increased rigidity of the arterial system. Treat¬ 
ing ISH, they say, will do nothing to reduce the risk of heart 
attack and stroke, because ISH simply marks the presence of 
aortic arteriosclerosis. 
SHEP is a cooperative study, with all 17 centers using the 
same protocol, recruiting patients with the same criteria and 
providing medication in the same fashion. A goal of 5,000 vol¬ 
unteer patients has been set nationwide, with 300 from the Yale 
SHEP study. 
Because this issue of whether to treat ISH is so important 
Dr. Henry L. Black, associate professor of medicine and principal 
investigator for the Systolic Hypertension in the Elderly Program 
(SHEP), watches as SHEP clinic coordinator Jan Davey, M.S.N., 
measures the blood pressure of Eugenia Zuraski of Branford, Conn 
Zuraski has been a patient in the SHEP program since December. 
to this population, we’re also looking at things other than 
strokes: other cardiovascular diseases and heart attacks, for ex¬ 
ample,” says Dr. Black. “We’re also looking in a formal way 
at whether or not we are causing or preventing dementia and de¬ 
pression with our medication.” 
In this double-blind study, half the group receives antihyper¬ 
tensive medications and half is given placebos. Participants 
have comprehensive cardiovascular monitoring every three 
months throughout the program. 
The participating centers send weekly data to a coordinating 
center in Houston, Tex., where a board of internists, car¬ 
diologists and neurologists monitors every event. “If it begins 
to look as if there is a statistically significant trend toward either 
the placebo or the active treatment being better, the study could 
be stopped early,” says Dr. Black. 
“Since it’s a placebo study, we're very sure that we will get 
an answer,” he says. “The answer may well be that we shouldn’t 
be treating the population with ISH, which I would consider a 
perfectly respectable answer to get. Either way, we'll have a 
better idea as to what to do.” 
The SHEP team also includes Dr. Charles K. Francis, 
associate professor of medicine and diagnostic radiology and 
director of the cardiac catheterization laboratory at YNHH; 
Dr. Samuel L. Bridgers, assistant professor of neurology; and 
Janice Davey, M.S.N., clinic coordinator and a 1976 graduate 












“About 20 years ago, I read a paper that just made me furious,” 
says Linda M. Bartoshuk, Ph.D., professor of epidemiology 
(environmental health) and psychology and fellow of the John 
B. Pierce Foundation. “It said that elderly patients complained 
about food, but that probably didn’t have anything to do with 
the real problem with their taste sense. Instead, they just had 
a ‘distaste for life’; they were just being cranky.” 
To refute the literature that she found so offensive. Professor 
Bartoshuk decided “to go out there and measure whatever sen¬ 
sory disturbances were present and support the complaints that 
elderly patients were making.” 
But something else happened. “We never found any taste 
loss,” she says. “The elderly taste system, at least as far as the 
real world perception of foods and beverages, is completely 
normal. Aging, per se, does not take a heavy toll on taste. It 
devastates smell.” 
This loss of ability to smell correctly has a profound effect 
on the ability to perceive flavors—an experience that most 
people refer to as “taste.” 
To explain the distinction: Taste comes from the oral cavity— 
the tongue, palate and throat; it comes in four varieties—salt, 
sweet, sour and bitter. Smell, from the nasal cavity, contributes 
flavor to food as it is eaten. Taste appears to be “hard-wired” 
and more primitive, whereas smell is labile, perhaps more 
learned. 
For example, says Professor Bartoshuk: “There is almost no 
real taste to roast beef; it’s all odor. And the odor input is going 
all the way from inside your mouth up to your nasal receptors, 
stimulating the sense of smell. So if you lose your sense of 
smell, you think you can’t taste.” 
Professor Bartoshuk and her colleagues discovered that al¬ 
though taste thresholds (the lowest concentration at which a 
taste is noticed) increase with age, the taste of “real world” con¬ 
centrations, which are far above threshold, appears to remain 
intact. 
John B. Pierce Foundation fellows Joseph C. Stevens, Ph D. (left), 
LindaM. Bartoshuk, PhD., and William S. Cain, Ph.D., demonstrate 
a taste test. Cain and Bartoshuk both are professors of epidemiology 
and psychology at the School of Medicine, and Stevens is senior 
research scientist and lecturer in psychology at Yale University. All 
three are investigating the relationship between taste and smell 
loss and aging. 
Olfaction, however, shows great losses with age. According 
to research conducted by two John B. Pierce Foundation fel¬ 
lows—William S. Cain, Ph.D., professor of epidemiology (en¬ 
vironmental health) and psychology at the School of Medicine, 
and Joseph C. Stevens, senior research scientist and lecturer in 
psychology at Yale—this loss begins while people are in their 
40s. 
Professor Bartoshuk believes that these discoveries may hold 
a key to the nutritional well-being of elders. “Properly function¬ 
ing taste and smell play a very important role in the quality of 
life and the way we choose to feed ourselves. 
“If olfaction is gone and taste is not, there may be an im¬ 
mediate remedy,” she says. “At Duke University, Dr. Susan 
Schiffman has increased the intensity of odors of foods without 
compromising the nutritional status.” Thus, artificial essences 
can make food more palatable to the elderly, even if the texture 
of the food has been altered to allow for easy swallowing. 
But because it is not yet clear whether losses of taste and 
smell with aging are functions of the aging process itself or are 
the result of other events, such as viral infections and head in¬ 
juries, that can occur over a lifetime, clinical treatment of taste 
loss in the elderly is still at an early stage. 
Professor Bartoshuk and her colleagues currently are study¬ 
ing the effects of viral infections, through evaluation of indi¬ 
vidual elderly patient histories combined with research on ani¬ 
mal models. They also are studying the relationship of dental 
condition and sensory loss in elders. 
“We may need to re-evaluate our clinical norms,” says Pro¬ 
fessor Bartoshuk. “We don’t want to test someone in the clinic 
who is 80, tell them they’ve got a taste loss, and look for clinical 
reasons for the loss if this loss is absolutely characteristic of ev¬ 
eryone who is 80.” 
In related research. Dr. Philip M. Sarrel, associate professor 
of obstetrics and gynecology and of psychiatry, is chief inves¬ 
tigator for a $700,000, multidisciplinary study funded by the 
National Institute on Aging on the effect of hormones on the 
female peripheral nervous system and the peripheral vascular 
system. The three-year study will examine the effects of estro¬ 
gen and progesterone on touch and vibration sense, peripheral 
blood flow and skin structure. 
Dr. Sarrell says that preliminary findings indicate that a lack 
of estrogen affects skin structure, peripheral nervous function¬ 
ing, cardiovascular functioning and psychiatric functioning and 
that estrogen replacement therapy can help correct these 
changes. 
The mid-life study program research team also includes 
Lawrence E. Marks, Ph.D., professor of epidemiology and psy¬ 
chology; Dr. Irwin M. Braverman, professor of dermatology; 
Dr. William M. Glazer, associate professor of psychiatry; Caro¬ 
lyn Mazure, Ph D., assistant clinical professor of psychi¬ 
atry (psychology); and Dr. Jean Bolognia, a postdoctoral fellow 
in dermatology who graduated from the School of Medicine in 
1980. Dr. Hal Morgenstern, former associate professor of 
epidemiology and public health and now at UCLA, is the 
project consultant epidemiologist. 
Dr. Braverman, in addition to his work on this project, has 
been investigating the role of elastic fibers and vessels in cutane¬ 
ous aging. 
ALZHEIMER’S DISEASE 
Dementias, once referred to by noted biomedical scientist Dr. 
Lewis Thomas as “the disease of the century,” are one of the 
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four most common categories of diseases affecting individuals 
65 years and older. One of the most prevalent of the dementias 
is Alzheimer’s disease. 
Alzheimer’s disease now affects an estimated one-to-two 
million Americans, and the number is increasing as the elderly 
population grows. It is a costly disease, requiring continuous 
care over many years for its victims. 
Individual convalescent care runs upwards of $30,000 per 
year for each Alzheimer’s victim. Federal expenditures for the 
disease are projected to be higher than $20 billion by 1990. Al¬ 
though the causes of Alzheimer’s disease still are unknown, lab¬ 
oratory researchers at the School of Medicine are finding clues 
to its etiology and possible treatment. 
Dr. Elias E. Manuelidis, professor of neuropathology 
(surgery) and neurology, has been studying virus dementias for 
more than 10 years with support from the National Institutes of 
Health. In the late 1970s, he was able to transmit Creutzfeldt- 
Jakob disease (CJD), a dementia caused by an unconventional 
virus, to convenient laboratory animals, such as guinea pigs, 
hamsters and mice. He used the animal models to study disease 
mechanisms both in CJD and in Alzheimer’s disease, which is 
difficult to discriminate on clinical grounds from CJD. 
“There are some neurochemical similarities and occasional 
overlapping lesions between the two diseases, and the familial 
incidence is roughly the same—12 percent of the families of 
both CJD and Alzheimer’s have a high incidence,” says Dr. 
Manuelidis. 
On the hypothesis that Alzheimer’s disease also is caused by 
a virus. Dr. Manuelidis and his wife. Dr. Laura M. Manuelidis, 
associate professor of neuropathology (surgery), are using ani¬ 
mal models to study its etiology. They believe that earlier at¬ 
tempts to transmit the disease to animals failed because the 
human victims were in Alzheimer’s end stages, where the virus 
may no longer be present. 
“We know from other viral diseases that the virus is present 
sometimes in the first or second day of the disease,” says Dr. 
E. Manuelidis. “For example, with poliomyelitis, when the in¬ 
dividuals come in for autopsy, the virus is no longer present. 
It destroys whatever it can, then is gone.” 
The Drs. Manuelidis’ current experiments in this area 
involve inoculating animals with blood of humans from high- 
incidence Alzheimer’s families, in hopes of isolating the dis¬ 
ease in its early, possibly viral, stages. 
The symptoms associated with Alzheimer’s disease—begin¬ 
ning with the loss of learned skills, such as arithmetic, and pro¬ 
gressing to memory loss and a virtual shutting down of the 
mind—result from its disastrous effect on the structure and 
function of the cerebral cortex. 
Neuropathologists have found that association areas of the 
cortex, including the prefrontal cortex, are a major location for 
plaques and tangles—the products of degeneration that serve as 
diagnostic markers of Alzheimer’s disease. 
Aged rhesus monkeys and other non-human primates also 
develop these senile plaques and tangles, as well as a decline 
in levels of various neurotransmitters. "We discovered that with 
aging, there is a sharp fall-off in the content of certain 
monoamines—norepinephrine and dopamine—in the cortex of 
aged animals. The same neurochemical deficits occur in aged 
humans and Alzheimer’s patients,” explains Patricia S. 
Goldman-Rakic, Ph.D., professor of neuroscience. 
This decline, says Professor Goldman-Rakic, can be traced 
to a loss of brainstem neurons, containing norepinephrine, that 
have widespread projections throughout the cerebral cortex. 
Patricia S. Goldman-Rakic, PhD., professor of neuroscience 
(left), and Amy Arnsten, Ph.D., assistant professor of neuroanatomy, 
have used adrenergic agonists to treat memory loss in monkeys. 
They currently are testing the alpha-2 adrenergic agonist clonidine 
as a potential drug for reversing loss of memory and cognitive 
functions in Alzheimer's patients. 
Dr. Elias E. Manuelidis, professor of neuropathology and surgery, 
believes that Alzheimer's disease may be caused by a virus. In the 
late 1970s, he demonstrated that a similar dementia, Creutzfeldt- 
Jakob disease(CJD), caused by an unconventional virus, could be 
transmitted to laboratory animals. 
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When the neurons die, their axons degenerate, and the cerebral 
cortex is deprived of its normal source of norepinephrine. 
Earlier experiments conducted at the National Institute of 
Mental Health by Professor Goldman-Rakic and colleagues 
showed that the depletion of catecholamines, such as 
norepinephrine, in the cortex of young adult monkeys resulted 
in specific memory and behavioral losses. 
But even more important was the discovery that they could 
then restore the lost memory and functions with adrenergic 
agonists, which replaced the depleted norepinephrine. “This 
was the first evidence that ‘replacement therapy’ could be used 
for memory loss,” explains Professor Goldman-Rakic. 
Professor Goldman-Rakic, Amy Amsten, Ph.D., assistant 
professor of neuroanatomy, and their associates believe it may 
be possible to treat Alzheimer’s disease similarly. Using aged 
monkeys as models, they have been testing the alpha-2 adrener¬ 
gic receptor agonist clonidine, which already is used to treat 
high blood pressure, Gilles de la Tourette’s syndrome and her¬ 
oin addiction, as a potential drug for reversing loss of memory 
and cognitive functions in Alzheimer’s patients. 
These researchers found clonidine to be effective in improv¬ 
ing memory and performance in non-human primates and re¬ 
ported their findings in the Dec. 13, 1985, issue of SCIENCE. 
They have since replicated these findings on 13 monkeys. 
Because the positive, cognitive-enhancing effects of the drug 
can be blocked by selective alpha-adrenergic antagonists, 
clonidine may be working through alpha-2 receptors in the 
brain. Studies carried out by Professor Goldman-Rakic and 
Dorothy W. Gallager, Ph.D., associate professor of psychiatry 
(pharmacology) and neuroanatomy, using the method of in vitro 
autoradiography, have revealed that alpha-2 receptors are pre¬ 
sent in high concentrations in the cortical areas important for the 
type of memory that has been examined. 
Clonidine is not an ideal drug, however, since it also pro¬ 
duces sedation in the dose range that would be set for improv¬ 
ing memory. While looking at ways to solve this problem. Pro¬ 
fessors Arnsten and Goldman-Rakic discovered alpha-2 recep¬ 
tor subtypes in the brain. Thus, it may be possible to dissociate 
the sedative and cognitive-enhancing properties of selective 
alpha adrenergic compounds, says Professor Goldman-Rakic. 
Clinical trials based on some of the preliminary findings of 
Professors Arnsten and Goldman-Rakic have begun at several 
medical centers throughout the country and are expected to 
begin soon at Yale under the direction of Dr. Alan P. Siegal, 
assistant professor of psych iatry. 
A woodcut from Bartholomaeus 
Anglicus, Le Proprietaire 
deschose, Nicolas Conteau, 
Paris, 1510, shows the ages 
of man. The book is in the 
collection of the Yale School 
of Medicine Historical Library. 
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CLINIMETRICS: NEW CHALLENGES 
IN MEDICAL MEASUREMENT 
by Dr. Alvan R. Feinstein 
Suppose you have been asked to choose between two baseball 
players, one of whom is batting .400 and the other .250. If you 
begin comparing the players by using the approach that now 
pervades medical literature, you would immediately ask about 
“statistical significance.” Thus, if the respective hits per times 
at bat were 2/5 vs. 1/4 for the two players, you would dismiss 
their batting averages of .400 vs. .250 as non-significant; but 
if the same results came from such numbers as 320/800 vs. 200/ 
800, you would be impressed by the distinction. 
If the numerical distinction seems “statistically significant,” 
you might next ask some questions that involve a knowledge of 
baseball, rather than statistics. Is the .400 hitter an outfielder, 
whereas the .250 hitter is a pitcher who wins 30 games a year? 
Do the two players have similar fielding averages? What about 
other aspects of their performance, such as runs batted in, slug¬ 
ging average or morale value to the team? 
Next, after considering these “clinical" features of the ac¬ 
tivities, you might want to know if the two players were being 
fairly compared. Does one play in the major leagues, for the 
New York Mets, whereas the other plays in the seven-sisters 
league, for Mount Holyoke College? Finally, you might ask 
about the accuracy of the basic, raw data. Have the batting de¬ 
tails been compiled by scorekeepers who used the same criteria 
for deciding how to identify and count walks, hits, errors, outs, 
sacrifice hits, fielder’s choices and times at bat? 
Aside from the initial question about “statistical signifi¬ 
cance,” all the other evaluative aspects of the two players' per¬ 
formances depended on “clinical judgment” about baseball. 
You used the judgment in recognizing important features of the 
evaluation that were not included in the batting-average statis¬ 
tics: the additional “clinical” attributes of the players, the fair¬ 
ness of the comparison, the accuracy of the basic data. 
Although the cited judgments might immediately be applied 
during a statistical evaluation of baseball players, analogous 
types of judgment are regularly neglected today when physi¬ 
cians do clinical forms of research or read the published reports. 
Instead, we tend to rely on a series of mathematical strate¬ 
gies. We use statistical tests to tell us whether the observed num¬ 
erical distinctions are “significant.” We use another statistical 
technique to assign the treatments compared in randomized 
trials of therapy. We apply algebraic formulas, such as Bayes 
Theorem, and special graphs, such as receiver-operating-char- 
acteristc (ROC) curves, to evaluate the performance of diagnos¬ 
tic agents. In using the formal technique of “decision analysis” 
Dr Alvan R. Feinstein is professor of medicine and 
epidemiology and director of the clinical epidemiology unit 
d the Robert Wood Johnson Clinical Scholars Program. 
for managerial conclusion, we multiply quantitative estimates 
of probabilities and “utility values” to get a mathematical score 
for each decision. 
All of this mathematical activity has become an interesting 
paradox in the postgraduate careers of the many physicians who 
chose medicine as an occupation because they liked people and 
liked science but hated math. 
MATHEMATICAL STRATEGIES 
The attention to mathematical strategies has many advantages. 
By demanding “statistical significance,” we avoid the fallacies 
that occurred years ago when major claims about huge differ¬ 
ences were based on tiny numbers whose distinctions could eas¬ 
ily have arisen by chance. By using randomized assignment of 
therapy, we avoid the type of biased comparisons that occurred 
in the days when surgical treatment of the prognostically good 
“operable” patients was contrasted with non-surgical treatment 
of the prognostically poor “inoperable” patients. By applying 
other formal mathematical methods to outline the decisions 
made in diagnosis or management, we are forced to give 
specific attention to important things that must be identified and 
considered during the process of making clinical decisions. 
On the other hand, an excessive emphasis on mathematical 
procedures has had some major disadvantages for patients, phy¬ 
sicians and the quality of both humanism and science in modem 
clinical practice. 
Perhaps the main problem is that many important types of 
clinical data and reasoning—the fundamental elements of “clin¬ 
ical judgment”—are either deliberately rejected or inadver¬ 
tently ignored during the mathemedical activities. 
Aside from the dehumanization that occurs when we pay no 
deliberate attention to clinical information about symptoms, 
functional status and other human reactions of patients, the 
statistical results used in clinical science become non-reproduc¬ 
ible. 
The results are non-reproducible because they lack clinical 
* precision: patients with the same disease can have strikingly dif¬ 
ferent outcomes that depend on unrecorded and unanalyzed 
clinical distinctions. Survival in two patients with the same 
localized cancer will differ if one of the patients is cachectic and 
the other is not. The ability to return to work after coronary 
surgery may often depend more on the patient’s pre-operative 
occupational status than on the anatomic state of the vascula¬ 
ture. 
If these and other important clinical features of prediagnostic 
and pretherapeutic conditions are not suitably identified and 
analyzed, the results of statistical studies will be inadequate 
for decisions in clinical science and for application in clinical 
practice. 
Dr. Alvan R. Feinstein's new book discusses strategies and tactics 
needed to express clinical, human observations in a manner suitable 
for the humanistic science of clinical medicine. 
PROBLEMS 
A separate set of problems arises in etiologic research intended 
to identify causes of disease or risk factors. To test noxious 
agents that may cause disease, we cannot apply the type of ran¬ 
domized trials used for testing therapeutic agents that may pre¬ 
vent or remedy disease. Consequently, noxious agents or risk 
factors are usually evaluated in epidemiologic studies con¬ 
ducted with “observational designs” that often lack the scientific 
precautions routinely employed in experimental plans for ran¬ 
domized trials. 
The epidemiologic research structures often use case-control 
and ecologic-association studies that are difficult for clinicians 
to understand, and that usually depend more on statistical than 
on scientific principles of research. The results of the studies are 
often substantially biased because the statistical methods may 
not contain suitable provisions for analyzing the human deci¬ 
sions and clinical data that are a fertile source of distortion in 
non-experimental information. 
These problems in clinical and epidemiologic science create 
a fascinating irony as the 20th century departs—leaving 
medicine in an age of molecular biology, magnificent com¬ 
puters and extraordinarily high-powered technology. 
The irony is the existence of a basic need, amid all the splen¬ 
did molecular and technologic achievements, for better scien¬ 
tific methods of measuring clinical and human phenomena. 
Because these phenomena cannot be expressed in angstroms, 
millimoles or other technologic dimensions, we need to im¬ 
prove the measurements that are done at fundamental human 
levels of observation and reasoning. 
The basic observational measurements occur when clinicians 
(and patients) express and rate the relative magnitude of such 
entities as pain, dyspnea, distress, anxiety, depression, fatigue, 
insomnia, disability, functional status, joy, grief, satisfaction 
and all the other distinctly human clinical features that differen¬ 
tiate people from films, tracings, fluids, tissues, cells, 
molecules or animals. In the informal ratings used for clinical 
communication, we may say that a patient has “moderate pain, 
severe dyspnea and is 4 -I- sick”. 
The ratings are important, often crucial, elements of descrip¬ 
tive clinical measurement. Yet they do not receive the efforts 
of calibration and standardization that are applied for descrip¬ 
tive measurement in the laboratory tests that are often much less 
valuable indications of a patient’s total condition. 
We do not develop or teach specific criteria for what is meant 
by moderate, severe or 4 + . Consequently, our statistical and 
computer colleagues, who justifiably loathe unreliable data, 
will usually dismiss the unstandardized clinical observations 
and ratings as being too “soft” to receive serious attention. The 
result is a computerized collection and statistical analysis of 
“hard” scientific data that are often dehumanized, because the 
key human information has been omitted. 
Even when formal attempts are made to record the human 
clinical information, we may not do a very good job. For exam¬ 
ple, oncologists have now discovered that ratings of a patient’s 
“performance status” are often prognostically more precise than 
citations of a cancer’s histologic type and anatomic spread. Yet 
the ratings of performance status do not distinguish impairments 
attributable to the cancer’s pathophysiologic derangements 
from disabilities caused by co-morbid associated diseases, de¬ 
pression or other non-oncologic factors. At the other extreme, 
clinicians may use intricate rating scales—for such attributes as 
anxiety, depression and health impairment—that have been 
deemed “reliable” and “valid” according to the mathematical 
strategies of psychosocial scientists. 
Despite impressive statistical results for reliability and valid¬ 
ity, however, the scales may be deficient in clinical “sensibility” 
because they contain 200 items, require an hour of time to com¬ 
plete, and do not focus on the main issues of clinical concern 
to the doctor or patient. 
CLINJMETR1CS 
In a new book called Clinimetrics, (published this year by Yale 
University Press), 1 have discussed the strategies and tactics 
needed to express clinical, human observations in a manner 
suitable for the humanistic science of clinical medicine. 
In some instances, we need to make better use of what is al¬ 
ready available; but many of the improvements will require the 
construction or development of new descriptive approaches and 
rating scales. For students, practitioners and investigators who 
want to observe and think as a humanistic physician, while ex¬ 
pressing the observations as a precise scientist, Clinimetrics 
may offer appealing reading. 
The subject of clinimetrics also has another potential attrac¬ 
tion. For clinicians who seek the immortality of being com¬ 
memorated with an eponym, abundant opportunities are avail¬ 
able in the creation of clinimetric indexes and rating scales. 
Many of the eponyms we learned in medical school bear the 
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names of the pathologists, physiologists, biochemists and 
microbiologists who identified diseases or etiologic agents in 
the 19th century and first part of the 20th century. 
An entirely new set of eponyms today, however, commemo¬ 
rate the clinimetrically oriented physicians whose names are 
cited in the Apgar Score, Jones Diagnostic Criteria, Killip Clas¬ 
sification, Lansbury Index, Norris Score, and even (dating back 
to some work I did many years ago when studying the treatment 
of obesity) the Feinstein Reduction Index. 
The issues I have just discussed in measurement refer to the 
process of observation and expression that produces raw data— 
whether the data describe a person’s height, serum cholesterol, 
magnitude of pain or severity of disability. 
A quite different form of measurement occurs when raw data 
that describe individual attributes are collected for groups of 
people, when the group information is summarized numerically 
with a mean, proportion or other statistical expression, and 
when the statistical summaries are contrasted for decisions 
about the results in the groups. This is the type of contrast that 
was considered in the first paragraph when raw information 
about the baseball performance of two players was summarized 
into batting averages, and when the averages were compared. 
The strategies derived from statistics will provide the means, 
proportions and other descriptive expressions that summarize 
data quantitatively. Mathematical methods also offer the calcu¬ 
lations of probability that lead to inferential decisions about 
“statistical significance.” What the statistical strategies do not 
supply, however, is the judgment that selects important clinical 
features to be noted and that uses those features to arrange for 
fair comparisons of groups. 
The act of randomization is an effective way to avoid bias 
when groups are formed in the selection of treatment, but ran¬ 
domization itself will not avoid bias when the treatments are 
carried out and when the outcomes are observed. Randomiza¬ 
tion also does not affect the suitability with which the research 
was originally planned so that the right kinds of treatment are 
being compared in the right kinds of patients. When the mea¬ 
sured results of two (or more) groups are contrasted, all of these 
other activities beyond randomization will involve clinical 
judgments to which mathematics has little to contribute. 
Most importantly, however, we cannot rely on randomized 
trials to answer the many questions that will involve quantitative 
contrasts in an age of burgeoning technology. Randomized 
trials will be too unethical, infeasible or costly for assembling 
the groups whose measured comparisons are needed to evaluate 
many therapeutic agents, to check most diagnostic agents, and 
to appraise almost all etiologic agents or risk factors for disease. 
In these circumstances, the measurements will have to come 
from groups collected after observation of the events that occur 
in ordinary clinical practice, without the statistical and scientific 
virtues of the experiments conducted as randomized trials. 
SCIENTIFIC CHALLENGES 
Accordingly, a major scientific challenge in clinical and 
epidemiologic research will be to develop suitable methods for 
identifying the cogent factors that produce biased or invalid 
comparisons in non-experimental studies, and to remove or ad¬ 
just those factors appropriately. 
Because so much intellectual effort has been devoted in the 
past few decades to randomization in studies of therapy and to 
other statistical strategies in studies of etiology, relatively little 
attention has been given to developing an appropriate set of sci¬ 
entific principles for identifying the sources of bias or distor¬ 
tion, and for developing appropriate methods and standards to 
deal with the challenges. 
Since most of those challenges involve a clinical sophistica¬ 
tion that has not been used in the conventional public health 
orientation of epidemiologic investigation, a new clinical ap¬ 
proach has been proposed in the past two decades. 
In another recent book. Clinical Epidemiology (W.B. Saun¬ 
ders Co., 1985), I have discussed the scientific challenges of 
this new field of research, identified some of its major problems 
and proposed some solutions. In addition to this book, four 
other books on clinical epidemiology have appeared in the past 
few years, reflecting the growing importance of this subject in 
modern medicine. 
As a research domain, clinical epidemiology deals with the 
methods of “measurement” used to form groups, plan compari¬ 
sons, and express results in a manner that warrants credibility 
according to both scientific and clinical standards of judgment. 
As a topic of medical education, clinical epidemiology con¬ 
tains the background that practicing clinicians will need for the 
difficult task of evaluating the claims made in conferences, lec¬ 
tures and publications in the medical literature. 
In the advances of modern medicine, we have developed a 
“basic science” for understanding and explaining the 
mechanisms of disease and biology. For dealing with the di¬ 
verse measurements that have become prime issues in the cur¬ 
rent practice of clinical medicine, a different set of scientific 
strategies is needed. Clinimetrics and Clinical Epidemiology 
offer a complementary, additional “basic science” for this 
work. 
CORRECTION 
A typo in the fall, 1986, issue of YALE MEDICINE, referring 
to the anonymous minimum competency examination for medi¬ 
cal students, may have had some students burning the midnight 
oil a little more than necessary. The sentence on page 7 in The 
Yale System article. Evaluation of Students—“The examina¬ 
tion should be written in such a way that each student who has 
participated in the coursework should be able to pass with a 
score of at least 6590.”—should have read, “...with a score of 
at least 65 percent.” 
YPI PROGRAM BLENDS 
THERAPY, SERVICE, RESEARCH 
By Alphonsus J. Mitchell 
When the Yale Psychiatric Institute moves back to the medical 
center in the summer of 1989, it anticipates more than the ad¬ 
vantages provided by a larger, more flexible space for its pro¬ 
gram. “A much richer relationship” between the institute and 
the various departments of the Yale School of Medicine is fore¬ 
seen by Dr. Gary L. Tischler, the director. 
The links between the institute and such departments as 
neurology, internal medicine, adolescent medicine and phar¬ 
macology have not been lacking during YPI’s 11-year sojourn 
on the Albertus Magnus College campus, about 2 Vi miles north 
of the medical center. 
But the return of YPI to this appropriate setting will generate 
more opportunities for consultation, evaluation, research and 
training. This can only add to the lustre of an institution which 
has earned through half a century a distinctive reputation for 
treating mental disorders in a clinical program that incorporates 
significant research efforts and the education of mental health 
professionals. 
YPI had its beginnings in 1935, developing out of the Insti¬ 
tute of Human Relations, an interdisciplinary program to study 
human behavior. YPI is an integral part of the department of 
psychiatry, overseen by a nine-member board of directors rep¬ 
resenting the School of Medicine, Yale-New Haven Hospital 
and the university. Although it formerly was exclusively con¬ 
cerned with mental disorders in older adults, the focus since the 
early 1960s has been on adolescents and young adults. 
The shift in focus was a logical development in YPI’s work, 
according to Dr. Tischler, the Charles B.G. Murphy Professor 
of Psychiatry, director of YPI since 1979, and, since July 1986, 
chairman of the department of psychiatry. “We know that 
adolescence is a time of life when a person is particularly vul¬ 
nerable to mental illness,” he says. “The most extreme form of 
mental illness, schizophrenia, has its usual age of onset during 
adolescence. Adolescence is also an age period when a person 
is particularly vulnerable to the effects of depressive disorders. 
There is growing evidence that the prevalence of these disorders 
among adolescents is greater than previously thought and that 
the course of early onset of affective disorder is particularly 
malignant if not energetically treated.” 
The young people admitted to the institute are patients in con¬ 
siderable peril. All of them previously have been treated in hos¬ 
pitals or outpatient programs without marked success. Some pa¬ 
tients—fewer than 10 percent—are destined to spend their lives 
in institutions. A small percentage of others will need highly re- 
Alphonsus J. Mitchell is the former editor of the Yale Alumni 
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Dr. Gary L. Tischler has directed the YPI and coordinated its 
return to the medical complex. 
stricted continuous supervision for most of their lives. “But,” 
says Dr. Tischler, “most are able to leave the hospital and lead 
fully productive lives, participating in a normal range of social 
and vocational activities.” 
YPI has a rated capacity of 66 beds, and it is usually filled 
or nearly filled with inpatients whose ages range from 14 to 35. 
The majority is on the younger end of the scale with the average 
age being 18. An additional 75 to 85 men and women are out¬ 
patients in the institute’s community services division. 
INTENSE TREATMENT 
YPI is out of the ordinary in that few institutions in the country 
are focused on young people with such severe and complicated 
cases that require long-term care—up to 18 months. It is even 
more unusual, Dr. Tischler believes, in the way its programs are 
tailored to the needs of each patient, “a blend of psychological 



























Art therapy is among the adjunctive therapies offered to the YPI 
patients. Here. William More, art therapist, (right) is working with 
a patient. 
Many of the YPI patients are adolescents and young adults who 
respond to recreational therapy, including volleyball, swimming 
and basketball. 
with a high level of intensity.” The aim is to rehabilitate and 
educate, “to help them reconstruct elements of their lives,” 
he says. 
In addition to primary diagnoses of schizophrenia or major 
depression, well over half of the patients admitted to the insti¬ 
tute have a secondary diagnosis of substance abuse or depen¬ 
dence. The abuse and dependence on drugs or alcohol may re¬ 
sult in temporary or permanent brain damage, and these prob¬ 
lems complicate the treatment. 
Consequently, a thorough evaluation, including neuropsy¬ 
chological and neurophysiological tests, is undertaken when the 
patient enters YPI to confirm or alter the original diagnosis and 
determine if any collateral conditions exist. There are some, 
but not many, surprises in the evaluations, according to Dr. 
Tischler. “Often the existence of a cognitive impairment has 
not been previously identified. Most people (in acute-care 
programs) are treated for the basic condition alone.” 
After 30 days, the individual patient’s treatment program is 
completely reviewed and, if necessary, reformulated. Every pa¬ 
tient is reviewed subsequently on a monthly basis, and the staff 
makes a detailed review quarterly. In addition, weekly rounds 
are led by senior medical staff members. 
Frequent assessments of patient response and progress are 
necessary in an institution where patients are confined for long 
periods. The assessments have an additional value in that the 
patient's condition and progress can be updated regularly in re¬ 
ports to parents and medical directors of insurance companies. 
The course of treatment at YPI is expensive, ranging up to 
$330 per day. Most patients are covered by a pre-paid health 
plan or insurance, according to YPI Deputy Director Sheila W. 
Wellington. “As with all specialized treatment, it is essential to 
make sure that the people here need the treatment they are get¬ 
ting. A very active quality assurance and utilization review pro¬ 
gram reduces the likelihood of unnecessary lengths of stay,” she 
explains. 
The expense of the program reflects its intensity. The profes¬ 
sional roster at YPI includes eight psychiatrists, four psycholo¬ 
gists, 64 nurses and nursing assistants, 16 social workers, four 
occupational therapists, nine recreational therapists, eight spe¬ 
cial education teachers, seven advanced residents in psychiatry, 
five postdoctoral fellows in psychology and four social work in¬ 
terns. In addition, the institute has an administrative and support 
staff of 50. 
FAMILY PARTICIPATION 
YPI has three clinical divisions: admissions and evaluation, the 
inpatient clinical program and community services. Dr. Ira 
Levine is the clinical director of the institute. The patient and 
family have their first encounter, quite naturally, with admis¬ 
sions and evaluation, headed by Christopher Greene, a clinical 
social worker. During the initial phase—while the patient's his¬ 
tory is being reviewed—members of the family are briefed 
on the program, which includes family participation in the 
treatment. 
“Families are an important resource for the patient, particu¬ 
larly with adolescents and young adults,” says Leonard Hill, 
who heads the family therapy program and the community ser¬ 
vices division. While some resistance to family therapy might 
be expected, he says that this is not the usual case. “Most people 
are terribly committed to their children. Many ask to be in¬ 
volved in the treatment. They may become discouraged and 
















Dr. Charles W. Gardner Jr., clinical professor of psychiatry, (left) 
and Dr. Ralph E. Hoffman, associate professor of psychiatry, 
discuss the relationship benveen the clinical and educational training 
programs. 
but it is one of our jobs to help both the patient and family 
develop realistic expectations about the course of illness and 
the process of recovery 
Upon admission, a patient may be confined to one of two 
closed units, one for young adolescents up to age 16 and the 
other for older adolescents and young adults. Each patient is 
provided an individual therapist, family therapist, primary 
nurse, primary psychiatric assistant, recreational therapist and 
occupational therapist. 
For younger patients, a normal range of developmental work 
is undertaken while psychopathologies are being addressed. 
The severity is indicated by such cases as: a 15-year old girl with 
history of drug abuse and several suicide attempts, and a boy 
with a history of delinquent behavior, exhibitionism and an air¬ 
line hijack attempt that led to court-ordered hospitalization. 
While impulsivity is often a problem for patients in this 
group, the physically secure environment contributes to their 
ability to bring it under control. 
Intensive treatment with individual and group psycho¬ 
therapies is provided for each patient, who meets at least three 
times a week with the primary therapist and usually once a week 
individually with the family therapist. He or she will also meet 
three times with a small psychotherapy group consisting of four 
to eight patients, a psychiatric resident, postdoctoral fellow and 
one or more staff members. 
The groups focus on daily activities in an effort to develop 
the patients’ understanding of their own behavior and their re¬ 
lationships with others. Special therapy groups meet once a 
week and focus on subjects such as substance abuse, gender and 
sexual development, orphans and adoption and sexual abuse. 
All patients and staff have a once-a-week community meeting 
to discuss social and administrative issues affecting life on the 
unit. 
PATIENT RESPONSIBILITY 
In all activities, patients steadily are encouraged to take as much 
responsibility as they can for decisions affecting their treatment. 
The younger adolescents, and other patients who have not 
finished high school, attend the Cedarhurst School, a fully 
accredited special education high school. 
Students from the YPI as well as day students from surround¬ 
ing school districts attend Cedarhurst. The school is located on 
the former Jackson estate, just north of the Albertus Magnus 
campus in Hamden. It provides an academic program with a 
therapeutic approach for about 50 students. Patients who cannot 
leave the inpatient setting for one reason or another are tutored 
at YPI. An extensive program of recreational therapy, social 
skill development and pre-vocation training is provided for each 
patient. 
Patients’ families who live within 125 miles of New Haven 
meet weekly with the family therapist (sometimes with the pa¬ 
tient) and are involved in parent groups, which meet weekly or 
bi-weekly. The individual family sessions explore relationships 
within that particular family; the group sessions focus on the 
needs and concerns of all the families who have a child in inten¬ 
sive treatment. A modified program is available to families liv¬ 
ing further away. 
The immediate safety of the patients is, of course, a major 
concern in the closed units. Diagnostic assumptions are re¬ 
assessed, and both biochemical and psychosocial treatments 
are undertaken with these patients. An integral part of the 
YPI approach is that patients are brought into community- 
based activities, adult education and individual programs that 
help them acquire practical living skills. 
Patients from either of the closed units may transfer to a 19- 
bed open unit. This unit admits patients directly from other 
acute-care hospitals as well. This transition and brief treatment 
unit introduces social/vocational rehabilitation and psychoedu- 
cational treatments to supplement those treatments already un¬ 
derway. They are aimed at developing the life skills necessary 
for living in the community outside the hospital. 
For instance, a critical skill is the ability to recognize impend¬ 
ing relapse and to know how to seek help. This same skill is em¬ 
phasized in family therapy sessions. A full-time discharge plan¬ 
ning coordinator works with the patient and family to assure the 
continuity of essential care after the patient leaves YPI. The 
transition to the outside world is no light matter for individuals 
Dr. Stephen Fleck, professor emeritus of psychiatry and public 
health, (left) has fostered much of the blend of research, service 
and training that characterizes the YPI, where the patient and his 
or her family are the primary focus. 
who have had the severe problems manifested in the YPI patient 
population. Some of them move into the community services 
program or to other outpatient or transitional programs near 
where they live. 
COMMUNITY SERVICES 
The community services division accommodates many more 
than the patients at the institute itself. It accepts referrals from 
both the inpatient division of YPI and other institutions, both 
public and private. The community services division has been 
located at the medical center for more than two years and is a 
block away from the new YPI site. 
All three of the community service programs focus on the ad¬ 
justment to ordinary life, to dealing with things that most people 
take for granted but which may be formidable hurdles for recov¬ 
ering psychiatric patients. “Some of these people are living in 
the community for the first time in years,” says Hill. “They’re 
terrified. We spend a lot of time motivating these people, chang¬ 
ing attitudes, giving them new habits.” 
From 20 to 30 people are accommodated in the day hospital 
at 350 Congress Ave., which offers intensive psychiatric treat¬ 
ment, social and vocational rehabilitation and training in com¬ 
munity living. Patients usually attend full time for six months, 
or longer if needed, while they gain confidence and then move 
to other YPI or community programs. 
The supervised apartment program provides supervised scat¬ 
ter site housing, including regular home visits by staff and indi¬ 
vidual and group meetings. 
The community work adjustment program provides several 
services. In The Workplace, a pre-vocational element of the 
program, patients are taught basic work-readiness skills: 
mobilizing themselves in the morning, how to dress for work, 
how to deal with questions others may ask, how to deal with 
. boss and other workers. Patients spend part of the day with 
counselors and occupational therapists. They discuss work- 
related issues and role play to prepare for various situations. 
Then they go to a work site, often a local thrift shop, to serve 
as work trainees for a couple of hours, and return for a debrief¬ 
ing about the experience. 
A second phase of the program involves placement in super¬ 
vised work located by the staff. “Many go out in group place¬ 
ment,” says Hill, “and they are supervised by a staff member 
at the job site. The coordinator spends a lot of time finding these 
job sites, and our promise to the employers is that we will pro¬ 
vide staff support for both patients and employers.” 
Usually, this first work experience is part-time, about 15 
hours a week, while the patients progress to a greater sense of 
independence. “We try to help them compartmentalize their 
lives a bit, to get them to think of work as just work,” says Hill. 
The program’s final phase involves counseling those who are 
ready to enter the marketplace—what jobs they ought to look 
for, how they should present themselves, how to use a support 
network. “Recovery rates relate strongly to the use of support 
networks,” Hill points out. “We encourage patients to use a 
group. It can be very important just to know someone to call 
when you have a problem. ” 
At present, the average YPI patient has a stay of about 12 
months. With the development of shorter term (30-90 days) and 
intermediate care (90-180 days) programs, the average length 
of stay for the entire program has decreased. 
Sheila Wellington notes that the number of admissions at YPI 
has been rising. Seventy patients were admitted in 1986, com¬ 
pared to 52 the year before. A good part of that increase may 
be attributed to shorter patient stays. 
This trend, she says, has developed from greater understand¬ 
ing throughout the mental health field of how treatment re¬ 
sources can be mobilized rapidly so that a person with severe 
mental illness can be brought back into the appropriate commu¬ 
nity settings and what it takes to support that person in the com¬ 
munity. "The number of day hospitals in the state has increased 
in response to the increases in resources for community-based 
programs and the knowledge of how to use them,” she says. 
The merits of YPI may be rightfully measured in terms of its 
success in bringing severely ill patients back to better health. 
The YPI experience, as disseminated through training mental 
health professionals and through research programs closely en¬ 
twined with clinical programs, form other aspects of the tripar¬ 
tite mission of training, research and service to the psychiatric 
patient. Thus, the YPI commitment of energies and resources 
has an impact that goes beyond these patients. 
YPI is, as Ms. Wellington says, “a coveted training site” for 
advanced psychiatric residents, pre- and post-doctoral fellows 
in psychology and students in nursing, social work and 
medicine. All those being training are exposed not only to ex¬ 
pert clinical work but also to fundamental research designed to 
improve their understanding of new developments in the field. 
RESEARCH 
The research, which develops naturally out of institute experi¬ 
ence is “investigator-driven,” arising on the initiative of indi¬ 
vidual staff members or units. However, continuity prevails in 
these pursuits. For instance, the center for family studies, a 
component of YPI now headed by assistant professor of psychi¬ 
atry Jeri A. Doane, studies family variables in relation to 
schizophrenia. “This work has made important contributions to 
the understanding of patterns within the family and their effect 
on mental illness and the response to it,” says Dr. Tischler. 
Dr. Ralph Hoffman, director of the center for biocognitive 
studies at YPI, has done important work on the relationship of 
language and psychosis; Philip Leaf of Yale’s center for mental 
health services, has published papers on patterns of care in the 
community and factors in the YPI program which have produc¬ 
ed tangible benefits. 
Dr. Tischler’s own work has dealt with evaluating the quality 
of patient care in mental health services and with social psychi¬ 
atry and psychiatric epidemiology. The move to new facilities 
will improve the research aspect of the institute’s work im¬ 
mediately. 
The chief benefits of the YPI move are not only more space 
but better space, 20,000 square feet of it. “We can accommodate 
more people,” says Dr. Tischler. “We will have room for more 
activity, for occupational and recreational therapy, creative 
arts therapy. The new facility will be a village that provides op¬ 
portunity for movement. The open wards are designed speci¬ 
fically to provide for patients progressing to more and more 
autonomy.” 
The entire setting is designed to facilitate better care for 
patients, better opportunities to educate and train and better 
avenues for research that can improve what we know of men¬ 
tal illness and mental health. 
Courtyards are an integral part of the architectural fabric of 
Yale University, and the same will be true of the new facilities 
for the Yale Psychiatric Institute. The noted California architect 
Frank O. Gehry, in collaboration with Allen Dehar Associates 
of New Haven, has created a courtyard as part of the YPI 
design—a village community complex. 
Founded in 1935, the YPI had been located near the school’s 
Institute of Human Relations until 1975. Then, the institute 
signed a 10-year lease for facilities at Albertus Magnus 
College. However, the space proved to be inadequate, and 
YPI initiated plans to relocate. 
Since the Connecticut Commission on Hospitals and Health 
Care approved the certificate of need in May 1985, many 
University and school leaders have spent innumerable hours 
planning the new facility. 
The $9.7 million project has begun with site preparation, 
removing existing buildings on the block bounded by Cedar 
and Liberty streets and Congress and Washington avenues. 
Groundbreaking is scheduled to take place this spring, and 
the new facilities are to be completed in 1989. 
“At the YPI, the clinical and academic programs interact, 
so that patient care reflects the highest standards of 
contemporary psychiatric practice,” said Dr. Gary Tischler, 
psychiatry department chairman and director of YPI. “The 
exceptional knowledge and experience acquired at YPI are 
put to work for the benefit of psychiatrically disturbed 
individuals throughout the United States.” 
Three patient buildings reflect levels of treatment, ranging 
from closed units for the most severe cases to open, apartment- 
style living areas. 
The building that faces Congress Avenue will accommodate 
administrative offices. The street level will provide commercial 
space, employing the same concept as the Yale Center for 
British Art on Chapel Street, where local merchants operate 
businesses on the museum’s first floor. 
Architect Gehry is familiar with both Yale and academia. 
He was the William F. and Charlotte Shepherd Davenport 
Visiting Professor of Architectural Design .at Yale in the fall 
of 1985; the following year, he was the focus of a 20-year 
retrospective exhibition at the Walker Art Center in 
Minneapolis. Among his recent projects are the Loyola Law 
School and the California Aerospace Museum and Theater. 
Architecture critics have described Gehry as “an artists’ 
architect,” adding that his houses, office buildings, museums 
and furniture possess originality and power. His ideas are 
provocative, and his work shows a close relationship to 
modem art, especially cubism. This is evident in the YPI 
protect. 
“In an era characterized by a remarkable proliferation of 
knowledge concerning the causes and nature of psychiatric 
illnesses, academic centers that span the realms of service 
and science have a unique opportunity to broaden our 
understanding and improve our ability to treat severe mental 
disorders,” said Dr. Tischler. “The move back to the medical 
center will allow us to take advantage of this opportunity.” 
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RESPONSE TO ALUMNI SURVEY: 
A DIALOGUE EMERGES 
by Drs. William L. Kissick and Nicholas PR. Spinelli 
In April 1986. Dr. Kissick and Dr. Spinelli wrote a paper 
evaluating the organization of the Association of Yale Alumni 
in Medicine, based on their combined eight years as presidents 
of the association (1977-1985). Last May, this paper and a 
questionnaire were distributed to all association members, 
including medical school graduates, former house staff and 
fellows of the Yale School of Medicine. A summary of the 
paper and a discussion of the responses to both the paper 
and the questionnaire follow. 
Traditionally, the major functions of the Association of Yale 
Alumni in Medicine have been to provide financial support to 
current medical students, to communicate news of the school 
via YALE MEDICINE and to organize reunions. But our paper 
concluded that these functions are hampered by a weak organi¬ 
zational structure that is poorly understood by the A YAM mem¬ 
bership and discourages meaningful participation by members. 
We recommended restructuring the association to provide 
better communication of personal alumni news; better under¬ 
standing of the needs of the School of Medicine; better profes¬ 
sional help to current students; more participation of alumni in 
the association; and more awareness and response on the part 
of the association to alumni needs and interests. 
GENERAL SUMMARY OF RESPONSES 
More than 10 percent of the approximately 5,000 association 
members returned completed questionnaires, and more than 60 
percent of respondents added comments. A recurring theme was 
gratitude for a Yale medical education, which time had proven 
to be a positive influence on professional careers. Interestingly, 
about 20 percent of all respondents are engaged in academic, 
rather than practice careers. 
Many respondents praised the unique Yale academic experi¬ 
ence in comparison to that of other academic environments with 
which they were familiar. 
SCHOOL-ALUMNI COMMUNICATION 
Respondents commented on three areas: 
1. YALE MEDICINE 
Although this publication received almost universally favora- 
/ V.v Kissick and Spinelli are past presidents of the Association 
oj Yale Alumni in Medicine. 
ble comments, respondents requested more news about the 
curriculum, academic changes, and student performance and 
attitudes. 
2. alumni news 
The most intense and universal complaint was the dearth of 
news concerning classmates. This deficiency is being addressed 
by the inclusion of a School of Medicine column in the Yale 
Alumni Magazine (note; not YALE MEDICINE). However, 
YALE MEDICINE will continue to publish professional news 
and class notes about alumni. To be effective, of course, each 
alumnus/a must forward personal news, news of classmates and 
fellow alums, and address changes to the Office of Medical 
Alumni Affairs, Yale University School of Medicine, 333 
Cedar St., P.O. Box 3333, New Haven, CT06510. 
3. alumni organizations 
The Association of Yale Alumni in Medicine is our autono¬ 
mous alumni organization, with its own bylaws. In the larger, 
university sphere, three "umbrella” alumni organizations—the 
Yale Alumni Fund, the Association of Yale Alumni (AYA) and 
the Yale University Office of Development—integrate all 
graduate and professional schools, as well as undergraduate 
class activities. The Association of Yale Alumni in Medicine 
functions as a component of all three. 
Responding alumni were more familiar with the structure and 
function of the Yale Medical Alumni Fund—a component of the 
Yale Alumni Fund—than with the other alumni organizations. 
Annual fund solicitation letters from appointed classmate 
agents were acknowledged by medical alumni as the most reli¬ 
able of all Yale correspondence. 
The questionnaire responses indicated that some confusion 
exists as to the relationship of Yale medical alumni to the univer¬ 
sity’s other two umbrella alumni organizations. For clarifica¬ 
tion, please refer to the short description that accompanies this 
article. 
SATELLITE REGIONAL PROGRAMS 
Although many respondents favored the development of region¬ 
al alumni satellite organizations by the AYA, some said they 
would have difficulty freeing time from busy medical or 
academic practices. Thus, the success of such attempted efforts 
would depend on the caliber of regional leadership and quality 
of programs. Regions of high alumni density may have the most 
success. As regions emerge, cooperation from alumni will be 
essential. The Hartford, Conn.; San Francisco; Washington, 
D.C./Bethesda, Md.; and Durham, N.C. areas already have or¬ 
ganized leadership and have held informational meetings. 
Dean Leon E. Rosenberg and the faculty enthusiastically sup¬ 
port providing Yale faculty programs for alumni groups. This 
initial enthusiasm suggests that these programs be developed 
further. 
The House Staff!Fellows-Alumni Status subcommittee is shown at one of its recent meetings. Pictured from left to right are (seated) 
Drs. Nina R. Horowitz, E. Maurice Wakeman, Richard Selzer, and (standing) Nicholas PR. Spinelli. Samuel D. Kushlan and 
John N. Forrest Jr. 
MEDICAL STUDENT WELL-BEING 
Perhaps the most touching aspect of the resultant “dialogue” 
was the alumni interest in meeting and assisting students. Most 
alums want the opportunity to communicate with today’s stu¬ 
dents, and many have agreed to provide bed and board for out- 
of-town students visiting for residency interviews. 
Students, too, are eager for such encounters. Most fre¬ 
quently, respondents suggested programs in which alumni 
provide students with a “tag along” clerkship in practice or 
research. While such experiences have so far been difficult to 
integrate into the academic curriculum, they may have greater 
potential in affiliated Connecticut loci. 
“ALUMNI PAPER”—A LEARNING EXPERIENCE 
As suspected, most alumni—75 percent—did not know or un¬ 
derstand the structure of our alumni association or the “bare- 
bones” character of its makeup. We hope that our work has 
clarified this. 
In response to this deficiency, the Office of Medical Alumni 
Affairs is planning to inform all Yale medical students about the 
alumni association. Future alumni class structure can be greatly 
assisted by identifying class leaders while they are still in 
school. 
Such class organization also can serve as a peer support struc¬ 
ture for the medical students. Participation by students of the 
Class of 1989 in the 25th reunion program of the Class of 1962 
in June 1986 exemplifies how mutually nourishing such stu¬ 
dent-alumni encounters may be. The alumni office will assist 
in promoting such future events. 
YALE HOUSE OFFICER/FELLOW AS ALUMNUS/A 
The commentary that accompanied the “dialogue” responses re¬ 
vealed a problem the authors had not anticipated: House officers 
and fellows who graduated neither from Yale College nor Yale 
School of Medicine, but who feel most intensely a Yale identity, 
repeatedly expressed feelings ranging from confusion to aliena¬ 
tion, particularly about their roles at alumni weekend reunions. 
Yet as medical students, we all remember house staff in our 
clinical rotations who were vital junior faculty and, indeed, role 
models for us. They are rightfully important members of our 
alumni club and are so identified in our bylaws. Therefore, a 
committee of involved and active former house staff alumni will 
be convened to study the problems presented, prescribe alterna¬ 




















BYLAWS REVIEW AND REVISION 
The bylaws of our association are as simple and as unstructured 
as the organization itself. First written in 1880, they last had 
minimal attention in 1971. When all committee functions de¬ 
scribed below are concluded, a bylaws revision subcommittee 
may be activated to review and update them. 
PROPOSED COMMITTEES TO WORK ON THE 
REORGANIZATION OF THE ASSOCIATION OF 
YALE ALUMNI IN MEDICINE 
A. Ad Hoc Committee for Organization and Bylaws Review 
This umbrella committee, chaired by Dr. William L. Kissick 
'57 was described in the May '86 paper. Its members include: 
William L. Kissick '57, chair 
Richard W. Breck '45 
Alexander R. Gaudio '63 
Carol Goldenthal '44 
Attilio V. Granata 'll 
Marie-LouiseT. Johnson '56 
R. Leonard Kemler'43 
Robert A. Kramer '55 
Thomas P. Kugelman '60 
Samuel D. Kushlan '35 
Dwight F. Miller '56 
John B. Ogilvie '34 
NicholasM. Passarelli '59 
Dorothea R. Peck '43 
Jerrold M. Post '60 
OraK. Smith '53 
Muriel D. Wolf'59 
B. Proposed Subcommittees 
1. Alumni Questionnaire Data Review 
This committee is already functioning. Its deliberations will as¬ 
sist the direction and intensity of future programs. 
Richard W. Breck '45 
Attilio V. Granata 'll 
Samuel D. Kushlan '35 
Dwight F. Miller '56, president, AYAM 
Dorothea R. Peck '43 
Nicholas PR. Spinelli '44 
2. Student Well-Being 
Attilio V. Granata ’77, chair 
Bernard H. Shen '81 
John B. Ogilvie '34 
Ora K. Smith '53 
Amy Lewis (student council president) '89 
3. Regional Satellites 
Washington, D.C.: Muriel D. Wolf '59, Jerrold M. Post 
'60 
Hartford, Conn.: R. Leonard Kemler '43, Carol 
Goldenthal '44, Alexander R. Gaudio '63 
San Francisco: A. John Anlyan '45, Lawrence G. Crowley 
'44 
4. House Staff/Fellows—Status 
Samuel D. Kushlan '35, organizer 
Nina R. Horowitz HS '79-84 
Richard Selzer HS '53-55, '57-60 
John N. Forrest Jr. HS '64-67, 69-70 
I Maurice Wakeman HS '60-63 
5. Bylaws Review and Revision 
Robert A. Kramer '55, co-chair 
Nicholas M. Passarelli '59, co-chair 
6. Alumni Communication 
This committee provides alumni news for YALE 
MEDICINE 
Richard W. Breck '45, chair 
Michael Kashgarian '58 
Dorothea R. Peck '43 
D. Helaine Patterson, director, YSM Office of Public 
Information 
Other committees will be formed as needed. Interested 
alumni may participate as committee members, even if they live 
too far away to attend most meetings. Suggestions from all 
alumni are encouraged. 
TABLE I 
Statistical Summary: 
Responses to Questions Enumerated in Questionnaire 
A. Alumni Communication 
1. Yale Medicine: satisfactory? yes 438 
no 84 
total 492 
2. personal news of classmates and 
alumni— satisfactory? yes 205 
no 330 
total 535 
3. news of alumni organizations— 
adequate? yes 100 
(AYA, alumni fund, development) no 63 
fair 16 
total 179 
(majority didn’t answer or understand 
this question—see explanatory paragraphs) 
B. Geographic regional programs: attractive, 




C. Interest in working with current Yale 




D. Aware AYAM organization structure 
and function before reading paper? yes 153 
no 355 
total 508 
E. Total respondents, as of September 1986 537 
CONCLUSIONS 
The AYAM paper, circulated in May 1986 to all alumni, 
elicited a gratifying response with diverse suggestions for our 
association’s future structure and function. These serious deci¬ 
sions should not be made by only a few association officers or 
even the 14-member executive committee. Therefore, numer¬ 
ous subcommittees are being set up to address each identified 
issue. They will be open to all interested alumni. 
These alumni will function tentatively as committee mem¬ 
bers. A word of caution is appropriate, however. Sev¬ 
eral alumni have commented: “Everything is fine as is; 
don’t change a thing; don’t build a nightmare administrative 
bureaucracy.” 
This sage counsel will be heeded as the dialogue continues. 
Meanwhile, the authors and the majority of respondents concur 
that the association and its staff can grow to be of even greater 
service to our school, its students and ourselves as fellow 
alumni. Participation by many and diverse alumni should pre¬ 
vent the possibilities of unrealistic expectations. 
The discussions will be conducted by already busy volunteer 
alumni, and the pace of the committees’ work will be slow and, 
indeed, deliberate. The counsel of our alumni will be thought¬ 
fully considered. Change, when recommended, will be to 
benefit the school, students and alumni. It will always involve 
the simplest administration possible. 
Finally, we wish to express our thanks for the abundant colle¬ 
gial warmth expressed by our alumni correspondents. It was 
perhaps best exemplified by an alumna from Monument Valley, 
Ariz.(“in the middle of nowhere”), now a physician in the U.S. 
Public Health Service. She offered to serve as tourguide to any 
YSM alum visiting the American desert, and she extended a 
similar invitation from three other Arizona-New Mexico YSM 
graduates. 
Is the Yale medical alumni mystique alive and well? You’d 
better believe it! 
Note: Please send personal and professional news, news of 
classmates, address changes or other information to: 
Director 
Office of Medical Alumni Affairs 
Yale University School of Medicine 
333 Cedar St., P.O. Box 3333 
New Haven, CT 06510 
To the same office, please send any suggestions for the future 
directions of the Association of Yale Alumni in Medicine. 
Alumni Glossary 
The Association of Yale Alumni in Medicine plans programs 
of specific interest to medical alumni. Like its parent organiza¬ 
tion, the Association of Yale Alumni (AYA), it provides a chan¬ 
nel of mutual communication between alumni and Yale. Six 
medical alumni serve as AYA delegates to report on activities 
and concerns of alumni of the School of Medicine. 
The Yale Medical School Alumni Fund is part of the Yale 
Alumni Fund, which was established in 1890 to raise unre¬ 
stricted funds for the university. Gifts to the fund by medical 
alumni are added to the Student Revolving Loan Fund to pro¬ 
vide financial aid to medical students. 
The Campaign for the Yale School of Medicine was launched 
in May, 1985 to raise $125 million for the school’s capital 
needs, including endowment, facility construction and renova¬ 
tion, and program start-up funds. 
Reunion 1986 
Alumni and guests who attended the 1986 reunion 
shared conversation and sustenance. So, plan to 
attend the 1987 reunion this June. Center: Dr. 
David Raskind '24 and his guest enjoyed the 1986 
reunion. Far right: Donald Moore '81 (right) and 
guest chat with John D. Thompson, M.S. '50, 





Dr. Cohen Receives 
First Professorship 
in Harris Program 
Dr. Donald J. Cohen, director of the Child 
Study Center and professor in the depart¬ 
ments of pediatrics, psychiatry and psy¬ 
chology, has been named as the first Irving 
B. Harris Professor of Child Psychiatry. 
The Harris professorship is a major com¬ 
ponent of the Harris Program in Child 
Psychiatry, Child Development and Social 
Policy created by a $5 million endowment 
provided by Irving Harris (Yale ’31) and 
Neison Harris (Yale ’36). 
The Harris Program consists of the Harris 
professorship, four assistant or associate 
professorships in child psychiatry, child de¬ 
velopment, child psychoanalysis and social 
policy, and a research fund. 
The Harris brothers are leading busi¬ 
nessmen and philanthropists. Irving Harris 
founded the Ounce of Prevention Fund and 
is a national advocate for young children 
and prevention of mental disorders. 
A child psychiatrist and psychoanalyst. 
Dr. Cohen joined the School of Medicine 
faculty in 1972 and has been the director of 
the Child Study Center since 1983. 
Dr. Cohen’s clinical and research activ¬ 
ities have focused on the serious neuropsy¬ 
chiatric disorders of childhood, including 
pervasive developmental disorders, such as 
autism, and stereotypic and tic disorders, 
such as Tourette’s syndrome. The research 
program he has led in the Child Study Cen¬ 
ter is characterized by the integration of 
multiple biological and behavioral perspec¬ 
tives on psychiatric disorders of childhood, 
and the linkage between research and clini¬ 
cal services. 
Dr. Cohen has published more than 200 
articles and monographs. Among his 
academic activities, he is co-director of the 
Yale Mental Health Clinical Research Cen¬ 
ter; vice president (for North America) of 
the International Association of Child and 
Adolescent Psychiatry and Allied Profes¬ 
sions; and a member of various editorial 
boards. 
He has served on the professional boards 
of the National Society for Autistic Chil¬ 
dren, the Tourette’s Syndrome Association, 
and Benhaven, the school and residential 
community for autistic individuals affiliated 
with the Child Study Center, where he is the 
psychiatric director. He also is a trustee of 
Brandeis University. 
A native of Chicago, Dr. Cohen received 
his B.A. degree from Brandeis in 1961 and 
an M.D. degree from Yale School of 
Medicine in 1966. He took his residency 
training at Harvard, Massachusetts Mental 
Health Center and Children’s Hospital 
Medical Centers, and spent two years at the 
National Institute of Mental Health and in 
the Office of Child Development in 
Washington, D.C. 
Dr. Weissman to be 
Sterling Professor 
Dr. Sherman M. Weissman, professor of 
human genetics, medicine and molecular 
biophysics and biochemistry, has been 
named Sterling Professor of Human Gene¬ 
tics, Medicine and Molecular Biophysics 
and Biochemistry. 
In his laboratory. Dr. Weissman is work¬ 
ing on deriving a molecular map of the 
human genome that would be used for gen¬ 
eral approaches to map genes and different 
forms of genes that can effect the likelihood 
of having various diseases. Other work fo¬ 
cuses on the SV 40 virus, an oncogenic 
virus; globin genes and genes of the im¬ 
mune system. He has published more than 
170 scholarly articles on his research. 
Dr. Weissman was a senior investigator 
at the National Cancer Institute metabolism 
service from 1960 until 1967, when he 
joined the Yale medical faculty as associate 
professor of medicine and molecular 
biophysics and biochemistry. He was 
named professor in 1972. 
A member of the National Academy of 
Sciences and the Connecticut Academy of 
Sciences and Engineering and a fellow of 
the American Association for the Advance¬ 
ment of Science, Dr. Weissman serves on 
several editorial boards and has participated 
on numerous special national committees 
relating to virology and cell biology. At 
Yale, he is a member of the University’s 
scientific planning committee and was 
associate director of the Comprehensive 
Cancer Center. 
A Chicago native, Dr. Weissman re¬ 
ceived an M.D. degree magna cum laude in 
1955 from Harvard Medical School, an 
M.S. degree in 1951 from the University of 
Chicago and a B.S. degree in 1950 from 
Northwestern University. He took his in¬ 
ternship at Boston City Hospital, was a clin¬ 
ical associate at the NIH and completed 
residency training at the Illinois Educa¬ 
tional and Research Hospital in Chicago. 
Dr. Farquhar Named 
Sterling Professor 
Marilyn G. Farquhar, Ph.D., professor of 
cell biology and pathology, has been named 
Sterling Professor of Cell Biology and 
Pathology. 
Dr. Farquhar’s current research interests 
include the investigation of pathways of 
membrane traffic and membrane recycling 
in glandular cells. She also is studying 
mechanisms of glomerular disease—that 
is, diseases that affect the special network 
of kidney capillaries that function to filter 
the blood. 
In 1984, she was elected a member of the 
National Academy of Sciences. Earlier, she 
was the recipient of a Research Career De¬ 
velopment Award from the National Insti¬ 
tute of General Medical Sciences. Her 
scholarly publications are among those 
most frequently cited. 
A past president of the American Society 
for Cell Biology, Dr. Farquhar participates 
in many professional societies and has 
served on the editorial boards of a number 
of scientific journals. Within the Univer¬ 
sity, she has served as director of medical 
studies of the department of cell biology and 
as chairman of the Basic Sciences Curricu¬ 
lum Committee. She is currently serving on 
the Biological Sciences Advisory and 
Senior Appointments Committees. 
A native of Tuiare, Calif., Dr. Farquhar 
received all three of her degrees: A.B., 
M.A. and Ph.D., from the University of 
California at Berkeley. She was a professor 
in the faculties of University of California 
at San Francisco and the Rockefeller Uni¬ 
versity before moving to Yale in 1973. 
Pediatrics Thanks 
Cancer Society 
The pediatric oncology division has 
thanked the Connecticut Division of the 
American Cancer Society for its program 
support of research, teaching and patient 
services in the School of Medicine. 
For the past four years, the Connecticut 
Division of the ACS, led by ACS staffer 
Jane Bemis, has—through its childhood 
cancer committee—brought the needs of 
children with cancer into a sharper focus in 
both the organization and the state. 
Dr. Diane M. Komp, professor of pediat¬ 
rics and former member of the ACS Na¬ 
tional Childhood Cancer Advisory Com¬ 
mittee, recently recognized Mrs. Bemis and 
the ACS for the “loving support of our pa¬ 
tients” in a presentation at the pediatric on¬ 
cology clinic’s chemotherapy room. 
Artist Ann Lehman created this new copper sculpture for the Magnetic Resonance Center. 
She's pictured here at the unveiling with Dr. Richard Greenspan (right) and Dr. H. Dirk 
Sostman, associate professor of diagnostic radiology. 
DRG Costs Must Include 
Post-Hospital Care 
Some of the money now saved on hospital 
costs should be used for home care pro¬ 
grams for the elderly, says School of 
Medicine Professor John D. Thompson, 
who helped to develop the DRG cost-con¬ 
trol system on which the federal govern¬ 
ment now bases Medicare payments. 
Thompson is a professor of public health 
(hospital administration) at the medical 
school and professor of nursing administra¬ 
tion at the School of Nursing, and he is a 
researcher with the Health Systems Man¬ 
agement Group at the Yale School of Orga¬ 
nization and Management. 
Since the federal government began 
using a DRG-based payment system for 
Medicare patients in 1983, hospital admis¬ 
sions have declined and the average hospital 
stay for both Medicare and non-Medicare 
inpatients has shortened. Thompson says he 
applauds these results. 
“Hospitals are unhealthy places for old 
folks,” he says. “The longer the hospital 
stay, the more chance there is of getting a 
nosocomial, or hospital-related, infection. 
We wanted to cut down on unnecessary 
utilization of hospitals. 
“Under the old system,” he says, “no one 
asked how long a patient should be in the 
hospital. The financial incentives made it 
difficult to determine that. Now, with the 
DRG system, we can begin to make some 
rational decisions.” 
But Thompson says he is not pleased with 
the overall failure to provide money for 
post-hospital care for Medicare patients. 
"Shorter terms of hospital care do not 
always translate into shorter terms of care 
altogether,” he says. “We have seen the 
tragedy that resulted from a previous policy 
of early discharge and deinstitutionalization 
of the mentally ill. There were no support 
services provided in the communities to 
which these patients were discharged. 
“Now we are worried that the same thing 
will happen to the Medicare patients: pa¬ 
tients will be discharged without the support 
services, such as home care, convalescent 
institutions and nursing homes, that they 
will need. Hospitals will be blamed for the 
problem, when actually it is just poor public 
policy.” 
Thompson also is analyzing the use of 
DRGs for pricing routine nursing costs in 
hospitals. In December, he presented a re¬ 
port, “DRGs and Nursing,” in London at 
the first international conference on “The 
Management and Financing of Hospital 
Services,” sponsored by the Health Systems 
Management Group. 
Copper Sculpture 
Created for MR Center 
A new sculpture, entitled “Freely Formed,” 
welcomes patients, researchers and guests 
coming to the Magnetic Resonance Center, 
a joint project of the School of Medicine and 
Yale-New Haven Hospital. 
Ann P. Lehman, an award-winning artist 
and teacher who lives in Bethany, Conn., 
created the work that was unveiled in Janu¬ 
ary by Dr. Richard H. Greenspan, associate 
dean for clinical affairs and former chair¬ 
man of the department of diagnostic radiol¬ 
ogy. Mrs. Lehman designed the sculpture 
specifically for the Magnetic Resonance 
Center’s main entrance, and the dramatic 
form seems to lean into its comer site. 
The hollow sculpture, which measures 
6'x4'x5', is made entirely of copper, pos¬ 
sessing a wonderfully mottled patina that 
the artist achieved by combining a variety of 
chemicals with heat. The ribbon-like 
sculpture is simultaneously strong and deli¬ 
cate, balanced on a single point. “It is soft, 
warm, flowing and non-threatening,” said 
Dr. Greenspan, who at the unveiling ex¬ 
pressed great appreciation for both the work 
and Mrs. Lehman’s creativity. He had com¬ 
missioned the sculpture. 
Reaction to the wavy piece has been very 
enthusiastic, with viewers noting a resem¬ 
blance to some MR images. 
The piece exemplifies the artist’s philos¬ 
ophy. Mrs. Lehman says: “Exploring the 
extent and variety to which metal can be 
manipulated interests me enormously. This 
concept has grown out of a fine educational 
experience (Smith, Cranbrook and Yale), 
combined with sensitivity to technology 
and the creative process. Intersecting forms 
and the unique abilities of metal are the 
methods of my imagery. Some 25 years of 
making metal sculpture have given me the 
experience to be both practical and erudite.” 
Mrs. Lehman has been active in the 
Greater New Haven arts community. In 
1960, she was one of the founders and first 
president of the Creative Arts Workshop, 
and she currently serves on the board of di¬ 
rectors and teaches metal sculpture at the 
workshop. She also is president of 
Artspace, Inc., an organization that pro¬ 
vides an exhibition gallery and dance re¬ 
hearsal performance space for community 
artists. 
Among her recent commissions include 
sculptures for Pepperidge Farm corporate 
headquarters, Armstrong Rubber Co., the 


















Placebos may actually help to relieve pain 
and cure illness, says Dr. Howard M. Spiro, 
professor of medicine and director of 
the school’s program for humanities in 
medicine. 
“The scientific approach to human 
medicine—the molecular model—is not 
sufficient by itself to answer all our patients’ 
needs,” he says. “Disease [the objective 
findings of the physician] differs from ill¬ 
ness [the subjective feelings of the patient], 
and placebos help the illness component of 
the disease." In his new book. Doctors, Pa¬ 
tients, and Placebos, published last year by 
Yale University Press, Dr. Spiro uses the 
placebo as a metaphor for the doctor-patient 
relationship and its effect on healing. 
“The placebo is a symbol of loyalty of the 
doctor to the patient,” he says. “Loyalty in¬ 
volves knowing what the patient wants, 
spending time with the patient, showing 
that the doctor cares and doing what is in the 
patient’s best interest.” 
While placebos alone cannot heal, Dr. 
Spiro says their effects on illness cannot be 
discounted. He cites evidence that “con¬ 
trolled clinical trials of healing in peptic 
ulcer suggest that more than half the people 
getting a placebo benefit from the placebo.” 
Their pain is quickly relieved just by being 
in the study. “We should look at why that 
happens and what placebo relief tells us 
about the doctor-patient relationship,” he 
urges. 
In Doctors, Patients, and Placebos, Dr. 
Spiro urges physicians to improve their re¬ 
lationships with patients, to talk and listen 
as much as they look and measure, and to 
treat illnesses as well as disease. 
He also hopes that medical school 
teachers will integrate science and intuition 
in teaching medical care, since intuition 
gives unique insights that science can test. 
“There is increasing emphasis on what 
can be seen, on the cellular basis of disease, 
and a kind of disdain for the rest,” says 
Dr. Spiro. The domination of laboratory 
medicine in current medical training “turns 
the physician into a scientist studying the 
cell and its subcellular processes, tracing its 
DNA rather than listening to, or even look¬ 
ing at, the person who is the patient. 
“But there should be no ‘forbidden ques¬ 
tions,”’ he says. “Medical science, using 
scientific criteria, should also examine the 
claims of holistic medicine, faith-healers 
and folk practitioners.” 
Dr. Spiro recommends that physicians- 
in-training be given more direct experience 
with patients who are not in hospitals, since 
those are the kinds of patients whom prac¬ 
ticing physicians are likely to see. “We 
should be training doctors not only in the 
biomechanical mode,” he says, “but also in 
seeing outpatients—people who are up and 
around—as we used to, 30 years ago.” 
Says Dr. Spiro: “Hospitals today are 
large intensive-care units. They are not the 
best place to train physicians to take care of 
patients who may need understanding as 
much as science.” 
Dr. Spiro received his M.D. from Har¬ 
vard Medical School in 1947 and has been 
a member of the Yale medical faculty since 
1955, when he established the gastroen¬ 
terology section at the Yale School of 
Medicine. He is author of a standard 
textbook in the field and is the editor of the 
Journal ofClincial Gastroenterology. 
Dr. Tsien Presented 
Javits Award to Study 
Calcium Channels 
Dr. Richard W. Tsien, professor of physiol¬ 
ogy, has been given a Javits Neuroscience 
Investigator Award for his distinguished 
record of contributions in neurological 
sciences. 
The U.S. Congress established special 
Awards to honor the late Sen. Jacob K. 
Javits of New York, and the National Ad¬ 
visory Neurological and Communicative 
Disorders and Stroke Council selects the 
recipients, whose research is supported for 
seven years. 
Dr. Tsien, a Rhodes Scholar who joined 
the Yale medical faculty in 1970, will focus 
his research on developing new approaches 
to studying the role of calcium channels in 
neuronal function. Specifically, he will 
examine the way calcium channels control 
the release of neurotransmitters and, in the 
long term, the changes in communication 
between nerve cells. 
His research may be applied in studying 
disorders of the nervous system, such as 
epilepsy, and in forms of defects in neuro- 
transmitter release. 
At Yale, Dr. Tsien and his colleagues 
have discovered new types of calcium chan¬ 
nels in neurons, heart muscle cells and 
smooth muscle cells. The new types of 
channels seem to be involved in important 
cellular functions, such as control of neuro¬ 
transmitter release and contraction. 
Calcium channels themselves are 
molecular pores that exist in cell membrane 
of all excitable cells. They possess the 
unique role of transforming electrical mes¬ 
sages into chemical messages by allowing 
calcium entry into cells. 
Unified Language 
Sought in Medicine 
Computers—those high-tech tools that en¬ 
gineers and mathematicians have used for 
years—have entered medicine, and re¬ 
searchers at Yale and elsewhere are working 
to develop a unified medical language 
(UML). 
With a two-year, $355,000 grant. Perry 
L. Miller, M.D., Ph.D., assistant professor 
of anesthesiology, will participate in the 
national project sponsored by the National 
Library of Medicine. 
The goal of the UML project is to develop 
a common vocabulary for physicians and 
other health professionals when using com¬ 
puters to retrieve and store bibliographic in¬ 
formation, abstract clinical records, access 
clinical data bases and help in diagnostic 
decision-making, according to Dr. Miller. 
“If the same language were to be used, 
then there would be no need for translation 
tables, books and other guides in order to 
move easily from one system to another,” 
he added. “With a common vocabulary, for 
example, clinical computer systems could 
gather bibliographic references relevant to a 
particular computer-based patient record." 
Currently, a variety of vocabularies are 
used, including the McSH (Medical Subject 
Heading) terms of the National Library of 
Medicine and the SNOMED classification 
scheme developed for pathology. Computer 
programs, such as the INTERNIST/ 
CADUCEUS diagnosis system, also use 
vocabularies to describe symptoms, signs, 
test results and diseases. 
At Yale, Dr. Miller and his colleagues 
will focus on liver disease, using a com¬ 
puter-based file describing nearly 10,000 
liver biopsy specimens meticulously com¬ 
piled under the direction of the late Dr. 
Gerald Klatskin, an internationally known 
liver specialist who was the David Paige 
Smith Professor Emeritus of Medicine. 
“We will see how relationships between 
terms may help improve bibliographic re¬ 
trieval,” Dr. Miller said. "One of our aims 
is to facilitate, for example, bibliographic 
retrieval of papers relating to a clinical 
question in a more focussed, or semanti¬ 
cally driven, way than the simple keyword 
retrieval now available,” he added. 
Collaborators include Jon S. Morrow, 
M. D., Ph D., and Dr. Kenneth W. Bar- 
wick, both associate professors of pathol¬ 
ogy, and Dr. Caroline A. Riely, associate 
professor of medicine. They will work in 
conjunction with the Yale Liver Center di¬ 
rected by Dr. James L. Boyer, professor of 
medicine. 
Besides Yale, groups at Harvard, the 
University of California at San Francisco 
and at the University of Pittsburgh and Car¬ 
negie Mellon University, collaboratively, 
are participating in the unified medical lan¬ 
guage project. 
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Andrea R. Gwosdow, Ph D., demonstrates the research apparatus used to measure the 
frictional force of fabrics, as she slowly pulls cloth across the forearm of Larry G. Berglund, 
Ph D. (behind curtain). 
The researchers hypothesize that the skin 
surface may become more adhesive when it 
is wet. “We think the skin softens when we 
sweat, allowing fabric fibers to dig into the 
skin,’’ says researcher Larry G. Berglund, 
Ph D., a visiting lecturer in environmental 
technologies at the Yale School of Architec¬ 
ture. The rougher the fabric, the more it re¬ 
sists sliding, he says. 
The research team also includes Andrea 
R. Gwosdow, Ph D., a postdoctoral fellow 
in the department of epidemiology and pub¬ 
lic health; and Joseph C. Stevens, Ph D., 
senior research scientist and lecturer in 
psychology. 
Of the six fabrics tested in the study (wor¬ 
sted wool, brushed cotton, cotton, silk, 
linen and burlap), silk consistently was 
rated by research subjects as feeling most 
pleasant and least textured (smooth), no 
matter how wet the skin surface. The fric¬ 
tion of silk against skin was measured to 
be less than half of the friction of the other 
fabrics under the same environmental 
conditions. 
But Dr. Stolwijk says the smoothness 
that makes a fabric feel pleasant in warm 
and humid climates can make the same fab¬ 
ric uncomfortable in the cold. 
“When you get into silk sheets in the win¬ 
tertime,” he says, “you feel cold; get into 
flannel sheets at the same temperature, and 
you feel warmer. The only difference is 
how the fabric fibers touch your skin." The 
nap of flannel keeps a portion of the cloth 
fibers away from the skin, says Dr. Stol¬ 
wijk. Thus, less of the skin surface is cooled 
by the fabric. And he says the warmer the 
skin surface feels, the warmer the whole 
body feels. 
NIH Funds Sperm 
Physiology Research 
on Male Infertility 
The National Institute of Child Health and 
Human Development, a division of the Na¬ 
tional Institutes of Health, has awarded Dr. 
Gabor B. Huszar, director of the sperm 
physiology laboratory at the School of 
Medicine, a three-year grant of $214,587 
for male infertility research. The grant 
began in August. Dr. Huszar is a research 
scientist in obstetrics and gynecology and 
pediatrics. 
Dr. Huszar is looking for biochemical 
markers that can predict sperm fertility. 
This research will concentrate on the activ¬ 
ity of key enzymes of energy synthesis and 
utilization, such as creatine phosphokinase 
and dynein ATPase (the principal structural 
protein and enzyme in sperm motility), and 
the pool of compounds important in energy 
transport, such as creatine and creatine 
phosphate. 
“We are measuring the activity of these 




What makes the same shirt feel soft in a dry 
climate yet scratchy in the tropics? How do 
fabrics affect our perceptions of comfort 
and discomfort in different environments? 
At the School of Medicine, a team of in¬ 
vestigators led by Dr. Jan A. J. Stolwijk, 
the Susan Dwight Bliss Professor and chair¬ 
man of the department of epidemiology and 
public health, is looking at how the physical 
properties of clothing influence human be¬ 
havior. The work is being conducted in col¬ 
laboration with researchers at the John B. 
Pierce Foundation Laboratory. 
“Textile makers say cloth has something 
called "hand,’ which is how it feels when 
you touch it,” says Dr. Stolwijk. “We tried 
to see whether there was another character¬ 
istic of cloth that would affect how comfort¬ 
able you would find it—and that would 
have to do with how much it pulls on the 
skin.” 
Their results, reported in a recent issue of 
Textile Research Journal, show that when 
the human body feels hot and moist, it per¬ 
ceives clothing texture more keenly; and as 
perceptions of clothing texture increase, 
physical comfort decreases. 
The researchers say these results could 
have a significant impact on the design of 
cloth and clothing for specific uses—work 
uniforms, protective clothing and hospital 
bedsheets, for example. 
The study marks the first time that re¬ 
searchers have been able to quantitatively 
relate perceptions of fabric texture and 
pleasantness to both the friction resulting 
from fabric rubbing over the skin surface 
and the amount of moisture on the skin. 
The research team developed a new tech¬ 
nique for measuring local skin moisture 
(“wettedness”). When this measurement 
rose above 30 percent, the measured 
coefficient of friction between the skin and 
fabric increased significantly, as did subjec¬ 
tive ratings of clothing discomfort. 
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normal and with low sperm counts, and we 
are looking at the correlation among sperm 
quality and the activity of these enzymes 
and the concentration of the energy transfer 
compounds. By a fractionation method 
based on sperm motility, we are preparing 
the best quality sperm population—those 
with the highest linear velocity,” says Dr. 
Huszar. 
About 40 percent of the 10 to 12 million 
infertile couples in the United States have a 
male infertility problem. If that infertility is 
attributed to oligospermia—a low concen¬ 
tration of sperm—improved quality sperm 
specimens may enhance the chances for 
pregnancy by intrauterine insemination and 
in vitro fertilization, says Dr. Huszar. 
For patients with normal sperm counts 
but sluggish sperm motility. Dr. Huszar is 
looking at biochemical methods of enhanc¬ 
ing sperm motility. 
Together with Neil J. MacLusky, Ph D., 
associate professor of obstetrics and 
gynecology and pharmacology; Dr. Alan 
H. DeCherney, the John Slade Ely Profes¬ 
sor of Obstetrics and Gynecology; Dr. 
Hasan Fakih, a former fellow in the depart¬ 
ment of obstetrics and gynecology, cur¬ 
rently at Michigan State University; and 
Theo Wallimann, Ph D , of the Institute fur 
Zellbiologie, Zurich, Switzerland, Dr. 
Huszar has published the first major paper 
pursuing this line of research, entitled “En¬ 
hancement of human sperm motility and 
velocity in vitro: effects of calcium and 
creatine phosphate,” in the November 1986 
issue of Fertility and Sterility. 
Yale, State Officials 
Study Airborne Toxins 
The Yale Comprehensive Cancer Center 
and the Connecticut Department of En¬ 
vironmental Protection will collaborate in a 
new program to identify and eliminate air¬ 
borne toxins that contribute to cancer and 
birth defects. 
In announcing the new program. Gov. 
William A. O’Neill said, “This cooperative 
program represents an innovative approach 
to the protection of our environment and 
public health that will tremendously benefit 
the citizens of our state.” It is the first pro¬ 
gram of its kind in the nation. 
For this program, Mrinal K. Sanyal, 
Ph D., research scientist in obstetrics and 
gynecology, has developed analytical tech¬ 
niques involving biological and human tis¬ 
sue testing. His new procedures greatly 
simplify the search for lethal toxins in air 
samples. 
The DEP will monitor the biological ef¬ 
fects of air pollutants on an ongoing basis at 
sites across the state and study the toxic ef¬ 
fects of various air samples. 
“The goal of this project is to identify lo¬ 
cations around the state that have toxic sub¬ 
stances in the air, to find the sources of those 
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substances and to clean them up,” Governor 
O’Neill said in late January. 
Dr. Alan C. Sartorelli, director of the 
Yale Comprehensive Cancer Center, added, 
“This collaboration could have a significant 
impact on reducing the incidence of cancer 
and birth defects in our state. It is our hope 
that this important initial study will lead to 
further collaborative projects between Yale 
and the state Department of Environmental 
Protection.” 
New Center Focuses 
on Pain Management 
The Department of Anesthesiology has ex¬ 
panded its pain management program by es¬ 
tablishing the Yale Center for Pain Manage¬ 
ment and naming Dr. Josef K. Wang as its 
first full-time faculty director. Dr. Wang, 
who left the Mayo Clinic in Rochester, 
Minn., to join the Yale medical faculty as 
professor of anesthesiology, set up the out¬ 
patient service to help patients who suffer 
from acute and chronic pain syndromes. 
The center is located in Hunter 4 at Yale- 
New Haven Hospital. 
“If we can manage pain effectively in the 
early stages, then fewer patients will suffer 
from chronic pain problems,” says Dr. 
Wang. “An aggressive approach, which 
combines physical therapy, exercise, re¬ 
gional pain control and medications, will 
help people who have developed such prob¬ 
lems as shingles or low-back or neck 
injuries,” the anesthesiologist says. “By 
managing pain earlier,” he contends, “indi¬ 
viduals may avoid psychological, emo¬ 
tional and social problems that may result 
from delayed treatment.” 
The Yale Center for Pain Management, 
which is part of the school’s Faculty Prac¬ 
tice Plan, employs a multidisciplinary ap¬ 
proach encompassing anesthesiology, psy¬ 
chology, orthopaedics, neurology and 
neurosurgery. 
Both outpatients and inpatients are 
treated for many types of pain, such as mus¬ 
cle, joint and cancer pain; headaches and 
pain following surgery, nerve injury, ampu¬ 
tation or spinal cord injury. Nerve blocks, 
nerve stimulation, medications and 
cryoanalgesia—low-temperature freezing 
of nerve fibers—are among the methods 
used to relieve pain. 
In the mid-1970s. Dr. Wang conducted 
basic research that resulted in pioneering 
techniques to inject narcotics into human 
spinal canals and control cancer pain. After 
10 years, he says that the procedure has be¬ 
come standard practice for treating some 
three million patients annually throughout 
the world. 
Some of this work was based on laborato¬ 
ry studies using spinal opiates to control 
pain that Dr. Luke M. Kitahata, professor 
of anesthesiology, conducted at Yale. This 
close association between basic science and 
clinical work in Yale’s anesthesiology de¬ 
partment attracted Dr. Wang to the School 
of Medicine. 
Dr. Wang has expanded his initial re¬ 
search on cancer pain management to in¬ 
clude postoperative pain, labor-related pain 
and body trauma. Most recently, he’s con¬ 
centrated on alleviating pain associated 
with heart attacks, pulmonary embolisms 
and pancreatitis. 
Dr. Wang cites several areas where more 
pain research is needed: massive bums, 
where patients may suffer pain for months 
until complete healing occurs; and kidney 
stones, where the excruciating pain may last 
only two or three days until individuals pass 
their stones. 
A Kobe, Japan, native who became an 
American citizen in 1970, Dr. Wang had 
been associated with the Mayo Clinic and 
Mayo Medical School since 1974. He 
helped establish the Mayo Pain Clinic and 
served as its first director from 1980 to 
1986, before coming to Yale in May 1986. 
New Grant Expands 
Brain Cell Studies 
Dr. D. Eugene Redmond Jr., associate pro¬ 
fessor of psychiatry at the School of 
Medicine, has been named program direc¬ 
tor for a three-year, federally funded study 
on how brain cell transplants effect a chemi¬ 
cal model of Parkinson's disease. 
For this work extending previous studies, 
Yale University will receive $1.8 million 
from the National Institute of Neurological 
and Communicative Disorders and Stroke. 
“Parkinson’s disease is one of the few 
brain disorders in which the deficit is under¬ 
standable and due to the loss of a particular 
kind of cell," Dr. Redmond said. “By using 
a drug, MPTP, to produce a functional 
model by destroying these same cells, we 
eventually hope to learn whether we can re¬ 
store function by replacing the lost cells 
through transplantation." 
The team’s previous transplant work has 
shown that nerve cells will grow and, even 
more importantly, organize and establish 
themselves like brain cells. The team hopes 
to find out whether the transplanted fetal 
primate brain cells send and receive mes¬ 
sages the same way as the original brain 
cells did, according to Dr. Redmond. 
The research program, which involves 
biomedical scientists at Yale and the Uni¬ 
versity of Rochester, includes four main 
projects. John R. Sladek Jr., Ph.D., profes¬ 
sor and chairman of neurobiology and 
anatomy, leads a University of Rochester 
team that will study the neuroanatomical 
distribution of changes produced by MPTP 
and the location and connections estab¬ 
lished by the transplants. 
Robert H. Roth, PhD., professor of psy¬ 
chiatry and pharmacology, serves as princi¬ 
pal investigator for project two, in which his 
team will use biochemical techniques to 
study transmitters and transmitter deficits. 
As principal investigator for project 
three. Dr. Redmond and his colleagues will 
characterize the motor, behavioral and cog¬ 
nitive changes. Dr. Benjamin S. Bunney, 
professor of psychiatry and pharmacology, 
will use new electrochemical methods to 
study chemical changes in awake behaving 
animals for the fourth project. 
The transplant work is conducted at the 
independent Axion Research Foundation 
Primate Facility in St. Kitts, a West Indian 
island where the African green monkeys are 
studied in a more natural environment. Tis¬ 
sue samples collected in St. Kitts are 
studied in New Haven and Rochester. 
FACULTY NEWS 
Dr. Bruce M. McDonald, clinical profes¬ 
sor of pediatrics, has been appointed senior 
vice president for medical affairs at 
Bridgeport Hospital. 
The Yale School of Medicine was well 
represented at the National Institute of 
Child Health and Human Development 
Child Health Day symposium on Oct. 6. 
Dr. Ruth Whittemore, clinical professor 
of pediatrics, presented a paper on “40 
Years in Pediatric Cardiology.” The sym¬ 
posium, held in conjunction with the begin¬ 
ning of the NIH centennial year, com¬ 
memorated 100 years of pediatric research. 
Other Yale participants were Dr. Charles 
Lowe '45, special assistant to NICHD di¬ 
rector Dr. John Crawford, and Dr. Harry 
H. Gordon '32 of Rye, N Y. 
The American College of Epidemiology 
presented its Abraham M. Lilienfeld Award 
to Dr. Alfred S. Evans, the John Rodman 
Paul Professor of Epidemiology and direc¬ 
tor of the World Health Organization Serum 
Reference Bank at Yale’s department of 
epidemiology and public health. 
The prestigious award was presented at 
the ACE annual meeting, held last fall at the 
School of Medicine. 
Dr. Evans was recognized for his con¬ 
tributions to the field of epidemiology and 
to science and public health, which 
“epitomize the high standards of craft and 
professionalism demonstrated in the life 
and career of Dr. Abraham M. Lilienfeld.” 
Dr. Evans came to Yale in 1946 to work 
with Dr. Paul, but was recalled into the 
Army in 1950. In 1952, he went to the Uni¬ 
versity of Wisconsin, where he became 
chairman of the department of preventive 
medicine and director of the state laboratory 
of hygiene. When Dr. Paul retired from 
Yale in 1966, Dr. Evans was called back to 
the School of Medicine to be professor of 
epidemiology and director of the WHO 
Serum Reference Bank. 
Joseph F. Hoffman, Ph D., the Eugene 
Higgins Professor of Physiology, received 
the first Aser Rothstein Award Nov. 21 in 
Toronto. Dr. Hoffman, who gave a lecture 
on the occasion of Dr. Rothstcin’s retire¬ 
ment, was recognized for his contributions 
to red cell membrane physiology. This 
award was established to honor Dr. Aser 
Rothstein, director of the Research Institute 
of the Hospital for Sick Children in Toronto. 
Dr. Dennis D. Spencer, professor of 
surgery (neurosurgery), has been appointed 
chief of the neurosurgery section in the de¬ 
partment of surgery. He has been acting 
chief since November 1984. 
Dr. Spencer, who completed residency 
training at Yale-New Haven Hospital and 
was named assistant professor of neuro¬ 
surgery in 1977, has focused his work on 
epilepsy, specifically treating intractable 
conditions with surgery. Estimates indicate 
that 100,000 patients in the United States 
could benefit from such a procedure. 
In December, Drs. Dennis and Susan S. 
Spencer traveled to Taiwan jointly on the 
Lennox Visiting Professorship sponsored 
by the Epilepsy Foundation of America. 
They presented lectures and began efforts to 
assist the department of neurology at Chang 
Gung Memorial Hospital in Taipei in set¬ 
ting up an epilepsy surgery program. Dr. 
Susan Spencer is an associate professor of 
neurology. 
The Camille and Henry Dreyfus Founda¬ 
tion, Inc. has named William J. McGin¬ 
nis, Ph.D., assistant professor of molecular 
biophysics and biochemistry, a Camille and 
Henry Dreyfus Teacher-Scholar. He is one 
of 12 young faculty members in the United 
States to receive the grants. 
As a teacher-scholar, McGinnis will ex¬ 
pand his work on the molecular genetics of 
pattern formation in animal development, 
using fruit flies as a model. He joined the 
Yale faculty in 1984. In January, the Na¬ 
tional Science Foundation selected McGin¬ 
nis as one of 200 engineers and scientists to 
receive Presidential Young Investigator 
Awards, which are intended to help univer¬ 
sities attract and retain outstanding young 
Ph.D.s who might otherwise pursue non¬ 
teaching careers. 
Frank H. Ruddle, Ph D., professor of 
biology and human genetics, and Dr. Leon 
E. Rosenberg, dean of the School of 
Medicine, have been selected to serve on 
the National Research Council Committee 
on Mapping and Sequencing the Human 
Genome. The committee also includes three 
Nobel Prize winners: Walter Gilbert, James 
Watson and Daniel Nathans. 
Dr. Allen C. Steere Jr., associate pro¬ 
fessor of medicine, arranged a day-long 
symposium at which four physicians from 
the Union of Soviet Socialist Republics par¬ 
ticipated. The December event was the re¬ 
turn portion of a U.S.-U.S.S.R. exchange 
program sponsored by the National Insti¬ 
tutes of Health and the U.S. Department of 
State. In 1985, Dr. Steere traveled to the 
U.S.S.R. to speak at the Third Congress of 
Rheumatology of the Soviet Union. 
The Soviet delegation—two rheumatol¬ 
ogists, a neurologist and an orthopedic 
surgeon—was especially interested in 
Lyme disease, a tick-borne infection that 
Yale medical researchers identified in 1975 
in Connecticut. The disease now occurs in 
the Soviet Union. 
The Soviet physicians, who spoke at the 
department of internal medicine grand 
rounds, expressed hope for peace, the dis¬ 
covery of new drugs to alleviate suffering, 
and greater cooperation between the United 
States and their own country. 
Dr. Anne McB. Curtis, professor of 
diagnostic radiology, has been named act¬ 
ing chairman of the School of Medicine de¬ 
partment of diagnostic radiology and acting 
chief of diagnostic imaging at Yale-New 
Haven Hospital. Dr. Curtis, who joined the 
Yale medical faculty in 1975, specializes in 
thoracic radiology. 
A native of New York City, Dr. Curtis re¬ 
ceived a B.A. degree in 1964 from 
Radcliffe College and an M.D. degree cum 
laude in 1970 from Yale School of 
Medicine. She interned and took one year of 
residency training in internal medicine at 
Yale-New Haven Hospital, and completed a 
three-year residency training program in 
diagnostic radiology at Yale-New Haven 
Hospital. 
She fills an opening created Oct. 1 when 
Dr. Richard H. Greenspan was named to the 
new position of associate dean for clinical 
affairs in the medical school. 
Dr. John S. Ebersole, associate profes¬ 
sor of neurology, began a one-year term as 
treasurer of the American Epilepsy Society 
at the 40th anniversary meeting last fall in 
Seattle. He also presented a paper on the 
mechanisms of social epileptogeneis at the 
EEG course. 
Dr. Pasko Rakic, professor of neurosci¬ 
ence and chairman of the section of 
neuroanatomy, has been presented the Karl 
Spencer Lashley Award for his research on 
development of the central nervous system. 
Established in 1957 by a gift to the Ameri¬ 
can Philosophical Society, the award is 
given periodically to recognize “useful and 
significant” work in neurobiology. 
Since 1965, Dr. Rakic, the Dorys 
McConnell Duberg Professor of Neurosci¬ 
ence, has been working on the mechanisms 
of neuronal proliferation, migration and de¬ 
velopment of synaptic connections in the 
brain. 
Among contributions cited at a fall cere- 
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mony in Philadelphia were the concept of 
membrane surface mediated neuronal-glial 
interactions in neuronal migration, discov¬ 
ery of neuronal abnormalities due to defects 
in single genetic loci in neurological mutant 
mice, and the role of selective elimination 
of supernumerary neurons and axons in for¬ 
mation of synaptic connections during pre- 
and postnatal development. 
The American Association of Blood 
Banks presented its 1986 Distinguished 
Service Award to Dr. Joseph R. Bove, pro¬ 
fessor of laboratory medicine at the School 
of Medicine and associate director of clini¬ 
cal laboratories at Yale-New Haven Hospi¬ 
tal, in recognition of his service as chairman 
of the association’s committee on trans¬ 
fusion-transmitted diseases. 
Dr. Bove has been instrumental in AABB 
efforts to create comprehensive policies on 
infectious diseases, especially AIDS. In ad¬ 
dition to his work as a consultant for the 
FDA Blood Products Advisory Committee, 
which he chaired from 1981 to 1983, Dr. 
Bove is chairman of the Connecticut State 
Department of Health Advisory Committee 
on Plasmapheresis and Blood Banking. He 
was a member of the Food and Drug Ad¬ 
ministration Panel for Blood and Blood De¬ 
rivatives and is past president of the New 
England Transfusion Society. 
Dr. Provence Named 
Professor Emeritus 
Dr. Sally Provence retired on Oct. 1, 1987 
and was named professor emeritus in the 
Child Study Center and pediatrics. Dr. 
Provence began her career at Yale in 1949 
as instructor in the Child Study Center and 
pediatrics. 
She created and designed the Child De¬ 
velopment Unit in the Child Study Center 
for the study and treatment of younger chil¬ 
dren; she served as its director from 1951 to 
1978. The wing that houses the unit will be 
named the Provence-Harris Wing in honor 
of Dr. Provence and Irving B. Harris, a 
child and family advocate who generously 
supports the Child Study Center. 
Dr. Provence is also a founding director 
of the National Center for Clinical Infant 
Programs; she currently serves as its presi¬ 
dent. 
She has been involved continuously in 
teaching, clinical research and clinical ser¬ 
vice, and has been particularly interested in 
applications of research for the improve¬ 
ment of services to children and parents. 
She is the author of many articles and 
several books on scientific and clinical as¬ 
pects of child development. 
Dr. Kashgarian to Edit 
YALE MEDICINE 
Dr. Michael Kashgarian, professor of pa¬ 
thology, has been named editor of YALE 
MEDICINE, the School of Medicine’s 
alumni magazine published three times 
a year. He succeeds Dr. Arthur Ebbert Jr., 
deputy dean and professor of medicine, 
who has relinquished his editorial duties. 
Dr. Kashgarian joined the School of 
Medicine faculty in 1964 as assistant pro¬ 
fessor of pathology, and was named profes¬ 
sor in 1977. He is vice chairman of the 
pathology department, a position he has 
held since 1976. He also served as associate 
chief pathologist at Yale-New Haven Hos¬ 
pital from 1976 to 1985. 
A New York City native. Dr. Kashgarian 
received an A.B. degree in 1954 from New 
York University and an M.D. degree in 
1958 from Yale School of Medicine. He 
took residency training at Barnes Hospital 
in St. Louis and Yale-New Haven Hospital. 
He also was a research fellow in renal phys¬ 
iology at the University of Goettingen. 
Much of Dr. Kashgarian’s research re¬ 
lates to the pathobiology of renal disease. 
Studies include the morphological corre¬ 
lates of ionic transport, the role of the 
The wing that houses the Child 
Development Unit will be named after 
Dr. Sally A. Provence (right) and Irving 
B. Harris of Chicago, a 1931 Yale College 
graduate and one of the nation’s leading 
advocates for children and families. They 
and others also founded the National 
Center for Clinical Infant Programs. 
glomerular mesangium in chronic 
glomerularsclerosis and the mechanisms of 
recovery from acute renal injury. He has 
published more than 160 articles in scholar¬ 
ly journals. 
Active on numerous editorial boards and 
professional organizations. Dr. Kashgarian 
served as president of the Connecticut Soci¬ 
ety of Pathologists in 1975 and is a fellow 
of the American Society of Clinical 
Pathologists and the College of American 
Pathologists. 
At Yale, Dr. Kashgarian has served as 
chairman of the medical school’s commit¬ 
tee on the well being of students and as a 
member of the affirmative action commit¬ 
tee. He also is a fellow of Jonathan Edwards 
College. In 1983-1984, he was president 




Two medical faculty members received the 
top awards at the 19th annual meeting of the 
American Society of Nephrology held Dec. 
7-10 in Washington, D.C. 
Dr. Emile L. Boulpaep, professor and 
chairman of the department of physiology, 
received the Homer W. Smith Award given 
by the ASN and the New York Heart As¬ 
sociation for outstanding achievements in 
renal physiology. 
For his award address. Dr. Boulpaep dis¬ 
cussed “Biomembranes and Epithelial Path¬ 
ways in Renal Tubule Transport.” 
An electrophysiologist. Dr. Boulpaep 
has made fundamental contributions to un¬ 
derstanding electrical current flow and elec¬ 
trical potential generation in single renal 
tubules. This has significantly contributed 
to understanding how the kidney handles 
water and ions. 
Dr. Boulpaep received an M.D. degree in 
1962 from the University of Louvain in Bel¬ 
gium and an honorary master of arts degree 
in 1979 from Yale University. He joined the 
Yale medical faculty in 1969 as assistant 
professor of physiology, and 10 years later 
was named professor and chairman of the 
department of physiology. 
Walter F. Boron, M.D , Ph D., associate 
professor of physiology, was presented the 
second annual Young Investigator Award 
given by the ASN and the American Heart 
Association. The award goes to an indi¬ 
vidual under age 41 for outstanding neph- 
rologic research. 
For two consecutive years, Yale faculty 
members have won this award. Last year. 
Dr. PeterS. Aronson, associate professor of 
medicine and physiology, received the 
same award. 
ALUMNI NEWS 
Dr. Beatrix A. Hamburg ’48, professor of 
psychiatry and pediatrics, Mount Sinai 
School of Medicine, City University of 
New York, has been elected to the Ameri¬ 
can Association for the Advancement of 
Science board of directors. Her four-year 
term began Feb. 19. 
Dr. Ian C. MacLean 65 HS, associate 
professor, department of rehabilitative 
medicine, Northwestern University Medi¬ 
cal School and a member of the attending 
staff at the Rehabilitation Institute of 
Chicago, was elected to the American 
Academy of Physical Medicine and Re¬ 
habilitation board of governors at its 48th 
annual assembly in October. After five 
years of service, the post leads to the presi¬ 
dency of the organization. 
Dr. David H. Shapiro ’65 HS, of Clear¬ 
water, Fla., was elected to the American 
College of Surgeons board of governors as 
a govemor-at-large from Florida. He began 
his three-year term Oct. 23. Dr. Shapiro 
practices general and vascular surgery in 
Clearwater and is an assistant clinical pro¬ 
fessor of surgery at the University of South 
Florida College of Medicine. 
W.W. Norton & Co. recently published 
The Crown Prince, a novel by Dr. John 
Barchilon ’65, who practices sports 
medicine in Los Angeles. The book is based 
on the life of the legendary concert pianist 
Paul Wittgenstein. Set in Vienna, Paris and 
Berlin, it is also the story of Maurice Ravel 
and the famous Concerto in D. 
Dr. Robert M. Pearl ’72, associate clin¬ 
ical professor, plastic and reconstructive 
surgery, Stanford University, was pre¬ 
sented the Robert H. Ivy Society Award at 
the American Society of Plastic and Recon¬ 
structive Surgeons (ASPRS) annual scien¬ 
tific meeting in Los Angeles, Oct. 27. The 
award, which recognizes excellence in 
preparation, presentation and delivery, is 
given to the physician whose presentation 
was selected as best during the ASPRS an¬ 
nual meeting the previous year. Dr. Pearl 
received the award for his paper on “Surgi¬ 
cal Management of Volumetric Changes in 
the Bony Orbit.” 
Dr. Robert J. DeLorenzo ’74, professor 
and chairman, department of neurology. 
Medical College of Virginia campus of Vir¬ 
ginia Commonwealth University, has re¬ 
ceived a Javits Neuroscience Investigator 
Award for research into the role calcium 
plays in brain cells, particularly cells dam¬ 
aged by stroke and epilepsy. The award 
honors the late U.S. Sen. Jacob K. Javits of 
New York. 
Dr. John J. Kao '77 will be promoted to 
associate professor of business administra¬ 
tion at the Harvard University Graduate 
School of Business Administration, effec¬ 
tive June 1987. 
In September, Dr. Jean L. McMahon 
’44 HS retired as director of rehabilitation 
services at the Children’s Hospital at the 
University of Colorado School of Medicine 
in Denver. 
Dr. Bernard Robert Rowen ’43, of 
Tacoma, Wash., has retired from his prac¬ 
tice in internal medicine. 
Gov. William A. O’Neill has appointed 
Dr. Frederick G. Adams ’70 M.P.H. to 
be the commissioner of health services 
for Connecticut. A Hartford dentist. Dr. 
Adams has served as dean of the University 
of Connecticut School of Allied Health Pro¬ 
fessions and vice president for student 
affairs and services at the University of 
Connecticut in Storrs. His appointment 
was effective March 1. 
Dr. John P. McGovern '46 HS, of 
Houston, has received the 1986 Distin¬ 
guished Alumnus Award of Alpha Epsilon 
Delta, the national premedical honor soci¬ 
ety. A past president of the American Col¬ 
lege of Allergists, Dr. McGovern founded 
the McGovern Allergy Clinic in Houston. 
He also holds faculty appointments at the 
Baylor College of Medicine and all six 
degree-granting schools in the University 
of Texas Health Science Center at Houston. 
Dr. Gary L. Schaer ’79 has been elected 
to fellowship in the American College of 
Cardiology. He is an assistant professor of 
medicine at Georgetown University Hospi¬ 
tal, Washington. 
Dr. William Barry Gault ’64 has been 
appointed to the NeWell Health Corporation 
Board of Overseers, in Newton, Mass. Dr. 
Gault, a practicing psychiatrist, is coordi¬ 
nator of the psychiatric training program for 
Tufts University medical students at New¬ 
ton-Wellesley Hospital, and he is chief 
of intensive treatment at Bournewood 
Hospital. 
Dr. Shu!man Named 
New NIAMS Director 
Dr. Lawrence E. Shulman ’45 Ph D. (pub¬ 
lic health), ’49 M.D. has been appointed 
director of the new National Institute of 
Arthritis and Musculoskeletal and Skin 
Diseases (NIAMS). 
As director, Dr. Shulman will oversee 
the conduct and support of federal programs 
in biomedical research and research training 
in arthritis and musculoskeletal and skin 
diseases. 
He was acting director of NIAMS since 
its establishment last April, and previously 
was director of the Division of Arthritis, 
Musculoskeletal and Skin Diseases at NIH. 
An internationally known rheumatolo¬ 
gist, Dr. Shulman’s research has focused on 
rheumatic diseases, such as lupus 
erythematosus and scleroderma. In 1974, 
he discovered eosinophilic fasciitis, also 
called Shulman’s disease. He has written 
more than 100 scientific papers and numer¬ 
ous sections in major textbooks of 
rheumatology and internal medicine. 
Dr. Shulman was president of the Ameri¬ 
can Rheumatism Association in 1974-75, 
and in 1979, the Arthritis Foundation gave 
him its distinguished service award. For 
the past four years, he has been president 
of the Pan American League Against 
Rheumatism. 
NEW BOOKS 
Aging Myths: Reversible Causes of Mind 
and Memory Loss, by Siegfried J. Kra, 
M. D., associate clinical professor of 
medicine. McGraw-Hill, Inc., (New York, 
N. Y.) 1986. 
Ambulatory Surgery and Office Procedures 
in Head and Neck Surgery, edited by Keat- 
Jin Lee, M.D., assistant clinical professor 
of surgery, and Carol Stewart, Southern 
New England Telephone Co. Harcourt 
Brace Jovanovich Publications, (New 
York, N.Y.) 1986. 
Bypass Surgery: Who Needs It?, by Sieg¬ 
fried J. Kra, M.D., associate clinical pro¬ 
fessor of medicine. W.W. Norton & Co., 
Inc. (New York, N.Y.) 1986. 
Doctors, Patients, and Placebos, by How¬ 
ard M. Spiro, M.D., professor of medicine. 
Yale University Press (New Haven, Conn.) 
1986. 
Ectopic Pregnancy, edited by Alan H. De- 
Chemey, M.D., John Slade Ely Professor 
of Obstetrics and Gynecology. Aspen Pub¬ 
lishers, Inc. (Rockville, Md.) 1986. 
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Foundations of In Vitro Fertilization, 
edited byC.M. Fredericks, Ph D., Medical 
University of South Carolina, Alan H. De- 
Chemey, M.D., John Slade Ely Professor 
of Obstetrics and Gynecology, and J.D. 
Paulson, M.D., Alexandria Infertility As¬ 
sociates in Va. Harper & Row Publishers, 
Inc. (Washington, D.C.) 1986. 
The Nurturing Father, by Kyle D. Pruett, 
M.D., associate clinical professor in the 
Child Study Center and psychiatry. Warner 
Books, Inc. (New York, N Y.) 1986. 
Reproductive Failure, edited by Alan H. 
DeCherney, M.D., John Slade Ely Profes¬ 
sor of Obstetrics and Gynecology. Chur¬ 
chill Livingston, Inc., (New York, N.Y.) 
1986. 
Reproductive Surgery, edited by Alan H 
DeCherney, M.D., John Slade Ely Profes¬ 
sor of Obstetrics and Gynecology, and 
Mary Lake Polan, M.D., associate profes¬ 
sor of obstetrics and gynecology. Year 
Book Medical Publishers, (Chicago, Ill.) 
1986. 
The Crown Prince, a novel, by John Barchi- 
lon, M.D. '65 of Los Angeles, Calif. W.W. 
Norton & Co., (New York, N.Y.) 1986. 
OBITUARIES 
Marguerite Lerner, M.D. 
Dr. Marguerite R. Lerner, professor of der¬ 
matology from 1973 to 1980, died March 3 
at her home in Woodbridge, Conn, after a 
long illness. She was the wife of Dr. Aaron 
B. Lerner, professor of dermatology. 
Dr. Lerner was born in Minneapolis on 
May 17, 1924. A summa cum laude 
graduate of the University of Minnesota in 
1945, she attended Johns Hopkins Medical 
Institutions, Baltimore, and received her 
M.D. degree from Case Western Reserve 
University School of Medicine, Cleveland, 
in 1950. 
Dr. Lerner came to Yale in 1957 as clin- 
cal instructor in dermatology, becoming as¬ 
sistant clinical professor of dematology in 
1960, associate clinical professor in 1966 
and professor of dermatology in 1973. She 
was instrumental in setting up dermatology 
services for the Yale Health Plan at Univer¬ 
sity Health Services and served as chief of 
dermatology services from 1971 to 1980. 
She wrote 15 children’s books, and in 
965 was awarded the Brotherhood Award 
tor Red Man, White Man, African Chief, a 
book on skin color. She also wrote Medical 
School The Interview and the Applicant, 
and was co-author, with her husband, of 
Dermatologic Medications. 
In 1980, in recognition of her talents as 
an author of children’s books, her family es¬ 
tablished the Marguerite Rush Lerner 
Award, which is given annually to a 
graduating medical student for outstanding 
creative writing. 
Besides her husband, she is survived by 
four sons. State Rep. Peter Lerner of Wood- 
bridge, Dr. Michael Lerner of Hamden, Dr. 
Ethan Lerner of Boston, and Seth Lerner of 
New Haven; a brother, Gilbert Rush of Los 
Angeles; and a sister, Pamela Smith of San 
Diego. 
Clarence D. Davis, M.D. 
Dr. Clarence D. Davis, professor emeritus 
of obstetrics and gynecology, died Jan. 26. 
in San Diego, Calif. He was 74. 
Dr. Davis began his career at Yale as 
associate professor of obstetrics and 
gynecology in 1957 and was professor of 
obstetrics and gynecology from 1964 until 
1978, when he was named professor 
emeritus. 
While in Connecticut, he was an obstetri¬ 
cal consultant to the maternal-child health 
section of the state Department of Health 
Services, lecturing and evaluating services 
at state hospitals. He is survived by his 
wife, Beatrice McKeller Davis; two sons, 
Daniel and Peter Davis, and a daughter, 
Susan Davis. 
Donald Silverman, M.D. 
Dr. Donald R Silverman, assistant clinical 
professor of medicine since 1977, died at 
his home in Westport, Conn, on Dec. 13. 
He was 48. 
Dr. Silverman was associated with sev¬ 
eral area hospitals, and was chief of the sec¬ 
tion of renology, department of medicine, 
at Bridgeport Hospital. 
He is survived by his wife, Lynne Nolan 
Silverman; his mother, Helen Weinstein 
Silverman; a son, Neal Silverman; a daugh¬ 
ter, Margaret Silverman; and a brother, 
Leon Silverman. 
Harold G. Higgins, M.D. 
Dr. Harold G. Higgins, assistant clinical 
professor of medicine from 1955 until 
1974, died Sept. 25 in Seattle He was 76. 
Dr. Higgins, an internist in New Haven 
for many years, was a World War II Army 
Medical Corps veteran; he received three 
bronze stars while serving as a battalion sur¬ 
geon in Europe. 
Besides his wife, Elizabeth McGuire 
Higgins, he is survived by three daughters 
and a son. 
IN MEMORIAM 
Stella Booth, M.D. 
(formerly Stella Wood) 
June 8, 1986 
’62 M.P.H. 
James Rae Ameill Jr. 
September 22, 1986 
’29 M.D. 
James C. Hart 
December 20, 1986 
’30 M.D. 
'39 M.P.H. 
Jean P. Davis 
October 2, 1986 
’43 M.D. 
Chester S. Bowers 
July 27, 1986 
’48 M.P.H. 
Boy Frame, M.D. 
August 1986 
’48 HS 
Ralph M. Gofstein 
August 1986 
'51 M.D. 
James R. Durham 
October 31, 1986 
’52 M.D. 
William R. Metzger, M.D. 
July 28, 1986 
'51 M.P.H. 
Frederick Snyder, M.D. 
January 26, 1986 
’57 HS 
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THE CAMPAIGN FOR THE 
YALE SCHOOL OF MEDICINE 
Gerontology Professorship 
Established 
The Department of Internal Medicine has a 
newly endowed professorship, thanks to a 
grant from The Humana Foundation of 
Louisville. The Humana Foundation Pro¬ 
fessorship will support a senior faculty 
member in the field of gerontology. 
The strength of the Yale geriatrics pro¬ 
gram was an important factor in the decision 
to award the grant, according to Sue B. 
Dorn, associate vice president for develop¬ 
ment and director of medical school de¬ 
velopment. One of the aims of the program 
is to keep elderly patients as independent as 
possible, thus limiting the care burdens on 
their families and communities. By retain¬ 
ing their independence, patients spend their 
later years with a greater sense of fulfillment 
and dignity. 
The Humana Foundation was established 
in 1981 by Humana, Inc., which owns and 
operates more than 80 hospitals in the 
United States and overseas. A Yale Law 
School alumnus, David A. Jones ’60, was 
a co-founder of Humana, Inc. and serves as 
its chairman and chief executive officer. 
F. David Rollo, M.D., Ph.D., is senior 
vice president for medical affairs of 
Humana, Inc. In a letter to Dean Leon E. 
Rosenberg, Dr. Rollo expressed the foun¬ 
dation’s eagerness to work with the school 
“in assuring that the Yale geriatric medicine 
model is appropriately appreciated and uti¬ 
lized in community medical centers.” 
New Haven Foundation 
Grant to Aid Women 
Yale’s Comprehensive Cancer Center has 
received a grant of $144,000 to purchase a 
van for a mobile mammography screening 
program. The George W. Mixter Fund of 
the New Haven Foundation provided funds 
for the purchase, and the Connecticut Divi¬ 
sion of the American Cancer Society 
awarded a grant of $75,000 to equip the 
unit. Yale-New Haven Hospital is providing 
additional support for the project. 
The program will provide convenient, in¬ 
expensive screening for early detection of 
breast cancer. At least 6,000 women 
throughout Connecticut will be examined 
yearly at a cost of no more than $50 each. 
It will be the first mobile mammography 
unit in the New York-New England area, 
and the only mobile facility offering mam¬ 
mography at no cost to women unable to 
pay. Phyllis J. Kornguth, M.D , Ph.D., as¬ 
sistant professor of diagnostic radiology, 
developed the program. 
The New Haven Foundation is the 
eleventh largest community foundation in 
the United States, and awards nearly $4 mil¬ 
lion in grants annually. 
Ogilvie Family 
Fund Established 
John B. Ogilvie’s wish to honor family 
members who have attended Yale has been 
fulfilled by his creation of an endowed loan 
fund in the School of Medicine. Dr. Ogilvie 
is a Sheffield graduate of Yale (B.S. 1931) 
and an alumnus of the School of Medicine 
(M.D. 1934). Two of his sons, John G. 
Ogilvie '64 and Donald Ogilvie ’65, at¬ 
tended Yale College. 
After 53 years in the field of general 
surgery, John B. (Jack) Ogilvie retired from 
practice this year, which will enable him to 
devote more time to The Campaign for the 
Yale School of Medicine. He is a member 
of the National Volunteer Committee for the 
campaign, and previously served as presi¬ 
dent of the Association of Yale Alumni in 
Medicine. 
This wrought iron grillwork adorns the 
second-floor balcony in the Medical 
Historical Library, which will be part of 
an expanded medical library funded 
through the campaign. 
Progress Report Summary 
Gifts and Pledges 
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Incoming mail to the Office of Alumni 
Affairs was abundant last summer and 
autumn, largely as a product of alumni 
questionnaire responses generated by the 
Kissick-Spinelli paper. (The questionnaire 
analysis is published in this issue.) 
Approximately 50 items of personal 
news were received for publication in a col¬ 
umn that began in the February issue of the 
Yale Alumni Magazine. Since magazine 
space is limited, some items may be delayed 
until subsequent issues. News items of a 
professional, rather than personal, nature 
will continue to be published in YALE 
MEDICINE. All alumni are invited to send 
items to the Office of Alumni Affairs. Ad¬ 
dress changes are especially requested. 
Most gratifying were the invitations from 
approximately 600 alumni who offered 
overnight bed and board to third- and 
fourth-year Yale medical students inter¬ 
viewing for residency training positions 
in hospitals in 38 cities. The cities or their 
suburbs include: New York, Boston, 
Pittsburgh, Miami, Baltimore, San Fran¬ 
cisco, Durham, N.C.; Torrance, Calif.; San 
Diego, Houston, Seattle, Portland, Maine; 
Minneapolis, Portland, Ore.; Livingston, 
N.J.; Chicago, Providence, Los Angeles, 
Burlington, Vt.; Denver, Nashville, St. 
Louis, Dallas, Rochester, N.Y.; Ann 
Arbor, Montreal, Washington, Irvine, 
Calif.; Cleveland, Buffalo, Rochester, 
Minn., Cincinnati, Tucson, Bangor, Maine; 
Birmingham, Gainesville and Toronto. 
Students generally spend an average of 
$1,500 during the interviewing process. 
The gracious hospitality of Yale alumni ena¬ 
bles students to save money. At the same 
time, communication between graduates 
and current students is increased. These 
multi-generational exchanges have proven 
to be quite stimulating for all participants, 
and we hope to expand the program to other 
cities. 
One of the most successful visits on the 
“Dean’s Tour” occurred Nov. 21 in San 
Francisco, where Dean Leon E. Rosenberg 
presented his “State of the Yale School of 
Medicine” address to 83 attendees. 
A. John Anlyan, M.D. ’45, of San Fran¬ 
cisco and LawrenceG. Crowley, M.D. ’44, 
of Palo Alto served as chairmen of the ele¬ 
gant dinner and reception at the Olympic 
Club, which preceded Dr. Rosenberg’s pre¬ 
sentation . The event’s content and social as¬ 
pects were so well received and appreciated 
that the group requested a return visit by a 
faculty member this fall. 
Tentatively scheduled to visit the Bay 
area group on Nov. 6 is Dr. Stephen 
G. Waxman, chairman of the department 
of neurology. Dr. Waxman’s research ad¬ 
dresses the molecular nature of the ner¬ 
vous system’s response to injury, trauma 
and multiple sclerosis. 
The Bay area alumni, co-chaired by Drs. 
Anlyan and Crowley, are a well-organized 
satellite alumni group. 
In addition to Drs. Anlyan and Crowley, 
the executive committee includes: Drs. 
Malcolm Bagshaw ’50, Robert A. Chase 
’47, Chandler Dawson ’56, Lee E. Farr ’32, 
Roger P. Friedenthal ’62, W. Keith Hadley 
’59, Avi J. Hettena '76, Jack Levin '57, 
Bennett F. Markel '57, Robert L. Mitchell 
’64, William M. Rogoway ’61, Richard A. 
Sinnott Jr. ’53 and Joseph F. Walter ’67. 
Dr. Stephen Waxman addressed the Yale 
Club of Washington, D C. on the topic 
“Sparks, Soup and Molecules: How the 
Nervous System Copes with Injury.” A 
banner number of undergrad and medical 
alumni attended March 3 at the City Tavern 
Club. After his talk the medical group 
hosted an informal supper, with Dr. Wax- 
man as guest. Muriel D. Wolf, M.D. ’59, 
of Children’s Hospital in Washington, is 
president of the Yale Club of Washington, 
DC. 
In addition to the student-aid initiatives 
previously mentioned, the alumni office has 
helped the second-year class achieve 
alumni attendance at the class show. A 
spring reception is planned for all medical 
students, with New Haven and other region¬ 
al alumni helping to serve as hosts. Efforts 
to increase such liaisons will continue. 
Identifying leadership potential as alumni at 
the student level is an initiative to be pur¬ 
sued. Student officers to serve alumni class 
functions already have been named in the 
third- and fourth-year classes this year. 
A core group of house staff/fellows has 
begun deliberating their special status as 
members of the Association of Yale Alumni 
in Medicine. Included on this charter house 
staff/fellows subcommittee are: Drs. Nina 
R. Horowitz HS ’79-84, assistant clinical 
professor of surgery; Richard Selzer HS 
’53-55, ’57-60, assistant clinical professor 
of surgery; John N. Forrest Jr. HS ’64-67, 
’69-70, professor of medicine; and E. 
Maurice Wakeman HS '60-63, assistant 
clinical professorof pediatrics. 
The subcommittee, organized by Dr. 
Samuel D. Kushlan ’35, clinical professor 
of medicine, will seek to define the group’s 
role in reunions, evaluate the need for sepa¬ 
rately structured reunions and update and 
correct deficient alumni records. 
During the weeks ahead, the reunion of 
1987 will occupy the energies of the Alumni 
Office. Please note the special events 
planned for the June 5-6 reunion weekend: 
1. Special senior alumni, including 
members of the 65th, 60th and numerous 
members of the 55th reunion class, will be 
honored at the annual meeting on June 6. 
2. The 50th reunion class, as well as 
the 55th and 5th reunion group, will be hon¬ 
ored at the Friends of the 50th Dinner on 
Saturday evening at the Graduates Club. 
3. A special Friday evening dance, 
first held last year, will be moved to Edward 
S. Harkness Hall on the medical school 
campus. Members of the entire hospital- 
medical school family will be invited to 
attend. Last year, the ambience of a family 
reunion was achieved. 
4. The Friday evening dinner, so suc¬ 
cessful last year, will be repeated, again in 
the President's Room at Woolsey Hall. This 
is open to all returnees who need dinner 
reservations. 
See everyone at reunion! 
Nicholas P R. Spinelli, M.D. '44 
Director of Alumni Affairs 
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Highlights: Medical Alumni 
Reunion Weekend 




Medical alumni registration 
Faculty seminars 
Yale School of Medicine Special Address 
Keynote Speaker: Lowell P. Weicker Jr. 





Medical alumni reunion dinner 
Yale School of Medicine reunion dance 
8 a.m. Yale School of Nursing annual alumnae college 
Keynote Address: Mary Mundinger, dean. School 









AYAPH and YUHAAA annual workshops* 
Panel discussions 
AYAPH and YUHAAA Keynote Address: Robert B. Helms, 
Ph.D., assistant secretary for planning and 
evaluation, U.S. Department of Health and Human 
Services, Washington 
2:15 p.m. AYAPH and YUHAAA combined annual meeting 
* Association of Yale Alumni in Public Health (AYAPH) 
Yale University Hospital Administration Alumni Association 
(YUHAAA) 
Saturday, June 6 
9:15 a.m. Greetings and remarks: Benno C. Schmidt Jr. 
10 a.m. 
11:30 a.m. 
President, Yale University 
Faculty seminars 
Annual meeting of the Association of Yale Alumni in 




Sherry and buffet luncheon 
Yale School of Medicine Class of 1962 reunion seminar 
School of Medicine Alumni Fund class agents meeting 
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SPLICING IN THE MD-GENE 
by HowardM. Spiro, M.D. 
(Delivered at the Yale School of Medicine graduation, 
May 25, 1987) 
It is always a pleasure to talk to colleagues, and from this morn¬ 
ing on you are fellow physicians. Congratulations to you all and 
the best to those around you. Enjoy this day while you can. Next 
month comes internship, residency, the PGY days that rob 
house-officership of its glamor. Difficult and responsible times 
lie ahead, even if sometime you join the chorus of the blessed 
singing praises to the great god Ortho-Ophtho-Oto or pray with 
the imagers at their icons in the radiology department. For now, 
relax, enjoy yourselves, vacation, don’t study the Washington 
University Manual. You’ve earned some good time off. That 
“M.D.” you practiced signing a few times over the past months 
does belong after your name. 
Dean Rosenberg and Dr. Spiro. 
That is really what I want to talk about, the splicing of the 
M.D. gene into your genome. Graduate from medical school 
and you are like those E. coli, forever making interferon or fer¬ 
tilizer, working endlessly, your identity forever changed. I was 
graduated from medical school 40 years ago this month, and I 
have to confess some trepidation at standing here, for I would 
have greeted with skepticism bordering on scorn any pro¬ 
nouncements from a physician who had graduated 40 years be¬ 
fore me, in “aught seven.” But one of the pleasures of academic 
life is the illusion that “students” keep you young in outlook, 
even as I bump against a horizon you can hardly glimpse. 














to share the ecstasy of laboratory pursuits when you are young, 
the joy of the clinic and the bedside in middle life, and finally 
to find happiness in the distance that the library lends. 
IDENTITY CHANGE 
Today marks the greatest change in your identity in your entire 
life, even though more of you in this class than in many before 
have had other and sometimes distinguished careers. You may 
marry or divorce, change companions several times, write 
poetry or win research prizes. In academic life you may be 
transmogrified into an assistant or associate professor, and ulti¬ 
mately you may even take on a new name with a named chair. 
You may even become a chair. Several of my friends and con¬ 
temporaries have turned into plaques, lectures, auditoriums, 
and one or two have even become buildings. As a gastroen¬ 
terologist, I hope to become a dining hall, or at least a salad bar, 
although some have suggested a sigmoidoscopy suite. 
In any case, this morning you were medical students and now 
you are physicians and for the rest of your lives you will sign 
“M.D.” after your name and answer the phone as “Dr. So and 
So.” You may claim, ungrammatically and inaccurately, “My 
name is Dr. So and So.” You may cling to the title when you 
have retired 40 or 50 years hence. So often, in the warmth of 
the winter lecture series in Florida, retired doctors sit in the front 
row in clean sport shirts and very quickly fall asleep. They are 
retired, but they come to medical lectures not so much, I think, 
to keep upon what is new, as to reaffirm theironly identity: “We 
are still physicians.” Most keep up their CME credits, to keep 
their licenses active. That Fountain of Youth has many fonts in 
Florida. 
In graduating you run the risk of abandoning your identity as 
a person for that of a physician. The wide-eyed enthusiast who 
was a dancer or an athlete, a chemist or a writer, or more often 
a college student who studied civilization and culture, is fun- 
neled into medical school to learn more cellular than human 
matters. The still occasionally innocent medical student is 
quickly filtered into the “burned out” PGY 3, who turns finally 
into a subspecialist. On the tombstone of a friend I fear to find, 
“He was born a man. but lived and died a gastroenterologist.” 
What you must fear is that gradually the person who is still you 
today will become entombed in the personna of the doctor. Like 
the ugly toad with yet a precious jewel in its head, we physicians 
wrap ourselves in white coats or in green operating gowns, to 
fatten, stiffen and forget that we were people once. We grow 
pompously so full of ourselves that it is very hard to find that 
precious jewel in the head, even by MRI. Make interferon if you 
must, but remember that we are all still E. coli. 
Several observations over the past few years have 
strengthened my conviction that we doctors are still just people 
taking care of people. The first is the placebo response; the sec¬ 
ond, what happens when a doctor thinks he is primarily a Scien¬ 
tist uncovering The Truth; and the third is what happens when 
a doctor falls sick. A brief moment on each. 
PLACEBO RESPONSE 
a doctor you can give a pill of no discernible pharmacologi- 
1 activity to someone in pain and the patient will feel better, 
gardless of whether relief comes from electric changes in the 
aologic network, or floats in on the tides of enkephalins 
lie opiate league, pain is relieved, in part because the pa¬ 
tient expects that your pill will help, that you will help. Such 
a response celebrates healing, to remind us that physicians treat 
more than microsomes. The lens of the placebo shows that pa¬ 
tients are more than a collection of organs or subcellular parti¬ 
cles; they respond to symbols, to love. They get better when 
someone cares. Someday, all disease will disappear when sci¬ 
ence wins it final triumph, but until then the goal of medical 
practice remains the relief of pain and suffering. Science, by the 
way, is a means to that end and not the end in itself. We some¬ 
times forget that in medical school when doctors are decked out, 
disguised as scientists. The goal of medicine is the care of pa¬ 
tients, always. Only sometimes can we cure, even in CCUs 
and ICUs. The relief that a placebo brings should remind you 
that physicians are more than conduits of power, pills and 
procedures. 
Your words and reassurance, the power of your person, 
which help to make up the therapeutic alliance of doctor and pa¬ 
tient, will sometimes be as important as your hands writing out 
prescriptions or even transplanting livers and hearts. The split 
between science and intuition, between reason and romanti¬ 
cism, of which you are so uncomfortably aware in medical 
school, can be annealed in the care of patients. Diseases, what 
the physician finds, are not helped by placebos, and the dualism 
may be uncomfortable, but illness, what the patient feels, what 
the patient fears, is relieved. Patients are more than their im¬ 
ages. Cure depends on science, and care on art; but poetry may 
sometimes physic your patient better than science and you will 
often treat despair along with disease. The relief that comes 
from a placebo stands for the promise that you make here today, 
to be a doctor, taking care of people. 
PHYSICIAN AS SCIENTIST 
Since some of you will follow research careers, I will remind 
you of Professor Hans Eppinger. A world-famous professor in 
Vienna whose papers are still quoted, at the time of the Nazi 
occupation of that city, Eppinger kept his position in the First 
Clinic even though he was of Jewish descent. He visited the 
concentration camps and ignored the evil around him. As the 
Second World War progressed, German submarines were being 
destroyed so fast that interest turned to whether sea water could 
be treated to be made palatable to sailors torpedoed and dying 
of thirst on their life rafts. Experiments on volunteers had al¬ 
ready shown that not to be the case, but the experiments were 
not beyond doubt. Eppinger insisted that prisoners in the con¬ 
centration camps be starved and forced to drink treated sea 
water to get what today we would call "statistical validity. ” He 
wanted to be sure of the truth. The experiments, duly carried 
out on gypsies, learned nothing new. 
Summoned after the war to the Nuremberg trials for war crim¬ 
inals, Professor Dr. Eppinger killed himself. He left no mes¬ 
sage of remorse, or at least none that his successors in Vienna 
will tell about. By the standards of his time Eppinger was not an 
evil man, and he was not unique. Even in the 1940s and '50s at 
Harvard—and at Yale—my colleages and I carried out experi¬ 
ments in which our goal was to find the answer to a question and 
not necessarily to help the patients. On this happy day, I do not 
want to dwell on such unpleasant matters, but I must comment 
on the effort to expunge such deeds from memory. 
Because I remembered Eppinger’s name from my own medi¬ 
cal school days, a few years ago I was appalled to find that a 
prize in his memory was being given out in Germany. A number 
of famous gastroenterologists had rejoiced in that prize, spon- 
in a break with tradition, Dean Rosenberg stepped aside and outgoing Deputy Dean Arthur Ebbert Jr. presented members of the Class of 
1987 with their diplomas. 
sored by a German pharmaceutical company, without appar¬ 
ently knowing about Eppinger’sdark side. His research was cel¬ 
ebrated, but his person had been forgotten. Because I had been 
much moved as a medical student by Eppinger’s complicity, I 
protested, and finally the prize was withdrawn. (Your classmate 
Jay Horwitz helped me in that endeavor.) My satisfaction was 
diminished by a host of angry letters from academic colleages in 
America. They complained that 1 had stirred up what should 
have laid buried. Those who protested were all good men (there 
were no women), but they had forgotten that we must continue 
to talk about the bad things that doctors can do in their search for 
the truth, even at Yale, if tomorrow we are not ourselves to do 
worse, and grow prouder still. 
PHYSICIAN AS PATIENT 
Finally, a comment on the paradox of the doctor who has to be¬ 
come a patient to learn that he is still a person. The trained de¬ 
tachment of our profession protects us physicians from getting 
too involved with our patients, but when too rehearsed and too 
repeated, that defending distance becomes our manner and that 
manner becomes ourselves. Few of us doctors any longer know 
how to deal with emotions in patients or ourselves. We find 
it far easier to examine the x-ray or the scan than to listen to 
the patient, to get the hard-copy of image or laboratory number 
than to heed what our patients would tell us. Sick doctors are 
very lonely patients. The first thing that happens when a doctor 
is admitted to the hospital is a sign going up on the door: 
“No Visitors.” 
Sick doctors want to be cared for. Autonomy may be held up 
for other patients, held up too high I think, but it is not some¬ 
thing physicians choose when they are sick. Almost to a man or 
woman, sick doctors tell how they want to be taken care of, so 
that they can give up their lonely vigil. They want decisions 
made for them, in their interest. The stories of doctors as pa¬ 
tients suggest that one of the goals of medical practice is to learn 
the patients’ interests so we can be loyal to those interests and 
make right decisions for them. You may be uncomfortably 
aware that I am praising paternalism, but it may be too much de¬ 
meaned these days. I have come away from reading stories of 
sick doctors with the conviction that if you are loyal to your pa¬ 
tient’s cause, even if it must sometimes be what you imagine 
that cause to be, you will care for the patient better than doctors 
who spread their wares to sick patients forced into unequal 
equality. The message from doctors who have been patients 
tells us that hope helps as much as truth, and that imagination, 
drama, passion, poetry and—yes, even love, will be as impor¬ 
tant in your medical practice as they should be in the rest of life. 
These stories, of the placebo response which tells of the relief 
that you can help patients bring to themselves, of the professor 
who forgot that people in prison camps were still human beings, 
and of the paradox of the doctor become patient, offer the last 
lesson for you in medical school: even with your M.D. degree, 
you will still be just people caring for other people. But, besides 
all this, and most of all, taking care of patients is great fun, the 
best way to spend your lives. Congratulations. Go out, take 




by Phyllis Joffe 
From administrative record keeping, to storage and retrieval 
of clinical and research data, to artificial intelligence sys¬ 
tems, medical informatics—biomedical computer science— 
is changing the face of medicine. And in today’s medical 
marketplace, computer-literate physicians increasingly have 
an edge. 
"There’s a tremendous amount of information relevant to pa¬ 
tient care, more than any one person can retain,” says Dr. Perry 
L. Miller, director of Yale’s medical informatics program. Dr. 
Miller, a physician with a Ph.D. in computer science from 
M. I.T., is associate professor of anesthesiology at the School 
of Medicine. 
“Across the board,” explains Dr. Miller, “the computer has 
the potential to follow in detail how a physician is practicing 
medicine and can alert him to things he may otherwise miss. It 
could improve medical care significantly.” 
At the School of Medicine, computers are playing a more 
central role in patient care, medical education and research. For 
example, a grant of $960,000 from the National Library of 
Medicine will support research by graduate students and post¬ 
doctoral fellows for five years as they explore the application 
of artificial intelligence techniques in medicine. The school is 
one of only eight academic medical centers in the United States 
that receive funds for research training in medical informatics. 
Dr. Miller’s interest in patient care, “especially where you 
have a number of clinical information systems, where clini¬ 
cal information is on-line and where it can increasingly be 
used to help the physician improve medical practice,” has 
led to his own research on “critiquing” systems—artificial 
intelligence that brings computer-based advice to practicing 
physicians. 
Dr. Miller believes that the critiquing approach is particularly 
suited to fields such as medicine, in which decisions frequently 
involve subjective judgment. Working from a physician’s own 
treatment plan, the critiquing system discusses the risks and 
benefits of the proposed approach and of any other preferred ap¬ 
proaches. “We are exploring how to design computer-based ad¬ 
vice so it is not telling the physician what to do, but rather 
critiquing his or her own style of practice and way of thinking,” 
he explains. 
Thus, says Dr. Miller, the computer complements, rather 
than substitutes for, a physician’s judgment: “No one is 
suggesting that we dispense with the physician and have the pa¬ 
tient interacting only with a computer. You need an experi¬ 
enced, intelligent, compassionate person. And most people re- 
1 is Joffe was writer, broadcast specialist in the 
heal school's public information office. 
spect the intuitive judgments that physicians make. But the 
computer has the ability to remember masses of information and 
the potential to integrate that in a flexible way with what the 
physician is doing.” 
PROJECTS 
In one project, Dr. Miller and Dr. Henry R. Black, associate 
professor of internal medicine, are evaluating an expert system, 
HT-ATTENDING, which critiques physicians’ plans for phar¬ 
macologic management of essential hypertension. Expert sys¬ 
tems are computer systems designed to incorporate human ex¬ 
pertise in real-world problem-solving domains. 
Along with Dr. Henry A. Swett, associate professor of diag¬ 
nostic radiology and associate director of the medical informa¬ 
tics program. Dr. Miller is developing expert systems to assist 
in radiologic diagnosis. The DxCON system critiques 
radiologic workup, and ICON critiques radiologic differential 
diagnosis. 
Dr. Miller and Dr. Jon Morrow, associate professor of 
pathology, have embarked on medical informatics projects that 
involve intelligent computer-aided instruction and bibliog¬ 
raphic retrieval in pathology. One system, PATHMASTER, is 
being developed for histologic diagnosis from slides of liver tis¬ 
sue. This intelligent computer-assisted instruction (ICAI) sys¬ 
tem is intended especially for use in teaching and consultation 
in pathology. Its goal is to help physician-users make correct 
diagnoses while it simultaneously teaches how to approach his¬ 
tologic diagnoses in an organized, criteria-based manner. 
Drs. Miller and Morrow also are working with Dr. Seth M. 
Powsner, assistant professor of psychiatry; Dr. Kenneth 
W. Barwick, associate professor of pathology; and Dr. Caroline 
A. Riely, associate professor of medicine, on a major research 
project supported by the Unified Medical Language Program 
of the National Library of Medicine. The project explores 
ways that semantic relationships—the underlying conceptual 
relations between terms—can assist in medical bibliographic 
retrieval. Drs. Miller and Morrow have chosen liver disease as 
their domain for that project, using as a resource an exten¬ 
sive file of liver cases that are part of Dr. Morrow’s pathology 
information system. 
Other currently active research projects in medical informat¬ 
ics include an exploration of novel computer-based diagnostic 
strategies in pathology, conducted by Dr. Jerome A. Silbert, as¬ 
sociate professor of laboratory medicine and pathology, and 
Roger Schank, Ph.D., professor of computer science; and vari¬ 
ous projects to develop expert systems for diagnosis and treat¬ 
ment in psychiatry, conducted by Dr. Powsner, Dr. Robert 
Byck, professor of psychiatry and pharmacology, and David 
Gelernter, Ph.D., associate professor of computer science. 
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UELCOHE TO THE YALE LIVER CENTER CORE COMPUTER SYSTEM 
Your Password: Good Afternoon, JON. 
Liver Option: 20 Ask the Or. Klatskin Bata Base for a Diagnosis 
ye leone to 'GIBOC', a consultative progran based on 
the Yale experience of the past 30 gears, including 
the files of the late Dr. Gerald Klatskin. 
The doctor is in, so if you would please just identify 
your patient, she will be glad to assist you with a differential 
diagnosis, (note, if your patient is not registered in the 
Liver Center Conjjmter Systen, you will need to do so before 
proceeding. Also please be sure to enter all relevant infomation 
on your patient, so the Doctor can help you. 
Enter specinen imber, hospital ranter, or part of 
Or, enter ? for wore infomation. 
n:| 
A living legacy: When world-renowned liver specialist and Yale professor Gerald Klatskin died in 1986, he left behind over 30 years of well- 
documented records on more than 7,000 patients. These data, along with those of other physicians, were organized into a computer database 
according to clinical history, biopsy and laboratory results, and diagnosis. So today, thanks to the computer, Dr. Klatskin's experience still 
serves Yale physicians and medical students as an aid to diagnosis and teaching. 
COMPUTER EDUCATION 
As computers assume an increasingly significant role in medical 
research, medical education and clinical practice, medical 
schools face the formidable task of integrating both the fast¬ 
changing technology and the resulting explosion of medical 
knowledge into the existing curriculum. 
To meet this challenge, the School of Medicine has embarked 
on a program designed to provide its students with computer lit¬ 
eracy that incorporates a critical understanding of the strengths 
and weaknesses of computers in clinical medicine. 
Under the aegis of Project Eli, a program established at Yale 
University to distribute $6 million of computer hardware do¬ 
nated by the International Business Machines Corp., the School 
of Medicine is creating a computer teaching laboratory in 
Lauder Hall. Project Eli also will allow the department of public 
health and epidemiology to upgrade its two existing computer 
rooms. 
Under Project Eli, networks of microcomputers will com¬ 
municate with each other throughout the university and with 
more powerful computers, such as the mainframes at the Yale 
Computing Center. In such networks, the microcomputers 
function as workstations, where most of the computing is done. 
The higher-level computers function as “servers,” which, upon 
demand, perform special functions for the workstations. 
The Lauder Hall computer teaching laboratory will house 10 
computer workstations. The units will be interconnected and 
eventually will be hooked up with the medical school computer 
network and the library’s miniMEDLINE database. MiniMED- 
LINE is a subset of the more than 3,400 journals comprising the 
National Library of Medicine MEDLINE database. 
Says Dr. Robert H. Gifford, associate dean for education and 
student affairs: "We need to network our computers, because 
our ability to ‘talk’ with each other through electronic mail and 
to access the library from medical school offices will be critical 













Drs. Perry L Miller and Jon Morrow discuss possible ways to 
update their PATHMASTER system of histological diagnosis of 
liver disease. 
Dr. Gifford heads an ad-hoc committee for computers in 
medical education, which is developing a plan for the Lauder 
Hall laboratory. 
The committee has suggested several possible uses for the fa¬ 
cility, including: formal instructional mini-courses on the uses 
of personal computers for medical students, residents and facul¬ 
ty; mini-courses on using library databases, such as MEDLINE 
and miniMEDLINE; practice for students taking computer- 
based national board exams; student review of on-line examina¬ 
tion questions that have been prepared by various departments; 
access to computer-assisted instructional programs currently 
available elsewhere; direct access to MEDLINE and miniMED¬ 
LINE for bibliographic retrieval; and word processing for medi¬ 
cal students. 
Dr. Gifford cautions that the computers will not be consid¬ 
ered as substitutes for personal interaction, such as direct con- 
net with patients and instructors. Rather, he says, the technol- 
ny will complement existing elements of medical education. 
He describes the computer as a non-judgmental resource that 
enhance learning; “Medical students, like most students, 
mietimes hesitant to ask questions. They don’t want to 
their ignorance. Well, there is no way that the computer 
to yell back at you to criticize your ignorance. There 
is no fear of being exposed.” 
s with most new ventures, there are problems still to be 
solved. Nonetheless, Dr. Gifford says, “it is important to move 
ahead and get the program started. We want to encourage the 
use of computers as educational tools as well as database tools. ” 
LIBRARY RESOURCES 
In the Yale Medical Library, two Project Eli IBM-AT com¬ 
puters already are in place. With the stimulus of a generous gift 
from Mrs. Betsey Cushing Whitney and her family, the future 
plans to renovate and expand the library also will prepare it for 
the automated future. “We have some catching up to do,” says 
medical library director Bella Z. Berson. 
“We are using our Project Eli computers to teach courses to 
help students organize their own reprint files, to prepare and 
manage their own databases and to learn to refine their search 
strategies when seeking information.” she says. For example, 
by using Boolean logic—combining two search terms with a 
conjunction such as ‘and’ or ‘or’—one can acquire more rele¬ 
vant information. ” 
In addition to Project Eli, the medical library offers courses 
on National Library of Medicine databases. “One of the 
courses, for example, helps people using their own microcom¬ 
puters to decide which MEDLINE access is best for their pur¬ 
poses,” says Berson. “A portion of the huge MEDLINE 













Computing Unit’s VAX equipment,” explains Berson. The 
unit, located in Sterling Hall of Medicine, houses two com¬ 
puters and a terminal room from which the computers can be 
used for special applications. 
ACADEMIC COMPUTING SUPPORT 
The Biomedical Computing Unit is the central academic com¬ 
puting support resource for the medical center. Unit director 
David Stagg, Ph.D., is a research scientist in pharmacology 
(biomedical computing) at the School of Medicine. In addition 
to the library services mounted on its VAX system, the unit pro¬ 
vides statistical analysis tools and molecular biology databases 
that currently are used by more than 100 researchers at the medi¬ 
cal school. 
The unit also installed the network that links the medical 
school with a Yale University-wide computer network. Stagg 
says this network is growing steadily, providing more and more 
access to research and teaching resources, library systems and 
world-wide electronic mail. 
“This is an exciting time for us, since we have just embarked 
on a joint project with the genetic epidemiology research group, 
led by Kenneth K. Kidd, to enhance our computing resource to 
a VAX 8800, which will be housed at the medical school,” says 
Stagg. Kenneth K. Kidd, Ph.D., is professor of human genetics 
and psychiatry. This $1 million VAX system, jointly funded by 
the National Institutes of Health, the National Science Founda¬ 
tion and the School of Medicine, represents a major upgrade. 
A substantial part of the system will be available to the medical 
center community via the Yale computer network, says Stagg. 
This new computer system and the expanded network will 
provide a state-of-the-art computing resource for the computer 
applications mentioned in this article and many other projects 
now underway or planned for the medical center. 
The medical library’s miniMEDLINE subset contains cita¬ 
tions from the past three years in 234 medical, nursing and allied 
health journals that are in the library’s collection. These include 
the 100 journals recommended by members of each school and 
department served by the medical library. 
The miniMEDLINE database is updated monthly by tapes 
purchased from the National Library of Medicine. Two 
Lynna Stone-Infeld, user support specialist, explains how each 
work station of the IBM network can function independently, allowing 
users to access the mainframe computer only when required for the 
most involved tasks. 
First-year medical student Sarah Davidson uses a personal computer 
in the Yale Medical School Library to scan the titles of articles that 
are catalogued on a compact disk, or CD. Each CD can hold 
600,000 citations, enough information to fill the Encyclopedia 
Britannica. 
miniMEDLINE terminals currently are available in the library 
for access during regular library hours. “We are now exploring 
the possibility of adding one more terminal as well as mak¬ 
ing miniMEDLINE information available in laboratories and 
offices in the medical center,” says Berson. 
The medical library also is a test site for an Institute for Scien¬ 
tific Information CD-ROM (compact disk, read-only memory) 
project. “The compact disk, which students, staff and faculty 
researchers may use, is mounted on a computer in our informa¬ 
tion room,” says Berson. “It contains subject access to the last 
six months of scientific literature. ” 
MiniMEDLINE and the ISI CD-ROM are end-user databases 
that allow the researcher quick, personal access to information. 
For more complex needs, researchers have more than 400 
databases available on-line through the library’s professionally 
staffed computer search service. 
Plans for the library include more space and greater use of 
new automation technology. The medical library will be part of 
the University library’s integrated computerized system that 
will allow readers to know if a book is in the collection, whether 
it is on order and whether it is available for circulation. The 
major components of this system should be in place by the time 
the library construction is completed. 
BILL CARTER 
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ON THE CENTENNIAL OF 
THE NATIONAL INSTITUTES 
OF HEALTH 
Throughout the United States, the public joined physicians 
and scientists in celebrating the Centennial of the National 
Institutes of Health. In Connecticut, Yale and the University 
of Connecticut joined to hold two special events honoring 
the NIH. First, the universities honored outstanding high 
school science students from throughout the state by inviting 
them to a seminar where State Health Commissioner Frederick 
G. Adams, '70 M.P.H., presented them with certificates. 
The students also heard scientists discuss topics ranging 
from AIDS to Lyme disease. Then, last September, the uni¬ 
versities sponsored a professional seminar entitled “Frontiers 
of Biomedical Research: The Next 100 Years.” Speakers 
included U.S. Sen. Lowell P. Weicker Jr., R-Conn.; Frank 
H. Ruddle, Ph.D., professor of biology and human genetics 
at Yale University; Sydney H. Croog, Ph.D., professor of 
behavioral sciences and community health at the University 
of Connecticut School of Dental Medicine and professor of 
psychiatry at the University of Connecticut School of Medicine; 
and Dr. James B. Wyngaarden, director of the NIH. 
To continue the celebration, YALE MEDICINE asked a 
distinguished panel of Yale medical alumni, faculty members, 
and former faculty and deans to reflect on the National 
Institutes of Health. Their comments reveal both NIH's 
influence and its diversified approach in fostering bio¬ 
medical science programs and research. 
by William L. Kissick, M.D., Dr.P.H. 
In the spring of 1966 the Surgeon General informed me that I 
would be responsible for implementing the Planning. Program¬ 
ing and Budgeting System (PPBS) in the United States Public 
Health Service. This analytic technique was developed by 
economists at the RAND Corporation in the 1950s to foster for¬ 
mulation of program options to link budgets with goals and was 
brought to the Kennedy Administration by Secretary of Defense 
Robert McNamara. 
Subsequently, President Johnson mandated the dissemi¬ 
nation of these cost-effectiveness strategies throughout his ad¬ 
ministration. At the time, the National Institutes of Health 
accounted for the largest expenditures in the Public Health 
Service. The Hill-Burton Program had been supporting con¬ 
struction of hospitals for almost two decades. The Health Pro¬ 
fessions Education Assistance Act, authorized in 1963 and 
amended in 1965, was just beginning to address the physician 
shortage. Regional Medical Programs, enacted in 1965, was 
mandated to improve the translation of these resources into 
medical practice. 
PPBS called for orchestration of these and other diverse inter¬ 
ests and initiatives into a coherent program as a means for the 
realization of specified goals. The NIH, under the leadership of 
Dr. James A. Shannon, sought to advance undifferentiated 
biomedical research. The Office of the Surgeon General 
searched for “increased quality life years" as an overarching 
goal to measure outcomes from diverse health programs. 
Economists in the Office of the Secretary, recruited from the 
RAND Corporation, sought a goal of “increased net present 
value of future income.” 
The Office of the Surgeon General was caught in a bureau¬ 
cratic battle between the double helix and the Dow Jones. This 
was actually fun when one had the privilege of playing in the 
same game with James Alyusius Shannon. His charm, intellect, 
vision and gall were to be admired. To hear Dr. Shannon testify 
to Congress, two-thirds of the NIH expenditures were devoted 
to conquering diseases through targeted, applied research. The 
next day, before a meeting of biomedical scientists, he extolled 
the virtues of investing two-thirds of NIH resources in basic, un¬ 
differentiated research. The more I listened to him, the more I 
realized that it was not duplicity, for he was correct on both 
scores. The subtle nuances, I would learn when he told the his¬ 
tory of the conquest of polio, were best understood by a distin¬ 
guished physician scientist. 
I remember vividly the day I suggested to Dr. Shannon that 
we develop a common data base so that the Office of the Sur¬ 
geon General and NIH could each aggregate budgetary informa¬ 
tion by our respective definitions of applied and undifferentiated 
research. He smiled, patted me on the shoulder and said, “Bill, 
you just ask me the questions; I’ll get you the answers.’’ Dr. 
Shannon taught me the role of budget busting in search of a goal 
higher than “increased net present value of future income.” For 
me, the Centenary of the National Institutes of Health recalls 
a scientific statesman and consummate bureaucrat, a legend in 
his own time, for whom an appropriate Nobel Prize would be 
in economics as well as medicine. 
Dr. Dorothy M. Horstmann is 
the John Rodman Paul Professor 
of Epidemiology and Pediatrics 
emeritus, and senior research 
scientist at the Yale School of 
Medicine. 
by Dorothy M. Horstmann, M.D. 
Having been a longtime worker in the field of infectious dis¬ 
eases, the early history of the National Institutes of Health par¬ 
ticularly interests me. This complex organization, which is 
made up of 11 diverse institutes located on a 306-acre campus 
in Bethesda, Md., began modestly 100 years ago when Dr. 
Joseph Kinyoun established the Laboratory of Hygiene at the 
Marine Hospital on Staten Island. It consisted of a single room 
designated for research on cholera and other infectious diseases. 
In subsequent years, the hygienic laboratory underwent succes¬ 
sive changes in title, mission and location, eventually emerging 
as the National Institute of Health in 1930, and in 1955—after 
a series of new institutes had been added—as the National Insti¬ 
tute of Allergy and Infectious Diseases (NIAID). 
In 1887 and through the early years of this century, such dis¬ 
eases as diphtheria, pertussis, typhoid fever, cholera and 
botulism were among the most prominent health problems in the 
United States and all challenged investigators at the hygienic 
laboratory. There also were epidemics of “new” diseases to be 
dealt with such as Rocky Mountain Spotted Fever and tula¬ 
remia. Identifying causative agents and determining modes of 
transmission carried risks; investigators not infrequently con¬ 
tracted diseases under study, and a few died. However, their 
pioneering work was rewarded with many successes, leading to 
means of prevention of a number of the epidemic diseases of 
the period. 
In more recent times, vaccines against poliomyelitis and 
hepatitis B have been achieved, but the appearance of “new” 
diseases apparently is a never-ending problem. In the past de¬ 
cade, Legionella pneumonia and toxic shock syndrome required 
major efforts to unravel their mysteries. Today, AIDS consti¬ 
tutes a national health crisis. Investigators at NIAID and the 
many university laboratories supported by this institute fortu¬ 
nately have made revolutionary advances in molecular biology 
and immunology, and as a result now have highly sensitive tools 
for tackling AIDS and other complex diseases. There can be no 
doubt that the first 100 years of the National Institutes of Health 
constitute a stunning success story. The second century begins 
on a high note with prospects or future successes that defy the 
imagination. 
by RichardL. Edelson, M.D. 
The National Institutes of Health has contributed enormously to 
the growth of medical academia in many ways. However, it is 
not widely appreciated that an extraordinarily high percentage 
of our current leaders in medical research and education were 
stimulated to enter academia as a result of their “military” ex¬ 
periences at the NIH during the later stages of the Vietnam war, 
a conflict which led so many of us to choose alternative service 
at the NIH. 
It was my good fortune to spend three very formative years 
at the NIH, as an associate in the National Cancer Institute, from 
1972 to 1975. During that period of national turmoil, virtually 
all male medical school graduates in my Yale medical school 
class of 1970 either were drafted, enlisted or made alternative 
service arrangements. One of the most desirable possibilities 
was to be among the few selected as NIH Associates. Accep¬ 
tance to that program permitted a two-year deferral of “mili¬ 
tary” service, thus enabling new physicians to begin specialty 
clinical training. The NIH also offered the opportunity of excit¬ 
ing research experiences in a very pleasant setting in Bethesda, 
Md. The fact that we had all performed research at Yale and 
could arrive for our interviews with bound theses made us 
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particularly attractive candidates for positions at the NIH 
and explains the disproportionately high representation of 
Yale graduates (approximately 20) among those 150 candidates 
finally accepted. 
The environment in which we worked was very conducive to 
both productive research and personal growth. The associates 
were given great responsibility in laboratories basically devoid 
of the funding pressures of university life. Clinical responsibili¬ 
ties largely were limited to the first year and were themselves 
quite enriching because of the spectrum of clinical material and 
the creative way with which it was dealt. There was an enor¬ 
mously contagious feeling that we were participating in exciting 
adventures and that we were contributing in important ways. 1 
am impressed that the NIH experience induced more than half 
of the associates to pursue academic careers and that so many 
of that cohort group have subsequently done so well. On the 
basis of that experience, we are attempting to create a similar 
environment for a postdoctoral M.D. fellow in the department 
of dermatology at Yale. 
Dr Robert W Berliner is dean 
emeritus, professor emeritus of 
physiology and medicine, and 
senior research scientist in 
physiology at the Yale School 
of Medicine. 
by Robert W. Berliner, M.D. 
The National Institutes of Health had a prolonged childhood. It 
had not yet achieved its adolescent growth spurt when I arrived 
at NIH in 1950, although the NIH was already 63 years old at 
that time. 1 joined what was then the National Heart Institute 
(other organs have since been added to its title); it was then a 
two-year-old infant. 
Jim Shannon was organizing the intramural research ac¬ 
tivities of the Heart Institute. The recruiting job he did at that 
time might have led one to expect the phenomenal role that he 
would later play as the director of NIH. The initial group of 20 
or so people that he brought together included at least 10 who 
became members of the National Academy of Sciences and two 
who were to win the Nobel Prize. 
Before he left the directorship of intramural research, he also 
recruited a group of younger people who were to form the Heart 
Institute house staff when the Clinical Center opened in 1953. 
They included two subsequent directors of the NIH. Thanks to 
the effects of the doctor draft, the intramural NIH became the 
training ground for an entire generation of leaders in internal 
medicine throughout the '50s and '60s. When I was honored by 
the Association of American Physicians in 1984, 1 pointed out 
it l our of the live councilors of the association and its secre- 
had spent some part of their careers in the Heart Institute, 
i Shannon left the Heart Institute in 1952, first to become 
associate director of NIH, and then director in 1955. Shortly 
thereafter the growth spurt began that made the NIH the source 
for the generous and wisely selected support of medical research 
that made it the world leader in both quality and quantity. In 
1950, the total appropriation for NIH was $52 million. It had 
crept up to about $70 million when Jim Shannon took over. 
When he retired in 1968, it was approaching $1.5 billion. The 
current NIH appropriation is some 100-fold greater than when 
I first knew it. 
When I joined the NIH in 1950 I was warned that no good 
could come from getting the federal government involved as a 
major supporter of medical research. As for becoming person¬ 
ally a part of the federal bureaucracy—horrors! Clearly, time 
has shown that at least one federal program can be run in 
exemplary fashion, and NIH is one of the few places where 
people take pride in being part of the federal government. 
Dr. William W.L. Glenn is 
Charles W. Ohse Professor 
emeritus and senior research 
scientist surgery at the Yale 
School of Medicine. 
by William W.L. Glenn, M.D. 
On June 16, 1948, when President Truman signed an act estab¬ 
lishing the National Heart Institute within the National Institutes 
of Health, he did so as the result of a groundswell of enthusiasm 
for federal support of research in heart disease, the major cause 
of death in America. A specific mandate of the National Heart 
Act was “to encourage and support research in cardiovascular 
disease.” Thus, 1948 was a propitious year in which to begin 
a career in cardiovascular surgery, as it was my good fortune 
to do in October of that year at Yale. With the collaboration of 
a number of colleagues, fellows, engineers, skilled technicians, 
and administrative and nursing staff, we embarked upon an ex¬ 
tremely active laboratory and clinical program destined to be 
carried on for over three decades. The continuous support of our 
program by the NIH from 1950 to 1987 enabled us to realize 
many of our research objectives. 
For the clinical investigator, the approach of the National In¬ 
stitutes of Health has two major attractions. First is long-term 
support for initiation, investigation and resolution of an idea. 
A problem presented at the bedside can be carried to the labora¬ 
tory for study, and the results of the study returned to the bed¬ 
side for clinical trial and long-term follow-up. Second is the 
freedom NIH provides for exploring new ideas that were not 
contemplated when the original research proposal was ap¬ 
proved. This combination of long-term commitment and flexi¬ 
bility is vital to quality research. 
Dr. Paul B. Beeson is professor 
of medicine emeritus at the 
University of Washington. 
by Paul B. Beeson, M.D. 
Many extraordinary advances in methods of diagnosis and treat¬ 
ment can be attributed to the National Institutes of Health, espe¬ 
cially during the past 40 years. 1 feel fortunate to have been pro¬ 
fessionally active at a time when so many exciting things were 
happening. Nevertheless I shall dwell here on some unantici¬ 
pated—and untoward—effects of our massive research efforts. 
One. The rapid accumulation of factual knowledge, together 
with the introduction of complex technologies in diagnosis and 
treatment, necessitated narrow specialization in medical prac¬ 
tice, especially by the clinicians on the faculties of medical 
schools, for whom research and acquisition of new information 
is an obligation. This trend was quickly followed by doctors in 
private practice, and the stampede into specialization has now 
brought us to a state where we seem to have too many specialists 
and not enough generalists for appropriate service to the Ameri¬ 
can people. 
Two. The complexities of modem diagnosis and treatment, 
especially as employed in hospitals, is expensive, and is impos¬ 
ing a substantial economic burden, to the extent that health care 
now amounts to more than 10% of the gross national product. 
Inasmuch as health benefits have become major components 
of employment contracts, this affects the cost of everything 
we buy. 
Three. Large charity hospitals which formerly were the prin¬ 
cipal sites of medical teaching, e.g., Boston City, Philadelphia 
General and Cook County, have encountered almost impossible 
financial difficulties, and no longer comprise the essential 
teaching resource, having been supplanted by private, often 
university- operated institutions where few charity patients are 
cared for, and where high-cost, tertiary-care medicine is em¬ 
phasized. In such places, medical students have a somewhat 
skewed perspective of the world of health problems. 
Four. The hidden costs: a) of operating tertiary-care hospi¬ 
tals; b) of conducting research; and c) of paying competitive 
salaries for clinical faculty members have created financial 
problems for our medical schools. Tuition has risen to the point 
where the majority of medical graduates now owe large debts. 
Five. Young doctors are choosing fields of practice which 
make use of technologic procedures in diagnosis or treatment, 
partly because these fields provide higher incomes than do those 
in which service is largely cognitive in nature. 
Six. The high cost of medical care, together with the high 
earnings of the medical profession, has contributed to a harmful 
increase in litigation and in the cost of malpractice insurance. 
All these have tended to change the character of medical prac¬ 
tice, reducing the popularity of autonomous personal-encounter 
careers, and favoring the establishment of group practices, large 
private clinics and health maintenance organizations. I under¬ 
stand that about half of all active clinicians are now working 
on a salaried basis, or in some kind of partnership system. It 
is astonishing to read that about 50,000 (10 percent) of the 
nation’s clinically active physicians are now salaried medical 
school faculty members. 
Additionally, we must take note of the demographic change 
that has come about during this century. When I entered the pro¬ 
fession a major aspect of our work had to do with acute infecti¬ 
ous processes. These have diminished in relative importance, 
and today’s challenge is to deal with the chronic degenerative 
processes that accompany aging. About a third of the national 
expenditure for health care now goes to the 11 percent of our 
population over age 65. 
Looking back over half a century it appears that advances 
came along just slowly enough that we failed to foresee the rip¬ 
ple effects they engendered. Today, no one can deny that a com¬ 
pelling need exists for reappraisal and for substantial alteration 
of our systems of medical education and medical practice. 
Dr. Thomas F. Ferris is Nesbitt 
Professor and chairman of the 
department of medicine at the 
University of Minnesota. 
ThomasF. Ferris, M.D. 
The celebration of the Centennial of the National Institutes of 
Health is a celebration of the accomplishments of biomedical 
research. NIH has provided the major support for biomedical 
research in the United States and the accomplishments of this 
effort, particularly in the 40 years since World War II, stand 
among mankind’s great achievements. More has been learned 
about human biology over the past 40 years than in prior re¬ 
corded history. Since the public is being reminded constantly 
of the cost of medical care and the ethical problems created by 
biomedical technology, it is appropriate that we celebrate im¬ 
provements in understanding disease and the relief of human 
suffering that has flowed from these efforts. 
As a medical student at Yale in the 1950s I recall learning that 
the nucleus of a cell contained desoxyribonucleic acid. Now, 
30 years later, the NIH is considering sponsoring a program to 
map the human genome. 
Fitkin 2 was filled the summer of my junior year with patients 
with acute poliomyelitis, many of them in iron lungs. We were 
taught that hypertension was part of the aging process; today, 
anti-hypertensive therapy has resulted in a striking reduction in 
cardiovascular mortality. Strokes that were once so common on 
medical wards now are relatively rare. We knew little of the im¬ 
munologic basis of renal injury and wondered if acute post- 
streptococcal nephritis or urinary tract infections caused chronic 
renal disease which was invariably fatal. Today transplantation 
gives patients with chronic renal failure an 85 percent chance 
of normal renal functions five years after the transplant. 
We knew from the differences in incubation time that two dif¬ 
ferent filterable agents caused hepatitis, but today viruses are 
cultured almost as routinely as bacteria. Bioassays for crude 
measurements of hormones in plasma have been replaced by 
accurate immunoassays. Leukemia was invariably fatal 
whereas chemotherapy and bone marrow transplantation now 
give a normal life to many. As an example of fatal disease, Paul 
Beeson presented to our class during our first week of medical 
school a young minister with lymphoma; today the patient 
would have an excellent chance of cure. In pathology, one of 
our most popular teachers humorously derided the possibility 
that cigarette smoking caused cancer. Open heart surgery was 
in the future, and talk of a heart, lung or liver transplant would 
have been considered unscientific fantasy. 
It has been a privilege to have lived during the time of these 
medical achievements. If NIH flourishes for another 100 years, 
my great-grandchildren may see the elimination of disease as 
a cause of premature death. 
Dr Gerard N. Burrow is the 
Sir John and Lady Eaton 
Professor and chairman, 
department of medicine, 
the University of Toronto. 
by GerardN. Burrow, M l). 
In several ways the National Institutes of Health has been my 
“alma mater” or “bountiful mother” in pursuing a career in 
academic medicine. To begin with, a National Health Training 
Grant funded my clinical fellowship in endocrinology. As part 
of that training I had to spend a period of time in a research labo¬ 
ratory. Dr. Philip Bondy, my supervisor, had just spent a sab¬ 
batical learning molecular biology, and my three months work¬ 
ing with him led to my career interest in bench research. My 
research fellowship with Dr. Bondy and subsequent research 
support during my first two years as a faculty member also came 
under the umbrella of the NIH Training Grant. Later, appoint¬ 
ment as director of the Clinical Investigation Centre, funded by 
the National Institutes of Health, provided financial support 
during those early years on the faculty. Eventually, I received 
my own national health research grants and a career develop¬ 
ment research award which provided my salary. 
Until I moved to Toronto, my entire academic medical career 
had been supported by the National Institutes of Health. Perhaps 
more germane is that the time in research spent during the 
real fellowship in endocrinology stimulated a permanent in¬ 
terest in the excitement of research and pushed me toward a 
career in academic medicine. 
I owe an inestimable debt of gratitude to Yale for nourishing 
me intellectually and to the National Institutes of Health for 
nourishing me financially. 
by Robert G. Petersdorf, M.D. 
For many of us who established academic medical careers in the 
’60s and ’70s, the National Institutes of Health became an inde¬ 
lible part of our professional lives. I was appointed to my first 
assistant professorship in 1958 at the conclusion of my chief re¬ 
sidency at Yale. For the first year-and-a-half, the sustenance of 
my laboratory work came as part of an NIH grant to my mentor. 
This research, in turn, helped me gain a position as associate 
professor of medicine at the University of Washington and chief 
of medicine at the old King County Hospital (now called Har- 
borview Medical Center). 
As soon as I began this job, grant writing to the NIH began 
in earnest. I applied for—and received—two research grants 
and became the principal investigator on a training grant. As a 
result of this generous NIH support, I was able to get a rapid 
start with my academic career. Within a short period of time, 
and with ample NIH support. I started a laboratory and recruited 
research fellows. NIH funding continued uninterrupted for the 
ensuing 20 years. 
This story has been repeated for thousands of young inves¬ 
tigators who have become beneficiaries of the NIH. I saw this 
from a different perspective as chairman of a department; NIH 
support was essential to recruit and retain new faculty. 
Our small, burgeoning medical service at King County Hos¬ 
pital received an enormous boost when NIH designated it as a 
clinical research center. I cannot overstate the importance of 
that modest CRC to the development of a research-oriented 
medical service in a county hospital. Several young inves¬ 
tigators in endocrinology, cardiology, hematology and infecti¬ 
ous disease used that center to begin their own academic care¬ 
ers. Although this CRC was eventually merged with a larger one 
at the University of Washington, it provided an important start 
for a group of young investigators. 
The value of the CRC program has been shown many times 
since then. As dean of the University of California in San Diego 
20 years later, I became principal investigator of the clinical re¬ 
search center. The presence of that funding instrument enabled 
us to complete a major recruitment, not to mention providing 
support for some very good clinical investigation. 
An important aspect of the NIH in most academics’ lives is 
service on NIH committees and site visit teams. I have always 
felt that this type of service is a debt academicians owe to the 
agency that has made academic life possible. Over the years, 
I have served on a training grant committee, an advisory council 
and the director’s advisory committee. Each of these assign¬ 
ments provided the opportunity for addressing challenging 
problems and for interacting with a host of outstanding col¬ 
leagues. Indeed, many of the friendships made in academic 
medicine are made around the table of NIH study sections and 
committees, and over dinner in a Bethesda watering hole. 
In my present position, as president of the Association of 
American Medical Colleges, much of the time, effort and re¬ 
sources of the AAMC and its staff are spent espousing the 
causes of the NIH. Some of our key staff are alumni of the NIH 
administration. Our constituency—the faculties of medical 
schools and teaching hospitals—depend on the continued 
health of the NIH. We therefore consider NIH advocacy a vital 
part of our agenda. Both the association and I as an individual 
feel that the NIH is part of the American academic culture, and 
that its support of research and research training is the major 
reason that American biomedicine leads the world. 
The NIH is a unique institution that we must preserve, nurture 
and cherish. More importantly, we must see to it that the role 
of the NIH in American biomedicine is strengthened so that 
it may do for our successors what it has done for our generation. 
Dr. Morton M. Kligerman is the 
Henry K. Pancoast Professor of 
Research Oncology at the 
University of Pennsylvania. 
by Morton M. Kligerman, M.D. 
Some of the background leading to the establishment of the Na¬ 
tional Cancer Institute’s radiation program and its importance 
to the department of radiation therapy at Yale University should 
be recorded. 
The need for support for the discipline of radiology by the Na¬ 
tional Institutes of Health had been stressed by several, includ¬ 
ing the Drs. Edward W. Chamberlain, Eugene Pendergrass and 
Robert Stone, of Temple University, and the Universitites of 
Pennsylvania and California at San Francisco, respectively. 
One consequence, during the latter half of the 1950s, was a 
Chicago conference the NCI sponsored when Dr. J. Rodney 
Heller was the director. This meeting of 10 radiation therapists 
was chaired by Dr. Henry S. Kaplan of Stanford University. 
Some of those attending included Drs. Gilbert Fletcher, Fer¬ 
nando Bloedom, Richard Chamerlain, Milton Friedman and the 
author. Consultants included Dr. Harold Johns, radiation phys¬ 
icist from Toronto, Robert F. Kallman, radiobiologist, and Lin¬ 
coln Moses, statistician, both of Stanford. 
The question posed was whether a collaboration among a 
group of academic radiation therapists was necessary to deter¬ 
mine best methods of treatment, and to agree that input from 
physicists, radiobiologists and statisticians was a requirement. 
The affirmative answer lead to a meeting at the NCI’s Stone 
House when the late Dr. Kenneth Endicott was NCI director and 
Dr. Gordon Zubrod was clinical director. The group of radiation 
therapists was expanded to 24, and the areas of agreement con¬ 
cerning the scope of such a collaboration were far greater than 
were the disagreements. 
This meeting lead to the development of a “white paper” 
recommending a program which would support research in ra¬ 
diation therapy, biology and physics, as well as research train¬ 
ing in these areas. The report, submitted to the NCI, stressed 
the importance of radiotherapy in cancer management and 
predicted that the need for radiation therapy, either alone or in 
combination with other forms of cancer management, would 
increase in the future. It also emphasized that radiobiology 
was the basic science of radiation therapy. 
This program was accepted, and funds were designated for 
its support through the mechanism of competitive grants. In 
1961, the division of radiation therapy of the department of 
radiology at Yale University received a training grant entitled 
“Research Training in Radiation Therapy,” and then in 1962, 
a research grant entitled "Radiation Therapy and Biology Re¬ 
search Program.” Though the author was the principal inves¬ 
tigator, the contribution of Dr. Paul Howard-Flanders was enor¬ 
mous. As a result of these grants, Yale became one of the first 
six specialized cancer centers. Some of the persons who trained 
under this program included Drs. Samuel Heilman, Peter Sci- 
betta, Gustavo Montano, John Chaffee, Stanley Order, James 
Fischer and Leonard Prosnitz. 
Special tribute must be paid to the NCI for instituting the dou¬ 
ble review system for grant application review by one’s peers, 
which was instrumental in making it possible for all potential 
investigators to receive a research award. In my opinion, this 
process was of singular importance in establishing American 
medical science’s superiority. 
Tribute also must be paid to the NCI staff whose effort and 
performance were extraordinary. I especially remember the 
contributions of Dr. Ralph G. Meader, associate director for 
grants and training; Ms. Helen Denson, program director for 
postdoctoral and special fellowships; and Dr. Samuel Herman, 
executive secretary of the radiation study section at the start of 







Sheila W. Wellington, M.PH '68, M.U.S. 
'68, has succeeded John A. Wilkinson as 
secretary of Yale University. Wilkinson, 
who had held the secretary's post for 20 
years, resigned to become headmaster of 
the Germantown Friends School in 
Philadelphia. Ms. Wellington, formerly 
deputy director of the Yale Psychiatric Insti¬ 
tute, has been long active in community 
affairs. 
University President Benno C. Schmidt 
Jr. commented, "I am extremely pleased 
that Sheila Wellington has accepted this 
critically important position at Yale. She 
will bring tremendous strength to the Office 
of the Secretary. Sheila is an experienced, 
skilled and energetic administrator. She has 
been a committed citizen of New Haven for 
many years, active with the political institu¬ 
tions and communities of this city. She is 
enormously intelligent, open and caring.” 
Ms. Wellington, who has taught in¬ 
troductory and advanced courses in admin¬ 
istration and mental health policy at Yale 
since 1974, has two degrees from the Uni¬ 
versity, both earned in 1968—a Master of 
Public Health degree from the department 
of epidemiology and public health and a 
Master of Urban Studies from the School of 
Art and Architecture. From 1980 to 1986, 
she was director of the Greater Bridgeport 
Community Mental Health Center. 
She joined the Hill-West Haven division 
of the Connecticut Mental Health Center in 
1968 and was its director from 1977 to 
1980. The center is sponsored jointly by 
Yale University and state agencies. In her 
new post, she became an officer of the Yale 
Corporation, the University’s governing 
board of trustees. 
“I am honored to be asked to serve the 
University and the wider community in the 
position of Secretary, and 1 look forward to 
following in the distinguished tradition of 
my predecessors,” Ms. Wellington said. 
Health Care Expert 
Elected Yale Trustee 
William L. Kissick, Yale ’53, '51 M.D., 
'59 M.P.H., '61 D.P.H., has been elected a 
trustee of Yale University after a nationwide 
balloting of alumni. Dr. Kissick, the 
George Seckel Pepper Professor of Public 
Health and Medicine at the University of 
Pennsylvania, succeeds Frederick B. Dent, 
'44. Dr. Kissick will serve a six-year term 
as a member of the Yale Corporation. 
When he received his last degree from 
Yale in 1961, Dr. Kissick went to 
Washington to work on health and science 
policy for the Kennedy administration. 
During seven years in the nation's capital, 
he helped to draft health programs, policies 
and legislation for the Kennedy and 
Johnson administrations while attached to 
the U.S. Public Health Service, the Depart¬ 
ment of Health, Education and Welfare and 
the White House. From 1965 to 1968, he di¬ 
rected strategic planning for the Surgeon 
General until President Johnson appointed 
him executive director of the National Ad¬ 
visory Commission on Health Facilities. 
In 1968 he became a member of the facul¬ 
ty at the University of Pennsylvania, where 
he organized research and educational pro¬ 
grams in health care. His joint professor¬ 
ships in the School of Medicine and the 
Wharton School at Pennsylvania estab¬ 
lished a national precedent. 
Dr. Kissick has served as an advisor, 
consultant or trustee of many national and 
international groups, including the World 
Health Organization, the U.S. Department 
of State, the Board of National Missions of 
the United Presbyterian Church and several 
Fortune 500 corporations. 
In the past 25 years, Dr. Kissick has been 
intimately involved in the affairs of Yale. 
His work on behalf of the University in¬ 
cludes service on the Alumni Schools Com¬ 
mittee and on the Board of Directors of the 
Yale Club of Washington, D C. In addition, 
he has been a director, vice president and 
president of the Association of Yale Alumni 
in Medicine; a member of the Development 
Board and the Alumni Fund for the Medical 
School; chairman of the Graduate and Pro¬ 
fessional Schools Committee; assistant 
chairman and vice chairman of the Yale 
Alumni Fund; and chairman of the Commit¬ 
tee on Medical Affairs of the University 
Council. 
Edwin Cadman Returns 
to Lead Department 
of Medicine 
Dr. Edwin C. Cadman, vice chairman of the 
department of medicine at the University of 
California at San Francisco and director of 
its Cancer Research Institute, became chair¬ 
man of the School of Medicine department 
of internal medicine and chief of medicine 
at Yale-New Haven Hospital on Sept. 1. Dr. 
Cadman returns to the medical school and 
hospital with which he was affiliated from 
1974 to 1983. 
He succeeds Dr. Samuel O. Thier, who 
became president of the Institute of 
Medicine in January 1986. During the inter¬ 
vening months, Dr. Robert M. Donaldson 
has served as acting department chairman. 
“Ed Cadman is nationally recognized as 
a clinician, teacher, researcher and admin¬ 
istrator. I am personally delighted that he 
will lead our school’s large and crucial de- 
Dr. Cadman 
partment of medicine,” says Dr. Feon E. 
Rosenberg, dean of the School of Medicine. 
“As a well-recognized leader in medical 
oncology, he has made major research 
contributions in the field of cancer 
chemotherapeutic agents. His work will 
strengthen the Yale Comprehensive Cancer 
Center,” the dean notes. The Yale Com¬ 
prehensive Cancer Center is a joint project 
of the School of Medicine and Yale-New 
Haven Hospital. 
During the past decade. Dr. Cadman has 
centered his research on the interaction of 
cancer drugs and cancer cells. For the last 
two years, he has concentrated on studying 
the mechanisms by which drug resistance is 
transferred among cells. Drug resistance is 
the most common cause of treatment failure 
in cancer patients. 
A native of Oregon, Dr. Cadman re¬ 
ceived a B. A. degree in 1967 from Stanford 
University and an M.D. degree magna cum 
laude in 1971 from the University of Ore¬ 
gon. He completed his internship and resi¬ 
dency training in medicine at Stanford Uni¬ 
versity Hospital. Between 1974 and 1976, 
Dr. Cadman took a postdoctoral fellowship 
in oncology at Yale University School of 
Medicine, after which he joined the faculty 
as assistant professor of medicine and phar¬ 
macology. He was named associate profes¬ 
sor in 1979. He also was an attending physi¬ 
cian at Yale-New Haven Hospital. 
At Yale, Dr. Cadman was noted for 
his teaching. In 1978, the department of 
medicine named him teacher of the year; in 
1982, the School of Medicine presented 
him the Francis Gilman Blake Award for 
outstanding teaching. 
In 1983, Dr. Cadman was named profes¬ 
sor of medicine and chief of hematology/ 
oncology at the University of California at 
San Francisco. Two years later, he was 
named the American Cancer Society Pro¬ 
fessor of Oncology. In 1986, he became 
vice chairman of the department of 
medicine and was named the David A. 
Wood Professor of Cancer Biology. He held 
both endowed professorships concurrently. 
In 1985, he served as president of the 
American Federation of Clinical Research. 
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Dean Rosenberg presents the Leah Lowenstein Award to Dr. Barbara Kinder. 
Dr. Feinstein Awarded 
International Prize 
Dr. Alvan R. Feinstein, professor of 
medicine and epidemiology, has received 
the prestigious J. Allyn Taylor International 
Prize in Medicine for 1987. He shared the 
prize with Peter Armitage, professor of 
biomathematics at Oxford University, and 
David L. Sackett, professor of clinical 
epidemiology and biostatistics at McMaster 
University. 
The Taylor prize, administered by the 
Robarts Research Institute in London, On¬ 
tario, and instituted in 1985, is awarded an¬ 
nually for “significant contributions to a 
field of basic or clinical research.” The sci¬ 
entific community nominates individuals, 
and a peer jury selects the recipients, who 
receive gold medals. 
The prize this year was given for work in 
“the basic principles and discipline of clini¬ 
cal evaluation.” Drs. Feinstein and Sackett 
were being honored for their pivotal work in 
establishing and developing the field of 
clinical epidemiology as a unique investiga¬ 
tive discipline for studying problems in 
medicine. Professor Armitage was selected 
for his work in biostatistics and in the design 
of clinical trials. 
Dr. Feinstein, who joined the Yale medi¬ 
cal faculty in 1962, has written four books 
as sole author and more than 300 papers on 
topics of clinical evaluation, epidemiology 
and biostatistics. He directs the clinical 
epidemiology unit at Yale, the introduction 
to clinical medicine course for medical stu¬ 
dents and the Robert Wood Johnson Clinical 
Scholars Program for post-residency fel¬ 
lows. He also is co-editor of the Journal of 
Chronic Diseases. 
Yale Model Program 
Featured at National 
Sickle Cell Conference 
A Yale pediatrician who developed the 
country’s first successful program for diag¬ 
nosis and treatment of infants with sickle 
cell disease says that early intervention 
is the key to saving the lives of children 
who have this incurable genetic illness, 
which affects as many as one in 500 black 
Americans. 
“In the last 15 years, we’ve identified 
and treated about 45 babies in New Haven 
with this potentially life-threatening dis¬ 
ease,” says Dr. Howard A. Pearson, chair¬ 
man of the pediatrics department at the 
School of Medicine and chief of the pediat¬ 
ric service at Y-NHH. “Using historical 
controls, we would have expected seven to 
10deaths in that group. But we had none.” 
Dr. Pearson was the introductory speaker 
for the National Institutes of Health Con¬ 
sensus Development Conference on New¬ 
born Screening for Sickle Cell Disease and 
Other Hemoglobinopathies, April 6-8, at 
N1H headquarters in Bethesda, Md. 
Sickle cell disease, also known as sickle 
cell anemia, is a genetic condition in which 
red blood cells change from a normal round 
shape to an abnormal sickle, or crescent 
shape. 
The disease causes unpredictable pain at¬ 
tacks and other serious health problems. 
Says Dr. Pearson: “If you look at the his¬ 
tory of this disease, you find that as many 
as 30-35 percent of affected children die be¬ 
fore reaching the age of five, and many of 
them die of infection. Sudden early death 
from catastrophic infection may be the first 
manifestation of the disease. ” 
Since June 1972, the Yale School of 
Medicine department of pediatrics has been 
testing all black and Hispanic babies bom at 
Y-NHH and the Hospital of St. Raphael, to 
identify those with sickle cell disease. Once 
an affected baby is identified, he or she is 
immediately enrolled in a special clinic for 
treatment, follow-up and emergency inter¬ 
vention. 
The Yale neonatal program for sickle cell 
anemia has been replicated throughout the 
world. The National Heart, Lung and Blood 
Institute used it as the model for its 
Cooperative Study of Sickle Cell Diseases. 
This 10-year national investigation took 
place at 21 institutions and enrolled nearly 
4,000 patients, beginning in 1977. 
Leah Lowenstein 
Award Presented 
The Office for Women in Medicine pre¬ 
sented the second annual Leah Lowenstein 
Award to Dr. Barbara K. Kinder, associate 
professor of surgery at the School of 
Medicine and chief of surgery at Yale Uni¬ 
versity Health Services. 
The award recognizes the medical school 
faculty member who most clearly provides 
positive images of women in the promotion 
of humane and egalitarian medical educa¬ 
tion. The recipient’s teaching style and per¬ 
sonal example have provided a model for 
the principle of equal opportunity espoused 
by the late feminist physician, dean and 
medical educator Leah Lowenstein 
throughout her career, according to Merle 
Waxman, director of the Office for Women 
in Medicine. 
On receiving the award. Dr. Kinder said, 
“In an era where the business of medicine 
seems all to often to be a major focus of stu¬ 
dent and practitioner concerns, it is ex¬ 
tremely important that the humanitarian as¬ 
pects of our profession not be neglected. An 
award such as the Leah Lowenstein Award 
honors not only its recipient, but bears wit¬ 
ness to the importance of a balance between 
technological expertise and human compas¬ 
sion in the practice of our craft.” 
Dr. Kinder joined the Yale medical facul¬ 
ty in 1977 as an assistant professor of 
surgery. A native of Washington, DC., she 
received a BA. degree magnacum laude in 
1967 from Smith College and an M.D. de¬ 
gree cum laude in 1971 from Yale School of 
Medicine. She took her residency training 
at Yale-New Haven Hospital, where she 
also is an attending surgeon. Dr. Kinder is 
president-elect of the Connecticut Society 
of American Board Surgeons. 
Dr. Kinder’s clinical and teaching inter¬ 
ests are surgical endocrinology and breast 
disease. She concentrates her research on 
the second messenger system in secretory 


















Trends in Medicine 
Ninety-four students who graduated from 
the School of Medicine in June participated 
in the national match program on March 18. 
They selected residency training programs 
mirroring national trends that graduates 
have set during the past seven years. 
According to Dr. Robert H. Gifford, as¬ 
sociate dean for education and student 
affairs, the most significant change was the 
marked decrease in the number of students 
choosing internal medicine as a career. 
"Only 24 students opted for internal 
medicine residencies, a decrease by more 
than 50 percent from 1980. 
“Even more striking was the fact that no 
student applied for an obstetrics and 
gynecology residency,” he says. "And 
general surgery had the lowest number of 
successful applicants in the past seven 
years." 
In contrast, psychiatry was very popular. 
Twice as many students entered the special¬ 
ty this year as compared with 1986, and five 
times as many students as in 1980. A 
dramatic increase was also seen in the 
number of students entering ophthalmology 
programs. 
"Emergency medicine, anesthesiology, 
therapeutic radiology and otolaryngology 
are newly popular specialties,” says Dr. 
Gifford, who added “the number of stu¬ 
dents who entered pediatrics and family 
practice has remained relatively constant 
during the past seven years.” 
Reasons for these trends are not entirely 
clear. However, Dr. Gifford says that the 
average debt of Yale medical graduates— 
now close to $40,000—may play some role 
in the selection of career specialties. 
Some educators also feel that medical 
students’ clinical experiences have become 
so heavily identified with highly specialized 
in-patient, intensive care that students are 
less likely to find role models in general 
medicine or surgery. 
The country’s litigious climate, the as¬ 
sociate dean notes, may also be a factor in 
residency selection for some graduates. 
CLASS OF 1987 Residency Positions 
CALIFORNIA 
Harbor-UCLA Medical Center, Torrance 
Michael Burg, emergency medicine 
David Granet, transitional 
Kaiser Foundation Hospital, San Francisco 
Andres Cortes, general surgery 
LA County-USC Medical Center, Los Angeles 
Alan Yamada, urology 
Martin Luther King Jr.-Drew Med. Ctr., Los Angeles 
Cecil Bowen, general surgery 
UCLA Neuropsychiatric Institute, Los Angeles 
Dan Karasic, psychiatry 
UCLA-San Fernando Valley Program, Sepulveda 
Rebekah Braslow, medicine 
University of California-San Diego Medical Center, San Diego 
Harlan Meyer, internal medicine 
University of California Hospital, San Francisco 
Jerome Chin, internal medicine 
Paul Wilson, psychiatry 
Stanford University Hospital, Stanford 
Mark vonZastrow, psychiatry 
COLORADO 
University of Colorado School of Medicine, Denver 
Ian Cook, general surgery 
Donna Klimowicz, psychiatry 
CONNECTICUT 
Danbury Hospital, Danbury 
Benjamin Chen, medicine 
Hospital of St. Raphael, New Haven 
Subba Gollamudi, transitional 
Hugh Hemmings, medicine 
St. Vincent’s Medical Center, Bridgeport 
Larry Amsel, transitional 
Peter Glazer. transitional 
University of Connecticut School of Medicine, Farmington 
Susan Thomas, family practice 
VVaterbury Hospital, Waterbury 
Michael Cooper, medicine 
Yale-New Haven Hospital, New Haven 
Lisa Berlin, pediatrics 
Cristina Brunet, internal medicine 
Richard Diana, orthopedic surgery> 
Glenn Healey, therapeutic radioloy 
Robert Homer, pathology 
Jay Horowitz, surgery 
Susan Kruger, psychiatry 
Robert Malison, psychiatry 
Matthew Miller, internal medicine 
Nancy Olson, psychiatry 
Lisa Panzini, internal medicine 
Tarik Ramahi, internal medicine 
Lauri Robertson, psychiatry 
Seth Rosenthal, medicine 
Patrick Ruwe, orthopedic surgery 
Terry Watnick, internal medicine 
Mark Widmann, medicine 
Nicole Vecchi, internal medicine 
Eugenia Vining, surgery 
DELAWARE 
Medical Center of Delaware, Newark 
Steve Gaskin, emergency medicine 
DISTRICT OF COLUMBIA 
Children’s Hospital National Medical Center 
Robert Englander, pediatrics 
ILLINOIS 
Illinois Masonic Medical Center, Chicago 
Louis Glazer, transitional 
University of Chicago Medical Center, Chicago 
Mark Block, surgery 
IOWA 
University of Iowa Hospitals & Clinics, Iowa City 
Kenneth Newhouse, orthopedic surgery 
MARYLAND 
F'rancis Scott Key Medical Center, Baltimore 
William Tse, internal medicine 
Johns Hopkins Hospital, Baltimore 
Cynthia Kapphahn, pediatrics 
Has anybody got a letter opener? Where are you going? Oh my gosh, I made it! Such 
excited comments echoed through the Sterling Hall mailroom shortly after noon on 
March 18—National Resident Match Day. 
Lynn Street (right) and Diane Louie 
share news of their future assignments. 
Photography: T. Charles Erickson 
At left, Judy Mayo, medical school registrar, (left) and Beverly Eastty.secretary in the 
student affairs office, distribute to graduating students letters about residency training 
positions. 
MASSACHUSETTS 
Boston City Hospital, Boston 
Peter Blier, pediatrics 
Colleen Collins, internal medicine 
Michael Solon, internal medicine 
Boston University School of Medicine, Boston 
Amita Chaudhary, transitional 
Brigham & Women’s Hospital, Boston 
John Gaziano, internal medicine 
John Keaney, internal medicine 
Diane Louie, pathology 
Cambridge Hospital, Cambridge 
Charles Brackett, internal medicine 
Ellen Dolnansky, transitional 
Lemuel Shattuck Hospital, Boston 
Roxanne Bartel, transitional 
Mount Auburn Hospital, Cambridge 
Marian Greenburg, medicine 
New England Medical Center, Boston 
Richard Tierney, general surgery 
University Hospital, Boston 
Jeffrey Barkin, internal medicine 
MINNESOTA 
Mayo Graduate School of Medicine, Rochester 
Robert Leggon, orthopedic surgery 
University of Minnesota Hospitals, Minneapolis 
Susan Bove, internal medicine 
M. Nick Burke, internal medicine 
MISSOURI 
Barnes Hospital, St. Louis 
Elliott Levy, general surgery 
NEW JERSEY 
UMDNJ-Robert W. Johnson Medical School, Piscataway 
Nancy Lee, internal medicine 
NEW YORK 
Lenox Hill Hospital, New York City 
Jesse Wardlow, surgery 
Long Island Jewish Medical Center, New Hyde Park 
Eric Jankelovits, pediatrics 
Maimonides Medical Center, Brooklyn 
Steven Blumenfrucht, medicine 
New York Hospital, New York City 
Suzanne Conzen, internal medicine 
Mindy Schuster, internal medicine 
New York University Medical Center, New York City 
Judith Green, internal medicine 
Lynn Street, internal medicine 
Presbyterian Hospital, New York City 
William Apfeldorf, psychiatry 
Andrew Bazos, orthopedic surgery 
Patricia Powell, psychiatry 
St. Vincent’s Hospital, New York City 
Kristen Mertz, transitional 
Winthrop-University Hospital, Mineola 
Robert Urban, medicine 
NORTH CAROLINA 
North Carolina Memorial Hospital, Chapel Hill 
Lisa Benaron, medicine/pediatrics 
Steven Sieber, internal medicine 
David Weingold, pediatrics 
OHIO 
CWRU-University Hospital, Cleveland 
Linda Lewin, pediatrics 
PENNSYLVANIA 
Allegheny General Hospital, Pittsburgh 
Eugene Fu, medicine 
Hospital of the University of Pennsylvania, Philadelphia 
David Fujii, general surgery 
Rebecca Kadish, anesthesiology 
Leslie Vogel, psychiatry 
Barry Weinstock, internal medicine 
Medical College of Pennsylvania, Philadelphia 
C. Christopher King, emergency medicine 
St. Christopher's Hospital, Philadelphia 
Douglas Nelson, pediatrics 
Temple University Hospital, Philadelphia 
Tammy Olsen, internal medicine 
RHODE ISLAND 
Rhode Island Hospital, Providence 
Ross Jenkins, surgery 
WASHINGTON 
University of Washington Affiliated Hospitals, Seattle 
Patricia Gibbs, family practice 






Fluvoxamine, a drug tested by physicians at 
the School of Medicine, has been found 
effective in relieving severely depressed 
patients who have not responded to other 
medication. 
Fluvoxamine has been used in clinical 
trials since the late 1970s but is not yet 
available in this country. The drug has been 
marketed in Europe for more than five years 
and accounts for about five percent of anti¬ 
depressants sold by prescription in some 
countries, according to Dr. Fawrence H. 
Price, assistant professor of psychiatry and 
the lead investigator. 
Drs. Pedro L. Delgado, a postdoctoral 
fellow at Yale; Dennis S. Chamey, as¬ 
sociate professor of psychiatry; and George 
Heninger, professor of psychiatry and di¬ 
rector of the Abraham Ribicoff Research 
Facilities at the Connecticut Mental Health 
Center, also participated in the fluvoxamine 
studies. 
The drug differs from most anti-depres¬ 
sants in structure and effects, according to 
Dr. Price. It is a unicyclic compound, hav¬ 
ing a one-ring chemical structure instead of 
the three-ring structure of a more familiar 
generation of anti-depressants. Its main fea¬ 
ture is its selective effect on the chemistry 
of the brain, particularly the serotonin sys¬ 
tem Serotonin is one of the major neuro¬ 
transmitters regulating mood, appetite, 
sleep, sex, aggression and other physiologi¬ 
cal functions. 
In the depressed state, according to one 
theory, serotonin is drained from the sys¬ 
tem Fluvoxamine blocks the reuptake of 
serotonin and increases the amount avail¬ 
able to other cells, says Dr. Price. Normal 
levels of serotonin are attained through 
other drug treatments. Dr. Price says, but 
only over a long term. 
In clinical trials at Yale, more than two- 
thirds of the 28 patients who completed 
the study—having previously failed to re¬ 
spond to standard medication and 
psychotherapy—were judged to have had a 
“good response” to the drug in six-week 
studies that included time when the patients 
received placebos This includes 30 percent 
who responded well to fluvoxamine and 
lithium, the latter having been in long use 
with depressed patients. 
The determination of a “good response” 
is based on both the judgment of the treating 
physician and a significant positive change 
measured by standard rating scales for pa¬ 
tient condition. The trials of fluvoxamine 
for approval by the U.S. Food and Drug Ad¬ 
ministration in (his country are in phase 
- of a four-phase procedure, says Dr. 
Price. The drug is available now only for 
designated investigators to use. 
A double-blind study by Dr. Wayne 
Goodman, assistant professor of psychi¬ 
atry, on the use of the drug fluvoxamine for 
treating obsessive-compulsive disorders 
also is underway. In this study, more than 
40 percent of a test group of 20 patients with 
the disorder who took the drug showed 
“good response.” They were measured by 
clinical judgment and changes in such rat¬ 
ings as the Yale/Brown Obsessive-Compul¬ 
sive Scale. Dr. Goodman, working with 
Drs. Chamey, Heninger and Price, has re¬ 
ported on this study. The main side effects 
from fluvoxamine, says Dr. Price, are 
nausea, mild headaches, restlessness and, 
in cases of long-term use, sedation. 
West Haven VA-Yale 
Team Identify 
New Hormone 
A research team collaborating at the Vet¬ 
erans Administration Medical Center in 
West Haven and School of Medicine has 
identified a new hormone that regulates the 
amount of calcium in the human skeleton. 
In doing so, the Yale-West Haven VA team 
solved a puzzle that has eluded scientists 
since the 1940s. 
This hormone—HHM factor, or humoral 
hypercalcemia of malignancy factor—re¬ 
moves calcium from bones and transfers it 
to the bloodstream, sometimes in exces¬ 
sively high concentrations, which in turn 
may lead to kidney failure, coma and death 
The process also can lead to bone calcium 
loss similar to osteoporosis. “We hope the 
information about this new hormone will 
provide a useful tool for figuring out the 
amount of calcium in bones and what os¬ 
teoporosis is about," says Dr. Andrew F. 
Stewart, associate professor of medicine at 
the School of Medicine and chief of endo¬ 
crinology at the VA Medical Center. 
To study HHM factor, the team examined 
cancerous tumors from 20 patients, ex¬ 
tracted the hormone, and purified it. 
“Healthy tissues make only small amounts 
of HHM factor; but, for unknown reasons, 
cancerous tumors produce large amounts of 
the hormone,” Dr. Stewart says. 
Abnormally high calcium concentrations 
in blood may occur in many patients with 
lung cancer, breast cancer, leukemias, 
gynecologic cancers and other tumors. 
“This new hormone, which transfers cal¬ 
cium from bones to the bloodstream, may 
help explain why tumors grow in some 
cancer patients,” Dr. Stewart says. “We 
don't know whether this HHM factor is ac¬ 
cidentally made by the tumors or whether 
the factor may be responsible for the 
tumors.... That’s another question we are 
going to work on.” 
Dr. Stewart envisions that physicians 
eventually may use the hormone as a means 
to diagnose the cause of hypercalcemia— 
abnormally high calcium concentrations in 
human blood—and as a test to screen for 
cancer. For cancer patients with elevated 
calcium, physicians may be able to follow 
HHM factor levels to determine the pa¬ 
tients’ responses to therapy. 
Dr. Stewart says that identification of this 
hormone implies that a gene exists to code 
for HHM factor. “The next step is to iden¬ 
tify that gene and to study what turns it on 
and off. We also want to look more closely 
at the relationship between the gene and 
cancer. This work is being conducted by 
Dr. Arthur E. Broadus, associate professor 
of medicine (endocrinology) and chief of 
the endocrine division at the School of 
Medicine; and Marguerite S. Mangin, 
Ph.D., associate research scientist in 
medicine at Yale. 
“Now that we have identified the hor¬ 
mone, we can work to clone it and readily 
produce more of it in order to conduct 
further studies. For instance, we’d like to 
know what body activities this hormone 
regulates, where it is made and what sub¬ 
stances or systems it ‘talks’ to," the endoc¬ 
rine researcher says. 
Dr. Stewart’s group published its 
findings in a May issue of the Journal of 
Biological Chemistry’ and presented the 
work at the American Society for Bone and 
Mineral Research annual meeting. 
Grants from the National Institute on 
Diabetes and Digestive and Kidney Dis¬ 
eases and the VA Medical Center in West 
Haven have supported this research. 
Dr. Stewart started work on the newly 
identified hormone in 1978 as a postdoc¬ 
toral fellow at Yale medical school in Dr. 
Broadus’ laboratory. Drs. Stewart, Broadus 
and their colleagues have continued the 
work at the endocrine research laboratory at 
Yale and the VA Medical Center in West 
Haven. 
Besides Drs. Stewart, Broadus and Man- 
gin, the team includes; Dr. William Burtis, 
assistant professor of medicine (endocrinol¬ 
ogy) at Yale and research associate at the 
VA Medical Center; and Dr. Karl F. 
Insogna, research associate at the VA and 
assistant professor of medicine at Yale. 
Major Federal Grant 
Supports New AIDS 
Research 
A team of Yale University biomedical sci¬ 
entists has begun a major research project 
which they hope will lead to a new drug 
treatment for AIDS. 
The research project, supported by a five- 
year grant that the National Institutes of 
Health has awarded Yale University, will 
center on subcellular research to understand 
the chemical structure of AIDS virus pro¬ 
teins in order to design new drugs or im¬ 
prove existing drugs. For the first year, the 
NIH has awarded $1 million to Yale. 
“This project represents a new direction 
in biomedical science’s fight to combat the 
deadly AIDS virus.... We will approach the 
HIV virus, which causes AIDS—acquired 
immune deficiency syndrome—through the 
framework of structural biology, a relative¬ 
ly new field which seeks to understand 
the chemistry of complex biological 
molecules,” says Donald M. Engelman, 
Ph. D., the project’s principal investigator. 
He also is professor and chairman of the 
Yale department of molecular biophysics 
and biochemistry and professor of biology. 
“With five years of federal support for 
our research, we see an opportunity for our 
basic scientific skills to be useful in helping 
to solve an important problem: how to keep 
millions of people from dying from this 
relentless disease,” Professor Engelman 
says. 
According to Halvor G. Aaslestad, 
Ph. D., assistant dean for research adminis¬ 
tration in the School of Medicine, this pro¬ 
gram project grant is the largest that the NIH 
has awarded Yale for basic AIDS research. 
The Yale group that Engelman leads is 
one of six funded by the NIH and managed 
by the National Institute of General Medical 
Sciences. Three other groups are based at 
universities: the University of California at 
San Francisco and at Los Angeles and 
Harvard University. Two laboratories are 
located at companies, including Agouron 
Pharmaceuticals Inc., La Jolla, Calif.; and 
SmithKline & French Laboratories, Inc., 
Swedeland, Pa. 
In conducting the research to determine 
the structure of protein molecules—which 
the virus uses to infect a cell and to make 
more virus—the Yale scientists plan to use 
the sophisticated technology of protein 
crystallography, which involves growing 
crystals of certain proteins and studying 
their structures by x-ray scattering. In doing 
so, the researchers will use techniques 
which omit human subjects or animals. 
According to Engelman, the Yale re¬ 
searchers want to map where each atom is 
located among the thousands of atoms that 
determine the protein’s chemical structure. 
“We will design new drugs that will fit 
chemically and stick to the protein we are 
studying, and perhaps successfully block 
the protein’s function,” says Engelman, a 
biophysicist who was named chairman of 
the molecular biophysics and biochemistry 
department in July. The department in¬ 
cludes faculty in Arts and Sciences and in 
the School of Medicine. 
A newly designed drug could possibly 
work in several ways, Engelman explains. 
“A drug either could stop the HIV virus 
from getting into cells, or it could block key 
steps necessary for the virus to grow within 
cells. The latter approach may be more use¬ 
ful for people with advanced cases of 
AIDS.” 
Engelman cautions that the progress of 
this basic scientific research may take many 
years, but he points out that AIDS has a long 
time-course. “AIDS often appears 10 to 15 
years after a person has been infected, so 
Dr. Donald Engelman 
even a solution which may take five or more 
years to develop still could be very useful,” 
he says. 
Yale scientists will pursue four main 
areas of laboratory research. Dr. William 
C. Summers, M.D., Ph.D., professor of 
therapeutic radiology, human genetics and 
molecular biophysics and biochemistry, 
and his colleagues will clone or copy indi¬ 
vidual HIV proteins and produce them in 
large quantities, either in E. coli or in cell 
culture systems. 
Then, they will purify the cloned protein 
and give it to Thomas A. Steitz, Ph D., 
professor of molecular biophysics and 
biochemistry, and his laboratory col¬ 
leagues, who plan to study the protein by 
using x-ray diffraction. 
Frederic M. Richards, Ph D., Henry 
Ford II Professor of Molecular Biophysics 
and Biochemistry, will conduct theoretical 
studies leading to drug designs. His work 
will be based on the previous structural 
studies. Finally, Engelman and his group 
will study the proteins responsible for get¬ 
ting the virus into cells. 
The four principal scientists will direct 
research in their own laboratories. In addi¬ 
tion, they will use the protein chemistry lab¬ 
oratory that Kenneth R. Williams, Ph.D., 
senior research scientist in molecular 
biophysics and biochemistry, heads in the 
Sterling Hall of Medicine and the Center for 
Structural Biology in Kline Biology Tower. 
HIV virus falls within a family of viruses 
called retroviruses. These RNA-contain- 
ing tumor viruses include herpes and such 
cancers as sarcomas, leukemias and lym¬ 
phomas. 
“If we learn how to deal with the HIV 
virus, then there may be other applications 
for our findings,” says Engelman. "Be¬ 
cause this work is fundamental, it poten¬ 
tially opens an entirely new direction in 
thinking about viral problems.” 
Human Genetics Opens 
DNA Diagnostic Lab 
The department of human genetics has 
opened a new DNA Diagnostic Laboratory 
that uses sophisticated recombinant DNA 
technology to test for three severe genetic 
disorders. 
The disorders are fragile X associated 
mental retardation, the most common cause 
of inherited mental retardation; X-linked 
muscular dystrophy and an enzyme defi¬ 
ciency of ornithine transcarbamylase, 
(OTCase). 
“In establishing this new laboratory, we 
will widen the coverage of available genetic 
services in the New England area,” says 
Carolyn W. Slay man, Ph. D., professor and 
chairman of human genetics and professor 
of physiology. 
The new laboratory expands the com¬ 
prehensive genetic services that physicians 
and other health professionals in human 
genetics offer at the Yale School of 
Medicine. Two other laboratories provide 
biochemical and cytogenetic chromosome 
analysis. Counseling services also are avail¬ 
able. 
Until recently, prenatal detection and 
diagnosis of single gene disorders have 
been limited. In less than 200 of approxi¬ 
mately 2,000 known genetic diseases, the 
defect has been identified. However, for 
more than 20 years, microscopic techniques 
to detect abnormal chromosomes in chil¬ 
dren with physical or mental abnormalities 
or in unborn fetuses have been available. 
“The genetic diseases for which the Yale 
lab will test and other genetic diseases make 
a significant impact on health care facilities 
and medical support,” Dr. Slayman notes. 
“In many cases, retarded or handicapped 
individuals with these genetic diseases re¬ 
quire considerable care. ” 
“The DNA Diagnostic Laboratory will 
apply newly developed techniques to detect 
inherited changes in DNA directly or to use 
naturally occurring variations in human 
DNA—called RFLPs, restriction fragment 
length polymorphisms—to track the sec¬ 
tion of the chromosome carrying the mutant 
gene from generation to generation within 
families,” explains Maurice J. Mahoney, 
M D., professor of human genetics, pediat¬ 
rics and obstetrics and gynecology. He also 
is acting director of the new laboratory. 
“This laboratory will allow both carrier de¬ 
tection and prenatal diagnosis to be possible 
in those families where it is appropriate to 
apply the tests,” Dr. Mahoney adds. 
The genes that cause the three inherited 
diseases for which the new laboratory will 
test are located on the larger of the two sex 
chromosomes, the “X," according to Pat¬ 
ricia D. Murphy, Ph D., assistant director 
of the laboratory. 
Consequently, males, who have sex 
chromosome constitution XY, have the mu¬ 
tation on their only X chromosome. They 
are seriously affected by the disruption the 
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disease gene causes. Females, who have 
sex chromosome constitution XX, can be 
carriers of the mutant gene on one X, but be¬ 
cause they have a normal copy of the gene 
on the other X, they are rarely and only 
mildly affected. Dr. Murphy explains. 
Located on the third floor of the William 
Wirt Winchester Building, the new labora¬ 
tory has been partially supported by a 
$150,000 grant from the Johnson & 
Johnson Co. of New Brunswick, N.J. The 
three-year grant comes from the corpora¬ 
tion’s focused giving program. 
In the future, the laboratory staff antici¬ 
pates adding tests for other disorders, such 
as cystic fibrosis, adult polycystic kidney 
disease, myotonic dystrophy and neurofi¬ 
bromatosis, according to Dr. Murphy, who 
holds a doctorate in human genetics. 
The laboratory also will serve as a site to 
test improved and new diagnostic proce¬ 
dures that members of the human genetics 
department develop, she adds. 
National health statistics show that one in 
1,500 to 2,000 men has marker X or fragile 
X syndrome. Mental deficit (IQ of 50 to 
60), hyperactivity, large and often protrud¬ 
ing ears and enlarged testicles characterize 
this syndrome. 
Females who carry the gene are relatively 
frequent, one in 700 to 1,000. These carrier 
women—whether or not they express the 
marker—are at increased risk of having 
some degree of mental retardation or learn¬ 
ing disability themselves. 
The gene that causes the two major forms 
of muscular dystrophy—Duchenne and 
Becker types—resides in another region of 
the X chromosome. These diseases occur in 
approximately one in 3,300 children. 
Women may be carriers of the gene. The 
disorder usually is first noticed when the 
child is learning to walk. The child may ex¬ 
perience progressive muscle weakness, 
until he is confined to a wheelchair. 
This confinement occurs about age 10 in 
the more severe form of muscular dys¬ 
trophy—Duchenne type—and later in the 
Becker type Boys with the Duchenne form 
have significantly shortened lifespans. 
Women who carry the gene rarely show any 
physical signs of the disorder, but half of 
theirsons will have muscular dystrophy. 
OTCase deficiency is less common. Male 
children born with the mutation die of am¬ 
monia poisoning within hours or days of 
birth. Girls who carry the gene occasionally 
can show somewhat milder symptoms. 
They require careful monitoring to prevent 
permanent brain damage due to high am¬ 




Adults disabled by psychiatric illness are 
learning to become productive workers in 
their communities, thanks to a transitional 
program available through the Yale Psychi¬ 
atric Institute. 
The Community Work Adjustment Pro¬ 
gram, part of the YPI Community Services 
Division, is designed for people who have 
been out of work for a long time or for those 
who have attempted jobs without success. 
“Our typical client has been in and out of 
psychiatric hospitals for 10 or more years, 
with psychiatric diagnoses that include 
schizophrenia, major affective disorders 
and personality disorders,” says Dr. Ira R. 
Levine, associate clinical professor of psy¬ 
chiatry at the medical school and senior 
clinical consultant to the Community Ser¬ 
vices Division. 
Community Services Division director 
W. Leonard Hill Jr., M.Div., M.S.W., ex¬ 
plains: “When clients come to us, they are 
relatively stable but are often still struggling 
with residual symptoms of prolonged men¬ 
tal illness. We have found that helping pa¬ 
tients re-enter the working world not only 
moves them closer to the goal of making 
them contributing members of society, but 
has the added benefit of considerably en¬ 
hancing their self-esteem 
Hill also is assistant clinical professor of 
psychiatry (social work) at the School of 
Medicine, and director of social work and 
coordinator of the family therapy program 
at YPI 
The work adjustment program teaches 
basic employment skills, such as getting up 
on time; calling employers to report lateness 
or absences; getting along with co-workers; 
accepting supervision; problem-solving on 
the job; learning to manage stress in the 
workplace; improving speed and stamina; 
and developing good grooming habits. 
The program offers a continuum of ser¬ 
vices. Initially, the “Workplace,” a voca¬ 
tionally oriented day treatment program, 
combines a protected work environment 
with group and individual counseling. 
From the “Workplace,” clients can move 
to unpaid, transitional employment in New 
Haven worksites—including the Salvation 
Army Thrift Shop and the Jewish Home for 
the Aged—that provide training oppor¬ 
tunities for the program’s clients. An addi¬ 
tional network of 60 agencies, including 
hospitals, museums, libraries, animal shel¬ 
ters and other social service organizations, 
supervise client-volunteers. 
Clients who go on to paid employment 
may fine-tune their work skills through a job 
maintenance program that includes indi¬ 
vidual counseling and job groups. For some 
patients, the work adjustment program co¬ 
ordinates services with the state Division of 
Rehabilitative Services, providing evalua¬ 
tion, placements and follow-up vocational 
services. 
“Counseling is the key to the success of 
this program,” says Hill. “Instead of feel¬ 
ing like mental patients, participants learn 
to identify themselves as workers. 
“By tailoring the program to individu¬ 
als," he adds, “we help the clients to find 
the niches where they function best. One of 
the program’s strengths is its diverse clien¬ 
tele—the Community Work Adjustment 
Program serves patients from all socio¬ 
economic backgrounds. ” 
In addition to its program for adults, the 
work adjustment program provides work¬ 
readiness services for adolescents through 
a joint venture with Yale’s Cedarhurst 
School, a special education secondary 
school in Hamden. 
A year ago, the Community Work Ad¬ 
justment Program received a grant from the 
State Department of Mental Health for work 
services through the Consortium of Com¬ 
munity Support Providers—a network of 
New Haven area agencies that provide as¬ 
sistance to people with disabilities. Funding 
for individual clients also comes from 
the Division of Rehabilitative Services, 
the Veterans Administration and private 
sources. 
Of the 20 clients referred by the consor¬ 
tium to the program, five have already 
moved on to competitive employment, 
where they are receiving a regular 
paycheck. “Others are moving in a similar 
direction,” says YPI Community Services 
Division director Hill. 
FACULTY NEWS 
Adrian M. Ostfeld, M.D., and Alan C. 
Sartorelli, Ph D., have been elected mem¬ 
bers of the Institute of Medicine, chartered 
in 1970 by the National Academy of Sci¬ 
ences to enlist distinguished members of the 
medical profession to examine policy mat¬ 
ters pertaining to the public’s health. 
Dr. Ostfeld is Anna M.R. Lauder Profes¬ 
sor of Epidemiology and Public Health, 
while Sartorelli is professor of pharmacol¬ 
ogy and director of the Yale Comprehensive 
Cancer Center. 
Dr. Michele Barry, associate professor 
of medicine at the School of Medicine and 
an attending physician at Yale-New Haven 
Hospital, has been selected to receive a 
W.K. Kellogg Foundation National Fellow¬ 
ship Award. 
Dr. Barry is one of 45 outstanding Amer¬ 
ican professionals who will pursue learning 
outside their area of expertise. Each Kel¬ 
logg fellow receives a three-year grant of 
$30,000 to fund his or her plan of study. 
Dr. Barry set up exchange programs for 
Yale physicians-in-training in Haiti and 
Tahzgania. In January she will return to Af¬ 
rica on a six-month sabbatical at the Univer¬ 
sity of Zimbabwe, where she will be visit¬ 
ing professor of medicine. 
At Yale, Dr. Barry serves as co-director 
of the International Travelers Clinic and the 
tropical medicine program, which she 
helped develop within the department of in¬ 
ternal medicine. She is founder and director 
of the Southeast Asian Refugee Health Care 
Clinic at Yale-New Haven Hospital. 
At commencement in May, Bank Street 
College of Education presented an honorary 
Doctor of Humane Letters degree to Dr. 
James P. Comer for his “exceptional ser¬ 
vice to children outside formal educational 
settings.” Dr. Comer, the Maurice Falk 
Professor in the Child Study Center and 
Psychiatry and associate dean for students, 
has worked with and written extensively 
about children, especially black children. 
He strongly advocates more humane set¬ 
tings for growth and learning. 
Dr. Kerry Cooper ’79, assistant clinical 
professor of medicine, was selected by first 
year assistant residents to receive the Be¬ 
nedict R. Harris Award, an award given an¬ 
nually to the physician who has contributed 
the most to teaching of house staff at Yale- 
New Haven Hospital. 
Dr. Ralph A. DeFronzo, associate pro¬ 
fessor of medicine, has received the 1987 
American Diabetes Association Award for 
Outstanding Scientific Achievement by a 
Young Investigator. The award, sponsored 
by Eli Lilly and Company, was presented at 
the association’s 47th annual meeting on 
June 6 in Indianapolis. Dr. DeFronzo has 
concentrated his efforts in the pathogenesis 
and treatment of non-insulin dependent 
(Type II) diabetes. 
Nigel D.F. Grindley, Ph D., professor 
of molecular biophysics and biochemistry, 
was one of 273 artists, scientists and schol¬ 
ars selected as a Guggenheim Fellow 
for 1987. Guggenheim fellowships are 
awarded for distinguished achievement and 
exceptional promise for future accomplish¬ 
ment. Grindley’s research will focus on 
protein-DNA complexes active in recombi¬ 
nation. 
Dr. Bernard Lytton, professor of 
surgery (urology), was named master of 
Jonathan Edwards College, oneof Yale’s 12 
residential colleges for undergraduates. His 
appointment was effective July 1. Dr. Lyt¬ 
ton is chief of the section of urology at Yale- 
New Haven Hospital and the Veterans Ad¬ 
ministration Medical Center in West Haven. 
In 1985, he received the American Urologi¬ 
cal Association’s Hugh Hampton Young 
Award for his contributions to urology. 
Donald M. Quinlan, Ph D., professor 
of psychiatry (psychology), was appointed 
master of Morse College, an undergraduate 
residential college at Yale, on July 1. Quin¬ 
lan, whose research focuses on psychologi¬ 
cal diagnostic testing, is chief psychologist 
at Yale-New Haven Hospital. He and Sid¬ 
ney J. Blatt, Ph.D., professor of psychiatry 
and psychology, are editing a book on 
depression. 
Robert Donaldson 
Named Deputy Dean 
Dr. Robert M. Donaldson Jr., acting chair¬ 
man of the School of Medicine’s depart¬ 
ment of internal medicine, became the 
school’s deputy dean on Sept. I. 
In announcing the appointment. Dr. 
Leon E. Rosenberg, dean of the School of 
Medicine, says "Bob Donaldson possesses 
lengthy experiences in medical administra¬ 
tion, both at Yale-New Haven Medical Cen¬ 
ter and the Veterans Administration Medi¬ 
cal Center in West Haven. He has been a 
creative laboratory scientist, a devoted 
teacher of students and residents and an 
excellent clinical chief. He leads by 
exemplary personal behavior, and he is 
committed to the highest standards of pa¬ 
tient care, research and education. ” 
Dr. Donaldson succeeds Dr. Arthur Eb- 
bert Jr., who has relinquished the dean’s 
office position to take a sabbatical leave of 
absence. Dr. Ebbert, professor of medicine, 
was the school’s first deputy dean, holding 
the position from 1974 through Aug. 31, 
1987. He also has been assistant and as¬ 
sociate dean, serving for 34 years in the 
dean’s office at Yale. “His contributions 
Dr. Robert Donaldson 
are extraordinary, and his unparalleled 
record of service and leadership will never 
be surpassed," says Dr. Rosenberg. 
Dr. Donaldson, the David Paige Smith 
Professor of Medicine, joined the Yale med¬ 
ical faculty in 1973 as professor and vice 
chairman of the department of internal 
medicine. Between 1973 and 1982, he was 
chief of the medical service at the Veterans 
Administration Medical Center in West 
Haven. For 20 months, he was acting chair¬ 
man of Yale's department of internal 
medicine. 
In his research and patient care activities, 
Dr. Donaldson has focused on the sub¬ 
specialty of gastroenterology. He has con¬ 
ducted basic research concerned with gas¬ 
tric function, vitamin B12 transport and 
intestinal bacteria. He also has performed 
clinical studies related to peptic ulcer dis¬ 
ease, liver disease and the diagnosis of gas¬ 
trointestinal disorders. 
Active in many professional societies. 
Dr. Donaldson served as president of the 
American Gastroenterological Association 
in 1979-80. He also has served on several 
advisory committees of the National Insti¬ 
tutes of Health. From 1970 to 1977, he 
served as editor of the scientific publication 
Gastroenterology and is now chairman of 
the journal’s editorial board. 
A native of Wellesley, Mass., Dr. 
Donaldson received a B.S. degree with high 
orations in 1949 from Yale University and 
an M.D. degree cum laude in 1952 from 
Boston University. After medical school, 
he interned at Montreal General Hospital 
and completed residency training at the Vet¬ 
erans Administration Hospital in Boston. 
He was a postdoctoral fellow in gastroen¬ 
terology at Peter Bent Brigham Hospital. 
He also served on the faculty at Boston Uni¬ 
versity, where he directed the gastroenterol¬ 
ogy division from 1967 to 1973. 
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Dr. Bernard Forget 
Forget Named 
New Associate Dean 
Dr. Bernard G. Forget, professor of 
medicine and of human genetics at Yale, has 
been appointed to the newly created posi¬ 
tion of associate dean for research affairs at 
the medical school, effective Nov. 1. 
“Bernard Forget is a distinguished 
molecular hematologist, a longstanding in¬ 
stitutional leader and a man of broad vision 
and principle. He will combine his new ad¬ 
ministrative responsibilities with his re¬ 
search efforts,” says Dr. Leon E. Rosen¬ 
berg, dean, in announcing the appointment 
Dr. Forget came to New Haven in 1976 
as associate professor of medicine and of 
human genetics and as chief of the hematol¬ 
ogy section in the department of internal 
medicine in the School of Medicine and at 
Yale-New Haven Hospital. He was named 
professor in 1978. 
During this time, he has centered his re¬ 
search on the molecular genetics of globin 
gene expression and genes for the red cell 
membrane protein called spectrin. 
Since 1985, he also has directed the phy¬ 
sician scientist research training program in 
the School of Medicine. He also serves as 
a member of the NIH’s Heart, Lung and 
Blood Research Review Committee. 
The author of more than 150 scientific 
publications, Dr Forget co-authored, with 
Dr. H. Franklin Bunn, professor of 
medicine at Harvard Medical School, the 
textbook Hemoglobin Molecular, Genetic 
and Clinical Aspects, published last year. 
I Ic also serves as an editorial board member 
lora number of journals. 
Dr Forget has been elected a member of 
American Society for Clinical Investi¬ 
gation and the Association of American 
Physicians. Before joining the Yale faculty. 
Dr. Forget taught at Harvard Medical 
School and was an attending physician at 
the Children’s Hospital Medical Center in 
Boston. 
A native of Rhode Island, Dr. Forget re¬ 
ceived an A.B degree in 1959 from the 
University of Montreal and an M.D. degree 
in 1963 from McGill University. He com¬ 
pleted residency training at the Massa¬ 
chusetts General Hospital in Boston, and 
between 1968 and 1971 conducted research 
as a fellow at the National Institutes of 
Health and the Children’s Hospital Medical 
Center. 
Two Designated 
As Harris Professors 
Dr James Leckman and Dr. Fred R. Vol- 
kmar were named to endowed professor¬ 
ships. Dr Leckman is the Neison Harris 
Associate Professor of Child Psychiatry and 
Pediatrics, and Dr. Fred R Volkmar is the 
Harris Assistant Professor of Child Psychi¬ 
atry, Pediatrics and Psychology. 
The Harris professorships are part of the 
new ly created Harris Program in Child Psy¬ 
chiatry, Child Development and Social Pol¬ 
icy, established last year at the Child Study 
Center with a $5 million gift from Yale 
alumni Irving B Harris and his brother 
Neison Harris, both of the Chicago area. 
Dr. Leckman is the research coordinator 
at the Child Study Center. His research in¬ 
volves children with severe developmental 
disorders and the relationship between 
genetic and environmental factors in the 
transmission and expression of those disor¬ 
ders. Dr. Leckman also serves as associate 
program director of the Children’s Clinical 
Research Center, a five-bed research unit 
funded by the National Institutes of Health. 
Dr. Volkmar’s work stresses the impor¬ 
tance of basic child development research 
on understanding clinical disorders. His re¬ 
search centers on investigations of develop¬ 
mental psychopathology in infants and chil¬ 
dren under age five, and studies of severe 
developmental disorders. He also is con¬ 
cerned with custody issues, developmental 
assessment and psychiatric diagnosis. 
Two Become 
Emeritus 
Dr. Nicholas M. Greene, professor of 
anesthesiology and attending anes¬ 
thesiologist at Yale-New Haven Hospital 
since 1955, was named professor emeritus 
of anesthesiology July I. Dr. Greene had 
been chairman of the department of anes¬ 
thesiology from 1955 to 1973. He also 
served as a consultant in anesthesiology to 
the Veterans Administration Medical Cen¬ 
ter in West Haven, Stamford Hospital and 
Waterbury Hospital. Dr. Greene has been 
editor-in-chief of the journal Anesthesia & 
Analgesia since 1977. From 1975 to 1978 
and from 1980 to 1982, he served on the 
School of Medicine admissions committee. 
Dr. Greene is an honorary fellow of the 
Faculty of Anaesthetists of the Royal Col¬ 
lege of Surgeons and an honorary member 
of the Japan Society of Anesthesia. 
Dr. David Seligson, a member of the 
School of Medicine faculty for 29 years, 
was named professor emeritus July I. Dr. 
Seligson was chairman of the department of 
laboratory medicine from 1971 to 1984. He 
also was director of clinical laboratories at 
Yale-New Haven Hospital from 1958 to 
1984. 
Dr. Seligson is a member and past presi¬ 
dent of the Academy of Clinical Laboratory 
Physicians and Scientists and the American 
Association of Clinical Chemists, and has 
been honored by both organizations for out¬ 
standing contributions to his field. 
Noted Pediatrician 
Assumes Chairmanship 
Dr. Joseph B. Warshaw has been appointed 
professor of pediatrics and chairman of the 
department of pediatrics at the School of 
Medicine, and chief of pediatrics at Yale- 
New Haven Hospital. His appointment was 
effective Aug. 1. 
He succeeds Dr. Howard A. Pearson, 
professor of pediatrics, who stepped down 
as chairman to rejoin the pediatric hematol¬ 
ogy division and continue his research on 
sickle cell disease and thalassemia. 
Dr. Warshaw was an associate professor, 
then a professor of pediatrics and obstetrics 
and gynecology at the medical school from 
1973 to 1982. He also was director of the di¬ 
vision of perinatal medicine at Yale-New 
Haven Medical Center and director of the 
newborn special care unit at the hospital 
during the same period. 
“We are pleased to have Dr. Warshaw 
back at Yale,” says Dr. Leon E. Rosenberg, 
dean of the School of Medicine. “He is a 
distinguished clinician, teacher, adminis¬ 
trator and investigator who has made major 
contributions to care of the newborn. ” 
Dr. Warshaw is returning to Yale from 
Texas, where he has been the George L. 
MacGregor Professor of the pediatrics de¬ 
partment at the University of Texas Health 
Science Center at Dallas, Southwestern 
Medical School, since 1984. He has been in 
Texas since 1982 as chairman of the Univer¬ 
sity of Texas pediatrics department, chief 
of staff at Children's Medical Center of 
Dallas, and chief of pediatrics at Parkland 
Memorial Hospital. 
“Dr. Warshaw is recognized internation¬ 
ally for his research on metabolic influences 
on fetal growth and development. There is 
no doubt that he is an outstanding leader in 
academic pediatrics and especially in the 
field of perinatal medicine. He was the 
unanimous choice of our search commit¬ 
tee," says Dean Rosenberg. 
In December 1986, Dr. Warshaw was ap¬ 
pointed to a four-year term on the National 
Advisory Child Health and Human De¬ 
velopment Council of the National Insti¬ 
tutes of Health. He is a member of the re¬ 
search advisory committee of the National 
March of Dimes Foundation; the committee 
on research of the American Academy of 
Pediatrics; the scientific advisory commit¬ 
tee of The Hospital for Sick Children in To¬ 
ronto, Canada; and the scientific advisory 
board of the St. Jude Children’s Research 
Hospital in Memphis, Tenn. 
Dr. Warshaw received his M.D. degree 
in 1961 from Duke University Medical 
School. He is a native of Miami, Fla. 
GALLERY 
Mr. O’Brien the Irish Giant the Tallest Man in the 
Known World Being Near Nine Feet High 
by John Kay (Scottish, 1742-1826) 
Patrick O’Brien, bom Patrick Cotter in 1760, is thought to have stood 8 feet 1 inch, 
somewhat less than the “near nine feet” which he claimed. Nevertheless, Cotter’s 
genuine stature, together with his personality and keen business sense, contributed to 
his becoming a celebrity. Adopting the name O’Brien, he advertised, as did other tall 
Irishmen, lineal descent from “the old and puissant king Bryan Boreau,” a hero of the 
11th century. In an age when many who suffered pituitary abnormalities were exploited 
by entrepreneurial showmen. Cotter assumed control of his own fortune. He acquired 
significant means by appearing at fairgrounds and in private showrooms where he 
collected one to two shillings for admission. When he visited Edinburgh in 1803 and 
was fitted for a greatcoat by a diminutive tailor, the event aroused great public curiosity 
which was duly addressed by the most popular printmaker of the city with the etching 
shown here. Shortly thereafter, symptoms resulting from Cotter’s acromegaly became 
debilitating and he retired from public life. He died in 1806. 
John Kay, the artist, apprenticed as a barber and was a member of Edinburgh’s 
Society of Surgeon-Barbers until he closed his prosperous shop to devote his full 
energies to portraiture and printmaking. His print is one of many representing the 
range of human dimensions to be found in the Clements C. Fry Collection of the Yale 
Medical Library.— Susan Wheeler 
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ALUMNI NEWS 
Dr. Myron E. Wegman '32, dean emeritus 
of the University of Michigan School of 
Public Health, received the 1986 National 
Sanitation Foundation’s Spes Hominum 
Award for his work as an environmentalist. 
Helen M. Tepperman ’42 PhD., and 
her husband. Dr. Jay Tepperman, received 
honorary Doctor of Science degrees at com¬ 
mencement at the State University of New 
York, Health Science Center at Syracuse. 
The Teppermans are professors emeriti of 
pharmacology at the SUNY Health Science 
Center Dr. Jay Tepperman was associated 
with the Yale medical school from 1940 to 
1944. 
Dr. Walter J. Burdette '42 presented a 
paper on “The Role of the Surgeon in the 
Management of Immune Deficiency Syn¬ 
drome” at the first Beijing Conference on 
General Surgery in the People’s Republic of 
China. Dr. Burdette, a general and thoracic 
surgeon in Houston, previously was chair¬ 
man of the departments of surgery at the 
Universities of Missouri and Utah and as¬ 
sociate director (research) at the University 
of Texas M.D. Anderson Hospital and 
Tumor Institute. 
Dr. R. Leonard Kemler ’43, associate 
clinical professor of surgery at the Univer¬ 
sity of Connectcut School of Medicine since 
Oct. 1, 1986, is president-elect of the 
Hartford County Medical Association. He 
will assume the presidency on April 20, 
1988. 
The Association of Community Cancer 
Centers presented its annual award for out¬ 
standing contribution to community cancer 
care to Dr. Robert Frelick '44. Frelick, a 
former ACCC president and one of its foun¬ 
ders, retired in July as National Cancer In¬ 
stitute program director of the Community 
Clinical Oncology Program. 
Dr. Robert E. Cooke ’44, professor and 
chairman of the department of pediatrics at 
the State University of New York at Buffalo 
School of Medicine, gave the keynote ad¬ 
dress at the National Institute of Child 
Health and Human Development 25th an¬ 
niversary program on Sept. 21 in Bethesda. 
Dr. Cooke, who was instrumental in creat¬ 
ing the institute—one of the 12 National In¬ 
stitutes of Health—presented his recollec¬ 
tions of the conceptualization and founding 
of the NICHD Dr Cooke also is chairman 
of the Scientific Advisory Committee of the 
Joseph P. Kennedy, Jr. Foundation. Dr. 
( ooke was a member of the Yale medical 
faculty from 1950 until 1956, serving as as¬ 
sociate professor of pediatrics and physiol¬ 
ogy when he resigned in 1956. 
The American College of Allergists, at 
its 42nd annual congress in March, created 
the John P. McGovern Society to honor Dr. 
John P. McGovern 46 HS, a past presi¬ 
dent of the ACA. In May, Pan American 
University, Edinburg, Texas, awarded its 
first honorary doctorate to Dr. McGovern, 
founder and chief consultant to the 
McGovern Allergy Clinic in Houston. 
Dr. Paul Talalay ’48, the John Jacob 
Abel Distinguished Service Professor in the 
department of pharmacology and molecular 
science at Johns Hopkins University School 
of Medicine, was elected to the National 
Academy of Sciences in April. 
Dr. David B. Skinner ’59 was named to 
the newly created position of president and 
chief executive officer of New York Hospi¬ 
tal, effective Oct. 1. The hospital, founded 
in 1771, has a total of 1,460 beds at its Man¬ 
hattan and Westchester locations. 
Col. William H. Heydorn ’ 59 is com¬ 
mander of the Letterman Army Medical 
Center at the Presidio of San Francisco. 
Col. Heydorn previously was chief of 
surgery at the hospital, one of eight U.S. 
Army medical centers. 
Dr. Muriel D. Wolf ’59, associate pro¬ 
fessor of pediatric cardiology at George 
Washington University School of Medicine 
in Washington, D C., has completed a term 
as the first woman president of the 
Washington Yale Club. 
At the annual meeting in San Diego, on 
Sept. 29, the American College of Radiol¬ 
ogy Board of Chancellors awarded Dr. 
Royal C. Hudson Jr. ’61, of Lincoln, R.I., 
a fellowship for his outstanding contribu¬ 
tions to the field of radiology. 
Dr. Robert I. Levy ’61, senior associate 
vice president for health sciences at Colum¬ 
bia University College of Physicians and 
Surgeons, has been named vice president 
for biomedical research for the Association 
of American Medical Colleges. His ap¬ 
pointment is effective Jan. 1,1988. 
In January 1987, New Jersey Gov. 
Thomas Kean awarded Dr. Leon Smith ’62 
HS, of Essex Fells, N.J., the first annual 
Clara Barton Medical Service Award for 
“outstanding effort and contributions to the 
welfare of human life.” Dr. Smith is direc¬ 
tor of medicine and chief of infectious dis¬ 
ease at Saint Michael’s Medical Center in 
Newark. 
Dr. Charles B. Anderson '62 serves as 
professor and chief of the division of gen¬ 
eral surgery at the Washington University 
School of Medicine and general surgeon-in¬ 
chief at Barnes Hospital, both in St. Louis. 
Dr. John T. Harrington ’62. professor 
of medicine at Tufts University School of 
Medicine, was appointed chief of medicine 
at Newton-Wellesley Hospital, a teaching 
affiliate of Tufts University School of 
Medicine, June 1, 1986. 
In an April 26 feature story. The New 
York Times asked prominent New Yorkers 
to predict which people, in their respective 
fields, will make a difference in the future 
of New York. For medicine. Dr. Mathilde 
Krimm, the founding co-chairwoman of the 
American Foundation for AIDS Research 
and an associate research scientist at St. 
Luke’s-Roosevelt Hospital Center and at 
Columbia University College of Physicians 
and Surgeons, selected Dr. Stephen C. 
Joseph ’63, New York City Commissioner 
of Health. Says Dr. Krim, "He's a humane 
person. He has an appropriate view of the 
relations of AIDS to socioeconomic prob¬ 
lems, such as the prevalence of AIDS in 
poverty.” 
Dr. Helen L. Smits ’67, of Essex, 
Conn ., has been appointed director of John 
Dempsey Hospital at the University of Con¬ 
necticut Health Center in Farmington. Dr. 
Smits, who was interim director since May 
1, 1986, is the fourth person and first physi¬ 
cian to direct the 232-bed hospital, which 
opened in 1979. It is the university's teach¬ 
ing hospital. 
Dr. John D. Baxter ’66, chief of the di¬ 
vision of endocrinology at the University of 
California at San Francisco, received the 
Medical Society of the State of New York's 
Albion O. Bernstein, M.D Award for 
pioneering work applying molecular and 
cell biology to the field of endocrinology. 
Elizabeth H. Avery ’68 M.P.H. of 
Gwynedd Valley, Pa., has become presi¬ 
dent and chief executive officer of The Lan- 
kenau Hospital and The Lankenau Hospital 
Foundation in Philadelphia. Her appoint¬ 
ment was effective June 22. 
Dr. Robert H. Posteraro '73, of Lub¬ 
bock, Texas, an associate professor in the 
department of radiology at Texas Tech Uni¬ 
versity Health Sciences Center School of 
Medicine, was elected to Sigma Xi and pro¬ 
moted to lieutenant colonel in the U.S. 
Army Reserve. 
Dr. Alvin H. Strelnick ’75, deputy 
chairman of the department of family 
medicine at Montefiore Medical Center in 
the Bronx and assistant professor in the de¬ 
partment of epidemiology and social 
medicine at the Albert Einstein College of 
Medicine, recieved a W. K. Kellogg Foun¬ 
dation fellowship. Dr. Strelnick will study 
urban communities to identify factors that 
contribute to their deterioration or vitality. 
Dr. Jeffrey L. Sklar ’77, assistant pro¬ 
fessor of pathology at Stanford University 
School of Medicine and director of the 
Molecular Diagnosis Service at Stanford 
Medical Center, and Dr. Abul K. Abbas, a 
pathologist at Harvard Medical School, 
shared the American Association of 
Pathologists 1987 Warner-Lambert/Parke- 
Davis Award, presented annually to an indi¬ 
vidual under 40 for meritorious research in 
experimental pathology. 
At a Sept. 28 convocation ceremony. 
Mount Sinai School of Medicine named Dr. 
Jon W. Gordon ’80 the G. Harold and Leila 
Y. Mathers Research Professor in Geriatrics 
and Adult Development. Dr. Gordon, as¬ 
sociate professor of molecular biology of 
geriatrics and adult development, and of 
obstetrics, gynecology and reproductive 
science at Mount Sinai, received the honor 
which recognizes his outstanding research 
in mammalian development. 
William Sabella ’83 M.P.H. was ap¬ 
pointed AIDS education coordinator and 
counselor at Yale-New Haven Hospital on 
Sept. 9. Sabella, a former state of Connect¬ 
icut AIDS coordinator, will develop risk-re¬ 
duction programs, provide AIDS education 
for the hospital staff and assist with counsel¬ 
ing individuals who test positive for HIV 
antibodies. 
Wichit Srisuphan ’83 Dr. PH. has been 
appointed dean of the faculty of nursing at 
Chian Mai University in Thailand. 
NEW BOOKS 
America's Family Support Programs, 
edited by Sharon L. Kagan, Ed.D., assis¬ 
tant professor in the Yale Child Study Cen¬ 
ter and psychiatry; Douglas R. Powell, Pur¬ 
due University; Bernice T. Weissbourd, 
Family Focus, Inc.; and Edward F. Zigler, 
Ph.D., Sterling Professor in the Yale Child 
Study Center and Psychiatry. Yale Univer¬ 
sity Press, 1987. 
Clinimetrics, by Alvan R. Feinstein, M.D. 
'54 HS, professor of medicine and 
epidemiology. Yale University Press, 1987. 
Healing AIDS Naturally, first edition, by 
Laurence Badgley, M.D. ’68, of San 
Bruno, Calif. Human Energy Press, (San 
Bruno, Calif.) 1986. 
Hospitals, Health, and People, by Albert 
W. Snoke, M.D., lecturer in public health 
and former director of Yale-New Haven 
Hospital. Yale University Press, 1987. 
The Human Vocal Tract, Anatomy, Func¬ 
tion, Development, and Evolution, by Ed¬ 
mund S. Crelin, Ph.D., D.Sc., professorof 
anatomy (surgery). Vantage Press, Inc., 
(New York, N.Y.) 1987. 
Laryngeal Function in Phonation and Re¬ 
spiration, edited by Thomas Baer, Ph.D., 
lecturer in surgery (otolaryngology); Clar¬ 
ence T. Sasaki, M.D. ’66, professor of 
surgery (otolaryngology); and Katherine S. 
Harris, Ph.D., City University of New 
York. Little, Brown and Co., (Boston, 
Mass.) 1987. 
Melancholia and Depression: From Hip¬ 
pocratic Times to Modern Times, by Stan¬ 
ley W. Jackson, M.D., professorof psychi¬ 
atry and history of medicine. Yale Univer¬ 
sity Press, 1986. 
Parents' Book for Raising a Healthy Child, 
by Morris A. Wessel, M.D. ’43, clinical 
professor of pediatrics. Ballantine Books, 
(New York, N.Y.) 1987. 
The Smoker's Book of Health: How to Keep 
Yourself Healthier and Reduce Your Smok¬ 
ing Risks, by Tom Ferguson, M.D. ’78, of 
Austin, Texas. G.P. Putnam’s Sons, (New 
York, N.Y.) 1987. 
Sports Fitness and Training, by Richard J. 
Mangi, M.D. ’68 HS, associate clinical 
professor of medicine; Peter Jokl, M.D. 
’68, professor of orthopaedics and rehabili¬ 
tation; and William Dayton, lecturer in or¬ 
thopaedics and rehabilitation. 
The Structure of Individual Psychotherapy, 
by Bernard D. Beitman, M.D. ’68, Univer¬ 
sity of Missouri-Columbia. Guilford Publi¬ 
cations, Inc. (New York, N.Y) 1986. 
Textbook of General Medicine and Primary 
Care, psychiatry section, by John Pearce, 
M.D. ’61, of Cambridge, Mass. Little 
Brown and Co., (Boston, Mass.) 1987. 
To Do No Harm, A Journey Through Medi¬ 
cal School, by Philip R. Reilly, M.D., ’81, 
Eunice Kennedy Shriver Center for Mental 
Retardation. Auburn House Publishing 
Co., (Dover, Mass.) 1987. 
Evidence, a novel, by Neil Ravin, M.D. ’81 
HS, Georgetown University School of 
Medicine. Charles Scribner’s Sons, (New 
York, N.Y) 1987. 
Second Seed, a novel, by Mary Lake Polan, 
M.D. ’75, Ph D., associate professor of 
obstetrics and gynecology. Charles 
Scribner’s Sons, (New York, N.Y.) 1987. 
OBITUARIES 
Max Alpert, M.D. 
Dr. Max Alpert ’28, of Bridgeport, Conn., 
died Aug. 3 after a brief illness. He was82. 
Bom in Russia, Dr. Alpert was educated 
at Yale and had practiced medicine in 
Bridgeport for 50 years. He is survived by 
his wife, Claire; a daughter, Rita Stein- 
berger; two brothers, Samuel and Herbert 
Alpert; and two grandsons. 
Thaddeus S. Danowski, M.D. 
Dr. Thaddeus S. Danowski ’40 died Sept. 
12 in Miami. He was a magna cum laude 
graduate of the Class of 1940 and a faculty 
member at Yale School of Medicine from 
1942 until 1947, when he resigned to 
become the Renziehausen Professor of 
Research Medicine and chairman of the 
department of research medicine at the 
University of Pittsburgh. 
Hugh L. Dwyer, M.D. 
Dr. Hugh L. Dwyer Jr. of Woodbridge, 
Conn., associate clinical professor of 
medicine, died Sept. 10 after a brief illness. 
He was the husband of Dr. Dorothea R. 
Peck ’43, associate clinical professor of 
diagnostic radiology. 
Bom in New Orleans on Aug. 21, 1917, 
Dr. Dwyer spent his childhood in Kansas 
City, Mo., and was a 1939 graduate of the 
University of Kansas. He attended the Uni¬ 
versity of Kansas Medical School and was 
graduated from Northwestern University 
Medical School in 1943. 
He trained as an intern and resident at 
Grace-New Haven Community Hospital, 
now Yale-New Haven Hospital, from 1943 
to 1948. During 1945 and 1946, he served 
as an Army Medical Corps physician with 
the Manhattan Project. He was a full-time 
faculty member at the Yale School of 
Medicine from 1948 until 1951, when he 
began his private practice. He continued his 
association with the medical school, be¬ 
coming associate clinical professor of 
medicine in 1952. 
He was president of the medical staff of 
Yale-New Haven Hospital from 1965 to 
1967 and a member of the hospital’s board 
of trustees from 1978 until 1984. As one of 
the first two physicians and the first commu¬ 
nity physician to serve as a trustee, he was 
instrumental in creating a stronger liaison 
between community physicians and full¬ 
time University physicians. 
In addition to his wife, he is survived by 
a daughter, Martha M. Dwyer; two sons, 
Hugh E. and Thomas Duane Dwyer; one 
brother, Frank Dwyer; and four sisters. 
25 
Martha Phillips, Joan O’Connor, Barbara 
O’Brien and Jeanne Lonergan. 
Memorial contributions may be made to 
the Hugh L Dwyer Memorial Fund at Yale- 
New Haven Hospital, or to the Hugh L. 
Dwyer Memorial Fund at the Yale Golf 
Course. 
ArthurS. Griswold, M.D. 
Dr. Arthur S. Griswold ’21, retired chief of 
orthopedic surgery at Bridgeport Hospital, 
died at his home in Bridgeport, Conn., on 
April 20. 
Bom of missionary parents in India, he 
came to the United States at age 12. He re¬ 
ceived his undergraduate degree from Yale 
College in 1918, and after graduating from 
the medical school in 1921, completed his 
internship at Bridgeport Hospital. In 1930, 
he became chief of orthopedic surgery. 
He is survived by his wife, Edith; two 
sons, Gordon and Robert Griswold; and five 
grandchildren. 
Seymour L. Handler, M.D. 
Dr Seymour L. Handler, associate clinical 
professor in the Yale Child Study Center 
and psychiatry since 1974, died at his home 
in Woodbndge, Conn., on May 31 after a 
long illness. He was 63. 
Dr Handler received his M.D. degree 
from the University of Louisville School of 
Medicine in 1950, and came to Yale in 1959 
as a resident in psychiatry. Dr. Handler also 
was a faculty member and former president 
of The Western New England Institute for 
Psychoanalysis. 
He is survived by his wife, Estelle; three 
sons, Michael, Robert and Thomas Hand¬ 
ler; a daughter, Margaret; and four grand¬ 
children 
James G. Hirsch, M.D. 
Dr. James G. Hirsch of New York City, co- 
chairman of the Campaign for the Yale 
School of Medicine, a successor trustee of 
the Yale Corporation and a member of the 
Yale Development Board, died May 25 at 
Memorial Sloan-Kettering Cancer Center in 
New York. He was 64. 
A biological scientist and medical 
educator, Dr. Hirsch was best known for his 
research in cell biology, particularly his 
studies of the relationship between white 
cells in the blood and immune reactions. 
Bom in St. Louis, Mo., in 1922, Dr. 
Hirsch was a 1942 magna cum laude 
graduate of Yale’s Sheffield Scientific 
School and a 1946 graduate of Columbia 
College of Physicians and Surgeons. After 
a two--year internship at Barnes Hospital in 
it. I ouis and two years as chief of medicine 
id pediatrics at Warren Air Force Base in 
rung, he joined the staff of the Rocke¬ 
feller Institute for Medical Research, now 
Rockefeller University. He remained there 
for 31 years, serving as dean of graduate 
studies from 1972 to 1980. In 1981, he 
became president of the Josiah Macy Jr. 
Foundation. 
As president of the Macy foundation, he 
helped develop medical education pro¬ 
grams for minorities and initiated a program 
to encourage doctoral candidates in the be¬ 
havioral sciences to pursue research on 
human disease. 
Nathan Levy, M.D. 
Dr. Nathan Levy ’27, of Branford. Conn., 
died April 12 after a brief illness. He was 
85. Educated at Yale, he practiced medicine 
in Branford for 58 years. He is survived by 
his wife, Bertha; a son. Dr. Harold D. Levy; 
a daughter, Elaine Kaplan; a sister, Bertha 
Rosenberg; and six grandchildren. He was 
predeceased by his first wife, Sadye Bren¬ 
ner Levy. 
Garner L. Lewis, M.D. 
Dr. Garner L. Lewis ’45, a radiologist in 
Simsbury, Conn., died Aug. 24. He was 
67. Educated at Yale, Dr. Lewis was a U.S. 
Navy physician until he retired in 1964 and 
entered private practice. Surviving are his 
wife, Grace Virginia "Jean” Lewis; two 
sons, Garner R. and Gregory P. Lewis; two 
daughters, Ruth Ann Coleman and Patricia 
Stoecker; a brother, Orville N. Lewis Jr.; 
a sister, Catherine Smith; and 11 grandchil¬ 
dren. 
Richard H. Mann, M.D. 
Dr. Richard H. Mann '46, retired chief of 
cardiology at Lancaster General Hospital in 
Pennsylvania, died May 25 at his home 
after a 17-month illness. He was 64. 
Two months before his death, Lancaster 
General Hospital honored him by establish¬ 
ing the Richard H. Mann, M.D., Endow¬ 
ment for the Advancement of Cardiology, 
and renaming its cardiology division the 
Richard H. Mann, M.D.. Division of Car¬ 
diology. Considered a Lancaster medical 
pioneer. Dr. Mann, who joined the medical 
staff at Lancaster General Hospital in 1954, 
was the first LGH physician to receive such 
an honor. 
Born in Lancaster, Dr. Mann received a 
bachelor’s degree from Yale’s Sheffield 
Scientific School in 1944 and his medical 
degree from the School of Medicine in 
1946. 
Surviving are his wife, Mary Jane; his 
mother, Anna Hess Mann; two daughters, 
Dana T. Hutchinson and Lisa H. Gemill; a 
son, Gregory S. Mann; four grandchildren; 
andabrother, William H Mann. 
Bruce S. Schoenberg, M.D. 
Dr. Bruce S. Schoenberg ’68, chief of the 
neuroepidemiology branch of the National 
Institute of Neurological and Communica¬ 
ble Disorders and Stroke, died July 14 of 
cancer. He was 44. 
A native of New Jersey, Dr. Schoenberg 
received a B. A. degree from the University 
of Pennsylvania in 1964 and his M.D. de¬ 
gree from Yale in 1968. He also received 
M. P H. and Dr. P. H. degrees from the Johns 
Hopkins University School of Hygiene 
and Public Health, and an M S. degree 
in neurology from the University of 
Minnesota. 
After graduating from the School of 
Medicine, Dr. Schoenberg continued his 
association with Yale as a part-time lecturer 
in public health (biometry) until 1981. He 
also was associated with the Georgetown 
University School of Medicine and the 
Mayo Clinic, and was a visiting professor in 
the neurology departments of universities in 
Mexico City, Llorence, Madrid, Beijing 
and Lima. 
Dr. Schoenberg was the founding editor- 
in-chief of the journal Neuroepidemiology 
and the author of the textbook Advances in 
Neurology: Neurological Epidemiology 
(Principles and Clinical Applications). 
Dr. Schoenberg joined the NINCDS in 
1975 as chief of the institute’s neuro¬ 
epidemiology section, and became chief of 
the neuroepidemiology branch in 1984. Dr. 
Schoenberg was widely respected for his 
contributions to the methodology of neuro- 
epidemiologic investigations. He helped 
establish centers for the study of neuro¬ 
logical disorders in more than a dozen 
countries in Asia, Africa, Europe and South 
America. 
On June 23, Dr. C. Everett Koop pre¬ 
sented Dr. Schoenberg with the Surgeon 
General’s Medallion—the Public Health 
Service’s highest honor—for his "unique 
contributions in the field of epidemiology 
and the neurosciences.” Dr. Schoenberg is 
only the seventh person to receive this 
honor. 
He is survived by his wife, Devera; 
his son, Ian Charles; his daughter, Claire 
Jennifer; and his parents, Mr. and Mrs. 
Mitchell Schoenberg. 
Virginia Lee Swanson, M.D. 
Dr. Virginia Lee Swanson '52, of Mon- 
tecito, Calif., died May 20 of cancer. Dr. 
Swanson was born in Sioux City, Iowa, on 
June 15, 1922, but she spent her childhood 
in Los Angeles. As a child she suffered 
from osteomyelitis Her experiences with 
hospitals and surgical procedures led to her 
decision to pursue a medical career. 
Dr. Swanson received a B.A. degree 
from the University of Southern California 
in 1947 and her M.D. degree from Yale in 
1952. After an internship in pathology, she 
spent two years in Copenhagen on a U.S. 
Public Health Service fellowship and re- 
turned to Yale in 1955 as chief resident and 
later assistant pathologist at Grace-New 
Haven Community Hospital, now Yale- 
New Haven Hospital. 
From 1959 to 1962, she worked as a civi¬ 
lian pathologist with the U.S. Army Com¬ 
mand in Japan and New Guinea, and from 
1962 to 1965 was chief of the pathology di¬ 
vision for the Tropical Medical Research 
Laboratory in San Juan, Puerto Rico. For 
her work, the University of Puerto Rico 
Medical School awarded her an honorary 
doctorate in 1965. 
After a year at the Walter Reed Army In¬ 
stitute of Pathology, Dr. Swanson was ap¬ 
pointed associate professor of pathology at 
the University of Southern California Medi¬ 
cal School and staff pathologist at the Chil¬ 
dren’s Hospital of Los Angeles. 
Although Dr. Swanson retired in 1982, 
she continued research in immunopathol- 
ogy and held appointments at the University 
of San Diego and the Scripps Institute of 
Oceanography. Most recently, she was a 
visiting fellow at the department of neuro¬ 
anatomy at Oxford University in England. 
She is survived by her husband. Dr. Mar¬ 
tin Kamen; a brother, Robert Swanson; and 
two sisters, Carole Swanson and Beverly 
Hill. 
William B. Terhune, M.D. 
Dr. William B. Terhune died June 26 in An¬ 
niston, Ala., of natural causes. He was 93. 
He had been a Yale School of Medicine fac¬ 
ulty member twice during his career. He 
was a clinical instructor in psychiatry from 
1920 to 1922 and a lecturer in psychiatry 
from 1922 to 1927. He returned in 1941, 
and was associate clinical professor of psy¬ 
chiatry from 1950 until he retired in 1960. 
Reuben Zucker, M.D. 
Dr. Reuben Zucker '44 died June 9 at the 
University Medical Center of Southern 
Nevada, where he had been a staff member 
since 1961. Dr. Zucker was 68. 
Bom May 24, 1919, in Waterbury, 
Conn., Dr. Zucker earned both his under¬ 
graduate and medical degrees from Yale 
University. Dr. Zucker was responsible for 
the first medical residency program at 
Southern Nevada Memorial Hospital, now 
University Medical Center of Southern 
Nevada. From 1963 to 1986, Dr. Zucker 
was chairman of Memorial Hospital’s Max 
C. Fleischman Library Committee, which 
in 1963 established the first medical library 
in Las Vegas. In appreciation of his work 
supporting academic programs and the Uni¬ 
versity library, Nevada Gov. Richard Bryan 
named April 9 as Reuben Zucker Day in 
Nevada. 
Surviving are his wife, Blanche; two 
sons, Jeffrey and David Zucker; a daughter, 
Ellen Frank; a stepdaughter, Kay Green; a 
stepson, Gary Marsh; and eight grandchil¬ 
dren. He is also survived by a sister. Belle 
Gruber, and a brother, Zal Zucker. 
IN MEMORIAM 
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Erratum 
Dr. Boy Frame, who died on Aug. 17, 
1986, was incorrectly listed in the spring 
1986 In Memoriam as a member of the 1948 
house staff. Dr. Frame was a 1948 graduate 
of the Yale School of Medicine. He com¬ 
pleted his internship and residency training 
at Massachusetts General Hospital. Dr. 
Frame was chairman of the department of 
medicine at the Henry Ford Hospital in De¬ 
troit, and clinical professor of internal 




Alan Sartorelli, PhD., professor of pharmacology (left), and Dr. Myron Genet, associate 
dean for government and community affairs, present U.S. Senator Lowed Weicker (R-Conn.) 
with the first annuaI Distinguished Service Award of the Yale Comprehensive Cancer 
Center for his long-term support of cancer research. 
The sun shone on June 5 and 6, and one of 
the most meterologically perfect alumni 
weekends in recent memory unfolded to a 
record attendance of the past graduates of 
the Schools of Medicine, Nursing and Pub¬ 
lic Health. 
Highlights of the weekend included 
superb scientific presentations on both Fri¬ 
day and Saturday by faculty members of 
eight clinical and basic science depart¬ 
ments. The programs were indeed of such 
excellence that strategies must be gener¬ 
ated to achieve wider audiences at future 
reunions. 
U.S. Sen. Lowell P. Wcicker Jr. pre¬ 
sented a rousing and uplifting keynote ad¬ 
dress Friday afternoon. Ignoring his pre¬ 
pared speech, he conducted a forum and 
dialogue with his audience, generating a 
spirited exchange on health care issues 
which ranged from AIDS to the funding 
of basic science research. He concluded, 
"There is no group in our society which en¬ 
joys greater credibility with the general 
public than the medical profession.” He 
emphasized that there has never been a time 
when health care issues were generating 
more questions of national concern. He em¬ 
phasized that the health professions should 
be heard. Greeted by Dean Leon E. Rosen¬ 
berg, the event concluded when Dean 
Judith Krauss of the School of Nursing pre¬ 
sented Senator Weicker a plaque making 
him an honorary member of the Yale Uni¬ 
versity School of Nursing Alumnae/i As¬ 
sociation for his support of research funds 
by Congress. 
The remainder of Friday was devoted to 
social pleasures of the dean's reception and 
a special alumni dinner and dance. Saturday 
reunion day began with a warm address of 
welcome by Sheila Wellington, secretary of 
Yale University. Mrs. Wellington, a 
graduate from our School of Public Health, 
was deputy director of the Yale Psychiatric 
Institute. She conveyed greetings from 
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Detail of the Sterling Hall of Medicine rotunda. 
“Surgical House Staff 
of the ’ 40 s” Reunion 
A reunion dinner of surgical house staff of 
early and mid-1940s took place June 5 at the 
New Haven Lawn Club. This reunion was 
the inspiration of John Frazer, HS ENT ’41- 
’44 recently retired chairman of otolaryn¬ 
gology at the University of Rochester. With 
the help of Charles Cheney ’41, HS ’46- 
’49, John organized a truly memorable 
gathering. 
Many of the attendees had had their resi¬ 
dency training interrupted by military ser¬ 
vice in World War II. After the war, several 
returned to complete their training. They 
were members of the house staff at the old 
New Haven Hospital, where all except the 
few married ones lived as well as worked. 
Salaries ranged from 0 to $100 monthly 
(chief resident). 
Nineteen former surgical house officers 
attended, including Frazer and Cheney, 
Ralph Alley, Lloyd Brown, Guido De 
Blasio, Mai Ellison, Harvey Kausel, Nat 
Kenigsberg, Ed Krementz, Frank Lepreau, 
Jack Parella, Nick Stahl, Bill Kenny (or¬ 
thopedics), Charlie Petrillo (ENT); Dee 
Peck and Arnold Janzen (both switched 
from surgery to radiology). Sid Cramer and 
A1 Kummer (radiology house staff) and 
Hugh Dwyer and Jim Twyman (internal 
medicine) were also included. Fifteen 
wives attended. Elaine Bemeike, widow of 
Bob (urology) and Pat Fiorito, widow of Joe 
(ob-gyn), were welcomed. Joe Milici, the 
Yale-New Haven Hospital barber, was 
guest of honor and was awarded the title of 
professor of depilatory surgery. 
Reminiscences were endless, and con¬ 
viviality unsurpassed. Each gave a resume 
of his academic or practice career—sev¬ 
eral still being in practice—though few 
doing surgery. 
The late Samuel C. Harvey chaired the 
department in the ’40s with Gustaf E. 
Lindskog following (1948-1966). Dr. 
Lindskog sent his greetings. 
It was a memorable event, and many ex¬ 
pressed their hope that it would be repeated 
with even more surgical house staff of the 
'40s attending. 





by Harry M. Zimmerman 
The alumni records of this class, which 
originally numbered 45 members in 1927, 
indicated that in February 1987, 15 mem¬ 
bers remained. Letters to them in early 
March announcing plans for a 60th reunion 
in New Haven failed to elicit a single re¬ 
sponse. Accordingly, I tried to reach as 
many classmates as possible by phone; this 
report is a summary of the results. 
I learned that Milton Berman, whose 
last address was Miami, died on July 11, 
1986. Henry Fineberg’s son, Coleman, in¬ 
formed us that several years ago his father 
had a severe stroke that completely in¬ 
capacitated him. He is confined to a nursing 
facility on Long Island. Coleman requested 
that we not attempt to communicate with his 
father in the future, because it creates a 
stressful situation for his mother. 
Meyer Friedenson, whose last known 
address was in New Rochelle, N.Y., failed 
to respond to repeated calls, and I finally 
was informed that his telephone had been 
disconnected. 
After speaking with Donald Gibson in 
West Redding, Conn., I received a note 
from him and a generous gift for the Medi¬ 
cal School Alumni Fund. He informed me 
that he was in good shape, but that his 
wife’s illness prevented him from attending 
ourreunion. 
I learned that Henry Glaubman of 
Hartford had passed away on March 29. For 
many years, Ernesto Icaza of Mexico City 
failed to respond to letters, and attempts to 
reach him by telephone have been equally 
unsuccessful. He is unknown at the Mexico 
address we have for him. 
I spoke with Albert Jablonsky on May 
27. He retired from practice about five years 
ago; he has not been well in recent years and 
has been hospitalized several times. He 
spends four months each year near Miami, 
and the remainder of the year at his home in 
Jeannette, Pa. Both he and Mrs. Jablonsky 
were not well enough to attend the reunion. 
It was a pleasure to speak with Lewis 
James in his home in Rocky Hill, Conn. He 
is generally in good shape, but two weeks 
previously had undergone a successful ab¬ 
dominal aortic aneurysm resection, which 
prevented his trip to New Haven on June 5. 
The news about Nathan Levy of Branford, 
which I learned from his son, also a physi¬ 
cian in Branford, was that Nate died in 
Florida of congestive heart failure on April 
12. His grandson, also a physician in Bran¬ 
ford, spoke at his memorial service. 
Attempts to reach William Meredith at 
his latest address in Stratford, Conn., were 
to no avail, both by letter and telephone. 
Equally disappointing were all attempts to 
reach Eugene Pfanner, for whom no cur¬ 
rent address is available. 
Moses Rothberg of Palm Harbor, Fla., 
supplied the information that his health and 
his wife’s health would not permit them to 
travel to New Haven. He gave up his prac¬ 
tice several years ago. 
Alfred Seibert, who now lives in Nor¬ 
wich, Vt., and is on his third cardiac 
pacemaker, was unable to attend because of 
recent cataract surgery. He still drives his 
car, but only for short distances. 
I reached Theodore Sills at his home in 
Columbus, Ohio. He, too, has had prob¬ 
lems with cataracts, which limit his abil¬ 
ity to travel, and so he had to forego the 
reunion. 
The news from Dawson Tyson was more 
encouraging, as far as travel to New Haven 
was concerned. In spite of coronary artery 
bypass surgery, Dawson was able to get 
around fairly well, and looked forward to 
seeing his classmates. 
We have lost contact with, and have no 
address for, our classmate, Cora Wong, 
who left the medical school after her first 
year to return to China. 
Thus, my wife Miriam and I, and Daw¬ 
son Tyson were the only representatives of 
the Class of ’27 who attended the reunion 
festivities. The program sparkled with sci¬ 
entific interest and good fellowship from the 
returning reunion classes. 
1932 
55th Reunion 
by Clement C. Clarke 
Seven classmates and four wives attended, 
as guests of the University, the Saturday 
night dinner now known as the “Friends of 
the 50th” dinner at the Graduates Club. 
They were Frank Carroll and Shirley, 
Rye, N. Y.; Clement C. Clarke (Clare was 
not well), Woodbridge; Robert Cushing 
and Robin, Long Island, N.Y.; Lee Farr 
and Miriam, Walnut Creek, Calif.; Conrad 
Lam and Marian, Farmington Hills, Mich.; 
Rudolph Vandeveer (his wife died in 
1986), Rome, N.Y.; and Myron Wegman 
(his wife was visiting friends), Ann Arbor, 
Mich. 
Nostalgic letters came from Edward 
Holland in Maine and Francis Wisner in 
California. Ned is not well. Francis, who 
lost his wife, is climbing California moun¬ 
tains and looking forward to walking the 
Chinese wall. 
Medical school Distinguished Service 
Awards were given to four honorees, two of 
whom—Conrad Lam and Myron Weg¬ 
man—were from ourclass. 
A unique feature of the “Friends of the 
50th” is that representatives of several 
classes are included. There were varying 
reactions to this feature. Some felt this cut 
short the intra-class visitation. 
Now that our class is over the “50” hill. 
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we can welcome every year. If you find 
yourself eastward bound at the time of the 
next reunion, let us know and we can have 
a special class reunion. 
1937 
50th Reunion 
by Wilbur D. Johnston 
Six members of the class attended the two- 
day alumni meeting. All were accompanied 
by their wives, except Wilbur Johnston, 
whose wife Betty died in 1982. Nature out¬ 
did herself in providing two fine June days. 
It enabled the alumni to enjoy a delightful 
luncheon, served in Harkness dining room 
and on the patio under a large tent for those 
who wished to chat and eat outdoors. Our 
class was particularly interested in the 
award presented to Dr. Harry Zimmer¬ 
man, and in the continuing educational pro¬ 
gram, which consisted of four excellent 
seminars, climaxed by an address by U.S. 
Sen. Lowell P. WeickerJr. of Connecticut. 
Jim Morrill and his wife Barbara have 
been enjoying retirement since 1978 at 
Heritage Village in Southbury, Conn. He 
had a private practice in pediatrics in New 
Jersey, and had been director of pediatrics 
at Saint Joseph’s Hospital Medical Center. 
Dennie Pratt and his wife are enjoying re¬ 
tirement in Bass Harbor, Maine. He is still 
best remembered by his ancestors’ activities 
in writing the Ballad of Chambers Street. A1 
Rosen, except for four years in the army, 
has practiced general medicine in New 
Haven and claims four children and seven 
grandchildren as his reasons for not retiring. 
Morgan Sargent retired in 1986, and is 
now living in Hingham, Mass. He still 
keeps his hand in at weekly hospital meet¬ 
ings, and spends many days on the golf 
course. He practiced for 40 years as a gen¬ 
eral surgeon and surgeon-in-chief at Quincy 
City Hospital. Al Spicer journeyed from 
Weepapaugh, R.I. where he is retired. Al 
continued his studies after graduation, re¬ 
ceived a dental degree and practiced dentis¬ 
try with his father. He and his wife have 
traveled extensively, recently in China. 
Wilbur Johnston retired after practicing 
orthodontics in New Haven for 49 years, al¬ 
though he is still active as a consultant at 
Yale-New Haven Hospital and clinical pro¬ 
fessor of surgery (dental) at Yale School of 
Medicine. 
We were the guests of honor at a sumptu¬ 
ous banquet at the Graduates Club; we 
asked Dr. Dawson Tyson, Class of 1927 to 
join us. Several members of the Class of 
1932 and many members of the Class of 
1982 also attended. The five-year alumni 
added youth to this festive occasion; we 
hope this joint meeting will encourage their 
return in future years. We were greeted 
warmly by Dr. Nicholas Spinelli, director 
for alumni affairs and Dean Leon E. 
Rosenberg. Also present was Dr. Dwight 
Miller, president of the alumni association. 
Several members who were unable to return 
sent warm greetings. These included David 
Dolowitz, our class agent; James 
DuShane, Jean Wells Hollingshead, Al 
King, John Thomas, Dunham Kirham 
and Bill Cooper. 
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UW'VEMitt school 
(1) A pause for posterity. (2) Will Melton, director of medical school development 
(left), explains Yale's ambitious plans for expanding the medical center complex. 
(3) Dr. Richard Swett, '67, contemplates the joys of lunch — and fatherhood. 
(4) Dr Dwight Miller, '56, president of the Association of Yale Alumni in 
Medicine (left) with Dean Rosenberg and Dr. Spinelli. 
1942 
45th Reunion 
by Michael A. Puzak 
We met in the upper room at Mory’s, a place 
that has changed a little less than we have, 
and for that matter, a lot less than the outer 
aspects of New Haven and the medical com¬ 
plex. The present medical students looked 
like teenagers, and we wondered if we 
looked that young when we first met. There 
were 24 of us, classmates, wives and 
friends. Although we had been concerned 
that we might not recognize each other, it 
was clear that even with changes in girth 
and hair patterns, we would have known 
each other if we met in the middle of Man¬ 
hattan. Each classmate and wife/guest was 
given a chance to speak on whatever they 
chose. The prevailing sentiments were not 
so much on past achievements but on newly 
found avocations, joys and enthusiasms in 
life. Fish and Wolfson are into art, some 
classmates are into music—the things we 
never had a moment for in training and prac¬ 
tice days. 
Returning classmates were Sam Budd, 
Jim Bunce, Walter Burdette, Ludmil 
Chotkowski, Nick Fish, Bill Harrison, 
Leo Kellerman, Mike Puzak, Sam Ritvo, 
Carter Stilson, Maurice Tulin, Edgar 
Taft, Irvin Wolfson and Charley 
Scholhamer. The food was fine, but feel¬ 
ings of mutual love, sympathy, empathy 
and support permeated the room. The phi¬ 
losophy of Maurice Tulin summed it up: 
“We were fortunate to be taught by giants 
at one of the only truly graduate schools in 
the country. I’ve never forgotten the values 
learned, they are constant. Only the facts 
change.” 
Telephone calls were successfully com¬ 
pleted with the following: Eugene de Hos- 
tos. Bill Bloomer, Vincent Collins, David 
Decker, Hendrik Dekruif, Allan 
Goodyer, Bill Fleeson, Elihu Friedmann, 
Steve Mullins, Randolph Page, Joseph 
Seronde and Philip Viscidi. Letters were 
received from: Davitt Felder, Elihu Fried¬ 
mann, Allan Goodyer, William Fleeson, 
Randolph Page and Philip Viscidi. Gene 
de Hostos suggests more frequent reunions. 
That thought brought on ideas for a winter 
reunion in the islands in a few years. Sug¬ 
gestions about this possibility would be 
welcomed. A more detailed letter is planned 
to be mailed to each member of the class. 
Please keep in touch. 
1947 
40th Reunion 
by Philip H. Phi I bin 
The Class of 1947 was well represented for 
the 40th. We congratulate the Yale Alumni 
in Medicine for the interesting professional 
program and update on the current state of 
the school. The dean’s reception and the 
YAM reunion dance were delightful, great 
sources of fun and relaxation. The latter 
was particularly enjoyable; ask Somberg, 
Lynch and Newton. 
The buffet luncheon on Saturday saw 
many of '47 continuing to refresh each other 
on current activities and plans. Then the 
class picture has to be interesting. Saturday 
night, thanks to Bill Maniatis’ labors, was 
outstanding. We met at the New Haven 
Medical Society building for cocktails and 
dinner, where Bill had for each, a beautiful 
pewter dish with the YAM logo. During 
cocktails and dinner, strolling musicians 
provided the right background. After din¬ 
ner, class members gave a short resume of 
their current activities and further plans. 
Brock Lynch is working full time for the 
VA in Massachusetts. Bill McClelland and 
Betty are still in Greenfield, Mass. Jack and 
(5) Connie Tolliver, assistant to the director of alumni 
affairs at the School of Medicine (left), reminisces 
with Dr. Harold Bornstein,'53, and his wife Maureen. 
(6) As Dr. Arthur Ebbert (left) shares a laugh with 
Drs. William Kissick, Leon Rosenberg and Nicholas 
Spinelli, Sheila Wellington, MPH '68, chats with Dr. 
Helen Langner, '22. (7) Merle Waxman, director of 
the Office for Women in Medicine, with Dr. Helen 
Langner, '22. At age 90, Dr. Langner maintains an 
active psychiatric practice. In the background are 
second-year medical students Tom Christopher and 
Vicky Barber. 
7 
Doris Cannon are outside Hartford, where 
he has sold his practice and his services to 
the hospital. He’s very happy with the deal. 
Igor Tamm was present, but Olive Pitkin 
could not make it. Root Ziegra and Marie 
are in the Philadelphia area and into houses. 
He works for a large pharmaceutical con¬ 
cern. Vic and Barbara Machcinski, and Pat 
Tddbury have retired to Cape Cod Hank 
and Lorraine Blansfield are about to test the 
waters of retirement. Ed Foord and Archie 
Dean still are laboring in the fields in New 
Jersey. Bob Kerin is still going strong, 
fixing bones in Connecticut. Coming great 
distances were the Friedlanders from San 
Francisco, the Youngs from Arizona, and 
Dick and Betty Carlin from Missouri. All 
are in active practice, except Betty who has 
decided to let Dick handle all professional 
problems. Down from Maine came Dick 
and Marion Britton, and from the Big 
Apple, Ellis Van Slyke. The Maches, 
Charles and Mary Ann, still love upper 
New York and their boat. Frank Epstein 
was down from the Boston area, and the 
Darrows from Vermont. George and Elbe 
Barnes came all the way from Tucson, 
where he heads the radiology program. 
From the New Haven area were Bob New¬ 
ton, Frank Horton, Brad Colwell, Roy 
Breg and Bill Collins. Bill Maniatis is in 
active surgical practice. 
Henry Williams and Larry Perry 
seemed very fit, both still in the harness. 
Alvin Somberg and his wife Claude, a 
Parisienne, made the dance, but couldn't 
get to the dinner. Rudman, Cavanaugh, 
Chernoff, Gehrs, Golbranson and Kim- 
merling signed up but never appeared, 
which was quite disappointing. 
There is much we could tell you of each 
of those attending, but space does not per¬ 
mit. You will have to make the 45th to ex¬ 
perience the fantastic emotions of reminisc¬ 
ing with friends from so long ago. 
1952 
35th Reunion 
by Harvey L. Young 
Thirteen class members attended the reun¬ 
ion dinner, which Bob Gerety arranged. As 
he has done at each reunion. Mo Bogdonoff 
presented a timely summary of medical 
education and health care as viewed by our 
35 years of experience. It was superb, but 
not recorded for our posterity. 
Our group included: Mo Bogdonoff and 
Diana; Frank and Barbara Coughlin; Bob 
and Maggie Gerety; Bill and Jean 
Klatchko; Milnor Morrison; Bob and 
Janice Nolan; Sid and Beth Paly; Jack and 
Peggy Roberts; Don Schultz; Doris and 
Garvall Booker; and Harvey and Hilda 
Young. Bob Gerety read two letters; one an 
invitation from Phil Deane to visit him in 
retirement on Shaw Island in the San Juan 
Islands of Puget Sound, and a letter from 
John Filley who has retired to Agoura, 
Calif. Several visited with Ray Duff at his 
Woodbridge home and reported on his re¬ 
covery from a severe and debilitating stroke 
last November. 
The evening’s sad note was the an¬ 
nouncement that our classmate Virginia 
Lee Swanson of California died May 20 of 
carcinoma of the lung. 
The reunion was memorable, and all 
present agreed that a greater effort should 




by Jack Levin 
The Class of 1957 held a successful 30th 
reunion, maintaining its tradition of well-at¬ 
tended reunions. Attending were Vince and 
Daria Andriole; Jack Blechner; Albert 
and Myrna Chun-Hoon; Lou and Madeline 
Cooper; Tom and Nancy Danaher; Joe 
Demis and his wife; Jim and Colleen Dorr; 
Ed Eyerman; Hal, Jo Ann and Mike Fal¬ 
lon; Ron and Estelle Fishbein; Tony and 
Mary Fons; Liz Forsyth; Gil, Carol, Greg 
and Cameron Hogan; Bob and Margaret 
Kaiser; Stan and Carole Kilty; Bill and 
Priscilla Kissick; Howie, Gretchen and 
Brad Minners; Bob and Jill Modlin; Herb 
and Anne Newman; Cliff and Barbara 
Reifler; Mel and Marianne Roberts; Leo 
MacCallum and his wife; Don Stahl; and 
Bill and Barbara Waskowitz. 
Continuing the pattern of our 25th reun¬ 
ion, our class assembled after the Saturday 
luncheon to hear presentations, organized 
by Ron Fishbein, by their classmates and to 
share experiences. Speakers were Bill Kiss¬ 
ick on “Managing the Medical Industrial 
Complex’’ and Hal Fallon on "Current and 
Future Trends in Internal Medicine”. 
Our Saturday evening class dinner was 
held again at the Pine Orchard home of Gil 
and Carol Hogan. However, this year we 
had sun rather than the torrential rains of 
1982, allowing those who attended to enjoy 
the lovely environment of Long Island 
Sound. Howie Minners assembled a collec¬ 
tion of biographic information from the ap¬ 
proximately three dozen class members 
who responded to his questionnaire. 
1962 
25th Reunion 
by Michael H. Alderman 
Members of the Class of 1962 assembled 
for their 25th reunion to discover that the 
passing years had neither muted the en¬ 
thusiasm that marked their undergraduate 
days nor dulled the sense of the adventure 
in medicine that had been so firmly estab¬ 
lished during their years at Yale. At one 
time or another during the weekend Drs. 
Alderman, Anderson, Bull, Cantor, 
Dann, Eisenfeld, German, Godley, Har¬ 
rington, Karney, Kosto, Marshall, Mar¬ 
tin, Matyszewshi, Miller, Psehirrer, Seil, 
Spencer and Stoutland appeared and par¬ 
ticipated in what proved to be a marvelous 
opportunity to see where we have been, get 
a sense of where we were, and least reli¬ 
ably, to take a stab at where we might be 
going. The sample tested—more than one- 
fourth of the class—although inadequate by 
rigorous epidemiological standards, was 
sufficiently large and representative to sup¬ 
port at least a few observations and tentative 
conclusions. 
The heterogeneous group that first came 
to the Yale School of Medicine more than a 
quarter century ago has not been 
homogenized either by that undergraduate 
experience or by what subsequently hap¬ 
pened. Our reunion program included a 
class meeting on Saturday afternoon in the 
Day Amphitheater, where each classmate 
had the chance to speak about anything he 
or she wished. Most chose to describe their 
post-graduation experience; many offered 
some general observations, and a few spoke 
more impersonally about the state of the 
world and medicine in broader terms. 
We were a spectrum of individuals that 
included solo clinicians or practitioners 
serving in structured private or public 
groups, academicians, including depart¬ 
ment chairpersons, directors of medical ser¬ 
vices, hospital administratiors, several lab¬ 
oratory bench scientists, a public advocate 
for AIDS patients, as well as a rural prac¬ 
titioner recently turned international foun¬ 
dation executive. 
Although it is always hazardous to char¬ 
acterize such a diverse group of robust indi¬ 
vidualists, I think it fair to conclude that 
those whose primary role was in medical 
practice were somewhat distressed by an 
unanticipated changing work environment. 
In contrast, those employed either academi¬ 
cally or in other structured positions (the 
two polar groups about equal in size) 
seemed, on the whole, more content with 
the present and optimistic about the future. 
The weekend of catching up and ex¬ 
changing among nearly 40 classmates and 
spouses produced a sense of good fellow¬ 
ship and a glow of warming nostalgia. We 
dined lavishly Saturday night at the New 
Haven Lawn Club, and, after a toast to all— 
both those present and in absentia—a thor¬ 
oughly successful 25th dissolved with the 
universally shared wish that we meet again 
soon, but no laterthan our 30th. 
1967 
20th Reunion 
bv Bob Kirkwood 
On Friday night Jim Dowaliby hosted an 
informal get-together at his home in New 
Haven. We sipped wine, enjoyed a deli¬ 
cious buffet dinner and renewed 
friendships. On Saturday night we had din¬ 
ner at Leon’s, the Italian restaurant just 
southeast of the campus, where many of us 
ate on Sunday nights during our time in 
medical school. 
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We had a good turnout. Those who came 
the greatest distance were Bill Perkins, 
Alex Dora, John Drews and Cindy Rapp 
Curry, all from California. Ken Crumley 
came from Albuquerque, N.M.; Gary 
Burget and Dennis Egnatz from Chicago; 
Ihor Zachary from Ohio; Bob Young and 
Dick Hart from Washington, D.C.; Karen 
Harkevey Toker and Joe Morris from 
Maryland. From the Northeast came Mar¬ 
tin Wand, Peter Herbert, Tony Lovell, 
Brian Rigney, Dick Swett, Dave Tilson, 
Jim Dowaliby and Laura Kirchman 
Manuelidis. 
Although some talk centered on our con¬ 
cerns about fundamental changes in 
medicine, our conversations quickly turned 
to our personal lives and accomplishments. 
We enjoyed two wonderfully warm and 
happy evenings together I sensed a strong 
feeling of friendship among us, the same 
supportive feeling that we had as a class 
throughout our four years in medical 
school. We toasted ourselves for having 
made it this far while still keeping our en¬ 
thusiasm for medicine, and we wished our¬ 
selves luck for the future. 
1972 
15th Reunion 
by Bruce B. Haak 
The 15th reunion of the Class of 1972 was 
as anticipated a memorable occasion. The 
class dinner was held at Reilly's Restaurant, 
and at the excellent suggestion of Jerry 
Meyer, and with some lead time, our 20th 
reunion will be scheduled for the New 
Haven Lawn Club. 
Mike Charney was voted as youngest 
looking among those in attendance. Tom 
Converse is practicing psychiatry in Provi¬ 
dence, R.I. Felix Freshwater was voted as 
having best memory of class events after 
quoting verbatim, Larry Temkin’s speech 
in his role as Byron Waxman from the class 
show of 1970. By the way, although Larry 
and his wife could not make it, he did send 
a nice letter indicating that he is practicing 
cardiology in Tuscon. His wife, Barbara, is 
practicing psychology, and they have two 
children, Joshua, 11, and Deborah, who 
was two in August. Frank Kahr and his 
wife Kathy have returned from Texas and 
now are in the Providence area. Frank, now 
known as the “Canoe Man,” has in his 
spare time handcrafted six small boats and 
canoes. Mike Kaufmann has turned the 
other cheek, so to speak, and now is practic¬ 
ing law in Boston. Donald and Ellen Kent 
brought their two lovely children to the din¬ 
ner. Phil Leibowtiz and Jerry Meyer held 
down one end of the table and reminisced 
about many of the events of the Class of ’72. 
Richard “Dickey” Robins and Helen are 
living in Columbus, Ga., where he prac¬ 
tices as a gastroenterologist. They live on 
the same street as his mother, says Helen. 
Phil Rothfeld, who lives in Woodbridge, is 
a practicing radiologist in the Connecticut 
Valley area. Gary Strauss is practicing on¬ 
cology in the Wooster area. Sherry and I are 
looking forward to a gala celebration for our 
20th reunion. Hope to see you all then! 
1977 
10th Reunion 
byAttilio V. Granata 
Amidst a sunny, pleasant New England 
weekend, 14 members of the Class of 1977 
gathered for two days of tours, conferences 
and nostalgia, climaxed by a reunion dinner 
on Saturday evening at the Graduates Club 
on Elm Street across from the New Haven 
green. Fortuitously, a photographer arrived 
at just the right moment to take a class pic¬ 
ture on the front steps. 
Along with 10 spouses or guests, the 14 
included: Marcia Arem, George Bolen, 
Jerry Brody, Harriet Comite, Sybil 
Duchin, Julia Frank, Attilio Granata, 
Bob Hand, Bob Mitchell, Mike Owens, 
Alan Penziner, Ricky Schneider, Gail 
Sullivan and Didi Wasserman. Julia 
Frank kindly provided us with her carefully 
cherished album of our second-year show, 
“Mephistofollies,” which had its pre- 
Broadway run at Harkness auditorium in 
December 1974. We all agreed that the 
show truly launched many of our future 
careers. 
After dinner. Dean Leon E. Rosenberg 
answered questions and helped us rekindle 
some memories. The alumni then updated 
each other on the whereabouts of most of 
the rest of the class. Attilio Granata shared 
letters he had received from those who 
could not attend, including John Witcomb, 
director, emergency services, St. Luke’s 
Hospital, Milwaukee; Vaughn Kirchoff as¬ 
sistant professor of internal medicine (in¬ 
fectious diseases) at the University of Iowa; 
and Tom Ferguson, widely known writer 
and speaker on self-care and the future of 
health, Austin, Texas. 
We felt that being together after 10 years 
provided a more realistic taste of past foun¬ 
dations, and gave us a bit of perspective. 
Members of the Class of 1977 toast our 
school, our teachers and each other, and 




by Stephanie Wolf-Rosenblum 
Paula Braverman 
None of the Class of 1982 could believe that 
five years had passed since that pouring, 
muddy day in May. Not only did the New 
Haven crowd come, including Lynn 
Tanoue, Stephanie Wolf-Rosenblum and 
Carrie Redlich, but Patty Kellner and 
Paula Braverman came from as far as 
Ohio; Joyce O’Shaughnessy from Balti¬ 
more; and Jeff Tepler and Daphne Hsu 
from New York. The largest city rep¬ 
resented was Boston with Bill Sikov, Jes¬ 
sica Herzstein, David August, Brian 
D’Angora, Michele Masi and Jed Gorlin. 
There was plenty of time for reminiscing at 
the dinner hosted by the 50th reunion class. 
The festivities continued on Sunday at an 
all-day brunch at Lynn’s house. 
Many of our classmates are still in train¬ 
ing. Bill, Jed and Jeff are doing heme-onc 
fellowships. Joyce is going into the NCI’s 
therapy evaluation program. Stephanie and 
Lynn are pulmonary fellows. Carrie is mov¬ 
ing to Seattle to follow suit after finishing 
occupational medicine in New Haven. 
David is paying back the NHSC by doing 
nutrition research at MIT and working part 
time with "a funky collection of ’60s radi¬ 
cals practicing internal medicine.” 
Michelle will be a neuro attending at the 
Brigham. Daphne is in pediatric cardiology 
at Columbia, and Patty is doing family prac¬ 
tice and urgent care at Case Western. Paula 
is moving from Cincinnati to do adolescent 
medicine at St. Christopher’s in Philadel¬ 
phia. Brian is leaving surgery to pursue 
radiology in Boston. 
We also heard about many others includ¬ 
ing Lew Rubin, a neonatologist at Boston 
Children’s, and three budding car¬ 
diologists, including Mary Vandervelde, 
pediatric, in Boston; Colin Lee in Vermont 
and Phil Sager in New Haven. The sur¬ 
geons in the group include Jose Guillem in 
New York and Bob Rizzo, who is going to 
Chicago to do CT. Radiology has proven 
popular, attracting Pat Toth and Henry 
Stein in New York from surgery and Paul 
Sylvan from medicine in New Haven. 
Henry will join Mike Katz to do radiology 
in Michigan. 
Ed Dohring will do ortho after his NHSC 
payback at an Indian reservation in New 
Mexico, and Muriel Cyrus will do ER 
medicine in Texas after finishing her 
payback in Alabama. Gus Simpson-Roth 
will begin ob-gyn in Arizona, while Ron 
Voit is in an ob-gyn practice on Maui. Dave 
Fassler and Bob Pierritini have a private 
psychiatric practice in Vermont. Dave has 
just finished an award-winning film on 
epilepsy. Other psychiatrists include Bob 
Rohrbaugh in New Haven and Rich Doan, 
pediatrics, in Pittsburgh. 
Finishing training are Laurie Katz, 
pathology in Philadelphia; Terry Massagli, 
rehabilitation in Seattle; Larry Ttirka, 
renal in Boston; Fred Drennan, GI in Seat¬ 
tle; Bert Ungricht, ophthalmology in Bos¬ 
ton; Don Stromquist, rheumatology in 
New York; and Kate Albert, Ph.D. at 
Rockefeller. Hugh Hemmings is taking 
his Ph D. degree to an anesthesia residency 
in Boston, while Jay Kranzler took his 
into business. 
On a final note we have started the Class 
of 20??: Mara Redlich-Revkin; Joshua 
Turka; Aaron and Debbie (Koenreich) Katz; 
Everett and Gavin Stem; Ariel and Raissa 
Wolf-Rosenblum; Sarah Tepler; Andrew 
Ungricht; Angie and Clarice Simpson-Roth 
and Conner Cyrus. 
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AYA IN MEDICINE 
ANNUAL MEETING 1987 
At the annual meeting of the Association of 
Yale Alumni in Medicine, President Dwight 
F. Miller introduced Dean Rosenberg, who 
outlined several ambitious building pro¬ 
jects, faculty appointments and honors. The 
dean also described the highly successful 
Student Research Day. 
Chairman R Leonard Kemler ’43, of the 
Yale School of Medicine reported receipts 
of $540,217 by the Medical School Alumni 
Fund as of May 27, exceeding our goal for 
the year of $500,000. A similar achieve¬ 
ment was reported by Mrs. Kay Flowe from 
the Public Health Alumni Fund, with a 
record $67,016 received, surpassing a goal 
of$50,000. 
The Distinguished Service awards for 
1987 were presented to four alumni: Dr. 
Myron E Wegman and Dr. Conrad R. Lam 
of the Class of 1932; Dr Arthur Ebbert, 
deputy dean of the Yale School of Medicine 
for the past 34 years; and Dr. Nicholas P R. 
Spinelli, director of Alumni Affairs and 
past president of the Association of Yale 
Alumni in Medicine. Dr. Ebbert, a graduate 
of the University of Virginia School of 
Medicine, was made an honorary and 
lifetime member of the Association of Yale 
Alumni in Medicine for his extraordinary 
service to alumni/ae, students and the 
school for so many years. 
President Dwight Miller also presented 
special citations to Dr. Helen P. Langner, 
Class of 1922, on the occasion of her 65th 
reunion and to Dr. Harry M. Zimmerman, 
Class of 1926, a distinguished teacher of 
neuropathology, on the occasion of his 60th 
reunion Dr. Miller also presented citations 
to each member of the 50th reunion to 
the respective class secretaries; Wilbur 
Johnston, ’37 and Dr. Michael H. Aider- 
man, ’62. 
Saturday afternoon provided special 
class seminars conducted by the 25th-year 
reunion group of 1962 and the 30th reunion 
Class of 1957. With the planning efforts of 
Drs. Michael Alderman, Dr. Fred Cantor 
and Dr A. Richard Pschirrcr, “Reflections 
of the Class of 1962 at 25’’ took place in 
103. The Class of 1957 presented Dr. 
William L. Kissick, “Managing the Medi¬ 
cal-Industrial Complex;’’ and Dr. Harold J. 
i allon Jr., "Current and Future Friends in 
Internal Medicine." The record perfor- 
lance achieved by Dr. R. Leonard Kemler, 
■1 ’ as chairman of the Alumni Fund, was 
discussed at the annual class agents meeting 
Saturday afternoon. The changing needs of 
student aid were discussed at length In¬ 
creasing scholarship awards are becoming 
necessary for some students in the light of 
the unrealistically high loan debt with 
which some students graduate. 
The evening concluded with the tradi¬ 
tional reunion class dinners held at many 
sites. Again, the fourth annual “Friends of 
the 50th'' dinner at the Graduates Club was 
a heartwarming event, with approximately 
70 guests saluting the Class of 1937. Also 
feted was the Class of 1932, with 15 pre¬ 
sent, and the Class of 1982, celebrating its 
first reunion with 17 members attending. 
Dr. Stephanie Wolf-Rosenblum moderated 
the commentary of this young group, which 
included two well-behaved “1982" infants. 
Dr. Nicholas P R Spinelli 
Director of A lumni Affairs 
At the 1987 A YA in Medicine Annual Meeting, (from left) Drs. Arthur Ebbert Jr., Nicholas 
Spinelli. Conrad Lamm and Myron Wegman were given Distinguished Service Awards for 













DISTINGUISHED SERVICE AWARDS 
Arthur Ebbert, Jr., M.D. 
Your extraordinary and unique service to Yale School of Medicine 
began in 1953 when Dean Vernon Lippard appointed you assistant 
dean of the School of Medicine and has been unparalleled in the 
history of the school. Your skills in this crucial executive role were 
to establish your remarkable record as deputy dean for the five 
succeeding deans, during your 34 years of service. Your sensitive 
concern and knowledge of all members of the school—faculty, 
student, administration, alumni—is now legend. Your personal 
knowledge of medical students, from the graduating Class of 1953, 
when you arrived, to the present, has rendered you the true archivist 
for our school and for our alumni association. You are an irreplaceable 
resource. Your ability to communicate with all of us has been a 
model of finesse, informed judgment and grace. 
We are fortunate today to have inducted you as permanent member 
of the Association of Yale Alumni in Medicine. We are blessed to 
look forward to your coming years in New Haven, and our ability 
to count upon your continued and unmatchable support. We thank 
you for your past assistance. It is with affection that the alumni 
association salutes you today. 
Conrad Ramsey Lam, M.D. 
Your distinguished career as a pioneer thoracic and cardiac surgeon, 
anchored in Henry Ford Hospital in Detroit, has brought you 
international awards and recognition. 
As the eldest of 11 children from central Texas, your Yale School 
of Medicine education was funded, in part, by your merchandising 
of musical instruments. The trumpet and music, as well as the 
study of medicine, occupied your youth and young adulthood. 
Although Detroit remained your academic home, you responded 
whenever our medical school sought your help as an alumnus. You 
served as chairman of the Yale Medical School Alumni Fund from 
1963 to 1966. You served as medical school representative to the 
Alumni Board during those years. 
In your long illustrious career, you remained a teacher and role 
model to many of our graduates. Despite your busy schedule, you 
devoted attention to your medical school when she sought your 
counsel or help. Your presence at and assistance with your class 
reunions has been as constant and unwavering as your love of 
music. One of a large number of distinguished and accomplished 
classmates of the Class of 1932, the Yale School of Medicine salutes 
you and thanks you today. 
Nicholas P.R. Spinelli, M.D. 
Your service, devotion and dedication to Yale spans 50 years, since 
you entered as a Yale freshman in 1937. 
Your Yale training after military service brought you home to 
practice as a general internist. You taught Yale medical students, 
and your service never strayed far from your academic source. 
When personal circumstances required that you leave practice in 
1968, you became director of medical education at Bridgeport 
Hospital. In this role, you assisted the Yale medical school to 
achieve formal affiliation with the teaching community hospitals of 
the region. The circle of your continued activity at our medical 
school thus grew in its linkages through the years. Since 1950, you 
have been Alumni Fund agent for your Class of 1944. You were 
chosen to be chairman of the Medical School Alumni Fund in the 
early '70s and have assisted in forming the board of directors of 
the fund, an effort which has energized annual giving. 
You have helped raise the consciousness of our medical graduates 
and house staff trainees to help meet the needs of our financially 
stressed students. 
You were honored to serve as president of the Association of 
Yale Alumni in Medicine from 1981 to 1985. In 1985, you were 
appointed director of medical alumni affairs. You have accelerated 
communication among our membership, without which our associ¬ 
ation cannot thrive. 
Your alma mater is grateful for your help and applauds you 
today. 
Myron E. Wegman, M.D. 
Fifty-five years ago, upon your graduation from the Yale School of 
Medicine, you began a medical career in academic pediatrics and 
public health. It was to take you through the byways of the world 
into top administrative positions in the World Health Organization 
and as secretary general of the Pan American Sanitary Bureau. In 
a life dedicated to medical education and international health, with 
teaching assignments at Columbia, Johns Hopkins, Cornell, 
Louisiana State University and extensively in Latin America, your 
path repeatedly brought you back to New Haven for service at 
Yale. From 1969 to 1972, your duties as chairman of the Yale 
Medical School Alumni Fund contributed to the process of growth 
which now renders the fund a major source of support to our 
students. Your energy, enthusiasm and support of our school and 
the remarkable Class of 1932 is acknowledged today by your alumni 
peers who have watched your career with pride, your service with 
gratitude. Although you are dean emeritus at the University’ of 
Michigan School of Public Health, you continue your journeys 
across the globe today with the youthful vigor which has marked 
your distinguished career. 
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1986-1987 ALUMNI FUND REPORT 
A Message from the Dean 
Our students express enormous anxieties 
and concern about the high costs of medical 
education today, and it is a poignant plea 
that they make. Many will graduate in June 
with an average indebtedness of $55,000. 
This burden threatens our ability to accept 
and educate the brightest young people re¬ 
gardless of their economic backgrounds. 
So as dean, finding additional financial 
aid for our medical students is one of the 
major issues which faces me, other admin¬ 
istrators and faculty in the School of 
Medicine and, of course, the students. 
The generous past support of medical 
school alumni/ae has been tremendously 
helpful in our efforts to address this pressing 
need. Your support in the form of unre¬ 
stricted gifts totaled more than $600,000 in 
1986-87, and I as dean greatly appreciate 
these gifts. Once again I have directed that 
your contributions be used to assist stu¬ 
dents, primarily through financial aid. 
It is gratifying to note that your total giv¬ 
ing has more than doubled during the past 
three academic years. Nonetheless, 1 re¬ 
main deeply concerned about the gap be¬ 
tween the funds that alumni/ae provide and 
the needs that medical students have. To as¬ 
sist our students and to ensure that tomor¬ 
row’s medical care and scientific research 
will remain at the high level of excellence 
we now enjoy, we must generate additional 
funds and develop new ways to finance 
medical education for the young people 
who feel the effects of the high costs of 
YALE MEDICAL SCHOOL 
ALUMNI FUND BOARD 
R. Leonard Kemler, M.D. '43, 
Chairman 
David Raskind, M.D. ’24 
I. Roswell Gallagher, M.D. ’30 
Harry Sherman, M.D. ’34 
uel D. Kushlan, M.D. ’35 
Malvin White, M.D. ’39 
is RR. Spinelli, M.D. ’44 
am McClelland, M.D. '47 
Raul Koehler, M.D. ’48 
Goodman, M.D. '51 
medical education and who may have their 
career choices influenced by these costs and 
subsequent indebtedness. 
As we work together to increase the 
amount of funds available for student finan¬ 
cial aid, we must explore new forms of 
financial aid to supplement our traditional 
loan awards. Your Alumni Association and 
its leaders—from President Dwight Miller 
to Medical School Alumni Fund Chairman 
Leonard Kemler—will play a significant 
role in helping the school set this course for 
our outstanding students. 
Dwight, Leonard, along with Sam 
Kushlan and Roswell Gallagher in their ef¬ 
forts as bequest and endowment co-chair¬ 
men, have worked ably to generate gifts to 
enlarge the Medical School Alumni Fund, 
and future leaders will be challenged to 
surpass iheir fund-raising successes. Dr. 
Nicholas Spinelli’s diligence, both as an 
alumnus and medical alumni association 
director, is appreciated, and Ms. Claire 
Lauterback’s consistent administrative con¬ 
tributions are noted too. 
During 1987, the many members and 
leaders of the Medical School Alumni 
Association have strongly supported the 
school and its students. I greatly value your 
important and generous contributions, 
which I hope you will sustain and surpass. 
Thank you. 
LeonE. Rosenberg, M.D. 
Dean 
Harold Bornstein Jr., M.D. '53 
Herbert Hurwitz, M.D. ’54 
Robert Kramer, M.D. ’55 
William Kissick, M.D. '57 
William Waskowitz, M.D. ’57 
Nicholas Passarelli, M.D. '59 
David Hill, M.D. ’65 
John Foster, M.D. ’71 
Douglas Berv, M.D. ’74 
Dean Rosenberg 
FUND OFFICERS 1986-87 
Medical School Alumni Fund 
R. Leonard Kemler, M.D. ’43, 
Chairman 
J. Roswell Gallagher, M.D. ’30 
Bequest and endowment co-chairman 
Samuel D. Kushlan, M.D. ’35 
Bequest and endowment co-chairman, 
and chairman, former house staff 
Public Health Alumni Fund 
Kathleen H. Howe. M.P.H. '56 
Chairman 
Message from the Medical 
School Alumni Fund 
Chairman 
Hooray! Hooray! You've done it again. As 
you will note in the accompanying report, 
the Yale Medical School Alumni Fund has 
again set a new record—$615,000 dollars. 
It must be satisfying to realize how many 
students you will be able to help with these 
monies. Mother Yale, the students and I are 
very grateful for your interest, efforts and 
success. The only cloud to darken this pic¬ 
ture is that participation remained at the 
same level. We must try to increase our per¬ 
centage of participation in future cam¬ 
paigns. 
To all of you who responded to the call, 
again, our heartfelt thanks. 
To those of you who have not partici¬ 
pated, please reconsider this year, and make 
a contribution to enable more students to 
participate in our loan and scholarship pro¬ 
gram and ease the financial burden on these 
deserving young men and women. 
Let's keep our momentum going with 
another record in giving and participation 
for the academic year 1987-88. 
R. Leonard Kemler, M.D. '43 
The Medical School Alumni Fund last year established the Sterling Association, a new 
gift club. Donors may join the Sterling Association by making contributions in any of 
the following six categories: 
Lifetime Benefactor $50,000 and above 
Patron $5,000-49,999 
Sponsor $2,000-4,999 
Fellow $ 1,000 - 1,999 
Associate $ 500 - 999 
Member $ 200 - 499 
First-year medical students pitch in and solicit alumni support for alma mater. (From 
left) Narisse Daye, Victoria Barber, Mindy Schuster and Matthew Miller. 
Kemler Increases Fundgiving 
R. Leonard Kemler, M.D. '43, has com¬ 
pleted his first year as chairman of the Yale 
Medical School Alumni Fund. In pursuing 
his goal of increasing the percentage of 
alumni who participate in fund giving. Dr. 
Kemler has attempted to speak with each of 
the approximately 100 class agents. Such 
personal communication has reaped many 
benefits. Some class agents of long stand¬ 
ing, weary after many years of service, have 
been replaced at their request. Other class¬ 
mates have been added to the roster to share 
the work load. 
In addition, leaders among current medi¬ 
cal students have been identified, and 
alumni have shared insights with them 
about the importance of laying the ground¬ 
work for class organization while they are 
still in school 
Dr. Kemler notes, “Not only does such 
organization serve a class in its alumni ac¬ 
tivities after graduation; it is an important 
psychological support system while they 
are still students. Bonds are forged which 
endure for a lifetime.” The Alumni Associ¬ 
ation has planned social events with Yale 
medical students and hopes to broaden such 
activities. 
As a result of these efforts, the Class of 
1988 already has selected two of its Alumni 
Fund class agents, and the Class of 1987 
graduated with its four agents well oriented 
to their tasks. This group includes: Subba 
Gollumudi, Mindy Schuster, Barry 
Weinstock and Mark Widmann. The associ¬ 
ation will assist the Classes of 1989 and 
1990 in similarefforts. 
Messages to Graduates and Friends of Epidemiology 
and Public Health 
The department’s faculty, students and staff 
are very appreciative of the contributions 
made to this year’s Yale Public Health 
Alumni Fund drive. We congratulate the 
alumni who reached new records both in 
participation and contributions. This clearly 
is the result of great effort on the part of 
alumni leadership combined with the deep 
gratitude and respect so many of our alumni 
feel toward Professor John D. Thompson, 
who influenced so many students. The 
department of epidemiology and public 
health is proud to share in the expression of 
this recognition of a dedicated teacher and 
respected researcher. 
JanA.J. Stolwijk, Ph D. 
Chairman and Susan Dwight Bliss 
Professor of Epidemiology 
and Public Health 
The Public Health Alumni Fund for 1986- 
87 and 1987-88, designated the John D. 
Thompson Scholarship Fund, surpassed its 
first- year goal by 50 percent! The early re¬ 
sponse was so good that the original 
$50,000 goal was raised to an unofficial 
$75,000, which was reached by the end of 
the fiscal year. 
Credit and many thanks for this extraor¬ 
dinary effort, honoring a teacher par excel¬ 
lence and mentor to several generations of 
hospital and health services administration 
students, go to many people: to Edward 
Noroian, MPH '58, who made a special and 
effective appeal to the graduates in health 
services administration; to Stephen Skorcz, 
MPH '70, president of the Yale University 
Hospital Administration Alumni, who 
wrote many personal follow-up solicita¬ 
tions; to the enthusiastic group of local 
alumni/ae who participated in a highly suc¬ 
cessful phonathon; and of course to all the 
dedicated class agents who assisted in the 
record-breaking event. 
We look forward to the continuing sup¬ 
port of all EPH alumni/ae and department 
friends in next year’s campaign, when the 
official goal will be $75,000, thus enabling 
the department to award three John D. 
Thompson Scholarships each year. 
Memorial Established 
Mrs. Berthold R. Comeau of Delray Beach, 
Fla., has established a memorial fund at the 
School of Medicine in memory of her late 
husband, Berthold R. Comeau, who re¬ 
ceived his medical degree from Yale in 1928 
and practiced medicine in New York 
throughout his long career. The gift will be 
used to support scholarships for students in 
the School of Medicine, and will be known 
as the Berthold R. Comeau Memorial Stu¬ 
dent Financial Aid Fund. 
When he learned of the gift. Dean Leon 
E. Rosenberg expressed his appreciation to 
Mrs. Comeau. “Assisting our students with 
adequate financial aid is a major concern of 
mine,” he said. "Our school is proud of our 
tradition of educating and training the very 
best students without regard to their finan¬ 
cial qualifications. We, therefore, are grate¬ 
ful to you for your much-needed help. With 
such kindness, we are encouraged that we 
will be able to continue in the tradition of 
excellence that has been the hallmark of our 
school.” 
Memorials 
Deceased medical alumni and friends may 
be memorialized by a gift at any time to the 
Medical School Alumni Fund Endowment 
in the name and class of the person so hon¬ 
ored. The next-of-kin of a deceased medi¬ 
cal alumnus/a is advised about this In 
Memoriam Program by a mailing from New 
Haven some weeks after the School of 
Medicine receives notification of the death. 
The letter of information includes a copy of 
The Testament of Remembrance in which 
the names of all persons so memorialized 
are listed in the medical section by class, 
thus establishing a lasting memorial. Do¬ 
nors receive a personal penned note of ap¬ 
preciation from me. Your inquiries and in¬ 
terest are welcome at any time. 
Deceased alumni and friends so honored 
for the first time in 1986-87 were: Berthold 
R. Comeau '28, Lewis Dickar '30, Edward 
T. O'Donnell '34, Boy Frame '48, 1942 de¬ 
ceased classmates, 1950 deceased class¬ 
mates, Bernhard H. Lisker '75, Anthony 
DeLuca and Thomas M Tierney. 
RichardG. Jordan 
Director. In Memoriam Program 
Kathleen H. Howe, M.P.H. '56 
Chairman 
Public Health Alumni Fund 
ALUMNI REPORT 
Drs. Richard Breck, '45 (left), and Nicholas 
Spinelli, '44. 
The Alumni Association gave an informal 
reception May 1 for medical students of all 
four classes. Approximately 100 students, 
alumns, faculty and administration assem¬ 
bled in Harkness Lounge. In an informal at¬ 
mosphere, refreshments were served, and 
good feeling and warmth prevailed. 
Students relaxed and discussed questions 
about the curriculum, future practice or 
teaching careers. Drs. Bernard Shen ’81 
and Attilio Granata 'll chair the associa¬ 
tion's Student Well-Being Committee. 
Plans to consult with officers of the Student 
Council to discuss possible future social 
events and opportunities to meet with 
alumni/ae informally were announced. 
The universally expressed request in 
1985 for more news of fellow alumni/ae has 
resulted in the publication of several col¬ 
umns entitled MEDICAL SCHOOL in the 
YALE ALUMNI MAGAZINE. After an in¬ 
itial flood of notes sent to the Medical 
Alumni Affairs office, the receipt of news 
items has tapered off. News is urgently 
requested of all, and a tear-out card is 
enclosed in this issue. Class columns, 
published in YALE MEDICINE, will high¬ 
light alumni news of professional honors 
or status changes; the YALE ALUMNI 
MAGAZINE will feature items of persona! 
and social interests. 
The response to the request for volunteers 
to provide overnight bed and board to Yale 
medical students visiting 40 cities for resi¬ 
dency interviews last year was most en¬ 
thusiastic. An early letter requesting such 
volunteers was mailed this summer for 
1987. This opportunity should provide an 
excellent means for students and alumni to 
exchange information and insights. 
Preparations for Alumni 1987 Reunions 
occupied most of the springtime. An 
Alumni Weekend event undergoing inter¬ 
esting changes each year is the “Friends of 
the 50th Dinner,” held on Saturday reunion 
night. It was begun four years ago as a spe¬ 
cial effort to honor the returning classmates 
of the 50th reunion class. Members of the 
older classes, faculty and school officers as¬ 
semble as guests of the association to share 
the 50th reunion class dinner and salute 
them as individuals. In 1986, the first reun¬ 
ion class (five years out) were added as 
guests or "friends.” The latter group histor¬ 
ically had poor attendance at their first reun¬ 
ion, usually for financial reasons. Gratify- 
ingly, nearly 20 percent of the fifth-year 
classes has appeared for two years, and 
most heartening has been the communica¬ 
tion and conviviality between the younger 
and the older grads. 
Since our last report, the subcommittee 
of House Staff Alumni has appointed Dr. 
John N. Forrest, Jr. as its chairman. Added 
to the committee have been Dr. Michael R. 
Berman, HS '73-’76, assistant clinical pro¬ 
fessor of obstetrics and gynecology; and Dr. 
G.J. Walker Smith, HS ’69-’73, professor 
of pathology. 
Alumni Records over the years has ex¬ 
perienced major deficiencies in the citation 
of former House Staff and Fellows, 
amounting to nearly 60 percent of them. 
Old records currently are being researched. 
When identified and located, these alumni/ 
ae will be polled as to their desire for active 
membership in the Association of Yale 
Alumni in Medicine. An intense identifi¬ 
cation with Yale medicine has been articu¬ 
lated by those “lost alumni/ae” who have 
phoned us. 
In 1988, this committee will attempt to 
define this group’s role in annual reunions, 
or perhaps more appropriately, reunions of 
their own groups. Subspecialty organiza¬ 
tions already exist and regularly provide 
their own continuing medical education 
seminars. Dr. Dorothea Peck’s description 
of the reunion of surgical house staff of the 
1940s, concurrently with the annual reun¬ 
ion, is typical of such events. Representa¬ 
tion of current medical house staff in pre¬ 
sent association activities seems desirable 
to underscore early on their membership 
in the alumni family and future network 
potential. 
This fall Yale medical faculty continued 
to make regional visits. Dr. Alvan R. Fein- 
stein, professor of medicine and epidemiol¬ 
ogy, spoke in Hartford on “Muddles in the 
Model”, discussing clinical decision-mak¬ 
ing. Dr. Robert Gifford, professor of 
medicine and associate dean for medical 
education and student affairs, spoke to the 
San Francisco and Bay area group on the 
current Yale medical school scene. 
Mr. Gail Ferris, director of alumni rec¬ 
ords, has announced that the Yale Univer¬ 
sity Directory will be kept current. It is 
available to all medical school graduates 
from the Rose Alumni House, Association 
of Yale Alumni, 232 York St., New Haven 
Conn.06520. 
It is hoped that our efforts of the past year 
have improved communication among 
alumni/ae, faculty and students. To transmit 
information, you must forward it to the 
Office of Alumni Affairs. With your coop¬ 
eration, the challenge and potential for 
alumni to assist ourselves is great. 
The director wishes to acknowledge the 
remarkable service and sage counsel proved 
by four local alumni/ae: Dr. Samuel 
Kushlan, ’35, Dr. Dorothea Peck, '43, Dr. 
Richard Breck, ’45, and Dr. John Ogilvie, 
’34. They provide assistance in fund raising 
(the Medical School Capital Campaign), 
editorial work, hospitality, social function 
planning and communications. Alumni/ae 
in the New Haven area with free time and 
specific interests are invited to volunteer for 
membership in this remarkable “kitchen 
cabinet.” Many thanks. 
Dr. Nicholas P R. Spinelli 
Director of Alumni Affairs 
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Medical School Alumni Fund Class Participation 
1985-86 1986-87 
AGENT TOTAL %PART TOTAL %PART 
1922 and prior 2,180 — 1,519 — 
1923 William Cohen 553 67 540 100 
1924 David M. Raskind 1,873 67 2,226 100 
1925 Alice Whittier 755 70 825 60 
1926 Maxwell Bogin 2,927 83 486 60 
1927 Harry Zimmerman 1,025 60 1,995 89 
1928 Max Alpert 3,569 77 53,765 69 
1929 Paul McAlenney 1,341 67 1,296 81 
1930 J. Edward Flynn 6,072 70 16,262 71 
1931 Michael D'Amico 2,923 79 1,274 71 
1932 Henry Brill 2,066 54 14,039 60 
1933 Franklin Foote 1,944 73 1,600 71 
1934 John Ogilvie 3,898 50 4,210 71 
1935 James Haralambie 12,837 57 17,020 59 
1936 Frederick Post 108,906* 53 4,239 29 
1937 David Dolowitz 1,540 53 6,013* 67 
1938 Nelson Ordway 1,065 53 1,036 63 
1939 Rebecca Solomon 18.441 67 2,976 58 
1940 James Ferguson 8,453 54 9,503 69 
1941 Charles Cheney 3,692* 69 17,008 75 
1942 Walter Burdette 2,519 53 56,144* 69 
1943A Dorothea Peck 2,908 70 5,406 72 
1943B S Brownlee Brinkley 2,171 55 2,815 69 
1944 Nicholas Spinelli 6,014 76 13,235 71 
1945 Richard Breck 4,025 60 3,520 57 
1946 Chales Judd 
Thomas Whelan 
58,100* 75 69,323 52 
1947 William Roy Breg 4,925 59 12,700* 69 
1948 Paul Koehler 6,067 62 6,461 55 
1949 Daniel Elliott 3,970 55 4,034 55 
1950 David Frucht 4.486 76 16,272 70 
1951 Lowell Goodman 6,884* 52 8,778 58 
1952 Harvey Young 8,432 57 11,320* 65 
1953 Vincent Gott 3,665 52 2,925 44 
1954 John Rose 5,088 68 5,273 63 
1955 Robert Kramer 6,370 60 5.294 55 
1956 John Gardner 15,300* 57 8,267 51 
1957 Ronald Fishbein 
Howard Minners 
8,121 64 16,043* 73 
1958 Andrew McGowan 
Paul Rudnick 
6,795 62 9,300 73 
1959 Asa Barnes 
Muriel Wolf 
13,898 65 9,769 67 
I960 Victor Altshul 
Thomas Kugelman 
8,819 58 8,101 57 
1961 Earl Baker 
Annoush Miridjanian 
13,000* 51 8,875 54 
1962 A. Richard Pschirrer 
Frank Hartman 
4,100 40 16,820* 54 
1963 Craig Llewellyn 7,395 58 7,577 54 
1964 William Houghton 
William Pratt 
9,130 72 10,520 66 
1965 David Hill 5,455 47 13,412 55 
1966 Mary Alice Houghton 
Gary Townsend 
5,445* 59 5,725 58 
1967 James Dowaliby 
Anthony Lovell 
6,877 70 15,644* 75 
1968 Frank Lucente 
Donald Lyman 
5,567 47 7,304 57 
1969 Lee Jampol 6,516 60 8,011 60 
1970 James Missett 3,526 45 4,104 56 
1971 John Cieply 
Barbara Kinder 
10,411* 61 8,495 48 
1972 Paul Lucky 4,983 41 11,178* 58 
1973 Lee Goldman 
John McQuade 
Jerrold Rosenbaum 
2,988 38 4,047 42 
1974 Amy Schecter 
Robert Schecter 
2,370 37 3,385 38 
Daniel Passeri 
Mary Jane Minkin 
1,715 23 1,825 24 
A William Levy 
Robert Taylor 
3,370* 39 3,085 29 
1977 Attilio Granata 
Ronald Vender 
1,350 31 2,380* 35 
1978 Duke Cameron 
Seth Powsner 
Thomas Smith 
1,520 29 1,935 25 
1979 Jeffrey Kaine 
Cynthia Sherman 
881 23 1,551 33 
1980 Eduardo Alfonso 
Cesar Molina 
870 26 1,220 27 
1981 Anthony Urbano 1,310* 24 965 19 
1982 Muriel Cyrus 
Jed Gorlin 
680 21 649* 23 
Stephanie Wolf-Rosenbaum 
1983 Michael Tom 
David Schwartz 
535 16 425 14 
1984 Hingge Hsu 
Jay Kostman 
325 11 620 23 
1985 Robert Higgins 
Fred Santoro 
2,299 94 725 26 
Javier Vizoso 15 






Alumni 467,234 577,069 22 
Former house staff 11,821 50 19,675 22 
Parents/friends 8,558 18 10,396 




Medical School Alumni Fund 
1985-86 1986-87 
NUMBER NUMBER PERCENT NUMBER NUMBER PERCENT 
SOLI- CONTRI- PARTICI- SOLI- CONTRI- PARTICI- 
CITED BUTED PATION TOTAL CITED BUTED PATION TOTAL 
Alumni 3,583 1,773 50 467,234 3,624 1,753 48 574,069 
Former 
House Staff 1,002 181 18 11,821 1,002 222 22 19,675 
Parents/Friends 432 79 18 8,558 432 93 22 10,396 
Int/Misc. 14,532 11,309 
TOTAL 5,017 2,032 41 502,145 5,058 2,068 41 615,449 
Public Health Alumni Fund 
1985-86 1986-87 
NUMBER NUMBER PERCENT NUMBER NUMBER PERCENT 
SOLI- CONTRI- PARTICI- SOLI- CONTRI- PARTICI- 
CITED BUTORS PATION TOTAL CITED BUTORS PATION TOTAL 
Alumni 1,938 618 32 35,201 2,044 669 33 72,455 
Int/Misc. - - _ 2,339 _ _ — 2,685 
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Public Health Alumni Fund Class Participation 
1985-86 1986-87 
AGENT TOTAL %PART TOTAL %PART 
1941 and prior 2,159 — 10,458 — 
1942 Eric Mood 420 60 425 60 
1943 Eric Mood 90 27 395 36 
1944 Eric Mood 275 22 250 22 
1945 135 50 80 29 
1946 75 29 100 29 
1947 330 48 140 35 
1948 Samuel Herman 675 44 750 41 
1949 Edgar Geibel 465 33 595 42 
1950 Eric Mood 685 43 1,150 43 
1951 Norton Chaucer 
Elizabeth Throm 
600 50 455 33 
1952 Yolande Lyon 695 41 1,075 40 
1953 Milton Sisselman 810 52 950 38 
1954 Eric Mood 85 21 100 21 
1955 Frances Ogasawara 485 44 345 44 
1956 David Boyd 672 50 373 40 
1957 Edward DeLouise 705 52 1.010 35 
1958 Philip Halien 1,175 29 3,760 36 
1959 Dorothy Wilson 430 38 835 46 
1960 R. John C. Pearson 1,159 43 195 22 
1961 William Slivka 1,075 40 580 32 
Joseph Prekup 400 
1962 Thomas R. Mayhugh 175 30 1,750 50 
1963 David Dolins 785 38 1,620 48 
1964 Estelle Siker 640 33 2,225 52 
1965 H. Patterson Harris 600 31 1,370 45 
1966 Allen Cohen 280 27 2,125 37 
1967 James Malloy 1,185 32 1,825 34 
1968 Arnold Saslow 1,705 51 1,645 41 
1969 Samuel Korper 
Robert Young 
955 32 36 
1970 Susan Balter 1,533 31 5,205 37 
1971 John Bihldorff 1,803 53 2,855 39 
1972 Dorothy Lewis 385 17 830 33 
1973 Judith Beatrice 
Gary Sax 
1,160 31 5,185 34 
1974 Thomas Benoit 
Karen Lindfors 
765 33 1,190 30 
1975 Linda Broker 1,602 35 4,142 32 
1976 Elaine Anderson 1,140 30 1,240 27 
1977 Dorothy Rice 918 29 3,015 30 
1978 Ann Freedman 1,123 29 2,988 30 
1979 Catherine H. Norton 
Ralph Tartaglione 
995 31 1,215 33 
1980 Christina Quinn 1,050 27 1,825 40 
1981 Angelo DeVita 
Barbara Gaugler 
1,235 29 855 29 
1982 Constance M Jarowey 
Jean L. Milton 
750 23 1,700 34 
1983 Jeffrey Hughes 
Mary Beth McNemey 
505 23 1,639 31 
1984 Anthony Alberg 
Leslie A. Balch 
265 15 365 12 
1985 Joan M. Cleary 
Katherine Fitzpatrick 
448 15 500 19 
1986 Indue Ahluwalla — — 720 19 
Aric Wilt — — 
Alumni gifts 35,201 72,455 
Intercst/misc. gift ;s 2,339 2,685 
TOTAL 37,540 32 75,140 33 
Medical School Alumni Fund Contributors to the 
Alumni 
1903 
Robert L. Rowley* 
1906 
Charles R Mitchell* 
1908 
Michael A. Parlato* 
1912 
Walter C. Tilden* 
1913 









Chester E. Hurwitz* 
Helen P. Langner 
1923 
William Cohen 
Julius A. Olean* 
Hyman W. Weinstein* 
1924 
John J Batchelor 
D. Anthony D'Espo 
David M. Raskind 
Myron A. Sallick 
Harold T Vogel 
1925 
Dorence S. Cowles 
Waldo F. Desmond 
William E. Hall 
Samuel Reback 
Eli H. Rubin* 
Welles A. Standish 
Alice A. S. Whittier 
1926 
Stanton T. Allison* 
Maxwell Bogin 
William H. Hahn* 




Wallace R. Bostwick* 
John M. Freiheit* 
Donald F. Gibson 
Albert Jablonsky 
Nathan Levy* 
William C. Meredith 
Moses Rothberg 
Alfred F. Seibert 
Theodore H Sills 
M Dawson Tyson 
Harry M. Zimmerman 
1928 
Max Alpert 
Berthold M. Comeau* 
Louis M D’Espo 
Sheldon A. Jacobson 
Edward P J Kearney 
Ralph E. Knutti 
R. Harold Lockhart 
Edward W. Ludwig* 
Nathan E. Ross 
Robert I. Rubinstein 
John M. Russell* 
Alvin A. Schaye* 
Lewis A. Scheuer 
1929 
James R Arneill Jr.* 
John W. Cass, Jr 
Frank H D'Andrea 
Charles J. Epstein 
Robert A. Frisch 
Olive Gates 
George S. Goldman 
Alexander O. Haff* 
John A. Hangen 
Harold J. Harris 
Paul F. McAlenney 
Tony L. Rakieten* 
William F. Roth* 
Russell B. Scobie 
Robert Tennant 
Newell Raymond Washburn* 




Daniel N. Beers* 
Frederick Fitzherbert Boyce 
Charles A. Breck* 
Lewis Dickar* 
Vincent A. Doroszka 
Knox H. Finley 
J. Edward Flynn 
J. Roswell Gallagher 
James C. Hart* 
Amy H. Hunter-Wilson 
Edmund L. Kitzmeyer 
Moses D Lischner 
James M. Lynch* 
John W. Maroney 
John C. Mendillo 
Paul Watson* 
Charles L. Wood 
1931 
Henry H. Briggs, Jr. 
Benjamin Castelman* 
Michael D’Amico 
Helen R Gilmore 
Paul A. Harper 
Harold E. Harrison 
Morris Freund Heller* 
Thomas C. Jaleski 
Rhoda M. Mickey 
Nelson Newmark 
Abraham J. Schechter 
James A. Stringham 
1932 
Louis K. Alpert 
Reginald V. Berry 
Henry Brill 
John T.B. Carmody 
Frank Carroll 
Clement C. Clarke 
Joseph P Donnelly 
Lee E. Farr 
Thomas E. Farthing* 
Lewis F. Foster 
Conrad R. Lam 
Arthur J. Present 
Elizabeth M. Ramsey 
Benjamin N. Tager 
Rudolph E. Vandeveer 
Myron E. Wegman 
Roland J. Wehger* 
1933 
Myron John Adams* 
Fred W. Buse 
Warren P Cordes 
Franklin M. Foote 
Jack Greenberg 
Daniel F. Harvey* 
George K. Hirst 
John G. Martin 
Raymond E. Miller 
Ashley Pond III* 
Paul L. Saffo 
Sidney Stringer* 
John J. Wolfe 




James F. Blades 
Joseph Budnitz 
Francis P Guida* 
Derick A. January 
Knowles B. Lawrence 
Herbert C. Miller 
Edward Thomas O’Donnell 
John B Ogilvie 




George A. Carden, Jr. 
Sawnie R. Gaston 
H Hoffman Groskloss 
James Quintin Haralambie 
W. Howard Horner 
Mildred Hartshorn January 
Samuel D. Kushlan 
Donald Peter Morris* 
Norman E. Peatfield 
Class of 1935 
John D Preece 
Norman P. Rindge 
Milton Rose* 
Clark P Searle 




Lester W. Burket 
Albert W. Diddle 
Margaret C. L. Gildea 
George Hahn* 
Louise G. Hutchins 
Philip M. LeCompte 




Edmund R. Blower 
William G. Cooper, Jr. 
David A. Dolowitz 
D. Crosby Greene 
Joseph B Hollinshead 
Benjamin F. Hoopes 
Wilbur D. Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P. Morrill 
Charles W. Neuhardt 
T. Dennie Pratt 
Alan A. Rozen 
Morgan Sargent 
Edward J. Shaw 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
Lorande M Woodruff 
1938 
Roy N. Barnett 
Henry L. Carideo 
S. Charles Kasdon 
Benjamin E. Lyons 
John J. McGillicuddy 
Edward Nichols 
Nelson K. Ordway 
Edward W. Pinkham, Jr. 
James Radcliffe, Jr 
George E. Roberge 
Lester J. Wallman 
J. Richard Zahn 
1939 
Harold H. Coppersmith 
Norman L. Cressy 
William H. Druckemiller 
Robert G. Ernst* 
John P Ferguson, Jr. 
Joseph B. Forman 
S. Jerome Greenfield 
Nathaniel Kenigsberg 
Arthur E. Laidlaw 
Ward J. McFarland 
James Peter Murphy 
Russell Nahigian 
Douglas S. Riggs 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
John D. Tobin 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 
1940 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
Thaddeus S. Danowski 
Wynant Dean 
Richard E. Dormont 
Robert M. Dunlap 
James F. Ferguson, Jr. 
Eugene J. Fitzpatrick, Jr. 
Henry D. Humphrey 
H. Stuart Irons, Jr. 
Donald G. Johnson 
Ira D. LeFevre, Jr. 
Paul D. Mac Lean 
Edward Martin 
William R. Oakes 
Maurice Ross 
W. Norman Sears* 
Joseph E. Sokal 
J. Champneys Taylor 
Patricia E. Wanning 
John B. Wells 
Helen H. Woods 
1941 
Robert H. AI way 
Robert H. Areson 
W. Randal Bell 
Knute E. Berger 
William A. Carey 
Joseph P Carson, Jr. 
Charles B. Cheney 
Herbert W. Diefendorf 
Robert Dine* 
John E. Fenton 
Lloyd D Flint 
John Franklin 
Robert L. Gilbert 
Frederick P. Glike 
William Edmund Kenney 
Sidney L. Lasell 
Bjom Lih 
F. Eugene Martin 
Willys M. Monroe 
Malcolm C Murfitt 
Edward B O'Connell 
Robert W. Ollayos 
Gioacchino S Parrella 
David V. Pecora 
Edwin D. Rogers 
Leslie Simmonds 
Janet H. Van Orden 
Irving Waltman 
1942 
William E Bloomer 
James M. Bunce 
Walter J. Burdette 
Robert E. Carroll 
Donald S. Childs, Jr. 
Ludmil A. Chotkowski 
Vincent J. Collins 





Allan V.N. Goodyer 
William Harrison, Jr 
Leo Kellerman 
John R Lincoln 
Patrick S Mullins 
Dean Nichols* 
Michael A. Puzak 
Samuel Ritvo 
Charles F. Scholhamer 
Richmond W. Smith, Jr. 
Edgar B. Taft, 
Maurice Tulin 
Francis P Voss* 
Arthur A. Ward, Jr. 
Irving Norman Wolfson 
Class of 1942 In Memoriam Fund 
1943 March 
Ralph D Alley 
John R. Brobeck 
Donal L. Dunphy 
Gerard Fountain 
Stuart L. Joslin 
R Leonard Kemler 
Joseph P. Kriss 
Jonathan T Lanman 
Douglas Lindsey 
J. Philip Loge 
Henry E. Markley 
Walter J. J. Nero 
Dorothea R. Peck 
Earl J, Rhoades 
Henry A. Riedel 
Bernard R Rowen 
Marcus E. Sanford 
Robert A. Sears 
Edward Hersey Soule 
Hilliard Spitz 
Nicholas M. Stahl 
Sophie Trent Stevens 
* deceased 
43 
Oliver G. Stonington 
Frederick A. Waldron 
John J. Weber 
Robert H. Wyatt 
1943 December 
John R. Almklov 
David G. Borden 
Robert F. Bradley 
S. Brownlee Brinkley 
Henry B. Bruyn, Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B Chase 
Hunter H. Comly 
Norman I. Condit 
Thomas D. Cook 
Ronald W. Cooke 
Joseph I. Epstein 
Robert H. Furman 
Victor C. Hackney 
Fred M Haddad 
Paul W Hughes 
Frank R Hurlbutt. Jr. 
Henry II Jones 
Joseph F Kell 
Sawyer E. Medbury 
Hoyt B. Miles, Jr. 
Ira A. Rashkoff 
Benjamin R Robinson, Jr. 
Donald W. Seldin 
Francis A Spellman 
C. Wesley Watson 
1944 
Carl E. Andrews 
John C. Coolidge 
George B. Corcoran, Jr 
Frank W. Countryman 
Lawrence G Crowley 
John H. Doherty 
Robert W. Frelick 
Carol Goldenthal 
Charles A Hall 
Robert I. Hinkley 
Donald W Holden 
W Raymond James 
Ward S. Jenkins 
Edith M. Jurka 
John Weaver King 
Frederick F. Krauskopf 
Ronald E. Losee 
Ellen P. MacKenzie 
Elias J Marsh 
Katharine Hawley Martin 
Joseph Massaro 
A Reese Matteson 
Paul E. Molumphy 
Lawrence K. Pickett 
Laurence G Roth 
Haynes W Sheppard 
Sarah P. Sherwood 
Eugene Smith 
Nicholas PR. Spinelli 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin W. Woodruff 
Reuben Zucker* 
1945 
George Howard Allison 
Albert S. Atwood 
Frederic M. Blodgett 
Richard W. Brcck 
Louise H. Burr 
Alice Shepard Cary 
Thomas P. Cotter 
Ldwa. t M. Daniels 
Robert S. Easton 
Alice Dershimer Friedman 
Raymond A. Gagliardi 
Philip S. Good 
Gove Hambidge, Jr. 
Herbert S. Hamed, Jr. 
Paul W Hoffert 
O Roger Hollan 
Hans R Huessy 
Leland W. Jones 
Raymond E. Lesser 
Gamer L Lewis 
Mark McD Lindsey 
James R Mason 
George W. Naumburg. Jr 
Fitzhugh C. Pannill 
Richard M Peters 
Charles E. Sherwood 
Joseph R Stanton 
Kenneth C. Steele 
1946 
Margaret J. Albrink 
William G Banfield, Jr 
Aaron T. Beck 
Franklin C. Behrle 
Linus W Cave 
Thomas J. Coleman 
Robert R Cooper, Jr. 
Thomas A. Doe 
Edward F. Edinger 
Gregory E Flynn 
Martin E. Gordon 
Charles S Judd, Jr. 
Benjamin F. Kitchen, Jr 
James A Kleeman 
Vincent J. Longo 
Richard H Mann* 
Thomas J Mathieu 
Hugh J McLane 
John H Morton 
Laura W. Neville 
John F. Neville, Jr. 
Francis G Reilly* 
David H. Riege 
Julian A. Sachs 
Donald P. Shedd 
Richard G. Sisson 
Robert R. Wagner 
Thomas J. Whelan, Jr. 
1947 
George R. Barnes, Jr. 
Albert W Bostrom, Jr. 
John E. Bowers 
W. Roy Breg, Jr. 
Richard G. Britton 
M Richard Carlin 
Charles R Cavanagh, Jr 
Roland G. Chambers 
Amoz I. Chemoff 
William F Collins, Jr. 
Bradford S. Colwell 
Robert P Darrow 
Archie L. Dean, Jr. 
Jean H. Dougherty 
Owen W, Doyle 
Franklin Harold Epstein 
Edward Foord 
Richard K. Friedlander 
Stephen W. Gehrs 
Frank H Horton 
Robert J. Kerin 
Don F. Kimmerling 
Anton N. Lethin, Jr. 
Richard P. Levy 
Brock Lynch 
Victor A. Machcinski 
Charles L. Mache, Jr. 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry 
Philip H Philbin 




Patricia B. Tudbury 
Ellis J. Van Slyck 
M Henry Williams, Jr. 
Sumner Root Ziegra 
1948 
Russell J Barmett 
George F. Batten 
Edith M. Beck 
Allyn G. Bridge 
Richard Steele Buker, Jr. 
Ruth E. Cortell 
Richard H. Cote 
G. Robert Downie 
Victor A. Drill 
Elizabeth Fuller Eisner 
Boy Frame* 
Emil Frei, 3d 
Julian Frieden 
Allan Green* 
B Herold Griffith 
Sylvia Preston Griffiths 
Richard M. Hannah 
Ross R. Harcus 
Paul B Koehler 
Robert E. Lempke 
John P Morris 
John B. Morrison 
Lewis P Rowland 
Benjamin F. Rush, Jr 
Gabriel A. Saviano* 
Jerome H. Shapiro 
Jessie Parkinson Spear 
Anne G. St. Goar 
Paul Talalay 
Wallace W. Turner 
Paul Woodbury Weld 
1949 
William G. Anlyan 
Henry W Baird, III* 
DeWitt C. Baldwin, Jr. 
William D. Bevis 
Jonathan S. Bishop 
Phillip G. Couchman 
Mary Pucci Couchman 
N Joel Ehrenkranz 
Daniel W. Elliott 
Gunnar O Eng 
Albert A. Fisk 
Eleanora C. Gordon 
Frederic W Gray 
Jackson Harris 
Gordon D Jensen 
Benjamin A. Johnson 
Timothy F. Nolan, Jr. 
Richard D. Otis 
Julian I. Pichel 
Edmund L Piper 
Charles L Rennell, Jr. 
Murray Z Rosenberg 
Daniel Rudman 
William H Sewell 
Lawrence E. Shulman 
R David Sudarsky 
Martha Vaughan 
1950 
Russell N. Anderson 
Lyal D. Asay 
Sylvia L. Axelrod 
John E. Borowy 
William H. Bucher 
Alvin Davis 
Claude W. Delia 
Kent Ellis 
Thomas J. Ferraro, Jr. 
Daniel Fine 
David A. Frucht 
Carl A. Gagliardi 
Melvin H. Kaplan 
Sidney S. Lee 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry L. McClelland 
John H. Meyers 
Orlando J Miller 
Robert T. Sceery 
Cynia B. Shimm 
Jane B. Shumway 
Martin E. Smith* 
John S. Strauss 
Robert H. Sturman 
Myra D. Tyler 
Class of 1950 In Memorial 
1951 
W. Robert Adams 
Frank R. Allen 
Thomas T. Amatruda, Jr. 
Stanley D. Ardell 
Eleanor Clay Bigley 
Daniel X. Freedman 
Sidney S. Furst 
Joseph M. Garland 
Lowell I. Goodman 
John T. Groel 
Robert N. Hamburger 
John V. Haxo 
Carrold K. Iverson 
Robert D. King 
Jocelyn S. Malkin 
Francis L. Merritt 
Paul D Millikin 
Walter S. Morgan 
Albert R Mowlem 
Richard S Munford 
Ismail Nik Nevin 
Charles A. Nugent. Jr. 
Gerard B Odell 
Arthur A. Pava 
Majic S. Potsaid 
William F. Stephenson 
John L. Sullivan 
William Taylor* 
James Walker 
Andrew S. Wong 
1952 
John W Arnold 
Maurice L Bogdonoff 
Frank A. Carone 
Willard R. Centerwall 
Siegried A Centerwall 
Frank R Coughlin, Jr. 
Richard N. deNiord, Jr. 
John P Filley 
Richard D Floyd 
Robert P Gerety 
William Joseph Johnson 
Thomas S Kelly 
William W. Klatchko 
N. Karle Mottet 
Robert F Owen 
Sidney Nathan Paly 
Robert G. Petersdorf 
Leon A. Phillips 
John Macklin Roberts 
Leonard Rush 
Elizabeth M Rush 
Mary Wheatland Schley 
Donald H. Schultz 
Robert B. Schultz 
Virginia Lee Swanson* 
John H Wagner, Jr. 
Doris L. Wethers 
John L. Wolff 
Harvey L. Young 
Robert Zeppa 
1954 
Frank P Berg 
Richard J. Bouchard 
George N. Bowers, Jr. 
Ralph K. Campbell 
John R. Cole 
Arthur C. Crovatto 
Donald D Davis 
Walter J Freeman 
John A. Gariepy 
Frank L. Gruskay 
Nicholas A Halasz 
Robert P. Hatch 
Walker R Heap, Jr 
Eva H. Henriksen 
Herbert S. Hurwitz 
Robert J T. Joy 
Donald S. Komfeld 
Richard Lamb 
Harry C. Miller. Jr. 
Paul N. Neufeld 
James J Nora 
Lowell E. Olson 
William J. Paule 
Anthony V. Piccirillo 
Richard D Pullen 
Jacques M. Quen 
Earl D. Rees 
John Keith Rose 
Elihu M. Schimmel 
Leonard M Silverman 
Robert L. Stein 
Martin B. Vita 
John W. Vosskuhler 
1955 
John B Atwater 
John C. Bailar, III 
George E. Becker 
E. Edward Bittar 
1953 
Claude Bloch 
Harold D Bomstein, Jr. 
William R. Chaffee 
Allen Chetrick 
Rex B Conn 
James P Dunn 
Donnell Dencil Etzwiler 
Vincent Lynn Gott 
Robert Emanuel Hamlisch 
A. Daniel Hauser 
George L. Hoffmann 
David Purdy Holman 
Fund Richard Robert Knowles, 3d 
Robert N. Melnick 
Robert L. Nolan 
Warwick Potter, Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
Barbara F Rosenberg 
Irwin K. Rosenberg 
Virginia C. Saft 
Ora K. Smith 
Lynn Cortland Stoker 
William Junior Vandervort 
William August Wilson 
* deceased 
Douglas G. Boyden 
Irwin M. Braverman 
Edward Noel Brennan 
Padraic Bums 
Leo R. Cardillo 
Nicholas A. Coassin 
Edward D. Coppola* 
Milton Corn 
Pasquale James Costa 
Robert G. Crounse 
John G. Daley 
Fred Wendell Doyle 
Leroy Engel 
F. Robert Fekety, Jr. 
Edwin G. Fernand 
Mahlon V.R. Freeman 
James Conway Garlington 
Barbara W. Gibson 
Paul Gonick 
Ion Gresser 
John H. Hodge 
D Franklin Johnson, Jr. 
Harry O. Kendall 
David R. Kessler 
Robert A. Kramer 
James Lum 
Joseph S. McGuire, Jr. 
Robert C. Nodine 
Gloria C. Onque 
John C. Pace, Jr. 
Robert H. Peters, Jr. 
Gregory Peterson, Jr. 
Robert A. Reich 
Paul J. Robinson 
F. Brantley Scott, Jr. 
Clement B. Sledge 
Phillip W. Smith 
1956 
Levon Z. Boyajian 
Rosalie A. Burns 
Joseph C. Cerny 
Edwin L. Child 
Chandler Dawson 
S. Evans Downing 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
John H. Gardner, III 
Sumner Gochberg 
George E. Green 
Arne G. Haavik 
Armen Charles Haig 
John Herd Hart 
Robert L. Hill 
William H. Hindle 
Marie-Louise T. Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Preston C. Manning 
Robert McDivitt 
Dwight F. Miller 
Norman F. Moon 
Donald J. Nalebuff 
William M. Narva 
A. Frederick North, Jr. 
David A. Page 
George W. Paulson 
Robert Lee Scheig 
James Scheuer 
Edward C. Senay 
Benjamin A. Shaver, Jr. 
Daniel R. Silbert 
1957 
Donald Agostinelli 
Joseph S. Amenta 
Jack Norman Blechner 
Richard I. Breuer 
Harry C. Briggs 
Carl A. Brinkman 
John P. Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
Harold Dick Cross 
John D’Agostino, Jr. 
Thomas H. Danaher 
James R. Dorr 
Edward Louis Eyerman, Jr. 
Salvatore Falbo 
Harold J. Fallon, Jr. 
Ronald H. Fishbein 
Robert E. Fishbein 
James R. Fitzgerald 
Anthony L. Fons, 3d 
Elizabeth H. Forsyth 
Edward O. Fox 
Gary A. Fry 
Robert H. Glass 
Anne H. Good 
Jack Peter Green 
Gilbert F. Hogan 
Warren R. Johnson 
Richard Lee Kahler 
Stanley E. Kilty 
William L. Kissick 
Willard A. Krehl 
Jack Levin 
Bennett F. Markel 
Mark D. Marshall 
Howard A. Minners 
Robert K. Modlin 
Hugh Lamson Moffet 
Herbert A. Newman 
Joseph S. Pagano 
Raymond E. Phillips 
Clifford B. Reifler 
Arnold Schoolman 
Kenneth A. Simon 
Charles A. Slanetz, Jr. 
Gilbert B. Solitare 
Robert W. Southworth 
Donald C. Stahl 
Arthur Taub 
Romeo Vidone 
William J. Waskowitz 
Herbert Winston 
James G. Zimmer 
1958 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
John P. Amot 
Peter Alfred Benson 
Gerard N. Burrow 
Benjamin Bursten 
David A. Carlson 
John A. Carlston 
Joseph James Cillo 
Robert V. Diserens 
Robert J. Donohue, Jr. 
Lawrence Dubin 
Donald A. Duncan 
Joel C. Eberlin 
Philip R. Fazzone 
Michael E. Fishman 
Peter A. Flynn 
Raymond A. Gaito 
John C. Gallagher 
Marcia Kraft Goin 
James Greenwald 
Charles A. Hall, Jr. 
Stanley Harris 
Michael Kashgarian 
Haskins K. Kashima 
Jay Ward Kislak 
Theodore W. Lieberman 
Myron Lotz 
Thomas J. Mauro, Jr. 
Michael J. McCabe 
Leo T. McCallum 
Andrew Joseph McGowan, Jr. 
John A. Merritt, Jr. 
Richard Charles Miller 
Albert Muggia 
Robert S. Neuwirth 
David W. O'Keeffe 
Carol F. Phillips 
David M. Pugh 
William B. Radcliffe 
Paul A. Rudnick 
Thomas R. Shea 
Bruce H. Sklarew 
Edward Lloyd Socolow 
Raymond W. Tbmer 
Margaret Smith Wenzel 
Joseph P. Wierzbinski, 3d 
John Patrick Wood 
Pauline B. Wood 
1959 
Scott Ingram Allen 
Carol J. Amick 
Robert M. Amick 
Asa Barnes, Jr. 
Francis A. Beer 
Jack F. Bowers 
William C. Butterfield 
Med. Class Of 1959 
Edwin M. Clayton 
Sidney M. Cohen 
Martin Colodzin 
Lyall S. Crary, Jr. 
Ronald C. De Conti 
Gerald Fenichel 
Robert L. Fisher 
Paul Jay Friedman 
Robert J. Gonyea 
Gerald B. Gordon 
W. Keith Hadley 
H. Rodney Hartmann 
William H. Heydom Me, Usa 
C. Richard Hinckley 
Leonard Inker 
John J. Jasaitis 
Edvardas Kaminskas 
Herbert J. Kaufmann, Jr. 
David W. Kingsbury 
Myron S.S. Lee 
Kathryn Huxtable Lewis 
John C. Marsh 
Brian J. McGrath 
James A. O’ 
Robert H. Ostberg 
Nicholas M. Passarelli 
Charles A. Phillips 
Lincoln T. Potter 
James D. Prokop 
James R. Ralph 
David Pardee Reed 
Joseph D. Saccio 
Constantine J. Sakles 
Marc D. Schwartz 
Owen A. Shteir 
Sanford P. Solomon 
Gene W. Spector 
James J. Stagnone 
Lisa A. Steiner 
Lois Withrow Tice* 
Leo H. Von Euler 
Muriel D. Wolf 
Class of 1959 
1960 
Victor Altshul 
Jack D. Barchas 
Ormond V. Brody 
Donald P. Buebendorf 
Thomas E. Carson 
Stanley M. K. Chung 
Francis D. Cogliano 
Jon E. Courtney 
John M. Davis 
David Paul Dunn* 
Caldwell B. Esselstyn, Jr. 
Warren H. Fisher 
Paul Jay Friedman 
James I. Gilman 
Maxwell E. Gottesman 
Roland H. Ingram, Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Susan T. Kleeman 
Thomas P. Kugelman 
Edward R. Lang 
Edward Longo 
Eugene G. McCarthy, Jr. 
Donald L. Miller 
Richard G. Morrill 
Allan W. Newcomb 
Buford L. Nichols, Jr. 
J. Thomas Okin 
Jerrold M. Post 
Nancy Rolick Powell 
Charles H. Robinson, Jr. 
Albert Matthew Ross 
Daniel J. Rubin 
John J. Schrogie 
Ross L. Snyder, Jr. 
Fred Stargardter 
Robert C. Wallach 
May Yung-Fun Woo Wang 
Ronald A. Yankee 
Class of I960 
1961 
Kenneth A. Arndt 
Frank H. Baker 
Albert A. Bechtoldt, Jr. 
Robert S. Briggs 
David William Brook 
Orson R. Dee 
Paul David Deiter 
Ralph J. DePonte 
Ronald A. Dierwechter 
Jon Dudley Dorman 
T. Wayne Downey 
John E. Fenn 
Edward C. Gilbert 
Robert Sterling Gillcash 
David D. Griffith 
Walter J. Hierholzer, Jr. 
Richard L. Keefe 
Robert Isaac Levy 
Hugh James Lurie 
Joseph Richard Lusby 
Sally Lockwood Marchesi 
Vincent T. Marchesi 
David B. Matloff 
Anoush Miridjanian 
Richard Allen Moore 
Norman I. Moss 
Roland D. Paegle 
John Curtis Parker 
William M. Rogoway 
Roy E. Ronke, Jr. 
Shaun J. Ruddy 
Stanley G. Schade 
Robert N. Taub 
Hugh C. Thompson, III 
Franklin H. Top, Jr. 
David E. Weaver 
Warren D. Widmann 
John R. Woodward 
1962 
Paul H. Ackerman 
Michael H. Alderman 
Charles B. Anderson 
Frederic P. Anderson 
Fredric K. Cantor 
Ray Allen Carlsen 
Thomas Newell Chase 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
I. Bruce Elfenbein 
John W. Foreman 
Leroy A. Forstrom 
Stephen John Flicker 
Anthony V. Furano 
John N. German 
John T. Harrington 
Frank R. Hartman 
Patricia C. Hassakis 
J. Dale Howe 
Gary Jacobson 
Walter Watson Kamey 
Glenn L. Kelly 
David E. Knoop 
John P. Lynch 
Carter L. Marshall 
Stanley E. Matyszewski 
David J. McConnell 
William A. Miller 
Malcolm S. Mitchell 
David D. Nicholas 
A. Richard Pschirrer 
David Seil 
James A E Spencer 
Nancy Ann Staley 
Larry Lee Stewart 
H. Oliver Stoutland 
Seth Thaler 
Sherwood Waldron, Jr. 
Stewart R. Wright 
1963 
Arthur Howard Ackerman 
Miguel R. Alonso 
V. Richard Back 
Charles W. Carl, Jr. 
Theodore J. Chu 
Gordon S. Cohen 
John E. Conte, Jr. 
James S. Dalsimer 
Dudley Seth Danoff 
Andrew Edin 
B. Allen Flaxman 
David H. Fram 
William T. Friedewald 
David H. Fulmer 
Alexander R. Gaudio 
Vincent F. Geremia, Jr. 
Lee D. Goldberg 
Peter B. Gregory 
Brian C. Judd 
Harold P. Kaplan 
Constantine D. Kyropoulos 
Edward C. Larkin 
William B. Lehmann 
Peter B. Livingston* 
Craig H. Llewellyn 
Edward G. Lund, Jr. 
Robert H. Margulis 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R. Pinnell 
Jay M. Pomerantz 
Lee Bland Talner 
Thomas W. Tillack 
* deceased 45 
Peter V. Tishler 
Lawrence Tremonti 
Peter G. Weiner 
Jerome Allen Winer 
Alfred J. Wise 
1964 
William A. Alonso 
Berton W. Ashman 
Sidney M. Baker 
Leland S. Berger 
Philip Blume 
Anthony J. Bravo 
Robert M. Briggs 
Thomas A. Cardella 
Joseph F J Curi 
Mary V. Digangi 
Beverly Ann Dudek 
Alfonso Esguerra 
Norman C. Fost 
Peter A. Gross 
John FB Haney 
Gene 1 Higashi 
Lawrence Horwitz 
William E. Knight 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
David B Leof 
James S. Levine 
Paul R. Lightfoot, Jr. 
Richard Murray Linburg 
Robert W. Lyons 
William F Matched 
Robert L. Mitchell 
Alan H. Morris 
James J. Murphy 
Donald A. O'Kieffe 
William B. Pratt 
Jack S. Rice, Jr 
Stanley J. Rosenberg 
Jonathan J Russ 
Norman Seher 
Robert L Shelton 
Diane Shrier 
Donald G. Skinner 
A Thomas Snoke 
Lyall C. Stilp, II 





Thomas T. Aoki 
Susan A. Aoki 
John H.M. Austin 
Paul Balter 
Victor J Burner 
Thomas B Caldwell. Ill 
Grant L. Christian 
Robert M. Cohn 
Gregory A. Culley 
Michael J. Cummings 
David S. Fedson 
Robert I. Finkel 
Frank J. Grady 
Robert Andre Gryboski 
James K. Gude 
Reid R Heffner, Jr. 
David A. Hill 
Carl E. Hunt 
Virginia Burnham Johnson 
Ronald J. Karpick 
Mohandas M. Kini 
Richard J. Kozera 
David B. Leof 
Sandra Chook Levine 
Philip D Manfrcdi 
Walter W. Noll 
A. Lawrence Ossias 
John A. Parrish 
Robert L. Pickens 
Alan N. Rachleff 
Gene A Robinson 
John F. Schilke 
Margretta Ann Reed Seashore 
John H. Seashore 
Charles J. Semonsky 
David M. Shames 
David P. Simmons 
Harlan Spitz 
Alan William Stone 
Robert G. Weiner 
Bert Yuan-Shu Wong 
1966 
Benjamin F. Balme 
John D. Baxter 
Patricia Bazemore 
Robert P Bazemore 
Frank C. Bell 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Joseph A. Donadio 
Robert E. Dragon 
Marvin A. Eisengart 
Jared M. Emery 
Robert N. Frank 
Peter D Gibbons 
Jeffrey B Gluckman 
Stanley I Greenspan 
J. McLeod Griffiss 
Robert A. Gunn 
Stuart T. Hauser 
Jay G. Hayden 
Mary Alice Houghton 
Richard J Howard 
Bruce W. Jackson 
Gordon R. Kelly 
Stuart M Kotler 
Wilbur L. Kukes 
Henry B Mann 
John Stephens Melish 
Marian Matheke Melish 
Harold Mellin 
Eli H. Newberger 
Edward J O'Keefe 
William D Peterson 
Joel Singer 
James D. Slavin, Jr. 
Mark Snider 
Gary L Townsend 
Jon S. Way land 
Joan T. Wayland 
Arne S. Youngberg 
1967 
Daniel L. Arons 
Arthur L. Beaudet 
Daniel J. Booser 
Gary C. Burget 
William T Cave, Jr. 
Mary Williams Clark 
Cynthia Rapp Curry 
Marian C. Davidson 
James Lucius Davis, III 
James J Dineen 
Alexander F. Dora 
James M. Dowaliby, II 
John A. Drews 
Peter R. Egbert 
Dennis Grant Egnatz 
Herbert W, Fclscnfeld 
Melvin Victor Goldblat 
Richard J. Hart, Jr. 
Richard L. Hcppner 
Peter N. Herbert 
George P Herr 
David L. Ingram 
Mary Jurbala 
J. Robert Kirkwood 
Melvyn Korobkin 
Anthony P Lovell 
Ralph G. Maurer 
Stephen W. Miller 
Joseph L. Morris 
Jennifer Robinson Niebyl 
John O. Pastore 
William E. Perkins 
Brian F. Rigney 
Robert I Roy 
Jonathan L. Saveli 
Alfred Q Scheuer 
Stephen C. Schimpff 
Sidney C. Smith, Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B Swett 
M. David Tilson, III 
Karen H. Toker 
Robert A. Vogel 
Robert A. Vollero 
Joseph F. Walter 
Martin Wand 
Redford B Williams, Jr. 
Robert J. Winer 
Robert S. K. Young 
Ihor George Zachary 
Peter M Zeman 
1968 
Philip L. Barry 
Grace Jordison Boxer 
Donald R. Coustan 
John Demarchi 
Edward M. Druy 
Barbara Mayer Egbert 
Alan G Finesilver 
William F. Flynn 
Richard A. Getnick 
Mark Gilbert Grand 
Leonard Grauer 
Ralph S. Greco 
John R Hill, II 
Harry S Holcomb, III 
Thomas R. Johnson 
Daniel E. Keim 
Jeffrey S. Lee 
Marc E Lippman 
Frank E. Lucente 
Donald O Lyman 
Stephen I Marglin 
Rodrigo Martinez 
Harmon Michelson 
David P Millet! 
Richard P. Mills 
Richard M. Morehead, Jr. 
John A. Ogden 
James W. Ogilvie 
Margot Onek 
Henry F. Panek 
Jackson B E Pickett, III 
Charles T. Post, Jr. 
Joseph L. Renda 
Gordon H Sasaki 
Jacob J. Schlesinger 
Frederick C. Sherman 
Elizabeth M. Short 
Howard W Siegel 
David A. Soskis 
Gerald L. Springer 
Lee H Strohl 
Edmund C. Tortolani. Jr 
Per Henrik Wickstrom 
1969 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
David A. Berkowitz 
N. Roger Cooke 
Leo M. Cooney, Jr 
Richard J Daly 
Charles A. Dinarello 
Ralph J. Falkenstein 
Gary S. Farnham 
Lesley Forman Fishelman 
Steven A. Frankel 
William H. Frazier 
Anna S. Gail 
Royal J. Gay 
Sander G. Genser 
Robert O. Gordon 
Thomas C. Howard 
Lee M. Jampol 
Joel Mark Kaufman 
Paul H Kelker 
John J Kelly, Jr. 
Rowena Korobkin 
Stephen Krant 
Lynn G. Lagerquist, Jr. 
Michael R Liebowitz 
Robert L. Marier 
Paul A. Markey 
Arnold F. Mazur 
Thomas F. Minehan 
Bruce K. Nagle 
Lionel M. Nelson 
Nancy Olmsted 
Deborah A. Putnam 
N. Burgess Record, Jr. 
Joseph D. Robinson 
Joseph M. Rochford 
Dennis J. Rudzinski 
David J. Sahn 
Adrian M. Schnall 
David J. Schulak 
Gerald J. Smallberg 
Michael S. Toren 
Robert J Walat 
Stephen R Webb 
Steven C. White 
1970 
Elissa B. Arons 
William Romney Burke 
Henry Chessin 
Michael J. Chusid 
C Norman Coleman 
James E. De Lano, Jr. 
Margaret W DeLano 
W Montague Downs 
Jonathan Ecker 
Robert Alan Epstein 
Bruce A. Fabric 
Thomas H. Gouge 
Marcus W Hedgcock, Jr. 
Paul C. Hessler 
Jay H Hoofnagle 
Robert E. Humphreys 
Jonathan D Katz 
Gerard T Kennealey 
William G. Koehne 
Mark A. Korsten 
Thomas L. Lewis 
Robert B. Litman 
Anne W. Lucky 
Roger A. Mason 
Leonard M. Milstone 
James R Missett 
William K Mueller 
John J. O’Brien 
W. Scott Peterson 
Robert M. Rosa 
Joel F. Rubinstein 
Dennis E. Shield 
Stuart S. Shorr 
Don H. Smith 
Richard Jay Solomon 
Richard A. St Onge 
Daniel A. Symonds 
Ray W. Tripp, III 
Brian Weiss 
C. Bruce Wenger 
Joellen Weme 
Daniel Wuensch 
Karl O. Wustrack 
1971 
Judith L. Bader 
Gregory W. Bartha 
Michael J Beierle 
Laurie J Bleicher 
Marian H Block 
Bruce Block 
Willard Cates, Jr. 
John L. Cieply 
Frederick L. Cohn 
Andrew D. Cook 
Michael Cynamon 
John S. Ebersole 
Leonard I. Eisenfeld 
Harvey Fern bach 
Fred Finkelman 
John W. Foster, Jr. 
Allan W. Graham 
Michael J. Hart 
William W. Hay, Jr. 
N. Timothy Jette 
Barbara K. Kinder 
William L. Krinsky 
David H Lippman 
William J Mangione 
Samuel S. Masters 
John C. Mills 
Patrick T. Minihan 
Richard Albert Moggio 
Robert Park 
John A. Patti 
Barry Bruce Perlman 
Stuart B Phillips 
Michael C. Piercey 
Anthony V. Proto 
Barry S. Rand 
David M. Rinzler 
James P. Southwick 
Jonathan W. Stewart 
Richard D. Travers 
Yvonne E. Vaucher 
Robert B. Vranian 
Albert Carl Weihl 
1972 
Robert D. Arbeit 
R. Michael Buckley, Jr. 
Michael A. Catalano 
Alan J Clark 
Philip L. Cohen 
Leonard H. Cohen 
Gloria Cummings* 
Robert F. Deblasi 
Norman M. Dinerman 
William H Druckemiller, Jr. 
William F. Duke 
M Felix Freshwater 
John P Fulkerson 
Robert B Geehr 
Dorothy M. Gohdes 
Andrew E. Hoover 
Thomas L. Horn 
Vernon H Humbert, Jr. 
Fred Hyde 
* deceased 
Anthony H. Jackson 
Jesse B. Jupiter 
Frank M. Kahr 
Roy A. Kaplan 
Donald L. Kent 
David L. Kneapler 
Philip W. Lebowitz 
Theodore M. Levin 
Stephen A. Liebhaber 
Paul A. Lucky 
Harry L. Malech 
Jeffrey S. Menkes 
Jerome H. Meyer 
Jorge A. Motta 
James A. Nathanson 
Thomas H. Ogden 
Edward J. Olinger 
Peter J. Panzarino, Jr. 
Louis Reik, Jr. 
William L. Risser 
Richard S. Robbins 
David H. Romond 
Philip M. Rothfeld 
Charles F. Scholhamer, Jr. 
John S. Smolowe 
Frederick D. Stock well 
Lawrence P. Temkin 
Philip J. Weyman 
Michael W. Yogman 
Steven M. Zeldis 
1973 
David A. Adler 
Marvin M. Chassin 
Joseph M. Connors 
David L. Coulter 
Christopher M. Doran 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert A. Florin 
Lee Goldman 
Gary V. Gordon 
Gary T. Grimes 
Neal Handel 
Wanda D. Huff 
David C. Johnson 
Andrew G. Kadar 
Michael S. Kramer 
Harold R. Mancusi-Ungaro, Jr. 
Mark G F McCormick 
John F. McQuade, III 
Claes M. Nilsson 
David E. Peach 
David Pickar 
John W. Popp, Jr. 
Charles F. Reynolds, III 
James S. Robertson 
Thomas J Romano 
Harry S. Romanowitz 
Jerrold F. Rosenbaum 
Joseph F. Simeone 
Robert A. Sirota 
John R. Stratton 
James F. Sullivan 
Thomas F. Sweeney 
Robert J. Ursano 
Christine A. Walsh 
Richard S.K. Young 
1974 
Stephen B. Arnold 
Irving M. Asher 
Leonard I. Banco 
Douglas A. Berv 
Neil Blumberg 
Peter J. Buchin 
Bert D. Collier, Jr. 
Paul David 
Vincent A. Di Maria 
Irl L. Extein 
Reginald K. Franklin 
Allan B. Friedland 
Michael A. Gerber 
Harvey Gerhard 
David Grant 
Robert F. Hempton 
Ancil A. Jones 
Robert M. Kolodner 
Leon F. Kraft 
Saul Lande 
Olusegun O. Lawoyin 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
Amy S. Schechter 
Robert J. Schechter 
James A. Strom 
George H. Talbot 
Carol C. Teitz 
John Jones Thompson 
1975 
Ralph E. Binder 
William S. Bush 
Chau V. Dang 
Stanley W. Gale 
James P. Grabman 
Carol L. Kandall 
Kevin Kane 
Richard J. Loewenstein 
Bruce B. McLucas 
Hyman J Milstein 
Mary Jane Minkin 
Edwin G. Olson 
George J. Pardos 
Daniel J Passeri 
Vivian Reznik 
Philip J. Rich 
Salvatore V. Romano, Jr. 
Fred P Rosenfelt 
Richard L. Roth 
Robert S. Sandler 
Steven A. Schwartz 
Barbara J. Stoll 
Henry S. Willner 
Douglas R Zusman 
1976 
Sarah S. Auchincloss 
Peter B. Bitterman 
Sharon L. Bonney 
Roger A Boshes 
Randall D. Cebul 
Helen Y. Y. Chang 
Pauline Y. Chao 
John D. Clemens 
Geoffrey Etherington 
Ira H. Gewolb 
Rose Hannah Goldman 
Glenn A. Gorlitsky 
Joel Kabak 
Norman V. Kohn 
William J. Lederer 
William K. Levy 
Paul R. Ramirez 
Mark C. Ruchman 
Lawrence E. Samelson 
Bonita F. Stanton 
Charles R. Swenson 
Jacob E. Tauber 
Robert F. Taylor 
Peter M. Ting 
John C. Wiles 
Jerome B. Zeldis 
1977 
Michael G. Adelberg 
John J. Boronow 
Richard D Bucholz 
Stuart Brian Dubin 
James A Fox 
Julia B. Frank 
Robert W. Hand 
Jeffrey Neal Hausfeld 
Bruce L. Inms 
Karen G. Kelly 
Howard K. Koh 
David J. Kreis, Jr 
Margaret S. McKenna 
Robert J. Mitchell 
Alan S. Penziner 
Theodore M. Pitts 
Steven J. Scheinman 
Ricky M. Schneider 
Susan Bromberg Schneider 
Simeon A. Schwartz 
Mark S. Smith 
Gail M. Sullivan 
Phyllis A. Taufield 
Ronald J. Vender 
Steven L. Warsof 
John E. Whitcomb 
J. Douglas White 
Daniel Wohlgelemter 
1978 
Michael J. Anderson 
Richard J. Baron 
Joann N. Bodurtha 
Booker T. Bush, Jr. 
Duke E. Cameron 
Howard M. Chase 
Eugene Glenn Fong 
Stuart M. Forman 
Arthur M. Gershkoff 
Linda J. Hall 
Robert Hershfield 
Robert L. Kraft 
Michael R Lemer 
Kenneth L. Marek 
Jose Luis Martinez 
Seth M. Powsner 
Donald C. Simonson 
Thomas Joseph Smith 
Rafael J. Tavares 
Caroline R. Taylor 
Marcia J. Wade 
Sharon R. Weinstein 




David A. Brenner 
J. Kenneth Burkus 
Stuart L. Bursten 
Isabel Cunningham 
John A. Fox 
Joel I. Franck 
Lloyd Friedman 
John Jay Gargus, PhD 
David E. Golan 
Bruce Halperin 
Edward C. Halperin 
Marc Hellerstein 
Jeffrey L. Kaine 
Michael K. Lindsay 
Shirley McCarthy 
Thomas R. Moore 
David E. Ness 
Barbara Ann Peters 
Jean Rosenthal 
Lynn K. Rudich 
Gary L. Schaer 
Eric A. Schwartz 
Cynthia Anne Sherman 
Alfred Windsor Sloan 
Pamela E. Smith 
Thomas Trumble 
John T. Woo 
Jeffrey Work 
1980 
David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R. Aronson 
David Allen August 
Jay M. Baraban 
Patricia Church Brown 
Michael W. Champeau 
Michael M. Chang 
Thomas F. Deering 
Jeffrey Neil Dornbusch 
Forrest John Doud 
Todd J. Garvin 
Marc F. Glickstein 
David Jay Goldberg 
Nancy S. Goldman 
Maria White Greenwald 
Gary I. Greenwald 
Barry M. Kacinski 
Theodore W. Marcy 
Cesar R. Molina 
Steven Ira Rosenfeld 
Jane G. Schweitzer 
Leslie W. Sojka 
Marcia R. Taylor 
1981 
Cynthia B. Aten 
Louann Brizendine 
Sherri L. Brown 
Stephen Wilson Burgos 
Patricia A. Burke 
Christine M. Duranceau, 
Paula M. Fracasso 
Judy E. Garber 
Robert S. Goldman 
Laurie J. Gordon 
Scott A. Hundahl 
Elliot Lach 
Mary Romig McKinstry 
Robert M. Milstein 
Richard L. Mogerman 
Robert B. Portney 
Barbara A. Roach 
Susan C. Schachner 
Dovelet Shashou 
Martin H. Teicher 
1982 
David August 
Sylvia R. Beck 
Muriel Cyrus 
Jed B. Gorlin 
Jessica Herzstein 
Daphne Hsu 
Rise Maura Jampel 
Henry Jampel 
Patricia Kellner 
Kathleen Anne Nolan 
Joyce A. O’Shaughnessy 
Dan B Odenheimer 
Carrie A. Redlich 
Robert J. Rizzo 
Lewis P. Rubin 
William M. Sikov 
Lynn T. Tanoue 
Jeffrey Tepler 
Albert L. Ungricht 
David A. White 
Stephanie Wolf-Rosenblum 
Charles D Wright 
1983 
John Taylor Adams* 
Robert E. Bookstein 
Elena Citkowitz 
Dianne Edgar 
David C. Helfgott 
William Kadish 
Ana Maria Lamas 
Laurie Margolies 
John H. Neal 
Dan A. Oren 
Augusta S. Roth 
Moshe Rubin, M.D. 
Daniel Paul Sabbeth 
David E. Schwartz 
Philip M. Spiro 
1984 
Charles S. Abrams 
Martha Ray Arden 
David I. Astrachan 
John F. Babich 
Leonard Bell 
Barbara Ann Coda 
Joseph G. DeSantis 
Conrad Jeffrey Duncan 
David A. Frank 
Kim A. Gutner 
Bruce G. Haffty 
Jeffrey N. Katz 
Michel Kliot 
Daniel M. Kolansky 
Jay R Kostman 
Richard L. Leff 
Lynn B. Mehlman 
Steven A. Porcelli 
William A Rios 
Paul B. Rothman 
PhD Mark Stein 
Fong Wang 
Charles M Zacks 
1985 
Michael Behrman 
Barry D. Bergquist 
Stafford R. Broumand 
Bryan DeSouza 
Barbara Guillette 
Robert S.D. Higgins 
Marie Hobart 
Stuart Neal Isaacs 
Michael A. Johnson 
Susan Korrick 
Shirley J. Lee 
Ted W. Love 
Anthony Marks 
John Jerome Merendino 
Elizabeth G. Moy 
Jon Nakamoto 
Robert D. Needlman 
Leslye C Pennypacker 
Samuel Richard Pesin 
Ellen C. Rieur 
Richard A. Ruiz 
Greg A. Sachs 
Fred Santoro 
Joshua D. Schor 
Louis J. Tesoro 
Class of 1985 
1986 
Catharine Ann Arnold 
Eric F. Bernstein 
Samir M. Bhatt 
Amanda B. Dill 






Manuel B Litchman 
Gregory J. Orloff 
D. Bradford Reich 
Gary L. Shapira 
Andrew W. Steele 
Eric P. Suan 
Steven Waisbren 
Former House Officers 
N Erick Albert 
Neil S. Alex 
Michael Francis Angel 
Abel A. Applebaum 
Alan Milford Aron 
Harold Lewis Atkins 
John M. A versa 
Adel H Ayoub 
Robert G. Bachand 
Ronald J Bailey 
Arnold M. Baskin 
Richard Bass 
Carl Bennett Bean 
Gerald A. Belkin 
Gregory Kent Bergey 
Larry Berte 
Kenneth R Berv 
Mary C Bibro 
Ralph Daniel Bien 
Richard A. Blasband 
William K Boss, Jr. 
Laurence A Boxer 
James L. Boyer 
Hubert B Bradbum, Jr 
Alan L Breed 
Steven A. Brody 
Thomas M. Brown, Jr 
Robert A. Buccino 
Daniel J. Buchalter 
Thomas N. Byrne 
William J. Callahan 
Dennis J. Card 
Victor Carpiniello 
Richard S. Casden 
J Richard Casuccio 
John C. Cate, IV 
Joseph B Chandler 
Whei C. Chang 
Girard A. Chapnick 
Richard Allen Chase 
Martin S. Chattman 
Chang Song Choi 
Michael Chun 
Leo J. Clark 
Lawrence S. Cohen 
Ian M. Cohen 
David L. Copen 
Sidney L. Cramer 
Robert E. Crootof 
F. Mitchell Cummins 
Martin Thomas Davis 
Daniel M. Divack 
Donald S. Dock 
Richard K. Donabedian 
John W Drake 
Alan Dror 
William R Drucker 
Patrick R. Duffy, Jr. 
Frank H. Duffy 
Tom W. Duke 
Israel Dvorctzky 
Marlene R. Eckstein 
Stephen A. Edelstein 
Lawrence B. Eisenberg 
Malcolm Mitchell Ellison 
Walter Ettinger 
Charles Farrow 
Alvan R. Feinstein 
I chard Webster Finner 
Morris A. Flaum 
Bruce T. Fletcher 
John N. Forrest, Jr 
Daniel J. Friedenson 
Gary E. Friedlaender 
Norman H. Gahm 
George O. Gelinas, Jr. 
David M. Gershenson 
V. Philip Glassman 
Leonard Gold 
Barry Goldberg 
Nelson H. Goldberg 
John W. Goldkrand 
Peter A. Goodhue 
Isaac Goodrich 
Richard Reed Gramse 
Willard F. Greenwald 
Gordon W. Grundy 
Joseph Guaraldo 
Hedda Ann Litowitz Haning 
Donald H. Harter 
Mary M Herman 
Stanley Hersh 
A Douglas Heymann 
Judith Hochstadt 
Clifford L. Hoyle 
David Smith Hubbell 
Eric A. Hyson 
Henry G. Jarecki 
Rollin M Johnson 
Robert M Johnston 
Clifford Joseph 
Juliana Haeng-Cha Kang 
Jill P Karpel 
Lee D Katz 
Bernard L. Kaye 
David J. Keller 
David M Kessner 
Stephen King 
Samuel C. Klagsbrun 
Lawrence E. Klein 
E. Larry Knight 
Richard Knobelman 
Thomas J. Koontz 
Eugene Kuchner 
Joel C. Labow 
Randi Leavitt 
Samuel M. Lemer 
Stanley B Levine 
Arthur L. Levy 
Joseph W. Lewis, Jr. 
Steven Macht 
Abraham Mandel 
Edward J Man well 
Kim Margolin 
Stephen Mariani 
Joan L. Martinez 
Frank Masino 
Richard J Maunder 
Pamela M McBogg 
John P McGovern 
Thalia Mesologites 
Gerald L. Meyers 
John H Monroe 
Patrick E. Moriarty 
Lloyd A. Moriber 
Lewis B Morrow 
John Moses 
Michael H Moses 
Hans C. Muechler 
Seymour Cy Nash 
George Nichols 
Gwendolyn B. Nichols 
Richard A. Norton 
William L. Nyhan 
Joseph Manuel Ortiz 
Raymond L. Osborne, Jr 
Robert L. Paltzik 
Gary R. Pasternack 
Pradip M. Pathare 
Gordon K. Phillips 
Emanuel T. Phillips 
Jerold J. Principato 
Erwin R. Rabin 
Edward L. Racek 
Gilbert A. Ratcliff 
Ranjit Rath 
Stephen Rawe 
Peter A. Rice 
Jeffrey P. Robbins 
Claude Roge 
Jean F. Rogier 
Leon E. Rosenberg 
Fred M Rosenbloom 
Stephen A. Ross 
Allen Rossman, III 
David R Rubinow 
Mary Sanders 
Michael Saruk 
Sheldon K. Schiff 
Lowell E. Schnipper 
Robert Schnurr 
Carl I. Schoenberger 
Marianne Ida Schuelein 
Louis N. Scotti 
James Thomas Sehn 
Richard Alan Selzer 
Howard Senter 
Edwin C. Sevennghaus 
Carlton C. Sexton 
Thomas E. Shaffer 
Daniel W. Shapiro 
Ezra A. Sharp 
Gary R. Siegel 
Joel Silidker 
Frederic N. Silverman 
Robert E. Silverman 
Paul I. Silverstein 
Earl J. Simburg 
Domenick Sisto 
Richard I. Staiman 
Sally K. Stansfield 
Don Starr 
John G. Steciw 
Sturla Stefansson 
Elsa L. Stone 
Fred Leslie Strieker 
Craig Summers 
Herbert Tabor 
I mad F. Tabry 
Troy L. Thompson, II 
Daniel W. VanHeeckeren 
Martyn A. Vickers, Jr. 
Milton Virshup 
E Maurice Wakeman 
Thomas A Warthin 
James E. Watson 
Alan Weinberg 
Lionelle Wells 
Ssu I. Weng 
Herbert Allan Wenner 
George Wharton 
Robert R White, 3d 




Robert C. Young 
Richard Walter Zimmerman 
Marvin Paul Zimmerman 
Lawrence H Zingesser 
Louis Zinterhofer 
Parents and Friends 
Mr. Irving Abelow 
Mr Myles H. Adelman 
Kurt I Altmann 
Nancy Andreoni 
Stanley August 
Mr. Robert August 
Drs. John and Marie Babich 
Stuart M. Berkman 
Malcolm Brochin 
Mr. Hormoz K. Broumand 
Harriet Farnsworth Brown* 
Mr. Harold Burg 
Ms. Minnie R. Cartwright 
Mr. & Mrs. Abe Cazen 
Ms. Betty Chelmow 
Mr. & Mrs. Richard S. Childs 
Mr. Howard Chin 
Mr. Henry A. Christopher 
Mrs. Susi Chung 
Mr. & Mrs. Sidney J. Cohen 
Mr. Fred C. Colin 
Mrs. Yvonne M. Conrad 
Willibald H. Conzen 
Mrs. Judy Coppola 
Anthony Deluca* 
Mr. Edward J. Dilisio 
Mr. Arthur E. Dolnansky 
Mr. & Mrs. Kenneth T Doran 
William G. Dyess 
Mr. Max Finkelman 
Gerald Wilfred Friedland 
Mr. Yuan C. Fu 
Mrs. Ana M. Garcia 
Dr. Jose M. Garcia-Madrid 
William J. German* 
Mrs. June Girard 
Dr Herbert I. Goldman 
William & Isabel Goodrich 
Mrs. Harold Grant 
Dr. Myron Greengold 
Mrs. Barbara J. Guillette 
Mr. Kenneth H. Gutner 
Frederick W. Heilman 
Carl Hirshfield 
Mr. Norman J. Hobbin 
Mrs. Gloria F. Holmes 
Jacques Hussussian 
Dr. & Mrs. Robert Karol 
John F. Keaney 
Mrs. Juanita Kessler 
Kenneth P Kinney 
Mr. Boris Kliot 
Mr. T. D. Lee, Jr. 
Mrs. Amy G. Lloyd 
Leighmin James Lu 
Mrs. Virginia G. Mannick 
Mr. James C. Marsters 
Mr Shizuo Matsui 
Mr Earl M. McChesney 
Harry Meisels 
Myron Roy Melamed 
Mr Arthur P Miller 
Pedro Miro 
Mr. & Mrs. Victor M. Newman 
Mr. Marshall D. Newton 
Dr William G. O 
Jon Ogland 
Mr. & Mrs. Louis Parent 
Mr. Samuel Perlman 
Mr Morris Price 
Mr. Edward A. Quattrocki 
R. Donald Reich 
Mrs. Yolanda Rivero 
Mrs. Yolanda Rivero 
Mr. Joel G. Roth 
Dr. & Mrs. Carl E. Rothschild 
Harold & Frances Sampson 
Henry S. Sanematsu 
Mr. Jacques Scharoun 
Dr. Joseph Schlesinger 
Arthur A. Shachner 
Mohan N. Shrestha 
Mr. Stanley M. Silverberg 
Mr. & Mrs. Philip Soskis 
Mr. Barry S. Spector 
Mrs. Gertrude Spinelli* 
Kenneth Alan Stein 
Argyle Stoute 
Prof. & Mr. Lubert Stryer 
Mr. Malcolm H. Stull 
Mrs. Leo Teitz 
Thomas M. Tierney 
T. Beers Townsend* 
Mr. Zaccheans O. Ukomadu 
Mrs. Albina K. Vazquez 
Mr. Harold Weinberg 
Mr. & Mrs. Milton Weinberg 
Jack Weingold 
James Wells* 
Marion W. West 
Mr. & Mrs. Herman H. Zusman 
* deceased 
Contributors to the Public Health Alumni Fund 1986-1987 
1921 
Ira V. Hiscock* 
1926 
John J. Batchelor 
1929 
Gertrude S. Boyle 
1930 
Ruth E. Grout 
1933 
Miriam M. Campbell 
Elizabeth Murphy 
Eunice Nickerson Tyler 
1934 
Amy H. Hunter-Wilson 
Iwao M. Moriyama 
1935 
Franklin M. Foote 
Almeda King 
1936 
M. Allen Pond 
1937 
Lidie V. Dyer 
Howard West 
William R. Willard 
1938 
Willard H. Boynton 
Richard K C Lee 
Katharine Hawley Martin 
Jean H. Nelbach 
1939 
Carl I. Cohen 
James C. Hart* 
1940 
Elizabeth H. Pitney 
1940 
Meyer J. Plishner* 
1941 





Arthur B. Robins 
Charles D. Spangler 
1943 
Carolyn S. Koffler 
Eric W. Mood 
Miriam H. Rohde 
Jane L. White 
Muriel Bliss Wilbur* 
1944 
Jean F. Heston 
Jane Y. Parker 
1945 
Roslyn R. Bilford 
Naomi Barer Golden 
Joe Bales Graber 
Lois M. Jund 
1946 
Dorothy B. Hamilton 
D. Patricia Nelson 
1947 
Anne E. Fulton 
Lillian L. Konick 
Raymond W. Leonard 
Edna Miller 




John B. Dibeler 
Mary L. Ellis 
Mary Margaret Fitzgerald 
Samuel S. Herman 
Richard E. Johnson 




Edgar L. Geibel 
Eleanor P. Kostant 
Hilda H. Kroeger 
Edmund R. Mattos 
William B. Parsons 
Elizabeth D. Robinton 
Mary C. Springer 
1950 
Henry G. Brickman 
Hilda B. Carr 
Helen P. Cleary 
Austin J. Evans 
Jerome M. Glassman 
Dorothy R. Granoff 
Martha P. Jayne 
Frances K. Reynolds 
Nathan M. Simon 
1951 
Clarissa E. Boyd 
Robert L. Johnson 
Leonard F. Menczer 
Emi T. Rausch 
Jessie Parkinson Spear 
Angelica Z. Syseskey 
Elizabeth Ulrich Throm 
Walter Wenkert 
John J. Zugich 
1952 
Cahit H. Corbacioglu 
Mary M. Del Piero 
Howard Dunphy 
Joanna Adele Henry 
Malcolm C. Hope 
Charles Holway Lawrance 
Sidney S. Lee 
Helen Kardys Loria 
Yolande F. Lyon 
Richard B. Ogrean 




Harold Robert Bemshock 
Graydon Dorsch 
William H. Hermann 
Fraser M. Mooney 
Laurence K. Rainsford 
Milton H. Sisselman 
Constance B. Thomas 
1954 
Donald R. Cowan 
Calvin P. Hatcher 
Ruth M. Taber 
1955 
Constance T. Beemer 
Amy L. Cawley 
Evelyn S. Farnsworth 
Morris London 
Mary Me C. Mogan 
Frances R. Ogasawara 
Gerald Rosenblatt 
Daniel E. Ross 
1956 
David D. Boyd 
Marvin H. Burton 
Kathleen H. Howe 
Paul C. Kaufman 
John F. Mullett 
Julia R. Nole 
Mary K. Ochiai 
Alice M. Wagner 
1957 
William A. Clermont 
Edward R. DeLouise 
Sheldon Selig King 
Jerome R. Sapolsky 
Shirley T. Steidel 
Sylvia R. Talbot 
Patricia A. Viscosi 
1958 
Eduardo Anzola 
Helen H. Davenport 
Thomas T. Flynn 
Normand E. Girard 
Philip B Hallen 
Edward H. Noroian 
Joseph A. Scorpion 
Mary K. Spiker 
Thomas P. Weil, PhD 
Robert Kenneth Wood 
1959 
Rita Dingman 
John T. Foster 
Folly Hofer 
Erica J. Koehler 
Marvin A. Lavenhar, PhD 
Hugh J. Maher 
John F. O’Connor 
Lee J. Podolin 
John S. Pullman 
Ellwyn D. Spiker 
Mattie Lee D. Wade 
Kenneth J. Williams 
Dorothy M. Wilson 
1960 
Gyla E. Brooks 
Thaddeus B. Curtz* 
Kathryn L. D'Amico 
Wouter Ekker 
R John C Pearson 
Hannah Clark Russell 
1961 
Gordon R. Beem 
Alfred E. Fletcher 
Helen M. O’Connell 
Joseph T. Prekup 
William R. Slivka 
Harold W. Wicks 
1962 
Richard B. Blakney 
Thomas A. Blumenthal 
John R. Galbraith 
Charles A. Macintosh 




Frank M. Isbell 
Edward M. Kenney 
Cecilio O. Maningas 
Jean M. Maynard 
George Eddy Parker 
David R. Sheehan 
Rosemary W. Stevens 
Samuel B. Webb, Jr. 
1964 
Maria S. Baisier 
Elizabeth C. Beilis 
Bartley H. Calder 
Katherine Maria Detre 
John S. T. Gallagher 
Linda F. George 
Carter L. Marshall 
Neal L. Maslan 
Carole S. Profant 
Theodore Rosenberg 
Estelle Siker 
Monroe W. Spero 
1965 
Robert M. Edwards 
H. Patterson Harris, Jr. 
William C. Harvey 
James F. Jekel 
Warren C. Kessler 
Michael E. Kove 
Peter J. Levin 
Norman R. Penner 
Elliot A. Segal 
Viola J. Spinelli 
Matagiese G. Tunoa 
Sarah L. Thmer 
David S. Weiner 
1966 
Richard W. Benfer 
Barbara L. Brody 
Allen Cohen 
Amalia P. Crago 
Dorothy Noyes Kane Evans 
Diana B. Fischer 
Robert C. Lowrie, Jr. 
Nancy Alfred Persily 
Gary J. Robinson 
Arthur J. Schreier 
1967 
Carlos E. Alvarez Herrera 




Joel Kavet, SCD 
Joseph F. Kukla 
Dennis J. Magid 
Patricia D. Mail 
James M. Malloy 
Nancy Ruth Phillips 
Brigitte Prusoff 
Bruce J. Steinhardt 
Robert L. Woodward 
1968 
Sonia M. Colon 
Joseph L. Dorsey 
Robert R. Everett 
Carl R Fischer 
Michael J. Geaney, Jr. 
Francis J. Greaney 
Susan F. Klein 
R. Elizabeth Leif 
Harold C. Lovely 
Jean C. MacCorison 
Robert F. Morisse 
John M. Patton 
Richard L. Petrelli 
Arnold R. Saslow 
Cornell Scott 
Elizabeth A. Small 
Elizabeth C. Wright 
1969 
Susan S. Addiss 
Janet A. Albrecht 
Victor Crown 
James M. Dawson, Jr. 
Gerald R. Harpel 
Charles T. Heaney 
Sylvia N. Holtzberg 
Charles C. Jeffrey 
Samuel P. Korper 
Judith B. Nichipor 
Phyllis J. Pallett 
Marva Serotkin 
Wanda Vierthaler 
Robert L. Young 
Chester W. Zamoch, Jr. 
1970 
Susan W. Balter 
Robert T. Beeman* 
Arthur A. Berarducci 
Michael B. Bracken, PhD 
Shan Cretin 
Forrest G. Dressier, Jr. 
Walter M. Gawlak 
Robert S. Gureasko 
C. P. Noel McCarthy 
Saro Palmeri 
David A. Pearson 
Nancy Norton Reitz 
Charlotte F. Schwartz 
Stephen Skorcz 
Brian D. Sullivan 
Carol B. Von Stein 
Donald S. Wilkinson 
Joseph A. Zaccagnino 
1971 
John Bihldorff 
Evelyn J. Bromet 
William F. Carey, Jr. 
Katrina H. Clark 
John A. Daeley 
Harvey Fembach 
William P. Ferretti 
Billie S. Hamblin 
Sara P. Hartman 
Wanda J. Hatmaker 
Mohamed Ismail Johnson 
William P. Koughan 
Bernard G. Koval 
Mark J. Magenheim 
Eugene S. Mayer 
Joseph S. McManus 
Nancy P. Mogielnicki 
Wan Hin Ooi 
Carol L. Paul 
Jane Silver 
deceased 49 
Robert E. Steele 
David L. Stockton 
1972 
David P. Barone 
Steven H. Beloff 
Frances L. Bushnell 
Catherine A. Connolly 
Daphne deJ. Gemmill 
Jean T. Harrison 
Dorothy N. Lewis 
Steven M. Lipsius 
Jorge A. Motta 
Sergio Ruschel 
Jo Ann K. Silverstein 
Gerald A. Starr 
Laurence A Tanner 
Joyce R. Waksman 
1973 
Emily M. Barclay 
Eva Danielsson Cohen 
Ellen B. Doft 
Bruce Goldman 
Marilyn S. Halper 
Hans V. Holt 
Helen B Hubert 
Chang S. Lao 
Dennis P May 
Dwight N. McNeill 
Charles D. Mross 
Marjorie E. Nelson 
Jacqueline M. Rosenthal 
Gary Dean Sax 
Janet B. Schoenberg 
Alice S. Stark 
Thomas J. Stranova 
Irene Trowell-Harris 
Bonnie C. Yankaskas 
Carl J. Zack 
1974 
Rose Salisbury Beer 
Thomas A. Benoit 
Ian B Berger 
Carl A. Cappello 
Beth G. Crocker 
J. Breckenridge Eagle 
Elizabeth M. Helming 
Kirby O. Kloter 
Roberta Lawrence 
Karen K. Lindfors 
Evelyn B. Mostow 
Edward J. Mullen 
Deborah Rose 
Shelley S. Shanok 
Abigail L. Smith 
Bienvenido G. Yangco 
1975 
Edith N. Baum 
Ralph E. Binder 
Gerald E. Bisbee, Jr 
Linda K. Broker 
Linda K. Demlo 
Gerard R Goulet 
William J. Grego, Jr. 
Anne H. Hall 
Edward J. Halloran 
Donald L. Harris 
Kenneth G. Hill 
Rosemary M. Johnson 
Barbara R Untcrman Jones 
Philip D. Kennedy 
Amy P. Kentera 
Kathy S. Keuning 
James E. Knoben 
Stuart I Lcfkowich 
John T Lynch 
Laurence F. McMahon, Jr. 
Eileen M. O’Gara 
Edward J. O'Neill 
Mary W. Palshaw 
William P. Quinn 
Audrey Weiner Solomon 
Nancy E. Stroup 
Raymond Chiu-Ping Tang 
John H. Tobin 
Maura M. Tobin 
Thomas J. Trudell 
Franziska U. Ulrich 
Pat Boylston Whitt 
1976 
Elaine P. Anderson 
William F. Appicelli 
Kathleen Keenan Bucholz 
Cynthia D. Butler 
Helen Y. Y. Chang 
Frances L. de Peyster 
Paul H Etkind 
Robert H. Frazier 
Annette B Garofalo 
Gail lies Genvert 
Cleve Lee Killingsworth 
Robert A Knauf 
Janina Levy 
Lawrence V. Meagher, Jr 
Gino A. Nalli 
James B. Rokos 
Robert Risdon Schwarz 
Mary Jo Shepard 
Thomas S. Wingardner, Jr. 
1977 
Richard B. Burford, Jr. 
Steven R. Cohen 
Chantal C. Dotoli 
Marsha E. Dunn 
Gerard J. Foley 
Paula Yaney Gambill 
Rhona Kantor Kershnar 
Teri J Klein 
Ronald F. LaPensee 
Polly W Marvin 
James M O’Connor 
Kristin K. O'Connor 
Veronica C. Oestreicher 
Harris Pastides 
Linda Mendelsohn Pottern 
Dorothy A. Rice 
William T. Richards 
Abby Rothschild 
Anthony V. Sardinas 
Carroll Schilling 
Young S. Shin 
Gail M. Sullivan 
Rose M. Truax 
Thomas H. Ulfelder 
Leon F. Vinci 
John Stephen Zil 
1978 
David S. Abernethy 
Kathleen M Berman 
Bradford A. Buxton 
Maura Carley 
Ann T. Freedman 
Janice F. Gold 
Cynthia R. Gross 
Olympia Hadjimichael 
Patricia S. Harfst 
Stephen W. Hildreth 
Jane E. Hill 
David W. Houck 
Margaret Long Karis 
Christopher M. Maylahn 
H. James Myers 
Marguerite Nelligan 
David W. Osborne 
Michael H. Owens 
Elizabeth L Pantelick 
Ellen D. Rothberg 
Karen C. Schneider 
Roberta Jo Shapiro 
Gloria Shappy-Meickle 
Karen Wolchuck Sher 
Marie Stoeckel 
Sydney S. Tang 
Bernadette S. Vissani 
Lucy Ellen Weiger 
1979 
Virginia P. Bainbridge 
Joann N. Bodurtha 
Jonathan Brenn 
Elizabeth S. Carter 
Richard T. D’Aquila 
Susan De Renzo 
Frances D. Dwyer 
Kathe P. Fox 
Judith B, Gancher 
Debra Haffner 
Bruce H. Heckman 
Shelley Helfer-Amira 
Loren R. Kantor 
Phillip S. Katz 
Karen Kmetzo 
Paul Anthony Kowalski 
Renee S. Leary 
Bennett Myles Locke 
Mary Elisabeth Lorenzi 
Osvaldo Marrero 
Laure C. Nichols 
Catherine Norton 
Dolores Perteet 
Marcia C Richardson 
Lisa K. Rosenfeld 
Elisabeth Luttgens Santulli 
William E. Schweizer 
Audrey P. Silvey 
Ralph Tartaglione, Jr. 
Ilene B. Wachs 
Louise Wise 
1980 
Phillip R Aaron 
Diane Denis Aye 
Curtis S. Breslin 
Antoinette M. Brooke 
Richard L. Buck 
Sheila Conneen 
Martha G. Dale 
Anne Morrison Danaher 
Phyllis F. Dower 
Alfred E. Fasulo, Jr. 
Audrey L. Fetter 
Barbara H. Granger 
Ellen B. Greif 
Irwin J Halperin 
Samuel S. Hamilton 
James P. Harisiades 
Virginia S. Humphrey 
Johanna C. Hunt 
Helen E. Kelly 
Yee-Lean Lee 
Robert V. Levine 
Kathleen A. Lewis 
Leroy F. Ludwig 
James S. Marks 
Linda L. Moraga 
Steven Morrow 
Jane Ungate O'Connor 
Ann L. Prestipino 
Christina P. Quinn 
Nancy Maguire Rhodes 
Jeri Ann Rose 
Kathleen M. Scribner 
Lydia A. Selling 
Marsha L. Silverman 
Richard Gerard Stracqualursi 
Gary F. Velat 
Carolyn K. Wells 
Philip A. Witman 
Marie L. Zanotti 
Barbara A. Zappas 
1981 
Jean Adnopoz 
Christopher J. Bevan 
Rebecca L. Calderon 
Kimberly J. Chauncey 
Rollin C. Chew 
Ann M. Dunbar 
Julia Eisenstein 
Brian J. Foley 
Kristen H. Forrest 
Ellen M. Gallagher 
Judy E. Garber 
Barbara A. Gaugler 
Louis M. Gonzalez 
Joan Urquhart Goodman 
Gerlinde B. Hermann 
Susan E. Jennings 
Jill L. Lapides 
Charles R. Lawson 
Blackford Middleton 
Howard J. Newman 
Mary E. Papke 
Gerald W. Robinson, Jr. 
Idalia Sanchez 
Elizabeth N. Shapiro 
Karin Swanson 
Keith D. Tait 
Nancy Schlesinger Weiss 
1982 
Margarita Acosta 
Jamie L. Amaral 
Jenny I. Andrus 
Janet M. Bedney 
Francis L. Crowley 
Barbara L. DeCesare 
Kathleen K. Devine 
Cyndie B. Gareleck 
Meryl Beth Gold 
James L. Hadler 
Nancy Conlee Hart 
Denise Heinemann 
Karla A Hitchcock 
Constance M. Jarowey 
Charles A. Klivans 
Ann Storms Kloter 
Kevin R Lucey 
Linda F. Me Caig 
William F. McKeon 
Jean L. Milton 
Tsuneki Mizuta 
David L. Mork 
Carolyn Xavier Oreutt 
Erica Pifer 
Susan G. Poland 
Mercedes H. Primer 
Marie Zullo Rice 
Sally R Rinaldi 
Christopher J Rogers 
Dale Allan Rublee 
Lisa E. Stone 
Carol L. Vander Wal 
Michele T. Visconti 
Sandra Michaelson Warren 
Alvin C. White 
Amy B Wilson 
Jill Okrent Zaheer 
1983 
Barbara W. Abraham 
Joseph A. Amatruda, Jr. 
Dean S. Archibald 
Eileen Conlon 
Robert A. Duncan 
D J Safiya Edwards 
Susan Faris 
Rosanne G. Flaks 
James N. Gaito 
Ellen M. Ginzler 
Halesteen Graham 
Virginia C. Hiland 
Jeffrey B. Hughes 
Nancy R. Kellett 
Sandra Knight 
Margaret M. Kolb 
Linda S. Leo 
Allen F. Levy 
Peter W. Lyden 
Wendy L McGill 
Scott K. Mock 
Judith F. Nelson 
Suzanne Nutt 
Nano G. Rush 
William Sabella 
Marilyn F. Vine 
Rita E. Watson 
Patricia C. Weber 
Vicki L Wilson 
Timothy B. Young 
1984 
Leslie A. Balch 
Jean L. Freeman 
Carolyn H. Grantham-Millman 
Penny H. Hausser 
Sarah M. Horwitz 
Robin B. Kupfer 
Jean G. Larson 
James H. Reich 
Julie A Russem 
Dennis G. Shrauger 
Gerald L. Springer 
Marie Ann Tobin 
1985 
Christine D. Berman 
John L. Binder 
Sally J Erdman 
Grace P. Erickson 
Katherine Santella Fitzpatrick 
Barbara K. Gottlieb-Ware 
Suzanne S. Huang 
Kathryn L. Keller 
Unhee Kim 
Merian D. Klein 
P. Douglas McConatha 
Susan M. Moore 
Heather Oliver 
Adrian J. Pinsince 
Marie V. Roberto 
Heidi Roberta Sulis 
Shirley J. Tirrell 
Terry Martin Zingman 
1986 
Andrea Lee Boissevain 
Lewis P Bower, Jr. 
Marie Irene Ciacco 
Lori Ann Cohen 
Robert S. Dobkin 
Joe Tom Easley 
Michelle F. Getches 
Michael S. Huncharek 
Wendy Lee 
Monica Ann O’Neill 
Tracey M Orloff 
Joseph M. Pajor 
* deceased 
Elizabeth G. Pelz 
Philip O. Renzullo 
Denise Amy Riedel 
Allen Arthur Ries 
Norman C. Schipke 
Carrie Shepard 
Eric Triffin 




Bruce P. Ameill 
Anthony J. DeLuca* 
Lorraine V. Klerman* 
U. Robert Merikangas* 
John L. Quigley 
George A. Silver 
C. Thomas Smith 
Nicholas PR Spinelli 
Virginia R. Towle 
Terrie Wetle 
Sterling Association 1986-1987 
Life-time Benefactor 
Berthold M. Comeau ’28* 
Robert R Wagner ’46 
Sponsor 
J. Roswell Gallagher '30 
Reginald V. Berry ’32 
James Quintin Haralambie ’35 
Theodore E. Allen ’40 
W. Randal Bell ’41 
Robert E. Carroll ’42 
William Harrison, Jr. ’42 
John C. Coolidge ’44 
Oliver Townsend Dann ’62 
Michael J. Cummings ’65 
M Felix Freshwater '72 
Class of 1950 In Memoriam Fund 
Patron 
Amy H. Hunter-Wilson ’30 
John B. Ogilvie ’34 
Sidney L. Lasell ’41 
Sidney S. Lee ’50 
Lowell I. Goodman ’51 
Sidney Nathan Paly ’52 
Mary Wheatland Schley ’52 
John D’Agostino, Jr. ’57 
Edward O. Fox ’57 
Leo H. Von Euler ’59 
J. Thomas Okin 60 
Dennis Grant Egnatz ’67 
Former House Officers 
Richard Allen Chase 
Parents and Friends 
Argyle Stoute 
Fellow 
David M. Raskind ’24 
Donald F. Gibson ’27 
Louis M. D’Esopo ’28 
Lewis A. Scheuer ’28 
Vincent A. Doroszka ’30 
John T.B. Carmody ’32 
Joseph P. Donnelly ’32 
Harry Sherman ’34 
Donald Peter Morris '35* 
George Hahn ’36* 
Frederick A. Post ’36 
Alfred E. King ’37 
Willys M. Monroe ’41 
Michael A. Puzak ’42 
Class of 1942 In Memoriam Fund 
Ralph D. Alley ’43 March 
Carl E. Andrews '44 
Lawrence G. Crowley ’44 
Nicholas PR. Spinelli ’44 
Thomas J. Coleman ’46 
Martin E. Gordon ’46 
George R Barnes, Jr. ’47 
W. Roy Breg, Jr. ’47 
Owen W. Doyle ’47 
Brock Lynch '47 
Paul B. Koehler ’48 
Russell N. Anderson ’50 
Lyal D. Asay ’50 
John E. Borowy ’50 
Claude W. Delia ’50 
Kent Ellis ’50 
Daniel Fine '50 
Harry L McClelland ’50 
Robert F. Owen ’52 
Robert B. Schultz ’52 
William H. Hindle ’56 
Albert K. Chun-Hoon '51 
Jack Levin ’57 
Clifford B. Reifler ’57 
Donald C. Stahl ’57 
Philip R. Fazzone ’58 
Paul A. Rudnick ’58 
Ralph J. DePonte ’61 
Anoush Miridjanian ’61 
Warren D. Widmann '61 
James A E Spencer ’62 
Robert E. Mueller ’63 
Peter G. Weiner ’63 
Leland S. Berger ’64 
Robert W. Lyons ’64 
Donald G. Skinner ’64 
Mohandas M. Kini ’65 
Jay G. Hayden ’66 
Gary L. Townsend ’66 
Richard J Hart, Jr. ’67 
George P. Herr ’67 
Robert I Roy ’67 
Jeffrey S. Lee ’68 
James W. Ogilvie ’68 
Laurie J. Bleicher ’71 
John W. Foster, Jr. ’71 
Richard Albert Moggio ’71 
Robert F. Deblasi ’72 
Former House Officers 
Samuel M. Lemer 
John P. McGovern 
Jerold J. Principato 
Parents and Friends 
Frederick W. Heilman 
Associate 
Robert L. Rowley ’03* 
Walter C. Tilden ’12* 
Nathan E. Ross ’28 
Knox H. Finley ’30 
Charles L. Wood ’30 
Norman E. Peatfield ’35 
David A. Dolowitz ’37 
Benjamin F. Hoopes ’37 
Wilbur D. Johnston, DDSM ’37 
Julia Mehlman ’37 
Charles W. Neuhardt ’37 
Alan A. Rozen ’37 
Morgan Sargent ’37 
William H. Druckemiller '39 
Rebecca Z. Solomon ’39 
Thaddeus S. Danowski ’40 
Robert H. Areson ’41 
Robert W. Ollayos ’41 
Leo Kellerman ’42 
Edgar B Taft, MD ’42 
Maurice Tulin ’42 
R. Leonard Kemler ’43 March 
Bernard R. Rowen ’43 March 
Henry H. Jones ’43 December 
Frederick F. Krauskopf ’44 
A. Reese Matteson ’44 
Eugene Smith ’44 
Franklin C. Behrle ’46 
William F. Collins, Jr. ’47 
William K. McClelland ’47 
Myron K. Nobil ’47 
Irving Rudman ’47 
Sumner Root Ziegra ’47 
Allyn G. Bridge ’48 
Richard Steele Buker, Jr. ’48 
Sylvia Preston Griffiths ’48 
Jerome H. Shapiro ’48 
Anne G. St. Goar ’48 
N. Joel Ehrenkranz ’49 
William H Bucher ’50 
Janus C. Lindner ’50 
Orlando J. Miller ’50 
Myra D. Tyler ’50 
Thomas T. Amatruda, Jr. ’51 
Gerard B. Odell ’51 
Donald H. Schultz '52 
Arthur C. Crovatto ’54 
Lowell E. Olson ’54 
Robert L. Stein ’54 
James Conway Garlington 55 
Mitchell Edson ’56 
John Herd Hart ’56 
Marie-Louise T. Johnson ’56 
Donald J. Nalebuff ’56 
Harry C. Briggs ’57 
Ronald H. Fishbein '51 
Robert J. Donohue, Jr. ’58 
Andrew Joseph McGowan, Jr. ’58 
Richard Charles Miller '58 
Raymond W. Turner ’58 
Carol J. Amick ’59 
Robert M. Amick ’59 
Paul Jay Friedman ’59 
H. Rodney Hartmann ’59 
James A. O’Neill, Jr. ’59 
James R Ralph ’59 
Paul Jay Friedman ’60 
Roland H. Ingram, Jr. ’60 
Albert A. Bechtoldt, Jr. ’61 
Robert S. Briggs ’61 
Jon Dudley Dorman ’61 
Charles B. Anderson ’62 
Ray Allen Carlsen ’62 
I Bruce Elfenbein ’62 
John N. German '62 
Carter L. Marshall ’62 
William A. Miller ’62 
A. Richard Pschirrer ’62 
David Seil ’62 
Nancy Ann Staley ’62 
H. Oliver Stoutland ’62 
Seth Thaler ’62 
Stewart R. Wright ’62 
Arthur Howard Ackerman ’63 
Alexander R. Gaudio ’63 
Lawrence Tremonti ’63 
Peter A. Gross ’64 
Richard Murray Linburg ’64 
A. Thomas Snoke ’64 
Oscar Wand ’64 
Paul Balter ’65 
David A. Hill '65 
Gene A. Robinson ’65 
John A. Drews ’67 
John O. Pastore ’67 
Joseph F. Walter ’67 
Redford B. Williams, Jr. ’67 
Daniel E. Keim ’68 
Charles T. Post, Jr. ’68 
Ralph J. Falkenstein ’69 
Paul A. Markey '69 
Joseph M. Rochford ’69 
Dennis J. Rudzinski ’69 
Adrian M. Schnall ’69 
Thomas H. Gouge '70 
John A. Patti ’71 
Jerome H. Meyer ’72 
Gary T. Grimes ’73 
Leon F. Kraft ’74 
Mark C. Ruchman ’76 
Former House Officers 
Samuel C. Klagsbrun 
Parents and Friends 
Willibald H. Conzen 
Gerald Wilfred Friedland 
R. Donald Reich 
Arthur A. Shachner 
Member 
Michael A. Parlato ’08* 
Helen P. Langner ’22 
William Cohen ’23 
Julius A. Olean ’23* 
D. Anthony D’Esopo ’24 
Myron A. Sallick ’24 
Harold T. Vogel ’24 
Waldo F. Desmond ’25 
Alice A. S. Whittier ’25 
Maxwell Bogin ’26 
John M. Freiheit ’27* 
Max Alpert ’28 
Sheldon A. Jacobson ’28 
Ralph E. Knutti ’28 
Tony L. Rakieten ’29* 
Robert Tennant ’29 
Paul A. Harper ’31 
Nelson Newmark ’31 
Lee E. Farr ’32 
Conrad R. Lam ’32 
Arthur J. Present ’32 
Benjamin N. Tager ’32 
Myron E. Wegman ’32 
Jack Greenberg ’33 
Ashley Pond III '33* 
Sidney Stringer ’33* 
George A. Carden, Jr. ’35 
Samuel D. Kushlan ’35 
Daniel Bergsma ’36 
Lester W. Burket ’36 
Albert W. Diddle ’36 
Margaret C. L. Gildea ’36 
Louise G. Hutchins ’36 
Philip M. LeCompte ’36 
Morris Tager '36 
William G. Cooper, Jr. ’37 
T. Dennie F*ratt '31 
Albert D. Spicer ’37 
Jean Wells '31 
Benjamin E. Lyons ’38 
J. Richard Zahn ’38 
John P. Ferguson, Jr. ’39 
S. Jerome Greenfield ’39 
Nathaniel Kenigsberg ’39 
Malvin F. White ’39 
Wynant Dean ’40 
Richard E. Dormont ’40 
Henry D. Humphrey ’40 
Edward Martin ’40 
Joseph E. Sokal '40 
Patricia E. Wanning ’40 
John B. Wells '40 
Helen H Woods ’40 
Herbert W. Diefendorf ’41 
Robert L. Gilbert ’41 
William Edmund Kenney ’41 
William E. Bloomer ‘42 
James M. Bunce ’42 
Walter J. Burdette ’42 
Ludmil A. Chotkowski ’42 
Vincent J. Collins '42 
William Fleeson ’42 
Elihu Friedmann ’42 
Samuel Ritvo ’42 
Charles F. Scholhamer ’42 
Irving Norman Wolfson ’42 
Jonathan T. Lanman ’43 March 
Douglas Lindsey ’43 March 
J. Philip Loge ’43 March 
* deceased 51 
Henry A. Riedel '43 March 
John J. Weber '43 March 
Robert H Wyatt '43 March 
Jane B. Cadbury '43 December 
Hunter H. Comly '43 December 
Robert H. Furman 
'43 December 
Hoyt B Miles, Jr. 
'43 December 
Francis A. Spellman 
'43 December 
Carol Goldenthal '44 
Charles A. Hall '44 
Donald W. Holden '44 
W. Raymond James '44 
Elias J. Marsh '44 
Paul E. Molumphy '44 
Laurence G Roth '44 
George Howard Allison '45 
Alice Shepard Cary '45 
Edward M. Daniels '45 
Robert S. Easton '45 
Alice Dershimer Friedman 45 
O. Roger Hollan '45 
George W. Naumburg, Jr. '45 
Richard M. Peters '45 
Aaron T. Beck '46 
Gregory E. Flynn '46 
Charles S Judd, Jr. '46* 
James A. Kleeman '46 
Thomas J. Mathieu '46 
Francis G. Reilly '46* 
Thomas J Whelan, Jr. '46 
Richard G. Britton '47 
Charles R. Cavanagh, Jr. '47 
Roland G. Chambers '47 
Archie L. Dean, Jr. ‘47 
Franklin Harold Epstein '47 
Richard K. Friedlander '47 
Stephen W. Gehrs ’47 
Robert J. Kerin '47 
Don F. Kimmerling '47 
Richard P. Levy '47 
Charles L. Mache, Jr. '47 
Olive E. Pitkin '47 
Igor Tamm '47 
Patricia B. Tudbury '47 
Ellis J. Van Slyck '47 
Russell J Barrnett '48 
Ruth E. Cortell '48 
G. Robert Downie '48 
Boy Frame '48* 
Ross R. Harcus '48 
William G. Anlyan '49 
Jonathan S. Bishop '49 
Jackson Harris '49 
Benjamin A. Johnson '49 
Timothy F. Nolan, Jr. '49 
Julian I. Pichel '49 
Charles L Rennell, Jr. ’49 
Daniel Rudman '49 
Martha Vaughan '49 
Sylvia L. Axelrod '50 
Carl A. Gagliardi '50 
Margaret S. Lyman '50 
Jane B. Shumway '50 
Eleanor Clay Bigley '51 
Daniel X. Freedman '51 
Sidney S. Furst '51 
Joseph M. Garland '51 
Robert N. Hamburger '51 
John V Haxo '51 
Carrold K. Iverson ’51 
Jocelyn S. Malkin ’51 
Francis L. Merritt ’51 
Albert R Mowlem '51 
Arthur A. Pava '51 
Majic S. Potsaid '51 
Andrew S Wong '51 
Maurice L. Bogdonoff '52 
Frank A. Carone '52 
Thomas S. Kelly '52 
Robert G. Petersdorf '52 
Leon A Phillips '52 
John Macklin Roberts '52 
John H. Wagner, Jr. '52 
John L. Wolff '52 
Harvey L. Young '52 
Robert Zeppa '52 
Harold D. Bomstein. Jr. '53 
James P. Dunn '53 
A. Daniel Hauser ’53 
David Purdy Holman ’53 
Richard Robert Knowles, 3d 
'53 
Paul G. Quie '53 
Richard J. Bouchard ’54 
Herbert S. Hurwitz ’54 
Robert J. T. Joy ’54 
Harry C. Miller, Jr. ’54 
Paul N. Neufeld '54 
Anthony V. Piccirillo '54 
Jacques M. Quen '54 
Leonard M. Silverman '54 
John W. Vosskuhler '54 
George E. Becker '55 
Padraic Bums '55 
Pasquale James Costa '55 
Leroy Engel '55 
F. Robert Fekety, Jr. '55 
Mahlon V.R Freeman '55 
Paul Gonick '55 
John H. Hodge ’55 
David R Kessler '55 
Robert A. Kramer '55 
James Lum '55 
Joseph S McGuire, Jr. '55 
Phillip W. Smith '55 
Levon Z. Boyajian ’56 
Rosalie A. Bums ’56 
Chandler Dawson ’56 
Thomas F. Ferris '56 
Sumner Gochberg '56 
George E. Green '56 
Arne G. Haavik '56 
George T. Kammerer '56 
Jerome O. Klein '56 
William V. Lewit '56 
Preston C. Manning '56 
Dwight F. Miller '56 
A. Frederick North, Jr. '56 
George W. Paulson '56 
Robert Lee Scheig '56 
James Scheuer '56 
Donald Agostinelli '57 
Richard I. Breuer ’57 
Carl A. Brinkman '51 
John P. Carey '57 
Louis Z. Cooper ’57 
Thomas H. Danaher '57 
James R. Dorr ’57 
Edward Louis Eyerman, Jr. 
’57 
Harold J. Fallon, Jr. ’57 
Anthony L. Fons, 3d '51 
Anne H. Good '51 
Richard Lee Kahler '51 
William L. Kissick '51 
Bennett F. Markel '57 
Mark D. Marshall '51 
Robert K. Modlin '51 
Hugh Lamson Moffet '57 
Herbert A. Newman '57 
Charles A. Slanctz, Jr. '57 
Joseph E. Angelo '58 
Gerard N. Burrow '58 
David A. Carlson ’58 
Lawrence Dubin ’58 
James Greenwald '58 
Stanley Harris '58 
Michael Kashgarian '58 
Theodore W. Lieberman '58 
Thomas J. Mauro, Jr. '58 
Leo T. McCallum '58 
Thomas R. Shea '58 
Margaret Smith Wenzel '58 
Asa Barnes, Jr. '59 
William C. Butterfield '59 
Martin Colodzin '59 
Robert L. Fisher '59 
William H. Heydom Me, 
Usa '59 
C. Richard Hinckley '59 
John J. Jasaitis '59 
Sanford P. Solomon '59 
Muriel D. Wolf '59 
Victor Altshul '60 
Jack D. Barchas '60 
Ormond V. Brody '60 
Donald P. Buebendorf '60 
Francis D. Cogliano '60 
Daniel M. Jones '60 
Thomas P. Kugelman '60 
Edward R. Lang '60 
Donald L. Miller '60 
Daniel J. Rubin '60 
Fred Stargardter '60 
May Yung-Fun Woo Wang 
'60 
Ronald A. Yankee '60 
Orson R Dee '61 
Paul David Deiter '61 
Ronald A. Dierwechter '61 
John E. Fenn '61 
Richard L. Keefe '61 
Norman I. Moss ’61 
Roland D. Paegle '61 
John Curtis Parker '61 
Shaun J Ruddy '61 
Hugh C. Thompson, III 61 
Michael H. Alderman '62 
Fredric K. Cantor '62 
John W. Foreman '62 
Stephen John Flicker '62 
John T. Harrington '62 
Frank R Hartman '62 
David E. Knoop '62 
John P. Lynch '62 
Stanley E. Matyszewski '62 
Larry Lee Stewart '62 
Sherwood Waldron, Jr. '62 
Miguel R. Alonso '63 
Charles W. Carl, Jr. '63 
Dudley Seth Danoff '63 
Peter B Gregory '63 
Harold P. Kaplan '63 
Edward G. Lund, Jr. '63 
Peter V. Tishler '63 
William A. Alonso '64 
Thomas A. Cardella '64 
Mary V. Digangi '64 
Beverly Ann Dudek '64 
Alfonso Esguerra '64 
Lewis Landsberg '64 
David B Leof '64 
James S. Levine '64 
William F. Matched '64 
Robert L. Mitchell '64 
William B. Pratt '64 
Stanley J Rosenberg '64 
Robert L. Shelton '64 
Diane Shrier '64 
Sigrid L. Tishler '64 
Stephen Waltman '64 
Robert M. Cohn ’65 
Gregory A. Culley '65 
Robert Andre Gryboski '65 
Carl E. Hunt '65 
Virginia Burnham Johnson '65 
Ronald J. Karpick '65 
David B Leof '65 
Sandra Chook Levine '65 
Philip D Manfredi '65 
A. Lawrence Ossias '65 
Robert L. Pickens '65 
Margretta Ann Reed Seashore 
'65 
John H Seashore '65 
Frank C. Bell '66 
Eugene Patrick Cassidy '66 
Robert N. Frank '66 
J McLeod Griffiss '66 
Robert A. Gunn '66 
Stuart T. Hauser '66 
Wilbur L. Kukes '66 
Daniel L. Arons '61 
Arthur L Beaudet '67 
Gary C. Burget '61 
Mary Williams Clark '67 
James Lucius Davis, ITT '61 
James J. Dineen '61 
James M. Dowaliby, II '61 
Herbert W. Felsenfeld '67 
Melvin Victor Goldblat '61 
Peter N. Herbert '61 
Mary Jurbala '61 
J. Robert Kirkwood '67 
Anthony P. Lovell '67 
Ralph G. Maurer '67 
Joseph L. Morris '61 
Brian F. Rigney '61 
Jonathan L. Saveli '61 
Stephen C. Schimpff '67 
Sidney C. Smith, Jr. '67 
Robert S. Steinberg '61 
Martin Wand '67 
Robert J Winer '61 
Robert S. K. Young '67 
Ihor George Zachary '67 
Richard A. Getnick ’68 
Ralph S. Greco '68 
John A. Ogden '68 
Margot Onek '68 
Gordon H. Sasaki '68 
Frederick C. Sherman '68 
Lee H. Strohl '68 
Per Henrik Wickstrom '68 
Leo M. Cooney, Jr. '69 
Richard J. Daly '69 
Lesley Forman Fishelman '69 
William H. Frazier '69 
Anna S. Gail '69 
Thomas C. Howard '69 
Joel Mark Kaufman '69 
Stephen Krant '69 
Robert L. Marier '69 
Nancy Olmsted '69 
Deborah A. Putnam '69 
Joseph D. Robinson '69 
Gerald J. Smallberg '69 
Michael S. Toren '69 
Robert M. Rosa '70 
Brian Weiss '70 
C. Bruce Wenger ’10 
Joellen Weme '70 
Judith L. Bader "71 
Gregory W. Bartha '71 
Michael J Beierle '71 
Marian H. Block '71 
Bruce Block '7! 
Frederick L. Cohn '71 
Fred Finkelman '71 
Barbara K. Kinder '71 
Patrick T. Minihan '71 
Robert B. Vranian '71 
Michael A. Catalano '12 
Philip L. Cohen '12 
William H. Druckemiller, Jr. '12 
Thomas L. Horn '12 
Vernon H. Humbert, Jr. '12 
Fred Hyde '72 
Roy A. Kaplan '72 
Donald L. Kent '12 
Peter J Panzarino, Jr. '72 
Lee Goldman '73 
Neal Handel '73 
Wanda D Huff '73 
David C. Johnson '73 
Andrew G. Kadar '73 
John F. McQuade, III '13 
James S. Robertson '73 
Harry S. Romanowitz '13 
John R. Stratton '73 
Thomas F. Sweeney '73 
Irving M. Asher ’74 
Neil Blumberg '74 
Bert D Collier, Jr. '74 
Irl L. Extein ’74 
Ancil A. Jones ’74 
Olusegun O. Lawoyin ’74 
James A. Strom '74 
Mary Jane Minkin ’75 
Roger A. Boshes '16 
William K. Levy ’76 
Charles R Swenson ’76 
Peter M. Ting '16 
Michael G. Adelberg 'll 
Stuart Brian Dubin ’77 
Alan S. Penziner 'll 
Ronald J. Vender 'll 
Stuart M. Forman ’78 
Jose Luis Martinez '78 
Marcia J. Wade '78 
Michael K. Lindsay '79 
Martin H. Teicher '81 
Amanda B. Dill '86 
D. Bradford Reich '86 
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Dennis J. Card 
Girard A. Chapnick 
Leo J. Clark 
Ian M. Cohen 
Stephen A. Edelstein 
Richard Webster Finner 
Clifford Joseph 
E. Larry Knight 
Gerald L. Meyers 
Gary R. Pasternack 
Emanuel T. Phillips 
Ranjit Rath 
Leon E. Rosenberg 
Parents and Friends 
Mrs. Gloria F. Holmes 
Mrs. Virginia G. Mannick 
Mr James C. Marsters 
Dr. & Mrs. Carl E. Rothschild 




P. O. Box 3333 
333 Cedar Street 
New Haven, Connecticut 06510 
NON—PROFIT ORG. 
U S. POSTAGE 
PAID 
NEW HAVEN. CT 
PERMIT NO 470 
m Gen®1 
YALE MEDICINE 
Alumni Bulletin of the School of Medicine 
Career Choice Versus Student Debt. 
Tipping the Balance? 
PP ™ ■ >Mn:Mery 




Alumni Bulletin of the School of Medicine 
Spring 1988; Vol. 22, No. 2 
1 To Break the Cycle of Poverty 
4 At the Infinitesimal Frontier of Physiology 
8 When Doctors Get Sick 
10 Career Choice Versus Student Debt: Tipping the Balance? 
16 Here and About 
21 Gallery 
21 In Progress 
24 Faculty News 
26 New Books 
27 Alumni News 
28 Obituaries 
29 In Memoriam 
30 Development Report 
31 Alumni Report 
32 Alumni Fund Notes 
YALE MEDICINE is distributed to members of the 
Association of Yale Alumni in Medicine, and students 
and friends of the School of Medicine. 
Communication may be addressed to Dr. Michael 
Kashgarian, editor; c/o the Office of Public 
Information, 350 Congress Ave., New Haven. Conn. 
06510 
Dr. Michael Kashgarian, professor of pathology, is edi¬ 
tor of YALE MEDICINE. The magazine is produced by 
him and the Office of Public Information: Helaine 
Patterson, director; Gregory Huth. publications editor; 
Eileen Dubois, staff assistant; and Leah D’Eugenio, se¬ 
nior administrative assistant. The tri-annual magazine is 
prepared in cooperation with the Alumni and Develop¬ 
ment offices at the School of Medicine, with assistance 
from Marc Arriens, layout and production. 
The cover features a 19th century balance scale from the Med¬ 
ical Library's Edward Clark Streeter Collection of Weights 
and Measures. Cover photo: Bill Carter 
ASSOCIATION OF 
YALE ALUMNI IN MEDICINE 
Dwight F. Miller, M.D. '56, president 
Thomas P. Kugelman, M.D. '60, vice president 
Muriel D. Wolf, M.D. '59, secretary' 
Nicholas PR. Spinelli, M.D. '44, past president 
EXECUTIVE COMMITTEE 
Joseph F.J. Curi, M.D. '64 
Martin E. Gordon. M.D. '46 
Attilio V. Granata, M.D. 'll 
James Q. Haralambie, M.D. '35 
Marie-Louise T. Johnson, M.D. '56 
John O. Pastore, M.D. '67 
Jerrold M. Post, M.D. '60 
Ora K. Smith. M.D. '53 
Romeo A. Vidone, M.D. '57 
Patricia A. Wanning, M.D. '40 
REPRESENTATIVES TO THE 
ASSOCIATION OF YALE ALUMNI (AYA) 
Alexander R. Gaudio, M.D. '63 
Gilbert F. Hogan. M.D. '57 
Edith M. Jurka, M.D. '44 
Mohandas M. Kini, M.D. '65 
Daniel W. Rahn, M.D. '76 
Warren D. Widmann, M.D. '61 
R. Leonard Kemler, M.D. '43, chairman. 
Medical School Alumni Fund 
TO BREAK THE CYCLE OF POVERTY 
by Irving Harris 
Editor’s note: Many Yale medical alumni have had experience 
with one of this nation's most serious public health problems: 
a cycle of poverty in which teenagers bear children who—if 
they survive—grow up socially and economically disadvan¬ 
taged. All too often these children bear the added burden of a 
physical or mental handicap that results from inadequate 
health care. And many go on to become the next generation of 
too-young parents as the cycle of poverty winds on. 
Is there any hope of breaking this pattern, especially in an 
era of federal cutbacks? 
One Yale College alumnus, Irving Harris, '31, a Chicago 
businessman, felt that there must be an alternative to simply 
turning our backs on the problem. He got involved in his com¬ 
munity and achieved remarkable results. 
Last year, Mr. Harris was invited to chronicle his success 
in the annual Clifford Beers Lecture at the Yale Child Study 
Center. YALE MEDICINE presents an excerpt from this 
lecture. 
Irving Harris 
As a businessman, I am frequently asked why I am concerned 
about child development and the cycle of poverty. My answer 
is simple: Because of the awesome effects of poverty on chil¬ 
dren and families, we cannot afford to go blithely about our 
lives thinking the problem will solve itself. 
In 1975, my friend Bernice Weissbourd began talking to 
me about her idea for organizing a family support system in 
Evanston, Ill. In 1965 and 1966, Bernice and Joan Costello, 
formerly of Yale, had operated a Head Start program in one of 
the housing projects in the inner city of Chicago. When 
she looked back at that experience, Bernice told me that the 
project had been both exhilarating and disappointing. 
She classified the children they worked with into three 
groups: A third were well-nurtured at home and would prob¬ 
ably make it in life even without a Head Start program; the 
second third needed, and really benefitted from. Head Start, 
but required good teaching to stay on track; the final third 
were so badly damaged by the time they arrived in Head Start 
that they could not be helped. 
THE CRITICAL THIRD 
Bernice believed that the only way to address the problem of 
this last group was primary prevention —to work with the 
mothers of those children from the time the babies were born 
or even earlier —during the first months of pregnancy. 
As a result, in 1976, Bernice Weissbourd created Family 
Focus, a non-profit social service organization whose clients 
are families with children under age three. The mission of the 
program is to help parents improve their knowledge of healthy 
child development and so enhance their parenting skills. Her 
husband and I shared the principal part of the cost. 
Family Focus began with a very good drop-in center in 
Evanston, Ill., a community of 100,000 which ranges from 
affluent to poor, about 77 percent white and 23 percent black. 
We expected that 50 families would use the center in its first 
year. To our surprise, 250 mothers and their children piled in. 
But we failed to attract the teenagers we had hoped would 
use the program. So four years later we opened a second cen¬ 
ter, located across from the high school. This did attract low- 
income youths, who named the center “Our Place.” Here we 
counseled many teenagers, including those who were preg¬ 
nant or parenting, and those who were not. 
The center was very successful. The health of those who 
were young mothers was clearly improved. The number of low 
birth weight babies was low. (In Chicago’s inner city, low 
birth weight affects 21 percent of all newborns; in our sample 
the percentage was six.) One of our goals was to encourage 
these young mothers to wait before having a second baby. 
In most cases we were successful, but there was still room 
for improvement. In a study of multiple births four years later, 
much to our surprise we found that all of the second and third 
children born to these young mothers were progeny of only six 
families. Those families —siblings and cousins —represented 
the hard core of Evanston's social problems and proved to be 
the most difficult to reach through our program. 
A mother and her six-month-old play games with a mirror at Christopher House, a Chicago Ounce of 1 I C- 1 MHU Jilt. 
FUNDING STRATEGIES 
We knew all along that the costs for Family Focus would not 
be cheap. We also knew that those costs would have to be jus¬ 
tified on one of two bases: humanitarian considerations or 
cost effectiveness. If the concern was purely humanitarian, 
the cynics would be sure to say, “Don't look to us for money. 
Tap the bleeding hearts.” To prove cost effectiveness, we 
would have to measure the damage —and determine the 
cost —of what happens when society does nothing. 
This is not an easy process. My own estimate suggested 
that $10,000 a year would not be a bad guess for what it costs 
if a child becomes a failure. Prison alone costs over $20,000 
a year. Retardation and other handicapping conditions, wel¬ 
fare, unemployability and teenage parenting are all 
expensive. 
Experts have said that my estimate is low, and the figures 
bear them out. A study of the 24,348 births to Illinois teen¬ 
agers in 1983 estimated annual costs at $35,000 per birth dur¬ 
ing the first five years of the children’s lives. That adds up to 
an annual cost of $853 million. 
Yet even at the conservative figure of $10,000 a year, the av¬ 
erage cost to society for a failed individual with a life ex¬ 
pectancy of only 30 years would come to $300,000. I have 
also estimated that at least 600,000 children are born each 
year at high risk of societal failure, and without intervention 
half will in fact fail. Again, my estimates are conservative. 
Despite such grim figures, and the fact that our preventive 
approach costs $1,000 per child, funding for Family Focus 
has been difficult to come by from the start. Early on, I 
thought our fund-raising prospects might improve if we ap¬ 
pealed to the self-interest of corporations and could place a 
center near a factory site. 
CLOSE TO HOME 
A logical corporation to initiate such an experiment was the 
Pittway Corp. of which I was chairman. Pittway manufac¬ 
tures smoke detectors in Aurora, III., which has a large pocket 
of poor Hispanic families who work for the company. 
Pittway supplied a substantial part of the funds needed to 
finance a Family Focus drop-in center in Aurora. This was to 
a three-yearexperiment, with the intent of interesting other 
\urora employers in joining as financial supporters. 
We asked the Illinois department of children and family 
services for $25,000 a year towards our estimated $100,000 
budget, believing that the Aurora center would be a model 
primary prevention program and could potentially reduce 
child abuse and neglect. 
We were pleasantly surprised when department Director 
Greg Coler volunteered to commit $400,000 if Pittway would 
match it. His goal was to establish six experimental sites that 
would test the concept of primary prevention. The Pittway 
board agreed to match the grant. Greg Coler invited me to 
think up a name for our public-private partnership, and that is 
how The Ounce of Prevention Fund was created. 
Without question, the state could not have established a 
radical experiment such as Ounce of Prevention using state 
funds alone. The matching grant greatly reduced the diffi¬ 
culty of gaining legislative approval. 
Greg Coler asked for a $400,000 grant from Pittway for one 
year only. He promised that once underway, the project would 
be funded in its second and third years by the state: After all, 
it would take only $800,000 a year from his department’s 
$260 million budget. 
From the corporate side, despite the fact that this was by far 
the largest grant the Pittway Corp. Charitable Foundation had 
ever considered, our board believed it was worthwhile, par¬ 
ticularly since that we were leveraging our $400,000 against 
$2 million from the state over three years. 
Pittway directors recognized that the long-term success of 
the corporation is dependent upon the economic and social 
health of the community, not only in Aurora but in all of the 
communities where the company operates a factory or offers 
its products for sale. The board felt that the issues related to 
early childhood development are of concern to the nation as 
a whole and that Pittway’s effort might have national 
significance. 
AN IDEA TAKES HOLD 
A public announcement of the new program was made in Jan¬ 
uary 1982. We requested proposals, insisting on a strong com¬ 
munity base. In the first year, with $800,000, we funded six 
programs. In the second year, the state increased its contri¬ 
bution to $2 million and in the third year to $4.5 million. This 
enabled us to add 22 programs. And in the fourth year, with 
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modest additional funding, we added 13 small experimental 
prevention programs. 
Ounce of Prevention sites usually offer home visiting, par¬ 
ent training, pregnancy prevention, support mechanisms to 
promote healthy family functioning and prevent child abuse 
and neglect, and in many instances, developmental infant and 
toddler day care. Ounce of Prevention also now manages 10 
federally funded Head Start programs for some 700 children. 
Pittway, incidentally, has continued its support at $250,000 
a year. This pot of flexible funding has been important to the 
growth and dynamism of Ounce of Prevention programs, 
which today include training for paraprofessionals in infant 
and toddler assessment, new programs to prevent sexual 
abuse, job training programs and other projects that collabo¬ 
rate with schools and churches to reach children put at risk 
by poverty. 
Despite our success, there is much more to be done. For 
instance, it was always clear that The Ounce of Prevention 
Fund and Family Focus were not helping the most difficult- 
to-reach, highest-risk families —including the "hard core," 
estimated at 6 percent of families who account for 50 to 70 
percent of the social problems that we are trying to counter. 
THE ELUSIVE PURSUIT 
We also became aware that Family Focus and Ounce of Pre¬ 
vention were not achieving our goal of promoting primary pre¬ 
vention. We were working mostly with adolescent mothers 
who already were pregnant or had had a baby. At best, we were 
trying to improve parenting skills and encourage young people 
not to have a second or third child while they were still of 
school age. 
Realizing that primary prevention meant trying to keep chil¬ 
dren from having their own first child, I hired a man named 
Bill Young to scout around the nation and see what was being 
done to successfully prevent first births. 
Regular home visits are key to the Ounce of Prevention Fund 
approach to supporting young parents. 
He discovered that the Comprehensive School-Based Med¬ 
ical Clinic in St. Paul, which offered medical care and family 
planning services, had managed to cut births to teenagers in 
one high-risk high school by 59 percent. While nationally, 
some 33 percent of adolescents have a second baby within two 
years after delivering their first child, St. Paul had been able 
to reduce this percentage to 1.4. 
With this information I returned to the state director of pub¬ 
lic aid. He agreed to fund one-half the cost of two such clinics 
if I could find private funding for the other half. 
To match the state’s funding, we would have to raise $1 mil¬ 
lion. This would provide $1 million for each clinic, to be spent 
over eight years. The Pittway Corporation Charitable Foun¬ 
dation agreed to give $75,000 a year for several years; and The 
Robert Wood Johnson Foundation agreed to provide additional 
funds. Since then, 10 more Chicago foundations, including 
the Chicago Community Trust, have joined the effort. 
THE STRUGGLE CONTINUES 
Surprising as it may seem, not everyone in the community has 
welcomed our efforts. Take, for example, the Moral Majority. 
Thanks to the efforts of Bill Young and Ruth Belzer, exec¬ 
utive director of the Harris Foundation, the city administra¬ 
tion and the Chicago board of education agreed to permit 
comprehensive clinics to be established at two Chicago high 
schools, DuSable and Orr. The vote of the board was 10 to one 
and reported in The Chicago Sun-Times and The Chicago 
Tribune, both of which noted that contraceptives would be dis¬ 
pensed to students. 
It should be mentioned that to use any of the clinics’ ser¬ 
vices, including birth-control counseling, students need writ¬ 
ten permission from their parents. Three months after the first 
clinic opened, a black minister, the head of the Illinois Moral 
Majority, wrote a letter of complaint to the governor and sent 
copies to 50 well-placed individuals, including the editor of 
the Sun-Times. 
The story ran under a banner headline: "The Pill Goes to 
School." The fact that 85 percent of the visits were for med¬ 
ical problems was not newsworthy. Only sex is news. 
Interestingly, all of the excitement generated by the news¬ 
paper, the pickets and the television cameras was of little con¬ 
cern to the families of DuSable students. Not a single call 
from a parent was received by the principal. The parents, the 
principal and the faculty wanted the clinic there. 
Nevertheless, the picketers did convince the president of the 
school board and two other board members to welch on their 
votes. We found ourselves in a new battle for approval of the 
second clinic, despite the approval granted six months earlier. 
We won that critical second vote six to five, but on the con¬ 
dition that before opening the second clinic at Orr High 
School, we were to survey the community and the students. 
We found that 85 percent of those responding favored opening 
a clinic that would dispense contraceptives. 
Since that episode, the state of Illinois has appropriated 
funds to fully support two more clinics. 
Our experience with these programs has led me to believe 
that by working together, perhaps we can use our education 
and insights to understand the causes of social failure and 
weed them out. Human motivation and social organization 
should not be insoluble mysteries. Nor should it be beyond our 
talents to eradicate the conditions that create a permanent 
underclass. 
Poverty is not preordained in heaven. It is a problem created 
by people. If we really want to, we can solve it. 
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AT THE INFINITESIMAL 
FRONTIER OF PHYSIOLOGY 
by Doris Falk and Gregory R. Hath 
When the “department of physiology” became the “depart¬ 
ment of cellular and molecular physiology” in July 1987, the 
name change formally affirmed the path the department has 
been following for a decade, a path that has led it to become 
one of the top graduate physiology departments in the country. 
“There was some concern when we first asked for the name 
change that we were departing from our educational mis¬ 
sion,” observes Professor Emile L. Boulpaep, M.D., chair¬ 
man of the department since 1979. “But our mission has not 
changed. We are simply adjusting the name to reflect our re¬ 
search activities.” Professor Walter F. Boron, M.D., Ph.D., 
acknowledges that those activities play a vital role —as re¬ 
flected by the department’s annual research budget of $4.5 
million. 
However, as the department’s director of medical studies. 
Dr. Boron is quick to add that research and educational efforts 
must complement each other. “We take our teaching respon¬ 
sibilities very seriously,” he concludes. 
Historically, physiology has dealt with the function of sys¬ 
tems and organs. This has remained the thrust of two major 
courses given by the department: basic physiology, taken by 
first-year medical students, and clinical correlations, where 
second-year students learn to apply basic physiology to patient 
care. 
Advanced graduate courses, however, which are elected by 
medical and graduate students as well as by M.D., Ph.D. can¬ 
didates, have come to reflect the sophisticated new techniques 
that have made it possible to study physiology at the cellular 
and even molecular levels. 
With such techniques gaining importance, adding the 
words ‘cellular and molecular' to the physiology department’s 
name reflects its position at the cutting edge of research. 
Thus, Dr. Boulpaep points out, the name change “should be 
useful in attracting new grants as well as the best young fac¬ 
ulty and graduate students.” 
A SINGULAR FOCUS 
Dr. Boulpaep believes that his department also has been 
strengthened by recruiting researchers who specialize in cel¬ 
lular functions related to membranes. While several faculty 
members carry on important studies at the supracellular 
level —into the organization of many cells —others specialize 
in the surface of single cells, and in some cases even the in¬ 
dividual molecules of the cell membrane. 
This contrasts with many physiology faculties that include 
a wide range of researchers who each specialize in a different 
an or system, and thus who may have little or no common 
research interests. 
“There’s truth to the old adage ‘Two heads are better than 
u Dr. Boulpaep suggests. “In our case, we have been for- 
■naugh to add depth to an already strong faculty by 
bringing together many of the brightest researchers in the field 
of membrane physiology.” 
At first glance, such a research focus might appear to be 
limiting. However, Dr. Boulpaep explains that in fact, mem¬ 
brane physiology is so basic that its study has applications to 
an extremely wide range of organs and systems. 
For example, departmental projects are throwing light on 
the mysteries of membrane transport in red blood cells, epi¬ 
thelial cells of the digestive tract, cardiac and skeletal-muscle 
cells and neurons. Such research is helping to explain the 
workings of such varied mechanisms as muscle contraction, 
color vision processing and electrolyte transport in the 
kidneys. 
From a teaching standpoint. Dr. Boulpaep explains that 
medical students in advanced courses gain from this approach 
in three ways: 
First, it allows students to learn about organ and system 
function in the most up-to-date fashion. 
Second, it orients them to an approach that is becoming in¬ 
creasingly important in other aspects of medicine. Dr. Boul¬ 
paep observes, “If students go into internal medicine, for 
Dr. Emile Boulpaep, a native of Belgium, adds a dash of 
Flemish flair as chairman of the department. 














example, they will discover the same trend to a cellular and 
molecular focus at the research level in the study of abnormal 
function.” 
Finally, students who undertake a senior thesis in cell and 
membrane transport will find that they gain knowledge that 
will make them highly marketable —and all the more so for 
having some of the leading researchers in the field as their 
advisors. 
The department’s 15 full-time faculty members divide their 
medical school teaching responsibilities between large lecture 
classes of 100 or more students and seminars where 10 to 12 
students can study specialized research in depth. A minority 
confine their attention solely to the department’s 15 graduate 
students. 
PURSUING THE INFINITESIMAL 
What are Yale medical students learning about the micro¬ 
scopic and even submicroscoic workings of cell membranes? 
In simple terms, Dr. Boulpaep explains that scientists have 
come to view cell membranes as a two-molecule deep “ocean 
of lipid, in which are floating many proteins.” These proteins 
can be divided into four basic groups —channels, transport¬ 
ers, pumps and receptors —according to the way they move 
materials in and out of the cell, thus regulating the intracell¬ 
ular environment. 
Dr. Boulpaep and several of his departmental colleagues 
specialize in channels, the molecules that regulate ionic flux 
through the surface of the cell. In this system, channel pro¬ 
teins can be seen as the “locks” that respond to electric sig¬ 
nals in the cell membrane. Channels cause an opening in the 
membrane, allowing calcium, sodium, potassium or other 
kinds of ions through, or they close the cell surface and stop 
all such movement. 
Channels have gained much prominence during the past few 
years because of the effectiveness of calcium channel-block¬ 
ing drugs in treating cardiac arrhythmias. Yet, as with so 
many modern medications, it was discovered that calcium- 
channel blockers were safe and effective before it was discov¬ 
ered why. 
Professor Richard W. Tsien, Ph.D., is leading a group that 
is trying to understand how these drugs work. “By under¬ 
standing how calcium channels function at the molecular 
level, we hope to throw some light on how calcium affects 
heart muscle contraction,” he explains. 
The human heart is not Professor Tsien’s only research in¬ 
terest. In 1986 the National Institute of Neurological and 
Communicative Disorders granted him a Javits Award that as¬ 
sures the university seven years of support for the Tsien 
team’s research into the role of calcium channels in neuronal 
function. This endeavor may have implications for the treat¬ 
ment of epilepsy and other disorders of the nervous system. 
Dr. Boron and others are investigating the second major cat¬ 
egory of cell membrane proteins: transporters. Transporters 
act as “barges” in the cell membrane’s lipid ocean, binding 
to ions or solutes, and then translocating these substances into 
or out of the cell. These proteins are essential for regulating 
intracellular ion composition, including the concentration of 
hydrogen. Dr. Boron’s lectures include discussion of a tech¬ 
nique he helped pioneer that uses hydrogen-sensitive microe¬ 
lectrodes and minute amounts of dyes to monitor rapid pH 
changes in single nerve, muscle and renal-tubule cells. 
One of Dr. Boron’s colleagues. Professor Peter S. Aronson, 
M.D., takes a different, but no less innovative tack to inves¬ 
tigate how transporters function. He employs radio-labeled 
Technicians pursue their vital work—producing much of the 
highly specialized equipment required by researchers—in the 
obscurity of the instrument shop. Widely respected, these 
craftsmen have filled requests for custom designed equipment 
from places as far away as East Germany and China. Here 
Brian Cullen, an electrical technician, looks on as Senior 
Electrial Technician Jo Wonowski tests a circuit board. 
Henry Paulson, a fifth-year M.D., Ph.D. student, consults 
with Assistant Professor Toni Claudio, Ph.D., about the data 
from a patch clamping experiment. 








































tracers and fluorescent probes in various epithelial cells to ob¬ 
serve the transport properties of cell membrane fragments. 
AGAINST THE GRADIENT 
Associate Professor Bliss Forbush III, Ph D., works with oth¬ 
ers at looking into the third major category of membrane pro¬ 
teins: pumps. Pumps —enzymes such as sodium-potassium 
ATPase —come to the fore when a cell needs to move an ion 
into or out of its interior, but neither its “locks,” the channels, 
nor its “barges,” the transporters, can do the job. 
For unlike these two proteins, which use an ion’s own elec¬ 
trochemical gradient to move it passively, a pump actively 
transports an ion or solute against its gradient, analogous to a 
water pump working against the force of gravity. 
Professor Forbush’s research may one day help in the treat¬ 
ment of blood cell disorders, and gastrointestinal and kidney 
diseases. Other Yale research into pumps may reveal the pos¬ 
sible tie between hypertension and the metabolism of sodium. 
It could also one day throw light on the workings of cardiac 
glycocides, medications whose effectiveness in preventing 
heart failure has remained a mystery since the physicians of 
ancient Greece began employing digitalis, the oldest and most 
famous of this drug group. 
Receptors round out the major categories of cell membrane 
proteins. These proteins are able to “recognize” and bind to 
specific compounds in the blood, such as hormones and neu¬ 
rotransmitters. Receptors also serve as “home ports” for an¬ 
tibodies and drugs as they combat disease within the cell. 
or Lawrence Cohen pauses during a brain storming 
si on. 
Because of receptors’ relationship to the therapeutic action 
of many drugs, much research into these proteins, at Yale as 
well as other institutions, takes place under the aegis of phar¬ 
macology. Nevertheless, the key role of receptors in mem¬ 
brane physiology has led the department to consider if some 
receptor researchers might not be logical additions to the 
physiology faculty. 
A COMMON DENOMINATOR 
The wide application of the research undertaken at the depart¬ 
ment of cellular and molecular physiology is reflected in the 
diverse sources from which the department receives outside 
funds. 
The National Institutes of Health sponsors the largest pro¬ 
portion of research. A majority of NIH institutes, ranging 
from “Heart, Lung and Blood” to “Cancer,” support depart¬ 
mental studies. Other grants come from such organizations as 
the American Heart Association, the Kidney Foundation and 
the National Multiple Sclerosis Society. The department does 
not engage in any contract work. 
Another sign of the research's extensive practical implica¬ 
tions comes from the diverse makeup of the department's fac¬ 
ulty. In addition to its 15 full-time primary appointments, 12 
hold joint appointments in physiology and other departments, 
ranging from epidemiology and public health to human ge¬ 
netics, internal medicine and pharmacology. 
In fact, as the applications of cellular and molecular re¬ 
search become more and more basic, they increasingly blur 
Hold the Arm & Hammer, Please 
To an uninformed observer, using government money to test 
the palates of lowly sea slugs might leave a scientific in¬ 
vestigator open to a congressional Golden Fleece Award. 
But in fact, the research of Professor Lawrence B. Cohen, 
Ph D., whose funding comes from the National Institute of 
Neurological and Communicable Diseases and Stroke, il¬ 
lustrates some of the important work being done at the su- 
pracellular level within the department of cellular and 
molecular physiology. Professor Cohen points out that the 
brains of even primitive animals, such as sea slugs, are dif¬ 
ficult to study because the millions of neurons in their 
brains are constantly active, while conventional techniques 
allow for only a few of these cells to be monitored at a time. 
However, Professor Cohen and his group have developed 
optical methods for studying more than 100 sea slug neu¬ 
rons simultaneously. First, the scientists apply dye or flu¬ 
orescent material to certain brain cell membranes of the 
animals. Then the researchers record by means of comput¬ 
erized photodetectors the changes that occur when the sea 
slugs learn a simple task, such as which of two paths lead 
to food not flavored with bicarbonate, a substance which 
the creatures find unpalatable. Such methods may one day 
lead to more effective methods to study the brains of higher 
animals, including humans. 
Professor Charles R. Michael, Ph.D., is investigating 
individual nerve cells in much higher animals. Old World 
monkeys. In research funded by the National Eye Institute, 
Professor Michael has surgically implanted electrodes in 
the cortex of the primates in an effort to discover which 
cells are responsible for color vision and what role each in¬ 
dividual cell might play in this type of perception. 
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the distinction between medical disciplines. As this trend con¬ 
tinues, departments are finding it advantageous to combine 
their strengths and apply jointly for grant funding. 
During the past few years, for example, the department has 
received program project grants to investigate transporters 
and pumps in conjunction with the departments of human ge¬ 
netics, medicine and pathology. And last year, the department 
earned five-year funding to work with the department of phar¬ 
macology in studying channels. 
This overlap of disciplines has encouraged interdepartmen¬ 
tal cooperation in other areas as well. Notes Dr. Boulpaep, 
“The more basic our research gets, the more we use the same 
instruments as other medical areas. This has led cellular and 
molecular physiology to share tissue culture and electron mi¬ 
croscopy labs with the departments of pathology and 
medicine.’’ 
What sort of future does Dr. Boulpaep predict for the his 
department? 
“The trend toward more shared research between depart¬ 
ments will continue. 1 also foresee increasing numbers of 
graduate students as the importance of our field —and our de¬ 
partment’s reputation for excellence —continue to grow.’’ 
Recording the Song of 
A Single Molecule 
Investigation of cell structure and function has received a 
major boost in recent years by improvements in the tech¬ 
nique known as “patch clamping.” Frederick J. Sigworth, 
Ph.D. (’79), assistant professor of physiology, is one of the 
pioneers in this field. He explains how he can use patch 
clamping to measure the electrical changes that occur when 
a single channel protein molecule opens its “lock” of 
atomic dimensions. 
The technique involves pressing against the cell wall a 
tiny glass pipette with an opening about half-a-micron 
wide. The tube is filled with a saline solution into which 
is placed a silver wire electrode that can measure the pico- 
ampere currents that flow in milliseconds through the 
cell surface. 
The pipette’s seal against the cell is so tight that a piece 
of the membrane —a patch —can be excised and placed 
in an experimental medium designed by the investigator. 
By monitoring the patch in its new, carefully controlled 
environment, the scientist can determine how even a 
single molecule reacts when exposed to various ions and 
electrical charges. 
Among its many applications, patch clamping is being 
used to study the movement of water and ions across the ep¬ 
ithelium of kidney tubules, neuromuscular transmission, 
and the mechanisms of the sense of smell. 
Fred Sigworth, Ph.D., displays a pipette he uses in patch 
clamping, a technique that he helped develop. 
JAMES ANDERSON 
Diary of a patch clamp. (1) A pipette with a tip half-a-micron wide is placed against the 
membrane of a cell. The junction is sealed with a charge from an electrode inside the pi¬ 
pette. (2) As suction is applied, a section of the membrane is drawn into the pipette. (3) 
The pipette is pulled away, excising a patch of the membrane along with some of the cell's 
cytoplasm. 
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WHEN DOCTORS GET SICK 
by Howard Spiro, M.D. 
Doctors make poor patients, everyone knows. They usually 
keep quiet about being sick, either as practitioners afraid that 
patients want a doctor who can be counted on, or as academics 
worried that their colleagues discount the future of someone 
wounded. But then we do get sick, just like anyone else, even 
if no one knows because most of us tend to keep on working 
unless the complaints put us to bed. 
Few physicians stay home with the flu and fewer of us are 
as careful of our own health as we tell our patients to be. 
Sometimes we think that we are less neurotic than they be¬ 
cause the hypochondriasis of medical school and residency 
has purged us of acting on our fears and led us to conclude that 
we are almost immortal. Most doctors know about sickness 
from their patients, not from their own experiences. 
Harvey Mandell, a clinical associate professor and medical 
director of the Backus Hospital, and 1 were discussing such 
matters one day after a lecture by Bob Byck in the Program for 
Humanities in Medicine recounting his own heart operation. 
Harvey and 1 have had lunch together on Fridays for over 30 
years, and yet as old friends aging together we had never really 
talked about doctors who had been sick. It was all the more 
surprising because Harvey himself had had a melanoma many 
years before. 
But Bob Byck's lecture gave us an idea. Recalling a book 
by Pinner and Miller, When Doctors are Patients, a collection 
of essays which had appeared in the 1950s, it seemed like the 
opportune time to put together a new collection. 
THE SILENT PHYSICIAN 
Indeed, the fruit of our efforts, When Doctors Get Sick, 
(Plenum 1987), has just appeared —and the job proved far 
harder than we had anticipated. Only a few doctors who have 
been patients have written about what they learned from the 
experience. Oliver Sacks comes first to mind because he has 
been the most prominent to do so recently. A small number of 
other physicians have described their travails in the pages of 
the Lancet and British Medical Journal, and even fewer have 
done so in our American journals. 
These individuals are exceptions because we physicians are 
always doing something, not writing about it. Our lives are far 
less contemplative than they could be because of the demands 
for action we face —and love —everyday. We have been trained 
to measure and not to reflect, and our fast-paced lives leave 
very little time for introspection. 
Though even Bob Byck was too busy —or too wary —to put 
his moving and humorous account down on paper for us, sev¬ 
eral other colleagues did agree to write about their own en- 
counters with illness. Of these, Kenneth Barwick, Charles 
Kleinman, Hastings Wright, and Barry Zaret, along with the 
i. Hugh Dwyer, are among the best known of our recent Yale 
lty. A few physicians who had been residents or teachers 
us ago at Yale also contributed. 
Y iy contributors have told me what a catharsis it was to 
"n their illness while writing their story. Reliving their 
frustrations and anxieties gave those physicians a chance to 
reorder their experience, to reframe it with the tranquility that 
comes from knowing how it all came out. They found new 
meanings in retrospect that at the time of their frenzy they 
could not have seen. 
But for many physicians the opportunity to tell the story of 
their illness was not an attractive one. For a few, those with 
emotional or drug problems, recounting their illness was just 
too painful. Though I cannot blame them, for some are very 
prominent individuals, we nevertheless could have learned 
so much from them about the contrasting worlds of doctor 
and patient. 
A YOUTHFUL PERSPECTIVE 
Some Yale medical students have already benefitted from 
When Doctors Get Sick. Last year a class of first-year stu¬ 
dents read some of these stories and their reactions were quite 
different from mine and some other physicians. “Heaven lies 
about us in our infancy," and first-year students have not yet 
been so acculturated into medical tradition that they see sick¬ 
ness with our blinders. They especially found fault with the 
implicit concern of the physicians’ doctors with the disease 
rather than the patient, a fault that I was too “trained" to 
recognize. 
Still, the students’ emotional reaction offers me hope that 
when physicians read these stories, they will not only reflect 
about them in the quiet of the evening, but also discuss and 
criticize them. 
Larry Cohen, the eminent cardiologist, tells me that he read 
one chapter of our book every morning while bicycling. (I was 
relieved to learn that Larry uses a stationary bicycle.) I like to 
think that when he read the story of Bob Seaver, a former Yale 
GI fellow who had to give up his practice in his 40s because 
of angina, Larry learned something new about the anxiety and 
frustrations of his own patients. 
PHYSICIAN HEAL THYSELF 
It is of course a paradox to be a patient and a doctor at the same 
time. As a doctor-patient you know a lot —or think you do — 
and your doctor gives you credit for knowing even more. For 
that reason the doctor-patient gets treated differently from 
most other people, sometimes better and sometimes worse, 
but rarely the same. 
Doctors generally deny their symptoms as long as they can 
and look for help only when the tension grows too great. They 
usually prefer to settle for a corridor consultation along the 
lines of, “What would you do about this little pain I've got?" 
Once physicians do reluctantly turn themselves over to be 
“worked up," they must then deal with conflicting impulses 
that result from their paradoxical patient-doctor role. Try as 
they might to be a good patient, someone who never com¬ 
plains, some physician-patients cannot overcome the urge to 
remain in charge. 



















This is certainly understandable, for every physician knows 
what mishaps may —and do —happen in a hospital or in an of¬ 
fice. So most doctors remain vigilant throughout their own 
treatment: Even as they're being watched, they are watching 
others. Our book tells of doctors who became monitors of IV 
drips to the extent of keeping a flashlight in the bed table 
drawer to check on patency of lines in the middle of the night. 
Others reacted to the doctor-patient paradox in a different 
way. These physicians wrote that they spent a lot of time look¬ 
ing for the “right’' doctor, and once they found one, let the 
physician take over. 
They wanted someone else to make decisions for them in 
their interest, and as I interpret it, did not want to spend a lot 
of time discussing what was to happen. In this regard, too, I 
have been impressed by how much many physician-patients 
want comfort and optimism, even at the expense of hard truth. 
This implicit trust may occur partially because doctors 
know that their physicians will be loyal to them as members of 
the same profession. Nevertheless, the approach of these phy¬ 
sicians to being a patient throws new light on the issue of pa¬ 
tient autonomy— making the patient equal to the doctor in 
decision making —that has been so widely discussed over the 
last decade. 
OUT OF SIGHT. . . 
Another observation. I was struck by the complete reliance of 
many physician-patients on technology, on seeing their illness 
on “hard copy” as quickly as possible. And I was likewise 
impressed by the reaction of the attending physicians to find¬ 
ing a structural defect: Once a doctor can see something 
wrong, he or she has to do something about it. 
One such doctor insisted that his patient, a reknowned 
radiologist, undergo angiography for extrasystoles which 
occurred only after strenuous tennis following a heavy meal 
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on a hot day. The radiologist subsequently was scheduled 
for immediate bypass surgery —to which he agreed only 
when he was promised that he would never have to undergo 
another angiogram. 
His doctor’s good-hearted insistence on seeing what was 
going on and, once he found a lesion, doing something about 
it, sounds familiar to me. Such stories make me wonder how 
much the increasing visual qualities of medicine make for ac¬ 
tions that are correct and even appropriate, but on occasion 
possibly not required. 
Since I know more about gallstones than hearts, I rest with 
the observation that the wonderful perspectives of ultra¬ 
sonography and computed tomography uncover gallstones 
which many times deserve to rest in peace. Yet once physi¬ 
cians see gallstones —even if the patient has no complaints — 
the doctors are tempted to do more than just look at them. 
Lithotripsy anyone? 
LESSONS IN ISOLATION 
The physician’s doctor must contend with his or her own set 
of problems, as well. For example, an immediate empathy, a 
merging of identity with the patient-physician does not always 
make it easy for the doctor to act as objectively as our credo 
tells us we should. 
I think this is one of the reasons why that “No Visitor’’ sign 
appears on the door of the doctor-patient’s room in the hos¬ 
pital. We say that it is to keep the patient from being bothered 
by visitors. But I suspect that the sign actually protects us 
while still vertical from having to confront our own vulnera¬ 
bility as reflected in our horizontal colleagues. Keeping this in 
mind, I hope that these stories will “open the door’’ to the 
sick physician, to give us the chance to see ourselves and our 
patients more as persons. 
I wish I could state that the physicians in our book changed 
their character after living the role of patient for a while. Not 
many claimed that they became better people for the experi¬ 
ence. Although a few boasted more tolerance, for some, the 
opposite reaction set in: “I was sick, I suffered and got better, 
and my patients can do the same.’’ 
How has putting this book together affected me? I do feel 
that I have learned something from every story. For instance, 
I have learned that you don’t have to be a physician 24 hours 
a day, and that human problems don’t always yield to medical 
solutions. 
Reading the manuscripts in this book has also convinced me 
more than ever that medical education must aim at ensuring 
that physicians do not become simply scientists or technicians 
taking care of disease. Doctors must remain caregivers to fel¬ 
low human beings. 
But probably the most profound way in which I hope I have 
changed is the way I deal with sick colleagues and those who 
have recently recovered from illness. Now I try not to turn 
away when a physician who has been sick passes by. I have 
learned to overcome my embarrassment in asking how he or 
she is doing. And when I stop to talk, it turns out not to be as 
difficult as I had feared. 
Coincidentally, my co-editor Harvey Mandell had a coro¬ 
nary artery bypass scheduled just about the time our book 
came out. Before our experience of working on this book, 
upon his return we might have first joked briefly about his ill¬ 
ness and then gone on forever to easier topics. Instead we 
talked often and intimately about the whole affair. 
Fortunately, he did very well and is back to having lunch, 
less lucullan than before, with me on Fridays. 
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CAREER CHOICE VERSUS 
STUDENT DEBT: 
TIPPING THE BALANCE? 
by Gregory R. Huth 
Throughout the early 1990s, the champagne corks will be 
popping for members of the Class of '81 who will be toasting 
the payoff of their medical school loans. They will have good 
cause to revel. Along with their diplomas, these graduates 
left Yale with an average debt of just over $20,000. 
For the Class of '88, however, the mean debt (the pun ap¬ 
plies) will have doubled —to over $40,000 —for the majority 
of students who borrowed to help finance their education. Dr. 
Robert H. Gifford, associate dean for education and student 
affairs, points out that 55 percent of 130 medical school se¬ 
niors have borrowed to pay for their professional education, 
with individual debts ranging from $3,000 to a whopping 
$80,660. 
In most cases, the more medical students owe, the more 
baffling the array of loans they face, and with more expensive 
terms. Even some federally insured loans feature rates that 
can reach 19 percent, with interest accruing from the moment 
a student signs on the dotted line. 
A NATIONAL I88UE 
The problem is not Yale's alone. More than 80 percent of med¬ 
ical students nationally borrow to finance their professional ed¬ 
ucation, and across the country tuitions are rising, especially at 
private institutions. 
For example, the Association of American Medical Colleges 
(AAMC) reports that fees for a first-year student entering a pri¬ 
vate medical school in 1980 totalled $7,910. By 1986 that figure 
had grown to $15,023. Correspondingly, debt burdens for med¬ 
ical students, which averaged $19,700 in 1981, have soared to 
$35,600 today. 
Moreover, there is no relief in sight from burgeoning debt bur¬ 
dens as rising costs are matched by federal policies that are mak¬ 
ing financial aid more expensive —and more difficult—to come 
by. Nationally, scholarships and grants to students are on the 
wane as well. 
Escalating medical student debt harbors disturbing ramifica¬ 
tions for the students, their schools and the nation's health care 
system. The AAMC. for instance, is conducting a study to dis¬ 
cover if increasing debt burdens are encouraging students to pur¬ 
sue lucrative subspecialties, where there is a glut of 
practitioners, while driving students away from primary care 
and research, where there are mounting shortages. 
Conversations with Yale students indicate that such a study 
is warranted. Confesses one second-year student: "I entered 
Yale assuming that I could do whatever I wanted with my 
medical education. I thought I might practice in a rural area, 
but now I feel that's not realistic. The pressure to pay off my 
loans is making me take a close look at surgery or some other 
well-paying specialty.” 
Another legacy of the debt dilemma may be the fourteen-year 
nationwide decline in the total number of applicants to medical 
schools and, according to a recent article in the Journal of the 
American Medical Association, a decreasing proportion of mi¬ 
nority student applicants. 
In coping with medical school debt, Yale has been able to 
maintain its competitive position among leading medical 
schools. Despite a 1987-88 tuition of $13,770 —which is more 
than double the figure of seven years ago —record contributions 











to the Medical School Alumni Fund for fiscal years 1986 and 
1987 have kept Yale medical students unencumbered by the 
loans with the most onerous terms. Furthermore, the propor¬ 
tions of minority applications and admissions to the school have 
not decreased, as has been the national trend. 
Nevertheless, some Yale medical students have not been able 
to avoid higher interest loans. And school officials fear that this 
may develop into a trend as the economic and political pressures 
intensify which have led to higher indebtedness among medical 
students nationwide. 
HISTORICAL TRENDS 
For many schools, a major part of the problem dates back to the 
early 1970s. As the Vietnam war wound down, the nation began 
to focus more on domestic concerns. Among the federal gov¬ 
ernment’s top priorities: heading off a projected doctor 
shortage. 
In response to this perceived threat, the U.S. Department of 
Health and Human Services worked with Congress to encourage 
medical schools to admit more students. This federal encour¬ 
agement came in the form of a capitation system which allotted 
money for every student enrolled. 
Financial aid to students also flowed. If a medical student 
wanted a low-interest federally insured loan, by and large it was 
there for the asking, regardless of financial need. Scholarships 
were not as pressing an issue because interest rates for loans 
ranged between 3 and 7 percent, and were relatively inexpensive 
to pay back. 
This flood of federal money had its intended effect —the 
national medical student population almost doubled, to 15,269, 
within 10 years. Faculties and facilities were expanded 
accordingly. 
By the 1980s, however, the political climate had changed. 
Even as President Ronald Reagan and Congress blamed each 
other for a record-smashing federal deficit, the government be¬ 
gan predicting a doctor glut for the 1990s. Inflation in health 
costs helped erode public support for the medical establishment, 
and student loan defaults became a major issue. 
The deficit and the doctor glut helped the administration and 
Congress eliminate capitation payments in 1980, a source of as¬ 
sistance that was never replaced. 
E3 living expenses for single students 
□ tuition 
Tuition at the medical school has more than doubled—to $13,770— 
between the years 1980-81 and 1987-88. Toted living costs for a 
single student increased during this time from $12,900 to $22,490. 
tology 
The Reagan years also marked the end of the era when a ma¬ 
jority of medical students could finance most of their education 
with loans under 8 percent. In fact, some students found them¬ 
selves saddled with federally insured loans with variable rates 
that reached 19 percent. 
The result of this mercurial national policy? Today, many 
schools of medicine find themselves with much expanded staff 
and facilities, yet faced with substantial cutbacks of the federal 
support that had nurtured this growth. 
Yale's budget also was affected by the abrupt elimination of 
capitation payments, which totaled $324,000 during 1980, the 
last full fiscal year they were provided. Fortunately, however, the 
capitation program had not induced the School of Medicine to 
increase its student population markedly—between 1970 and 
1982, enrollment increased by only 10, to 102. 
Though not faced with the consequences of overexpansion, 
Yale still has had contend with the rising costs that are part of 
operating a leading medical school. Most of these costs come 
under the categories of maintaining a top faculty and updating 
facilities and equipment to keep current with sophisticated med¬ 
ical technology. 
Higher tuitions have been able to ease only a small part of the 
resulting financial squeeze. Tuitions pay for only between 6 and 
8 percent of a student's medical education. 
Thus, Yale and other medical schools, saddled with increas¬ 
ing costs, and their students, confronted with rising tuitions, are 
approaching the 1990s with a wary eye on their finances. 
Director of Financial Aid Pamela Nyiri sums up how difficult 
the situation has gotten for the average Yale medical student. 
“Since I came to this job in 1980, the financial aid scenario has 
gotten worse every year. Tuitions keep going up, and the federal 
government keeps making loan money less available and more 
difficult to apply for, especially for middle-income families. Un¬ 
less we can come up with creative alternatives to finance med¬ 
ical education, our population of students will consist only of 
the very rich and the very poor.' ’ 
INTO THE LABYRINTH 
To best understand how the debt dilemma affects Yale medical 
students, one should follow the process of how they apply and 
are considered for financial aid. 
First, applicants must comply with a federal requirement that 
the financial need of students and their parents be documented. 
To assist in this “needs analysis,’ ‘ the financial aid office enlists 
the Graduate and Professional Financial Aid Service (GAPS- 











FAS) one of several national firms that specializes in needs 
assessment. 
GAPSFAS provides students with a comprehensive financial 
questionnaire that they and their parents fill out along with sup¬ 
porting documentation, such as federal and state income tax re¬ 
turns. A GAPSFAS form must be resubmitted by students and 
their families every year that financial help is requested. 
Once a prospective freshman is accepted, the financial aid of¬ 
fice uses the GAPSFAS information to implement a new method 
mandated by Congress to determine how much financial aid, if 
any, medical students should receive. 
This involves a series of calculations that determines how 
much in loans and scholarships the student will be offered — 
each applicant’s needs are analyzed using one of 14 formulas. 
Yale offers the student the financial aid package that provides 
the most favorable terms. 
Pamela Nyiri points out that Yale, Harvard and other leading 
private medical schools use a “unit loan” in their standard fi¬ 
nancial aid packages. For a student whose family agrees to pro¬ 
vide the “family contribution,” the unit loan is the maximum 
amount that the student should have to borrow to finance his or 
her education for the school year. Additional financial aid is 
provided in the form of scholarships. 
For example, during the current academic year, the unit loan 
comes to $12,500. If the financial aid office calculates that a 
student requires an additional $8,500 to pay for annual ex- 
Medical Student Loans— 
An Overview 
Federally Insured Loans while student is in school; no 
Perkins Loans RATE: 5 percent, deferred while 
grace period for repayment. 
in school Health Education RATE: Variable, 33/4 percent 
MAXIMUM: $18,000, includ¬ 
Assistance Loan above treasury bill rate 







TERMS: Must provide needs 
analysis. In addition to a one- 
year forbearance, deferment for 
as long as it takes to obtain a li¬ 
cense. Deferments also for full¬ 
time students, or while in the 
Armed Forces, VISTA or Peace 
Corps. Ten years to pay, mini¬ 
mum $50/month plus interest. 
RATE: 8 percent, deferred while 
in school 
MAXIMUM: $54,750 
TERMS: Same as Perkins 
RATE: 9 percent, deferred while 
in school 
MAXIMUM: Tuition plus 
$2,500 
TERMS: Same as above, except 
for maximum four-year defer¬ 
ment without government service 
RATE: Variable, 33/4 percent 
above U.S. Treasury bill rate 
MAXIMUM: $20,000 
TERMS: Same as GSL, except 
interest accrues and capitalizes 
TERMS: Same as Supplemental 
Loan for .Students, except one- 
year grace period, and maximum 
four-year deferment without gov¬ 
ernment service 
Uninsured Loans 
RATE: 12 percent 
MAXIMUM: Depends on funds 
available 
TERMS: Same as Supplemental 
Loan for Students 
NOTE: Rates are set to cover the 
costs of administration and losses 
through borrower death, disabil¬ 
ity and default. 
RATE: Market rate 
MAXIMUM: Varies among pro¬ 
grams, with a range of $40,000 
to $120,000 
TERMS: High service charges. 
Student must pass credit check. 
Except for MEDLOAN, student 
repays loan while still enrolled, 
with deferred loans available only 
at higher rates. 
Yale Revolving 
Loan Fund 
SHARE or FELP, 
AAMC MEDLOAN 
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penses, then this amount is provided in scholarships. 
Notably, the amount of the unit loan depends on how much 
scholarship money there is available: The more scholarship 
money there is to go around, the lower the unit loan. 
The financial aid package assumes a different look, however, 
when a student’s family does not contribute what is required ac¬ 
cording to the needs analysis. To make up for the missing family 
contribution, the student must take out other loans, at higher in¬ 
terest rates than those the unit loan comprises. |See “Medical 
Student Loans —An Overview.”J 
The parental support provision is not a flawless criterion to 
insure that finite loan resources are distributed fairly. Though it 
does succeed in keeping the children of wealthy families from 
borrowing needlessly for their education, the provision also can 
cause some truly needy students to “fall through the cracks” 
and end up deeply in debt. 
Many students in their 30s or even older—who have been liv¬ 
ing independently for years —do not feel it fair to prevail on their 
parents for support, especially if the parents are at or near re¬ 
tirement. In other cases parents refuse to support the student. 
Such refusal is not always hostile or even voluntary. In many 
cases parents prove to be “assets-rich and cash-poor”: Despite 
their “paper wealth,” they have no money to contribute to their 
offspring’s education. [See “A Tale of Two Students.”] 
O unit loan total for four years 
♦ unit loan 
The unit loan of $12,500 for the 1987-88 academic year actually 
represents a decrease from the $13,250 level reached during 1985- 
1986. Lower unit loans have been made possible because all gifts to 
the Yale Medical School Alumni Fund that are available for current 
use have been designated for scholarships. 
A Tale of Two Students 
Editor's note: In an attempt to distribute limited loan funds eq¬ 
uitably, the federal government requires every medical student 
who applies for financial aid to undergo a needs analysis. While 
this approach does keep children from wealthy families from un¬ 
necessary borrowing, it also forces some truly needy students to 
accept higher interest loans. 
A major shortcoming of needs analysis: The formula for cal¬ 
culating how much parents should contribute to their children's 
education fails to take into account how long a student has been 
financially independent. Neither does it make allowances for 
parents who may be ‘ 'assets-rich and cash-poor,'' as illustrated 
by the following accounts of two second-year Yale medical stu¬ 
dents. (Names have been changed for the sake of privacy.) 
John was a teenager when his parents divorced. He went to 
live with his mother, and his father stopped support when John 
turned 18. The young man was able to put himself through col¬ 
lege by a combination of scholarships, loans and odd jobs. 
After he entered medical school, however, John's needs anal¬ 
ysis took into account his father’s assets as well as his mother’s. 
Indeed, the parental obligation to help pay for John's education 
also extended to his father’s second wife, whom John barely 
knows. 
The father’s new wife owns a farm where the couple now 
lives. Because of this asset —though John’s father brings home 
only $22,000 a year—he and his second wife are supposed to 
contribute $10,000 a year toward John’s education. To make up 
for this sum —an obligation that John’s father will never pay — 
John takes out a government-insured loan at a 12 percent interest 
rate. John estimates that when he graduates from medical 
school, he will face an $80,000 debt. 
Andrea, who is in her mid-30s, finds herself facing another 
“catch-22.” Her parents, elderly and retired, live on a fixed in¬ 
come of just over $20,000. They have virtually no savings. 
Years ago, however, in the era before steep housing inflation, 
they had bought a small home in an affluent suburb. 
Because of this asset, the needs analysis stipulates that An¬ 
drea’s parents should be contributing $17,000 per year to her ed¬ 
ucation. In fact, they can provide nothing. This high parental 
obligation —impossible to meet without her parents selling their 
home —means that Andrea receives no scholarship aid. 
During her first two years of medical school, Andrea has 
been spending her recess and vacation working overtime to min¬ 
imize the amount of higher interest loans she will have to bear 
in lieu of the parental contribution. Thus far she has managed to 
keep her total loans down to $30,000, although she knows that 
her third-year academic obligations will keep her from contin¬ 
uing any outside work. 
As a result, upon graduation in 1990, Andrea expects to have 
accrued between $70,000 to $80,000 in debt. She wonders if 
this will keep her from pursuing her goal of working in aca¬ 
demic medicine, where she hopes to be an advocate for the poor 
and underserved. 
“A medical education, especially at Yale, is so rewarding,” 
Andrea muses. “It’s just a shame that I’m so often distracted, 
worrying about money.” 










The shrinking number of medical school applicants nationally 
adds the dimension of interschool competition to the financial 
aid problem. Yale must compete not only with independent in¬ 
stitutions but also with prestigious state schools that offer low 
tuitions. 
Compare Yale's tuition of $13,770 with the $3,600 residents 
of Texas pay at the University of Texas at Houston. California 
residents can attend the University of California at San Fran¬ 
cisco for an annual tuition of $1,600. 
Even in the face of such figures, though, many factors argue 
in favor of Yale. Among them: 
• Prospective students know that they will receive the highest 
quality preparation in either clinical or research medicine. 
• Many will be attracted by the Yale System, which offers flex¬ 
ibility in choosing courses and deemphasizes competition and 
testing. 
• The school's reputation for excellence insures that Yale grad¬ 
uates have a broad range of career choices. 
Soaring medical student debts could threaten this third ad¬ 
vantage, however, especially for students who wish to pursue 
lower-paying careers in research or in practices among the un¬ 
derserved. Again, federal cutbacks have exacerbated the 
problem. 
Observes Dr. Myron Genel, associate dean for government 
and community affairs. "The National Health Service Corps of¬ 
fers loan forgiveness of up to $25,000 annually to new M.D.s 
who serve certain underserved populations. But this year only 
40 to 50 doctors will be able to join the program because of an 
inadequate appropriation of $2 million.'' 
Dr. Genel adds that Armed Forces scholarships have survived 
with their otter of free tuition and a stipend for military service, 
but the program is more difficult than ever to enter because of 
great demand. 
1 en Yale's policy of admitting students without regard to fi- 
mcial need —another competitive advantage —faces the dan- 
ot being rendered moot. This will happen if many 
Gukites from middle-income backgrounds decide against en- 
’ because of the debt burdens they and their families will 
have to bear. 
innately, the Yale medical school administration and the 
alumni are working together to keep this from happening. 
In 1986, Dean Leon E. Rosenberg began a policy of ear¬ 
marking for scholarships all gifts to the Medical School Alumni 
Fund that are available for current use. Such alumni support is 
augmented by scholarship endowments and funds that the dean 
earmarks from his discretionary budget. 
This academic year, the dean designated $317,000 for 
scholarships, which was complemented by $245,000 in 
endowment income and $235,000 in alumni contributions. A 
significant increase in alumni giving from the previous year 
made it necessary to raise the unit loan only 2 percent —from 
$12,250 to $12,500. 
Though not faced with the consequences of overexpansion, 
Yale still has had to contend with the rising costs that are a part 
of operating a leading medical school. Most of these costs come 
under the categories of maintaining a top faculty and updating 
facilities and equipment to keep current with sophisticated med¬ 
ical technology. 
This, in turn, allowed financial aid director Nyiri to keep stu¬ 
dent loans —aside from those given in lieu of the family contri¬ 
bution—at or below a 9 percent interest rate. This development 
will have a profound, positive effect on the finances of schol¬ 
arship students. Observes Ms. Nyiri, "Last year's generous out¬ 
pouring of support from the alumni saved Yale medical students 
who are on financial aid thousands of dollars in interest 
payments.” 
She also points out that from a recruitment standpoint, this 
has helped Yale stay competitive. For instance, the debt burdens 
of 1987 Yale and University of Connecticut medical graduates 
were comparable, although the state school's tuition is about 
half, according to a recent New York Times article. 
Dean Rosenberg underscores the importance of continued 
alumni support. "In this era of federal stringency and rising 
costs, we rely on the financial support of our alumni more than 
ever. Educating tomorrow's Yale physicians —this school's 
heirs —must always be a cooperative effort between Yale and its 
alumni.” 
At a recent executive committee meeting of the Association 
of Yale Alumni in Medicine, however, members expressed con¬ 
cern that donations for the current fiscal year were running 
$200,000 behind last year's record pace. 
"Should the alumni decrease their giving.” the dean points 
out. "scholarships will decrease, and many Yale medical stu- 











The Class of 1988 
A profile of those who borrow 
to finance their medical education 
Estimated Mean Debt 
Medicine $40,000 
Physician Associate 23,000 
Epidemiology and Public Health 25,600 
Estimated Maximum Debt 
Medicine $80,600 
Physician Associate 30,100 
Epidemiology and Public Health 40,100 
The debts of physician associate and epidemiology and public health 
students tend not to be as high as those of medical students, who, on 
average, take more years to complete their degree. Nevertheless, in¬ 
debtedness also affects PA and EPH students seriously, because they 
receive lower salaries than do most new doctors. 
dents will literally be the poorer for it. We must get the word out 
to the alumni about the great degree to which our students ben¬ 
efit directly from their gifts.” 
LOOKING TO THE FUTURE 
Given the current economic and political climate, medical ed¬ 
ucation administrators and their allies are trying to make the 
best out of a difficult situation. 
One of the few promising developments is a loan administra¬ 
tion program called MEDLOANS which was recently unveiled 
by the Association of American Medical Colleges. Among 
other features, the program offers a simplified application pro¬ 
cess for applying for government loans. 
MEDLOANS also makes higher interest non-government 
loans somewhat less expensive by requiring no payments while 
the recipient is in school or in the early part of the residency pe¬ 
riod. The program also offers a graduated payment plan so that 
physicians can make lower payments during the first, less lu¬ 
crative years of practice. 
Meanwhile, at Yale, administrators and alumni leaders are 
discussing contingencies that could ease the pressure of mount¬ 
ing student debts. 
Associate Dean Gifford is considering an income-contingent 
plan whereby borrowers who receive financial aid would pay a 
percentage of their salary until the debt incurred by their grad¬ 
uating class is paid off. Because those who earn smaller salaries 
would pay less, students could choose research or other lower 
paying areas of medicine without fear of how they could support 
their medical school debts. 
Another approach calls for alumni classes to sponsor individ¬ 
ual students with scholarships or low-interest loans. Such 
awards would go to students who stated a career preference for 
a lower paying or underserved area of medicine. 
Neither approach, however, would be without its problems. 
The first invokes the memory of the Tuition Postponement Op¬ 
tion, a percentage-payback plan that was instituted at Yale Col¬ 
lege in the early 1970s. It was discontinued after only a few 
years because low-interest government loans became available 
and not enough students chose to enlist. 
The second plan would require a fundamental change in the 
school's philosophy of providing financial aid. Through the 
current unit loan system, scholarships are provided in a uniform 
fashion and on a needs-basis only. Scholarships based on career 
interest, while easing the debt burden of some students, would 
engender complaints of others who do not receive extra schol¬ 
arship aid despite similar needs and interests. 
As the dialogue over long-term strategy continues, however, 
a specter looms over the immediate future: The cost of attending 
medical school will keep escalating even as the prospects for 
low-interest student loans continue to dim. 
For the Yale University School of Medicine to continue her 
legacy of attracting the best students from all walks of life, sup¬ 
port from her alumni must continue to grow. 

























Just as physicians diagnose their patients' 
condition, a new School of Medicine task 
force will examine the medical curriculum 
and diagnose the four-year educational 
program. 
“The best aspects of the Yale curricu¬ 
lum are its flexibility and diversity," says 
Dr. Edward J. Benz Jr., professor of med¬ 
icine and human genetics and chairman of 
the task force on curriculum evaluation. 
“While we would like to know that every 
Yale graduate comes out well educated, 
all of our students don't necessarily have 
to take the same courses." 
Hallmarks of the Yale System are the 
minimum number of required lectures and 
the thesis requirement. “We will not rec¬ 
ommend any changes in these areas; we 
will not tamper with things sacred to the 
curriculum, and we will preserve its flex¬ 
ibility," Dr. Benz says. 
The task force, which includes depart¬ 
ment chairmen, members of the curricu¬ 
lum committee, faculty and medical 
students, is not empowered to write a new 
curriculum, Dr. Benz emphasizes. "We 
are simply going to study it." At the same 
time, the school's curriculum committee, 
a separate group which he also chairs, will 
continue to monitor ongoing course 
offerings. 
Basically, the task force will: 
- Define the goals of a Yale medical 
education which trains both professors 
and practitioners. 
- Hold the curriculum up against cer¬ 
tain educational standards to see whether 
such essential aspects as nutrition and out¬ 
patient practice are being taught and to see 
whether such basic science courses as 
physiology and pharmacology are com¬ 
plementing clinical experiences. 
- Recommend, in a broad way, the 
scope of any curriculum revisions. This 
process may range from revising some 
areas to writing a new curriculum. The 
task force then will provide guidelines 
about which areas need to be preserved or 
strengthened. 
Among specific questions that the task 
force will address are: What are the best 
ways to teach students the clinical skills 
the\ need'1 How do educators relate vast 
amounts of basic science information to 
the complexities of clinical care? Should 
basic sciences be reintroduced in the 
fourth year? Is teaching an activity that is 
sufficiently recognized and rewarded at 
Yale? 
I he risk force has invited faculty, stu- 
and recent graduates to present their 
the curriculum. In addition. Dr. 
Benz has written to peer institutions, such 
as Stanford and Johns Hopkins, to learn 
about their educational programs. “While 
we are looking for ideas and insights from 
others, we don’t want to repeat someone 
else’s mistakes,” he notes. 
The work is expected to be completed 
by the end of May, Dr. Benz projects, add¬ 
ing "We are not predicting answers or so¬ 
lutions until we get the data." 
Why did Dean Leon E. Rosenberg ap¬ 
point the curriculum task force? 
Several factors indicated the merit of 
such a move. Recently, the faculty agreed 
to introduce a new course, "Professional 
Responsibility." during the second year, 
but it was difficult to find a place in the 
curriculum. This pointed up the need to 
look at the curriculum in anticipation of 
future course additions that will adapt 
physician education to new challenges. 
There also is a need to take a closer look 
at the fourth-year program, where stu¬ 
dents may benefit from a more structured 
approach. Now, Dr. Benz says, these stu¬ 
dents spend considerable time interview¬ 
ing for residency positions and writing 
their theses. 
Among suggestions the task force will 
consider is reintroducing basic sciences in 
the fourth year, after students have had 
some clinical experience. "Basic science 
and clinical experience are two universes 
that students have to master. Integrating 
these areas is very important if physicians 
wish to stay current and help their pa¬ 
tients,” notes Dr. Benz. 
The current approach, which divides 
the curriculum into two distinct parts, may 
not allow students to appreciate how the 
basic sciences and clinical experiences are 
intertwined. Dr. Benz explains. “One 
needs to think of these four years of med¬ 
ical school as the first stage of on¬ 
going education, not just as single-shot 
training. . . . Physicians should always 
use basic science to try to understand what 
happens to patients.” 
Members of the Task Force for Curric¬ 
ulum Evaluation include: 
Walter F. Boron. M.D., Ph.D., professor 
of cellular and molecular physiology 
Dr. Ann M. Curtis, professor of 
diagnostic radiology 
Dr. Richard L. Edelson, professor and 
chairman of the department of 
dermatology 
Sonya S. Erickson, third-year medical 
student 
Dr. Robert H. Gifford, associate dean for 
education and student affairs 
Dr. Richard J. Gusberg, associate 
professor of surgery 
Ethan A. Halm, second-year medical 
student 
Dr. Barbara Kinder, associate professor 
of surgery 
Vincent T. Marchesi. M.D., Ph.D., 
chairman of the department of 
pathology and the Anthony N. Brady 
Professor of Pathology. Cell Biology 
and Biology 
Dr. Dwight F. Miller, associate clinical 
professor of pathology and president 
of the Association of Yale Alumni in 
Medicine 
Gordon M. Shepherd, M.D., D.Phil., 
professor of neuroscience 
Walter M. Stadler, fourth-year medical 
student 
Arthur J. Viseltear, Ph.D., associate 
professor of the history of medicine 
and public health 
Dr. Joseph B. Warshaw, professor and 
chairman of the department of 
pediatrics 
Novel Mentorship System 
Stimulates Networking 
The Office for Women in Medicine has ini¬ 
tiated a novel system whereby spouses of 
School of Medicine faculty will be paired 
as mentors for partners of postdoctoral fel¬ 
lows. residents and interns. 
“The mentorship system will provide 
both professional and social networks," 
says Merle Waxman, the director of the 
Office for Women in Medicine, who has 
established the program. 
"We expect the mentors to be important 
role models during this period of intense 
training when the spouses of postdoctoral 
fellows, residents and interns have to cope 
with a variety of issues, and often feel 
stressed, anxious or socially isolated," 
says Ms. Waxman. 
“We expect that mentors will provide 
an introduction to Yale University, Yale- 
New Haven Hospital and the Greater New 
Haven area, to the intricacies of being a 
medical partner, and to the ways in which 
couples can effectively balance busy 
careers with family responsibilities," 
she adds. 
The mentorship program is an out¬ 
growth of recommendations made by the 
housestaff support group, called Support 
Plus. The group was organized last year by 
two psychotherapists who are in private 
practice and are medical spouses. 
Yale-New Haven 
Board Elections 
Dr. Leon Rosenberg, dean of the School of 
Medicine, and Sheila Wellington, ’68 
M.P.H., M.U.S., secretary of Yale Uni¬ 
versity, were elected to Yale-New Haven 
Hospital's 28-member board of trustees in 
December, 1987. Also elected was George 
W. Edwards, Jr., chairman of the board 
and chief executive officer of United 
Illuminating. 
YALE MEDICINE Spring 1988 
Yale Physicians Building Enhances Patient Care dean for clinical affairs, notes that the 
new building consolidates and central¬ 
izes many of the specialty ambulatory 
patient care services that full-time fac¬ 
ulty physicians provide patients who 
are referred from throughout the North¬ 
east and around the world. In the past, 
these services have been at sites scat¬ 
tered throughout Yale-New Haven 
Medical Center. 
A number of outpatient specialty 
services have not moved, including in¬ 
ternal medicine, which remains in the 
Dana Clinic Building. It is easily ac¬ 
cessible to the Yale Physicians Build¬ 
ing via a second-floor pedestrian bridge 
over Howard Avenue. The Yale Eye 
Center also remains in its newly reno¬ 
vated space in the Boardman Building. 
For the convenience of patients, the 
Yale Physicians Building also houses 
satellites of a number of Yale-New Ha¬ 
ven Hospital services, including diag¬ 
nostic imaging, electrocardiography, 
clinical laboratories and physical ther¬ 
apy. A Medical Center Pharmacy sat¬ 
ellite is located on the first floor. 
The building is fully accessible to 
the handicapped; it includes handi¬ 
capped parking immediately adjacent 
to the building, ramps and a revolving 
entrance door which accommodates 
wheelchairs. Additional patient park¬ 
ing adjoins the facility. 
“This summer, we will have a com¬ 
puterized patient appointment sched¬ 
uling system installed,” Dr. Greenspan 
explains. “The system will simplify 
the scheduling of appointments for re¬ 
ferring physicians and their patients and 
also will provide patients with preregis¬ 
tration information.” 
Faculty offices for four medical school 
departments or sections are now housed 
in the new building. These include ear, 
nose and throat; orthopaedics and reha¬ 
bilitation; plastic surgery and urology. 
Ellerbe Associates, Inc., an architec¬ 
tural and engineering firm based in Min¬ 
neapolis, Minn., designed the new 
building, while Morganti Inc. of Ridge¬ 
field, Conn., served as the primary 
contractor. 
The Yale Physicians Building: exterior view 
BILL CARTER atrium 
In early March, the School of Medicine 
opened the Yale Physicians Building, a 
four-story, $13 million facility located 
at 800 Howard Ave. 
“The building represents a major 
step for the school to operate more ef¬ 
ficiently its specialty ambulatory care 
programs which are essential compo¬ 
nents of our mission,” explains Dean 
Leon E. Rosenberg. 
The 95,000 square-foot building in¬ 
cludes specialty care services in der¬ 
matology, ear, nose and throat; 
neurology, obstetrics and gynecology, 
medical oncology, orthopaedics and re¬ 
habilitation, pediatrics, surgery and 
urology. In addition, the genetic coun¬ 
seling service has moved into the new 
facility. 
Dr. Richard H. Greenspan, associate 
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EPH Receives $311,000 
Recruitment Grant 
The department of epidemiology and 
public health has received a three- 
year federal grant to encourage minor¬ 
ity and economically disadvantaged 
students to obtain graduate education 
leading to careers in public health. 
The new Health Careers Opportu¬ 
nity Program (HCOP) is funded by a 
S311,000 grant from the U.S. Depart¬ 
ment of Health and Human Services. 
EPH is one of the few graduate and 
professional schools to receive the 
award. Most grants go to undergrad¬ 
uate colleges to recruit high school 
students into he a 1th- oriented 
programs. 
The new HCOP grant encourages 
students to seek graduate education in 
order to enter the health field where 
their views and talents are needed. 
“We are very pleased to receive 
this grant,” says Professor Stolwijk, 
the principal investigator. “In this 
time of tight money, the federal gov¬ 
ernment has recognized our commit¬ 
ment to promoting educational 
opportunities for minorities and the 
economically disadvantaged.” 
Professor Stolwijk notes that while 
the HCOP grant will complement the 
comprehensive teaching program al¬ 
ready in place, it will be administered 
in the student Resource Center, which 
counsels students about careers and 
practicum opportunities. 
Comments Matthew Lopes, assis¬ 
tant director of the center, “HHS 
awarded this grant because we argued 
successfully that the field of public 
health needs these professionals. It is 
a field where students can choose 
from among a wide variety of vital, 
fulfilling careers.” 
He adds that while EPH minority 
enrollments have not followed the 
downward national trend, the HCOP 
grant should allow the department — 
which is an accredited school of pub¬ 
lic health —and other health schools 
to increase their numbers of minority 
students as these students become 
aware of career opportunities in the 
health field. 
The EPH Resource Center will re- 
cuit students, provide academic sup¬ 
port if it is needed, and assist them in 
obtaining health experience. Students 
in their junior college year are helped 
with their senior course selections. 
Mr. Lopes has already visited col¬ 
leges in Connecticut, Rhode Island, 
Virginia, Massachusetts and Georgia. 
Career advisors at some of these 
schools will also visit Yale to see the 
program in action. A committee of 
students, faculty and health profes¬ 
sionals will advise and monitor the 
program. 
As part of the HCOP grant, Yale in¬ 
vestigators will study why some stu¬ 
dents elect to go to graduate school 
and why some choose health careers 
but others do not. 
Sports Medicine Center 
Opens at Long Wharf 
The Sports Medicine Center, a joint effort 
of the department of orthopaedics and 
rehabilitation at the School of Medicine 
and Yale-New Haven Hospital, opened in 
January. 
Physicians at the center, located adja¬ 
cent to the Gaylord/YNHH Rehabilita¬ 
tion Center at Long Wharf, will diagnose 
and treat sports medicine problems and 
injuries. 
‘ ‘The Sports Medicine Center brings to¬ 
gether outstanding expertise and facilities. 
It provides state-of-the-art patient care, 
including diagnosis, treatment and reha¬ 
bilitation. At the same time, it serves a 
worthwhile teaching function,” states Dr. 
Gary E. Friedlaender, chief and chairman 
of orthopaedics and rehabilitation at the 
hospital and medical school. 
Dr. Peter Jokl, professor of orthopaed¬ 
ics and rehabilitation, will direct the cen¬ 
ter, along with Dr. J. Kevin Lynch, 
assistant clinical professor. 
The Class of 1991: Who's Who 
Nina J. Abramson, Brooklyn, N.Y. 
B.A. (chemistry) City University of New York, Brooklyn. 1987 
Jeanne Bari Acknian, Chappaqua. N.Y. 
B.S. (biology) Harvard University, 1987 
Marc Edward Agronin, Appleton, Wis. 
B.A. (philosophy/psychology) Harvard University’, 1987 
Cargill Herley Alleyne, Washington. D.C. 
B.S. (chemistry/mathematics) George Washington University, 1986 
Jorge Guillermo Arroyo II, Tampa, Fla. 
B . A. (engineering/neurobiology) Amherst College, 1987 
Stephen Michael Bell, Milton, Mass. 
B.A. (biology) Harvard University, 1986 
Stacy Ann Beller, Bowie, Md. 
B. A. (biology) Wellesley College, 1985 
Ulrienne Louise Bennett, New York City 
B \. (biology) Vassar College, 1981 
Peter Samuel Bernstein, Setauket, N.Y. 
B.A. (English) Yale University, 1986 
Mark Steven Bianchi, Brooklyn, N.Y. 
B.A. (biology) New York University, 1986 
Michael Jason Borodkin, New York City 
B.A. (history) University of Pennsylvania, 1987 
Elizabeth Ann Bower, Woodside, Calif. 
B.A. (biology) Stanford University, 1984 
Marcus Otho Butler, Houston, Texas 
B.S. (biology) Rice University, 1987 
Michael Anthony Capozza, Houston, Texas 
B.A. (biochemistry/biology) University of California, San Diego 
1987 
Steven Brooks Care, Oberlin, Ohio 
B.A. (philosophy) Yale University. 1986 
Jeffrey Donald Carter, St. Louis, Mo. 
B.A. (African and Afro-American studies/biology) Washington 
University, 1987 
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Jonathan Theodore Chai, Syracuse. N Y. 
B.S. (biology) Stanford University, 1985 
Ada Cheung, Alberta, Canada 
B.S. (medical microbiology) Stanford University, 1987 
Christopher John Cohen, Swarthmore, Pa. 
B.A. (biology) Swarthmore University, 1986 
Daryl Keith Daniels, West Newton, Mass. 
B.A. (biology) Washington University, 1986 
Sarah Ann Davidson, Larchmont, N.Y. 
B.A. (English) Columbia University, 1987 
Frederic White-Brown Deleyiannis, Alexandria, Va. 
B.A. (history) University of Pennsylvania, 1987 
David Jeffrey Eisenman, Teaneck. N.Y. 
B.A. (classical studies) Columbia University, 1987 
Elizabeth Denise Elguera, Elmhurst, N.Y. 
B.A. (biology) Johns Hopkins University, 1986 
Mark Alan Epstein, Dallas, Texas 
B.A. (biology) Stanford University, 1986 
Amin Fazeli, Berverly Hills, Calif. 
(biology) University of California, Los Angeles, 1987 
Daniel William Fitzgerald, Sudbury, Mass. 
B.A. (philosophy) University of Notre Dame, 1986 
Douglas Theodore Fleming, Princeton. N.J. 
B.A. (religious studies) Yale University, 1984 
Colleen Daun Foy, Madison. Wis. 
B.A. (anthropology) University of Wisconsin, 1982 
Gaetane Caroljean Francis, Cambridge, Mass. 
B.S. (biology/engineering) Massachusetts Institute of Technology, 
1986 
David Frankfurter, Jamesville. N.Y. 
B.S. (psychology) Syracuse University, 1986 
Jean Louise Fraser, Atlanta, Ga. 
B.A. (biology) University of Chicago, 1987 
Gwendolyn Grant, New York City 
B.A. (art) Amherst College. 1981 
Leacroft Fitz-Henley Green, Bronx, N.Y. 
B.A. (theology) Atlantic Union College, 1978 
Michele Yolanda Griffith .Teaneck, N.J. 
B.A. (biology) University of Pennsylvania, 1987 
James Akio Hartleroad, Indianapolis, Ind. 
B.S. (biochemistry) Indiana University, 1986 
Irene Marion Hegeman, Eastport, N.Y. 
B.S. (biology) Cornell University, 1987 
Carl Thomas Henningson, Hazlet. N.J. 
B.S. (chemistry) Seton Hall University, 1987 
James Whitney Hicks, New Haven, Conn. 
B.A. (classical civilization) Yale University, 1987 
Class of 1991 Profile 
The Class of 1991, comprised of 66 men and 38 women, was se¬ 
lected from 1,935 applicants representing more than 40 colleges. 
The class includes four students accepted through the early decision 
plan, 10 students enrolled in the M.D., Ph.D program, three chil¬ 
dren of Yale University faculty and seven children of alumni, two of 
whom are children of medical school alumni. Three of the first-year 
students hold Ph.D. degrees and six have master’s degrees. 
Black Americans and other minority students comprise 24 percent 
of the Class of 1991. Four of the students are foreign nationals. Stu¬ 
dents in the Class of 1991 range in age from 19 to 35. with a mean 
age of 23. 
As in previous classes, the majority of the Class of 1991 were sci¬ 
ence majors as undergraduates, but one third of the students had ma¬ 
jors in the humanities and social sciences, 6 percent more than the 
Class of 1990. 
Twelve of the first-year students are Yale alumni, 10 are Harvard 
graduates and seven graduated from the University of Pennsylvania. 
Lawrence James Hirsch, Holmdel. N.J. 
B.A. (computer science) University of Pennsylvania, 1987 
John Sheda Ho, Killeen, Texas 
B.S. (biology) Johns Hopkins University, 1987 
Elizabeth Hopkins Holt, New Haven. Conn. 
B.S. (biology) Columbia University, 1986 
Larry Horesh, Atlanta, Ga. (physics) Georgia Institute of 
Technology, 1986 
Karen Mei Hsieh, Towson, Md. 
B.A. (biochemistry) Harvard University, 1986 
Doris Monica larovici, Forest Hills, N.Y. 
B.S. (biology) Yale University, 1987 
Richard George Ihnat, Nishanic, N.J. 
B.A. (biology) Rutgers University, 1987 
Richard Geoffrey Ingber, Cambridge, Mass. 
B.A. (English) Harvard University, 1973 
M.A., Ph.D. (comparative literature) Harvard University, 1983 
Paul Allen Isenbarger, Whittier, Calif. 
B.A. (chemistry) Whittier College, 1987 
Alan Bruce Jotowitz, Teaneck. N. J 
B.S. (pre-health sciences) Yeshiva College, 1986 
John Edmund Kilty, Hillsborough. Calif. 
B.A. (physiology) University of California, San Diego, 1987 
Hi mi Tina Kim, Menands, N.Y. 
B.S. (economics) Harvard University, 1986 
Kurt Treider Kubicka, Yardley, Penn. 
B.A. (biology/economics) Cornell University, 1987 
Helena Akua Kwakwa, Accra-North. Ghana 
B.A. (chemistry) Bryn Mawr College, 1987 
Kenneth Allen Laughinghouse, Mantoloking, N.J. 
B.A. (chemistry) Dartmouth College, 1987 
James Scott Levine, St. Louis Park, Minn. 
B.A. (biology) Harvard University, 1986 
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David Bruce Lim, Livermore, Calif. 
B.A. (physiology) University of California, Davis, 1987 
Doris Da May Lin, Ephrata, Penn. 
B.A. (chemistry) University of Pennsylvania, 1986 
Thomas Samuel Lin, Texas City, Texas 
B.A. (chemistry) Harvard University, 1987 
Francis Matthew Lobo, Scranton, Penn. 
B.A. (biology) University of Pennsylvania, 1985 
Monica Lee McDonald, Blaine, Minn. 
B.S. (biology/genetics) University of Utah, 1987 
Edward Leonard McNellis, Nanuet. N Y. 
B.S. (pharmacy) Duquesne University, 1984 
Peter Sebastian Marcus, Anaheim, Calif. 
B.A. (history) Tulane University, 1987 
Ellen Ann Markstein, Springfield, N.J. 
B.A. (biology) Williams College, 1986 
Funda Meric, Lawrenceville, N.J. 
Hacettepe University {Turkey) 
David Bernard Miklos, White Oak, Penn. 
B.S. (pre-professional studies) University of Notre Dame. 1987 
Kent K. Min, Woodcliff Lake, N.J. 
B.A. (biology) Brown University, 1987 
Jane Elizabeth Minturn, Torrance, Calif. 
B.S. (biology) University of Southern California, 1986 
Quoc Ai Nguyen, Huntington Beach, Calif. 
B.S. (biochemistry) University of California, Irvine, 1987 
John McIntosh Ninos, Fayetteville, N Y. 
B.A. (biology) Dartmouth College, 1985 
Gonzalo Javier Paz-Soldan, Weston, Mass. 
B.A. (biology) Boston Universitty, 1987 
Andrew Fisher Phillips, Princeton. N.J. 
B.A. (chemistry) Amherst College, 1987 
John Luther Phillips, Tarrytown, N Y. 
B.S. (biology) Wesleyan University, 1987 
Eleanor Susan Poliak, South Bend, Ind. 
B.A. (biochemistry) Harvard University, 1985 
Marc Nicholas Potenza, Highland Park, N.J. 
B.S.. M.S. (molecular biophysics & biochemistry) 
Yale University, 1987 
Pablo Alejandro Quintela, Jr., Hialeah. Fla. 
B.A. (chemistry) University of Miami, 1987 
Eric Alan Richard, Warwick, R.I. 
BSE. (engineering) University of Pennsylvania, 1987 
Lauren Renee Rodgers, Yardley, Penn. 
B.A. (chemistry) Princeton University, 1984 
\I ichael Fedele Romanelli, Saint James, N Y. 
B.A. (philosophy) Princeton University, 1987 
Elizabeth Rubin Roth, New Haven. Conn. 
B V (history) Yale University, 1985 
Kathryn Marie Ryder, Lexington, Mass. 
B.S. (biology/psychology) Yale University, 1987 
Daniel Benjamin Saal, West Orange, N.J. 
B.S. (biology) Massachusetts Institute of Technology, 1987 
Jeffrey Scott Schechner, Brookline, Mass. 
B.A. (biology) Boston University, 1987 
Marc Seltzer, New York City 
B.S. (meteorology science) McGill University, 1983 
M.S. (meteorology science) Massachusetts Institute of Technology 
1984 
Grant Harper Shumaker, Fairfax Station, Va. 
B.A. (biology) Harvard University, 1987 
Ann Marion Smith, Essex Fells, N.J. 
B.S. (psychology) Duke University, 1987 
Robin Lisa Smith, New York City 
B.A. (psychology) Yale University, 1986 
Gina Michelle Solomon, New York City 
B.A. (comparative literature) Brown University, 1986 
Robert Matheson Spillane, Woodland Hills, Calif. 
B.A. (chemistry) California State University. Northridge, 1987 
James Edward Stanislaw, Warren. Ohio 
B.S. (pre-professional studies) University of Notre Dame, 1987 
Christopher Charles Steevens, Claremont, Calif. 
B.A. (psychology) Stanford University, 1986 
Margaret Reba Stevens, New Haven, Conn. 
B.A. (psychology) Harvard University, 1986 
Jivin Gerard Tantisira, Glendale, Calif 
B.S. (psychology) University of Southern California, 1982 
M.S. (biology) California State University, 1985 
Chloe Lynne Thio, Marietta, Ga. 
B.A. (biochemistry) University of Pennsylvania, 1987 
Margaret Maria Toth, Lakewood, Ohio 
B.A. (anthropology) Case Western Reserve University, 1987 
Anthony Yu-Ning Tse, Gaithersburg. Md. 
B.A. (biochemistry) Dartmouth College, 1987 
Steven Jay Ugent, Milwaukee, Wis. 
B.A. (biology/Spanish) Washington University, 1987 
David Andrew Utzschneider, Cantonsville. Md. 
B.A. (physics) Bowdoin College, 1985 
Marco Verga, Dix Hills, N.Y. 
B.S. (biochemistry) State University of New York, Stony Brook. 
1987 
Ellis Lorenzo Webster, Anguilla, West Indies 
B.S. (biology) University of the Virgin Islands, West Indies, 1986 
Symphorosa Magdaleine Williams, Silver Spring, Md. 
B.S. (zoology) Howard University, 1987 
Mindy Ellen Wiser. Freehold, N.J. 
B.A. (economics) Brown University, 1987 
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Waichi Wong, Jamaica, N.Y. 
B.S. (molecular biophysics & biochemistry) Yale University, 1986 
James Su-Min Yeh, Bethesda, Md. 
B.S. (chemistry) Yale University, 1987 
Sang-Wook Tim Yoon, Eastman, Ga. 
B.S. (engineering) Massachusetts Institute of Technology, 1987 
EPH Class of 1989 Profile 
In the department of epidemiology and public health , 71 women and 43 men are enrolled 
in the first-year class. One student is enrolled in a combined M.D., M.P.H. program, and 
five are seeking a combined master’s degree in nursing and public health. 
The Class of 1989, which includes 16 foreign nationals and 27 black and other minority 
students, comes from 19 states and 14 countries. Fifteen first-year students are nurses; 16 
hold M.D. degrees; one student has a D.V.M. degree and one has a J.D. degree. The re¬ 
mainder earned undergraduate degrees in the sciences and liberal arts. 
The department of epidemiology and public health, in addition to being a department of 
the medical school, is an accredited school of public health. 
GALLERY 
The Anatomist Overtaken by the Watch . . . 
by William Austin (British, 1721-1820) 
In the 18th century, anatomists and surgeons were not viewed kindly by the public. 
This was due, in part, to the practice of dissection and the illegal means of procuring 
subjects —resurrection —literally raising the dead. William Austin's print, published 
in 1773, implicates William Hunter, one of England's most prominent anatomists, in a 
grave robbing incident. Hunter flees to the right as the watchman, hired to protect the 
sanctity of the cemetery, sounds his rattle in a call for help. The watchman holds unto 
a burly resurrectionist, typical of the professionals who supplied the dissecting rooms 
of London hospitals and private schools, such as Hunter's at Great Windmill Street. 
The body of Miss Watts, in a hamper for its removal, has fallen to the ground. It is un¬ 
likely that a physician of Hunter’s stature would have ventured into the cemetery him¬ 
self, but that he employed others to do so is certain. That fact that the subject, Miss 










Two scientists from the Yale School of 
Medicine —one an expert on secretory 
cells and another on how our senses per¬ 
ceive the world —have received Javits 
Neuroscience Investigator Awards from 
the National Institutes of Health. 
William Douglas, M.D., F.R.S., pro¬ 
fessor of pharmacology, will use his seven- 
year, $1.1 million award to continue his 
longstanding investigation into how cal¬ 
cium and other mediators allow cells to 
“understand” an outside stimulus as a 
message to begin secretory activity. His 
research may have implications for dis¬ 
eases such as cystic fibrosis and diabetes, 
in which patients’ secretory cells behave 
pathologically. 
Lawrence E. Marks, Ph.D., professor 
of epidemiology and psychology, and fel¬ 
low and associate director of the John B. 
Pierce Foundation Laboratory, received 
his award to support research on percep¬ 
tual processes in the senses of touch, hear¬ 
ing, vision and taste. It extends a current 
five-year NIH grant for two years, and 
brings his total funding from the federal 
agency to $789,000. 
The Javits Award is granted through the 
National Institute of Neurological and Com- 
municative Disorders and Stroke, and is 
named in honor of the late U.S. Sen. Jacob 
Javits of New York. It is given to research 
scientists “who have a distinguished re¬ 
cord of contributions in some field of neu¬ 
rological or communicative sciences and 
who can be expected to be highly produc¬ 
tive over the next seven years.” 
$1.25 Million Grant 
Funds Spinal Study 
The National Institute of Neurological and 
Communicative Disorders and Stroke has 
awarded Yale a five-year $1.25 million 
grant to study a new approach to spinal an¬ 
algesia. Principal investigator Dr. Luke 
M. Kitahata, professor of anesthesiology 
at the School of Medicine, will test 
whether newly developed experimental op¬ 
iate-derivatives are feasible for spinal an¬ 
algesia. These drugs promise effective and 
long-lasting analgesia without the side ef¬ 
fects that accompany the opioid analgesics 
now in use. 
Dr. Kitahata’s pioneering studies on the 
effects of anesthetics and opioid analge¬ 
sics on spinal cord function have involved 
a sophisticated technique that records the 
functioning of single neurons, the cells 
that play a key role in transmitting nerve 
impulses. 
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Major Research Project 
on Dyslexia Begins 
Researchers at the School of Medicine, in 
cooperation with the Haskins Laborato¬ 
ries, have initiated a major new research 
project combining powerful new technol¬ 
ogies and innovative approaches to better 
understand dyslexia. 
Dr. Bennett A. Shaywitz. associate pro¬ 
fessor of pediatrics, neurology, and at the 
Child Study Center, is the principal inves¬ 
tigator for the five-year project funded last 
fall by the National Institute of Child 
Health and Human Disorders. The $4 mil¬ 
lion grant to Yale University will enable 
Dr. Shaywitz and his colleagues to extend 
their work on learning and attention dis¬ 
orders in children. 
"This comprehensive project represents 
a major step forward in understanding dys¬ 
lexia. It offers, for the first time, the po¬ 
tential of using magnetic resonance 
imaging (MRl) data to provide detailed 
pictures of the anatomy, as well as inno¬ 
vative electrophysiologic measures to ex¬ 
amine the brains of school children with 
dyslexia,” says Dr. Shaywitz. 
The MRI information will be combined 
with state-of-the-art linguistic testing to 
focus on the precise anatomic areas related 
to language and reading and to relate ana¬ 
tomic patterns found in the brains of dys¬ 
lexic children to specific reading patterns. 
Dyslexics, according to Dr. Shaywitz, 
"have difficulty learning, even though 
they may have conventional instruction, 
adequate intelligence and educational op¬ 
portunities. . . . From both its prevalence 
and its impact on children and families, 
the disorder presents a major concern to 
educators, physicians and families. 
"Our new research project will allow us 
to approach this important disorder in the 
same serious fashion that we use to inves¬ 
tigate other disorders, such as diabetes.” 
the pediatric neurologist says. “The study 
also will have broad implications for pub¬ 
lic policy on education of individuals with 
dyslexia.” 
The project has four components: 
• learning about the relationship be¬ 
tween language and reading in chil¬ 
dren between ages l'l2 and 9'U 
years. This will involve magnetic 
resonance imaging and even newer 
electroencephalographic tech¬ 
niques to examine dyslexic chil¬ 
dren’s brains; 
• studying the genetic patterns of 
reading disability in children, their 
siblings and parents; 
• studying the relationship of atten¬ 
tion disorders to reading disorders; 
• relating the kinds of reading disa¬ 
bilities found in the children stud¬ 
ied to learning disabilities in a more 
general population. 
Dr. Kashgarian Leads 
Kidney Study 
An interdisciplinary team in the School of 
Medicine has started a new research proj¬ 
ect to define the way cells respond in ini¬ 
tiating and perpetuating the disease 
processes that lead to chronic kidney 
failure. 
Dr. Michael Kashgarian. professor of 
pathology and vice chairman of the pa¬ 
thology department, is directing the pro¬ 
gram project for which the National 
Institutes of Health has granted $1.5 mil¬ 
lion to Yale University. The research will 
focus on the kidney. 
“Chronic renal disease is one of the ma¬ 
jor medical expenditures in the United 
States," says Dr. Kashgarian, who esti¬ 
mates that more than $4 billion per year 
is spent on dialysis and kidney 
transplantation. 
”We plan to use molecular biological 
techniques to examine the cellular proc¬ 
esses which lead to chronic renal disease,'' 
explains Dr. Kashgarian, “and we have 
initiated three main studies.” Specifi- 
cially. the team will look at: 
— endothelial cells and supporting 
molecules in chronic renal disease of 
diabetes 
— kidney filter cells and supporting 
molecules in progressive renal diseases, 
ranging from early kidney scarring to loss 
of kidney function 
— cells of the kidney tubules which 
transport salt and water and their reaction 
to injury and recovery. 
The three-year research project brings 
together basic scientists who are collabo¬ 
rating to examine practical problems re¬ 
lated to various aspects of chronic renal 
disease. In this innovative approach, they 
are applying fundamental scientific infor¬ 
mation and new techniques to the study of 
kidney disease. 
"We now have molecular probes to look 
at the interaction of cells, w'hat they pro¬ 
duce and how these products are regulated 
in cells, what stimulates synthesis and 
how cells respond to injury. With new 
techniques, we can look at the cellular 
events that control the disease response," 
Dr. Kashgarian explains. 
For instance, the researchers hope to 
learn more about the factors that cause kid¬ 
ney disease to progress even after a kidney 
injury has been treated. This often results 
in the loss of kidney function, the treat¬ 
ment of which drains the patient's finan¬ 
cial resources. 
In addition, the researchers are looking 
at the cellular and molecular aspects of 
how a cell organizes its own structure and 
how' this relates to the way salt and water 
are transported in the kidney. 
Coinvestigators with Dr. Kashgarian 
are: Dr. Heinz Furthmayr. professor of pa¬ 
thology; Joseph A. Madri, M.D., Ph.D.. 




ward J. Benz Jr., professor of medicine 
and human genetics; Dr. Bemd Sterzel. as¬ 
sociate professor of medicine; Harald 
Foellmer. Ph.D., assistant professor of 
medicine; Mark S. Mooseker. Ph.D., as¬ 
sociate professor of biology and cell biol¬ 
ogy, and Jon S. Morrow. M.D.. Ph.D., 
associate professor of pathology. 
Frozen Brain Cells 
Transplanted in Monkeys 
Researchers at Yale University and the 
University of Rochester have successfully 
frozen and preserved monkey brain cells, 
and these cells have survived transplanta¬ 
tion in three monkeys. 
The brain cells, called dopamine neu¬ 
rons. use the chemical substance dopa¬ 
mine to control subtle motor movements, 
among other central nervous system func¬ 
tions. If primates or humans lose nearly all 
of their dopamine neurons, they show' the 
signs of Parkinson's disease. 
In May 1986. the Yale-Rochester team 
w'as the first to publish a scientific report 
on the survival of transplanted brain cells 
in primates. In these animal studies, the 
reseachers reversed the symptoms of Par¬ 
kinson's disease in monkeys by transplant 
ing fresh fetal dopamine neurons. 
In the new studies, the team has devel¬ 
oped cryopreservation—freezing and stor¬ 
ing-techniques which will move physicians 
and biomedical scientists a step closer toward 
clinical applications to treat Parkinson's dis¬ 
ease in humans, according to Dr. D. Eugene 
Redmond Jr., professor of psychiatry and di¬ 
rector of the neurobehavior laboratory in 
the School of Medicine. He also is director 
of the Yale-Rochester primate neural trans¬ 
plant program. 
These animal studies, completed last year, 
were reported in the current issue of Brain Re¬ 
search. an international journal published in 
.Amsterdam. Timothy J. Collier. Ph.D., as¬ 
sistant professor of neurobiology and anatomy 
at the University of Rochester, is the first au¬ 
thor of the report. 
In conducting the federally funded re¬ 
search. the Yale-Rochester team found that it 
could grow the same dopamine cells in tissue 
culture after the cells were frozen and stored 
in liquid nitrogen. Cells stored for as long as 
28 days remained viable. 
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Investigators Win 
MERIT Awards 
Of 13 Yale scientists who earned MERIT 
research awards in 1987 from the National 
Institutes of Health, 11 are faculty mem¬ 
bers of the School of Medicine. MERIT 
(Method to Extend Research in Time) is an 
NIH program that provides from seven to 
10 years of support for medical research to 
principal investigators with a longstand¬ 
ing record of excellence. 
Investigators may not apply for MERIT 
awards. The NIH National Advisory 
Boards which evaluate proposals for 
standard five-year research grants recom¬ 
mend the awards for only the most prom¬ 
ising research. This reduces the paper 
work award winners must put into raising 
money for long-term projects, thus freeing 
time that the scientists can dedicate to 
their research. Last year, the NIH made 
187 MERIT awards in the United States 
for a total of more than $40 million. Av¬ 
erage annual payments to Yale researchers 
for the awards are in the range of $130,000 
to $150,000. 
Observes H.G. Aaslestad, director of 
grants and contract administration for the 
School of Medicine, "The Merit Awards 
illustrate the excellence of the medical 
school’s scientific faculty, as determined 
by their peers and by high level NIH offi¬ 
cials." He points out that Yale had the sec¬ 
ond highest number of MERIT awards 
among the nation's medical schools, be¬ 
hind the University of California at San 
Francisco, which had 18 winners. 
The following summary highlights the 
research projects of MERIT award recipi¬ 
ents who are faculty members of the Yale 
School of Medicine: 
• Dr. Philip W. Askenase, professor 
of medicine and pathology. Dr. As- 
kenase’s work focuses on the role of 
certain T cells in skin hypersensi¬ 
tivity. His research may have a bear- 
ing on understanding allergic 
diseases and on the functioning of 
body’s immune system. 
• Ari H. Helenius, Ph.D., professor 
of cell biology, is attempting to 
learn more about how viruses in¬ 
vade cells and then use the host 
cells’ genetic material to multiply. 
His study is focusing on both the 
cellular and the molecular levels 
and may help in understanding the 
flu virus. 
• James D. Jamieson, M.D., Ph.D., 
professor of cell biology and chair¬ 
man of the cell biology department, 
is studying how the pancreas sorts 
and targets secretory proteins 
within the organ's individual cells. 
His research has implications for 
diseases such as cystic fibrosis and 
pancreatic cancer, in which cell po¬ 
larity is lost. 
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• Kenneth K. Kidd, Ph.D., professor 
of human genetics and psychiatry, 
is attempting to locate within 
strands of human DNA the genes 
that may cause schizophrenia, 
Tourette's syndrome and other 
mental disorders. 
• Dr. I. George Miller, the John F. 
Enders Professor of Pediatric Infec¬ 
tious Disease, Epidemiology, and 
Molecular Biophysics and Bio¬ 
chemistry, is studying on a molec¬ 
ular level the Epstein-Barr virus, 
associated with mononucleosis, 
herpes and other diseases. His team 
is trying to discover how the virus 
multiplies in immunodeficient in¬ 
dividuals, such as AIDS victims 
and organ transplant patients. 
• Dr. George E. Palade, Sterling Pro¬ 
fessor Emeritus of Cell Biology and 
senior research scientist in cell bi¬ 
ology, will continue his molecular 
research into the workings of the 
vascular endothelium, the cells that 
line blood vessels. His research is 
shedding light on how cardiovas¬ 
cular diseases develop. 
• Howard Rasmussen, M.D., Ph.D., 
professor of medicine, physiology 
and cell biology, is investigating 
various aspects of cell physiology, 
including how information is com¬ 
municated from a cell’s exterior to 
its interior via calcium channels. 
• John Kenneth Rose, Ph.D., profes¬ 
sor of pathology and cell biology, is 
leading a molecular investigation 
into how some viruses target them¬ 
selves to particular membranes 
within the body, and then reproduce 
once they reach those membranes. 
His study will help in the fight 
against such virus infections. 
• Dr. Leon E. Rosenberg, the C.N.H. 
Long Professor of Human Genetics, 
Medicine and Pediatrics, and dean 
of the School of Medicine, is at¬ 
tempting to illuminate how inborn 
errors in metabolizing certain 
amino acids may be related to such 
conditions as Down’s syndrome. 
His research could lead to more ef¬ 
fective prenatal diagnosis of inher¬ 
ited diseases. 
• Dr. Kay Tanaka, professor of hu¬ 
man genetics, is spearheading re¬ 
search about the genetic evolution 
of certain inherited metabolic dis¬ 
orders such as isovaleric acidemia 
and glutaric aciduria. Understand¬ 
ing the history of such diseases on a 
molecular level may reveal clues to 
possible cures. 
• Dr. Robert B. Tesh, associate pro¬ 
fessor of epidemiology, is studying 
insect-borne viruses such as yellow 
fever, dengue and Japanese enceph¬ 
alitis, that are submitted to the 
World Health Organization’s Ref¬ 
erence Center for Arboviruses, part 
of the Yale Arbovirus Research 
Unit. The unit also trains research¬ 
ers from around the globe to iden¬ 
tify such viruses. 
FACULTY NEWS 
Dr. Shope Presented 
Arbovirology Award 
Dr. Robert E. Shope, professor of epide¬ 
miology and director of the Yale Arbovirus 
Research Unit, was the co-recipient of the 
Richard Moreland Taylor Award for 1987 
of the American Committee on Arthropod- 
borne Viruses. He was recognized for 
his outstanding achievement in the field of 
arbovirology during the annual meeting 
of the American Society of Tropical 
Medicine and Hygiene last December in 
Los Angeles. 
Established in 1966 and presented every 
three years, the award honors the late Dr. 
Taylor, who was a Rockefeller Foundation 
staff member before teaching in Yale’s 
department of epidemiology and public 
health. Dr. Taylor died in 1981. 
Both men have centered much of their 
research on arthropod-borne viruses, or 
arboviruses —pathogens that are transmit¬ 
ted by the bite of infected arthropods, such 
as ticks, mosquitoes and sandflies, and 
usually involve a reservoir host. 
Dr. Shope’s contributions to the knowl¬ 
edge of arboviruses and certain other vi¬ 
ruses linked to them have been described 
as “exceptional, original and pioneer¬ 
ing.” Among his outstanding achieve¬ 
ments are his work on rabies. Rift Valley 
fever and the reassortment of genetic ma¬ 
terial among virus serotypes. 
One of Dr. Shope's colleagues. Dr. Jordi 
Casals, professor emeritus of epidemiol¬ 
ogy and now professorial lecturer at Mount 
Sinai School of Medicine, recently de¬ 
scribed the work of this “complete arbov- 
irologist.” He wrote: 
“From the time of Pasteur, until Dr. 
Shope proved otherwise, rabies virus had 
been considered to be an agent totally dis¬ 
tinct; the only one of its type with no an¬ 
tigenic relatives or variants. 
"As a result of Dr. Shope’s work and its 
influence on other investigators, rabies 
lost its aloofness, became identified as part 
of a family of viruses mostly arthropod- 
borne. Even more importantly, antigenic 
differences between isolates became ap¬ 
parent, a fact which had a great impact on 
diagnosis, strain selection for vaccination 
and on the epidemiology of the disease. 
“A similar situation developed with 
Rift Valley fever, a disease of considerable 
veterinary and medical importance. The 
virus causing it had been known for about 
50 years. But Dr. Shope's investigations 
on the serological properties of the phle- 
hotomus fever antigenic group of viruses 
lted in the unexpected finding that Rift 
Valley fever virus was a member of this 
.'roup, subsequently named the genus 
nhlebovirus. This finding came shortly 
alter the devastating 1977 epidemic in 
I \ pt m which Dr. Shope contributed with 
distinction. It also resulted in new guide¬ 
lines for specific diagnosis and epidemiol¬ 
ogical investigations. 
“A third important contribution by Dr. 
Shope concerns his work on reassortment 
of genetic material between arboviruses. 
Investigators who first defined the anti¬ 
genic group C had noticed that strains of 
Caraparu virus, identified as such by hem¬ 
agglutination-inhibition and neutraliza¬ 
tion tests, reacted in one of two different 
ways in the complement-fixation test: Cer¬ 
tain strains cross-reacted by CF with the 
other group C viruses, certain other strains 
did not. In fact, the latter strains of Cara¬ 
paru failed to react with the former; it 
seemed as through some strains of virus 
were deficient in the group C common 
antigen. 
“Dr. Shope came up with a brilliant 
concept: the rapid turnover of group C vi¬ 
ruses in the Belem area of Brazil made it 
conceivable that an occasional strain 
might by chance, in nature, acquire pieces 
of genetic material from another group C 
virus yielding a recombinant with altered 
antigenic properties. 
“Today, exchange of genetic material 
between viruses is almost a daily routine 
laboratory procedure, but this was not so 
in the mid-1960s. At a later date and in as¬ 
sociation with other colleagues. Dr. Shope 
studied genomic reassortment in the Cali¬ 
fornia group and showed changes in the re- 
si stance of mice to experimental 
inoculation correlating to the presence or 
absence of a given RNA piece.” 
Drs. Rosenberg, Ruddle 
Endorse Federal Gene 
Mapping Project 
Dean Leon E. Rosenberg and his col¬ 
league Frank Ruddle, Ph.D., professor of 
biology and human genetics, served on a 
National Research Council committee that 
unanimously endorsed a $3 billion na¬ 
tional effort to map the human genome. 
The massive project, which would pin¬ 
point the location of all human genes and 
establish how their chemical building 
blocks are sequenced, would cost $200 
million annually for the next 15 years. 
Yale would play a major role in any such 
project by virtue of the Human Gene Map¬ 
ping Library, located at Science Park in 
New Haven. With Professor Ruddle as its 
co-founder and director, the library offers 
the largest gene data base in the country. 
The committee concluded that gene 
mapping offers the best hope of identify¬ 
ing the genes responsible for 3,000 inher¬ 
ited diseases, including cystic fibrosis, 
Huntington’s disease and certain kinds of 
Alzheimer’s disease. 
Included on the distinguished 15-mem- 
ber panel was James D. Watson, who dis¬ 
covered the double helix structure of DNA. 
Dr. Baldwin to Head 
Cardiothoracic Surgery 
Dr. John C. Baldwin, an internationally 
renowned heart and lung transplant sur¬ 
geon, has been appointed professor and 
chief of cardiothoracic surgery at the Yale 
School of Medicine and Yale-New Haven 
Hospital. 
He comes to New Haven from the Stan¬ 
ford University Medical Center, where 
among his many responsibilities, he was 
an assistant professor of cardiovascular 
surgery and head of the heart-lung trans¬ 
plantation program. 
For his joint hospital-medical school ap¬ 
pointment, Dr. Baldwin will be responsi¬ 
ble for program and educational 
development in the cardiothoracic section 
of the department of surgery. He will teach 
at the medical school and serve as an at¬ 
tending surgeon at the hospital. 
“Dr. Baldwin comes to this position 
with a reputation for being an exceptional 
surgeon, as well as a committed academi¬ 
cian,” commented Dr. William F. Collins 
Jr., chairman and the Harvey and Kate 
Cushing Professor of Surgery. “He is a pi¬ 
oneer in the field of heart and lung trans¬ 
plants among children with cystic fibrosis. 
This novel surgery is a potentially crucial 
treatment for this common and lethal dis¬ 
ease which usually kills by causing pul¬ 
monary failure.” 
The new chief of cardiothoracic surgery 
said he was attracted to the position be¬ 
cause of the hospital's reputation as a 
leading clinical center and the strength of 
the medical school's basic scientific 
research. 
“The beauty of basic cardiothoracic re¬ 
search is that it can be so readily applied to 
clinical practice. This is particularly true 
in the area of lung preservation where 
basic research has quickly led to success in 
the distant procurement for heart-lung 
grafts,” Dr. Baldwin noted. 
While the distant transport of hearts for 
transplantation has been common practice 
for years, even short-term preservation of 
donor lungs had proven difficult, thus pre¬ 
cluding the possibility for such transplants 
to patients in faraway locations. Tech¬ 
niques developed by Dr. Baldwin and 
other Stanford researchers have led to 
longer viability for donor lungs, thus al¬ 
lowing for the transport of these life-sav¬ 
ing organs across city, state and even 
international borders. 
Dr. Baldwin said that among his top 
priorities were to strengthen the laboratory 
for clinical practice at the cardiothoracic 
section, and expand the clinical program 
for training residents. 
His international awards include a 1985 
designation as Medalist of the Gothenburg 
Thoracic Society in Sweden. In 1987 Dr. 
Baldwin was awarded the Madaile de la 
Ville de Bordeaux from the French Tho¬ 
racic Society. 











Arthur Ebbert Lounge 
Students gather in the Arthur Ebbert Lounge. 
“Ask Art Ebbert.” 
For 34 years, that refrain has echoed 
throughout Sterling Hall of Medicine as 
legions of medical students, faculty and 
staff have sought Dr. Arthur Ebbert’s wise 
counsel and advice during his tenure as as¬ 
sistant dean, associate dean and the 
school’s first deputy dean. 
People still seek him out, and Dean 
Leon E. Rosenberg and others have tapped 
him for several special projects requiring 
his quiet diplomacy even though Dr. Eb¬ 
bert relinquished his position as deuty 
dean in August and began a long-overdue 
sabbatical year. 
Last June, the dean hosted an afternoon 
reception honoring Dr. Ebbert. More than 
600 faculty. University administrators, 
medical alumni, hospital colleagues and 
friends attended the Yale-blue event in the 
Edward S. Harkness Courtyard. 
The outdoor celebration for the gentle¬ 
man who has been the soul of the medical 
school for 34 years marked the end of an 
era: the Ebbert era, according to Dean Ro¬ 
senberg, one of the five deans with whom 
Dr. Ebbert has worked. 
Under sunny skies, words of praise 
were spoken in animated conversations 
and in the special remarks offered by 
Deans Rosenberg and Robert Berliner, 
who also read comments from former 
deans Fritz Redlich and Lewis Thomas 
and from Peg Lippard, the widow of Dr. 
Lippard. Dr. Dorothy M. Horstmann, the 
John Rodman Paul Professor Emeritus of 
Epidemiology and Pediatrics, spoke on 
behalf of the faculty. 
To recognize his extraordinary contri¬ 
butions and service to Yale, the third-floor 
lounge in the Jane Ellen Hope Building 
has been named the Arthur Ebbert 
Lounge, Dr. Rosenberg announced at the 
reception. Since then. Dr. Ebbert’s por¬ 
trait, painted by William F. Draper of New 
York City, has been hung in the lounge, 
along with a gray slate plaque citing his 
service to the school. And the deputy 
dean’s responsibilities have been handed 
on to Dr. Robert M. Donaldson, also a 
professor of medicine. 
A native of Wheeling, W. Va., Dr. Eb¬ 
bert received his B.A. and M.D. degrees 
from the University of Virginia, where he 
also completed residency training in inter¬ 
nal medicine. In 1953, he joined the Yale 
faculty as an instructor in medicine and 
was asked by Dean Lippard to serve also 
as assistant dean of postgraduate medical 
education. Although Dr. Ebbert intended 
to stay only a year or two, he remained as 
a member of the faculty in internal medi¬ 
cine and rose through the deanery ranks. 
During his service in the dean’s office, 
he has seen many changes in the School 
for Medicine. For instance, the size of the 
entering class of M.D. candidates rose 
from 80 to 102 students; the number of 
M.P.H. students increased from 29 to 
more than 200, and the physician associ¬ 
ate program was established. 
The faculty increased from approxi¬ 
mately 150 to more than 700. New depart¬ 
ments have been established, including 
anesthesiology, cell biology, dermatol¬ 
ogy, human genetics, laboratory medi¬ 
cine, neurology, ophthalmology and visual 
science, and orthopaedics and 
rehabilitation. 
The buildings constructed during Dr. Eb¬ 
bert’s tenure have changed the face of the 
school, beginning with the Edward S. 
Harkness Hall in 1955 and extending to the 
recently completed Yale Physicians Build¬ 
ing. The growth of the medical center has 
been tremendous, he noted, and the sur¬ 
rounding neighborhood has completely 
changed. 
Dr. Ebbert recently observed, “One thing 
which has not changed in the past 34 years 
is the quality of our students; they are still 
the best to be found anywhere.” 
During his sabbatical year. Dr. Ebbert has 
been reading, writing, thinking and travel¬ 
ing, as well as skiing and sailing. 
Yale Ranks Third 
In NIH Funding 
For the second consecutive year, during FY 
1987 Yale ranked third among 124 medical 
schools receiving support from the National 
Institutes of Health. Including both direct 
and indirect costs, the school received over 
$89.7 million from the NIH. Ranking above 
Yale were the University of California at 
San Francisco ($102 million), and Johns 
Hopkins ($93.5 million). 
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Dr. White 
Dr. Robert White to Lead 
Diagnostic Radiology 
Dr. Robert I. White Jr., formerly professor 
of radiology and of medicine at Johns Hop¬ 
kins University, has been named chairman 
of the Yale University School of Medicine 
department of diagnostic radiology and 
chief of this service at Yale-New Haven 
Hospital. 
Dr. White succeeds Dr. Richard H. 
Greenspan, who earlier was named to the 
newly created position of associate dean 
for clinical affairs. 
"We are delighted that Dr. White will 
lead our diagnostic radiology department. 
He is an internationally recognized leader 
in the field of cardiovascular and interven¬ 
tional radiology, and he has a well-earned 
reputation as an outstanding teacher, re¬ 
searcher and physician,” says Dean Leon 
E. Rosenberg. 
Comments Dr. White, “Radiologists 
often have been referred to as the cartog¬ 
raphers of the human body. We now are de¬ 
veloping a new breed of radiologists who 
do more than use x-rays to ‘map’ the body. 
Instead we use imaging technology to 
study disease and make an impact on 
treatment.” 
Dr. White has concentrated his profes¬ 
sional work on interventional radiology, a 
medical specialty that employs radiologi- 
cally guided wires, catheters, stone bas¬ 
kets. balloons and drug infusions. 
One of Dr. White’s many clinical inno¬ 
vations is a treatment for varicocele, a type 
of male infertility. Also, in 1980, he and 
his colleagues performed the first balloon 
valve surgery to open heart valves blocked 
by congenital heart disease. Dr. White has 
done pioneering work in treating lung mal¬ 
formations as well. 
\ native of Los Angeles, Dr. White re¬ 
ceived a B.A. degree in 1959 from Po¬ 
mona College and an M.D. degree magna 
cum laude in 1963 from the Baylor Uni¬ 
versity College of Medicine. He was an 
Osier intern in medicine at Johns Hopkins 
Hospital. In 1969. he completed residency 
training in radiology and medicine at 
Johns Hopkins Hospital and then joined 
the university faculty as an instructor in 
radiology. 
At Johns Hopkins University, Dr. White 
directed seven cardiovascular diagnostic 
laboratories from 1971 until 1988. He was 
named assistant professor of radiology in 
1971 and was appointed professor of ra¬ 
diology in 1977. He also holds joint ap¬ 
pointments in medicine, pediatrics and 
surgery. 
A fellow of the American College of Ra¬ 
diology, Dr. White served as secretary, 
vice president and president of the Ameri¬ 
can Society of Cardiovascular and Inter¬ 
ventional Radiology from 1982 to 1985. 
He also was a scholar in radiological re¬ 
search of the James Picker Foundation. 
A prolific author. Dr. White has pub¬ 
lished more than 170 articles in scientific 
journals. 
Dr. Bunney Awarded 
First Lieber Prize 
Dr. Benjamin S. Bunney, acting chairman 
of the department of psychiatry, has been 
awarded the $50,000 Lieber Prize by the 
National Alliance for Research on Schiz¬ 
ophrenia and Depression (NARSAD). 
Dr Bunney, also professor of psychiatry 
and of pharmacology, is the first recipient 
of the award, which recognizes outstand¬ 
ing achievement in research on mental ill¬ 
ness. The prize was established this year 
with a gift by Constance and Stephen Lie¬ 
ber of Mamaroneck, N.Y. Dr. Bunney will 
use the prize to replace outdated labora¬ 
tory equipment. 
Dr. Bunney's research has focused on 
the brain's dopamine system, which has 
been implicated in the major neuronal dys¬ 
function of schizophrenia. He has also pi¬ 
oneered research on the effects of 
antipsychotic drugs on the brain, and how 
they effect transmissions in the dopamine 
system. 
“This is a particularly exciting time to 
be working in the area of brain function,” 
says Dr. Bunney. “There has been an ex¬ 
plosive growth in both the fields of neuros¬ 
cience and population and molecular 
genetics. Because of this, the tools are 
now becoming available which allow us to 
answer questions that we couldn’t answer 
before.” 
Dr. Evans Wins 
Military Award 
Alfred S. Evans, M.D., M.P.H., the John 
Rodman Paul Professor of Epidemiology, 
has been awarded the John R. Seal Award 
for his contributions to military medicine. 
The annual award, given by the Society of 
Medical Consultants to the Armed Forces, 
cites Dr. Evans’ long history of contribu¬ 
tions to the U.S. military, beginning with 
his service as an active duty medical offi¬ 
cer in Japan in 1944. Over the years Dr. 
Evans has also served as a preventive med¬ 
icine consultant to several U.S. Surgeons 
General, and has advised the Navy Sub¬ 
marine Service, NASA's Manned Space 
and Space Shuttle Programs and the World 
Health Organization’s Tropical Medicine 
Program. 
NEW BOOKS 
The American Disease: Origins of Nar¬ 
cotic Control, an expanded edition, by Dr. 
David F. Musto, professor in the Child 
Study Center, psychiatry, and the history 
of medicine. Oxford University Press, 
(New York) 1988. 
Early Schooling: The National Debate, 
edited by Sharon L. Kagan Ed.D., asso¬ 
ciate research scientist in the Child Study 
Center, and Edward F. Zigler, Ph.D., Ster¬ 
ling Professor of Psychology and professor 
in the Child Study Center. Yale University 
Press. 1988. 
Manual of Cardiac Arrhythmias: A Prac¬ 
tical Guide to Clinical Management, ed¬ 
ited by Dr. Stephen C. Vlay ’75, State 
University of New York at Stony Brook. 
Little, Brown and Co., (Boston, Mass.) 
1987. 
Medicine on Trial, by Charles Inlander of 
Emmaus, Penn., Lowell S. Levin. Ed.D., 
M.P.H., professor of public health, and Ed 
Weiner of Philadelphia. Prentice-Hall 
Inc., (New York) 1988. 
The Parental Leave Crisis: Toward a Na¬ 
tional Policy, edited by Edward F. Zigler, 
Ph.D., Sterling Professor of Psychology 
and professor in the Child Study Center, 
and Meryl Frank, director of the infant 
care leave project at The Busch Center in 
Child Development and Social Policy, Yale 
University. Yale University Press, 1988. 
When Doctors Get Sick, edited by Dr. 
Harvey Mandell, associate clinical profes¬ 
sor of medicine, and Dr. Howard Spiro, 
professor of medicine. Plenum Publishing 
Corp., (New York) 1988. 
Dr. Pruett Earns 
Book Award 
Dr. Kyle D. Pruett, associate clinical pro¬ 
fessor in the Child Study Center and psy- 
chiatry, has won American Health 
Magazine's Book Award for The Nurtur¬ 
ing Father: Journey Toward the Complete 
Man. Dr. Pruett’s book tells of 17 families 
in which the father stays home to provide 
childcare. 
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ALUMNI NEWS 
The University Foundation at the State 
University of New York at Albany named 
I)r. Ralph I). Alley 43, '51 HS as 1987 
Citizen Laureate, the foundation’s highest 
award for civic and academic community 
representatives. Dr. Alley, a thoracic sur¬ 
geon who introduced open heart surgery to 
northern New York in 1958, was honored 
for his contributions to medical science 
and education. A past president of the So¬ 
ciety of Thoracic Surgeons, Dr. Allen is a 
member of the board of governors of the 
American College of Surgeons and direc¬ 
tor of the American Board of Thoracic 
Surgery. 
Dr. Henry Jones '43, '46 HS, a radiol¬ 
ogist at Stanford University for nearly 40 
years, has received the Association of 
University Radiologists Gold Medal 
Award for distinguished service. 
Dr. Donald W. Seldin 43, 46 HS re¬ 
signed Feb. 1, after 35 years as chairman 
of the department of internal medicine at 
Southwestern Medical School at the Uni¬ 
versity of Texas Health Science Center at 
Dallas. 
His accomplishments in shaping the ac¬ 
ademic program at Southwestern Medical 
School were described in a major feature 
story in The New York Times, published 
Feb. 13. Dr. Seldin, a former instructor 
and assistant professor of medicine at 
Yale, began his career at Southwestern in 
1951. At that time the school consisted of 
a series of abandoned army barracks with 
no funding for permanent buildings. In 
1952, as Dr. Seldin planned a return to 
Yale, a new dean. Dr. George Aagard, per¬ 
suaded him to become chairman of the de¬ 
partment of internal medicine, a 
department of one —Dr. Seldin. Today the 
department has 150 faculty members. 
Dr. Seldin developed Southwestern's 
basic sciences and research faculty by per¬ 
suading many of his brightest students to 
make their careers in academic medicine at 
Southwestern. Among them are Nobel lau¬ 
reate Dr. Joseph L. Goldstein, and South¬ 
western's current president. Dr. Kern 
Wildenthal. His successor is another for¬ 
mer student. Dr. Daniel W. Foster, an in¬ 
ternationally known diabetes specialist. 
Dr. John P. McGovern 46 HS, founder 
and chief consultant to the McGovern Al¬ 
lergy Clinic in Houston, has been ap¬ 
pointed to a four-year term on the National 
Advisory Council on Alcohol Abuse and 
Alcoholism. 
Dr. William G. Anlyan '49 has been 
appointed chancellor of Duke University 
effective July 1. Dr. Anlyan, chancellor for 
health affairs at Duke since 1983, and ex¬ 
ecutive vice president since 1987, began 
his career at Duke in 1949 as a resident in 
general and thoracic surgery. He was pro¬ 
moted to professor of surgery in 1961. He 
was named dean of the School of Medicine 
in 1964, and in 1969, after having served 
one year as dean and associate provost, 
was appointed vice president for health af¬ 
fairs, a position he held until 1983, when 
he was appointed chancellor for health 
affairs. 
As chancellor. Dr. Anlyan will serve on 
the university’s committee of chief exec¬ 
utive officers and will oversee major as¬ 
pects of Duke’s external affairs. He also 
will take an important role in alumni rela¬ 
tions and selected aspects of fund raising. 
At Yale, President Benno C. Schmidt Jr. 
has appointed Dr. Anlyan chairman of the 
University Council Committee on Medical 
Affairs, the presidential advisory commit¬ 
tee that studies major scientific and medi¬ 
cal issues. He will serve a five-year term. 
In an editorial in the Panamerican Fed¬ 
eration of Associated Medical Faculties 
newsletter, federation chief Dr. Jose Felix 
Patino '52, '58 HS. of Bogota, Columbia, 
urged faculties at Latin American medical 
schools to emphasize recent progress in 
molecular biology and scientific medicine. 
Dr. Robert G. Petersdorf '52, presi¬ 
dent of the Association of American Med¬ 
ical Colleges, received the American 
Society of Internal Medicine "Distin¬ 
guished Internist of 1987" award at its an¬ 
nual meeting Oct. 15 in Washington, D.C. 
The award is presented annually to an in¬ 
ternist who has made outstanding contri¬ 
butions to the social and economic aspects 
of medicine and has helped to promote 
cost-effective, high-quality care. 
Dr. Thomas F. Ferris 57, '63 HS, Nes¬ 
bitt Professor and chairman of the depart¬ 
ment of medicine at the University of 
Minnesota, has been elected president of 
the American Society of Nephrology. His 
one-year term began Jan. 1. 
Dr. Gerard N. Burrow '58, '65 HS, 
formerly chairman of the department of 
medicine and the Sir John and Lady Eaton 
Professor at the University of Toronto and 
physician-in-chief of Toronto General 
Hospital, became vice chancellor for 
health sciences and dean of the University 
of California, San Diego, School of Med¬ 
icine on March 1. He succeeds Dr. Robert 
G. Petersdorf '52. 
After completing his education and 
training at Yale, Dr. Burrow joined the fac¬ 
ulty and was professor of medicine, when 
he left Yale in 1976 to become director of 
the division of endocrinology metabolism 
at Toronto General Hospital, and professor 
in the Banting and Best Department of 
Medicine Research at the University of To¬ 
ronto. A member of numerous profes¬ 
sional organizations. Dr. Burrow has 
recently completed terms as president of 
both the American Thyroid Association 
and the Canadian Association of Profes¬ 
sors of Medicine. He also has served as 
director of the American Thyroid 
Association. 
At the Connecticut Division's 1987 
leadership conference and annual dinner 
Oct. 24, the American Cancer Society 
awarded Dr. John C. Marsh '59, profes¬ 
sor of medicine and lecturer in pharmacol¬ 
ogy, a bronze medal, the highest national 
award given to ACS volunteers. Dr. 
Marsh, an oncologist and an immediate 
past president of the Connecticut Division, 
became an ACS volunteer in 1971. Since 
that time he has served the society in sev¬ 
eral capacities on the national, state and 
local levels. 
Dr. Robert I. Levy '61, '63 HS became 
president of the Sandoz Research Institute 
in East Hanover, N.J. on Jan. 1. He will 
not be joining the Association of American 
Medical Colleges staff as was previously 
announced. 
Dr. H. Steven Moffic 71, associate 
professor of psychiatry at Baylor College 
of Medicine in Houston, published his 
thoughts on the changes in medicine in a 
fictional account of his 15th reunion in The 
Pharos of Alpha Omega Alpha, Summer 
1987, Vol. 50, No. 3. 
Dr. Peter S. Kennedy '71 HS, an on¬ 
cologist at St. Vincent Medical Center in 
Los Angeles and assistant clinical profes¬ 
sor of medicine at the University of South¬ 
ern California School of Medicine, was 
named associate principal investigator for 
the Community Oncology Program, a pro¬ 
gram established by the National Cancer 
Institute to make innovative cancer treat¬ 
ment programs available to patients in 
community hospitals. As director of clin¬ 
ical practices for the Los Angeles Oncol¬ 
ogic Institute, an affiliate of St. Vincent 
Medical Center, Dr. Kennedy is director of 
the oncology unit and chairman of both the 
department of medicine and the depart¬ 
ment of hematology-oncology. 
Dr. Stephen C. Vlay '75 was promoted 
to associate professor of medicine at the 
State University of New York at Stony 
Brook. Dr. Vlay, a cardiologist, is director 
of the Stony Brook Arrhythmia Study and 
Sudden Death Prevention Center and direc¬ 
tor of the Coronary Care Unit at University 
Hospital. 
Dr. Anne Flitcraft '77. assistant profes¬ 
sor of medicine at the University of Con¬ 
necticut School of Medicine and her 
husband, sociologist Evan Stark, in co-op¬ 
eration with the Office for Women in Medi- 
cine, presented a state-wide training 
conference at Yale on Jan. 21 on the identi¬ 
fication and treatment of victims of domestic 
violence. Dr. Flitcraft is director of the Do¬ 
mestic Violence Training Project: A Pro¬ 
gram for Health Professionals, developed in 
accordance with Connecticut’s new Family 
Violence Prevention and Response Act. 
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Massimo E. Calabresi, 
M. D., Dr. P.H. 
Dr. Massimo E. Calabresi, Dr. P.H. '44, 
clinical professor emeritus of medicine, 
died Feb. 28 at his home in New Haven. He 
wras 84. 
A native of Italy and former chief car¬ 
diologist at the University of Milan, Dr. 
Calabresi was an early opponent of the fas¬ 
cist movement. His activities in helping to 
circulate an underground anti-fascist 
newspaper forced him to leave Italy in 
1939. He came to Yale in 1940 as a re¬ 
search fellow and was named assistant 
clinical professor of medicine in 1941, as¬ 
sociate clinical professor in 1959, and 
clinical professor emeritus in 1971. 
Dr. Calabresi worked as a cardiac phys¬ 
iologist for the Connecticut Department of 
Health from 1950 to 1952, when he be¬ 
came chief of the cardiovascular section at 
the Veterans Administration Medical Cen¬ 
ter in West Haven. His work in cardiology led 
to innovative treatments for hypertension. 
Dean Leon E. Rosenberg, who met Dr. 
Calabresi during his residency training in 
internal medicine at the Veteran’s hospi¬ 
tal, remembers Dr. Calabresi “as one of 
the most compassionate and devoted phy¬ 
sicians I’ve ever known. Moreover, I found 
his commitment to the education of stu¬ 
dents and house officers as total as his 
devotion to patients. Over the years my 
admiration for this modest, noble man was 
continually reinforced, and like so many of 
those he taught, I shall miss him greatly.” 
His wife. Bianca, who for many years 
was a professor and chairman of the Italian 
department at Albertus Magnus College in 
New Haven, died in 1982. Surviving are 
his sons, Guido Calabresi, dean of the 
Yale Law School, and Dr. Paul Calabresi, 
chairman of the department of medicine at 
Brown University; a sister, Renata Cala¬ 
bresi; and six grandchildren. 
Henry I. Fineberg, M.D. 
Dr. Henry I. Fineberg ’27 died in New 
York Oct. 4, 1987. He^was 83. Dr. Fine¬ 
berg served as president of the Medical So¬ 
ciety of New York from 1959 to 1960, and 
its executive vice president from 1961 until 
his retirement in 1982. A New York dele¬ 
gate to the AMA House of Delegates from 
1959 to 1978. he was chairman of the del¬ 
egation from 1961 to 1969. Dr. Fineberg 
specialized in communicable diseases, 
and from 1939 to 1940, he was physician- 
in-charge at Kingston Avenue Hospital for 
Communicable Diseases in Brooklyn, 
N. Y., and in 1942 was named medical su¬ 
perintendent of Queens Hospital Center. 
Dr Fineberg was 1927 class agent for 
the Medical School Alumni Fund and a 
lit president of the Yale Alumni Associ- 
1 ion ol Queens, N.Y. He is survived by 
his wife, Grace; a daughter, Karen; and a 
son, Coleman. 
William U. Gardner, 
Ph.D. 
William U. Gardner, Ebenezer K. Hunt 
Professor Emeritus of Anatomy and chair¬ 
man of the anatomy department from 1943 
to 1967, died Feb. 14 in Yale-New Haven 
Hospital of Parkinson’s disease. He was 
80. 
Professor Gardner began his career 
at Yale in 1933 as a National Council 
Research fellow. He was appointed to the 
faculty in 1935, and in 1943 was named 
Ebenezer K. Hunt Professor of Anatomy 
and department chairman. He was a strong 
supporter of the Yale System of medical 
education, and in the early 1940s devel¬ 
oped a method of teaching anatomy called 
prosection, which was adopted nation¬ 
wide. Professor Gardner's research fo¬ 
cused on reproductive endocrinology and 
the intluence of hormones on abnormal and 
malignant growths. 
An internationally recognized scientist. 
Professor Gardner received several honor¬ 
ary degrees, including one from the Uni¬ 
versity of Perugia in Italy. He was a former 
president of the International Union 
Against Cancer, the American Association 
for Cancer Research and the American As¬ 
sociation of Anatomists. An associate ed¬ 
itor of several scientific journals, he also 
served on numerous advisory boards, in¬ 
cluding those of the National Research 
Council, U.S. Public Health Service, Na¬ 
tional Cancer Institute, American Cancer 
Society, and National Board of Medical 
Examiners. 
Mr. Gardner was named Ebenezer K. 
Hunt Professor Emeritus at his retirement 
in 1974. He served as scientific director of 
the Council of Tobacco Research from 
1974 to 1984. 
He is survived by his wife, Catherine. 
Memorial contributions may be made to 
the William U. Gardner Loan Fund, estab¬ 
lished in 1973 to provide financial aid to 
medical students. 
Patrick S. Mullins, M.D. 
Dr. Patrick S. Mullins ’42 of Morehead 
City. N.C. died December 18, 1987. He 
was 73. Surviving are his wife, Margaret; 
a daughter Patricia Ann Dyk; two sons, 
Terrence Thomas and Kevin Michael; and 
one grandchild. 
Paul J. Myerson, M.D. 
Dr. Paul Joseph Myerson, assistant profes¬ 
sor of radiology from 1975 to 1980, died 
Jan. 2 at Ormond Memorial Hospital in 
Florida. Dr. Myerson, 48, had lived in Or¬ 
mond Beach, Fla. since 1981. He leaves 
his wife, Sandra; two sons, Terry and Neal; 
two brothers. Dr. Daniel A. Myerson, with 
whom he practiced, and Dr. Manny 
Myerson. 
Hugh R. Williams, M.D. 
Dr. Hugh R. Williams ’46 died Dec. 9, 
1987 of prostatic cancer at his home in 
Royal Oak, Md. He was 65. Dr. Williams 
was director of the Talbot County Mental 
Health Clinic in Easton, Md., from 1977 
to 1985 and the in-patient psychiatrist at 
Franklin Square Hospital in Baltimore 
from 1985 until early 1987. 
Dr. Williams had been an assistant pro¬ 
fessor of psychiatry at the State University 
of New York at Buffalo and at the Univer¬ 
sity of Colorado Medical Center. He also 
was associated with Mary Imogene Bas¬ 
sett Hospital in Cooperstown, N.Y., and 
the Geisinger Medical Center in Danville, 
Penn., and had a private practice in High¬ 
land Park. N.J. 
Surviving are his wife, Irene; four sons, 
Hugh Jr., David, Mark and Paul; a daugh¬ 
ter, Margaret Karl; a sister, Anne Sullivan 
and four grandchildren. 
Robert P. Zanes Jr., 
M.D. 
Dr. Robert P. Zanes, associate clinical pro¬ 
fessor of medicine since 1978, died Jan. 13 
after a brief illness. Dr. Zanes was a mem¬ 
ber of the executive committee of the Yale 
Comprehensive Cancer Center and was as¬ 
sociated with several New Haven area hos¬ 
pitals. He had been chief of the oncology 
section and director of the oncology unit at 
the Hospital of St. Raphael from 1975 to 
1982, when he became medical director of 
Connecticut Hospice in Branford. From 
1985 to 1987, he was vice president for 
medical affairs. He remained at hospice in 
1987 as a staff physician. 
He is survived by his wife. Carmela; 
two sons. Robert and Richard; a step-son, 
Clifford John Dudley, and a step-daughter, 
Clotilde Dudley; a sister, Priscilla Buckley; 
and one grandchild. 
Memorials 
Contributions made in memory of de¬ 
ceased alumni are put into the Medical 
School Alumni Fund endowment in the de¬ 
cedent’s name. Classmates receive fund 
credit in the year the gift is made. Income 
from these gifts is added, in perpetuity, to 
the Medical School Alumni Fund and 
credited to the deceased and his or her 
class. 
Names of all alumni remembered 
through this program are listed in the 
fund’s Testament of Remembrance, and 
the memorialized alumni are considered 
contributors to the fund forever. 
The next of kin is informed of contri¬ 
butions made to this person's memory. 
Yale Medical School 
In Memoriam Program 
P.O. Box 1890 
New Haven, CT 06508 
(203)432-5844 
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IN MEMORIAM 
Waldo F. Desmond 
September 7, 1987 
’25 M.D. 
William H. Holden, M.D. 
August 13, 1984 
’26 HS 
Henry Irwin Fineberg 
October 4, 1987 
’27 M.D. 
Vincent A. Doroszka 
September 6, 1987 
’30 M.D. 
Donald G. Barton 
October 20, 1986 
’33 M.D. 
Merriwell T. Shelton, M.D. 
October 3, 1987 
’33 HS 
Derick A. January 
June 27, 1987 
’34 M.D. 
Russell C. Norton, M.D. 
February 25. 1987 
ex med ’39 
Ruth G. Taylor 
January 17, 1988 
ex pbh ’40 
Patrick S. Mullins 
December 18, 1987 
’42 M.D. 
MassimoE. Calabresi, M.D. 
February 28, 1988 
’44 Dr. P.H. 
Hugh R. Williams 
December 9, 1987 
’46 M.D. 
Blackburn S. Joslin, M.D. 
February 26, 1986 
ex HS ’48 
H. Lester Medlinsky, M.D. 
March 21, 1987 
’60 HS 
Martin R. Krigman, M.D. 
October 27, 1986 
’61 HS 
Amalia P. Crago 
November 13, 1987 
’66 M.P.H. 
Alan M. Gutman, M.D. 
June 5, 1987 
’67 HS 
John F. Neil ’73 M.D. 
Harry I. Kaminsky 
December 29, 1987 
’86 PA 
tremely difficult for underendowed depart¬ 
ments to attract the most talented young 
men and women to academic careers. 
Dr. Swanson enrolled at Yale in 1948 
thanks to the encouragement of famed Yale 
physiologist. Dr. John Fulton. Her interest 
in research was kindled when she served as 
a laboratory helper in the renowned pri¬ 
mate laboratory directed by Dr. Gertrude 
Van Wagenen. Through Dr. Van Wagenen 
she met the virologist and faculty member 
Dr. Dorothy Horstmann, the first woman 
to achieve full professorial status in the 
School of Medicine. The two became life¬ 
long friends of Dr. Swanson. 
After completing a USPHS Fellowship, 
Dr. Swanson returned to serve as chief res¬ 
ident and later assistant pathologist at 
Grace-New Haven Community Hospital. 
From there her career led her to hospital 
pathology work overseas and eventually to 
distinguished service as staff pathologist 
and professor at Children’s Hospital, the 
pediatric division of the University of 
Southern California Medical School. 
In 1982 she chose to concentrate on her 
research interests, studying human tumor 
transplants in nude mice at the University 
of California San Diego, changes during 
aging in spawning salmon through Scripps 
Institute of Oceanography, and temporal 
lobe induced epilepsy in children during a 
visiting fellowship at the Department of 
Neuroanatomy at Oxford University. She 
maintained close contact with her friends 
at Yale, even during her final illness. 
In a moving eulogy of Dr. Swanson, her 
husband Dr. Martin D. Kamen, himself an 
internationally known biochemist, wrote, 
“In searching through her desk I found a 
clipping she had saved of a remark attrib¬ 
uted to Winston Churchill which is apt: 
‘You make a living by what you get, but 
you make a life by what you give.’ 
Gilman Professorship 
Established 
Real Estate Bequest 
Establishes Fund 
An alumna of the Class of 1952 of the 
School of Medicine has endowed a fund to 
support untenured faculty members in the 
department of pathology. The will of Vir¬ 
ginia Swanson Kamen, M.D., who died 
on May 20, 1987, directed that Yale re¬ 
ceive a one-half interest in a 122-unit 
apartment complex in Modesto, Califor¬ 
nia. The proceeds from the sale of the 
property by Yale will establish the Vir¬ 
ginia L. Swanson Sustaining Fund for 
Junior Faculty. 
By helping to launch careers of prom¬ 
ising young scientists. Dr. Swanson's be¬ 
quest meets a crucial need. Much research 
funding is awarded on the basis of an in¬ 
vestigator's prior results rather than his or 
her future promise. This makes it ex¬ 
A challenge grant from The Burroughs 
Wellcome Fund proved to be the catalyst 
for the establishment of the first endowed 
professorship in the department of phar¬ 
macology at Yale. The chair will honor the 
late Alfred Gilman ’28S, Ph.D. ’31, who 
was a member of the National Academy of 
Sciences, a Yale faculty member, and one 
of the most important pharmacologists of 
his generation. 
Dr. Gilman’s book. The Pharmacolog¬ 
ical Basis of Therapeutics, coauthored with 
Louis S. Goodman, M.D., is now in its sev¬ 
enth printing. 
Dr. Gilman served for more than 20 
years as an advisor to the Burroughs Well¬ 
come Fund. The foundation was estab¬ 
lished in 1955 to provide financial aid for 
the advancement of medical knowledge by 
research and is financially supported by 
the pharmaceutical firms, Burroughs Well¬ 
come Co. 
The Burroughs Wellcome Fund Chal¬ 
lenge was met through memorial gifts 
from family and friends of Dr. Gilman and 
by corporate contributions from Hoff- 
mann-La Roche and Macmillan, Inc., Dr. 
Gilman’s publisher. A major anonymous 
gift completed funding of the Alfred Gil¬ 
man Professorship of Pharmacology. 
The Yale Corporation appointed Alan 
C. Sartorelli, Ph.D., as the first Gilman 
Professor. A member of the pharmacology 
faculty since 1961, Dr. Sartorelli served as 
chairman of the department from 1977 un¬ 
til he was named director of the Yale Com¬ 
prehensive Cancer Center. He edits two 
pharmacology journals and serves as pres¬ 
ident of the American Association for 
Cancer Research and the Association of 
American Cancer Institutes. In June 1987, 
he was elected to the Institute of Medicine 
of the National Academy of Sciences. 
Why The “Double Ask”? 
As part of the Yale School of Medicine’s 
first capital campaign, volunteers will be 
contacting you, our alumni, to ask for 
your support. 
Gifts from alumni and friends enhance 
the school’s academic programs and over 
the years have sustained the quality of 
medical teaching and research at Yale. 
Most alumni gifts come in response to so¬ 
licitations by the Yale Medical School Al¬ 
umni Fund. These unrestricted gifts are 
applied by the dean for current use in fi¬ 
nancial aid for medical students. 
A major impediment to the school’s 
progress is its limited endowment re¬ 
sources. The Campaign for Yale School of 
Medicine was launched in 1985 to address 
this problem and to meet other immediate 
capital needs of the school. 
The alumni fund remains a leading 
priority of the school, and campaign so¬ 
licitations are intended to build upon an¬ 
nual alumni giving, not to replace it. The 
“Double Ask’’ means that alumni are 
being asked to continue their level of giv¬ 
ing to the Yale Medical School Alumni 
Fund and to contribute toward strength¬ 
ening of the school’s endowment through 
the Campaign for Yale School of 
Medicine. 
This is an important opportunity for al¬ 
umni to help to insure that your alma ma¬ 
ter will continue to be a leader in medical 
discovery and clinical treatment, and in 
preparing young people for the new era in 
medicine. 
Office of Development 
Yale School of Medicine 
350 Congress Avenue, Wing C-3 
P.O. Box 3761 Yale Station 
New' Haven, Connecticut 06520 
(203) 785-4420 
Yale Medical School Alumni Fund 
P.O. Box 1890 
New1 Haven, Connecticut, 06508 
(203) 432-6075 
















Artist's rendering of the Center for Molecular Medicine 
Markey Trust Grants 
$12.1 Million 
One of the largest foundation grants the 
University has ever received will establish 
a new research program in the soon-to-be- 
constructed Center for Molecular Medi¬ 
cine. The Lucille P. Markey Charitable 
Trust of Miami, Fla., will provide $12.1 
million over five years to fund the center's 
program in molecular oncology and de¬ 
velopment, which will be directed by Dr. 
Sherman M. Weissman, Sterling Profes¬ 
sor of Human Genetics, Medicine and 
Molecular Biophysics and Biochemistry. 
An acknowledged leader in studies of 
gene structure and function. Dr. Weiss¬ 
man will lead a team of approximately 
eight faculty members and their staffs who 
will study cells whose regulatory mecha¬ 
nisms influence cell growth and replica¬ 
tion and the development of the organism. 
In announcing this significant gift. 
Dean Leon E. Rosenberg said, “Much has 
PVA Supports 
Neuroscience Center 
The Paralyzed Veterans of America, a 
congressionally chartered organization 
with a longstanding interest in spinal cord 
injury, has pledged $1.5 million to the 
School of Medicine for support of spinal 
cord injury research and laboratory facili¬ 
ties. The research will be conducted in a 
new facility constructed at the Veterans 
Administration Medical Center in West 
Haven. The facility will be dedicated 
May 14 as the PVA/EPVA Center for Neuro¬ 
science and Regeneration Research of 
Yale University. 
Yale's chairman of neurology, Stephen 
G. Waxman, M.D.. Ph.D., will direct the 
new center. Dr. Waxman is an internation¬ 
ally known expert in spinal cord injury and 
disease. The center’s research will focus 
on ways in which the nervous system re¬ 
sponds to injury, as well as the growth and 
already been learned about the structure, 
function and location of cancer-causing 
genes called oncogenes. However, we still 
understand very little about how these 
genes act during normal development and 
differentiation. The Markey Trust’s cru¬ 
cial gift will enable Yale to mount a major 
new program in molecular oncology and 
development at an unusually opportune 
time for progress and understanding of hu¬ 
man biology and disease." 
The will of the late Lucille P. Markey 
established the trust in 1983, and directed 
that its assets be used exclusively for sup¬ 
porting and encouraging basic medical re¬ 
search. Mrs. Markey was the owner of 
Calumet Farm, a thoroughbred breeding 
and racing stable in Lexington, Ky. 
Since 1984, Yale also has benefited 
through the trusts's Markey Predoctoral 
Fellowship Program which provides three 
years of financial aid for Ph.D. candidates 
in the departments of physiology and hu¬ 
man genetics. 
regeneration of nerve cells, their interac¬ 
tion with glial or supporting cells, and 
ways in which they develop the capacity to 
conduct nerve impulses. 
PVA represents more than 12,500 mem¬ 
bers who participate through 40 chapters 
around the nation. Its largest chapter. 
Eastern Paralyzed Veterans Association 
(EPVA), is based in New York. R. Jack 
Powell, executive director of PVA, an¬ 
nounced the grant in a letter to Dean Leon 
E. Rosenberg. “For PVA. our major finan¬ 
cial commitment to this center and the un¬ 
qualified support clearly evident from PVA 
chapters and friends nationwide under¬ 
scores our solemn and continuing commit¬ 
ment to dedicate our best efforts, energy, 
time and resources, not only to improve 
the lives of those with spinal cord injury or 
disease, but also to provide aggressive 
leadership in the crucial quest for a cure 
for all mankind,” Powell said. 
Campaign Update 
As the following summary shows, gifts 
and pledges to The Campaign for Yale 
School of Medicine totalled $140,235,500 
as of December 31, 1987. This represents 
nearly four years of intensive activity on 
the part of the dean, faculty members and 
a corps of volunteers across the country led 
by Campaign Chairman Frank A. Sprole. 
Plans are now underway to bring the 
campaign to a successful conclusion by 
July 1, 1988, through a nationwide effort 
to reach all graduates of the School of 
Medicine to ask for their participation in 
this, the first major capital campaign 
mounted by the school. The alumni solic¬ 
itation will be directed toward completing 
the campaign objectives which have not 
yet been fully met. Foremost among these 
is the need for endowment funds. Thus far, 
$25 million in endowment gifts have been 
received toward the original goal of $59 
million. John B. Ogilvie '31S, M.D. '34 
is Chairman of the Alumni Division of 
the campaign. 
Progress Report 
December 31, 1987 
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Admissions. Dr. Robert Gifford, asso¬ 
ciate dean for student affairs, is continuing 
to provide personal interviews to all appli¬ 
cants to the school who are children of al- 
unrni. In other admissions news, this 
winter. Dean of Admissions Thomas Lentz 
has begun to solicit the help of the alumni 
in interviewing medical student candi¬ 
dates. Such help is particularly needed for 
students from faraway places, who often 
cannot afford the trip to New Haven for an 
interview. Alumni who would like to con¬ 
duct such interviews should contact the 
alumni office. 
Building “Class Consciousness.” 
For the first time, student class agents and 
officers have been appointed for each of 
the four medical classes. Dinner was 
shared with the class agents by Dr. Leon¬ 
ard Kemler, chairman of the fund, and Ms. 
Claire Lauterback, its director. We hope 
such social events will reinforce the stu¬ 
dents’ continued participation in the asso¬ 
ciation after they graduate. 
The association plans to sponsor one of 
the school's monthly student teas this 
spring. We also hope that medical students 
will participate in the reunion weekend of 
June 10. 11. Students will be invited to 
conduct tours of the ever-changing medi¬ 
cal campus, as well as to enjoy the social 
activities of the reunion weekend. 
The alumni office participated in fresh¬ 
man orientation last September. We hope 
an expanded group of alumni will attend 
the freshman welcome party scheduled for 
September 1988. 
Career Counseling. Students —espe¬ 
cially women students —often query the 
alumni office to see if they can receive 
counseling regarding career choices. They 
sometimes ask if they could speak with al¬ 
umni who practice in a particular specialty 
that the students are interested in. 
Such encounters, however desirable, are 
difficult to schedule due to time con¬ 
straints for both students and alum practi¬ 
tioners. To make this process easier, a 
committee is being organized which will 
include students and alums, with an em¬ 
phasis on younger graduates. This group 
will suggest possible initiatives for the 
coming year. 
Financial Aid. The issue commanding 
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most concern in our most recent alumni 
survey was the economic and emotional 
well-being of the current medical student. 
Reflecting an increasing concern over stu¬ 
dent need. Dean Rosenberg has earmarked 
for scholarships all unencumbered gifts to 
the Yale Medical School Alumni Fund that 
are available for current use. 
For the year ended July 1, 1987, donations 
to the fund totalled a record $615,000, of 
which $235,000 went to scholarships. 
Gifts to the Medical School Alumni Fund 
have risen approximately $100,000 an¬ 
nually during the past two years, and must 
continue to increase if Yale is to stay com¬ 
petitive with other leading medical schools 
in providing financial aid. 
An article highlighting the increasing 
stress provoked by current student indebt¬ 
edness is featured in this issue of YALE 
MEDICINE. Though it should be empha¬ 
sized that loan defaults are less than 1 per¬ 
cent at Yale Medical School, many 
students fear that at current rates of inter¬ 
est, loan indebtedness is becoming 
insupportable. 
Because of the current federal deficit, 
there is only a slim hope that programs for 
loan forgiveness will be developed at this 
level. Thus, our association may find its 
primary and most compelling mission as 
that of student advocacy in the financial 
arena: We should develop new mecha¬ 
nisms for scholarship support, with coun¬ 
sel and assistance from the office of 
student affairs. For example, a class re¬ 
union gift might be dedicated to "adopting 
a needy student,” or selecting the "Class 
of 19xx Scholar.” 
House Staff/Fellows —Alumni Sta¬ 
tus in AYAM. The 1985 survey pro¬ 
duced many inquiries concerning the 
alumni status of residents and fellows who 
had not received Yale degrees. While not 
considered alumni by the University, they 
are members of the Association of Yale 
Alumni in Medicine according to its by¬ 
laws. As such, former house staff and fel¬ 
lows are entitled to receive YALE 
MEDICINE and AYAM literature and cor¬ 
respondence. My office receives several 
calls every year from such members con¬ 
cerning this issue. Many display an intense 
loyalty for, and a close identity with, Yale 
for the specialty training they received 
here. 
Alumni records have long been deficient 
in recording past house staff and fellows 
because department directors regularly 
fail to register these physicians at the com¬ 
pletion of their training. A subcommittee 
chaired by Dr. John Forrest of the depart¬ 
ment of medicine met with representatives 
from each of the major clinical depart¬ 
ments to discuss this problem. 
As a result of this effort, communica¬ 
tion was reestablished with 471 former 
house staff and fellows, who were ex¬ 
tended an invitation to join the associa¬ 
tion. The committee will now consider 
scheduling departmental reunions, which 
are often arranged informally at specialty 
society meetings distant from New Haven. 
Perhaps such reunions could be set up 
on a regular basis to coincide with the 
spring medical school reunion, as cur¬ 
rently occurs with surgery, orthopaedics 
and opthalmology. As members of AYAM, 
all house staff and fellows should be 
warmly greeted upon their initial arrival 
on campus, and their rights and privileges 
in the organization made clear. 
The appointment of many new depart¬ 
ment chairmen should provide the oppor¬ 
tunity for departmental fund raising efforts 
to aid defined projects relevant to the 
chairman’s needs. This could be done with 
the help of the development office, with 
both the resident/fellow and department 
receiving credit. The constant need by 
both the school and chairmen for unre¬ 
stricted funds is ever present, and should 
be directed through the efforts of the Yale 
Medical School Alumni Fund, for many 
years supervised and assisted by Samuel 
Kushlan, M.D., ’35. 
The opportunities described present 
"unfinished business” of this subcommit¬ 
tee and under the leadership of Dr. Forrest 
should be further addressed in 1988. 
A final note in closing. We are receiving 
a good response from alumni who are re¬ 
turning their tear-out cards from YALE 
MEDICINE, complete with news of their 
whereabouts and activities. Items of per¬ 
sonal news will be listed in the medical 
school column in the Yale alumni maga¬ 
zine, while professional news will appear 
in YALE MEDICINE. 
Keep those cards and letters coming. 
Nicholas P.R. Spinelli, M.D. '44 
Director of Alumni Affairs 
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ALUMNI FUND NOTES 
Recent Gifts 
Each year, thousands of School of Medi¬ 
cine alumni and friends give to the alumni 
fund to provide support essential to the 
school's educational strength. Each gift 
is important, helping to underwrite oper¬ 
ating costs while expressing the generos¬ 
ity of the many individuals who believe in 
the school’s mission. Each has been 
gratefully received. The following exam¬ 
ples represent the commitment and gen¬ 
erosity of those who continue to offer that 
support. 
The Robert and Jane 
Frelick Charitable Trust 
Dr. Robert Frelick and his wife, Mrs. Jane 
Frelick, received their degrees from Yale 
in 1944: Dr. Frelick from the medical 
school and Mrs. Frelick from the nursing 
school. To support both schools and to 
make gifts to their grandchildren, the Fre- 
licks recently established a charitable 
trust. This trust will pay incomes to their 
grandchildren for the next 15 years. At the 
end of that time, the assets of the trust will 
be equally divided between the Class of 
1944 alumni fund endowments of both the 
medical and nursing Schools. This gift ar¬ 
rangement will entitle the Frelicks to a 
substantial income tax charitable deduc¬ 
tion and other tax benefits, and it will en¬ 
able them to achieve two goals with the 
same asset: a substantial gift to their 
grandchildren and a generous contribution 
to the medical and nursing Schools. 
The Thomas H. Drews 
And Mary Jones Drews 
Scholarship Fund 
John A. Drews, a member of the Class of 
1967, recently established a scholarship 
fund in honor of his parents. Fie did so by 
purchasing a life insurance policy that will 
deliver substantial proceeds to the school. 
In making his gift. Dr. Drews commented: 
“My parents have provided me with enor¬ 
mous financial and emotional support 
throughout my educational career, and 
this gift seeks to acknowledge this support 
and to express my gratitude for it." 
Income For Life 
You can make a gift and in return receive 
a lifetime income and an income tax de¬ 
duction as well as other tax benefits. 
• An 80-year-old can contribute 
$10,000 and receive a guaranteed life 
time income of $900 a year, as well 
as an income tax deduction of nearly 
$6,000. 
• A 70-year-old can contribute $10,000 
and receive about $600 in income in 
the first year, with income increases 
of approximately 5 percent in each 
succeeding year as well as a tax de¬ 
duction of $4,800. 
• A 60-year-old can contribute $10,000 
this year, receive an immediate in¬ 
come tax deduction of $7,750 and, 
starting in 10 years at his 70th birth¬ 
day, receive $1,160 a year for life. 
Please call (203) 432-5855 collect for 
further information. 
The J. Roswell Gallagher 
Endowment Fund 
Dr. J. Roswell Gallagher, ’25, ’30 M.D., 
is a long-standing chairman of the medical 
school alumni fund endowment program, 
and he has provided important support to 
both his Yale College and medical school 
classes with a series of life-income gifts, 
beginning in 1976. Each gift has entitled 
him to significant tax benefits, as well as 
to a life-income for both himself and Mrs. 
Gallagher. These gifts will be combined at 
a future date to establish the J. Roswell 
Gallagher Scholarship. 
About the life-income gift option. Dr. 
Gallagher has commented: “I have been 
very pleased with the results of my gift ar¬ 
rangements with Yale. The tax and in¬ 
come benefits from a life-income plan are 
considerable, and they offer alumni the 
opportunity to make significant contribu¬ 
tions at a very reduced cost. I heartily en¬ 
dorse this program and urge all alumni to 
participate.” 
W hy Send a Small Gift? 
Some alumni of the School of Medicine 
are reluctant to send along small gifts to 
the alumni fund, because such donations 
might appear inconsequential next to the 
gifts of thousands or even millions of dol¬ 
lars that the school receives. What these 
alumni may not know is that even a modest 
gift helps the School of Medicine solicit 
large contributions from sources that look 
to the percentage of alumni giving in de¬ 
ciding whether or not to support the 
school. 
Hence, no matter how large or small, 
your gift to the Yale Medical School Alum¬ 
ni Fund goes to work for your alma mater. 
The Yale Medical School Alumni Fund 
P.O. Box 1890 
New Haven, CT 06508 
(203)432-2810 
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Highlights: Medical Alumni 
Reunion Weekend 
Friday, June 10 
8 a.m. Medical alumni/ae registration 
1:30 p.m. Class reunion seminars 
4 p.m. Special address: Robert G. Petersdorf, M.D. '52, 
President, Association of American Medical Colleges 
5 p.m. Dean's reception 






Nursing alumni/ae registration 
Keynote address: Ada Sue Hinshaw, M.S.N. '63, Ph.D., 
R.N., F.A.A.N., Director, National Center for Nursing 
Research 
Luncheon and special address 
Faculty presentation 
Social hour and dinner 
8 a.m. Hospital administration alumni association (YUHAAA) 
and EPH alumni/ae registration 
9 a.m. Alumni/ae workshops 
Noon YUHAAA business meeting 
1 p.m. Alumni/ae workshops 
Saturday, June 11 
9:15 Medical faculty seminars 
10:30 Medical alumni/ae reunion seminar 
11:45 AY A in Medicine annual meeting 
All medical graduates are welcome to attend reunion weekend. Reunion 
festivities will be held for classes ending in the years “3” or “8". 
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06510. 
Dr. Michael Kashgarian, professor of pathology, is editor of 
YALE MEDICINE. The magazine is produced by him and the 
Office of Public Information: Helaine Patterson, director; 
Gregory Huth, publications editor; and Leah D'Eugenio, 
senior administrative assistant. The tri-annual magazine is 
prepared in cooperation with the Alumni and Development 
offices at the School of Medicine, with assistance from 
Victoria Chave, layout and production. 
The cover features Joel Black, PhD., assistant professor of 
neurology, preparing a “freeze-fracture” slide for electron 
microscopy. The technique is helping Yale medical scientists 
further their quest to understand nerve function. Photo 
credit: James Anderson. 
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CONFRONTING ARMAGEDDON 
“Nuclear war cannot be won and must never be fought.” President Ronald Reagan, in a letter 
to the International Physicians for the Prevention of Nuclear War (IPPNW), Spring 1983 
“The physicians have really done a great thing; you have convinced the Soviet military that 
they cannot win a nuclear war” State Department official, Washington, 1984 
“// we all agree, and all these heads of state and the Pope say we are correct—/ mean, if 
everything's so good, why is everything so bad?” Georgii Arbatov, leading Soviet expert on the 
United States, addressing an IPPNW Congress, 1983 
IPPNW 
IPPNW co-presidents Lown, an American, and Chazov, a Soviet, conduct a press conference before the Nobel Prize ceremonies in Oslo in 
December 1985. The author. Dr. John Pastore, is at the far right. 
by Dr. John O. Pastore '67 
Academician Arbatov’s melancholy observation, an echo of 
sentiments from the American side, captures the essence of 
the physicians' movement against the nuclear arms race. 
The United States and the Soviet Union have recently 
concluded, and their leaders have signed, the first treaty that 
will result in dismantling a whole class of nuclear weapons. 
Before the treaty’s ink was dry, it was assumed that the 
Intermediate Nuclear Force (INF) accord would be ratified in 
the U.S. Senate without effective opposition and its stringent 
verification measures would render the treaty virtually 
impossible to violate without detection. 
From the American standpoint, and particularly for 
President Ronald Reagan, the asymmetry of the treaty—with 
four times as many Soviet as U.S. missiles being 
dismantled—represents a great triumph. The INF treaty will 
probably ensure that the Republican Party will emerge from 
its convention in New Orleans this summer claiming effective 
management of the Russians and their dynamic leader 
Mikhail Gorbachev. In fact, so impressive is the President’s 
Dr. John Pastore, a cardiologist at St. Elizabeth's 
Hospital of Boston and associate professor of medicine at 
Tufts University School of Medicine, graduated from the Yale 
School of Medicine in 1967. Since 1984 he has been the 
secretary of International Physicians for the Prevention of 
Nuclear War. 
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achievement in purely political terms that as of this spring. 
Democratic contenders for the presidential nomination had 
barely mentioned the nuclear arms race. 
Yet. no matter how exciting or politically effective, the INF 
agreement is little more than a symbolic first step on the road 
to nuclear disarmament. Consider that less than 4 percent of 
the world’s nuclear weapons will be removed as a result of the 
agreement. No nuclear weapons capable of reaching the 
United States will be dismantled. And the agreement leaves in 
place the system of nuclear blackmail we euphemistically call 
"deterrence.” Maybe that’s what Arbatov meant: Though we 
have attended to a single symptom, the disease festers at a 
much deeper level. 
It’s possible that before the end of the Reagan presidency a 
major arms control achievement—a 50 percent reduction in 
superpower stockpiles—will become a reality. Conventional 
wisdom has it that the Soviets want the reductions just as 
much as those Americans who care for Reagan's place in 
history. It seems that only the intransigence of the American 
right (sensing betrayal by a lame duck president once their 
stalwart) or the impenetrable vagaries of Soviet domestic 
politics could forestall a 50 percent reduction. 
Certainly, you say, such a reduction would satisfy, at least 
temporarily, the “peaceniks,” including the physicians 
internationally clamoring for nuclear disarmament. But the 
answer is an emphatic no, as anyone familiar with the history 
of International Physicians for the Prevention of Nuclear War 
(IPPNW) would surmise. Perhaps I can explain. 
WHERE WE HAVE BEEN 
In the early 1960s, a small band of physicians played a key 
role in the passage of the Limited Test Ban Treaty that ended 
atmospheric nuclear test explosions by the United States and 
the Soviet Union. Concerned mothers in the American 
Midwest and the doctors demonstrated that Strontium 90, a 
radioactive isotope liberated into the atmosphere during 
nuclear testing, behaved biologically like calcium—collecting 
in the deciduous teeth of babies because it was in the milk 
from cows that grazed on grasses containing the isotope. 
The resulting public outrage helped the Kennedy 
administration achieve the atmospheric test ban, signed in 
1963. With this success. Physicians for Social Responsibility 
(PSR) was off and running. Movement leaders published 
articles in prestigious medical journals extrapolating about the 
effects of nuclear explosions over major American cities, and 
proclaimed in churches, universities and town meeting halls 
that nuclear war could not be survived. 
Thus was born the so-called “bombing run,” a one-hour 
lecture on the effects of a megaton blast over Boston, New 
York or San Francisco. People listened, and some were 
energized to act, but an escalating war in Southeast Asia, 
along with the civil rights issue, soon dominated the agenda 
of social concern. Husbands, sons and brothers were dying in 
Vietnam, even as “freedom riders” perished here at home. 
PSR members continued to publish in scholarly medical 
periodicals, but the most important outlets—the mass media 
in the United States—were focusing on other issues. 
Meanwhile, underground nuclear test explosions continued 
at the annual rate of approximately 30 in the United States 
and 20 in the Soviet Union. But the principle of “out of sight, 
iu o! mind” held true; few noticed what was happening. The 
led test ban had created the illusion that the nuclear arms 
had been slowed, if not stopped, and public outrage was 
ed because the atmosphere was no longer being 
animated. A new generation took office in the U.S. 
Congress—people who had never witnessed the frightening 
power of a nuclear blast. 
In a tit-for-tat “policy,” the nuclear superpowers engaged 
in an open-ended arms race, with atomic weapons on each 
side soon reaching the tens of thousands. Many missiles 
packed the firepower of 80 or 100 Hiroshimas. Deadly 
accuracy was “improved,” and the possibility of a disabling 
first strike by one’s enemy became the defense planner’s 
nightmare. 
A TURNING POINT 
In 1978, shortly after the Three Mile Island nuclear reactor 
accident in Pennsylvania, a small group of Boston doctors, 
including Helen Caldicott, Eric Chivian and Ira Helfand, 
revived the dormant Physicians for Social Responsibility. At 
first the organization was concerned with both nuclear power 
and weapons, but its leaders soon decided to focus solely on 
nuclear weapons—an approach that has continued in the 
succeeding 10 years. 
In late 1979 and early 1980, another group of Boston 
doctors, members of the rejuvenated PSR, joined with 
prominent leaders in Soviet medicine to found an 
international organization against the nuclear arms race. Six 
of them—three Soviets and three Americans—met in the 
restaurant of a Geneva hotel and, during a dramatic and 
sometimes tumultuous weekend, hammered out the principles 
that would guide this risky new endeavor. 
The Americans—Bernard Lown, James Muller and Eric 
Chivian—and the Soviets—Evgueni Chazov, Leonid Ilyin 
and Mikhail Kuzin—agreed that heading off a nuclear conflict 
would be the single agenda item of the International 
Physicians for the Prevention of Nuclear War. Through 
IPPNW, physicians from around the world would demonstrate 
their professional commitment to protect life and preserve 
health. Moreover, the organization would be neutral and 
disseminate the same information about nuclear war to all 
nations. 
On the American side, many prominent physicians played 
an important role in the formative months, including Herbert 
Abrams, Helen Caldicott, David Greer and Howard Hiatt. 
Bernard Lown’s living room in Newton, Mass., was the scene 
for many lively evenings as IPPNW went through a neonatal 
period in the early 1980s. 
The wisdom of focusing on the nuclear arms race became 
apparent as disparate political philosophies and attitudes 
toward the Soviet Union surfaced within the group. But to 
paraphrase Samuel Johnson, "There is nothing like the threat 
of nuclear annihilation to concentrate the mind,” and there 
were no substantive disagreements on that score. 
A MEETING OF MINDS 
Perhaps more importantly, the Soviet physicians agreed with 
us not only on general principles, but also on details and 
strategy. Many times a plan would be hatched in the Lown 
living room, completely American in formulation, and we 
would telex or phone the details to Dr. Chazov in Moscow. If 
the matter were especially important, the next day the 
Russians often would notify us simply that they agreed! For 
those of us nurtured on cold war platitudes about the Soviets, 
it took a while to get used to this challenge to our 
preconceptions. 
It bears emphasizing that this international unanimity was 
manifest only on our single-issue official agenda. Many of us 
continued to engage our new Soviet colleagues (and yes, 
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friends) in heated private discussions on other matters, 
reflecting the differences between our two social and political 
systems. 
Some in the West felt that we should “go public” with 
these disagreements—especially on human rights. My own 
experience has been that our effectiveness has come through 
quiet diplomacy rather than attempts to embarrass our Soviet 
colleagues. Several Soviet emigres now living in the West 
bear witness to the success of that approach. 
Beginning in 1981, the main event on the 1PPNW annual 
calendar has been its international congress. The first, held 
near Washington, D.C., attracted 70 doctors from 12 
countries. 
1PPNW growth has been dramatic since that first 
international meeting. The seventh congress, which took place 
in Moscow in June 1987, attracted more than 2,600 delegates 
representing more than 60 countries. Fifty-five of those 
nations are now official affiliates of IPPNW. 
Physicians for Social Responsibility, the U.S. affiliate of 
IPPNW, has enrolled more than 40,000 physicians and 
medical students, and another 10,000 health care workers, 
including nurses, who also have their own autonomous 
Nurses Alliance. 
WIDE WORLD 
EYES ON THE PRIZE 
The greatest boon to the international physicians movement 
undoubtedly came in 1985, when IPPNW was awarded the 
Nobel Peace Prize. The Nobel Committee cited the 
federation’s “considerable service to mankind by spreading 
authoritative information and by creating an awareness of the 
catastrophic consequences of atomic warfare.” 
Perhaps for the first time, IPPNW came to be regarded as a 
threat by those espousing a contrary view of the nuclear arms 
race, whose rationale spans a spectrum from “Nuclear 
weapons have guaranteed the peace” to “Why not spend the 
Russians into submission.” Thus, controversy attended the 
peace prize. 
Its nominal focus was the human rights orientation of the 
Soviet Dr. Chazov, who by then had served alongside Dr. 
Lown as a co-president of the federation for five years. Dr. 
Chazov held that office without any aspersions on his 
character. In fact, among the emigre community in the Boston 
area. Dr. Chazov was highly regarded as a cardiologist, 
although one with close ties to the Soviet leadership. He was 
reputed to be the private cardiologist of Leonid Brezhnev and 
his successors. 
Almost as soon as the IPPNW’s Nobel Peace Prize was 
announced, however, the media in the Federal Republic of 
Germany brandished a letter co-signed by Dr. Chazov and 
about 20 other scientists in the early 1970s. The letter 
criticized Andrei Sakharov, the dissident Soviet physicist who 
was later exiled to Gorky. Those opposed to Soviet-American 
rapprochement seized upon the incident with glee. 
Regardless of one's attitude toward the Russians, Dr. 
Chazov or Sakharov, the controversy was a source of pain for 
those of us who struggled through it. My own view is that the 
Nobel Prize was awarded to a worldwide federation in more 
than 50 countries, and not to any individual. Dr. Chazov had 
to speak for himself on the Sakharov affair, that predated his 
work with us by nearly 10 years. The work itself was not only 
beyond reproach but a service to humanity. 
In December 1985, the media’s attention was abruptly 
redirected by a propitious development. At the Nobel Prize 
press conference in Oslo, a Soviet journalist collapsed in view 
of the world as these contentious issues were being hurled at 
us by the assembled reporters. 
That evening millions of television viewers worldwide saw 
on the news an international group of physicians, including 
Soviet and American cardiologists, leap to the aid of Lev 
Novikov, who had just become a victim of sudden cardiac 
death. As an example of international cooperation, the 
moment was poetic; a few skeptics even suggested that 
IPPNW had staged the rescue. Happily, Novikov survived and 
now speaks occasionally on behalf of IPPNW. 
PEACEFUL PROLIFERATION 
The incident catapulted the physicians movement into the 
spotlight. It did not stifle our critics, of course, but it certainly 
reinforced our credentials as doctors. The dramatic and 
successful resuscitation of Mr. Novikov did not hurt 
recruiting, either. 
(At left) Drs. Chazov (white shirt) and Lown (in vest) use closed 
chest massage to revive a Soviet journalist at the 1985 Nobel press 
conference. Dr. Pastore, in the foreground, monitors the patient's 
pulse. 
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IPPNW now represents 175,000 physicians in 55 countries. 
It i the fastest growing medical organization in the world and 
the only one with a co-presidency shared by an American and 
a Soviet. Our current vice presidents are from Sweden, 
Hungary, Argentina, Australia and Canada. 
The International Council, the governing body for the 
federation, is comprised of councilors from each of our 55 
affiliates. The People’s Republic of China is the only nuclear 
weapons state not officially represented on the council, but 
prominent Chinese physicians have attended as active 
observers at each of the last three world congresses. The 
future of our organization is limited only by finances; 
imagination and daring have never been a problem. 
For instance, IPPNW played an important role in getting 
the Soviet Union to institute a unilateral 18-month 
moratorium on nuclear test explosions from August 1985 to 
January 1987. The Soviets initially resisted our arguments 
that they stop nuclear testing. They felt that the United States 
would not halt its own test explosion program and that few in 
the West would be made aware that the Soviet side had indeed 
done so. 
YEAR 
Nuclear test explosions by the superpowers continue. (Courtesy: 
Union of Concerned Scientists.) 
The Soviets were partially right. The United States did not 
join the nuclear explosions moratorium, despite the active 
advocacy of the Western anti-nuclear movement. On the other 
hand, the Soviets’ willingness to stop test explosions was 
highlighted and the comprehensive test issue ban was 
rejuvenated before a wide Western audience. 
IPPNW has launched CEASE FIRE ’88, a concerted effort 
to gain worldwide support for a comprehensive test ban treaty. 
Our affiliates around the world are protesting each U.S. or 
Soviet nuclear test explosion—not only with letters and 
telegrams, but also by seeking meetings with the ambassadors 
from the offending superpower resident in the affiliate 
country. We are giving it our best shot. 
Together with our American affiliate, PSR, we shall 
continue to bring Soviet physicians to the United States and 
send our doctors to the Soviet Union. The anti-nuclear 
message is the same on both sides. 
An independent corporation, SatelLife, has been formed to 
inch, with the cooperation of Soviet space scientists, a 
lunications satellite for medical purposes. SatelLife will 
mate health information to developing countries, and 
educational and communication needs of their 
health-care deliverers. 
IPPNW has long maintained that the heavens should be 
used to lift humanity’s spirits and improve health worldwide. 
We are not simply against weapons in space. We advocate 
using space to elevate humanity to a new plane of inter¬ 
national cooperation. 
WHERE WE ARE GOING 
Since Hiroshima and Nagasaki, physicians have realized that 
upwards of 80 percent of all medical personnel would be 
killed outright in the event of a nuclear war—and the 
survivors would function more as patients than doctors. Once 
the Nagasaki weapon demolished that city’s Medical 
University—immediately killing 90 percent of those inside 
and destroying all supplies—we had all the evidence we 
needed about the physicians’ role regarding nuclear war. The 
only cure is prevention. 
There are still pockets of hard core nuclear war strategists 
in the militaries of the United States and the Soviet Union. 
But thanks in large part to the physicians, it is no longer 
considered intelligent to speak of nuclear war as ‘'winnable.” 
So in large measure, our first battle has been won. 
But much more needs to be done. The world still bristles 
with 55,000 nuclear weapons—more than 95 percent of which 
are in the hands of the United States and the Soviet Union. 
Even after dismantling medium and some short-range missiles 
in Europe following ratification of the INF accord, there will 
still be more than 50,000 instruments of genocide on our 
small planet, with a combined firepower of one million 
Hiroshimas. 
Beginning last year, the International Physicians for the 
Prevention of Nuclear War has espoused the goal of eliminat¬ 
ing all nuclear weapons. Our physicians are not arms con¬ 
trollers.The career arms controller objects to abolition on the 
grounds that nuclear weapons cannot be “disinvented.” We 
agree that knowledge, scientific or general, cannot be 
eradicated; but the use of that knowledge is controllable. The 
real problem is that nuclear weapons have become an integral 
part of the defense postures of the United States and the 
Soviet Union. 
However, it is naive and delusional to believe that 
humanity and nuclear weapons can coexist indefinitely. We 
must learn to defend ourselves without nuclear weapons, 
because their use would terminate civilization as we know it. 
We also are continuing our grassroots educational efforts. 
At the urging of the World Health Organization, IPPNW is 
preparing a curriculum on the medical effects of nuclear war 
and the nuclear arms race that medical schools around the 
world can use. It is distressing that few medical schools teach 
about what many experts have called humanity's most 
important public health problem. 
Considering the many Yale medical academicians who 
provided leadership to the Atomic Bomb Casualty 
Commission in Hiroshima and Nagasaki, it would be 
appropriate that our own medical school play a larger role in 
developing and using this important curriculum. 
Anyone interested in attending the 1989 IPPNW congress 
in Hiroshima—and all are invited—should contact a local 
chapter of Physicians for Social Responsibility. 
When that next congress meets, the Albert Einstein quote 
on the IPPNW letterhead will seem even more immediate; 
“We shall require a substantially new manner of thinking if 
mankind is to survive.” But it will take more than thinking; it 
will take all the optimism and work physicians and their 
patients can muster. 
We think the future is worth it. YM 
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YALE NEUROLOGY: 
EXPANDING HOPE’S HORIZON 
Dr. Stephen Waxman in his new laboratory. PHOTOS BY JAMES ANDERSON 
by Nancy Pappas 
Few injuries or diseases are more devastating than those that 
affect the central nervous system. Some 300,000 Americans 
have been left quadriplegic or paraplegic by spinal cord 
injuries. Their numbers increase by some 14,000 each year. 
Another 250,000 suffer from multiple sclerosis, with its 
unpredictable course of neurologic disability caused by the 
demyelination of nerve fibers. 
Moreover, these conditions disproportionately affect young 
people in the prime of their family- and career-building years. 
This enormous human toll has stimulated considerable 
scientific research—but frustratingly little progress toward 
effective treatments or cures. 
Stephen G. Waxman, M.D., Ph.D., professor of neurology 
and chairman of the School of Medicine’s neurology 
department since 1986, is determined to change all that. 
Observes Dr. Waxman, who is also chief of neurology at Yale- 
New Haven Hospital and a staff physician in neurology at the 
VA Medical Center in West Haven, “The traditional picture is 
that if something happens to the central nervous system, 
there’s no recovery. Recently, it's become clear that the picture 
may not have to be so pessimistic.” 
Dr. Waxman and his colleagues are collaborating on a 
series of research efforts designed to illuminate the basic 
mechanisms of central nervous system development, function, 
injury and recovery. Working in a new, custom-designed 
research facility built by Yale on the grounds of the Veterans 
Administration Medical Center, the group is attacking these 
problems with a combination of state-of-the-art research 
techniques. 
“We’re doing basic science,” emphasizes Jeffery Kocsis, 
Ph.D., associate professor of neurology. “We can’t promise to 
make wheelchair patients walk. But that’s in the back of our 
minds.” 
NEW RESEARCH CENTER 
An intense, confident man. Dr. Waxman describes the 
evolution of this new research center. It all began, he explains, 
when Dr. Leon E. Rosenberg, dean of the medical school, 
recruited him from Stanford University School of Medicine to 
Nancy Pappas is a free-lance medical writer. 
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lead Yale’s neurology department. 
Dr. Waxman had already earned widespread recognition 
for his work on neural regeneration and on the molecular 
neurobiology of myelinated nerve fibers. He had assembled a 
first-rate group of collaborators, several of whom have since 
joined the Yale faculty. 
In the process of moving his research operations from 
Stanford to Yale, Dr. Waxman recalls, he began to dream 
aloud about the ideal research facility. It would, he said, be 
designed to embrace the kind of intellectual and practical 
collaboration that had already developed within the group. 
schools,” Kocsis notes. “People get scattered all over the 
place, and it's hard to get together. Here, we're right across 
the hall from each other.” 
The center currently houses Drs. Waxman, Kocsis and two 
other senior members of the research team, Beth Friedman, 
Ph.D., and Joel A. Black, Ph.D., both assistant professors of 
neurology. Each collaborator leads one of the center's four 
primary laboratories, where research is carried out by teams 
comprising graduate students, postdoctoral fellows and 
laboratory assistants. 
At least once a week, the four investigators meet formally 
Dr. Waxman encourages informal 
meetings among his team’s members. 
Here he shares a lighter moment with 
Jeffery Kocsis (left). Beth Friedman 
and Joel Black. 
“Finally, I said to Lee Rosenberg, ‘Why don’t you build us a 
research center?' And he did it!" Waxman recalls. 
Open since early 1988 and dedicated in May, the center is 
housed in a single-story brick building on the campus of the 
VA Medical Center. In keeping with its close ties with the 
medical school, the VA made the land available to Yale on a 
long-term lease. 
"We're happy to be at the VA because they have a 
longstanding interest in diseases of the CNS,” Dr. Waxman 
says, speaking as the center’s director. 
A major source of funds for the new building and 
program—$1.5 million—came from the Paralyzed Veterans 
of America and one of its chapters, the Eastern Paralyzed 
Veterans Association. In recognition of the groups’ support, 
the center has been named the PVA/EPVA Center for 
Neuroscience and Regeneration Research of Yale University. 
Showing visitors around the new, H-shaped building, 
Jeffery Kocsis, the center’s associate director, talks of the rare 
privilege of being able to design a scientific research facility 
from scratch. Every principal investigator has been given 
plenty of room for equipment and staff, and the floor plan has 
been laid out to encourage easy contact between the various 
research teams housed there. 
This is not as common as one might imagine in medical 
to discuss the progress of their work and search for ways to 
enhance each other's efforts. Dr. Waxman likes his 
researchers to collaborate informally, as well. Blackboards 
hang in the hallways to encourage spur-of-the-moment 
discussions. 
The center’s research activities flow in many directions, 
but all. Dr. Waxman says, with a common goal: "Our projects 
are variations on the theme of functional recovery after 
damage to the central nervous system. What are the 
mechanisms surrounding it? How can we encourage it? We 
hope our basic research will throw some light on these 
issues.” 
PURSUING THE DREAM 
To the public, recovery from neurological disease or injury 
seems synonymous with regeneration of nervous tissue. But 
Dr. Waxman points out that in many such disorders "though 
there's not a reconstitution of structure, we get recovery of 
function.” Limbs paralyzed or eyes blinded by multiple 
sclerosis can start working again, even though the myelin 
insulation is still stripped from the nerves. Stroke victims may 
regain their speech or powers of movement, even though their 
brain tissue remains damaged. 
continued on page 9 
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The Platinum Portraits of Freeze-Fracture 
Critical to Yale’s research into spinal cord injury and multiple 
sclerosis is the ability to inspect the membranes of nerve 
fibers in the finest possible detail—down to individual ion 
channels and protein receptors. 
That is where Joel Black, Ph.D., comes in. An assistant 
professor of neurology, he is a specialist in an esoteric—but 
extremely useful—electron microscopy technique called 
freeze-fracture. This technique produces detailed platinum 
castings of split membranes that produce minutely detailed 
electron micrographs. 
“Joel is one of the people at the forefront of applying this 
technique to the central nervous system,” notes Dr. Stephen 
G. Waxman, professor and chairman of the department of 
neurology. 
Black demonstrates the technique in his new laboratory at 
the PVA/EPVA Center for Neuroscience and Regeneration 
Research of Yale University, which features a $120,000 
freeze-fracture machine. 
Freeze-fracture, he explains, is like hitting a block of ice 
with a hard, sharp object, only on a minute scale. The 
researcher begins by putting tiny bits of nerve tissue—in this 
instance, from the optic nerves of laboratory rats—on 
confetti-sized gold-and-copper mounts, then flash-freezing 
these in a vat of liquid nitrogen. 
Then he sets the frozen mounts on a bottle cap-sized 
“table,” and inserts the whole assembly into the supercooled 
vacuum chamber of his freeze-fracture machine. 
Here a sharp blade slashes forward, breaking the nerve 
tissue apart. “The fracture follows the pathway of least 
resistance,” Black explains. In most cases, the tissue fractures 
between the two layers of lipid molecules that make up the 
cell membrane. When the fracture plane reaches a protein 
penetrating this double layer, it tends to go over or under the 
protein—leaving it intact for study—rather than splitting it. 
“I have no control over the fracture plane. It’s just a 
random event,” Black explains. Nevertheless, about 90 
percent of the fractures produce usable images. 
Next, Black directs a fine platinum vapor at the exposed 
membrane face, in effect spray-painting it with a thin layer of 
metal only several molecules thick. Then he layers carbon 
over the platinum to stabilize it (the carbon, transparent to 
electrons, will not show up on the electron micrograph). 
Finally, he uses chemicals to digest away the nerve tissue 
itself. 
What’s left is a perfectly detailed casting of the nerve 
membrane that is totally impervious to electrons, and 
therefore completely visible to the electron microscope. 
Next comes an even greater challenge. “The difficult part 
of the technique is interpreting the micrographs, because the 
image you get is so different than conventional thin-section 
microscopy,” Black says. “You’re looking at vast amounts of 
membrane instead of the customary thin cross-section.” 
Black points out that by using freeze-fracture to look at 
large areas of membrane, he can see the spatial organization 
of proteins within the membrane. 
Having mastered this demanding technique. Black is now 
trying to extend its utility. “The drawback of conventional 
freeze-fracture is that if you look at a particle, you can’t tell 
anything about its composition. Is it a glycoprotein, a 
lipoprotein? We don’t know.” 
Black is working with a colleague, Beth Friedman, Ph.D., 
A freeze-fracture electron micrograph taken by Joel Black shows a 
myelinated axon magnified 50,000 times. (A) The node of Ranvier, 
site of action potential propagation, is bounded top and bottom by 
paranodal axon membranes (B), which have a scalloped 
appearance due to constriction by overlying oligodendrocyte 
processes. Numerous intramembranous proteins are apparent 
within the nodal membrane. 
assistant professor of neurology, who specializes in the use of 
antibodies in research, to combine their two disciplines to 
overcome this problem. They hope to find an antibody that 
will stick to specific membrane proteins, and in turn tag this 
signal antibody with yet another antibody whose tail sports a 
trace of electron-dense colloidal gold. Under the electron 
microscope, these tagged proteins should stand out like so 
many push-pins, giving the researchers valuable information 
about the identity and distribution of various proteins. 
Notes Black: 
“Once we work out this technique, it will have 
wide-ranging possibilities for other investigations, 
since we will be able to tag specific molecules for study 
in the electron microscope.” 
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The Emerging Option of Epilepsy Surgery 
One of the traditional strengths of the neurology department is 
the treatment of epilepsy. “Epilepsy treatment and research 
are among the ‘jewels in the crown’ of this department. They 
are a major factor in our claim to leadership in the field of 
neurology,” notes Dr. Stephen G. Waxman, chairman. 
Surgery is beginning to play a more prominent role in 
relieving epileptic symptoms, for in spite of steady 
improvement in drug therapy, an estimated 30 percent of 
people with focal seizures—seizures that originate in a 
localized part of the brain—can't be helped by drugs. 
For some of these individuals, a Yale neurology- 
neurosurgery team can offer a new lease on life through the 
removal of seizure-generating portions of the brain. The Yale 
team, one of just a handful around the country with expertise 
in this demanding treatment, receives referrals from all over 
the world. 
"It's one of the most rewarding things 1 can think of in 
medicine—to be able to help people who have been 
devastated their whole lives,” says Susan S. Spencer, M.D., 
associate professor of neurology. “Among ideal candidates, 
carefully selected, over 90 percent are able to have the surgery 
with minimal neurological deficit and with cure or near-cure.” 
years, is only just coming into its own as an established 
treatment for drug-resistant seizures. Dr. Susan Spencer 
estimates that as a result, as many as 300,000 people in the 
United States may need the surgery but are not getting it. 
“It is becoming more popular because it really works,” she 
observes. “It’s gratifying to be able to treat a chronic disease 
and in many instances to cure it.” 
In the 15 years since the surgery program began, demand 
has increased to the point where the team is performing an 
average of two operations a week. “We have grown so busy it 
takes close to two years from the start of pre-operative 
evaluation to the finish of the surgery," Dr. Spencer says. 
Many of the team’s patients have been so disabled by 
seizures that they have been confined to their homes, unable 
to work or go to school. Successful surgery enables them to 
lead essentially normal lives. 
The key to successful surgery. Dr. Spencer explains, is a 
careful pre-operative evaluation of patients. 
“First we must establish that seizures are all arising from a 
small part of the brain, and that this tissue can be removed 
without causing a lot of neurological problems in the 
individual,” she points out. “Those are a lot of ‘ifs’. 
“Sometimes the localization of the spot requires dangerous 
procedures such as placing electrodes deep in the brain. This 
carries a 2 percent risk of hemorrhage or infection,” she notes. 
“There are not that many centers capable of doing these 
kinds of evaluations,” Dr. Spencer observes. “It really 
requires a team approach involving neurologists, neuro- 
Dr. Susan Spencer tests the 
periferal vision of a young 
patient whose epilepsy has 
been successfully managed 
with brain surgery. 
Epilepsy research was begun at Yale in the 1950s by 
Gilbert H. Glaser, M.D., Sc.D., professor of neurology and 
former chairman of the department. In addition to Dr. 
Spencer, the team’s neurologists include Dr. Richard H. 
Mattson, professor of neurology and director of medical 
tidies in the neurology department, and Dr. Peter D. 
amson, associate professor of neurology. The team's 
surgeon is Dr. Dennis D. Spencer, professor of 
neur airgery, and Susan Spencer’s husband. 
surgery, although done occasionally for many 
psychologists and neurosurgeons.” 
Precise localization of the epileptic focus enables the 
surgeon to remove only that part of the brain and no other, she 
explains, thus sparing as much normal tissue as possible. 
In recent years, the team has been moving toward doing the 
surgery on younger and younger patients. “Most of our 
patients are young adults," Dr. Spencer points out. “But we are 
seeing more and more children. With any removal of brain 
tissue, if you do the surgery early in life the brain recovers and 
compensates better.” 
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“We want to get at the principles of how nerve cells 
reorganize after injury—the whole issue of plasticity," Dr. 
Waxman explains. 
Already Dr. Waxman and his colleagues have begun 
illuminating the question of remissions in multiple sclerosis. 
They expect that this work, which they began at Stanford, 
will be greatly enhanced by their move to Yale. 
That is because the Yale faculty includes people like J. 
Murdoch Ritchie, Ph.D., Sc.D., Eugene Higgins Professor of 
Pharmacology and one of the world’s experts on the 
physiology of the myelinated nerve fibers damaged in 
multiple sclerosis. In fact. Professor Ritchie and Dr. Waxman 
co-authored research reports before the latter moved to Yale. 
Thanks to their newly combined forces, Dr. Waxman says, 
“in terms of understanding the physiology of multiple 
sclerosis, Yale is the best place in the world.” 
Dr. Waxman explains that normally, many fibers in the 
central nervous system are covered by a sheath of myelin, a 
lipid that acts as an electrical insulator. But the myelin does 
not coat the fiber continuously as electrical insulation covers 
a copper wire. At microscopic intervals the myelin sheath is 
absent, exposing the nerve surface underneath. 
These unmyelinated segments, known as “nodes of 
Ranvier,” make possible an extremely efficient means of 
electrical transmission known as saltatory—literally, jumping 
or leaping—conduction. In saltatory conduction, the electrical 
impulse generated at the nerve body does not move steadily 
down the fiber. Instead, the impulse builds at one node until it 
is strong enough to jump to the next. 
This type of conduction is controlled by sodium and 
potassium channels, specialized protein molecules that 
penetrate the fiber membrane. Professors Ritchie and 
Waxman have demonstrated that the sodium channels on 
nerve fibers are densely clustered at each node of Ranvier. 
When stimulated by the arrival of an electrical pulse, the 
channels open to flood the fiber with positively charged 
sodium ions. 
When the charge at the node builds to a critical point, the 
current begins “searching” for a place to go. It cannot simply 
travel continuously along the fiber because between the 
nodes, underneath the myelin sheath, there are few sodium 
channels. Moreover, the fiber is coated under the myelin with 
current-resisting potassium channels. 
Nor can the current leak into the surrounding extracellular 
space; the insulating myelin blocks that route. That leaves the 
current only one means of progression: to leap to the next 
node, micrometers down the fiber. 
When multiple sclerosis attacks and destroys myelin 
(presumably through some autoimmune process), this 
electrical system is disrupted. Instead of leaping from one 
node to another, the impulse travels into the area between the 
nodes, where the potassium channels dissipate it uselessly. 
This dissipation of nerve impulses is responsible for the 
paralysis, loss of sensation and blindness that occur after 
damage to the myelin. 
MEDICAL DETECTIVES 
While Ritchie, Kocsis and Waxman all have made major 
contributions to the understanding of this means of 
conduction, Kocsis works most directly on the 
electrophysiological aspects of demyelinating disease. His 
research involves pulsing minuscule electrical currents 
through individual rodent axons in various states of 
In his specially shielded lah, Jeffery Kocsis prepares an experiment 
in which he will place a microelectrode within a single rodent nerve 
fiber. 
myelination and demyelination. He then records their 
electrical behavior by placing tiny, specially fabricated 
micro-electrodes within single nerve fibers that are less than 
one hundredth of a millimeter in diameter. 
The researcher works from a room within a room, a large 
metal mesh cage designed to keep out stray electromagnetic 
signals that could disrupt his delicate measurements. 
“The mandate is to gain a better understanding of how 
axons work, and develop pharmacological means to make 
them perform better after they have been injured,” Kocsis 
notes. 
One phenomenon being studied intensely is in the area of 
multiple sclerosis. In some cases nerves renew their ability to 
transmit electrical impulses effectively—even though they 
have not regained their myelin coatings. 
Assistant Professor Joel Black has contributed importantly 
to this question with a specialized technique called freeze- 
fracture electron microscopy, which produces incredibly 
detailed pictures of the molecules within membrane surfaces 
of nerve fibers. “The technique allows us to look at large 
areas of membranes and to see the spatial organization of 
molecules within the membranes,” he explains. (See “The 
Platinum Portraits of Freeze-Fracture.”) 
Using Black’s freeze-fracture pictures and Kocsis’ 
electrophysiological findings, the team has established that 
the demyelinated region begins to acquire conduction¬ 
enhancing sodium channels—enough, it seems, to keep the 
current flowing across the unmyelinated wasteland of nerve 
fiber damaged by multiple sclerosis. One line of research. Dr. 
Waxman says, is to see whether drugs can speed this process, 
or perhaps neutralize the conduction-dampening potassium 
channels. 
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To this end, the group has begun in vitro experiments with 
4-uminopyridine, a potassium channel blocker. "We have been 
able to induce reliable conduction in demyelinated nerve 
l ibers. Dr. Waxman reports. “But we still have to understand 
more about this drug before we test it clinically. The potential 
side effects are very significant.” 
Dr. Waxman is also interested in the possibility of inducing 
remyelination of central nervous system tissue. If 
demyelination occurs in the peripheral nervous system—as it 
does in the Guillain-Barre syndrome, for example—Schwann 
cells simply extrude new myelin and recovery eventually 
occurs. Dr. Waxman notes. But in the central nervous system, 
oligodendrocytes, not Schwann cells, make myelin and they 
do not switch on so readily. 
"We would like to be able to turn this cell on so that 
remyelination will occur in demyelinating diseases,” Dr. 
Waxman says. "We are searching for the instructional 
molecules on the axon that tell the oligodendrocyte, 
‘myelinate me.'” 
Using freeze-fracture technology. Black has detected what 
he takes to be just such molecules. He made this finding by 
examining fibers taken from the optic nerves of rats at a point 
in development characterized by rapid myelination. At just 
the time when they instruct oligodendrocytes to form myelin, 
the axons exhibit a new population of protein molecules on 
their surfaces. 
Chemically prevented from being myelinated, the fibers 
nevertheless displayed numerous protein particles on the areas 
of fiber that ordinarily would have received coats of myelin. 
The particles were conspicuously absent on the areas destined 
to become unmyelinated nodes of Ranvier. “It seems the 
signal is programmed into the neuron,” Black concludes. 
Now the problem has been handed to Beth Friedman, who 
will attack it with her research specialty: 
immunocytochemistry. Using monoclonal antibody probes 
that stick to specific molecules and show up on electron 
micrographs, she is able to track changes that occur in 
specific molecules on nerve cells undergoing development, 
myelination or demyelination. To investigate the mysterious 
myelination-signal proteins, she is attempting to locate 
antibodies that attach to those particular molecules. This 
approach, if successful, will provide the group with a handle 
on the molecules that turn on myelination, and that hopefully 
can be used to turn on remyelination. 
BIEL CARTER 
SPINAL CORD INJURY 
At first glance, multiple sclerosis—a chronic 
disease—-wouldn't seem to have much in common with the 
acute disability caused by spinal cord injury. But there is an 
important connection. 
Jeffery Kocsis points out that many cases of paraplegia and 
quadriplegia occur not because the spinal cord is completely 
severed, but because of demyelination that occurs in reaction 
to contusion and edema at the injury site. 
“You can have a person with functional total paraplegia, 
who has a number of intact, though demyelinated, fibers 
coursing through the area of contusion,” he notes. 
An important goal is to get these demyelinated axons to 
conduct impulses. Thus, an effective treatment for the 
demyelination of multiple sclerosis may also apply to spinal 
injury. 
The investigators also plan to pursue the traditional goal of 
spinal injury research: the regeneration of damaged central 
nervous system fibers. 
Drs. Waxman and Kocsis both observe that research on 
nerve regeneration acquired an unsavory reputation a decade 
or so ago, when several investigators at other centers 
promised breakthroughs within specified time periods, then 
failed to deliver. 
This image has improved in recent years. Dr. Waxman 
adds. One reason for the change is the steady progress of 
careful research into neural development and regrowth being 
conducted by his own group and others like it. Dr. Waxman 
says he is pleased that the Paralyzed Veterans of America has 
supported this approach with its grant. Other grants have 
followed, like a recent $60,000 gift from the Daniel Heumann 
Fund for Spinal Cord Research, named for a young New 
Yorker who was paralyzed in a 1985 auto accident. 
This research. Dr. Waxman emphasizes, involves a 
painstaking inquiry into the most basic cellular and molecular 
processes that could take years, even decades, to evolve into 
clinically useful findings. 
“What causes axons to initiate growth and develop the 
machinery to generate electrical impulses? How can we 
induce regenerating axons to traverse scar tissue barriers in 
the central nervous system? What guides a growing or 
regenerating axon to the right target?” Dr. Waxman asks. 
“Every one of these problems needs work.” 
Asked if it will ever be possible to heal severed or 
functionally damaged spinal cords. Dr. Waxman answers 
carefully: “What I think is a minimal goal is to get some 
subset of fibers to cross the injured region.” He points out that 
even if a mere 10 percent of fibers in the cord survive and 
function, it is enough to enable a person to walk. 
Waxman leaves no doubt that he considers his department 
up to the challenge. “We have the best people. And everyone 
is passionately committed to it,” he concludes. YM 
(At left) Dr. Waxman converses with two veterans at the May 
dedication of the PVA/EPVA Center for Neuroscience and 
Regeneration Research of Yale University. 
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Dr. Adrian M. Ostfeld 
I 
I finished medical school in 1915. 
War in the background. 
But I had no part of it. 
I can see me now. 
Lanky fellow I always was. 
Night time studying in the kitchen. 
I had my feet in ice cold water. 
Drinking black coffee by the quart. 
Jabbing my leg with an ice pick 
To stay awake and learn. 
Medical school was very tough. 
So much anatomy. So many names 
Of bumps on bones I had to learn. 
All that materia medica. 
Hundreds of plants and drugs I read about. 
Sometimes I felt so stuffed with facts that I 
Could see me pop and spew those facts for miles 
The way a seed pod does in early fall. 
Prescription writing was so difficult. 
Infusions, decoctions, sublimates and all. 
How many drops or parts of this and that? 
How did I ever keep those matters straight! 
Sometimes they showed us patients in the pit. 
That’s what we called the amphitheatre. 
They’d take their clothes and point to parts diseased. 
And talk as if the patient wasn’t there. 
I felt embarrassed at the time. 
But we were all discerning gentlemen 
And it did seem a dandy way to learn. 
1 felt so honored when, in cap and gown. 
They shook my hand and gave me my degree. 
You’re Medicinae Doctor now, I thought, 
A new successor to Hippocrates. 
On graduation afternoon, I bought a model T 
And started practice in my parents’ home. 
My patients all came from the neighborhood. 
Most of them kids and pregnant women. 
Some women at the change of life, but damn few men. 
I always listened hard to patients’ talk 
And tried to give them peace of mind if nothing else. 
It was pathetic how they trusted me. 
How glad they were when my old model T 
Pulled up in front of where the patient lived. 
How often there was nothing I could do 
Except to sit and fret and look concerned. 
I always said—and some thought it a joke— 
That hospitals were no place for sick people. 
It’s where you went to die, was what I thought 
When I first put my shingle on the door. 
And I had many a patient die at home. 
It’s not like now when death is sanitized. 
We quarantine our dead and dying well. 
We went so much by custom than by fact. 
The journals then were full of anecdotes 
And quaint reports but not a lot of science. 
For a while it was autointoxication 
That was the root of all disease. 
High colonics were the order of the day. 
I never put much faith in all that stuff. 
But many top men took the view 
That every bit of poison in the gut 
Must be removed. 
We took real risks in my day too. 
Many a time a TB patient coughed into my face, 
Or a skin rash I palpated without gloves 
Turned out to be contagious syphilis. 
Lues was what we used to call it then 
So we could name it in polite society. 
But I was lucky, too, I guess. 
I never caught anything from my patients 
Except sometimes their pain and helplessness. 
Some patients really made me mad. 
They said I didn’t help them. Sometimes true. 
But when they claimed I didn’t care about them 
Or that I charged too much, that really angered me. 
I knew what all my families earned. 
I always knew just what my fee should be. 
And if they couldn’t pay it right away. 
Why, I could always wait a month or two. 
Dr. Adrian M. Ostfeld is the Anna MR. Lauder Professor of 
Epidemiology and Public Health. Last year he was elected 
to the Institute of Medicine. 
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In the late thirties when sulfoamides 
Came in and started widely to be used, 
1 saw a whole new ball game coming up. 
For each disease a treatment was my hope. 
(I even remember that old radio joke 
About the brand new sulfa drug, so new. 
They didn't even have a disease for it yet.) 
But by the time I quit the game in fifty-one 
We'd only made a little progress in that way. 
Surgery was much safer, that was true. 
And penicillin changed things for all time. 
Infections started on a downward trend. 
But heart disease and cancer got all out of hand. 
I’m glad I quit just when I did. 
I’d never have been able to keep up. 
All those new tests and x-rays, EKGs, 
Were starting to puzzle me. 
Seemed biochemistry was taking over medicine. 
And that was good for medicine but not for me. 
Got way out of sight in growth and in complexity 
Blood clotting, and the new hormones, microbial sensitivities. 
Biopsies, frozen sections and surgical pathology 
All left this poor old doctor way behind. 
For about 10 years or so, ’til sixty-one, 
I still looked at my journals as they came. 
But more and more I was not reading them. 
So me and my old woman went to Florida. 
We used to swim a little, play some golf. 
But gave that up. It got to be too much. 
We have our bridge game every Thursday night. 
I read the newspapers although 
The print is getting much too fine for me. 
I garden some but most of what I do 
Is watch TV and walk around the block. 
Now all that's left of my degree 
And thirty-six years of practice 
Is that the neighbors call me "doc". 
Thank God for the G.I. Bill of Rights. 
Before the war, I was a poor old country boy. 
I always felt like I was smart. 
And now I had the med school funds in hand. 
Just call me Vector. All my classmates did. 
That's a force with magnitude and direction. 
I'm aimed at life like an arrow. 
And I’ve always picked out the right target. 
One thing really got to me in school. 
I he faculty was in a civil war 
B tv .vn the basic scientists and the clinicians. 
1 he basic scientists taught us 
But all they really cared about 
A as their research and their graduate students. 
I tell like they looked down on us 
\nd on the part-time doctors on the staff. 
I he clinical men were hard to find sometimes, 
for lectures, sometimes missing rounds. 
The house staff were the ones who taught us most. 
1 figured they're the ones who graded us 
So I tried the old brown nose technique on them. 
I told the surgery residents I was going into surgery. 
And the medicine house staff I had medicine in mind. 
The pediatricians that I loved to work with kids. 
I didn't lie to the psychiatrists. 
Near the end of my senior year 
1 saw how things stacked up in clinical academia. 
Surgeons made the money. Internists pulled the strings. 
I decided my talent lay in medicine. 
I ended up board certified. 
At first I thought of going home to practice. 
I'd halfway promised folks there that I would. 
But my wife had seen the bright lights 
And I certainly did not want to be 
file only specialist in Idabel, Oklahoma, 
Right down the road from De Queen, Arkansas. 
So I stayed in the big city with the big hospital. 
Old Vector, I stayed aimed and pointed. 
I joined a group of very smart men. 
1 kept my mouth shut, started rounds at seven 
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Then came the fight for Medicare. 
We couldn't make the politicians see 
That none of us ever turned down 
An older patient who really couldn’t pay. 
Nor did our standards ever fall 
When we took care of poor but honest folks. 
Most of us came into medicine to help people 
And we needed independence to do that, 
Not stacks of government regulations. 
Politicians don’t know how to practice medicine 
But they sure knew how to beat us. 
Three words are not in my vocabulary, though— 
“Surrender” and "Medicare assignment.” 
By 1970 I was pretty well fixed. 
I devoted a little more time to fun. 
I went to all my medical alumni meetings. 
We’d learn some cardiology the easy way. 
On soft deck chairs in warm tropical waters. 
It wasn’t too much later, though. 
That I saw danger signals all around. 
Internal medicine fragmented. 
And, drowning in subspecialies, 
I didn’t feel secure in what I knew. 
Then an orthopedic surgeon, tenant of mine. 
Got sued for a cool million and lost. 
The message came home loud and clear: 
Practice defensive medicine! Cover your ass! 
Send ’em to the superspecialist— 
And get a CATSCAN to be sure. 
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And was very, very nice to the house staff. 
They weren't making any more than I did 
When I was a resident, about a hundred a month. 
Bourbon for house staff parties was my gift 
And something special when they took extra good care 
Of one of my very sick or puzzling patients. 
It took me three whole years to realize 
That I was seeing as many patients 
As both my partners put together. I hushed my mouth. 
For two years I nursed every nickel. 
And was very nice to the other men’s patients. 
Then I pulled out. Leased a big office in the new suburb 
And took most of the group’s patients with me. 
I bought suburban land, held it four years. 
Resold the land and tripled my investment. 
When central city looked like it was moribund, 
I bought out a medical lab 
And moved it lock, stock and barrel 
To the suburb of my choice. 
I worked those years as hard as I could work. 
But I never sacrificed my standards for care 
Just to make an extra buck. 
Then along comes the HMO, 
Based on the muddled principle 
That if you brought together 
The bottom third of the graduating class. 
They’d make fewer mistakes than practicing alone. 
That made as much sense to me 
As fancy public housing in the slums. 
Everyone’s amazed how fast those buildings run down 
But what the heck could you expect 
When you pile a lot of losers under one roof? 
Old Vector started thinking to himself 
There’s trouble coming sure if you don’t switch. 
And then in 1983,1 got a break. 
There’s a small college near my summer home 
Just about sixteen hundred students. Real nice place. 
We'd go there sometimes for plays and such. 
Their health service doc suddenly ups and dies. 
The dean asked me if I was interested. 
The salary they offered me per year 
Was more than any of the faculty 
But less than half what my investments made. 
1 took their job, and feeling mighty good, 
I felt like I shucked a sack of cement. 
Now I work only three or four hours a day. 
See nothing but colds and ankle sprains. 
And give advice, sometimes, on safer sex. 
But what the heck! I’m doing what I like 
And looking out for good old number one. 
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In 1968 I was a flower child. 
And campaigned hard for Gene McCarthy's run. 
So I had seen a little bit of life 
Before my own bright college years. 
I went to Carleton. majoring in history. 
Then spent two dry and lonely, humbling years 
In the Peace Corps in Northern Africa. 
Nutrition was the greatest need I saw 
For all those bloated-bellied kids 
And mothers smiling while they slowly starved. 
The cry of a really hungry baby 
Will stay with me until the day I die 
Or lose my mind to Alzheimer’s disease. 
It makes you feel that you must feed that kid 
And steal or murder just to get the food 
To quiet that awful, awful cry. 
A farmer or a doctor was the way for me 
But I thought medicine more challenging. 
I breezed through college science and some math. 
Then took the MCATs and did well on them, 
Sent out my application to the schools I liked 
And got accepted at my second choice. 
I borrowed from my dad and from the bank. 
To pay tuition and to house and feed myself 
Took nineteen thousand dollars my first year. 
My freshman year was really culture shock. 
The facts of science hit me like a swarm of bees. 
Cell biology, biophysics, biochemistry. 
The threads of neuroscience, immunology 
And the marvelous checks and balances maintained 
By molecules complex beyond belief. 
I was lost in wonder at the miracles 
Of human reproduction, growth and life. 
In that same year, I met a classmate 
Whose views on life and human needs were much like mine, 
And we were married in our second year. 
The clinical years posed a problem I have not resolved: 
How to put that wonderful science I had learned 
In service to the people of the world. 
I saw that pharmacology 
Had placed a mighty arsenal of drugs 
In service to us, even though some side effects 
Must keep the patient and the doctor ever watchful. 
But how did my knowledge of glucose metabolism 
Provide calories to starving Africans? 
How did my knowledge of the hypothalamus 
Keep teenagers away from drugs and cigarettes? 
I still don't have the answers. 
\n- ither thing I really didn’t like 
\h< ut the growing reliance on technology 
Was that it even further cut 
Communication of patient with the doc. 
The patients sometimes went 
From complaint to CATSCAN 
Without a history or examination in between. 
Graduation was remarkable for me. 
But in my cap and gown no one could see 
That I was six months pregnant, full of joy. 
1 don't know how we made it through our first parental year. 
My husband and my baby and myself. 
Bottles, diapers, au pairs and an endless need to sleep 
Are things that stay the strongest on my mind. 
And then, most marvelous of days, first laugh. 
First crawl, first word and then first walk. 
In Africa and in my infant son 
Were linked the greatest human needs I could perceive. 
I couldn't feed the hungry of the world, 
But if I practiced pediatrics well. 
I'd maximize life chances for a lot of kids. 
Well, maybe that’s a little grandiose. 
I'll do the best I can. 
By the time we'd finished residencies 
My husband and I owed eighty-five thousand dollars. 
We had to start in earning right away. 
We joined an HMO and liked it there. 
The need was great. There was so much to do. 
Each of us saw about two dozen kids per day 
Both sick and well, with problems great and small. 
To me the most wonderful thing in the world 
Is a really happy baby. 
To hear the contented babbling of a child 
Is as close to heaven as I expect to get. 
Today’s my birthday. I am thirty-five 
And full of questions still: 
Do we want another child? 
To send another child into the world, 
A world encased in filth. 
Is not a choice that I can lightly make. 
We spend our billions on nuclear bombs 
When for a tiny fraction of the cost 
We could make hunger disappear. 
But what can I do about this insanity? 
Shall I go to work for WHO? 
Write letters to my congressman 
And add them to the ocean of his mail. 
Or take, perhaps, the plunge. 
And challenge him for office? 
What can 1 do to bring the wisdom 
Of our science to serve the people of a world 
Beset by war and hunger, blind leaders, 
Old men with money in their eyes, 
Preoccupied with looking tough and resolute 
And carefully avoiding all the time 
The screams of hungry babies, broken lives? 
YM 
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LOOKING BACK AT TOMORROW 
by Gregory R. Huth 
In an era of laser surgery and submicroscopic research, some 
may view the history of medicine as anachronistic. Those who 
do, however, ought to glimpse at the calendar of Dr. David 
Musto, a professor who shares an appointment between the 
Child Study Center and the history of medicine. 
When The New York Times needed an authority to 
comment on waning drug use among the middle class, they 
called on Dr. Musto, author of the landmark book The 
American Disease. A short time later, nationally syndicated 
journalist William Raspberry interviewed him and dedicated 
an entire column to Dr. Musto’s research into cocaine use in 
tum-of-the-century Washington, D.C. 
About the same time ABC’s “Nightline” and CBS’s 
“Sunday Morning” approached the physician/historian to lend 
some perspective to the debate over providing clean needles 
to addicts, and comment on proposals to legalize street drugs. 
More recently. Dr. Musto was appointed as historical 
consultant to the presidential AIDS commission. 
Although Dr. Musto’s area of interest makes him one the 
most publicly visible faculty members at the School of 
Medicine, he is but one of several scholars affiliated with the 
history of medicine section who are producing volumes of 
fascinating, useful—and sometimes disturbing—research. 
These scholars also teach some of the most popular courses at 
the School of Medicine. 
“It is both fitting and necessary that as a leader in scientific 
and medical research, Yale should also teach the background 
from which these disciplines have sprung,” observes Joseph 
S. Fruton, Ph.D. Fruton, the Eugene Higgins Professor 
Emeritus of Biochemistry, is the author of Molecules and 
Life. This history of biochemistry earned him the coveted 
Pfizer Prize of the History of Science Society in 1973. 
The scholarship of section chairman Frederic L. Holmes, 
Ph.D, the Avalon Professor of the History of Medicine and 
Biology, illustrates the respect the section has earned in both 
the history of science and of medicine. Holmes' book Claude 
Bernard and Animal Chemistry earned him the Pfizer Prize in 
1975. Then, three years later, the same book won the William 
H. Welch Medal of the American Association for the History 
of Medicine. 
Professor Holmes sees the section’s dual emphasis on 
science and medicine as characteristic of the School of 
Medicine: “Although the history of science emerged as a 
distinct subspecialty about 25 years ago, at Yale you can't 
draw a line where this discipline leaves off and the history of 
medicine begins. This reflects the character of a medical 
school where basic research goes hand-in-hand with clinical 
care.” 
Students from the medical school and throughout the 
university have affirmed the quality of the section’s 
scholarship by their enthusiastic response to its classes. 
Moreover, as many as 20 students carry this enthusiasm 
outside the classroom by joining the Nathan Smith Club, 
where they deliver papers in the history of medicine at 
monthly meetings. And every year several students turn to the 
section for advisors when they pursue an M.D. thesis in the 
field of medical history. 
Gregory R. Huth is publications editor at the School of 
Medicine’s Office of Public Informtion. 
BILL CARTER 
Frederic Holmes, history of medicine chairman, flanked by the section's other primary faculty members, Arthur Viseltear (left) and John Warner. 
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This year, the Class of 1988 paid one of its highest honors 
to Arthur Viseltear, Ph.D., associate professor of the 
history of medicine and public health, by voting him co¬ 
recipient of the Francis Gilman Blake Award for 
distinguished teaching. Viseltear’s courses range from the 
introductory “History of Medicine” to "The Physician in 
Modem Society" and "Government and Health Policy." 
Arthur Viseltear and Thomas R. Forbes, Ph.D., the 
Ebenezer K. Hunt Professor Emeritus of Anatomy and an 
expert in the history of forensic medicine, are traditionally 
invited to offer their reflections on the Hippocratic Oath and 
Prayer of Maimonides that are delivered to fourth-year 
students on graduation day at a private ceremony. 
Phis early morning ritual evokes Viseltear’s 1981 medical 
school commencement address, “Looking Back at 
Tomorrow,” in which he challenged his audience to pursue 
history "to see if we can determine what we might choose to 
remember, what we might wish to preserve, and what needs 
to be reevaluated.” 
A DELICATE BALANCE 
The contrasting styles Dr. Musto and the other section 
members—the one appealing to a wide, general audience, the 
other to the academy—illustrate a duality in the section that 
its chairman strives to keep in balance. Observes Professor 
Holmes, "We always walk a tightrope between the practical 
and the academic. The work of Dr. Musto has a high public 
profile because it shows how the history of medicine provides 
a broader perspective on one of today’s most serious public 
health problems. At the same time, section members also 
pursue important historical issues that may be of less interest 
to the public.” 
II hues interviews Sir Hans Adolph Krebs in 1978. The 
ixsician died in 1981. 
Professor Holmes sees a parallel with this situation in 
research medicine. “Scientists are pleased, of course, when 
their research turns out to have a clinical application. At the 
same time, this does not discourage them from carrying out 
the basic research that adds to our general body of 
knowledge.” 
The duality between the practical and the academic even 
shows itself in the careers of individual section faculty 
members. Arthur Viseltear, for example, spent two years in 
the late 1970s in Washington, D.C., as a Robert Wood 
Johnson Health Policy Fellow assigned to the Institute of 
Medicine and to Senator Edward M. Kennedy’s health 
subcommittee. 
While he still teaches courses in national health policy, 
Viseltear has focused his latest research efforts on 20th- 
century history. He has established at Yale a major archive, 
“The Contemporary Medical Care and Health Policy 
Collection," that contains the papers of more than 40 health 
policy statesmen and institutions. 
One of those statesmen is C.-E.A. Winslow. Associate 
Professor Viseltear is currently preparing a biography of this 
20th-century Yale legend, who is widely regarded as the 
"father of modern public health.” 
Another recent Viseltear study documents the rise and fall 
of a bold educational experiment that the School of Medicine 
began in 1928, the Institute of Human Relations (IHR). This 
program, designed to make the school “civically 
constructive," brought under one roof varied resources made 
available by the divinity, law and nursing schools and the 
departments of economics, political science and sociology. 
IHR was discontinued in the early 1950s, the victim of a 
philosophical shift at the school in which medicine was 
viewed as a discipline distinct from the social sciences. 
Why Viseltear’s focus on Yale? 
Replies the historian, "By examining the particular, in this 
case Yale, I hope to reveal the universal with respect to 
contemporary medicine and medical education.” 
THE SWEAT OF GENIUS 
Section chairman Frederic L. Holmes throws light on the 
universal in another historical field—the development of 
research. His work documents the methods of leading 
scientists whose research spans three centuries, beginning in 
the late 1700s. Professor Holmes’ scholarship helps us 
appreciate how much hard work medical researchers over the 
centuries have put into pursuing answers to the human body’s 
most difficult puzzles. 
"There’s a stereotyped view of creative scientists, where 
discovery occurs due to a kind of ‘eureka effect' 
characterized by a flash of insight,” Professor Holmes 
observes. While he does not downplay the importance of such 
experiences. Holmes points out that they almost always 
culminate years of difficult, frustrating research. 
Professor Holmes’ 1985 book. Lavoisier and the 
Chemistry of Life: An Exploration of Scientific Creativity, 
highlights the career of one of the late 18th century’s greatest 
medical researchers. Antoine Lavoisier not only discovered 
oxygen but also suggested its role in releasing energy in the 
human body. 
Professor Holmes award-winning work, Claude Bernard 
and Animal Chemistry, chronicles the career of the scientist 
who was first to explain the glycogen function of the liver 
and other important organ processes. The French physician’s 
continued on page 18 
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A Brief History of the Section A Beaumont Medical Club Member's Coup 
Although the section of the history of medicine was 
established only in 1979, it has deep roots in School of 
Medicine tradition. Since the 1920s, for example, the 
Beaumont Medical Club, established by medical school 
faculty members, has served as a focal point for the study and 
appreciation of medical history. 
Moreover, for the last 30 years, beginning with Dr. Samuel 
Clarke Harvey, members of the department of surgery have 
sponsored annual lectures in the history of medicine. And 
medical students have long expressed their interest in the 
subject through the Nathan Smith Club, where they present 
historical papers at monthly meetings. 
A distinguished neurophysiologist during the 1930s, ’40s 
and ’50s, Dr. John F. Fulton was a major influence in 
promoting interest in the history of medicine at Yale. One of 
the driving forces behind the Medical Historical Library and 
its outstanding collection of old and rare medical works, in 
1951 Fulton also worked with the School of Medicine to 
establish a department of the history of medicine, and served 
as its first chairman until his death in 1960. 
That same year, with the addition of Professor Derek Price, 
the department was expanded—to encompass the history of 
science and medicine—and was jointly administered by the 
medical school and the faculty of arts and sciences. During 
this decade, the department grew to a peak of seven members, 
and developed a highly successful Ph.D. program. Among the 
graduate students who obtained their degrees in those years 
are leading scholars and teachers of history of science and 
medicine today. 
During the financially pressured years of the early 1970s, 
however, the university disbanded the department. A number 
of medical school faculty members, concerned to preserve the 
long tradition of teaching and scholarship in the discipline, 
persuaded then Dean Robert W. Berliner to establish an 
autonomous Section of the History of Medicine with two 
tenured faculty positions. 
In 1979, Frederic L. Holmes, Ph.D., was appointed 
professor of the history of medicine, and Arthur J. Viseltear, 
Ph.D., M.P.H., associate professor of the history of medicine 
and public health. Together they constituted the new section 
of history of medicine, housed in John Fulton's old offices in 
the historical library. 
In 1984 the section obtained approval from the Graduate 
School of Arts and Sciences to initiate a Ph.D. program in the 
history of medicine and life sciences, and Dean Leon E. 
Rosenberg supported the creation of a third, non-tenured, 
faculty position to help carry out this expanded activity. In 
1986 John Harley Warner, Ph.D., was appointed assistant 
professor of the history of medicine. 
Currently, two Ph.D. students are pursuing their degrees at 
the section, with another two first-year Ph.D students and a 
transfer student arriving in the fall. 
In addition to its medical and graduate school 
responsibilities, the section offers Yale College courses in the 
history of medicine and of the life sciences. 
Frederic L. Holmes, Ph.D. 
Though most of the 50 or so members of the Beaumont 
Medical Club content themselves to attend monthly lectures 
that keep them abreast of the latest issues and controversies 
in the field, others engage history as an avocation. Some, in 
fact, pursue their interest by writing scholarly articles and 
books. 
One such devotee is former club president Dr. Sherwin B. 
Nuland, '55, an associate clinical professor in surgery and 
full-time private surgeon in New Haven. His recently 
published book. Doctors, has been selected as a Book-of-the- 
Month Club alternate and Paperback Book Club main 
selection. The book traces the history of physicians who 
changed the course of medicine from the time of Hippocrates 
to the present. 
Dr. Nuland, a 20-year member of the Beaumont Club, 
credits the group with nurturing his interest in the history of 
medicine. “The fellowship and intellectual camaraderie of the 
Beaumont Club has been one of the major influences in my 
historical studies.” He adds with a smile, “Participating in the 
club is something like playing baseball in the old semi-pro 
leagues. It brings professionals and talented amateurs 
together to produce a top-quality product.” 
Yale Student's History Paper 
Wins National Recognition 
Francis M. Lobo: 
Osier Medal 
winner 
Yale medical students as well as faculty have won distinction 
in the history of medicine. Francis M. Lobo, ’91, was 
awarded the 1988 William Osier Medal from the American 
Association for the History of Medicine for his essay, "John 
Haygarth, Smallpox and Religious Dissent in 18th-Century 
England.” The award is given for the best unpublished essay 
written by a medical student in the history of medicine. 
Mr. Lobo, a 1985 graduate of the University of 
Pennsylvania, wrote the paper while attending the Wellcome 
Unit of the History of Medicine at the University of 
Cambridge. In conjunction with the prize, he was flown to 
New Orleans in May to present his essay at the association’s 
annual meeting. His paper will be considered for publication 
in the Bulletin of the History of Medicine. 
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continued from page 16 
ntific approach to the human body allowed him to 
establish physiology as an experimental field in the mid-18th 
century. 
In recent months, Professor Holmes has completed a book 
about the pioneering work of Nobel laureate Sir Hans Adolph 
Krebs. During the early part of this century, Krebs, a German 
physician who emigrated to England, identified some of the 
processes of intermediary metabolism. The metabolic cycles 
he discovered, one of which is generally known as the "Krebs 
cycle,” explain such important mechanisms as the pathway 
through which the body oxidizes food and synthesizes urea. 
Is there any common thread running through the careers of 
these great scientists? Professor Holmes believes so: a 
carefully reasoned, logical inquiry into the human organism. 
"We tend to think of medicine as ascending out of an age ot 
ignorance over the last three centuries. But in fact, at a 
fundamental level modern medical research has more in 
common with its forebears than we might think," the historian 
concludes. 
Dr. Stanley W. Jackson says that his historical studies have 
led him to a similar view. A section member and professor of 
psychiatry, he also serves as acting executive director of the 
Yale Psychiatric Institute. His most recent book is 
Melancholia and Depression: From Hippocratic Times to 
Modern Times. 
To illustrate the sophistication of some medical 
investigators from the past. Dr. Jackson cites a monograph 
published by Dr. John Haygarth in the 1790s. Haygarth 
wanted to test the efficacy of instruments called metallic 
tractors. Doctors of the period routinely used these devices to 
"draw out” pain and inflammation by running them above the 
affected area. 
"Haygarth devised a classic controlled study,” notes Dr. 
Jackson. “For half his patients, the experimental group, he 
used metallic tractors for therapy. For the other half, the 
controls, he used wooden tractors painted to look like metal. 
The results of the groups were identical.” This experiment 
disproved the effectiveness of metallic tractors. 
DISQUIETING LESSONS 
John H. Warner, Ph.D., an assistant professor in the section, 
studies the role that medical practice plays in 19th-century 
culture. He believes that the mirror of history also reminds 
today's practitioners to keep their own theories and practices 
in perspective. Warner’s research into the treatments delivered 
by hospital physicians in the mid-1800s shows that theraputic 
practices can take on special significance when the profession 
finds itself under attack and threatened economically, as it 
does today. 
A Warner study entitled "Power and Identity in American 
Medicine” focuses on doctors practicing at Commercial 
Hospital in Cincinnati. The scholar’s review of hospital 
records show that the once standard use of “heroic depletive 
therapeutics"—bleeding patients heavily, or purging them with 
powerful laxatives or emetics—was in steady decline among 
American doctors during the mid-1800s. Curiously, however, 
i 10-year period these practices enjoyed a marked 
’ ice among Commercial Hospital’s physicians. 
The Yule Medical Historical Library, opened in 1941, 
. r 90.000 books and manuscripts dating back to the 
one of the most important resources of its kind in the 
Why this peculiar pattern in Cincinnati? Warner discovered 
that the city had become a stronghold of alternative medicine, 
with practitioners of eclectic, homeopathic and physiobotanic 
healing winning away many patients from orthodox 
physicians. Complained one doctor to a lay friend in an 1851 
letter, “even the longest established and most estimable 
physicians have yielded large and lucrative portions of their 
practice to homeopathy, & etc....” 
Warner’s interpretation of these developments: “The 
revival of heroic depletion...was one device that regular 
physicians used to cope with an erosion of their professional 
power and control that could, they feared, lead to collapse." 
In other words, the historian suggests that the Commercial 
Hospital doctors used dramatic, highly visible depleting 
“therapies” as a kind of symbol of orthodoxy that affirmed 
their identity as the only bona fide healers in the community. 
Lest the modern observer shrug off the doctors’ behavior as 
that of an isolated group of hysterical practitioners, the 
historian raises the disturbing possibility of a parallel with the 
present. 
Warner thinks that today’s physicians should consider 
whether the increasing use of some heroic, high-technology 
procedures—such as heart transplants—might not represent 
another symbolic crusade of a profession that finds itself 
challenged on many fronts. Taking the traditional historian’s 
stance, he does not presume to answer this question, but rather 
raises an important issue for examination and debate. 
John Warner’s scholarship affirms what Dr. Stanley 
Jackson terms a “central lesson” of the history of medicine. 
“Historical scholarship does more than give us respect for the 
past. It humbles us. It makes us realize that we had better not 
be too certain or overconfident.” 
Dr. Jackson concludes, “Many of today’s medical findings 
will hold up, but we need to be reminded that some will 
change.” YM 
BILL CARTER 
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GALLERY 
Metallic-Tractors 
by James Gillray (British, 1757-1815) 
COURTESY YALE MEDICAL HISTORICAL LIBRARY 
In James Gillray’s “Metallic-Tractors,” the patient 
recoils from the tractors being applied by a 
disinterested operator. The popular print does not 
appear to be an advertisement for this form of therapy. 
It was secretly commissioned, however, by Benjamin 
Perkins, proprietor of the tractors in London, who 
apparently considered a print by London’s foremost 
caricaturist to be a powerful advertising medium. 
Perkins commissioned the print at a time when the 
efficacy of the tractors was being questioned and when 
his business was being threatened by adverse publicity. 
Metallic tractors, invented by Dr. Elisha Perkins, a 
prominent Connecticut surgeon, were a popular 
therapy at the turn of the 19th century. In published 
testimonials, the metal rods were claimed to effect 
cures of epilepsy, gout, rheumatism, bums, and more. 
when drawn across the afflicted area. The tractors were 
introduced in London by the inventor’s son, Benjamin 
Perkins, in 1795, shortly after his graduation from 
Yale. The claims for the tractors and their popularity 
prompted John Haygarth, a physician at Bath, to 
conduct a controlled therapeutic trial. A pair of 
wooden tractors, painted to look like the metallic 
tractors, were applied alternately with those of Perkins 
in five cases of rheumatism and found to have equal 
effects. The results were published in 1800 in a 
pamphlet “Of the Imagination, as a Cause and as a 
Cure of Disorders of the Body; Exemplified by 
Fictitious Tractors and Epidemical Convulsions.” The 
pamphlet was reprinted in 1801, the date of Gillray's 
print. 
—Susan Wheeler 
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HERE AND ABOUT 
Two Appointed to 
National Commission 
Dr. Donald J. Cohen, director of the Yale 
Child Study Center, and Irving B. Harris, 
a Chicago businessman and child advo¬ 
cate who is an associate of the Child 
Study Center, have been selected to serve 
on the newly created National Commis¬ 
sion on Children. 
The 36-member commission includes 
individuals who provide services, activi¬ 
ties or research for children, public offi¬ 
cials, and parents or representatives of 
parent organizations. 
The President. U.S. House of Repre¬ 
sentatives and the U.S. Senate each 
appoint 12 members. Dr. Cohen, also the 
Irving B. Harris Professor of Child Psy¬ 
chiatry and professor of pediatrics, psychi¬ 
atry and psychology, was appointed by the 
House, while Harris, a 1931 Yale College 
graduate and benefactor of the endowed 
professorship that bears his name, was 
named by the Senate. 
The commission will serve as a forum 
on behalf of children, conducting public 
hearings on their status and on ways to 
safeguard and enhance their physical, 
mental and emotional well-being. It also 
will make recommendations on child 
health, and social and support services for 
children and their parents. The commis¬ 
sion is scheduled to report next March. 
Among the issues the commission will 
address: reducing infant mortality and the 
number of low-birth-weight babies, 
improving child nutrition, preventing and 
treating child neglect and abuse, encour¬ 
aging academic excellence among chil¬ 
dren and reducing poverty. 
The commission also has been charged 
to identify how the public and private sec¬ 
tors can work together to identify defi¬ 
ciencies in local family support services 
and to develop recommendations for 
meeting the needs of families and children 
in a coordinated way. 
Postage Stamp Honors 
Dr. Harvey Cushing 
The U.S. Postal Service released a 45-cent 
stamp honoring Dr. Harvey W. Cushing, 
the lather of neurosurgery. The stamp, one 
of the Great Americans series, was issued 
June 17 in Cleveland, Ohio, Dr. Cushing’s 
birthplace. 
Noted artist Bradbury Thompson based 
e design for the stamp on a charcoal por¬ 
trait ol Dr. Cushing by John Singer Sar¬ 
gent. which hangs in the Yale University 
Art Gallery. 
Dr. Cushing was an American surgeon, 
author and artist who laid the foundation 
for the field of brain surgery. Bom in 
Cleveland in 1869, he received his B.A. 
degree at Yale in 1891 and M.D. degree at 
Harvard in 1895. He studied under noted 
American surgeon W.S. Halsted for four 
years at Johns Hopkins, followed by a 
year in Europe under Swiss surgeon 
Theodor Kocher. 
Dr. Cushing returned to Johns Hopkins 
in 1901. He remained there until he 
became surgeon-in-chief at Peter Brent 
Brigham Hospital in Boston in 1912 and 
Mosely Professor of Surgery at Harvard 
Medical School. After retiring in 1932, he 
served as neurologist and medical histori¬ 
an at Yale. Before his death in 1939, he 
and two colleagues established the Yale 
Medical Library. 
As an innovator who had a command¬ 
ing influence on the progress of medicine 
and surgery throughout the world, Dr. 
Cushing was one of the first in the United 
States to use x-rays and the first to rou¬ 
tinely take blood pressure readings during 
operations and in general practice. He also 
developed the use of electric cautery in 
brain surgery. 
Dr. Cushing was among the first to 
operate on the pituitary gland, describing 
a condition which now is know as “Cush¬ 
ing’s syndrome," and contributing to the 
overall understanding of the gland. He 
also made many laboratory studies of the 
nervous system. 
However, his most notable achieve¬ 
ments were in the development of many 
of the techniques and procedures for 
surgery of the brain and spinal cord that 
still are fundamental to the field of neuro¬ 
surgery. His work has been credited with 
reducing the mortality rate in brain opera¬ 
tions from nearly 100 percent to less than 
10 percent. 
In addition to his surgical skills, he 
won a Pulitzer Prize for his book. Life of 
Sir William Osier, in 1926. His talent as 
an artist is evident in his illustrations that 
describe his medical work and enhance his 
travel diaries. Dr. Cushing also took 
strong positions on better hospital and 
classroom training for medical students. 
Paul Newman Receives 
Honorary Degree 
Actor, director and philanthropist Paul 
Newman was among the nine individuals 
who received honorary degrees at the Yale 
University commencement on May 30. 
Mr. Newman was awarded the degree of 
Doctor of Humane Letters for his service 
to others. 
Paul Newman's Hole in the Wall Gang 
Camp for children with life-threatening 
diseases opened June 26. The camp ses¬ 
sions, which will run through Aug. 18, 
will offer seriously ill boys and girls, age 
seven to 17, a camping experience as 
close as possible to that which is available 
to healthy youngsters. The 300-acre camp, 
built on the town boundaries of Ashford 
and Eastford, Conn., was designed to 
resemble the Old West, with log cabins, a 
corral filled with animals and an old-fash¬ 
ioned music hall. 
Children will attend the camp free of 
charge. Half of the budget supporting the 
camp comes from Mr. Newman's food 
companies. The Internal Revenue Service 
required that the other half be from private 
and corporate donors. 
Yale-New Haven Hospital is providing 
administrative direction, medical and 
nursing staff support and other services. 
Dr. Howard A. Pearson, former chairman 
of the department of pediatrics in the med¬ 
ical school and former chief of pediatrics 
for the hospital, provides medical supervi¬ 
sion at the new camp. At the camp’s June 
dedication, it was announced that the 
camp pond was being named Pearson 
Pond, in honor of Dr. Pearson. 
Also providing services to the camp 
will be specialists in pediatric hematology 
from the University of Connecticut, 
Brown University School of Medicine, 
Baystate Medical Center in Springfield. 
Mass., and the University of Mas¬ 
sachusetts School of Medicine. 
MICHAEL MARSLANI) 
Paul Newman 
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Class of 1988 Residency Placements 
CALIFORNIA 
Cedars-Sinai Medical Center, Los Angeles 
Lisa Matzer, internal medicine 
Harbor-LCLA Medical Center, Torrance 
Martin Chenevert, emergency medicine 
Mercy Hospital, San Diego 
Mitchell Sklar, transitional 
Stanford University Hospital, Palo Alto 
Dean Kedes, internal medicine 
Mitchell Sklar, diagnostic radiology 
Hedayatollah Zaghi, internal medicine 
UCLA Medical Center, Los Angeles 
E. Ted Parks, orthopaedic surgery 
UCLA Neuropsychiatric Institute, Los Angeles 
Steven Dobscha, psychiatry 
Joshua Freedman, psychiatry 
University of California, San Francisco 
John Belzer, orthopaedic surgery 
Allen Bowling, internal medicine!neurology 
David Chelmow, obstetrics and gynecology 
Jonathan Friedes, obstetrics and gynecology 
Linda Hudak, psychiatry 
Richard Jenkins, medicine-primary 
CONNECTICUT 
Hospital of St. Raphael, New Haven 
Cynthia DeAngelis, transitional 
Thomas Handler, transitional 
Peggy Liao, medicine-preliminary 
Pedro Miro, medicine-preliminary 
Susanna Park, medicine-preliminary 
Norwalk Hospital, Norwalk 
Frederick Long, medicine-preliminary 
Waterbury Hospital Health Center, Waterbury 
Francis Cutruzzola, medicine-preliminary 
Geraldine Ruffa, medicine-preliminary 
Yale-New Haven Hospital, New Haven 
Sibel Akyol, psychiatry 
Stephen Bowers, medicine-preliminary 
Martha Brochin, pediatrics 
Robert Brown, orthopaedic surgery 
Cynthia DeAngelis, ophthalmology 
Charisse Deutch, medicine-preliminary 
Kenneth Easterling, orthopaedic surgery 
Thomas Handler, diagnostic radiology 
Carla Jones, obstetrics and gynecology 
Rhonda Karol, medicine-preliminary 
Robert Kim, internal medicine 
David Klimstra, pathology 
Peggy Liao, ophthalmology 
Elizabeth Murphy, general surgery 
Autry Parker, transitional 
Michael Rigsby, internal medicine 
Geraldine Ruffa, neurology 
Susan Valley, medicine-preliminarylanesthesiology 
Leslie Weinstein, surgery-preliminary/otolaryngology 
Terry Yee, surgery-preliminary/urology 
DISTRICT OF COLUMBIA 
Children's Hospital National Medical Center 
Carol Miller, pediatrics 
Washington Hospital Center 
Daniel Schwarz, surgery-preliminary 
FLORIDA 
Jackson Memorial Hospital, Miami 
Gregory Brown, internal medicine 
Odett Stanley-Brown, pediatrics 
ILLINOIS 
Children's Memorial Hospital, Chicago 
Cristina Bengoa, pediatrics 
Irene Freeman, pediatrics 
Illinois Masonic Medical Center, Chicago 
Michael Mockovak, transitional 
Michael Reese Hospital, Chicago 
Walter Stadler, internal medicine 
University of Chicago Medical Center, Chicago 
Stephen Bowers, emergency medicine 
Lisa Conrad, internal medicine 
Robin Komegay, pediatrics 
Andres Rodriguez, internal medicine 
University of Illinois, Chicago 
Michael Mockovak, ophthalmology 
LOUISIANA 
Tulane University School of Medicine, New Orleans 
Elizabeth Mannick, pediatrics 
MARYLAND 
Francis Scott Key Medical Center, Baltimore 
M. Kathleen Carney, internal medicine 
Johns Hopkins Hospital, Baltimore 
Kenneth Andreoni, general surgery 
Geraldine Mogavero, diagnostic radiology 
Eva Simmons, internal medicine 
MASSACHUSETTS 
Beth Israel Hospital, Boston 
David Ives, internal medicine 
Ellen Weinstein, medicine-preliminary 
1988 National Match Results 
The results of the 1988 National Resident Matching Program were 
announced March 23. Of 19,513 positions offered this year, 16,119 
were filled. U.S. graduates were matched into 13,496 of these; the 
balance were filled by foreign medical graduates, U.S. physicians 
who had graduated in previous years and osteopathic physicians. 
Within the primary care specialities, fewer U.S. students matched 
into family practice programs than in any previous year of this 
decade. Only 1,494 positions were filled, a 16 percent decrease in 
U.S. graduates entering family practice as compared to 1987. There 
were 3 percent fewer U.S. graduates entering categorical programs in 
internal medicine than in 1987, but the percentage in primary care 
internal medicine programs increased by 17 percent, from 173 to 
209. Pediatric positions filled by U.S. graduates decreased by only 
53. The number of U.S. graduates entering Ob/Gyn programs 
increased from 828 to 903. 
—The Association of American Medical Colleges 
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Boston University School of Medicine, Boston 
Carlton Bamswell, general surgery 
Donna Richman, internal medicine 
Brigham and Women's Hospital, Boston 
Lenore Soodak, obstetrics and gynecology 
Pradeep Varma, diagnostic radiology 
Massachusetts Eve and Ear Hospital, Boston 
Susanna Park, ophthalmology 
McLean Hospital, McLean 
Leslie Jacobsen, psychiatry 
New England Deaconess Hospital, Boston 
Michael Mahig, internal medicine 
Tufts/New England Medical Center, Boston 
Jonathan Borden, general surgery!neurosurgery 
MISSOURI 
Barnes Hospital, St. Louis 
Kelle Moley, obstetrics and gynecology 
NEW YORK 
Beth Israel Medical Center, New York City 
Pradeep Varma, medicine-preliminary 
Cornell University/New York Hospital, New York City 
Charisse Deutch, neurology 
PENNSYLVANIA 
Abington Memorial Hospital, Abington 
Geraldine Mogavero, medicine-preliminary 
Hospital of the University of Pennsylvania, Philadelphia 
Laura Dember, internal medicine 
Robert Dorns, pathology 
Amy Justice, internal medicine 
Joseph King, neurosurgery 
Peter Merkel, internal medicine 
Temple University, Philadelphia 
Joi Barrett, internal medicine 
WASHINGTON 
Group Health Cooperative of Puget Sound, Seattle 
David Cowan, family practice 
University of Washington Affiliated Hospital, Seattle 
David Galbraith, surgery-preliminary 
Janice Janas, otolaryngology 
John Nienow, medicine-primary 
Henry Rice, general surgery 
WISCONSIN 
Medical College of Wisconsin, Milwaukee 
Pedro Miro, diagnostic radiology 
Frederick Long, medicine-preliminary 
Mary Imogene Bassett Hospital, Cooperstown 
Laura Kuckes, transitional 
Montefiore/Einstein Affiliated Hospitals, Bronx 
Leslie Jacobsen, pediatrics 
Mount Sinai Hospital, New York City 
Larry Amsel, psychiatry 
Vivian Orey, pediatrics 
Michael Rothschild, surgery-preliminary!otolaryngology 
The New York Hospital, New York City 
Amy Bloch, psychiatry 
Nicole Davis, obstetrics and gynecology 
Jose Dizon, internal medicine 
Laura Kuckes, psychiatry 
Robert Root, psychiatry 
Lisa Straus, general surgery 
New York University Medical Center, New York City 
Leigh Hutchinson, internal medicine 
Frederick Lang, surgery-preliminary! neurosurgery 
Presbyterian Hospital, New York City 
Francis Cutruzzola, diagnostic radiology 
Lance Markbreiter, orthopaedic surgery 
Steven Slovic, general surgery 
Linda Washington, internal medicine 
Strong Memorial Hospital, Rochester 
Edgar Blair, internal medicine 
Brent Tatum, internal medicine 
NEW HAMPSHIRE 
Dartmouth-Hitchcock Medical Center, Hanover 
Timothy James, general surgery 
NEW JERSEY 
UMDNJ-New Jersey Medical School, Newark 
Khristine Lindo, general surgery 
NORTH CAROLINA 
Duke University Medical Center, Durham 
K. Lisa Cairns, medicine-preliminary 
1 rederick Long, diagnostic radiology 
rth Carolina Memorial Hospital, Chapel Hill 
F I Miclau, orthopaedic surgery 
Yale School of Medicine 
Residency Applications 1983-1988 
1983 1984 1985 1986 1987 1988 
Total No. in Class 98 108 101 104 96 99 
Medicine (total) 45 47 43 50 50 40 
Medicine (3 year) 39 33 31 37 24 23 
Medicine (1 year) 6 8 12 13 16 17 
Surgery (total) 15 19 19 21 11 15 
Surgery (categorical) 10 10 13 15 7 8 
Surgery (1 year) 5 9 9 6 4 6 
Obstetrics/gynecology 3 9 11 4 0 6 
Pediatrics 8 8 10 7 8 8 
Pediatrics (1 year) 0 0 1 2 1 1 
Psychiatry 14 7 6 9 15 9 
Orthopaedic surgery 5 4 2 1 5 7 
Diagnostic radiology 4 6 6 3 2 7 
Ophthalmology 3 3 5 5 7 4 
ER medicine 1 1 1 0 3 2 
Ear, nose & throat 2 2 2 1 3 3 
Family practice 5 2 1 2 2 1 
Primary care 0 0 0 0 1 2 
Neurology 1 1 1 3 1 3 
Anesthesiology 1 1 0 3 4 1 
Neurosurgery 1 2 2 2 1 3 
Urology 0 2 0 0 1 1 
Pediatrics/medicine 0 0 1 0 1 0 
Occupational medicine 0 0 1 0 0 0 
Pediatric neurology 0 0 1 0 0 0 
Dermatology 0 0 1 0 0 3 
Transitional/flexible 5 2 4 4 3 6 
Radiation therapy 0 1 1 1 3 1 
Pathology 0 3 0 2 2 2 
Rehabilitation medicine 0 0 0 0 1 0 
Research, teaching 0 5 3 4 5 1 
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President Schmidt Visits 
Medical School Council 
Yale President Benno C. Schmidt Jr. pre¬ 
sented remarks to the Medical School 
Council on March 17. He outlined four 
trends that he saw as key to the School of 
Medicine's role in the University. 
• Inter-departmental and inter-school bar¬ 
riers are coming down. Students and 
researchers from various disciplines are 
working together more closely. The 
president said that the Center for Molec¬ 
ular Medicine will further encourage 
such collaboration. 
• The University is entering a period of 
extensive physical expansion and 
rebuilding. “I am entirely devoted to the 
tremendous building and renovation 
efforts that are ongoing at the School of 
Medicine,” President Schmidt com¬ 
mented. 
• Yale is involving itself more deeply in 
the cultural and economic development 
of New Haven. The University and the 
medical school have a keen interest in 
redevelopment projects such as Down¬ 
town South in the Hill neighborhood, 
and a possible biomedical research park 
along the Route 34 extension. 
• The University is increasingly stressing 
the historical roots and ethical responsi¬ 
bilities of the professional disciplines 
that it teaches. President Schmidt noted 
that the School of Medicine has a long 
tradition of emphasizing the social 
responsibility of medicine. 
Yale Journal Seeks 
Editors, Software 
The Yale Journal of Biology and 
Medicine has instituted a new category of 
member for its editorial board. In addition 
to student and faculty editors, the journal 
is now appointing a limited number of 
editors-at-large from among its former 
student editors. To qualify, candidates 
must apply to the editorial board and must 
recruit at least one paper per year that is 
accepted for publication in the journal. 
Appointments as editor-at-large are 
renewed annually. Reappointment 
depends on continuing activity by the can¬ 
didate. Suzanne Lande, managing editor 
of the journal, welcomes inquiries from 
alumni of the journal’s board. 
The increasing importance of comput¬ 
ers for scholarly and medical purposes has 
led The Yale Journal of Biology and 
Medicine to initiate a new section of soft¬ 
ware reviews. Programs may be submitted 
for review to The Yale Journal of Biology 
and Medicine, 333 Cedar St., New Haven, 
CT 06510. Reviewers are recruited from 
medical students and faculty, and they are 
entitled to keep the software after it has 
been reviewed. 
BILL CARTER 
Yale President Benno C. Schmidt Jr. flanked by Dr. John H. Seashore, president of the Medical School Council, and Dean Leon E Rosenberg 
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IN PROGRESS 
Dr. Black Promotes 
Heart Disease Prevention 
Dr. Henry R. Black, associate professor of 
medicine, has received a Preventive Car¬ 
diology Academic Award from the 
National Heart, Lung and Blood Institute 
of the National Institutes of Health. 
With the award, a five-year grant that 
began July 1, Dr. Black will develop a 
preventive cardiology program designed 
to focus medical school curriculum on 
emphasizing prevention of cardiovascular 
disease. 
According to Dr. Black, “cardiovascu¬ 
lar disease is the biggest killer in the Unit¬ 
ed States, and up to now most of our 
attention has been directed at treating peo¬ 
ple who already have cardiovascular dis¬ 
ease. 
"The success of treating hypertension 
has made it clear that preventive efforts 
pay off. If we have similar success in 
treating lipid disorders and getting people 
to stop or never to start smoking, we hope 
to reduce significantly the impact of car¬ 
diovascular disease.” 
Dr. Black says the National Heart, 
Lung and Blood Institute is committed to 
preventive cardiology education, and is 
providing awards to insure that medical 
students and house staff are familiar with 
developments in this rapidly expanding 
field. In addition to supplementing the 
current curriculum, which is directed 
toward treating in-patients with cardiovas¬ 
cular disease, the preventive cardiology 
program will foster interdisciplinary col¬ 
laboration among faculty and broaden 
training and research opportunities for 
medical students and house staff. 
Dr. Black has assembled a team of fac¬ 
ulty representing internal medicine, 
surgery, epidemiology and public health, 
psychology and psychiatry to work with 
him in designing and implementing the 
program. A nine-member preventive car¬ 
diology program advisory committee also 
has been established to review program 
materials and proposed curriculum 
changes. 
"The essence of the program is to pro¬ 
vide students with an expert's view on 
what they should know in preventive car¬ 
diology," says Dr. Black. The faculty will 
provide material in their area of expertise 
to students and house staff. Senior internal 
medicine house staff in their role as teach¬ 
ing residents will impart that knowledge 
to medical students during the students’ 
internal medicine clerkship. In this way, 
the program will also insure that internal 
medicine house staff are aware of current 
concepts in preventive cardiology. 
faculty will serve as advisers to stu¬ 
dents provide articles for a preventive 
ardioli>y\ newsletter to be edited by Dr. 
Dr. Henry R Black 
Black, help run a student journal club and 
suggest topics for theses. In collaboration 
with Dr. Perry Miller, associate professor 
of anesthesiology, computer-based expert 
systems for managing hypertension and 
lipid disorders will be further developed 
and improved. 
The preventive cardiology program 
faculty and their areas of expertise are: 
behavior modification and stress man¬ 
agement. Gary E. Schwartz, Ph.D., 
professor of psychology and psychia¬ 
try, and Lynda H. Powell, Ph.D., assis¬ 
tant professor of epidemiology; 
biostatistics and preventive medicine, Dr. 
James F. Jekel, the Charles E-A. 
Winslow Professor of Public Health; 
cardiovascular epidemiology, Dr. Adrian 
M. Ostfeld, the Anna M.R. Lauder 
Professor of Epidemiology and Public 
Health; 
diabetes and obesity. Dr. Robert S. Sher- 
win, professor of medicine; 
exercise, Dr. Frans Wackers, professor of 
diagnostic radiology and medicine; 
hypertension, Dr. Marvin Moser, clinical 
professor of medicine; 
lipids, Dr. Kenneth L. Cohen, associate 
professor of medicine; 
peripheral vascular disease and surgical 
aspects of preventive cardiology, Dr. 
Richard J. Gusberg, associate professor 
of surgery; 
smoking, Dr. Richard A. Matthay, profes¬ 
sor of medicine. 
Grant Furthers Research 
On Psychotropic Drugs 
A multidisciplinary team headed by Dr. 
George K. Aghajanian, professor of psy¬ 
chiatry and pharmacology, will expand its 
research into the neurophysiological and 
neurochemical factors in mental illness. 
The group hopes to develop more effec¬ 
tive and safer drugs to use in treating peo¬ 
ple with mental illness and in helping drug 
addicts cope with withdrawal. 
The research is being supported in part 
by a $500,000 unrestricted grant that the 
Bristol-Myers Company has awarded Yale 
University. The grant is one of five that 
the pharmaceutical company has made to 
universities this year. 
Dr. Aghajanian and his colleagues con¬ 
duct their research in the Abraham Ribi- 
coff Research Facilities at the Connecticut 
Mental Health Center, a collaborative 
effort of the University and the Connecti¬ 
cut Department of Mental Health. Their 
laboratory adjoins a clinical research unit, 
an arrangement that enables biomedical 
scientists and physicians to quickly apply 
basic scientific discovery to the clinical 
arena. 
Dr. Aghajanian, director of the biologi¬ 
cal research training program in psychia¬ 
try, describes his team’s research focus as 
"the possible biological bases of disorders 
from depression and schizophrenia to drug 
abuse." 
The research concentrates in three 
areas—the mechanisms of action of hallu¬ 
cinogenic drugs, opiate withdrawal and 
anti-depressant drugs. These processes 
involve the three major neurotransmitters- 
dopamine, norepinephrine and sero¬ 
tonin—that are believed to be involved in 
psychiatric disorders. Imbalances in these 
substances have been linked to such major 
psychiatric illnesses as anxiety, depression 
and schizophrenia. 
"The drugs we now have to use for the 
treatment of major psychiatric disorders 
were almost all discovered serendipitous- 
ly," Dr. Aghajanian says. "But we can use 
these drugs to identify the brain processes 
involved in the disorder. Then our 
research on the processes may reveal the 
mechanisms of the disease, and lead to the 
development of more specific drugs with 
fewer side effects." 
Researchers hope one day that bio¬ 
chemical testing techniques will be avail¬ 
able to use in the diagnosis or early 
detection of psychiatric illness. 
The Yale findings could lead to ways 
to make drugs more efficacious for some 
10 to 15 percent of Americans who at 
some time in their lives will suffer from 
serious depressive illnesses. 
Researchers are investigating new anti¬ 
psychotic agents which react to the sero- 
tonin-2 receptor—the same receptor site 
that hallucinogens interact with. Most 
anti-psychotic agents interact with the 
dopamine receptor and, with continued 
long-term use, can cause irreversible neu¬ 
rological dysfunction. 
Researchers also hope that studies of 
the way hallucinogens interact with the 
serotonin-2 receptor will lead to the devel¬ 
opment of anti-psychotic drugs with fewer 
toxic side effects. In addition, Dr. Aghaja- 
nian’s basic research on opiate receptors 
provides information from which clinical 
researchers hope to develop drugs to assist 
opiate and heroin addicts through 
withdrawal. 
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Medical Library Expands 
A $10.2 million construction project has 
begun that will increase the size of the 
medical library by nearly half. The 58,000 
square foot expansion, which includes 
room for offices and stacks, is scheduled 
to be completed by 1990. 
The library will be renamed the Harvey 
Cushing/John Hay Whitney Medical 
Library. 
Yale-Harvard Study 
Suggests Shyness Inborn 
A joint study by researchers at Yale and 
Harvard bolsters earlier evidence that 
some children are bom to be shy and that 
the tendency persists as they grow older. 
According to the study, between 10 and 15 
percent of all children are extremely shy, 
and many of them may be shy because 
their nervous systems react more vigor¬ 
ously to new situations and strangers. 
Shy children in the study responded to 
new situations with higher than average 
heart rates, blood pressure and muscle ten¬ 
sion as well as greater pupil dilation and 
higher levels of norepinephrine, a brain 
chemical produced during stress. Further¬ 
more, they tended to have higher heart 
rates even when sleeping, suggesting pos¬ 
sible inborn differences. 
The study, which is the first to link 
physiological factors to shy behavior in 
children, followed Boston-area children 
between the ages of 1 1/2 and 7 1/2 and 
compared them to children who were 
extremely outgoing. Although a few of the 
older children appeared to outgrow their 
shyness, most still hesitated before joining 
in play sessions with unfamiliar children. 
About 400 children were evaluated for the 
study published April 8 in the journal 
Science. 
"We would tell parents who want to 
change their shy child’s behavior that their 
efforts are perhaps better spent helping the 
child adapt to shyness,” says T Steven 
Reznick, assistant professor of psychology 
at Yale, who was joined in the research by 
Harvard psychologists Jerome Kagan and 
Nancy Snidman. "While shy children may 
never become the life of the party, with 
their parents’ help they can learn to enjoy 
the party." 
Yale Prof Fuels Pilot 
Of Daedelus Flight 
On April 23, when Kanellos Kanellopou- 
los plunged into the Aegean Sea 30 feet off 
Santorini island, he had MIT to thank for 
the Daedelus, the ultralight aircraft that 
allowed him to pedal there from Crete. 
And he had a Yale professor to thank for 
the drink that fueled him—and cooled 
him—in his record setting human-powered 
tlight. 
Ethan R. Nadel, Ph.D., professor of 
epidemiology (environmental health) and 
physiology, and a fellow at the John B. 
Pierce Foundation Laboratory, developed a 
drink for the four-hour, 74-mile Daedelus 
Bight that provided both cooling and calo¬ 
ries by employing a glucose molecule that 
passes through the stomach lining to the 
blood stream without digestion. 
Kannelopoulos, the Greek national 
bicycling champion, sipped the liquid dur¬ 
ing the course of his flight, that more than 
tripled the distance record for straight-line 
human-powered flight set by Bryan Allen 
on June 12, 1979. On that date, Allen 
piloted the Gossamer Albatross across the 
English Channel. 
The flight of the Daedelus—35 centuries after its mythical namesake. 
Bristol-Myers Increases 
Cancer Center Support 
A $3 million, five-year research agree¬ 
ment to develop anticancer drugs has been 
announced between Bristol-Myers Co. 
and the Yale Comprehensive Cancer Cen¬ 
ter (YCCC). 
The collaboration will continue a suc¬ 
cessful partnership between Bristol- 
Myers, the world’s largest researcher and 
developer of anticancer drugs, and YCCC, 
one of the few institutions where scientists 
involved in researching such drugs work 
together from the first laboratory experi¬ 
ments through clinical trials among 
patients. 
Previous agreements between Bristol- 
Myers and the center date back to 1977. 
when the company granted $500,000 over 
five years. A subsequent six-year grant 
provided $3 million for six years. These 
funds helped the center play a leading role 
in developing several important anticancer 
drugs, notes Alan C. Sartorelli, Ph.D., 
Alfred Gilman Professor of Pharmacology 
and center director. 
"The cooperative research agreement 
has provided an excellent opportunity for 
Yale and Bristol-Myers scientists to com¬ 
bine our skills in areas of mutual research 
interests and apply them to the solution of 
some of the most perplexing areas of can¬ 
cer chemotherapy," comments Professor 
Sartorelli. "These areas include the devel¬ 
opment of promising new anticancer 
antibiotics as well as methods to search 
for new drugs capable of converting 
malignant cells to benign cells.” 
Professor Sartorelli adds that while 
Yale researchers have the resources to 
identify new drugs with the potential for 
treating cancer, the resources of industry 
are necessary to conduct toxicology tests 
for safety. 
Bristol-Myers has the option to license 
anticancer drugs developed by participat¬ 
ing Yale faculty during the the agreement. 
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Student Research Day 
On Tuesday, May 10, 40 students from all 
four c lasses of the School of Medicine 
presented at the second annual poster 
session of Student Research Day. Stu¬ 
dents represented each of the school’s 17 
departments, and made up the largest 
research day to date. 
Dr. Arnold S. Reiman, editor of The 
New England Journal of Medicine, deliv¬ 
ered the first Lee E. Farr, M D. Lecture , 
"Communicating the Results of Medical 
Research: Ethics, Economics and the 
Media." 
The following includes an excerpt 
from the opening remarks of Dr. John N. 
Forrest, Jr. director of the office of stu¬ 
dent research, and abstracts of the award 
winning theses of five students, who made 
oral presentations. 
Opening Remarks 
Student research and the required thesis 
have been a part of Yale School of 
Medicine since 1839, when graduating 
students presented their thesis work to the 
Connecticut Board of Medical Examiners. 
It would not be an exaggeration to say that 
the student research presented here today 
surpasses that of the past 149 years in its 
substance and diversity of biological sci¬ 
ences. The students presenting and listen¬ 
ing today may be interested to know the 
tradition of student research: 
Vesalius published his anatomy text on 
the day after graduation (obviously in the 
days before the match) and that the best 
work of many investigators including 
Charles Best’s discovery of insulin and 
Jay MacLean’s discovery of heparin was 
accomplished as medical students. It is 
notable that two of our distinguished 
departmental chairmen who are members 
of the National Academy of Sciences, 
Chuck Stevens of the section of molecular 
neurobiology and Vince Marchesi of the 
department of pathology, began their 
research careers as Yale medical students. 
Today’s activities demonstrate that this 
tradition is intact. 
Dr. John N. Forrest Jr.. 
Abstracts 
Sulfation of Proteoglycan w ithin 
Exocrine Storage Granules: A Possible 
Role in Secretory Packaging. 
Edgar Allen Blair. 1988 
A proteoglycan is amplified in parotid 
secretion granules of rats chronically stim¬ 
ulated with isoproterenol which can be 
radiolabeled by injecting the animal with 
35S-inorganic sulfate and which, upon 
SDS-polyacrylamide gel electro-phoresis, 
appears as a closely spaced ladder of 
bands. Chondroitinase AC or ABC diges¬ 
tion results in loss of the ladder pattern on 
SDS gels, and amino acid analysis of the 
purified proteoglycan reveals it to be a 
proline-rich protein with an amino acid 
composition almost identical to that previ¬ 
ously reported for a well characterized 
acidic proline-rich protein from rat parotid 
(50). The proteoglycan also incorporates 
radiolabel when isolated granules form 
chronically stimulated rats are incubated 
in vitro with the activated sulfate donor 
35S-phosphadenosine phosphosulfate 
([35-S]PAPS). 35S incorporation is sensi¬ 
tive to known inhibitors of PAPS transport 
and is associated in large part with intact 
granules, based on sedimentation and 
autoradiographic analyses. Incorporation 
into secretory granules appears to be 
lower in magnitude than that occurring in 
a Golgi-containing fraction. Thus granule- 
associated sulfation may reflect 
“spillover” of an activity that is more 
proximally focused in the intracellular 
transport pathway. A hypothesis is 
advanced that Golgi- and granule-level 
sulfation facilitates secretory packaging 
and is amplified in the chronically stimu¬ 
lated parotid in order to reduce the fixed 
positive charge contributed by the large 
amount of basic secretory protein. 
An Effective New Prognostic Staging 
System for Acquired Immunodeficiency 
Syndrome (AIDS). 
Amy Caroline Justice, 1988 
To evaluate promising new treatments for 
acquired immunodeficiency syndrome 
(AIDS), without the ethical dilemma of 
concurrent placebo controls, an effective 
system is needed for prognostic staging. 
Such a system has not been developed, 
because investigators have either concen¬ 
trated on the prognostic transition from 
HIV-positivity to overt AIDS, or have 
staged the overt syndrome mainly accord¬ 
ing to morphologic evidence. In 76 con¬ 
secutive patients with AIDS treated at 
Yale-New Haven Hospital during 1981- 
86, 3 major functional deficits were found 
to be important predictors of death. They 
were: substantial neurologic deficit (e.g. 
seizures, severe lethargy, aphasia); severe 
hypoxemia (arterial pO2<50); or any 1 of 
3 cytopenias (Hematocrit <30, WBC 
<2,500, or platelets <140,000). Stage III 
was assigned to patients with “bone mar¬ 
row" failure, classified as any 2 of the 3 
cytopenias; Stage II was assigned for any 
of the neural, respiratory, or single hema¬ 
tologic deficits; and Stage I had none of 
the deficits. For the “development set” of 
76 patients, 4-month survival rates in the 
three stages were I, 25/28 (89%); II, 19/38 
(50%); and III, 3/10 (30%). The corre¬ 
sponding median months of survival were 
10.8, 3.85, and 2.3. The next 42 consecu¬ 
tive patients during 1986-87 were used as 
a “challenge set." The corresponding sur¬ 
vival rates for 16, 19, and 7 persons in 
each stage were I, 69%; II, 42%; and III. 
29% at 4 months, with median survival 
times of 7.2, 1.6. and 0.7 months. The 
challenge set results thus confirmed the 
prognostic gradient. 
This prognostic staging system, based 
on functional deficits, is simple to use, 
noninvasive, and inexpensive. It offers an 
effective way to predict prognosis for 
individual patients, and to improve 
evaluations when treatments are compared 
with or without use of randomized trials. 
Five members of the Class of 1988 made oral presentations at Student Research Day. (From 
left) seated: Peter Merkel, Edgar Blair and Amy Justice. Standing: David Klimstra and Kelle 
Moley. PHOTOS BY BILL carter 
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Insulin Resistance and Hyperinsuline- 
mia Precede Insulin Deficiency in 
Hypertransfused Patients with Tha¬ 
lassemia Major. 
Peter Alexander Merkel, 1988 
Diabetes mellitus in patients receiving 
hypertransfusion therapy for thalassemia 
major is usually attributed to damage to p 
cells. To examine whether iron overload 
might lead to insulin resistance even 
before the development of impaired 
insulin secretion, 12 children with tha¬ 
lassemia major (4 prepubertal, 8 pubertal) 
with normal or only modestly impaired 
glucose tolerance on chelation therapy 
were studied. Each patient received intra¬ 
venous insulin (40 m|i/m~ min) to raise 
plasma insulin to =80 pU/ml for 2 hours 
while plasma glucose was maintained at 
90 ± 5 mg/dl by a variable rate glucose 
infusion (euglycemic insulin clamp tech¬ 
nique). Under these conditions of eug- 
lycemia and hyperinsulinemia, the glucose 
infusion rate reflects total body glucose 
metabolism (M) and is an index of insulin 
sensitivity. In prepubertal patients with 
thalassemia major, M values (319 ± 23 
mg/m~ min) were similar to those in pre¬ 
pubertal normal controls (315+41 mg/m~ 
min, P=not significant). In contrast, 
insulin sensitivity was markedly reduced 
in pubertal thalassemics (151 ± 17 vs. 224 
± 15 mg/m- min in normal pubertal con¬ 
trols, p<0.01). The reduction in insulin 
sensitivity in patients with thalassemia 
major was correlated with iron load (r=- 
0.77, p<0.01). The pubertal, but not the 
prepubertal thalassemics, had an excessive 
rise in plasma insulin levels after oral glu¬ 
cose (p<0.001). Furthermore, in response 
to a standard 125 mg/dl (6.9 mmol/1) 
hyperglycemic stimulus (hyperglycemic 
clamp technique), 2-3 fold greater than 
normal early and late insulin and C-pep- 
tide responses were demonstrated in the 
pubertal patients. These data suggest that 
insulin sensitivity is reduced in children 
with thalassemia major when they reach 
puberty due, in part, to chronic iron over¬ 
load. Compensatory increases in insulin 
secretion may help maintain normal glu¬ 
cose tolerance in the face of insulin resis¬ 
tance at this stage of the disease. Increased 
insulin secretion due to insulin resistance 
may contribute to [3-cell exhaustion in tha¬ 
lassemia major. 
Manifestation of Diabetes Mellitus on 
Mouse Follicular and Pre-Implantation 
Embryo Development: An In Vitro and 
In Vivo Investigation. 
Kelle Harbert Moley, 1988 
This thesis examines the manifestations of 
a chemically induced, in vivo diabetic 
state on follicular and pre-embryo devel¬ 
opment. In addition, the influence of indi¬ 
vidual metabolic derangements existing in 
the uncontrolled diabetic state on in vitro 
pre-embryo development was examined. 
Dr. John N. Forrest, director of the office of student research, reviews the poster of Ken 
Andrioni '88 (right), while Ole Aassar '90 looks on. 
The poster of Frederick Lang '88 (right), grabs the attention of Dr. Bennett A. Shaywitz, asso¬ 
ciate professor of pediatrics, neurology, and the Child Study Center. 
An in vivo diabetic state was created in 
mice by intraperitoneal injection of strep- 
tozotocin (S, 300 mg/kg) or alloxan (A, 
330mg/kg). Ovarian follicular develop¬ 
ment was assessed by germinal vesicle 
breakdown (GVBD) in oocytes recovered 
from follicles 8 hours after hCG adminis¬ 
tration. GVBD was noted in 57% of 
oocytes from control animals, but was sig¬ 
nificantly less in oocytes recovered from 
streptozotocin (24%) and alloxan (42%) 
diabetic groups (p<0.001). This delay in 
oocyte maturation was reversed by in vivo 
insulin administration to the diabetic mice 
(GVBD controls, 60%; S, 60%; A, 57%). 
Additionally, an early in vivo delay in pre¬ 
embryo development was evident at 
recovery of pre-embryos 48 hours. This 
developmental delay was also seen in the 
72 hours in vitro culture of the two-cell 
embryos recovered from diabetic animals. 
Compared to controls, pre-embryos from 
alloxan or streptozotocin diabetic mice 
exhibited markedly impaired growth as 
assessed by both 1) distribution of devel¬ 
opmental stages at each 24 hour observa¬ 
tion period for up to 72 hours in culture; 
and 2) overall rate of development. 
With in vivo insulin administration, the 
early in vivo pre-embryo growth delay, 
was reversed and was not significantly 
different from control. To examine the 
effects of individual metabolic distur¬ 
bances in a diabetic state on pre-embryo 
development, pre-embryos from non-dia¬ 
betic mice were cultured in vitro in elevat¬ 
ed concentrations of d-glucose, 
acetoacetate, lactate, amino acids or lipids. 
Compared to controls, pre-embryos cul¬ 
tured in elevated glucose levels 
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Dr. Robert H. Gifford, associate dean of medical education and student affairs, chats with Dr. 
and Mrs. Lee E. Farr. Dr. Farr 32. HS '33-'34, endowed the annual lecture that premiered at 
this year's Student Research Day. 
(950mg/dl) exhibited markedly retarded 
overall growth rates (p<0.005). No signifi¬ 
cant difference in overall growth rate or 
distribution of developmental stages was 
seen in elevated concentrations of lactate 
(5mM) or elevated concentrations of 
lipids (250 mg/dl). Pre-embryos cultured 
in both concentrations of amino acids 
(7mM) demonstrated an overall retarda¬ 
tion in growth rate (p=0.001). 
Pre-embryos incubated in elevated 
concentrations of acetoacetate (lOmM) 
demonstrated the most marked growth 
retardation. By 72 hours, only 8% of the 
total number of pre-embryos cultured in 
acetoacetate were at a 4-call developmen¬ 
tal stage or above versus 97% of total con¬ 
trol pre-embryos. 
In conclusion, diabetes mellitus has the 
potential to deleteriously affect oocyte 
maturation as well as pre-implantation 
embryo development, and that these dia¬ 
betic manifestations are partially reversed 
by insulin administration and improve¬ 
ment in metabolic control. Culturing pre¬ 
embryos in vitro in elevated concentra¬ 
tions of glucose or ketones recreates the in 
vivo diabetic state. 
MIH'K Cells Synthesize Increased 
Basement Membrane Heparin Sulfate 
Proteoglycans Upon Polarization. 
David S. Klimstra, 19X8 
Preconfluent and confluent (polarized) 
MDCK cell cultures grown on plastic 
were labeled (16 h) with '^SC>4 and pro¬ 
teoglycans were isolated from the cell lay¬ 
ers and medium. In both preconfluent and 
(influent cultures, most of the proteogly- 
ans (>60%) were found in the cell layer. 
With confluence the ratio of HSPG to CS- 
DSPCi in the cell layer increased four fold 
due to an 80% decrease in CS-DSPG pro¬ 
duction. The amount of total HSPGs pro¬ 
duced per cell did not change. The 
HSPG/CS-DSPG ratio in the medium 
remained constant with polarization. 
When HSPGs from the cell layers were 
analyzed by hydrophobic chromatography, 
only a small fraction (<10%) bound to 
octyl-Sepharose columns (potentially 
membrane-intercalated HSPGs) at both 
stages of growth. In preconfluent cell lay¬ 
ers, 35% of the total HSPGs could be pre¬ 
cipitated with an antibody to basement 
membrane HSPG, and the amount 
increased to 65% after polarization. By 
immunoelectron microscopy, basement 
membrane HSPGs were seen concentrated 
along lateral cell surfaces with occasional 
basal staining in preconfluent cells, 
whereas after polarization large amounts 
were deposited in a loosely-organized 
matrix exclusively along the basal cell 
surfaces. No morphologically recogniz¬ 
able basement membrane was seen at 
either stage of growth. When confluent 
monolayers were grown on permeable fil¬ 
ters, most of the proteoglycans were 
secreted into the medium (basal = 63%, 
apical = 29%). Most (82%) of the base¬ 
ment membrane HSPGs were found in the 
basal medium, while only 11% were in the 
apical medium. 
The main conclusions that can be 
drawn from this work are: 1) confluent 
MDCK cell layers synthesize twice as 
much as basement membrane HSPG as 
preconfluent cell layers: 2) basement 
membrane HSPGs are localized exclusive¬ 
ly basally only after polarization; and 3) 
MDCK cells grown on filters deliver base¬ 
ment member HSPGs predominantly to 
the basal cell surface for secretion into the 
basal medium. 
Neuroscience Center 
Dedicated in May 
On a beautiful spring day the School of 
Medicine, the Paralyzed Veterans of 
America (PVA) and the Eastern Paralyzed 
Veterans Association (EPVA) joined the 
Veterans Administration to celebrate the 
fruits of a remarkable collaboration. 
May 14 marked the dedication of the 
PVA/EPVA Center for Neuroscience and 
Regeneration Research of Yale University. 
The single story, 4,500-square-foot facility 
on the grounds of the Veterans Adminis¬ 
tration Medical Center in West Haven will 
enable scientists to study how the nervous 
system, especially the spinal cord, adapts 
to injury. The researchers also will investi¬ 
gate such diseases as multiple sclerosis. 
A remarkable example of civic, gov¬ 
ernmental and scientific cooperation, the 
Veterans Administration made the land 
available to Yale through a long-term leas¬ 
ing arrangement. The PVA provided $1.5 
million to help support the center’s con¬ 
struction and research. And the School of 
Medicine brought together a renowned 
research team of physicians and scientists, 
headed by Stephen G. Waxman, M.D., 
Ph D., professor and chairman of neurolo¬ 
gy. (See “Yale Neurology: Expanding 
Hope’s Horizon.”) 
Observed Dean Leon E. Rosenberg: 
“With the combined forces of our various 
resources, I feel confident that we will 
continue to make steady progress which 
will benefit those with spinal cord dys¬ 
function and disease. Dr. Waxman and his 
colleagues will strive for innovation and 
discovery; as important, they will see that 
their students go forth from Yale with the 
same depth of compassion and determina¬ 
tion they clearly have.” 
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Dr. Philip K. Bondy, associate dean for 
veterans administration medical center 
and professor of medicine, was among the 
speakers at Columbia College's May 14 
reunion for the Class of 1938. He present¬ 
ed an update on osteoporosis. Dr. Bondy 
received a B.A. degree in biology from 
Columbia in 1938. 
Marilyn G. Farquhar, Ph D.. Sterling 
Professor of Cell Biology and Pathology, 
delivered the 31st annual Maude Abbott 
Lecture on March 1 at the 77th annual 
meeting of the U.S. and Canadian Acade¬ 
my of Pathology. Professor Farquhar, the 
first woman chosen to deliver the lecture, 
discussed “A Cell Biologist’s View of 
Glomerular Permeability and Pathology.” 
The kidney, and in particular the 
glomerus, the kidney’s filtering apparatus, 
has been one of Professor Farquhar’s 
major research interests. She has also 
studied and characterized a variety of cell 
components and their functions. Her 
research on the enzymes known as periox- 
idases led to automated blood cell count¬ 
ing, and she was the first to make detailed 
studies of the fine structure of kidney 
biopsies. 
During the 65th annual graduation cer¬ 
emony on June 5, the University of New 
Haven awarded a doctor of humane letters 
to Dr. John E. Fenn, clinical professor of 
surgery at the School of Medicine and 
chief of staff at Yale-New Haven Hospital. 
Dr. Fenn was recognized for his more 
than 30 years of research and patient care 
in the field of cardiovascular surgery. As a 
surgeon, teacher, administrator and mem¬ 
million check from PVA leaders. 
ber of many advisory and decision-mak¬ 
ing committees at YNHH and the medical 
school, he has helped shape and foster the 
technological advances that have revolu¬ 
tionized in the practice of medicine and 
surgery. He also has been involved in such 
social concerns as problems of the aged, 
status of women and bioethics and has 
encouraged young people to enter the 
medical profession. 
Dr. Myron Genel, professor of pedi¬ 
atrics and associate dean for government 
and community affairs, addressed the May 
1988 reunion meeting of the Children’s 
Hospital of Philadelphia Alumni Organi¬ 
zation on “The Gender Verification Con¬ 
troversy: Athletic Sex in International 
Competition.” Dr. Genel has been 
engaged in an international campaign to 
eliminate the use of sex chromatin for 
gender verification of female athletes in 
international athletic competition. 
The Behavioral and Social Sciences 
Section of the Gerontological Society of 
America has awarded Judith Rodin, 
Ph.D., professor of psychology, psychiatry 
and medicine, and Philip R. Allen, Ph D., 
professor of psychology, the 1987 Distin¬ 
guished Creative Contribution to Geron¬ 
tology Award for their paper “Aging and 
Health: Effects of the Sense of Control.” 
The article, which was published in the 
September 1986 edition of Science, exam¬ 
ined the linking mechanisms interrelating 
aging and health. 
The American College of Physicians 
has presented its William C. Menninger 
Memorial Award to Dr. Morton F. 
Reiser, the Albert E. Kent Professor of 
Psychiatry, for “his distinguished contri¬ 
butions to our understanding of the inter¬ 
actions of the mind and body, and in 
recognition of his major achievements in 
the field of psychiatric education.” 
Dr. George E. Palade, Sterling Pro¬ 
fessor of Cell Biology, special adviser to 
the dean and senior research scientist in 
cell biology, was a Lee Kuan Yew Distin¬ 
guished Visitor at the National University 
of Singapore (NUS) from Feb. 22 to Feb. 
29. 
He also visited the New Institute for 
Molecular Biology and the Science Park 
associated with NUS. One of the Science 
Park companies produces AIDS test kits 
for the American market. 
Eight members of the Yale Compre¬ 
hensive Cancer Center have received the 
New Haven Foundation's Argali L. and 
Ann G. Hull fund Cancer Research 
Awrds. The awards, up to $20,000 and 
granted for one year, are given to support 
innovative research in the fields of cancer 
cause, therapy and prevention. Recipients 
include: Marianne Berwick, Ph.D., asso¬ 
ciate research scientists in epidemiology 
and public health; Neal C. Birnberg, 
Ph.D., assistant professor of pharmaco¬ 
logy; Dr. Robert Dubrow, assistant pro¬ 
fessor of epidemiology and public health; 
Maureen Gilmore-Herbert, Ph.D., 
associate research scientists in internal 
medicine; Dr. Ben Z. Katz, assistant pro¬ 
fessor of pediatrics and epidemiology and 
public health: I).Y. Anendra Kumar, 
Ph.D., associate research scientists, human 
genetics; Dr. Thomas F. Patterson, post¬ 
doctoral fellow in medicine; and Eliot M. 
Rosen, M.D., Ph.D., assistant professor of 
therapeutic radiology. 
Elaine E. Grant, P.A., director of the 
medical school’s physician associate pro¬ 
gram, has been selected to receive a 
Twentieth Anniversary Appreciation 
Award from the American Academy of 
Physician Assistants. Twenty such awards 
were presented during a May 20 dinner at 
the Los Angeles Biltmore to P.A.s who 
have made a significant contribution to the 
profession. 
Barry M. Kacinski, M.D., Ph D., 
assistant professor of therapeutic radiolo¬ 
gy and a lecturer in molecular biophysics 
and biochemistry, has been awarded 
$100,000 a year for five years by the Bris¬ 
tol-Myers Company. The company has 
committed $16 million nationally in 
research grants to investigators studying 
how tumors develop resistence to anti¬ 
cancer drugs. Dr. Kacinski will apply the 
grant to research into the role of the fms 
oncogene in ovarian and endometrial can¬ 
cer. 
Dr. Norman J. Siegel, professor of 
pediatrics and medicine and vice chairman 
of the department of pediatrics, was 
installed as president of the American 
Society of Pediatric Nephrology during its 
annual meeting in Washington, D.C., May 
2. His one-year term began June 1. 
Dr. Vincent T. Marchesi, chairman of the 
department of pathology, was elected to 
the National Academy of Sciences. Dr. 
Marchesi, also the Anthony N. Brady Pro¬ 
fessor of Pathology, Cell Biology and 
Biology, is one of 61 new members elect¬ 
ed during the academy's 125th annual 
meeting in Washington, D.C. He is the 
15th medical faculty member selected for 
membership. 
Dr. Vincent T. Marchesi 
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Professor Ruddle Named 
To Sterling Chair 
President Benno C. Schmidt Jr. has 
appointed Frank H. Ruddle, Ph.D., to an 
endowed professorship. Professor Ruddle, 
the Ross Granville Harrison Professor of 
Biology and Human Genetics, has been 
appointed Sterling Professor of Biology. 
Professor Ruddle’s primary concern is 
mammalian genetics, cell biology and 
development. His laboratory maps gene 
locations, determines structural organiza¬ 
tion at the chromosome and molecular 
levels and examines patterns of gene 
expression and mechanisms of regulation. 
Professor Ruddle, who specializes in 
exploring how hereditary traits are passed 
from one generation to another, also is the 
co-founder and director of the Human 
Gene Mapping Library, located in Science 
Park in New Haven. The library houses 
the largest gene data base in the country, 
containing information about more than 
1,500 identified human genes. 
Professor Ruddle’s experiments estab¬ 
lished that fruit flies and mice share simi¬ 
lar genetic patterns. Some of these 
patterns appear to be so basic that they 
have survived intact in different species 
through more than a billion years of evo¬ 
lution. His current research focuses on 
"controller genes,” which appear to con¬ 
trol how similar gene sequences are 
expressed differently in flies and mice. 
The recipient of numerous honors. Pro¬ 
fessor Ruddle was recently awarded the 
1988 Katherine Berkan Judd Award by the 
Memorial Sloan-Kettering Cancer Center. 
John Thompson Feted 
At Retirement Gala 
The Yale University Hospital Administra¬ 
tion Alumni Association honored John D. 
Thompson, professor of public health 
(hospital administration) and nursing 
administration, at a retirement gala March 
29 at the Museum of Fine Arts in Boston. 
The Whiffenpoofs entertained during 
the reception and dinner, which was 
attended by Professor Thompson’s family 
and more than 300 alumni and friends of 
the hospital administration program. 
An alumnus representing each decade 
from the 1950s to the 1980s spoke during 
the program, which was entitled “JDT - 
His Life at Yale by Decades.” In addition, 
representatives of the Class of 1988 pre¬ 
sented him with a Memory Book contain¬ 
ing approximately 75 commemorative 
letters from faculty, alumni and friends of 
the hospital administration program. Pres¬ 
ident Ronald Reagan and Mrs. Reagan 
also sent a letter commending Professor 
Thompson on his accomplishments in the 
health-care field and wishing him well in 
his retirement. Highlighting the evening 
was the presentation of a retirement trip to 
Vienna, Austria, during the 1988 opera 
season. 
Thirteen contributors, donating 
between $400 and $1,500 each, assisted in 
defraying the costs of the party, consid¬ 
ered to be the largest gathering of gradu¬ 




Seven members of the Yale medical facul¬ 
ty retired July 1, and the Yale Corporation 
has named them emeriti professors. 
Dr. Philip K. Bondy, professor of 
medicine, associate dean for veterans 
affairs and a member of the medical 
school faculty since 1952, was named pro¬ 
fessor emeritus of medicine and consul¬ 
tant to the medical school on veterans 
administration affairs. He will continue as 
chief of staff for the Veterans Administra¬ 
tion Medical Center in West Haven. 
Alfred S. Evans, M.D., M.P.H., the 
John Rodman Paul Professor of Epidemi¬ 
ology, is a leading infectious disease clini¬ 
cian. His main interests are Epstein-Barr 
virus, viruses and cancer, epidemiology 
and the law, and medieval history. An 
assistant professor of medicine from 1949 
to 1951, Dr. Evans returned to Yale in 
1966 as professor of epidemiology, chief 
of the section of international epidemiolo¬ 
gy and director of the World Health Orga¬ 
nization Serum Reference Bank. In 1982, 
he was named the John Rodman Paul Pro¬ 
fessor of Epidemiology. 
Dr. Evans also served as editor-in-chief 
of The Yale Journal of Biology and 
Medicine from 1972 to 1973 and from 
1974 to 1976. 
Paul Howard-Flanders, Ph.D, professor 
of therapeutic radiology (radiobiology) 
and molecular biophysics, joined the Yale 
faculty in 1959. Director of the radiobiol¬ 
ogy laboratory since 1963, his research 
interests involve enzyme purification for 
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Judith Rodin to Lead Minority Recruitment Study genetic recombination and repair; biochemi¬ 
cal mechanisms of mutagenesis by carcino¬ 
genic agents and radiation; and enzymatic 
repair of DNA recombinants. Each year 
since 1963, Dr. Howard-Flanders has 
received a Research Career Award from the 
U.S. Public Health Service. 
Chief of the Veterans Administration 
Medical Center laboratory service from 1974 
to 1987, Dr. Leonard S. Kaplow, professor of 
pathology and laboratory medicine, has been 
a member of the Yale faculty for 24 years. A 
pioneer in the fields of hematologic cyto¬ 
chemistry and How cytometry, he is best 
known for his methods for staining and eval¬ 
uating leukocyte enzymes, which have 
become standard procedures throughout the 
world. He is a fellow of the American Soci¬ 
ety of Clinical Pathologists and a past presi¬ 
dent of the Histochemical Society. 
George F. Mahl, Ph.D., who joined the 
Yale faculty in 1947, was named assistant 
professor of psychiatry and psychology in 
1950, and was promoted to professor of psy¬ 
chiatry and psychology in 1964. His 
research interests include psychophysiology, 
psychoanalysis, the dynamics of personality, 
and nonverbal and speech behaviors. Sever¬ 
al of Professor Mahl's publications have 
been translated and published in Japanese, 
German and Italian. 
Sofia Simmonds, Ph.D., professor of 
molecular biophysics and biochemistry, has 
been a Yale faculty member since 1945. Her 
research has encompassed microbiology, 
genetics and biochemistry. She received the 
Garvan Medal in 1969, an award that recog¬ 
nizes outstanding women scientists. A fel¬ 
low of Calhoun College, she served as 
associate dean of Yale College and dean of 
undergraduate studies during the spring 
semester. 
John D. Thompson, M.S., professor of 
public health (hospital administration) and 
professor of nursing administration at the 
School of Nursing, is a leader in health care 
administration. His major research under¬ 
takings include the economics of maternity 
service, studies in hospital function and 
design, and the use of diagnosis-based clini¬ 
cal and financial information systems for 
reimbursement, management, planning and 
quality evaluation in hospitals. The Diagno¬ 
sis-Related Group (DRG) concept was 
developed by Professor Thompson and Pro¬ 
fessor Robert B. Fetter of the Yale School of 
Organization and Management. Director of 
the program in hospital administration since 
1961, Professor Thompson joined the Yale 
faculty in 1956. 
Yale President Benno C. Schmidt Jr. has 
appointed Judith Rodin, Ph.D., the Phillip 
R. Allen Professor of Psychology and pro¬ 
fessor of medicine and psychiatry, to chair 
a faculty committee that will study the 
University’s policies regarding recruit¬ 
ment and retention of minority-group fac¬ 
ulty. 
The 13-member committee, compris¬ 
ing faculty from throughout the Universi- 
The Office for Women in Medicine has 
presented the third annual Leah Lowen- 
stein Award to Dr. Laura R. Ment, associ¬ 
ate professor of pediatrics and neurology. 
The award recognizes the medical 
school faculty member who most clearly 
provides positive images of women in 
promoting humane and egalitarian medi¬ 
cal education. The recipient’s teaching 
style and personal example provide a 
model for the principle of equal opportu¬ 
nity espoused by the late feminist physi¬ 
cian, dean and medical educator Leah 
Lowenstein, according to Merle Waxman, 
director of the Office for Women in 
Medicine. 
Leah Lowenstein Award recipients are 
selected from nominations that students 
submit. Wrote one student: “She is smart, 
competent and has a terrific sense of 
humor! She is great with patients. It has 
been wonderful to really be aware of her 
ty, will recommend how to attract minori¬ 
ty-group scholars to Yale. Dwight T. 
Janerich, D.D.S., M.P.H., another medical 
school faculty member, will join Professor 
Rodin on the panel. He is professor of epi¬ 
demiology, associate director of 
control/prevention of the Cancer Control 
Research Center and director of the Can¬ 
cer Control Research Unit. 
presence during my pediatrics rotation. 
There are truly so few women role models 
for us....I am grateful for the presence of 
this very nice and intelligent woman who 
does clearly provide a positive image of 
women in medicine.” 
Dr. Ment joined the Yale medical fac¬ 
ulty in 1979 as an assistant professor of 
pediatrics and neurology. She received 
B.A. and M.MSc. degrees in 1970 and 
1972, respectively, from Brown Universi¬ 
ty and an M.D. degree in 1973 from Tufts 
University. She completed residency train¬ 
ing at Massachusetts General Hospital and 
also was a visiting fellow in pediatric neu¬ 
rology at Hammersmith Hospital in Lon¬ 
don. 
Dr. Ment, a mother of three who has 
published more than 60 scientific articles, 
has focused her research on neonatal neu¬ 
rologic disorders, such as cerebral hemor¬ 
rhages and stroke. 
Dr. Ment Presented Leah Lowenstein Award 
BILL CARTER 
Dr. Laura Ment receives the Leah Lowenstein Award from Dean Leon E. Rosenberg. 
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EPH Researcher 
Wins CDC Honor 
Rebeca Rico-Hesse, Ph.D., assistant pro¬ 
fessor of epidemiology, has won the 1988 
Charles C. Shepard Science Award, the 
Centers for Disease Control’s preeminent 
science award. 
Ms. Rico-Hesse’s scientific publica¬ 
tion, titled "Geographic Distribution of 
Wild Poliovirus Type 1 Genotypes” and 
published in the journal Virology, was 
judged the outstanding scientific paper 
from among 1,117 manuscripts published 
in peer-reviewed journals by CDC authors 
in 1987. The papers were evaluated on 
their scientific merit and the significance 
of the work’s impact on the CDC’s mis¬ 
sion. 
She conducted the research for this 
paper while she was a National Research 
Council postdoctoral fellow at the CDC in 
Atlanta. 
The award-winning publication 
explains a laboratory method for deter¬ 
mining the geographic origin of polio 
virus strains that cause epidemics. Basi¬ 
cally, the method calls for studying the 
evolution or lineage of viruses by deter¬ 
mining their genetic content. With this 
information, health professionals may 
eradicate epidemic viruses in countries 
where epidemics may occur. 
Although public health efforts have 
virtually eliminated poliomyelitis in the 
United States, the viruses annually cause 
approximately 400,000 new cases of the 
paralytic disease in developing countries. 
Ms. Rico-Hesse, who received a Ph.D. 
degree in 1985 in microbiology from Cor¬ 
nell University and joined the Yale faculty 
last fall, is concentrating her research on 
the evolution and epidemiology of 
mosquito-borne viruses occurring in the 
tropics. 
Dr. Strauss Receives 
Van Amerigen Award 
Dr. John S. Strauss, professor of psychia¬ 
try at the Yale School of Medicine, has 
been presented the van Amerigen Award 
in Psychiatric Rehabilitation by the Amer¬ 
ican Psychiatric Association (APA). 
The award is given annually to an indi¬ 
vidual, institution or organization that has 
made an outstanding contribution to the 
field of psychiatric rehabilitation and care 
for the chronically mentally ill. The award 
was established in memory of Mr. Arnold 
I van Amerigen, who made many contri¬ 
butions to the psychiatric rehabilitation of 
the mentally ill. 
Dr. Strauss has made outstanding con¬ 
tributions to the field through his research 
and involvement with psychiatric rehabili¬ 
tation programs at international, national 
and local levels. 
Nationally, he, along with Dr. Morton 
Silverman and Courtenay M. Harding, 
Ph.D., assistant professor of psychiatry 
(psychology), organized a National Insti¬ 
tute of Mental Health-sponsored confer¬ 
ence on work as treatment for psychiatric 
disorders. Dr. Strauss also has served as a 
consultant to the APA on the joint project 
with the Social Security Administration to 
develop more effective assessments of 
psychiatric disability. He serves on the 
board of the Boston University Center for 
Rehabilitation Research and Training in 
Mental Health and as a consultant to the 
Veterans Administration for developing a 
national rehabilitation research agenda. 
Locally, Dr. Strauss chaired the Con¬ 
sortium for Community Support Pro¬ 
grams, an agency that provides 
coordinated management of rehabilitation, 
resocialization and supported living set¬ 
tings in the New Haven area. 
He helped found the Consortium for 
Rehabilitation Services of Greater New 
Haven, an organization that brings togeth¬ 
er staff of many agencies providing psy¬ 
chiatric rehabilitation. And he leads an 
effort to organize a consumer support 
group for persons with mental illness. 
In his research. Dr. Strauss has concen¬ 
trated on various aspects of social func¬ 
tioning and how they relate to the course 
and outcome of severe mental disorders. 
His early work established the importance 
of work and social relationships in pre¬ 
dicting and reflecting outcomes of disor¬ 
der. He and his colleagues were the first to 
suggest that social relations, work and 
symptoms represented open-linked sys¬ 
tems of functioning, central to the theory 
and treatment of severe psychiatric disor¬ 
ders. This work led Dr. Strauss to generate 
innovative methods for research in psychi¬ 
atric rehabilitation. 
E. Kirstin Dahl Named 
To Harris Professorship 
The Yale Corporation has named E. 
Kirsten Dahl, Ph.D., assistant clinical pro¬ 
fessor in the Child Study Center, to be the 
first Harris Assistant Professor of Child 
Psychoanalysis. Her appointment was 
effective July 1. 
The professorship, as well as several 
others, was established with funds from a 
$5 million gift from Irving and Neison 
Harris, two Chicago area brothers and 
businessmen who graduated from Yale 
College. 
Professor Dahl graduated from Anti¬ 
och College in 1963. Her early work as a 
nursery' school teacher lead her into her 
chosen field, and she earned an M.S. 
degree in child development in 1971 from 
the Bank Street College of Education. She 
completed a Ph.D. degree in 1978 at Yale, 
where she trained under Dr. Sally A. 
Provence, now professor emeritus in the 
Child Study Center (child development) 
and pediatrics and senior research scientist 
in the Child Study Center. 
Since 1971 Professor Dahl has been 
associated with the Yale Child Study Cen¬ 
ter, first as a research associate and also as 
director of the early childhood educational 
and therapeutic programs from 1978 to 
1983. 
In her clinical work. Professor Dahl 
treats children who experience a variety of 
psychological problems, including depres¬ 
sion, anxiety and phobias, including fear 
of thunderstorms or clowns. 
A child psychoanalyst, Professor Dahl 
has centered her research on the meaning 
of children’s play. The Harris professor¬ 
ship will allow her to continue research on 
the play of normal children, aged 4 to 6 
years, during clinical interviews with psy¬ 
choanalysts. As she and her colleagues 
learn about the ways in which normal 
children communicate their imaginative 
world through play, they will develop sys¬ 
tematic methodologies to study the com¬ 
munication of emotionally disturbed 
children in clinical settings. 
Two Win Javits Awards 
In the Neurosciences 
Two School of Medicine faculty members 
have been selected to receive Javits Neu¬ 
roscience Investigator Awards which pro¬ 
vide grant support for up to seven years. 
The recipients are lisa R. Schwartz, 
Ph.D., associate professor of surgery (oto¬ 
laryngology) and neuroanatomy, and Car¬ 
ole C. LaMotte, Ph.D.. associate professor 
of research in surgery (neurosurgery) and 
anesthesiology. 
According to the National Advisory 
Neurological and Communicative Disor¬ 
ders and Stroke Council, these Yale 
researchers have demonstrated scientific 
excellence and exceptional productivity, 
are pursuing research of significant scien¬ 
tific importance and have proposed work 
of the highest scientific merit. 
Professor Schwartz’ research is aimed 
at identifying the structure, connections 
and chemical properties of neurons in the 
inner ear and lower brainstem which pro¬ 
cess information about sound. This basic 
research will help physicians understand 
how neurons in the auditory system con¬ 
tact one another, and the nature of chemi¬ 
cal signals used to send information 
between them, going from ear to ear. 
"Ultimately, if we understand how the 
system works in normal hearing adult ani¬ 
mals, we may be able to identify what 
goes wrong in aging or genetically con¬ 
trolled diseases which effect hearing,” she 
explains. 
Professor LaMotte’s research will con¬ 
centrate on identifying and analyzing neu¬ 
ral elements of spinal pain and 
temperature pathways in primates. She 
will compare the organization and func¬ 
tional physiology of the three major areas 
of the spinal grey in order to gain a better 
understanding of the areas. 
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I)r. Byron C. Smith ’34-’38 HS continues 
to practice ophthalmic plastic surgery in 
New York City. 
Dr. Robert L. Gilbert ’41 has retired 
to Naples, Fla., and serves as medical 
director/physician in residence at Bentley 
Village Life Care Community. 
The University of Missouri-Columbia 
Medical Alumni Organization has named 
Dr. Samuel P.W. Black ’44-’50 HS an 
honorary alumnus. The award was pre¬ 
sented to Dr. Black for his commitment to 
the school and the alumni organization at 
the Missouri State Medical Association’s 
annual meeting in April. Dr. Black, pro¬ 
fessor emeritus of surgery at the Universi¬ 
ty of Missouri-Columbia School of 
Medicine, directs the Intracranial 
Aneurysm Study with the department of 
pathology and serves as a consulting neu¬ 
rosurgeon for several Missouri hospitals. 
Dr. Karel B. Absolon ’52, of 
Rockville, Md., an emeritus professor of 
surgery and former academic chairman at 
the University of Illinois College of 
Medicine at Urbana-Champaign, has 
authored several books (see New Books) 
and is interested in reviewing scholarly 
works of Yale colleagues for publication. 
Dr. Eva Henriksen MacLean ’54 
retired from her position with the Los 
Angeles County/University of Southern 
California Medical Center effective Oct. 
31, 1987; she is now a full-time associate 
professor of anesthesiology at the Univer¬ 
sity of Southern California School of 
Medicine. 
Dr. William H. Hindle ’56 has joined 
the department of obstetrics and gynecolo¬ 
gy of the University of Southern Califor¬ 
nia School of Medicine as director of the 
Breast Diagnostic Center, Women’s Hos¬ 
pital, Los Angeles County/University of 
Southern California Medical Center. 
Dr. George Miz.ner ’56-’58 HS prac¬ 
tices psychiatry and psychoanalysis in 
Denver, Colo., and is associate clinical 
professor of psychiatry at the University 
of Colorado Health Sciences Center 
School of Medicine. A former past presi¬ 
dent of the Colorado Psychiatric Society, 
he serves as a representative to the Ameri¬ 
can Psychiatric Association Assembly. 
Dr. David W. Kingsbury ’59 joined 
the Howard Hughes Medical Institute in 
July as a senior scientific officer. Dr. 
Kingsbury, a virologist who has worked 
extensively with paramyxoviruses, has 
been a member at St. Jude Children’s 
Research Hospital and professor at the 
University of Tennessee, Memphis, Col¬ 
lege of Medicine since 1969. 
Retired U.S. Air Force Col. Richard 
C. Yeomans ’67 M.P.H. began a one-year 
chemical dependency counselor training 
program at the Hazelden Foundation in 
Center City, Minn., on March 1. 
Dr. David H. Shapiro ’67 ’71 HS, of 
Clearwater, Fla., a governor of the Ameri¬ 
can College of Surgeons and a recent 
appointee to the Florida Cancer Control 
and Research Advisory Board, testified 
for the National Cancer Advisory Board 
on the need for cooperation between the 
National Cancer Institute and community 
hospitals. He expressed concern that com¬ 
munity hospitals designated as Cancer 
Treatment Centers by the American Col¬ 
lege of Surgeons were not included in 
patient referrals by NCI’s Cancer Informa¬ 
tion Service telephone hotline. 
BILL CARTER 
Yale President Benno C. Schmidt Jr., Dr. Robert Petersdorf '52 and Dean Leon E Rosenberg spoke at Alumni Weekend 1988. Full Alumni Week¬ 
end coverage will follow in the fall edition of YALE MEDICINE. 
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Dr. Marc Estes Lippman ’68, senior 
investigator and head ot the medical 
breast cancer section, medicine branch at 
the National Cancer Institute since 1976, 
has been named director of the George¬ 
town University Vincent T. Lombardi 
Cancer Center effective July 1. Dr. Lipp¬ 
man was among the first to work on estro¬ 
gen and progesterone receptors as 
important predictors for the use of 
endocrine therapy for breast cancer. As 
director, he hopes to establish state-of-the- 
art research and treatment programs in 
breast, colon and prostate cancers. 
I)r. Gerald R. Harpel 69 M.P.H., of 
Acadia, Calif., is chairman, department of 
obstetrics/gynecology, Methodist Hospital 
of Southern California and associate pro¬ 
fessor, clinical obstetrics/gynecology at 
the University of Southern California 
School of Medicine. 
In February, Dr. Paul Hessler III ’70, 
of Barrington, R.I., was appointed director 
of the combined departments of radiology 
of Woonsocket and Fogarty Hospitals in 
Rhode Island. He recently completed his 
second term as president of the 
Woonsocket District Medical Society. 
Dr. Raymond L. Sphar 72 M.P.H. 
manages the U.S. Department of Defense 
biomedical research program for the 
Office of the Secretary of Defense. He 
previously commanded the Naval Medical 
Research Institute in Bethesda, Md. 
Dr. Caroline Deegan '72, a Maryknoll 
missionary nun since 1983, recently com¬ 
pleted three years as head of internal 
medicine in a government hospital in Oco- 
tal, Nicaragua, 20 miles south of the Hon¬ 
duran border. She was the only internist 
for 150,000 people and the only cardiolo¬ 
gist for 500,000 people. Dr. Deegan 
expects to return to Nicaragua in 1989 and 
will probably teach in the medical school 
in Leon. 
Dr. Harold R. Mancusi-Ungaro Jr. 
’73, formerly assistant professor of 
surgery and director, University Hospital 
Bum Unit at the University of Colorado 
Health Sciences Center, became associate 
professor, chief of the division of plastic 
surgery', and director of the Bum Center at 
the University of New Mexico on June 1. 
Dr. Ronald Neumann ’74, of 
Potomac, Md., was named chief of the 
nuclear medicine department at the 
National Institutes of Health on Feb. 1. 
Dr. Kwaku Ohene-Frempong ’75, of 
F.lkins Park, Pa., has been assistant profes- 
>r of pediatrics at the University of Penn- 
Ivania and pediatric hematologist and 
ccior of the sickle cell program at the 
Children’s Hospital of Philadelphia since 
The American Association of Patholo¬ 
gists presented its 1988 Wamer-Lam- 
bert/Parke Davis Award to Dr. Jordan S. 
Pober ’77, associate professor of patholo¬ 
gy at Harvard Medical School and Brig¬ 
ham and Women’s Hospital in Boston. 
The award, given annually to an individu¬ 
al under age 40, recognizes meritorious 
research in experimental pathology. 
Dr. Steven M. Shoum ’78, of Mass- 
apequa, N.Y., serves as director of the 
department of anesthesiology at South 
Nassau Communities Hospital and presi¬ 
dent of district VIII of the New York State 
Society of Anesthesiologists. 
After completing residency in 
orthopaedic surgery and a fellowship in 
sports medicine, Dr. David S. Weiss ’81 
is in private practice specializing in sports 
and dance medicine in New York City. He 
also serves as attending surgeon at the 
Hospital for Joint Diseases Orthopaedic 
Institute. 
Michael S. Huncharek ’86 M.P.H., a 
first-year medical student at Boston Uni¬ 
versity School of Medicine, was recently 
named a J.M. Scholar by the J.M. Founda¬ 
tion for training in alcohol and drug abuse. 
Catherine McQuilkin, J.D., M.P.H. 
’86 joined the law firm of Sills, Cummis 
m Newark, N.J., as an associate in the 
products liability department on March 1. 
The firm recently filed the first fetal alco¬ 
hol syndrome cases. 
Dr. Seldin Awarded 
Honorary Degree 
Dr. Donald W. Seldin ’43, ’46 HS, the 
William Buchanan Professor of Internal 
Medicine, University of Texas Southwest¬ 
ern Medical School, was awarded an hon¬ 
orary Doctor of Laws degree at the Yale 
University commencement on May 30. 
Yale President Benno C. Schmidt Jr. cited 
Dr. Seldin as a distinguished leader in 
American medicine and principal intellec¬ 
tual architect of a new medical school, 
whose blend of “academic rigor, poetic ele¬ 
gance and inspired teaching forged a 
generation of great medical scientists and 
scholars.” 
Dr. Seldin, who retired Feb. 1 after 35 
years as chairman of the department of 
internal medicine at Southwestern Medical 
School, developed Southwestern’s basic 
sciences and research faculty by persuading 
many of his brightest students to make their 
careers in academic medicine at Southwest¬ 
ern. 
When Dr. Seldin became chairman of 
the department of internal medicine in 
1951, it was a department of one—Dr. 
Seldin. The school was a series of aban¬ 
doned army barracks with no funding for 
permanent buildings. Today the depart¬ 
ment has 150 faculty members, and the 
medical school is a sprawling, modem 
medical complex. 
Dr. Donald W. Seldin '43, '46 HS was 
awarded an honorary Doctor of Laws 
degree at the University commencement. 
Until his recent retirement, he ser\’ed for 
35 years as the chairman of the depart - 
ment of internal medicine at Southwest¬ 
ern Medical School. 
NEW BOOKS 
Changing Families, A Guide for Kids and 
Grown-ups, by Dr. David Fassler ’82, 
Michele Lash, M.Ed., A.T.R. and Sally B. 
Ives, Ph.D. Waterfront Books (Burlington, 
Vt.) 1988. 
Dance Medicine: A Comprehensive 
Guide, edited by Dr. Allan J. Ryan ’36 and 
Robert E. Stephens, Ph.D. Pluribus Press 
(Chicago) 1987. 
Divorce Workbook: A Guide For Kids 
and Families, by Sally Ives, Ph.D., Dr. 
David Fassler ’82 and Michele Lash, 
M.Ed., A.T.R. Waterfront Books (Burling¬ 
ton, Vt.) 1988. 
Doctors: The Biography of Medicine, by 
Dr. Sherwin B. Nuland ’55, associate clin¬ 
ical professor of medicine. Alfred A. 
Knopf (New York) 1988. 
From G. Prochaska to J.E. Purkinje, by 
Dr. K.B. Absolon ’52. Kabel Publications 
(Rockville, Md.) 1987. 
Physical Diagnosis, by Dr. Siegfried J. 
Kra, associate clinical professor of 
medicine. Norton (New York) 1987. 
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IN MEMORIAM 
Thomas J. Walz 
January 3, 1988 
'22 HS 
Meyer Friedenson 
January 19, 1987 
’27 M.D. 
Mamie F. Hulsman 
November 1987 
’28 M.P.H. 
Harold J. Harris 
November 22, 1987 
.ex med ’29 
Moses D. Lischner 
March 8, 1988 
’30 M.D. 
Theodore P. Merrick 
February 15, 1987 
’34 M.D. 
Teresa F. Rhoads 
May 12, 1987 
’34 HS 
Edward R. Mountain 
March 12, 1988 
’37 M.D. 
Russell Nahigian 
January 6, 1988 
’39 M.D. 
William R. Oakes ’40 M.D. 
John R. McDermott 
February 22, 1988 
’41 M.D. 
Jonathan T. Lanman 
July 13, 1987 
’43 M.D. 
Robert A. Sears 
January 20, 1988 
’43 M.D. 
Richard G. Britton 
January 20, 1988 
’47 M.D. 




February 2, 1988 
’53 M.D. 
Gilbert M.P. Leiv 
April 28, 1987 
’55 M.D. 
Mark Snider 
September 8, 1987 
’66 M.D. 
OBITUARIES 
Albert W. Snoke, M.D. 
Dr. Albert W. Snoke, lecturer in public 
health and a consultant in health adminis¬ 
tration, died April 18 of a heart attack at 
his home in Hamden, Conn. He was 80. 
Dr. Snoke had been professor of hospi¬ 
tal administration and director of Grace- 
Dr Albert W. Snoke was director of 
Grace-New Haven Community Hospital 
in 1965 when it revised its affiliation 
agreement with the University and was 
renamed Yale-New Haven Hospital. 
New Haven Community Hospital and 
Yale-New Haven Hospital from 1946 to 
1968. Dr. Snoke was director of the hospi¬ 
tal when in 1965 it revised its affiliation 
agreement with the University and 
changed its name to Yale-New Haven 
Hospital. 
He served as coordinator of health ser¬ 
vices for the state of Illinois from 1968 to 
1973. 
A past president of the American Hos¬ 
pital Association and the Connecticut 
Hospital Association, he supported the 
creation of the Medicare system and the 
development of health maintenance orga¬ 
nizations. In his book Hospitals, Health 
and People, published last year, he 
reproved hospitals for appearing to be pre¬ 
occupied with the “bottom line,” rather 
than with patient care, and offered admin¬ 
istrators advice on many facets of hospital 
administration, including reimbursement 
and cost containment. 
Dr. Snoke's wife. Dr. Pamie Hamilton 
Snoke, died in 1981. He is survived by 
two sons. Dr. A. Thomas Snoke and Dr. J. 
Arthur Snoke. 
Russell V. Nahigian, M.D. 
Dr. Russell Nahigian ’39, died Jan. 6 of a 
ruptured aneurysm of the abdominal aorta 
at his home in Birmingham, Mich. An 
internist. Dr. Nahigian had practiced in the 
Detroit area until his retirement in 1987. 
He is survived by his wife, Mary; two 
sons, Lawrence and Kenneth; two daugh¬ 
ters, Nancy Cipparone and Carol Jeffrey; 
one sister, Mrs. Nuvarite Gullan, and sev¬ 
eral grandchildren. 
Jonathan T. Lanman, M.D. 
Dr. Jonathan T. Lanman ’43, of Bethesda, 
Md., died of a lung ailment Feb. 22 at his 
home. He was 70. 
A former chainnan of the department 
of pediatrics at the Downstate Medical 
Center in Brooklyn, N.Y., and a professor 
of pediatrics at New York University, Dr. 
Lanman directed the Center for Research 
for Mothers and Children at the National 
Institute of Child Health and Human 
Development, National Institutes of 
Health, from 1976 to 1978. Prior to his 
appointment with the NIH, he was associ¬ 
ate director of the biomedical division of 
the Population Council. 
Surviving are his wife, the former 
Janet Edgerton; a daughter, Jacqueline 
Sheehan; a son, Jonathan Jr.; a sister, Har¬ 
riet L. Fulton, and two brothers, William 
and Henry. 
Memorial Gifts 
Deceased medical alumni and friends may 
be memorialized by a gift at any time to 
the Medical School Alumni Fund Endow¬ 
ment in the name and class of the person 
so honored. The next-of-kin of a deceased 
medical alumnus/a is advised about this In 
Memoriam Program by a mailing from 
New Haven some weeks after the School 
of Medicine receives notification of the 
death. The letter of information includes a 
copy of The Testament of Remembrance in 
which the names of all persons so memori¬ 
alized are listed in the medical section by 
class, thus establishing a lasting memorial. 
Donors receive a personal penned note of 
appreciation from me. Your inquiries and 
interest are welcome at any time. 
Richard G. Jordan 
Director, In Memoriam Program 
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Yale Club. The inherent message here is 
that as alumni/ae we should seek member¬ 
ship in our local Yale Clubs. The net¬ 
working potential in our communities for 
such participation is again suggested. The 
issue of alumni networking underlines the 
need for updating the medical school 
alumni directory last published in 1984. It 
is hoped that this can be accomplished in 
1989. The committee addressing the 
alumni status of former house staff at 
Yale-New Haven Hospital also has been 
active. Alumni Records has added more 
than 1,000 names not previously record¬ 
ed, and further corrections in this list are 
planned this summer. 
With the arrival of several new depart¬ 
ment chairmen in the past year, interest in 
soliciting fellow/house staff members for 
targeted projects is anticipated. Contribu¬ 
tions for unrestricted funds from this 
source occur regularly, currently under the 
supervision of Dr. Samuel Kushlan ’35, 
and will continue to be requested by the 
alumni fund. With the assistance of fund 
facilities and personnel, a small percent¬ 
age of such needed unrestricted endow¬ 
ment may be assigned by the dean. 
Our major office effort this winter was 
the planning and promotion of the reunion 
held on June 10 and 11. Of special interest 
was the address by Dr. Robert Petersdorf 
'52, president of the Association of Amer¬ 
ican Medical Colleges, who discussed the 
BILL CARTER 
Bail) Vt.P.H '67 and Dr Helen L Smils '67 join Professor Emeritus John D. 
on an Alumni Weekend panel entitled "Managing the Medieal Industrial Com- 
<derator Dr. William Kissiek '57 is not pictured. 
Since our last report, the alumni office has 
increased communication with medical 
students and the financial aid office con¬ 
cerning scholarship student needs. Ms. 
Pamela Nyiri presented detailed data to 
Yale Medical School Alumni Fund board 
members about changing regulations gov¬ 
erning student assistance. Fund Chairman 
Dr. Leonard Kemler, Director Claire Lau- 
terback and the board have thereby been 
oriented as to directions of further fund 
efforts. 
Meetings with student volunteers have 
provided agents for all four classes, with 
eight self-appointed agents for the fresh¬ 
man class of 1991! We plan continued 
communication to emphasize our mission 
with this group, which represents the four 
classes. The objective of alumni efforts to 
aid the school and its future students will 
be identified early. We hope that support 
activities, such as alumni networking, will 
be addressed with increased benefit for 
ourselves as alumni as reward for partici¬ 
pation in association affairs, initiatives 
never previously emphasized. 
Another positive development this 
spring regarding student aid is the eligibil¬ 
ity of graduate students for Yale Club 
scholarships. Previously these scholar¬ 
ships had been restricted to Yale College 
students. This achievement was the result 
of a major effort on the part of John W. 
Foster '72, of the Eastern Connecticut 
decreasing pool of applicants to medical 
schools nationally; curriculum reform; the 
changing environment of medical educa¬ 
tion; and a summary of current threats and 
challenges to medicine. President Dwight 
Miller represents our association on the 
curriculum review committee. 
On June 11, seminars were held updat¬ 
ing alumni about developments in the neu¬ 
rosciences; explaining advances in genetic 
mapping and diagnosis; and outlining the 
Yale experience with AIDS. In addition, a 
seminar moderated by Dr. William 
Kissiek '57, entitled "Managing the Medi¬ 
cal Industrial Complex," featured several 
noted panelists. They anticipated changes 
in systems of health care delivery and the 
need to provide specialized professional 
management by physicians (Dr. Helen L. 
Smits, '67); by nurses (Professor John D. 
Thompson, department of epidemiology 
and public health) and by the health care 
manager (David R. Baily M.P.H. '67). 
Dr. Robert H. Gifford, associate dean 
for education and student affairs, contin¬ 
ues to interview applicants who are chil¬ 
dren of alumni/ae, with 11 interviews 
personally held by Dr. Gifford to date this 
year. Three such applicants were accepted 
in 1986-87. Because the applicant pool to 
Yale remains superior in quality, disap¬ 
pointments were inevitable despite the 
fact that alumni children with equivalent 
records are given preference. The grade 
point average (on a scale of 4.0) was 3.72 
in the present freshman group. A profile 
of the freshman student may be obtained 
in the Facts booklet obtainable on request 
at the alumni office. 
News for our medical school column 
in the Yale Alumni Magazine has been 
erratic in arriving. Please use the tear-out 
card in YALE MEDICINE, or write to us 
directly. The University publication is 
printed nine times annually, but the col¬ 
umn appears only when we have enough 
news. 
We are grateful for the assistance of 
our alumni in (a) interviewing students for 
the school when travel to New Haven was 
not possible; (b) providing bed-board 
assistance to Yale seniors seeking residen¬ 
cy; and (c) serving as consultants to senior 
students seeking critiques of residency 
programs. Our communications are 
improving. Please let the alumni office 
know how it can be more helpful to you. 
Dr. Nicholas PR. Spinelli '44 
Director of Alumni Affairs 
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If You Did Not Receive the Spring Edition... 
We have received a number of inquiries from readers in the 
New Haven area about their not receiving the spring edition of 
YALE MEDICINE, which was mailed in early May. After 
following this up with our mailing contractor and the U.S. 
Postal Service, we have determined that some copies of the 
spring issue got lost in the mail. This is a matter of serious 
concern to us, because the spring edition featured an article on 
the medical student financial aid crisis and other important 
information. 
We would be happy to mail the spring YALE MEDICINE 
to anyone on our distribution list who did not receive a copy. 
To have this issue mailed to you, simply return one of the 
postcards included with this edition, state your request and 
include your name and address. 
We apologize for any inconvenience this may have caused 
our readers. 
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